Citrus Sinensis ID: 012228
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | 2.2.26 [Sep-21-2011] | |||||||
| Q9MAM1 | 447 | CBL-interacting serine/th | yes | no | 0.929 | 0.973 | 0.755 | 0.0 | |
| Q10SC8 | 456 | CBL-interacting protein k | yes | no | 0.920 | 0.945 | 0.718 | 0.0 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.912 | 0.885 | 0.678 | 0.0 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.925 | 0.962 | 0.668 | 0.0 | |
| Q2QY53 | 438 | CBL-interacting protein k | no | no | 0.920 | 0.984 | 0.663 | 0.0 | |
| Q2V452 | 441 | CBL-interacting serine/th | no | no | 0.918 | 0.975 | 0.646 | 1e-179 | |
| Q2RAX3 | 454 | CBL-interacting protein k | no | no | 0.920 | 0.949 | 0.641 | 1e-179 | |
| Q6X4A2 | 449 | CBL-interacting protein k | no | no | 0.914 | 0.953 | 0.635 | 1e-176 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.918 | 0.979 | 0.637 | 1e-174 | |
| Q8LIG4 | 445 | CBL-interacting protein k | no | no | 0.920 | 0.968 | 0.607 | 1e-165 |
| >sp|Q9MAM1|CIPK9_ARATH CBL-interacting serine/threonine-protein kinase 9 OS=Arabidopsis thaliana GN=CIPK9 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 735 bits (1898), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/462 (75%), Positives = 399/462 (86%), Gaps = 27/462 (5%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
PASRTRVG YE+GRTLGEGSFAKVK+AKN TGD AIKI+DR++V RHKMVEQ+KREI
Sbjct: 9 TPASRTRVGNYEMGRTLGEGSFAKVKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKREI 68
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
STMKLIKHPNV++IIEVMASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLIN
Sbjct: 69 STMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLIN 128
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
AVDYCHSRGV+HRDLKPENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAP
Sbjct: 129 AVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAP 188
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244
EVL+DKGYDG A+DVWSCGVILFVLMAG+LPFDE NLM LY++
Sbjct: 189 EVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKR----------------- 231
Query: 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
IC+A+FSCP WFS GAK++IKRIL+PNP TR++I+++LEDEWFKKGYKPP
Sbjct: 232 ---------ICKAEFSCPPWFSQGAKRVIKRILEPNPITRISIAELLEDEWFKKGYKPPS 282
Query: 305 FDK-EEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLV 363
FD+ +E++ +DDVDA F++SKE LVTEKKEKPVSMNAFELIS + FSLENLFEKQ LV
Sbjct: 283 FDQDDEDITIDDVDAAFSNSKECLVTEKKEKPVSMNAFELISSSSEFSLENLFEKQAQLV 342
Query: 364 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVA 423
K+ETRFTSQR +EIMSK+EE AKPLGFNVRK NYK+K++GDK+GRKGQLSVATEVFEVA
Sbjct: 343 KKETRFTSQRSASEIMSKMEETAKPLGFNVRKDNYKIKMKGDKSGRKGQLSVATEVFEVA 402
Query: 424 PTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEE 465
P+LH+VE+RKTGGDTLEFHKFYK FSSGLKDVVW + EE
Sbjct: 403 PSLHVVELRKTGGDTLEFHKFYKNFSSGLKDVVWNTDAAAEE 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q10SC8|CIPK9_ORYSJ CBL-interacting protein kinase 9 OS=Oryza sativa subsp. japonica GN=CIPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 685 bits (1767), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/459 (71%), Positives = 381/459 (83%), Gaps = 28/459 (6%)
Query: 6 PASRT-RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
PA RT RVG+YELG+T+GEGSFAKVK A++ TGD +AIK++DR+ VLRHKMVEQIKREI
Sbjct: 17 PARRTTRVGRYELGKTIGEGSFAKVKVARDTRTGDTLAIKVLDRNHVLRHKMVEQIKREI 76
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
STMKLIKHPNV+++ EVMASK+KIY+VLE++DGGELFDKI GRL EDEARRYF QLIN
Sbjct: 77 STMKLIKHPNVVQLHEVMASKSKIYMVLEYVDGGELFDKIVNSGRLGEDEARRYFHQLIN 136
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
AVDYCHSRGV+HRDLKPENLLLDS+G LK+SDFGLSA + Q +EDGLLHTACGTPNYVAP
Sbjct: 137 AVDYCHSRGVYHRDLKPENLLLDSHGALKVSDFGLSAFAPQTKEDGLLHTACGTPNYVAP 196
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244
EVL DKGYDG A+DVWSCG+ILFVLMAG+LPFD+ NLM LY+
Sbjct: 197 EVLADKGYDGMAADVWSCGIILFVLMAGYLPFDDPNLMTLYK------------------ 238
Query: 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
IC+A SCP WFSSGAKK IKRILDPNP TR+TI+Q+LED+WFKK YKPP
Sbjct: 239 --------LICKAKVSCPHWFSSGAKKFIKRILDPNPCTRITIAQILEDDWFKKDYKPPL 290
Query: 305 FDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQT-GLV 363
F++ E+V+LDDVDA F+ S+ENLV EK+EKP SMNAF LISR++ F+L NLFEK+ G+V
Sbjct: 291 FEQGEDVSLDDVDAAFDCSEENLVAEKREKPESMNAFALISRSQGFNLGNLFEKEMMGMV 350
Query: 364 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVA 423
KRET FTSQ P EIMSKIEEA PLGFNVRK NYKMKL+GDKTGRKG LSVATEVFEVA
Sbjct: 351 KRETSFTSQCTPQEIMSKIEEACGPLGFNVRKQNYKMKLKGDKTGRKGYLSVATEVFEVA 410
Query: 424 PTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEEN 462
P+LH+VE+RKTGGDTLEFH FY FSS LKD+VW++E +
Sbjct: 411 PSLHMVELRKTGGDTLEFHNFYNNFSSELKDIVWKSESD 449
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 657 bits (1696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/461 (67%), Positives = 385/461 (83%), Gaps = 34/461 (7%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
VGKYELGRTLGEG+FAKVKFA+NVE GD VAIK++D+++VL++KM+ QIKREISTMKLIK
Sbjct: 28 VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
HPNVI++ EVMASKTKIY VLEF+ GGELFDKI+ +GRLKEDEAR+YFQQLINAVDYCHS
Sbjct: 88 HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
RGV+HRDLKPENLLLD+ G LK+SDFGLSA+ QQVREDGLLHT CGTPNYVAPEV+N+KG
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
YDG +D+WSCGVILFVLMAG+LPF++SNL +LY+K
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKK------------------------ 243
Query: 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 311
I +A+F+CP WFS+ AKKLIKRILDPNP TR+T ++++E+EWFKKGYK P F+ +V
Sbjct: 244 --IFKAEFTCPPWFSASAKKLIKRILDPNPATRITFAEVIENEWFKKGYKAPKFE-NADV 300
Query: 312 NLDDVDAIFNDSKE--NLVTEKKEK----PVSMNAFELISRTKSFSLENLFEKQTGLVKR 365
+LDDVDAIF+DS E NLV E++E+ PV+MNAFELIS ++ +L +LFEKQ GLVKR
Sbjct: 301 SLDDVDAIFDDSGESKNLVVERREEGLKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKR 360
Query: 366 ETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPT 425
+TRFTS+ NEI++KIE AA P+GF+V+ NYKMKL G+K+GRKGQL+VATEVF+VAP+
Sbjct: 361 KTRFTSKSSANEIVTKIEAAAAPMGFDVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPS 420
Query: 426 LHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQA-EENKEE 465
L++VE+RK+GGDTLEFHKFYK ++GLKD+VW+ +E KEE
Sbjct: 421 LYMVEMRKSGGDTLEFHKFYKNLTTGLKDIVWKTIDEEKEE 461
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 654 bits (1688), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 310/464 (66%), Positives = 383/464 (82%), Gaps = 31/464 (6%)
Query: 3 VKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR 62
+ V RTRVG+YELGRTLGEG+FAKVKFA+N ++G+ VAIKI+D+D+VL+HKM+ QIKR
Sbjct: 1 MSVSGGRTRVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKR 60
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQL 122
EISTMKLI+HPNVI++ EVMASKTKIYIV+E + GGELFDKIA GRLKED+AR+YFQQL
Sbjct: 61 EISTMKLIRHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQL 120
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
INAVDYCHSRGV+HRDLKPENLLLD+ G LK+SDFGLSA+SQQVREDGLLHT CGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYV 180
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242
APEV+N+KGYDG +D+WSCGVILFVLMAG+LPF++SNLM+LY+K
Sbjct: 181 APEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKK--------------- 225
Query: 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
I +ADFSCPSWFS+ AKKLIK+ILDPNP TR+TI++++ +EWFKKGY+P
Sbjct: 226 -----------IFKADFSCPSWFSTSAKKLIKKILDPNPSTRITIAELINNEWFKKGYQP 274
Query: 303 PHFDKEEEVNLDDVDAIFNDS--KENLVTEKKE-KPVSMNAFELISRTKSFSLENLFEKQ 359
P F+ + VNLDD+++IFN+S + LV E++E +P MNAFELIS ++ +L LFEKQ
Sbjct: 275 PRFETAD-VNLDDINSIFNESGDQTQLVVERREERPSVMNAFELISTSQGLNLGTLFEKQ 333
Query: 360 T-GLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATE 418
+ G VKRETRF S+ P NEI+SKIE AA P+GFNV+K NYK+KLQG+ GRKGQL++ATE
Sbjct: 334 SQGSVKRETRFASRLPANEILSKIEAAAGPMGFNVQKRNYKLKLQGENPGRKGQLAIATE 393
Query: 419 VFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEEN 462
VFEV P+L++VE+RK+ GDTLEFHKFY S+GLKDV+W+ E +
Sbjct: 394 VFEVTPSLYMVELRKSNGDTLEFHKFYHNISNGLKDVMWKPESS 437
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 638 bits (1645), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 304/458 (66%), Positives = 373/458 (81%), Gaps = 27/458 (5%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ RVGKYELGRT+GEG+FAKVKFA++ ETGD VAIKI+D+++VL+HKMVEQIKREISTMK
Sbjct: 7 KRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMK 66
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
LIKHPNV++I EVM SKTKIYIVLE++ GGELFD I HGR++EDEARRYFQQLINAVDY
Sbjct: 67 LIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDY 126
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
CHSRGV+HRDLKPENLLLDSYG LK+SDFGLSA+SQQ+++DGLLHT CGTPNYVAPEVL
Sbjct: 127 CHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLE 186
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248
D+GYDG +D+WSCGVILFVL+AG+LPF++SNLM LY+K+S
Sbjct: 187 DQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISN------------------ 228
Query: 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
A+F+ P W S AK+L+ RILDPNP TR+TI ++LEDEWFKKGYK P FD++
Sbjct: 229 --------AEFTFPPWTSFPAKRLLTRILDPNPMTRVTIPEILEDEWFKKGYKRPEFDEK 280
Query: 309 EEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETR 368
+ LDDV A+FNDS+E+ VTEKKE+P ++NAFELIS + +L NLF+ + KRETR
Sbjct: 281 YDTTLDDVYAVFNDSEEHHVTEKKEEPEALNAFELISMSAGLNLGNLFDSEQEF-KRETR 339
Query: 369 FTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHI 428
FTS+ PP EI+ KIEEAAKPLGF+V+K NYK++L+ K GRKG L+VATE+ +VAP+LH+
Sbjct: 340 FTSKCPPKEIVRKIEEAAKPLGFDVQKKNYKLRLEKVKAGRKGNLNVATEILQVAPSLHM 399
Query: 429 VEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEEL 466
VEVRK GDTLEFHKFYK S LKDVVW++++ + +L
Sbjct: 400 VEVRKAKGDTLEFHKFYKNLSRTLKDVVWKSDDLQNQL 437
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 629 bits (1621), Expect = e-179, Method: Compositional matrix adjust.
Identities = 296/458 (64%), Positives = 374/458 (81%), Gaps = 28/458 (6%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ RVGKYE+GRT+GEG+FAKVKFA+N ETG+ VA+KI+D+++VL+HKM EQI+REI+TMK
Sbjct: 8 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMK 67
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
LIKHPNV+++ EVMASKTKI+I+LE++ GGELFDKI GR+KEDEARRYFQQLI+AVDY
Sbjct: 68 LIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDY 127
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
CHSRGV+HRDLKPENLLLDSYG LKISDFGLSA+SQQVR+DGLLHT+CGTPNYVAPEVLN
Sbjct: 128 CHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLN 187
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248
D+GYDG +D+WSCGV+L+VL+AG+LPFD+SNLM LY+K+S+
Sbjct: 188 DRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISS------------------ 229
Query: 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
+F+CP W S GA KLI RILDPNP TR+T ++ EDEWFKK YKPP F++
Sbjct: 230 --------GEFNCPPWLSLGAMKLITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEER 281
Query: 309 EEVNLDDVDAIFNDSKENLVTEKK-EKPVSMNAFELISRTKSFSLENLFEKQTGLVKRET 367
++ N+DD+DA+F DS+E+LVTEK+ E+P ++NAFE+IS ++ +LENLF+ + KRET
Sbjct: 282 DDSNMDDIDAVFKDSEEHLVTEKREEQPAAINAFEIISMSRGLNLENLFDPEQEF-KRET 340
Query: 368 RFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLH 427
R T + NEI+ KIEEAAKPLGF+V+K NYKM+L+ K GRKG L+VATE+F+VAP+LH
Sbjct: 341 RITLRGGANEIIEKIEEAAKPLGFDVQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLH 400
Query: 428 IVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEE 465
+V+V K+ GDTLEFHKFYKK S+ L+ VVW E K+E
Sbjct: 401 MVQVSKSKGDTLEFHKFYKKLSNSLEQVVWTNNEVKKE 438
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 629 bits (1621), Expect = e-179, Method: Compositional matrix adjust.
Identities = 304/474 (64%), Positives = 373/474 (78%), Gaps = 43/474 (9%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ RVGKYELGRT+GEG+FAKVKFA++ ETGD VAIKI+D+++VL+HKMVEQIKREISTMK
Sbjct: 7 KRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMK 66
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
LIKHPNV++I EVM SKT IYIVLE++ GGELFD I HGR++EDEARRYFQQLINAVDY
Sbjct: 67 LIKHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDY 126
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
CHSRGV+HRDLKPENLLLDSYG LK+SDFGLSA+SQQ+++DGLLHT CGTPNYVAPEVL
Sbjct: 127 CHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLE 186
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248
D+GYDG +D+WSCGVILFVL+AG+LPF++SNLM LY+K+S
Sbjct: 187 DQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISN------------------ 228
Query: 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
A+F+ P W S AK+L+ RILDPNP TR+TI ++LEDEWFKKGYK P FD++
Sbjct: 229 --------AEFTFPPWTSFPAKRLLTRILDPNPMTRITIPEILEDEWFKKGYKRPEFDEK 280
Query: 309 EEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETR 368
+ LDDVDA+FNDS+E+ VTEKKE+P ++NAFELIS + +L NLF+ + KRETR
Sbjct: 281 YDTTLDDVDAVFNDSEEHHVTEKKEEPEALNAFELISMSAGLNLGNLFDSEQEF-KRETR 339
Query: 369 FTSQRPPNEIMSKIEEAAKPLGFNVRKGNY----------------KMKLQGDKTGRKGQ 412
FTS+ PP EI+ KIEEAAKPLGF+V+K NY K++L+ K GRKG
Sbjct: 340 FTSKCPPKEIVRKIEEAAKPLGFDVQKKNYKICSPCLTTICMNIPFKLRLEKVKAGRKGN 399
Query: 413 LSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEEL 466
L+VATE+ +VAP+LH+VEVRK GDTLEFHKFYK S LKDVVW++++ + +L
Sbjct: 400 LNVATEILQVAPSLHMVEVRKAKGDTLEFHKFYKNLSRTLKDVVWKSDDLQNQL 453
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6X4A2|CIPKV_ORYSJ CBL-interacting protein kinase 31 OS=Oryza sativa subsp. japonica GN=CIPK31 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 618 bits (1594), Expect = e-176, Method: Compositional matrix adjust.
Identities = 290/456 (63%), Positives = 368/456 (80%), Gaps = 28/456 (6%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
P + RVGKYELGRT+GEG+FAKV+FAKN E + VAIKI+D+++V +H++VEQI+REI
Sbjct: 11 PKVKRRVGKYELGRTIGEGTFAKVRFAKNTENDEPVAIKILDKEKVQKHRLVEQIRREIC 70
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
TMKL+KHPNV+++ EVM SK +I+IVLE++ GGELF+ IA +GRLKE+EAR+YFQQLINA
Sbjct: 71 TMKLVKHPNVVRLFEVMGSKARIFIVLEYVTGGELFEIIATNGRLKEEEARKYFQQLINA 130
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
VDYCHSRGV+HRDLK ENLLLD+ G LK+SDFGLSA+++QV+ DGLLHT CGTPNYVAPE
Sbjct: 131 VDYCHSRGVYHRDLKLENLLLDASGNLKVSDFGLSALTEQVKADGLLHTTCGTPNYVAPE 190
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245
V+ D+GYDG A+D+WSCGVIL+VL+AGFLPF++ N++ALY+K+S
Sbjct: 191 VIEDRGYDGAAADIWSCGVILYVLLAGFLPFEDDNIIALYKKIS---------------- 234
Query: 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 305
A F+CPSWFS+GAKKLI RILDPNP TR+TISQ+LED WFKKGYKPP F
Sbjct: 235 ----------EAQFTCPSWFSTGAKKLITRILDPNPTTRITISQILEDPWFKKGYKPPVF 284
Query: 306 DKEEEVNLDDVDAIFNDSKENLVTEKKE-KPVSMNAFELISRTKSFSLENLFEKQTGLVK 364
D++ E + DDVDA F DS++ V E+ E +P SMNAFELIS ++ +L+NLFE + K
Sbjct: 285 DEKYETSFDDVDAAFGDSEDRHVKEETEDQPTSMNAFELISLNQALNLDNLFEAKKEY-K 343
Query: 365 RETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAP 424
RETRFTSQ PP EI++KIEEAAKPLGF+++K NYKM+++ K GRKG L+VATEVF+VAP
Sbjct: 344 RETRFTSQCPPKEIITKIEEAAKPLGFDIQKKNYKMRMENLKAGRKGNLNVATEVFQVAP 403
Query: 425 TLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAE 460
+LH+VE++K GDTLEF KFY+ S+ LKDVVW+ +
Sbjct: 404 SLHVVELKKAKGDTLEFQKFYRTLSTQLKDVVWKCD 439
|
Involved in cold stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 613 bits (1580), Expect = e-174, Method: Compositional matrix adjust.
Identities = 292/458 (63%), Positives = 363/458 (79%), Gaps = 28/458 (6%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
P + RVGKYE+G+TLG+G+FAKV+ A N ETG+ VA+KI+D+++VL+HKM EQI+REI
Sbjct: 4 PKVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREIC 63
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
TMKLI HPNV+++ EV+ASKTKIYIVLEF GGELFDKI GRLKE+ AR+YFQQLINA
Sbjct: 64 TMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINA 123
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
VDYCHSRGV+HRDLKPENLLLD+ G LK+SDFGLSA+S+QVR DGLLHTACGTPNY APE
Sbjct: 124 VDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPE 183
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245
VLND+GYDG +D+WSCGVILFVL+AG+LPF++SNLM LY+K
Sbjct: 184 VLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKK------------------ 225
Query: 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 305
I ++ CP W S GAK LI RILDPNP TR+TI ++L D WFKK YKP F
Sbjct: 226 --------IIAGEYHCPPWLSPGAKNLIVRILDPNPMTRITIPEVLGDAWFKKNYKPAVF 277
Query: 306 DKEEEVNLDDVDAIFNDSKENLVTEKK-EKPVSMNAFELISRTKSFSLENLFEKQTGLVK 364
+++EE NLDDVDA+F DS+E+ VTEKK E+P SMNAFELIS +++ L NLFE++ G K
Sbjct: 278 EEKEEANLDDVDAVFKDSEEHHVTEKKEEQPTSMNAFELISMSRALDLGNLFEEEEGF-K 336
Query: 365 RETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAP 424
RETRF ++ N+++ KIEEA+KPLGF+++K NYKM+L+ GRKG L VATE+F+V+P
Sbjct: 337 RETRFAAKGAANDLVQKIEEASKPLGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSP 396
Query: 425 TLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEEN 462
+LH++EVRKT GDTLEFHKFYKK S+ L DVVW++ E+
Sbjct: 397 SLHMIEVRKTKGDTLEFHKFYKKLSTSLNDVVWKSGES 434
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LIG4|CIPK3_ORYSJ CBL-interacting protein kinase 3 OS=Oryza sativa subsp. japonica GN=CIPK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 581 bits (1497), Expect = e-165, Method: Compositional matrix adjust.
Identities = 279/459 (60%), Positives = 353/459 (76%), Gaps = 28/459 (6%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
R +GKYELGR +G+G+FAKV+FAKN+ETGD VAIKI+D+ +V +H++VEQI+REI TMK
Sbjct: 13 RRCLGKYELGRAIGQGTFAKVRFAKNMETGDHVAIKILDKAKVQKHRLVEQIRREICTMK 72
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
LI+HPNV+ + EVM SKT+I+IVLE++ GGEL D IA GRLKEDEAR+YFQQLINAVDY
Sbjct: 73 LIQHPNVVHLHEVMGSKTRIFIVLEYVMGGELHDIIATSGRLKEDEARKYFQQLINAVDY 132
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
CHSRGV+HRDLK ENLLLD+ G +K+SDFGLSAIS+QV+ DGLLHT CGTPNYVAPEV+
Sbjct: 133 CHSRGVYHRDLKLENLLLDTAGNIKVSDFGLSAISEQVKADGLLHTTCGTPNYVAPEVIE 192
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248
DKGYDG +D+WSCGVILFVL+AG+LPF++ N+++LY K+S
Sbjct: 193 DKGYDGALADLWSCGVILFVLLAGYLPFEDENIVSLYNKISG------------------ 234
Query: 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
A F+CPSWFS+ AK+LI RILDPNP TR+T SQ+L+D+WFKKGY+ P FD +
Sbjct: 235 --------AQFTCPSWFSAEAKRLIARILDPNPATRITTSQVLQDQWFKKGYESPVFDDK 286
Query: 309 EEVNLDDVDAIFNDSKENLVTEK-KEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRET 367
DV F DS+E V E +E+P MNAFELIS K +L+N FE KRET
Sbjct: 287 YYPYFHDVYDAFGDSEEKHVKEAMEEQPTLMNAFELISLNKGLNLDNFFESDKKY-KRET 345
Query: 368 RFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLH 427
RFTSQ PP EI+++IEEAA LGFN++K NY+M+++ K GRKG L++ATEVF+VAP+LH
Sbjct: 346 RFTSQCPPKEIINRIEEAANLLGFNIQKRNYRMRMENIKEGRKGHLNIATEVFQVAPSLH 405
Query: 428 IVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEEL 466
+VE++K GDTLEF KFY+ S+ LKDVVW+ E+ E++
Sbjct: 406 VVELKKAKGDTLEFQKFYQTLSTQLKDVVWELEDAAEDM 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | ||||||
| 296088995 | 440 | unnamed protein product [Vitis vinifera] | 0.940 | 1.0 | 0.783 | 0.0 | |
| 224064356 | 441 | predicted protein [Populus trichocarpa] | 0.942 | 1.0 | 0.788 | 0.0 | |
| 224993580 | 441 | CBL-interacting protein kinase 12 [Popul | 0.942 | 1.0 | 0.781 | 0.0 | |
| 224128033 | 442 | predicted protein [Populus trichocarpa] | 0.944 | 1.0 | 0.771 | 0.0 | |
| 30677898 | 449 | CBL-interacting serine/threonine-protein | 0.933 | 0.973 | 0.757 | 0.0 | |
| 15223317 | 447 | CBL-interacting serine/threonine-protein | 0.929 | 0.973 | 0.755 | 0.0 | |
| 14423524 | 447 | similar to wpk4 protein kinase [Arabidop | 0.929 | 0.973 | 0.753 | 0.0 | |
| 359489408 | 419 | PREDICTED: CBL-interacting serine/threon | 0.891 | 0.995 | 0.787 | 0.0 | |
| 6715641 | 453 | T25K16.13 [Arabidopsis thaliana] | 0.933 | 0.964 | 0.751 | 0.0 | |
| 449520201 | 441 | PREDICTED: CBL-interacting serine/threon | 0.938 | 0.995 | 0.752 | 0.0 |
| >gi|296088995|emb|CBI38698.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1986), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/466 (78%), Positives = 412/466 (88%), Gaps = 26/466 (5%)
Query: 3 VKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR 62
+KVPA+RTRVG+YE+G+TLGEGSFAKVK+A+N +TGD VAIK++DRD VLRHKMVEQIKR
Sbjct: 1 MKVPATRTRVGRYEIGKTLGEGSFAKVKYARNSDTGDSVAIKVLDRDHVLRHKMVEQIKR 60
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQL 122
EISTMKLIKHPNV+ I EVMASKTKIYIV+EF+DGGELFD+IAK+GRLKEDEARRYFQQL
Sbjct: 61 EISTMKLIKHPNVVTIFEVMASKTKIYIVVEFVDGGELFDRIAKNGRLKEDEARRYFQQL 120
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
INAVDYCHSRGV+HRDLKPENLLLDSYGVLKISDFGLSA+SQQVREDGL HTACGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDSYGVLKISDFGLSALSQQVREDGLFHTACGTPNYV 180
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242
APEVLN+KGYDG ++D+WSCGVILFVL+AG+LPFDE +LMALY+K
Sbjct: 181 APEVLNNKGYDGASADIWSCGVILFVLLAGYLPFDEVSLMALYKK--------------- 225
Query: 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
IC+ADFSCPSW S GAKKLI RILDPNP TR+TI ++LED WFKKGY+P
Sbjct: 226 -----------ICKADFSCPSWLSPGAKKLINRILDPNPVTRITIPEILEDGWFKKGYQP 274
Query: 303 PHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGL 362
F +EE+VN+DDVDA FN+S+ENLVTE+KEKPVSMNAFELISR++SF+LENLF KQ GL
Sbjct: 275 TCFQQEEDVNVDDVDAAFNNSEENLVTERKEKPVSMNAFELISRSQSFNLENLFGKQAGL 334
Query: 363 VKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEV 422
VKRET FTSQRP +EIMSKIEE AKPLGFNVRK NYKMKLQGDKTGRKG LSVATEVFEV
Sbjct: 335 VKRETSFTSQRPAHEIMSKIEETAKPLGFNVRKQNYKMKLQGDKTGRKGHLSVATEVFEV 394
Query: 423 APTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEELRA 468
AP+LH+VE+RKTGGDTLEFHKFYK FSSGLKD+VW++E N EELR+
Sbjct: 395 APSLHMVELRKTGGDTLEFHKFYKSFSSGLKDIVWKSEANTEELRS 440
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224064356|ref|XP_002301435.1| predicted protein [Populus trichocarpa] gi|116265942|gb|ABJ91219.1| CBL-interacting protein kinase 12 [Populus trichocarpa] gi|222843161|gb|EEE80708.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 765 bits (1975), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/467 (78%), Positives = 410/467 (87%), Gaps = 26/467 (5%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
MSVKVPA+RTRVGKYELG+T+GEGSFAKVK AKNV+TGD VAIKI+DRDQVLRHKMVEQ+
Sbjct: 1 MSVKVPAARTRVGKYELGKTIGEGSFAKVKVAKNVQTGDVVAIKILDRDQVLRHKMVEQL 60
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
KREISTMKLIKHPNVIKI EVMASKTKIYIV+EF+DGGELFDKIAKHGRLKEDEARRYFQ
Sbjct: 61 KREISTMKLIKHPNVIKIFEVMASKTKIYIVIEFVDGGELFDKIAKHGRLKEDEARRYFQ 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QLI AVDYCHSRGVFHRDLKPENLLLDS GVLK+SDFGLSA+SQQ+R DGLLHTACGTPN
Sbjct: 121 QLIKAVDYCHSRGVFHRDLKPENLLLDSRGVLKVSDFGLSALSQQLRGDGLLHTACGTPN 180
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240
YVAPEVL D+GYDG ASDVWSCGVIL+VLMAGFLPF ES+L+ LYRK
Sbjct: 181 YVAPEVLRDQGYDGTASDVWSCGVILYVLMAGFLPFSESSLVVLYRK------------- 227
Query: 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300
ICRADF+ PSWFSSGAKKLIKRILDP P TR+T+S++LEDEWFKKGY
Sbjct: 228 -------------ICRADFTFPSWFSSGAKKLIKRILDPKPLTRITVSEILEDEWFKKGY 274
Query: 301 KPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQT 360
KPP F++EE+VN+DDVDA+FNDSKE+LVTE+K KPVS+NAFELIS+T+ FSL+NLF KQ
Sbjct: 275 KPPQFEQEEDVNIDDVDAVFNDSKEHLVTERKVKPVSINAFELISKTQGFSLDNLFGKQA 334
Query: 361 GLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVF 420
G+VKRET S P NEIMS+IEEAAKPLGFNV K NYKMKL+GDK+GRKGQLSVATEVF
Sbjct: 335 GVVKRETHIASHSPANEIMSRIEEAAKPLGFNVDKRNYKMKLKGDKSGRKGQLSVATEVF 394
Query: 421 EVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEELR 467
EVAP+LH+VE+RK GGDTLEFHKFYK FSSGLKDVVW++++ E LR
Sbjct: 395 EVAPSLHMVELRKIGGDTLEFHKFYKSFSSGLKDVVWKSDQTIEGLR 441
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224993580|gb|ACN76469.1| CBL-interacting protein kinase 12 [Populus euphratica] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/467 (78%), Positives = 407/467 (87%), Gaps = 26/467 (5%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
MSVKVPA+RTRVGKYELG+T+GEGSFAKVK AKNV+TGD VAIKI+DRDQVLRHK VEQ+
Sbjct: 1 MSVKVPAARTRVGKYELGKTIGEGSFAKVKVAKNVQTGDVVAIKILDRDQVLRHKTVEQL 60
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
KREISTMKLIKHPNVIKI EVMAS+TKIYIV+EF++GGELFDKIAKHGRLKEDEARRYFQ
Sbjct: 61 KREISTMKLIKHPNVIKIFEVMASRTKIYIVIEFVEGGELFDKIAKHGRLKEDEARRYFQ 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QLI A DYCHSRGVFHRDLKPENLLLDS GVLK+SDFGLSA+SQQ+R DGLLH ACGTPN
Sbjct: 121 QLIKAADYCHSRGVFHRDLKPENLLLDSRGVLKVSDFGLSALSQQLRGDGLLHAACGTPN 180
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240
YVAPEVL D+GYDG ASDVWSCGVIL+VLMAGFLPF ES+L+ LYRK
Sbjct: 181 YVAPEVLRDQGYDGTASDVWSCGVILYVLMAGFLPFSESSLVVLYRK------------- 227
Query: 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300
ICRADF+ PSWFSSGAKKLIKRILDP P TR+T+S++LEDEWFKKGY
Sbjct: 228 -------------ICRADFTFPSWFSSGAKKLIKRILDPQPLTRITVSEILEDEWFKKGY 274
Query: 301 KPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQT 360
KPP F++EE+VN+DDVDA+FNDSKE+LVTE+K KPVSMNAFELISRT+ FSL+NLF KQ
Sbjct: 275 KPPQFEQEEDVNIDDVDAVFNDSKEHLVTERKVKPVSMNAFELISRTQGFSLDNLFGKQA 334
Query: 361 GLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVF 420
G+VKRET S P NEIMS+IEEAAKPLGFNV K NYKMKL+GDK+GRKGQLSVATEVF
Sbjct: 335 GVVKRETHIASHSPANEIMSRIEEAAKPLGFNVDKRNYKMKLKGDKSGRKGQLSVATEVF 394
Query: 421 EVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEELR 467
EVAP+LH+VE+RK GGDTLEFHKFYK FSSGLKDVVW++++ E LR
Sbjct: 395 EVAPSLHMVELRKIGGDTLEFHKFYKSFSSGLKDVVWKSDQTIEGLR 441
|
Source: Populus euphratica Species: Populus euphratica Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128033|ref|XP_002320224.1| predicted protein [Populus trichocarpa] gi|116265944|gb|ABJ91220.1| CBL-interacting protein kinase 13 [Populus trichocarpa] gi|222860997|gb|EEE98539.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1945), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/468 (77%), Positives = 406/468 (86%), Gaps = 26/468 (5%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
MS K +RTRVGKYELG+T+GEGSFAKVK AKNVETGD VAIKI+DR+QVLRHKMVEQ+
Sbjct: 1 MSAKGQGTRTRVGKYELGKTIGEGSFAKVKVAKNVETGDVVAIKILDREQVLRHKMVEQL 60
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
KREISTMKLIKHPNVIKI EVMASKTKIYIV+EF+DGGELFDKIAKHGRL+EDEARRYFQ
Sbjct: 61 KREISTMKLIKHPNVIKIFEVMASKTKIYIVIEFVDGGELFDKIAKHGRLREDEARRYFQ 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QLINAVDYCHSRGVFHRDLKPENLLLDS+GVLK+SDFGLSA+SQQ++ DGLLHTACGTPN
Sbjct: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSHGVLKVSDFGLSALSQQLQGDGLLHTACGTPN 180
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240
YVAPEVL DKGYDG ASDVWSCGVIL+VLMAG+LPFDE++LMALY
Sbjct: 181 YVAPEVLKDKGYDGTASDVWSCGVILYVLMAGYLPFDETSLMALY--------------- 225
Query: 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300
L+IC ADF+ PSWFSSGAKKLIKRILDP P TR+T+++++EDEWFKKGY
Sbjct: 226 -----------LKICSADFTFPSWFSSGAKKLIKRILDPEPLTRITVAEIIEDEWFKKGY 274
Query: 301 KPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQT 360
+PP F++EE VN+DDVDA+FND KE+LVTEKK+KP SMNAFELIS+T+ FSLENLF KQ
Sbjct: 275 RPPQFEQEEHVNVDDVDAVFNDLKEHLVTEKKKKPASMNAFELISKTQGFSLENLFGKQA 334
Query: 361 GLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVF 420
G VKRETR S P NEIMS+IEEAAKPLGFNV K NYKMKL+GDK GRKGQLSVATEVF
Sbjct: 335 GFVKRETRIASHSPANEIMSRIEEAAKPLGFNVDKRNYKMKLKGDKGGRKGQLSVATEVF 394
Query: 421 EVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEELRA 468
EVAP+LH+VE+RK GGDTLEFH FYK FSSGLKDVVW++++ E LR+
Sbjct: 395 EVAPSLHMVELRKIGGDTLEFHNFYKSFSSGLKDVVWKSDQTIEGLRS 442
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30677898|ref|NP_849570.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] gi|13249117|gb|AAK16684.1|AF295664_1 CBL-interacting protein kinase 9 [Arabidopsis thaliana] gi|332189122|gb|AEE27243.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1904), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/462 (75%), Positives = 401/462 (86%), Gaps = 25/462 (5%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
PASRTRVG YE+GRTLGEGSFAKVK+AKN TGD AIKI+DR++V RHKMVEQ+KREI
Sbjct: 9 TPASRTRVGNYEMGRTLGEGSFAKVKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKREI 68
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
STMKLIKHPNV++IIEVMASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLIN
Sbjct: 69 STMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLIN 128
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
AVDYCHSRGV+HRDLKPENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAP
Sbjct: 129 AVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAP 188
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244
EVL+DKGYDG A+DVWSCGVILFVLMAG+LPFDE NLM LY++V
Sbjct: 189 EVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKRV---------------- 232
Query: 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
+IC+A+FSCP WFS GAK++IKRIL+PNP TR++I+++LEDEWFKKGYKPP
Sbjct: 233 --------RICKAEFSCPPWFSQGAKRVIKRILEPNPITRISIAELLEDEWFKKGYKPPS 284
Query: 305 FDK-EEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLV 363
FD+ +E++ +DDVDA F++SKE LVTEKKEKPVSMNAFELIS + FSLENLFEKQ LV
Sbjct: 285 FDQDDEDITIDDVDAAFSNSKECLVTEKKEKPVSMNAFELISSSSEFSLENLFEKQAQLV 344
Query: 364 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVA 423
K+ETRFTSQR +EIMSK+EE AKPLGFNVRK NYK+K++GDK+GRKGQLSVATEVFEVA
Sbjct: 345 KKETRFTSQRSASEIMSKMEETAKPLGFNVRKDNYKIKMKGDKSGRKGQLSVATEVFEVA 404
Query: 424 PTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEE 465
P+LH+VE+RKTGGDTLEFHKFYK FSSGLKDVVW + EE
Sbjct: 405 PSLHVVELRKTGGDTLEFHKFYKNFSSGLKDVVWNTDAAAEE 446
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223317|ref|NP_171622.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] gi|259016207|sp|Q9MAM1.2|CIPK9_ARATH RecName: Full=CBL-interacting serine/threonine-protein kinase 9; AltName: Full=SNF1-related kinase 3.12; AltName: Full=SOS2-like protein kinase PKS6 gi|332189123|gb|AEE27244.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 735 bits (1898), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/462 (75%), Positives = 399/462 (86%), Gaps = 27/462 (5%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
PASRTRVG YE+GRTLGEGSFAKVK+AKN TGD AIKI+DR++V RHKMVEQ+KREI
Sbjct: 9 TPASRTRVGNYEMGRTLGEGSFAKVKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKREI 68
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
STMKLIKHPNV++IIEVMASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLIN
Sbjct: 69 STMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLIN 128
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
AVDYCHSRGV+HRDLKPENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAP
Sbjct: 129 AVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAP 188
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244
EVL+DKGYDG A+DVWSCGVILFVLMAG+LPFDE NLM LY++
Sbjct: 189 EVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKR----------------- 231
Query: 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
IC+A+FSCP WFS GAK++IKRIL+PNP TR++I+++LEDEWFKKGYKPP
Sbjct: 232 ---------ICKAEFSCPPWFSQGAKRVIKRILEPNPITRISIAELLEDEWFKKGYKPPS 282
Query: 305 FDK-EEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLV 363
FD+ +E++ +DDVDA F++SKE LVTEKKEKPVSMNAFELIS + FSLENLFEKQ LV
Sbjct: 283 FDQDDEDITIDDVDAAFSNSKECLVTEKKEKPVSMNAFELISSSSEFSLENLFEKQAQLV 342
Query: 364 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVA 423
K+ETRFTSQR +EIMSK+EE AKPLGFNVRK NYK+K++GDK+GRKGQLSVATEVFEVA
Sbjct: 343 KKETRFTSQRSASEIMSKMEETAKPLGFNVRKDNYKIKMKGDKSGRKGQLSVATEVFEVA 402
Query: 424 PTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEE 465
P+LH+VE+RKTGGDTLEFHKFYK FSSGLKDVVW + EE
Sbjct: 403 PSLHVVELRKTGGDTLEFHKFYKNFSSGLKDVVWNTDAAAEE 444
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|14423524|gb|AAK62444.1|AF386999_1 similar to wpk4 protein kinase [Arabidopsis thaliana] gi|20259788|gb|AAM13241.1| similar to wpk4 protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/462 (75%), Positives = 398/462 (86%), Gaps = 27/462 (5%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
PASRTRVG YE+GRTLGEGSFAK K+AKN TGD AIKI+DR++V RHKMVEQ+KREI
Sbjct: 9 TPASRTRVGNYEMGRTLGEGSFAKAKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKREI 68
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
STMKLIKHPNV++IIEVMASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLIN
Sbjct: 69 STMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLIN 128
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
AVDYCHSRGV+HRDLKPENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAP
Sbjct: 129 AVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAP 188
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244
EVL+DKGYDG A+DVWSCGVILFVLMAG+LPFDE NLM LY++
Sbjct: 189 EVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKR----------------- 231
Query: 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
IC+A+FSCP WFS GAK++IKRIL+PNP TR++I+++LEDEWFKKGYKPP
Sbjct: 232 ---------ICKAEFSCPPWFSQGAKRVIKRILEPNPITRISIAELLEDEWFKKGYKPPS 282
Query: 305 FDK-EEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLV 363
FD+ +E++ +DDVDA F++SKE LVTEKKEKPVSMNAFELIS + FSLENLFEKQ LV
Sbjct: 283 FDQDDEDITIDDVDAAFSNSKECLVTEKKEKPVSMNAFELISSSSEFSLENLFEKQAQLV 342
Query: 364 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVA 423
K+ETRFTSQR +EIMSK+EE AKPLGFNVRK NYK+K++GDK+GRKGQLSVATEVFEVA
Sbjct: 343 KKETRFTSQRSASEIMSKMEETAKPLGFNVRKDNYKIKMKGDKSGRKGQLSVATEVFEVA 402
Query: 424 PTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEE 465
P+LH+VE+RKTGGDTLEFHKFYK FSSGLKDVVW + EE
Sbjct: 403 PSLHVVELRKTGGDTLEFHKFYKNFSSGLKDVVWNTDAAAEE 444
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489408|ref|XP_002267089.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 9 [Vitis vinifera] gi|229609825|gb|ACQ83528.1| CBL-interacting protein kinase 12 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1892), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/443 (78%), Positives = 392/443 (88%), Gaps = 26/443 (5%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
MS+KVPA+RTRVG+YE+G+TLGEGSFAKVK+A+N +TGD VAIK++DRD VLRHKMVEQI
Sbjct: 1 MSMKVPATRTRVGRYEIGKTLGEGSFAKVKYARNSDTGDSVAIKVLDRDHVLRHKMVEQI 60
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
KREISTMKLIKHPNV+ I EVMASKTKIYIV+EF+DGGELFD+IAK+GRLKEDEARRYFQ
Sbjct: 61 KREISTMKLIKHPNVVTIFEVMASKTKIYIVVEFVDGGELFDRIAKNGRLKEDEARRYFQ 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QLINAVDYCHSRGV+HRDLKPENLLLDSYGVLKISDFGLSA+SQQVREDGL HTACGTPN
Sbjct: 121 QLINAVDYCHSRGVYHRDLKPENLLLDSYGVLKISDFGLSALSQQVREDGLFHTACGTPN 180
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240
YVAPEVLN+KGYDG ++D+WSCGVILFVL+AG+LPFDE +LMALY+K
Sbjct: 181 YVAPEVLNNKGYDGASADIWSCGVILFVLLAGYLPFDEVSLMALYKK------------- 227
Query: 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300
IC+ADFSCPSW S GAKKLI RILDPNP TR+TI ++LED WFKKGY
Sbjct: 228 -------------ICKADFSCPSWLSPGAKKLINRILDPNPVTRITIPEILEDGWFKKGY 274
Query: 301 KPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQT 360
+P F +EE+VN+DDVDA FN+S+ENLVTE+KEKPVSMNAFELISR++SF+LENLF KQ
Sbjct: 275 QPTCFQQEEDVNVDDVDAAFNNSEENLVTERKEKPVSMNAFELISRSQSFNLENLFGKQA 334
Query: 361 GLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVF 420
GLVKRET FTSQRP +EIMSKIEE AKPLGFNVRK NYKMKLQGDKTGRKG LSVATEVF
Sbjct: 335 GLVKRETSFTSQRPAHEIMSKIEETAKPLGFNVRKQNYKMKLQGDKTGRKGHLSVATEVF 394
Query: 421 EVAPTLHIVEVRKTGGDTLEFHK 443
EVAP+LH+VE+RKTGGDTLEFHK
Sbjct: 395 EVAPSLHMVELRKTGGDTLEFHK 417
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|6715641|gb|AAF26468.1|AC007323_9 T25K16.13 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 732 bits (1890), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/466 (75%), Positives = 401/466 (86%), Gaps = 29/466 (6%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
PASRTRVG YE+GRTLGEGSFAKVK+AKN TGD AIKI+DR++V RHKMVEQ+KREI
Sbjct: 9 TPASRTRVGNYEMGRTLGEGSFAKVKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKREI 68
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
STMKLIKHPNV++IIEVMASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLIN
Sbjct: 69 STMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLIN 128
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
AVDYCHSRGV+HRDLKPENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAP
Sbjct: 129 AVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAP 188
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244
EVL+DKGYDG A+DVWSCGVILFVLMAG+LPFDE NLM LY++V
Sbjct: 189 EVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKRV---------------- 232
Query: 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
+IC+A+FSCP WFS GAK++IKRIL+PNP TR++I+++LEDEWFKKGYKPP
Sbjct: 233 --------RICKAEFSCPPWFSQGAKRVIKRILEPNPITRISIAELLEDEWFKKGYKPPS 284
Query: 305 FDK-EEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLV 363
FD+ +E++ +DDVDA F++SKE LVTEKKEKPVSMNAFELIS + FSLENLFEKQ LV
Sbjct: 285 FDQDDEDITIDDVDAAFSNSKECLVTEKKEKPVSMNAFELISSSSEFSLENLFEKQAQLV 344
Query: 364 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVA 423
K+ETRFTSQR +EIMSK+EE AKPLGFNVRK NYK+K++GDK+GRKGQLSVATEVFEVA
Sbjct: 345 KKETRFTSQRSASEIMSKMEETAKPLGFNVRKDNYKIKMKGDKSGRKGQLSVATEVFEVA 404
Query: 424 PTLHIVEVRKTGGDTLEFHK----FYKKFSSGLKDVVWQAEENKEE 465
P+LH+VE+RKTGGDTLEFHK FYK FSSGLKDVVW + EE
Sbjct: 405 PSLHVVELRKTGGDTLEFHKVCDSFYKNFSSGLKDVVWNTDAAAEE 450
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449520201|ref|XP_004167122.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 9-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 732 bits (1889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/465 (75%), Positives = 397/465 (85%), Gaps = 26/465 (5%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
M+VK P +RTRVGKYELG+TLGEG+FAKVKFAKNVE GD+VAIKI+DR++ LRH+MVEQI
Sbjct: 1 MNVKSPPTRTRVGKYELGKTLGEGTFAKVKFAKNVENGDYVAIKILDREKALRHRMVEQI 60
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
KREIST+K+IKHPNV KI EVMASK+KIYIVLE+ DGGELFDKIA GRLKEDEAR+YF
Sbjct: 61 KREISTLKVIKHPNVCKIYEVMASKSKIYIVLEYADGGELFDKIAAKGRLKEDEARKYFH 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QLINAVDYCHSRGV+HRDLKPENLLLDS+ VLK+SDFGLSA SQQVR DGLLHTACGTPN
Sbjct: 121 QLINAVDYCHSRGVYHRDLKPENLLLDSHDVLKVSDFGLSAFSQQVRGDGLLHTACGTPN 180
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240
YVAPEVLNDKGYDG +SD+WSCGVILFVLMAGFLPFDE NLM LYRK+S
Sbjct: 181 YVAPEVLNDKGYDGSSSDLWSCGVILFVLMAGFLPFDEPNLMCLYRKIS----------- 229
Query: 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300
+ADF+ PSWFSSGAK L++RILDP+P TR++I+++ ED WFKK Y
Sbjct: 230 ---------------KADFAFPSWFSSGAKNLVRRILDPDPTTRISIAEIQEDPWFKKDY 274
Query: 301 KPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQT 360
P HF+ EE++ LDDVDA F+ SKE+LVTE+KEKPVSMNAFELISR+ FSLENLFEKQ
Sbjct: 275 TPAHFEVEEDITLDDVDAAFSSSKEHLVTERKEKPVSMNAFELISRSPGFSLENLFEKQK 334
Query: 361 GLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVF 420
+ KRETRFTSQ P NEIMSKIEE AKP+GFNVRK +YKMKLQGDKTGRKG LS+ATEVF
Sbjct: 335 TVAKRETRFTSQSPANEIMSKIEETAKPMGFNVRKRDYKMKLQGDKTGRKGHLSIATEVF 394
Query: 421 EVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEE 465
EVAP+LH+VE+RKTGGDTLEFHKFYK FSSGLKD+VW+ +EN E
Sbjct: 395 EVAPSLHMVELRKTGGDTLEFHKFYKSFSSGLKDIVWRTDENTVE 439
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 468 | ||||||
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.480 | 0.498 | 0.764 | 5.7e-165 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.476 | 0.507 | 0.739 | 6.8e-160 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.472 | 0.495 | 0.650 | 2e-132 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.472 | 0.496 | 0.681 | 1e-128 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.459 | 0.487 | 0.643 | 8.6e-117 | |
| TAIR|locus:2152370 | 483 | CIPK19 "CBL-interacting protei | 0.461 | 0.447 | 0.640 | 5.1e-114 | |
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.508 | 0.534 | 0.615 | 9.9e-114 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.508 | 0.487 | 0.605 | 7.9e-112 | |
| TAIR|locus:2090537 | 444 | CIPK1 "CBL-interacting protein | 0.465 | 0.490 | 0.605 | 7.1e-111 | |
| TAIR|locus:1005716169 | 831 | AT5G21222 [Arabidopsis thalian | 0.487 | 0.274 | 0.675 | 2.1e-107 |
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 956 (341.6 bits), Expect = 5.7e-165, Sum P(2) = 5.7e-165
Identities = 172/225 (76%), Positives = 210/225 (93%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ RVGKYE+GRT+GEG+FAKVKFA+N ETG+ VA+KI+D+++VL+HKM EQI+REI+TMK
Sbjct: 18 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMK 77
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
LIKHPNV+++ EVMASKTKI+I+LE++ GGELFDKI GR+KEDEARRYFQQLI+AVDY
Sbjct: 78 LIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDY 137
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
CHSRGV+HRDLKPENLLLDSYG LKISDFGLSA+SQQVR+DGLLHT+CGTPNYVAPEVLN
Sbjct: 138 CHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLN 197
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHF 233
D+GYDG +D+WSCGV+L+VL+AG+LPFD+SNLM LY+K+S+ F
Sbjct: 198 DRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEF 242
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 901 (322.2 bits), Expect = 6.8e-160, Sum P(2) = 6.8e-160
Identities = 165/223 (73%), Positives = 199/223 (89%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
P + RVGKYE+G+TLG+G+FAKV+ A N ETG+ VA+KI+D+++VL+HKM EQI+REI
Sbjct: 4 PKVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREIC 63
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
TMKLI HPNV+++ EV+ASKTKIYIVLEF GGELFDKI GRLKE+ AR+YFQQLINA
Sbjct: 64 TMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINA 123
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
VDYCHSRGV+HRDLKPENLLLD+ G LK+SDFGLSA+S+QVR DGLLHTACGTPNY APE
Sbjct: 124 VDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPE 183
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
VLND+GYDG +D+WSCGVILFVL+AG+LPF++SNLM LY+K+
Sbjct: 184 VLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKI 226
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 802 (287.4 bits), Expect = 2.0e-132, Sum P(2) = 2.0e-132
Identities = 145/223 (65%), Positives = 191/223 (85%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
RVGKYE+GRT+GEG+FAKVKFA+N +TGD VAIKI+ + +L+++MV+QIKREIS MK++
Sbjct: 7 RVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISIMKIV 66
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+HPN++++ EV+AS +KIYIVLEF+ GGELFD+I GRL+E E+R+YFQQL++AV +CH
Sbjct: 67 RHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAHCH 126
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+GV+HRDLKPENLLLD+ G LK+SDFGLSA+ Q+ E LL T CGTPNYVAPEVL+ +
Sbjct: 127 CKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEVLSGQ 184
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHF 233
GYDG A+D+WSCGVILFV++AG+LPF E++L LYRK++ F
Sbjct: 185 GYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEF 227
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 819 (293.4 bits), Expect = 1.0e-128, Sum P(2) = 1.0e-128
Identities = 152/223 (68%), Positives = 188/223 (84%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+VGKYELGRT+GEG+FAKVKFA+N ETG+ VA+KIVDR +++ KMV+QIKREIS MKL+
Sbjct: 5 KVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLV 64
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+HP V+++ EV+AS+TKIYI+LE+I GGELFDKI ++GRL E EAR+YF QLI+ VDYCH
Sbjct: 65 RHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCH 124
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
S+GV+HRDLKPENLLLDS G LKISDFGLSA+ +Q +L T CGTPNYVAPEVL+ K
Sbjct: 125 SKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVT--ILKTTCGTPNYVAPEVLSHK 182
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHF 233
GY+G +D+WSCGVIL+VLMAG+LPFDE +L LY K+ F
Sbjct: 183 GYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEF 225
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 771 (276.5 bits), Expect = 8.6e-117, Sum P(2) = 8.6e-117
Identities = 139/216 (64%), Positives = 183/216 (84%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
G+YELGR LG G+FAKV A+N++TG VA+K+V +++V++ MV+QIKREIS M+++KH
Sbjct: 22 GRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMVKH 81
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
PN++++ EVMASK+KIY +E + GGELF K+AK GRL+ED AR YFQQLI+AVD+CHSR
Sbjct: 82 PNIVELHEVMASKSKIYFAMELVRGGELFAKVAK-GRLREDVARVYFQQLISAVDFCHSR 140
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
GV+HRDLKPENLLLD G LK++DFGLSA ++ +++DGLLHT CGTP YVAPEV+ KGY
Sbjct: 141 GVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKGY 200
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
DG +D+WSCGVILFVL+AG+LPF + NL+ +YRK+
Sbjct: 201 DGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKI 236
|
|
| TAIR|locus:2152370 CIPK19 "CBL-interacting protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 784 (281.0 bits), Expect = 5.1e-114, Sum P(3) = 5.1e-114
Identities = 139/217 (64%), Positives = 184/217 (84%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+GKYE+GR LG G+FAKV A+N ++G+ VAIK++D+++VL+ ++ IKREIS ++ ++
Sbjct: 25 LGKYEMGRLLGHGTFAKVYLARNAQSGESVAIKVIDKEKVLKSGLIAHIKREISILRRVR 84
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
HPN++++ EVMA+K+KIY V+E++ GGELF+K+AK GRLKE+ AR+YFQQLI+AV +CH
Sbjct: 85 HPNIVQLFEVMATKSKIYFVMEYVKGGELFNKVAK-GRLKEEMARKYFQQLISAVSFCHF 143
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
RGV+HRDLKPENLLLD G LK+SDFGLSA+S Q+R+DGL HT CGTP YVAPEVL KG
Sbjct: 144 RGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARKG 203
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
YDG D+WSCGVILFVLMAGFLPF + N+MA+Y+K+
Sbjct: 204 YDGAKVDIWSCGVILFVLMAGFLPFHDRNVMAMYKKI 240
|
|
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 789 (282.8 bits), Expect = 9.9e-114, Sum P(2) = 9.9e-114
Identities = 149/242 (61%), Positives = 192/242 (79%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK-MVEQIKREISTM 67
R GKYE+GR LG+G+FAKV + K + G+ VAIK++++DQV++ M+EQIKREIS M
Sbjct: 6 RVLFGKYEMGRLLGKGTFAKVYYGKEIIGGECVAIKVINKDQVMKRPGMMEQIKREISIM 65
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
KL++HPN++++ EVMA+KTKI+ V+EF+ GGELF KI+K G+L ED ARRYFQQLI+AVD
Sbjct: 66 KLVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKISK-GKLHEDAARRYFQQLISAVD 124
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
YCHSRGV HRDLKPENLLLD G LKISDFGLSA+ +Q+ +DGLLHT CGTP YVAPEVL
Sbjct: 125 YCHSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVAPEVL 184
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV--STFHFLSVYGESYKKCT 245
KGYDG +D+WSCGV+L+VL+AG LPF + NLM +YRK+ + F F + ++
Sbjct: 185 KKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEARRLI 244
Query: 246 NK 247
+K
Sbjct: 245 SK 246
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 7.9e-112, Sum P(2) = 7.9e-112
Identities = 146/241 (60%), Positives = 190/241 (78%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
R KYE+GR LG+G+F KV + K + TG+ VAIKI+++DQV R M+EQIKREIS M+
Sbjct: 37 RVLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIKREISIMR 96
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
L++HPN++++ EVMA+KTKI+ ++E++ GGELF KI K G+LKED AR+YFQQLI+AVD+
Sbjct: 97 LVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIVK-GKLKEDSARKYFQQLISAVDF 155
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
CHSRGV HRDLKPENLL+D G LK+SDFGLSA+ +Q+ +DGLLHT CGTP YVAPEVL
Sbjct: 156 CHSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAYVAPEVLR 215
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV--STFHFLSVYGESYKKCTN 246
KGYDG D+WSCG+IL+VL+AGFLPF + NLM +YRK+ S F + + K+ +
Sbjct: 216 KKGYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSPESKRLIS 275
Query: 247 K 247
K
Sbjct: 276 K 276
|
|
| TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 742 (266.3 bits), Expect = 7.1e-111, Sum P(2) = 7.1e-111
Identities = 132/218 (60%), Positives = 177/218 (81%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
R+GKYELGRTLGEG+F KVKFAK+ +G A+KI+D+ ++ QIKREI T+K++
Sbjct: 16 RLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKREIRTLKML 75
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
KHP+++++ EV+ASKTKI +V+E + GGELFD+I +G+L E + R+ FQQLI+ + YCH
Sbjct: 76 KHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQLIDGISYCH 135
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
S+GVFHRDLK EN+LLD+ G +KI+DFGLSA+ Q R+DGLLHT CG+PNYVAPEVL ++
Sbjct: 136 SKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 195
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
GYDG ASD+WSCGVIL+V++ G LPFD+ NL LY+K+
Sbjct: 196 GYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLYQKI 233
|
|
| TAIR|locus:1005716169 AT5G21222 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 829 (296.9 bits), Expect = 2.1e-107, Sum P(2) = 2.1e-107
Identities = 154/228 (67%), Positives = 190/228 (83%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
P R VGKYE+GR +GE +F K++ A + ETGD VA+ I+D+D+VL+HKM EQIKREIS
Sbjct: 4 PKVRRWVGKYEVGRLIGECNFGKLRSAVDTETGDPVALMILDKDKVLKHKMAEQIKREIS 63
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
MKLI HPNV+++ EV+ASK KIYIVLEFI GG+LFDKI GR+ EDEA+RYFQQLINA
Sbjct: 64 IMKLINHPNVVQLYEVLASKAKIYIVLEFISGGKLFDKIKNDGRMNEDEAQRYFQQLINA 123
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
VDYCHSRGV+HRDLKPENLLLD+ LK+++FGL A+SQQ DGL HTACG P+Y APE
Sbjct: 124 VDYCHSRGVYHRDLKPENLLLDAQENLKVAEFGLIALSQQAGGDGLRHTACGNPDYAAPE 183
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHF 233
VLND+GYDG +D+WSCGVILFVL+AG+LPF++S+L LY+K+S+ F
Sbjct: 184 VLNDQGYDGAKADLWSCGVILFVLLAGYLPFEDSSLTTLYKKISSADF 231
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9MAM1 | CIPK9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7554 | 0.9294 | 0.9731 | yes | no |
| Q10SC8 | CIPK9_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7189 | 0.9209 | 0.9451 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 468 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-103 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-91 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-73 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-71 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-69 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-67 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-66 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-59 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-59 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-57 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-56 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-54 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-52 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-52 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-51 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-49 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-49 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-48 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 3e-46 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-44 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-44 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-43 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-43 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-43 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-42 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-42 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-42 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-42 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-42 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-41 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-41 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-41 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-41 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-41 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-41 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-40 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-40 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-40 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-40 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-40 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-39 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-39 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-39 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-39 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-38 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-38 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-38 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-38 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-38 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-38 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-38 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-37 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-37 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-37 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-36 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-36 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-36 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-35 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-35 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-35 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-34 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-34 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-34 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-34 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-34 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-34 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-34 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-34 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-34 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-33 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-33 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-33 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-33 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-33 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-33 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-33 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-33 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-33 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-33 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-33 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-32 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-32 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-32 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-32 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-32 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-32 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-32 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-32 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-32 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-32 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-32 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-32 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-31 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-31 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-31 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-31 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-31 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-31 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-31 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-30 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-30 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-30 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-30 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-30 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-29 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-29 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-28 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-28 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-28 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-27 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-27 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-27 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-27 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-27 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-26 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-26 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-26 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-25 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-25 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-25 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-25 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-25 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-24 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-24 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-24 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-24 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-24 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-24 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-24 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-23 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 1e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-23 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-23 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-23 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-22 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-21 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-20 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-20 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-18 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-17 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-14 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-13 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-10 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 306 bits (787), Expect = e-103
Identities = 113/283 (39%), Positives = 171/283 (60%), Gaps = 30/283 (10%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
YE+ LGEGSF KV A++ +TG VAIK++ + ++ K E+I REI +K +KHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKLKHPN 58
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++++ +V + K+Y+V+E+ +GG+LFD + K GRL EDEAR Y +Q+++A++Y HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
HRDLKPEN+LLD G +K++DFGL+ Q+ L T GTP Y+APEVL KGY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYG- 174
Query: 195 RASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253
+A D+WS GVIL+ L+ G PF + L+ L++K+ K
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKI---------------GKPKPP---- 215
Query: 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296
S AK LI+++L +P+ R+T + L+ +F
Sbjct: 216 ----FPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 278 bits (714), Expect = 1e-91
Identities = 107/287 (37%), Positives = 159/287 (55%), Gaps = 32/287 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
YEL R LG GSF V AK+ TG VA+KI+ + + K + +REI ++ + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++++I+ K +Y+V+E+ +GG+LFD +++ G L EDEA++ Q++ ++Y HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
HRDLKPEN+LLD GV+KI+DFGL+ + ++ L T GTP Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 195 RASDVWSCGVILFVLMAGFLPFDES---NLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
DVWS GVIL+ L+ G PF + + L R++
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILG--------------------- 216
Query: 252 LQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296
+F P W S AK LIK+ L+ +P R T ++L+ WF
Sbjct: 217 ---PPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 3e-73
Identities = 94/270 (34%), Positives = 151/270 (55%), Gaps = 32/270 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E +TLG GSF +V ++ +G + A+KI+ + ++++ K VE + E ++ I+HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++ + + +Y+V+E++ GGELF + K GR E AR Y Q++ A++Y HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RDLKPENLLLDS G +KI+DFG + R G +T CGTP Y+APE++ KGY G
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFA-----KRVKGRTYTLCGTPEYLAPEIILSKGY-G 176
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254
+A D W+ G++++ ++AG+ PF + N + +Y K I
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK--------------------------I 210
Query: 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTR 284
PS+FS AK LI+ +L + R
Sbjct: 211 LEGKVRFPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (574), Expect = 8e-71
Identities = 94/266 (35%), Positives = 146/266 (54%), Gaps = 29/266 (10%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG+GSF KV + +TG A+K++ + ++++ K VE E + + I HP ++K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
++ K+Y+VLE+ GGELF ++K GR E+ AR Y +++ A++Y HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 141 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 200
PEN+LLD+ G +K++DFGL+ E +T CGTP Y+APEVL KGY G+A D W
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177
Query: 201 SCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFS 260
S GV+L+ ++ G PF + +Y K I +
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEK--------------------------ILKDPLR 211
Query: 261 CPSWFSSGAKKLIKRILDPNPDTRMT 286
P + S A+ LI +L +P R+
Sbjct: 212 FPEFLSPEARDLISGLLQKDPTKRLG 237
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 2e-69
Identities = 85/191 (44%), Positives = 124/191 (64%), Gaps = 6/191 (3%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LGEG F V A++ +TG VAIKI+ ++ ++E++ REI +K + HPN++K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
V + +Y+V+E+ +GG L D + ++ G+L EDE R Q++ ++Y HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 140 KPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
KPEN+LLDS G +K++DFGLS + + LL T GTP Y+APEVL KGY SD
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 199 VWSCGVILFVL 209
+WS GVIL+ L
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 2e-67
Identities = 92/283 (32%), Positives = 147/283 (51%), Gaps = 33/283 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KYE+ + +G+GSF KV + G +K +D + K E E+ +K + HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLNHP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLINAVDYC 129
N+IK E K K+ IV+E+ DGG+L KI K + E++ +F QL A+ Y
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
HSR + HRD+KP+N+ L S G++K+ DFG+S + + L T GTP Y++PE+ +
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQN 177
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249
K Y+ SD+WS G +L+ L PF+ NL+ L K+ + G+ Y ++YS
Sbjct: 178 KPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-------LKGQ-YPPIPSQYS 228
Query: 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
L+ L+ +L +P+ R +I+Q+L+
Sbjct: 229 SELR-----------------NLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 213 bits (546), Expect = 2e-66
Identities = 87/286 (30%), Positives = 145/286 (50%), Gaps = 29/286 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
++ G LG GSF V A + +TG+ +A+K V+ + +E ++REI + ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHP 59
Query: 74 NVIKII--EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
N+++ E K + I LE++ GG L + K G+L E R+Y +Q++ + Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
G+ HRD+K N+L+DS GV+K++DFG + + + GTP ++APEV+ +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y GRA+D+WS G + + G P+ E N MA K+ + GE
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS------GEP---------- 222
Query: 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296
+I P S AK +++ L +P R T ++L+ +
Sbjct: 223 -PEI-------PEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 2e-59
Identities = 94/298 (31%), Positives = 155/298 (52%), Gaps = 46/298 (15%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHP 73
++ G+ +GEGSF+ V AK ET AIKI+D+ Q+++ K V+ +K E + +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+IK+ + +Y VLE+ GEL I K+G L E R Y +++ A++Y HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAI------SQQVREDGLLH------------TA 175
+ HRDLKPEN+LLD +KI+DFG + + + + D +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235
GT YV+PE+LN+K G++SD+W+ G I++ ++ G PF SN ++K+
Sbjct: 183 VGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI------- 234
Query: 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293
K ++S P F AK LI+++L +P R+ +++ ++
Sbjct: 235 ------LKL-------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 8e-59
Identities = 86/283 (30%), Positives = 143/283 (50%), Gaps = 34/283 (12%)
Query: 24 GSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA 83
G++ +V AK TGD AIK++ + ++R V+Q+ E + + P V+K+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 84 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 143
K +Y+V+E++ GG+L + G L ED AR Y +++ A++Y HS G+ HRDLKP+N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 144 LLLDSYGVLKISDFGLSAISQQVREDGLL------HTACGTPNYVAPEVLNDKGYDGRAS 197
+L+DS G LK++DFGLS + R+ L GTP+Y+APEV+ +G+ +
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257
D WS G IL+ + G PF +++ + K + +
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNI---------------LNGKIEW-PEDVEV 226
Query: 258 DFSCPSWFSSGAKKLIKRILDPNPDTRM---TISQMLEDEWFK 297
S A LI ++L P+P+ R+ +I ++ +FK
Sbjct: 227 --------SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 4e-57
Identities = 96/282 (34%), Positives = 157/282 (55%), Gaps = 32/282 (11%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
K S ++ +E+G TLG GSF +V+ AK+ TG++ AIK + + ++L+ K V+ + +E
Sbjct: 9 KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQE 68
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
S + + HP ++ ++ + ++Y +LEF+ GGELF + K GR D A+ Y +L+
Sbjct: 69 KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV 128
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
A +Y HS+ + +RDLKPENLLLD+ G +K++DFG +++V + T CGTP Y+A
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGF---AKKVPDR--TFTLCGTPEYLA 183
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243
PEV+ KG+ G+A D W+ GV+L+ +AG+ PF + +Y K
Sbjct: 184 PEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK---------------- 226
Query: 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 285
I P+WF A+ L+K +L + R+
Sbjct: 227 ----------ILAGRLKFPNWFDGRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 1e-56
Identities = 91/283 (32%), Positives = 141/283 (49%), Gaps = 35/283 (12%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG G F +V+ K A+K V + ++ E I E ++ HP ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
K IY+++E+ GGEL+ + G E AR Y ++ A +Y H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 141 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 200
PENLLLDS G +K+ DFG + + ++ T CGTP YVAPE++ +KGYD + D W
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKT---WTFCGTPEYVAPEIILNKGYD-FSVDYW 176
Query: 201 SCGVILFVLMAGFLPFDESNL--MALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRAD 258
S G++L+ L+ G PF E + M +Y + K K +
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDIL-------------KGNGKLEF-------- 215
Query: 259 FSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWF 296
P++ AK LIK++L NP+ R+ I + + +WF
Sbjct: 216 ---PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 8e-54
Identities = 93/284 (32%), Positives = 146/284 (51%), Gaps = 33/284 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E+ +G+G F +V A++ TG VAIK++ + K E+I EI +K KHP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK-LESKEKK--EKIINEIQILKKCKHP 57
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSR 132
N++K K +++IV+EF GG L D + + + L E + ++L+ ++Y HS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
G+ HRD+K N+LL S G +K+ DFGLSA Q+ + +T GTP ++APEV+N K Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 193 DGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
D +A D+WS G I + +A G P+ E M K++T
Sbjct: 175 DYKA-DIWSLG-ITAIELAEGKPPYSELPPMKALFKIATNGP----------------PG 216
Query: 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295
L+ P +S K +K+ L NP+ R T Q+L+ +
Sbjct: 217 LR-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 2e-52
Identities = 92/288 (31%), Positives = 137/288 (47%), Gaps = 39/288 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ----IKREISTMKL 69
Y+LG +G G+F V N+ETGDFVAIK Q+ K+ E+ I +EI +K
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIK-----QISLEKIKEEALKSIMQEIDLLKN 55
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+KHPN++K I + + +YI+LE+ + G L I K G E Y Q++ + Y
Sbjct: 56 LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
H +GV HRD+K N+L GV+K++DFG++ + GTP ++APEV+
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLN--DVSKDDASVVGTPYWMAPEVIEM 173
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKVSTFHFLSVYGESYKKCTNKY 248
G ASD+WS G + L+ G P+ + N M AL+R V H
Sbjct: 174 SGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH---------------- 216
Query: 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296
L P S K + + +P+ R T Q+L+ W
Sbjct: 217 -PPL---------PEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 3e-52
Identities = 88/292 (30%), Positives = 147/292 (50%), Gaps = 39/292 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+++ G +G G+F KV A N++TG+ +A+K + R Q K +++I E+ ++L+KHP
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA--RRYFQQLINAVDYCHS 131
N++K V + K+YI +E+ GG L + + +HGR+ DE R Y QL+ + Y HS
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAYLHS 117
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAI--SQQVREDGLLHTACGTPNYVAPEVL-- 187
G+ HRD+KP N+ LD GV+K+ DFG + + + + GTP Y+APEV+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 188 -NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246
KG+ GRA+D+WS G ++ + G P+ E N
Sbjct: 178 GKGKGH-GRAADIWSLGCVVLEMATGKRPWSE-------------------------LDN 211
Query: 247 KYSYTLQIC---RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295
++ + + S K + R L+ +P R T S++L+ +
Sbjct: 212 EFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 1e-51
Identities = 103/383 (26%), Positives = 170/383 (44%), Gaps = 28/383 (7%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y + R LGEGSF +V A++ + VA+K++ + + K VE+ REI + + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 74 -NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYC 129
N++K+ + + +Y+V+E++DGG L D + K GR L E EA Q+++A++Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 130 HSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAI----SQQVREDGLLHTACGTPNYVAP 184
HS+G+ HRD+KPEN+LLD G V+K+ DFGL+ + L T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 185 EVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242
EVL Y +SD+WS G+ L+ L+ G PF+ + + +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK----IILELPTP 233
Query: 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
+ S S P S A L+K++L +P R++ S L + K
Sbjct: 234 SLASPLSP---------SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH-LKL 283
Query: 303 PHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGL 362
D + + DD + +L + + S + L
Sbjct: 284 KESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSS 343
Query: 363 VKRETRFTSQRPPNEIMSKIEEA 385
+ + S + +
Sbjct: 344 SPHNSSSLLLSTASSKRSSLPKI 366
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (432), Expect = 2e-49
Identities = 85/303 (28%), Positives = 145/303 (47%), Gaps = 42/303 (13%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK-------REISTM 67
YE LGEG++ V A++ +TG+ VA+K + ++ + + REIS +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--------RLDNEEEGIPSTALREISLL 52
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAV 126
K +KHPN++K+++V+ ++ K+Y+V E+ D +L + K L + + QL+ +
Sbjct: 53 KELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPN----- 180
YCHS + HRDLKP+N+L++ GVLK++DFGL+ A +R T
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--------THEVVTLW 163
Query: 181 YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTFHFL---- 234
Y APE+L K Y A D+WS G I ++ G F +S + L++ F L
Sbjct: 164 YRAPEILLGSKHYST-AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK---IFQILGTPT 219
Query: 235 -SVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293
+ K K ++ + L+ ++L NP R++ + L+
Sbjct: 220 EESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279
Query: 294 EWF 296
+F
Sbjct: 280 PYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 4e-49
Identities = 86/292 (29%), Positives = 140/292 (47%), Gaps = 42/292 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
YE+ T+G+GSF V+ + G + K +D + + +Q+ E++ ++ +KHP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHP 59
Query: 74 NVIKII--EVMASKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVD 127
N+++ + S +YIV+E+ +GG+L I K ++E+ R QL+ A+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 128 YCHSRG-----VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
CH+R V HRDLKP N+ LD+ +K+ DFGL+ I + T GTP Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYM 177
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242
+PE LN YD SD+WS G +++ L A PF N + L K
Sbjct: 178 SPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASK--------------- 221
Query: 243 KCTNKYSYTLQICRADFSC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293
I F P +SS ++IK +L+ +PD R + ++L+
Sbjct: 222 -----------IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 8e-48
Identities = 68/214 (31%), Positives = 128/214 (59%), Gaps = 6/214 (2%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
E +T+G G+F +V ++ + + A+K++ +V+R K + + E +K + HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+I++ + +Y+++E++ GGELF + GR Y +++ A++Y HS+ +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RDLKPEN+LLD G +K++DFG ++++R+ T CGTP Y+APEV+ KG+
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGF---AKKLRDR--TWTLCGTPEYLAPEVIQSKGH-N 176
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
+A D W+ G++++ ++ G+ PF + N +Y K+
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-46
Identities = 65/117 (55%), Positives = 84/117 (71%), Gaps = 2/117 (1%)
Query: 339 NAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGN- 397
NAF+LIS + L LFE++ VKRETRFTS++P EI+ K+EEAAK LGF VRK
Sbjct: 1 NAFDLISLSSGLDLSGLFEEE-DEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKE 59
Query: 398 YKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKD 454
+KL+G K GRKG+L+V+ EVFEV P+L +VEV+K+ GDTLE+HKF+K L
Sbjct: 60 GGVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 5e-44
Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 37/289 (12%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKI--VDRDQVLRHKMVEQIKREISTMKLIKHP 73
E + LG+GS V ++ TG A+K VD D+ R Q+ RE+ T++ + P
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK----QLLRELKTLRSCESP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-R 132
V+K + +I IVLE++DGG L D + K G++ E +Q++ +DY H+ R
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
+ HRD+KP NLL++S G +KI+DFG+S + + +T GT Y++PE + +
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQCNTFVGTVTYMSPERIQGE-S 176
Query: 193 DGRASDVWSCGVILFVLMAGFLPF---DESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249
A+D+WS G+ L G PF + + L + + G
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-------CDGPPP-------- 221
Query: 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
FS + I L +P R + +++L+ + KK
Sbjct: 222 ---------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 5e-44
Identities = 86/304 (28%), Positives = 141/304 (46%), Gaps = 39/304 (12%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
YE +GEG++ +V A+N +TG+ VA+K + + + REI ++ ++HPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE-KEGFPITAIREIKLLQKLRHPN 59
Query: 75 VIKIIEVMASKTK--IYIVLEFIDGGELFD--KIAKHGRLK--EDEARRYFQQLINAVDY 128
++++ E++ SK K IY+V E++D D + +K E + + Y +QL+ + Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL- 187
HS G+ HRD+K N+L+++ GVLK++DFGL A R T Y PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRPPELLL 174
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMAL------------YRKVSTFH 232
Y G D+WS G IL L G F E + + VS
Sbjct: 175 GATRY-GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233
Query: 233 FLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
+ ++ K Y + R F A L+ ++L +P R++ Q L+
Sbjct: 234 W-------FENLKPKKPYK-RRLREFFK--HLIDPSALDLLDKLLTLDPKKRISADQALQ 283
Query: 293 DEWF 296
E+F
Sbjct: 284 HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 68/244 (27%), Positives = 125/244 (51%), Gaps = 28/244 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ + +G G+F +V ++ +TG A+K++ + +++ + ++ E + P
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++K+ + +Y+V+E++ GG+L + + + E+ AR Y +L+ A+D H G
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSA---------------ISQQVREDGLLH------ 173
HRD+KP+N+L+D+ G +K++DFGL + R++ L+
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 174 ------TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227
+ GTP+Y+APEVL Y G D WS GVIL+ ++ GF PF L Y K
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241
Query: 228 VSTF 231
+ +
Sbjct: 242 IINW 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 84/264 (31%), Positives = 133/264 (50%), Gaps = 32/264 (12%)
Query: 24 GSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-PNVIKIIEVM 82
G+F V AK TGD+ AIK++ + ++ V +K E + M + P V K+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 83 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 142
SK +Y+V+E+++GG+ I G L ED A++Y +++ V+ H RG+ HRD+KPE
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126
Query: 143 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVLNDKGYDGRASDVWS 201
NLL+D G LK++DFGLS +GL + GTP+Y+APE + G D + SD WS
Sbjct: 127 NLLIDQTGHLKLTDFGLS-------RNGLENKKFVGTPDYLAPETILGVG-DDKMSDWWS 178
Query: 202 CGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSC 261
G ++F + G+ PF A++ + + + ++ C
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDAVFDNIL---------------SRRINWPE---EVKEFC 220
Query: 262 PSWFSSGAKKLIKRILDPNPDTRM 285
S A LI R+L +P R+
Sbjct: 221 ----SPEAVDLINRLLCMDPAKRL 240
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-43
Identities = 85/271 (31%), Positives = 149/271 (54%), Gaps = 33/271 (12%)
Query: 19 RTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRH-KMVEQIKREISTMKLIKHPN 74
+ LG+G + KV + V +TG A+K++ + ++R+ K K E + ++ +KHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++ +I + K+Y++LE++ GGELF + + G ED A Y ++ A+++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RDLKPEN+LLD+ G +K++DFGL + + E + HT CGT Y+APE+L G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254
+A D WS G +++ ++ G PF E+ KK +K I
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFT--------------------AENRKKTIDK------I 212
Query: 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRM 285
+ + P + + A+ L+K++L NP +R+
Sbjct: 213 LKGKLNLPPYLTPEARDLLKKLLKRNPSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-42
Identities = 85/268 (31%), Positives = 142/268 (52%), Gaps = 30/268 (11%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77
+ LG+GSF KV A+ T + A+K++ +D +L+ VE E + L KHP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ +K +++ V+E+++GG+L I + GR E AR Y +++ + + H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLDS G +KI+DFG+ + + T CGTP+Y+APE+L+ + Y G A
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257
D W+ GV+L+ ++AG PF+ + L++ I
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQ--------------------------SILED 211
Query: 258 DFSCPSWFSSGAKKLIKRILDPNPDTRM 285
+ P W S AK ++K L NP+ R+
Sbjct: 212 EVRYPRWLSKEAKSILKSFLTKNPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-42
Identities = 75/211 (35%), Positives = 121/211 (57%), Gaps = 4/211 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIK 77
+ +G+GSF KV AK+ G F A+K++ + +L+ K + I E + + K +KHP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + K+Y VL++++GGELF + + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLKPEN+LLDS G + ++DFGL + + T CGTP Y+APEVL + YD R
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
D W G +L+ ++ G PF + +Y +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 4e-42
Identities = 82/280 (29%), Positives = 141/280 (50%), Gaps = 28/280 (10%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH--KMVEQIKREISTMKLIKH 72
+ G+ LG+G+F +V +V+TG +A+K V D K V ++ EI +K ++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
+++ + + I +E++ GG + D++ +G L E R+Y +Q++ V+Y HS
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG-LLHTACGTPNYVAPEVLNDKG 191
+ HRD+K N+L DS G +K+ DFG S Q + G + + GTP +++PEV++ +G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
Y GR +DVWS G + ++ P+ E MA K++T + TN
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT------------QPTN---PQ 227
Query: 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 291
L PS S A+ ++R N R + ++L
Sbjct: 228 L---------PSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 4e-42
Identities = 83/287 (28%), Positives = 142/287 (49%), Gaps = 33/287 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y+ +GEG+ +V A + TG VAIK + LR + E I EI MK KHP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHP 75
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSR 132
N++ + ++++V+E++DGG L D I ++ R+ E + ++++ ++Y HS+
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
V HRD+K +N+LL G +K++DFG +A Q +E ++ GTP ++APEV+ K Y
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAA--QLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 193 DGRASDVWSCGVILFVLMAGFLP-FDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
+ D+WS G++ + G P E L AL+ ++T K
Sbjct: 194 GPKV-DIWSLGIMCIEMAEGEPPYLREPPLRALFL-ITT-----------KGI------- 233
Query: 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
P +S K + + L +P+ R + ++L+ + KK
Sbjct: 234 -----PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 4e-42
Identities = 89/325 (27%), Positives = 151/325 (46%), Gaps = 39/325 (12%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G+G + +V AK +TG+ VA+K + + + + V + E + K ++K++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
+Y+ +E++ GG+ + G L ED AR Y ++ AVD H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 141 PENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
PEN L+D+ G +K++DFGLS ++ ++ G+P+Y+APEVL KGYD D
Sbjct: 129 PENFLIDASGHIKLTDFGLSKGIVT-------YANSVVGSPDYMAPEVLRGKGYD-FTVD 180
Query: 199 VWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRAD 258
WS G +L+ + GF PF S + + + +K+ + Y R +
Sbjct: 181 YWSLGCMLYEFLCGFPPFSGSTPNETWENL----------KYWKETLQRPVYDDP--RFN 228
Query: 259 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK-------GYKPPHFDKEEEV 311
S +W LI ++++ ++ + +FK+ KPP + E
Sbjct: 229 LSDEAW------DLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPELE-- 280
Query: 312 NLDDVDAIFNDSKENLVTEKKEKPV 336
++D + D EN K K V
Sbjct: 281 --SEIDTGYFDDFENEDDMAKYKDV 303
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 5e-42
Identities = 73/198 (36%), Positives = 116/198 (58%), Gaps = 3/198 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG+G+F KV + TG + A+KI+ ++ ++ V E ++ +HP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
+ ++ V+E+ +GGELF +++ ED AR Y ++++A+ Y HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
LK ENL+LD G +KI+DFGL + + + + T CGTP Y+APEVL D Y GRA D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 199 VWSCGVILFVLMAGFLPF 216
W GV+++ +M G LPF
Sbjct: 178 WWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 83/281 (29%), Positives = 140/281 (49%), Gaps = 29/281 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIV--DRDQVLRHKMVEQIKREISTMKLIK 71
++ G LG GSF V N++ GDF A+K V D + V+Q+++EI+ + ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
HPN+++ + + +YI LE + GG L + K+G E R Y +Q++ ++Y H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
R HRD+K N+L+D+ GV+K++DFG+ ++QV E + G+P ++APEV+ +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGM---AKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
G A+D+WS G + + G P+ + +A K+ L
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP---------------- 221
Query: 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
P S AK I + L +P R T +++LE
Sbjct: 222 --------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 93/302 (30%), Positives = 140/302 (46%), Gaps = 39/302 (12%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--REISTMKLIKH 72
Y+ +GEG++ V A++ TG+ VAIK + REI +K + H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR---FESEGIPKTALREIKLLKELNH 57
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
PN+IK+++V K +Y+V EF+D +L + L E + Y QL+ + +CH
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCH 115
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVL-N 188
S G+ HRDLKPENLL+++ GVLK++DFGL ++ +T T Y APE+L
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGL---ARSFGSPVRPYTHYVVTRWYRAPELLLG 172
Query: 189 DKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246
DKGY D+WS G I L++ P S + L F G +
Sbjct: 173 DKGY-STPVDIWSVGCIFAELLSRRPLFPGK-SEIDQL------FKIFRTLGTPDPEVWP 224
Query: 247 KYSYTLQICRAD-FSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDE 294
K++ + R FS P S A L+ ++L +P R+T Q L
Sbjct: 225 KFT---SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP 281
Query: 295 WF 296
+F
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 3e-41
Identities = 70/219 (31%), Positives = 129/219 (58%), Gaps = 11/219 (5%)
Query: 18 GRTLGEGSFAKVKFAKNVETGDFVAIK-------IVDRDQVLRHKMVEQIKREISTMKLI 70
G +G+G++ +V A NV TG+ +A+K I R + MV+ ++ EI T+K +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
H N+++ + ++ + I LE++ GG + + +GR +E R + +Q++ + Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND- 189
S+G+ HRDLK +NLL+D+ G+ KISDFG+S S + ++ + G+ ++APEV++
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 190 -KGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYR 226
+GY + D+WS G ++ + AG P+ DE + A+++
Sbjct: 186 SQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-41
Identities = 97/321 (30%), Positives = 149/321 (46%), Gaps = 50/321 (15%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REISTMKL 69
+YE G+ LGEG++A V A++ ETG VAIK + + R + + I REI ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQE 58
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVD 127
+KHPN+I +++V K+ I +V EF++ +K+ K L + + Y + ++
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN------- 180
Y HS + HRDLKP NLL+ S GVLK++DFGL+ + G+PN
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQV 163
Query: 181 ----YVAPEVLNDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKVSTFHFL 234
Y APE+L + G D+WS G I L+ FLP +S++ L + F L
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDIDQLGK---IFEAL 219
Query: 235 SVYGESYKKCTNKYSYTLQICRADFSCPSW---F---SSGAKKLIKRILDPNPDTRMTIS 288
E ++ F F S A L++R+L NP+ R+T
Sbjct: 220 GTPTEENWPGVTSLPDYVEF--KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITAR 277
Query: 289 QMLEDEWFKKGYKPPHFDKEE 309
Q LE +F P +
Sbjct: 278 QALEHPYFSN--DPAPTPPSQ 296
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-41
Identities = 76/211 (36%), Positives = 121/211 (57%), Gaps = 4/211 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIK 77
+ +G+GSF KV AK G F A+K++ + +L+ K I E + + K +KHP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + K+Y VL++++GGELF + + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLKPEN+LLDS G + ++DFGL + V + T CGTP Y+APEVL + YD R
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
D W G +L+ ++ G PF ++ +Y +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-41
Identities = 81/268 (30%), Positives = 136/268 (50%), Gaps = 30/268 (11%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIK 77
R LG+GSF KV A+ E+G A+K++ +D +L+ VE E + L + HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + +++ V+EF++GG+L I K R E AR Y ++ +A+ + H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLD G K++DFG+ + + T CGTP+Y+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMC--KEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257
D W+ GV+L+ ++ G PF+ N L+ I
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEA--------------------------ILND 211
Query: 258 DFSCPSWFSSGAKKLIKRILDPNPDTRM 285
+ P+W S A ++K + NP R+
Sbjct: 212 EVVYPTWLSQDAVDILKAFMTKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 35/281 (12%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+++ + LG+GS+ V K + F A+K VD + K E EI + + HPN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDL-GSMSQKEREDAVNEIRILASVNHPN 60
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLK----EDEARRYFQQLINAVDYCH 130
+I E K+ IV+E+ G+L I+K + + E E R F QL+ + H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ + HRDLK N+LL + ++KI D G+S + ++ + T GTP+Y+APEV +
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVWKGR 176
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y SD+WS G +L+ + PF+ ++ L KV KY
Sbjct: 177 PYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV---------------QRGKYP- 219
Query: 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 291
P +S + I+ +L P R ++L
Sbjct: 220 ---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 71/205 (34%), Positives = 111/205 (54%), Gaps = 12/205 (5%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIK---IVDRDQVLRHKMVEQIKREISTMKL 69
KYE+ +GEG++ V +N TG+ VAIK + D+ ++ + RE+ ++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK----KTALREVKVLRQ 56
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
++H N++ + E K ++Y+V E+++ L A G L D R Y QL+ A+ YC
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVL- 187
HS + HRD+KPEN+L+ GVLK+ DFG + A+ + L T Y APE+L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPELLV 174
Query: 188 NDKGYDGRASDVWSCGVILFVLMAG 212
D Y G+ DVW+ G I+ L+ G
Sbjct: 175 GDTNY-GKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 71/224 (31%), Positives = 115/224 (51%), Gaps = 13/224 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REISTMKL 69
+Y++ +GEG+ V AK+ ETG+ VA+K +V ++ I REI ++
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALK-----KVALRRLEGGIPNQALREIKALQA 55
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDY 128
+HP V+K+++V + +V+E++ +L + + R L E + + Y + L+ V Y
Sbjct: 56 CQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
H+ G+ HRDLKP NLL+ + GVLKI+DFGL+ + E L T Y APE+L
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARL-FSEEEPRLYSHQVATRWYRAPELLY 173
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFD-ESNLMALYRKVSTF 231
D+W+ G I L+ G F E+++ L T
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTL 217
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-40
Identities = 83/236 (35%), Positives = 139/236 (58%), Gaps = 24/236 (10%)
Query: 19 RTLGEGSFAKVKFAKNV---ETGDFVAIKIVD------RDQVLRHKMVEQIKREISTMKL 69
+ LG+GSF KV + + + G A+K++ RD+V R KM I E++
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVN---- 56
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
HP ++K+ ++ K+Y++L+F+ GG+LF +++K E++ + Y +L A+D+
Sbjct: 57 --HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 114
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
HS G+ +RDLKPEN+LLD G +K++DFGLS + + + ++ CGT Y+APEV+N
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPF-----DESNLMALYRKVSTFHFLSVYGES 240
+G+ +++D WS GV++F ++ G LPF E+ M L K+ FLS +S
Sbjct: 173 RGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 72/198 (36%), Positives = 118/198 (59%), Gaps = 3/198 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG+G+F KV + TG + A+KI+ ++ ++ V E ++ +HP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
+ ++ V+E+ +GGELF +++ E+ AR Y ++++A++Y HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
+K ENL+LD G +KI+DFGL + + + + T CGTP Y+APEVL D Y GRA D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 199 VWSCGVILFVLMAGFLPF 216
W GV+++ +M G LPF
Sbjct: 178 WWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 85/267 (31%), Positives = 139/267 (52%), Gaps = 29/267 (10%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG+G+F KV + +G + A+KI+ ++ ++ V E +K +HP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
+K ++ V+E+++GGELF +++ ED R Y ++++A+DY HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
LK ENL+LD G +KI+DFGL + + + + T CGTP Y+APEVL D Y GRA D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 199 VWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRAD 258
W GV+++ +M G LPF Y + ++K I D
Sbjct: 178 WWGLGVVMYEMMCGRLPF--------------------YNQDHEKLFE------LILMED 211
Query: 259 FSCPSWFSSGAKKLIKRILDPNPDTRM 285
P S+ AK L+ +L +P+ R+
Sbjct: 212 IKFPRTLSADAKSLLSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 61/203 (30%), Positives = 115/203 (56%), Gaps = 4/203 (1%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+EL R +G+G+F KV + +T A+K +++ + + V + E ++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++ + + +Y+V++ + GG+L +++ + E++ + + +++ A++Y HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
HRD+KP+N+LLD G + I+DF ++ V D L + GTP Y+APEVL +GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATK---VTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 195 RASDVWSCGVILFVLMAGFLPFD 217
A D WS GV + + G P+
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 3e-39
Identities = 76/211 (36%), Positives = 123/211 (58%), Gaps = 4/211 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIK 77
+ +G+GSF KV A++ F A+K++ + +L+ K + I E + + K +KHP ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + K+Y VL++I+GGELF + + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLKPEN+LLDS G + ++DFGL + + +G T CGTP Y+APEVL+ + YD R
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLC--KENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
D W G +L+ ++ G PF N +Y +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 7e-39
Identities = 74/208 (35%), Positives = 120/208 (57%), Gaps = 3/208 (1%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G+GSF KV + +T A+K + + ++ V E + + + P ++ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
S K+Y+VL FI+GGELF + + GR AR Y +L+ A++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 141 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 200
PEN+LLD G + + DFGL ++ +++D +T CGTP Y+APE+L GY +A D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 201 SCGVILFVLMAGFLPFDESNLMALYRKV 228
+ GV+L+ ++ G PF + N+ +YRK+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-39
Identities = 91/284 (32%), Positives = 139/284 (48%), Gaps = 39/284 (13%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVD--RDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
LG+G+F KV A++ ETG F A KI+ ++ L MVE I + KHPN++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE-----IDILSECKHPNIVGL 67
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHR 137
E + K++I++EF DGG L + + R L E + R +Q++ A+++ HS V HR
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN-----DKGY 192
DLK N+LL G +K++DFG+SA ++ T GTP ++APEV+ D Y
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNK--STLQKRDTFIGTPYWMAPEVVACETFKDNPY 185
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252
D +A D+WS G+ L L P E N M + K+ E
Sbjct: 186 DYKA-DIWSLGITLIELAQMEPPHHELNPMRVLLKILK-------SEPPT---------- 227
Query: 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296
PS +SS +K L +PD R T +++L+ +
Sbjct: 228 ------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-38
Identities = 85/288 (29%), Positives = 147/288 (51%), Gaps = 35/288 (12%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+G +++ + +G+G F+ V A + G VA+K V +++ K + +EI +K +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGEL---FDKIAKHGRL-KEDEARRYFQQLINAVD 127
HPNVIK + ++ IVLE D G+L K RL E +YF QL +A++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI-SQQVREDGLLHTACGTPNYVAPEV 186
+ HS+ + HRD+KP N+ + + GV+K+ D GL S + H+ GTP Y++PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---AHSLVGTPYYMSPER 177
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKVSTFHFLSVYGESYKKC 244
+++ GY+ + SD+WS G +L+ + A PF D+ NL +L +K+ + + + Y
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHY--- 233
Query: 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
S + L+ R ++P+P+ R IS +L+
Sbjct: 234 ---------------------SEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 84/294 (28%), Positives = 139/294 (47%), Gaps = 41/294 (13%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
YEL +G G+ A V A + + VAIK +D ++ V+++++E+ M HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK--CQTSVDELRKEVQAMSQCNHPN 60
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCH 130
V+K ++++V+ ++ GG L D I K G L E ++++ ++Y H
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQV-REDGLLHTACGTPNYVAPEVLN 188
S G HRD+K N+LL G +KI+DFG+SA ++ R + T GTP ++APEV+
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 189 -DKGYDGRASDVWSCGVILFVLMAGFLPFD-----ESNLMALYRKVSTFHFLSVYGESYK 242
GYD +A D+WS G+ L G P+ + ++ L + G YK
Sbjct: 180 QVHGYDFKA-DIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLE----TGADYK 234
Query: 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296
K +S +K+I L +P R T ++L+ ++F
Sbjct: 235 K---------------------YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-38
Identities = 86/285 (30%), Positives = 141/285 (49%), Gaps = 37/285 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KYE R +G G+F V + V IK + +Q+ + + E +KL+ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHS 131
N+I+ E + IV+E+ GG L + I K L ED +F Q++ A+ + H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 132 RGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ + HRDLK +N+LLD + V+KI DFG IS+ + +T GTP Y++PE+ K
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFG---ISKILSSKSKAYTVVGTPCYISPELCEGK 176
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV--STFHFLSVYGESYKKCTNKY 248
Y+ + SD+W+ G +L+ L + F+ +NL AL K+ TF +S ++Y
Sbjct: 177 PYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS----------DRY 225
Query: 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293
S L ++LI +L+ +P R +SQ++
Sbjct: 226 SPDL-----------------RQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 92/303 (30%), Positives = 138/303 (45%), Gaps = 41/303 (13%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--------REI-S 65
Y++ + LG+G+F V A+N ETG+ VAIK KM ++ RE+ S
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIK----------KMKKKFYSWEECMNLREVKS 50
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLI 123
KL +HPN++K+ EV ++Y V E+++G L+ K K E R Q++
Sbjct: 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
+ + H G FHRDLKPENLL+ V+KI+DFGL ++++R T Y A
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGL---AREIRSRPPYTDYVSTRWYRA 166
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDESNLM-ALYRKVSTFHFLSVYGESY 241
PE+L D+W+ G I+ L P F S+ + LY+ S L +
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEIDQLYKICSV---LGTPTKQD 222
Query: 242 ----KKCTNKYSYTLQICRA----DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293
K +K + + S A LIK +L +P R T SQ L+
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNA--SPEAIDLIKDMLRWDPKKRPTASQALQH 280
Query: 294 EWF 296
+F
Sbjct: 281 PYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 6e-38
Identities = 74/211 (35%), Positives = 119/211 (56%), Gaps = 4/211 (1%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIK 77
+ +G+GSF KV AK G A+K++ + VL K + I E + + K +KHP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + K+Y VL+F++GGELF + + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLKPEN+LLDS G + ++DFGL + + + T CGTP Y+APEV+ + YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD-NTV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
D W G +L+ ++ G PF ++ +Y +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 75/199 (37%), Positives = 119/199 (59%), Gaps = 4/199 (2%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG+G+F KV K TG + A+KI+ ++ ++ V E ++ +HP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHR 137
+ ++ V+E+ +GGELF +++ ED AR Y ++++A+DY HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK ENL+LD G +KI+DFGL + +++ + T CGTP Y+APEVL D Y GRA
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 198 DVWSCGVILFVLMAGFLPF 216
D W GV+++ +M G LPF
Sbjct: 178 DWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 8e-38
Identities = 74/212 (34%), Positives = 123/212 (58%), Gaps = 9/212 (4%)
Query: 19 RTLGEGSFAKVKFAKNVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVI 76
RTLG GSF +V A + DF VAIK ++ ++++ K V+ + E + I HP +
Sbjct: 36 RTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFH 136
+ ++ +Y+VLEF+ GGE F + ++ R D Y Q++ +Y S + +
Sbjct: 95 NLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
RDLKPENLLLD G +K++DFG + + D +T CGTP Y+APE+L + G+ G+A
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGH-GKA 208
Query: 197 SDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
+D W+ G+ ++ ++ G PF + + +Y+K+
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPLLIYQKI 240
|
Length = 340 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 98/301 (32%), Positives = 153/301 (50%), Gaps = 34/301 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKI-VDRDQVLRHKMVEQIK-REISTMKLIK 71
KYE +GEGS+ V K+ ETG VAIK ++ + KMV++I REI +K ++
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED---DKMVKKIAMREIRMLKQLR 58
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
H N++ +IEV K ++Y+V EF+D L D L E R+Y Q++ +++CHS
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVL- 187
+ HRD+KPEN+L+ GV+K+ DFG + A +V D + T Y APE+L
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELLV 173
Query: 188 NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKVSTF-HFLSVYGESYKKC 244
D Y GRA D+W+ G ++ ++ G P D S++ LY + + + + E ++K
Sbjct: 174 GDTKY-GRAVDIWAVGCLVTEMLTGEPLFPGD-SDIDQLYHIIKCLGNLIPRHQEIFQK- 230
Query: 245 TNKYSYTLQICR---------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295
+ R + P S L K+ L +PD R + SQ+L E+
Sbjct: 231 ----NPLFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
Query: 296 F 296
F
Sbjct: 286 F 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 81/278 (29%), Positives = 147/278 (52%), Gaps = 31/278 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLI 70
+EL R LG G++ KV + V + G A+K++ + ++ + K E + E ++ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 71 KH-PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ P ++ + + TK++++L++++GGELF + + E E R Y +++ A+D+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN- 188
H G+ +RD+K EN+LLDS G + ++DFGLS E+ ++ CGT Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRG 180
Query: 189 -DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247
G+D +A D WS GV+ F L+ G PF +V GE + ++
Sbjct: 181 GSGGHD-KAVDWWSLGVLTFELLTGASPF------------------TVDGE--QNSQSE 219
Query: 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 285
S + + F P S+ A+ I+++L+ +P R+
Sbjct: 220 ISRRILKSKPPF--PKTMSAEARDFIQKLLEKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 86/279 (30%), Positives = 142/279 (50%), Gaps = 32/279 (11%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77
+ LG+GSF KV A+ T + AIK++ +D +L+ V+ E + L KHP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ +K +++ V+E+++GG+L +I + + E +R Y ++ A+ + H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLD+ G K++DFG+ + + T CGTP+Y+APE+L + Y G +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMC--KEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257
D W+ GV+++ +MAG PF+ N L+ ES I
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLF-------------ES-------------ILHD 211
Query: 258 DFSCPSWFSSGAKKLIKRILDPNPDTRM--TISQMLEDE 294
D P W S A ++K + NP+ R+ SQ ED
Sbjct: 212 DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDA 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 98/336 (29%), Positives = 156/336 (46%), Gaps = 47/336 (13%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77
+ LG+GSF KV A+ T +F AIK + +D VL VE E + L +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ +K ++ V+E+++GG+L I GR E AR Y ++I + + H +G+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLD G +KI+DFG+ + + +G T CGTP+Y+APE+L + Y+ +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYN-ESV 177
Query: 198 DVWSCGVILFVLMAGFLPF---DESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254
D WS GV+L+ ++ G PF DE L F I
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDEL---------FD--------------------SI 208
Query: 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK---------PPHF 305
P W S AK + ++ + +P R+ + + F +G PP F
Sbjct: 209 LNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPF 268
Query: 306 DKEEEVNLD--DVDAIFNDSKENLVTEKKEKPVSMN 339
+ + D + D F + K L K+ SM+
Sbjct: 269 KPKVKSPSDASNFDREFTNEKVRLSPVDKKLLASMD 304
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 90/327 (27%), Positives = 159/327 (48%), Gaps = 39/327 (11%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77
R +G GS+AKV + +T A+K++ ++ V + ++ ++ E + HP ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ ++++++ V+EF+ GG+L + + +L E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLD+ G +K++D+G+ + +R T CGTPNY+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMC--KEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ-ICR 256
D W+ GV++F +MAG PFD + G S N Y Q I
Sbjct: 178 DWWALGVLMFEMMAGRSPFD------------------IVGMSDNPDQNTEDYLFQVILE 219
Query: 257 ADFSCPSWFSSGAKKLIKRILDPNPDTRM------TISQMLEDEWFK---------KGYK 301
P S A ++K L+ +P R+ + +F+ K
Sbjct: 220 KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVL 279
Query: 302 PP-HFDKEEEVNLDDVDAIFNDSKENL 327
PP + E + +LD+ D F D L
Sbjct: 280 PPYKPNIESDRDLDNFDPQFTDEPVQL 306
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 72/250 (28%), Positives = 121/250 (48%), Gaps = 37/250 (14%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E + +G G+F +V+ + +TG A+K + + ++L + V ++ E + +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
V+K+ + +Y+++E++ GG++ + K E+E R Y + I A+D H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGL-------------------------SAISQQVRED 169
HRD+KP+NLLLD+ G +K+SDFGL IS+ +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 170 GLLHT-----------ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE 218
T GTP+Y+APEV GY + D WS GVI++ ++ G+ PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 219 SNLMALYRKV 228
N YRK+
Sbjct: 242 DNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 2e-35
Identities = 81/269 (30%), Positives = 142/269 (52%), Gaps = 23/269 (8%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIK 77
R +G GS+AKV + +T A+K+V ++ V + ++ ++ E + HP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ ++++++ V+E+++GG+L + + +L E+ AR Y ++ A++Y H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLDS G +K++D+G+ + +R T CGTPNY+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 198 DVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ-ICR 256
D W+ GV++F +MAG PFD + G S N Y Q I
Sbjct: 178 DWWALGVLMFEMMAGRSPFD------------------IVGSSDNPDQNTEDYLFQVILE 219
Query: 257 ADFSCPSWFSSGAKKLIKRILDPNPDTRM 285
P S A ++K L+ +P R+
Sbjct: 220 KQIRIPRSLSVKAASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 68/209 (32%), Positives = 112/209 (53%), Gaps = 9/209 (4%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+++ LGEGS+ V A + ETG VAIK+V ++ L ++I +EIS +K P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-----QEIIKEISILKQCDSPY 59
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRG 133
++K T ++IV+E+ G + D + + L E+E Q + ++Y HS
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
HRD+K N+LL+ G K++DFG+S Q +T GTP ++APEV+ + GY+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLM 222
+A D+WS G+ + G P+ + + M
Sbjct: 178 NKA-DIWSLGITAIEMAEGKPPYSDIHPM 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 70/213 (32%), Positives = 124/213 (58%), Gaps = 7/213 (3%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI--KREISTMKLIKH-PNVIK 77
+G+G+F +V + +T A+K++ + +++ K V +R I L+ P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + + +Y+V +++ GGELF + K GR ED A+ Y +L+ A+++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRA 196
DLKPEN+LLD+ G + + DFGLS + ++ +T CGT Y+APEV L++KGY +
Sbjct: 121 DLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 197 SDVWSCGVILFVLMAGFLPFDESNLMALYRKVS 229
D WS GV++F + G+ PF + +YR ++
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA 210
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-35
Identities = 69/222 (31%), Positives = 123/222 (55%), Gaps = 10/222 (4%)
Query: 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---RHKMVEQIKREISTMKLIKHPN 74
G+ LG G+F+ A++V+TG +A+K V + + ++VE +++EI M + HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+I+++ + + +E++ GG + ++K+G KE Y +QL+ + Y H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 135 FHRDLKPENLLLDSYG-VLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
HRD+K NLL+DS G L+I+DFG +A ++ GT ++APEVL +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDE---SNLMALYRKVST 230
Y GR+ DVWS G ++ + P++ SN +AL K+++
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 93/342 (27%), Positives = 150/342 (43%), Gaps = 64/342 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIK-I--VDRDQVLRHKMVEQIKREISTMKLI 70
+YEL + +G G++ V A + TG VAIK I V D + ++I REI ++ +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLID----AKRILREIKLLRHL 56
Query: 71 KHPNVIKIIEVMASKTK-----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ-QLIN 124
+H N+I +++++ + +YIV E ++ K+ K + D+ +YF Q++
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQYFLYQILR 114
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYV- 182
+ Y HS V HRDLKP N+L++S LKI DFGL+ + E G L T YV
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-----TE-YVV 168
Query: 183 -----APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH---- 232
APE+ L+ Y +A D+WS G I L+ L+
Sbjct: 169 TRWYRAPELLLSSSRYT-KAIDIWSVGCIFAELLTRK---------PLFPGRDYIDQLNL 218
Query: 233 FLSVYG----ESYKKCTN----KYSYTLQIC-RADFS--CPSWFSSGAKKLIKRILDPNP 281
+ V G E K T+ Y +L + S P S A L++++L +P
Sbjct: 219 IVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDP 277
Query: 282 DTRMTISQMLEDEWFKKGYKP---------PHFDKEEEVNLD 314
R+T + L + + + P FD ++ L
Sbjct: 278 KKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELT 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 80/276 (28%), Positives = 147/276 (53%), Gaps = 28/276 (10%)
Query: 15 YELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQ-VLRHKMVEQIKREISTMKLI 70
+EL + LG G++ KV + V +TG A+K++ + V + K VE + E + ++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 71 KH-PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ P ++ + ++ K++++L+++ GGE+F + + EDE R Y ++I A+++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
H G+ +RD+K EN+LLDS G + ++DFGLS E ++ CGT Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSK-EFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249
KG G+A D WS G+++F L+ G PF ++ GE +
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPF------------------TLEGER----NTQSE 218
Query: 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 285
+ +I + D PS+ A+ L+ ++L +P R+
Sbjct: 219 VSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 82/281 (29%), Positives = 147/281 (52%), Gaps = 31/281 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY + +GEGSF K K+ E G IK ++ + + K E+ ++E++ + +KHP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRL-KEDEARRYFQQLINAVDYCHS 131
N+++ E +YIV+++ +GG+L+ KI A+ G L ED+ +F Q+ A+ + H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
R + HRD+K +N+ L G +K+ DFG++ + E L T GTP Y++PE+ ++
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
Y+ + SD+W+ G +L+ + F+ N+ L K+ + G SY ++ YSY
Sbjct: 178 YNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI-------IRG-SYPPVSSHYSYD 228
Query: 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
L + L+ ++ NP R +++ +LE
Sbjct: 229 L-----------------RNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 70/230 (30%), Positives = 130/230 (56%), Gaps = 9/230 (3%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
K+ + + Y++ + +G G+F +V+ ++ + A+K++ + ++++ E
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
M P V+++ +Y+V+E++ GG+L + ++ + + E A+ Y +++
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVV 152
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH--TACGTPNY 181
A+D HS G+ HRD+KP+N+LLD +G LK++DFG ++ E G++ TA GTP+Y
Sbjct: 153 LALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVRCDTAVGTPDY 209
Query: 182 VAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
++PEVL + GY GR D WS GV LF ++ G PF +L+ Y K+
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 73/221 (33%), Positives = 123/221 (55%), Gaps = 6/221 (2%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIV--DRDQVLRHKMVEQIKREISTMKLIKH 72
+ LG+ LG G+F +V + +TG +A+K V D D K V ++ EI +K ++H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 73 PNVIKIIEVMASKT--KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+++ + K+ I +E++ GG + D++ +G L E+ RRY +Q++ V Y H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL-LHTACGTPNYVAPEVLND 189
S + HRD+K N+L DS G +K+ DFG S Q + G + + GTP +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVST 230
+GY GR +DVWS + ++ P+ E MA K++T
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 82/280 (29%), Positives = 131/280 (46%), Gaps = 31/280 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
Y R LG+G+F + + E V K V+ + L K EI + L++HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPN 60
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYCHSR 132
+I + I +E+ +GG L+DKI K +E+ Y Q+++AV Y H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
G+ HRD+K N+ L G++K+ DFG+S I E + T GTP Y++PE+ Y
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS--EYSMAETVVGTPYYMSPELCQGVKY 178
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252
+ + SD+W+ G +L+ L+ FD +N + L K+ V G YT
Sbjct: 179 NFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKI-------VQGN----------YTP 220
Query: 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
S +SS L+ +L +P+ R T ++L+
Sbjct: 221 V--------VSVYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 68/198 (34%), Positives = 118/198 (59%), Gaps = 4/198 (2%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKII 79
LG+GSF KV A+ T + AIKI+ +D +++ VE E + L P + ++
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
+ ++Y V+E+++GG+L I + G+ KE A Y ++ + + HS+G+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 199
K +N++LD+ G +KI+DFG+ + + T CGTP+Y+APE++ + Y G++ D
Sbjct: 128 KLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 200 WSCGVILFVLMAGFLPFD 217
W+ GV+L+ ++AG PFD
Sbjct: 185 WAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 83/283 (29%), Positives = 143/283 (50%), Gaps = 34/283 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+YE+ + +GEGSF K+ AK + IK +D + + K E K+E+ + +KHP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGRL-KEDEARRYFQQLINAVDYCHS 131
N++ +++IV+E+ DGG+L +I + G L ED+ +F Q+ + + H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 132 RGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
R + HRD+K +N+ L G V K+ DFG++ E L +T GTP Y++PE+ ++
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNR 177
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y+ + +D+WS G +L+ L PF+ +NL L
Sbjct: 178 PYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQL-------------------------- 210
Query: 251 TLQICRADFSCPS-WFSSGAKKLIKRILDPNPDTRMTISQMLE 292
L+IC+ F+ S FS + LI ++ +P R +I+ +L+
Sbjct: 211 VLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 67/223 (30%), Positives = 114/223 (51%), Gaps = 7/223 (3%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+++ +G G F +V+ + TGD A+K++ + +L + V + E + + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRG 133
+ ++ K +Y+V+E+ GG+L + ++ + ED A+ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
HRD+KPEN+L+D G +K++DFG SA + GTP+Y+APEVL D
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181
Query: 194 GRAS-----DVWSCGVILFVLMAGFLPFDESNLMALYRKVSTF 231
G+ + D WS GVI + ++ G PF E Y + F
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF 224
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 9e-34
Identities = 69/253 (27%), Positives = 115/253 (45%), Gaps = 20/253 (7%)
Query: 16 ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
LG+ LGEG+F +V VA+K + D + E+ RE M+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLD 59
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGEL--FDKIAKHGRLKEDEARRYFQQLINAVDYC 129
HPN++K++ V + + IV+E++ GG+L + + + L + + Q+ ++Y
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-P-NYVAPEVL 187
S+ HRDL N L+ V+KISDFGL S+ + +D G P ++APE L
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 188 NDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246
+ + SDVWS GV+L+ + G P+ + + + + L C
Sbjct: 177 KEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL----PKPPNCPP 231
Query: 247 K-YSYTLQICRAD 258
+ Y LQ D
Sbjct: 232 ELYKLMLQCWAED 244
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 77/237 (32%), Positives = 137/237 (57%), Gaps = 12/237 (5%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKII 79
LG+GSF KV A+ T + AIKI+ +D V++ VE E + L K P + ++
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
+ ++Y V+E+++GG+L +I + GR KE A Y ++ + + HS+G+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 199
K +N++LDS G +KI+DFG+ + + + T CGTP+Y+APE++ + Y G++ D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC--KENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 200 WSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICR 256
W+ GV+L+ ++AG PF+ + L++ + + +Y K +K + + IC+
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------AYPKSMSKEA--VAICK 233
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 72/230 (31%), Positives = 129/230 (56%), Gaps = 9/230 (3%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
K+ R + YE+ + +G G+F +V+ ++ T A+K++ + ++++ E
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
M P V+++ +Y+V+E++ GG+L + ++ + + E AR Y +++
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVV 152
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH--TACGTPNY 181
A+D HS G HRD+KP+N+LLD G LK++DFG ++ ++G++ TA GTP+Y
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMNKEGMVRCDTAVGTPDY 209
Query: 182 VAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
++PEVL + GY GR D WS GV L+ ++ G PF +L+ Y K+
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 78/238 (32%), Positives = 136/238 (57%), Gaps = 12/238 (5%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKII 79
LG+GSF KV A+ T + AIKI+ +D V++ VE E + L K P + ++
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
+ ++Y V+E+++GG+L I + G+ KE +A Y ++ + + H RG+ +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 199
K +N++LDS G +KI+DFG+ + + + T CGTP+Y+APE++ + Y G++ D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 200 WSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257
W+ GV+L+ ++AG PFD + L++ + + SY K +K + + IC+
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIME------HNVSYPKSLSKEA--VSICKG 234
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 65/213 (30%), Positives = 114/213 (53%), Gaps = 9/213 (4%)
Query: 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVD---RDQVLRHKMVEQIKREISTMKLIKHPN 74
G LG+G++ V + G +A+K V+ + + K E+++ E+ +K +KH N
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+++ + I I +EF+ GG + + + G L E +Y +Q+++ V Y H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 135 FHRDLKPENLLLDSYGVLKISDFG----LSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
HRD+K N++L G++K+ DFG L+ + +L + GTP ++APEV+N+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMA 223
GY GR SD+WS G +F + G P + +A
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLA 215
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 95/306 (31%), Positives = 143/306 (46%), Gaps = 44/306 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE-----QIK----REI 64
KYE +GEGS+ V +N ETG VAIK K VE IK REI
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIK----------KFVESEDDPVIKKIALREI 51
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLI 123
+K +KHPN++ +IEV K K+++V E+ D + +++ K+ R + E ++ Q +
Sbjct: 52 RMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTL 110
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
AV++CH HRD+KPEN+L+ G +K+ DFG + I T Y A
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRA 168
Query: 184 PEVL-NDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKVSTFHFL-----S 235
PE+L D Y G DVW+ G + L+ G P +S++ LY T L
Sbjct: 169 PELLVGDTQY-GPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226
Query: 236 VYGESYKKCTNKYSYTLQICRADFSCP-----SWFSSGAKKLIKRILDPNPDTRMTISQM 290
++ TN++ L I + P SS A +K L +P R++ ++
Sbjct: 227 IFS------TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280
Query: 291 LEDEWF 296
LE +F
Sbjct: 281 LEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 85/287 (29%), Positives = 143/287 (49%), Gaps = 33/287 (11%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ +++ + +G G F++V A + VA+K V +++ K + +EI +K +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI---AKHGRL-KEDEARRYFQQLINAVD 127
HPNVIK ++ ++ IVLE D G+L I K RL E +YF QL +AV+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
+ HSR V HRD+KP N+ + + GV+K+ D GL + H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKVSTFHFLSVYGESYKKCT 245
++ GY+ + SD+WS G +L+ + A PF D+ NL +L +K+ + + E Y
Sbjct: 179 HENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHY---- 233
Query: 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
S ++L+ + P+PD R I + +
Sbjct: 234 --------------------SEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 42/239 (17%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+T+G G+F +V + V+T A+K + + VL +K E + + V+K+
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
K +Y V+++I GG++ + + G +ED AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 139 LKPENLLLDSYGVLKISDFGLSA------------ISQQVREDG---------------- 170
+KP+N+L+D G +K++DFGL R+D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 171 -------------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 216
L H+ GTPNY+APEVL GY + D WS GVIL+ ++ G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDF----VAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
ELG+ LGEG+F +V G+ VA+K + + E+ E S MK +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLS 59
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCH 130
HPN+++++ V +YIV E++ GG+L D + KHG L + + Q+ ++Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVL 187
S+ HRDL N L+ V+KISDFGL S+ + ED G ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGL---SRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 188 NDKGYDGRASDVWSCGVILFVLMA-GFLPF 216
D + SDVWS GV+L+ + G P+
Sbjct: 177 KDGKFT-SKSDVWSFGVLLWEIFTLGEQPY 205
|
Length = 258 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 85/293 (29%), Positives = 137/293 (46%), Gaps = 33/293 (11%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LGEG++A V +N TG+ VA+K + D REIS MK +KH N++++ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 81 VMASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
V+ ++ K+ +V E++D + D G L + + + QL+ + +CH V HRD
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125
Query: 139 LKPENLLLDSYGVLKISDFGL--------SAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
LKP+NLL++ G LK++DFGL + S +V T Y AP+VL
Sbjct: 126 LKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----------TLWYRAPDVLLGS 175
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPF----DESNLMALYRKVSTFHFLSVYGESYKKCTN 246
+ D+WS G I+ ++ G F +E L+ ++R + T + G S
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ---LP 232
Query: 247 KYSYTLQIC-RADFSC--PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296
+Y T D P L+ R+L NP+ R++ L+ WF
Sbjct: 233 EYKPTFPRYPPQDLQQLFPH-ADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 72/194 (37%), Positives = 105/194 (54%), Gaps = 9/194 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+GEG++ V A++ TG+ VA+K + + I REIS +K + HPN++++++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-REISLLKELNHPNIVRLLD 65
Query: 81 VMASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
V+ S+ K+Y+V EF+D + D G L + Y QL+ + YCHS V HRD
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124
Query: 139 LKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
LKP+NLL+D G LK++DFGL+ A VR H T Y APE+L
Sbjct: 125 LKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVV-TLWYRAPEILLGSRQYSTPV 181
Query: 198 DVWSCGVILFVLMA 211
D+WS G I F M
Sbjct: 182 DIWSIGCI-FAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 86/306 (28%), Positives = 139/306 (45%), Gaps = 43/306 (14%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--- 71
YE +GEG++ V A+++ TG FVA+K V R + + REI+ +K ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 72 HPNVIKIIEV-----MASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLIN 124
HPN++++++V + K+ +V E +D K K G L + + +QL+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLR 118
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI-SQQVREDGLLHTACGTPNYVA 183
VD+ HS + HRDLKP+N+L+ S G +KI+DFGL+ I S ++ L + T Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA----LTSVVVTLWYRA 174
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVS-------TFHFLSV 236
PEVL Y D+WS G I L L+R S F + +
Sbjct: 175 PEVLLQSSY-ATPVDMWSVGCIFAEL---------FRRRPLFRGTSEADQLDKIFDVIGL 224
Query: 237 YGE------SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQM 290
E ++ + F P G L+K++L NP R++ +
Sbjct: 225 PSEEEWPRNVSLPRSS-FPSYTPRSFKSF-VPEICEEGL-DLLKKMLTFNPHKRISAFEA 281
Query: 291 LEDEWF 296
L+ +F
Sbjct: 282 LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-33
Identities = 77/234 (32%), Positives = 119/234 (50%), Gaps = 24/234 (10%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIV---DRDQVLRHKMVE 58
S P++ + + E +G G+ V + TG A+K++ D V R
Sbjct: 63 SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----- 117
Query: 59 QIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY 118
QI REI ++ + HPNV+K ++ +I ++LEF+DGG L + D AR
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-- 175
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
Q+++ + Y H R + HRD+KP NLL++S +KI+DFG+S I Q + +++ GT
Sbjct: 176 --QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGT 231
Query: 179 PNYVAPEV----LNDKGYDGRASDVWSCGVILFVLMAGFLPF------DESNLM 222
Y++PE LN YDG A D+WS GV + G PF D ++LM
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM 285
|
Length = 353 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 67/216 (31%), Positives = 112/216 (51%), Gaps = 6/216 (2%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ +G+GSF V A+K +D ++ R + E+ E + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSY 60
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSR 132
+I+ E K K+ IV+E+ + G+L + L ED+ R+F Q++ + + HS+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
+ HRD+K NL LD+Y +KI D G++ + +T GTP Y++PE+ DK Y
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDKPY 178
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
+ + SDVW+ GV+L+ G PFD +N AL K+
Sbjct: 179 NEK-SDVWALGVVLYECCTGKHPFDANNQGALILKI 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 75/288 (26%), Positives = 140/288 (48%), Gaps = 44/288 (15%)
Query: 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-----LRHK-MVEQIKREISTMKLIK 71
G +G GSF V N +G+ +A+K V+ V R + M++ + REI+ +K ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
H N+++ + + I LE++ GG + + +G +E R + +Q++ ++Y H+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--PN------YVA 183
RG+ HRD+K N+L+D+ G +KISDFG IS+++ E L T P+ ++A
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFG---ISKKL-EANSLSTKTNGARPSLQGSVFWMA 180
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243
PEV+ Y R +D+WS G ++ ++ G PF + + K+
Sbjct: 181 PEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-------------- 225
Query: 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 291
+ + PS SS A +++ + + + R T +++L
Sbjct: 226 ---------ENASPEI--PSNISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 7e-33
Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 19/252 (7%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDF----VAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
LG+ LGEG+F +V K G VA+K + D + +E+ RE M+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASE--QQIEEFLREARIMRKLD 59
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCH 130
HPNV+K++ V + +YIV+E+++GG+L + K+ +L + + Q+ ++Y
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-P-NYVAPEVLN 188
S+ HRDL N L+ V+KISDFGL S+ + +D G P ++APE L
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 189 DKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247
+ + SDVWS GV+L+ + G P+ + + + + L C +
Sbjct: 177 EGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL----PQPPNCPPE 231
Query: 248 -YSYTLQICRAD 258
Y LQ D
Sbjct: 232 LYDLMLQCWAED 243
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 1e-32
Identities = 89/297 (29%), Positives = 146/297 (49%), Gaps = 49/297 (16%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVD--RDQVLRHKMVEQIKREISTMKLIKH 72
+E+ LG+G+F KV AKN ETG A K+++ ++ L MVE I + H
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVE-----IEILATCNH 68
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHS 131
P ++K++ K++I++EF GG + + + R L E + + +Q++ A+ Y HS
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV--REDGLLHTACGTPNYVAPEV--- 186
+ HRDLK N+LL G +K++DFG+SA + + R D + GTP ++APEV
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMC 184
Query: 187 --LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244
+ D YD +A D+WS G+ L + P E N M +
Sbjct: 185 ETMKDTPYDYKA-DIWSLGITLIEMAQIEPPHHELNPMRVL------------------- 224
Query: 245 TNKYSYTLQICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
L+I +++ S PS +S + +K LD +P+TR + +Q+LE +
Sbjct: 225 -------LKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 62/192 (32%), Positives = 105/192 (54%), Gaps = 8/192 (4%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ L +G+GSF +V A + T VAIK++D ++ +E I++EI + + P
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+ K +K++I++E+ GG D + K G+L E ++++ ++Y H G
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL-LHTACGTPNYVAPEVLNDKGY 192
HRD+K N+LL G +K++DFG+S Q+ +T GTP ++APEV+ GY
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 193 DGRASDVWSCGV 204
D +A D+WS G+
Sbjct: 176 DEKA-DIWSLGI 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 73/210 (34%), Positives = 123/210 (58%), Gaps = 14/210 (6%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVD-RDQVLRHKMVEQIKREISTMKLIKHPNVIKII 79
+GEGS V A + TG VA+K +D R Q R E + E+ M+ +HPN++++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR----ELLFNEVVIMRDYQHPNIVEMY 82
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
++++V+EF++GG L D I H R+ E++ ++ A+ + H++GV HRD+
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDI 141
Query: 140 KPENLLLDSYGVLKISDFGLSA-ISQQV-REDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
K +++LL S G +K+SDFG A +S++V R L+ GTP ++APEV++ Y
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPYGTEV- 196
Query: 198 DVWSCGVILFVLMAGFLP-FDESNLMALYR 226
D+WS G+++ ++ G P F+E L A+ R
Sbjct: 197 DIWSLGIMVIEMVDGEPPYFNEPPLQAMKR 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 67/230 (29%), Positives = 127/230 (55%), Gaps = 9/230 (3%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
K+ R + +++ + +G G+F +V+ ++ + A+K++ + ++++ E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
M ++++ +Y+V+E++ GG+L + ++ + + E AR Y +++
Sbjct: 94 RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVV 152
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH--TACGTPNY 181
A+D HS G HRD+KP+N+LLD G LK++DFG ++ +G++ TA GTP+Y
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMDANGMVRCDTAVGTPDY 209
Query: 182 VAPEVLNDKGYD---GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
++PEVL +G D GR D WS GV L+ ++ G PF +L+ Y K+
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 63/200 (31%), Positives = 121/200 (60%), Gaps = 4/200 (2%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIK 77
R +G GS+AKV + + A+K+V ++ V + ++ ++ E + +P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + +++++V+E+++GG+L + + +L E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLD+ G +K++D+G+ + + T CGTPNY+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMC--KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 198 DVWSCGVILFVLMAGFLPFD 217
D W+ GV++F +MAG PFD
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 72/247 (29%), Positives = 120/247 (48%), Gaps = 34/247 (13%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E + +G G+F +V+ + +TG A+KI+ + +L + V I+ E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
V+K+ K +Y+++EF+ GG++ + K L E+ + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGL---------------------------------SA 161
HRD+KP+NLLLD+ G +K+SDFGL A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL 221
+ + L ++ GTP+Y+APEV GY+ + D WS GVI++ ++ G+ PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 222 MALYRKV 228
YRKV
Sbjct: 242 QETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI---KREISTMKLIKHPNVIK 77
LG G F KV A+ +TG+ AIK + + ++ VE + KR T +HP ++
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ ++ + V+E+ GG+L I E A Y ++ + Y H + +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH-----TACGTPNYVAPEVLNDKGY 192
DLK +NLLLD+ G +KI+DFGL ++G+ T CGTP ++APEVL + Y
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFCGTPEFLAPEVLTETSY 178
Query: 193 DGRASDVWSCGVILFVLMAGFLPF 216
RA D W GV+++ ++ G PF
Sbjct: 179 -TRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 5e-32
Identities = 83/284 (29%), Positives = 139/284 (48%), Gaps = 36/284 (12%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77
+ LG+GSF KV A+ G++ A+K + +D VL VE E + L ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ +K ++ V+EF++GG+L I GR A Y +++ + + HS+G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N++LD G +KI+DFG+ + V D T CGTP+Y+APE+L Y +
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYT-FSV 177
Query: 198 DVWSCGVILFVLMAGFLPF---DESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254
D WS GV+L+ ++ G PF DE L R V T H+
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIR-VDTPHY--------------------- 215
Query: 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
P W + +K +++++ + +P R+ + + F K
Sbjct: 216 -------PRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 92/313 (29%), Positives = 169/313 (53%), Gaps = 42/313 (13%)
Query: 15 YELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLI 70
+EL + LG G++ KV + V ++G A+K++ + ++ + K E + E ++ I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 71 KH-PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ P ++ + + TK++++L++I+GGELF +++ R KE E + Y +++ A+++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL--LHTACGTPNYVAPEVL 187
H G+ +RD+K EN+LLDS G + ++DFGL S++ ED + ++ CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGL---SKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 188 --NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245
D G+D +A D WS GV+++ L+ G PF +V GE
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPF------------------TVDGEK----N 215
Query: 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 305
++ + +I +++ P S+ AK +I+R+L +P R+ DE K P F
Sbjct: 216 SQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH----PFF 271
Query: 306 DKEEEVNLDDVDA 318
K +N DD+ A
Sbjct: 272 QK---INWDDLAA 281
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 72/193 (37%), Positives = 108/193 (55%), Gaps = 9/193 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+GEG++ V A+N TG+ VA+K + D I REIS +K + HPN++K+++
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 66
Query: 81 VMASKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
V+ ++ K+Y+V EF+ D + D G + + Y QL+ + +CHS V HRD
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSG-IPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125
Query: 139 LKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
LKP+NLL+++ G +K++DFGL+ A VR H T Y APE+L Y A
Sbjct: 126 LKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYSTAV 182
Query: 198 DVWSCGVILFVLM 210
D+WS G I F M
Sbjct: 183 DIWSLGCI-FAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 70/218 (32%), Positives = 123/218 (56%), Gaps = 6/218 (2%)
Query: 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIV--DRDQVLRHKMVEQIKREISTMKLIKHPNV 75
G+ LG+G+F +V +V+TG +A K V D + K V ++ EI +K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 76 IKIIEVMASKTK--IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++ + + + + I +E++ GG + D++ +G L E R+Y +Q++ + Y HS
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL-LHTACGTPNYVAPEVLNDKGY 192
+ HRD+K N+L DS G +K+ DFG S Q + G + + GTP +++PEV++ +GY
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVST 230
GR +DVWS G + ++ P+ E MA K++T
Sbjct: 187 -GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 73/223 (32%), Positives = 121/223 (54%), Gaps = 23/223 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIV---DRDQVLRHKMVEQIKREISTMKLI 70
YEL + +G G++ V A+++ TG+ VAIK++ D E I++EIS +K
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF------EIIQQEISMLKEC 57
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDY 128
+HPN++ + K++IV+E+ GG L D I + R L E + ++ + + Y
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVL 187
H G HRD+K N+LL G +K++DFG+SA ++ + + + GTP ++APEV
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR---KSFIGTPYWMAPEVA 173
Query: 188 NDK---GYDGRASDVWSCGVILFVLMAGFLP--FDESNLMALY 225
+ GYDG+ D+W+ G I + +A P FD + AL+
Sbjct: 174 AVERKGGYDGKC-DIWALG-ITAIELAELQPPMFDLHPMRALF 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 66/215 (30%), Positives = 116/215 (53%), Gaps = 14/215 (6%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E + + G++ V ++ ET A+K +++ ++ ++Q+ E + ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
V+ + +K + +V+E+++GG+ + G L D AR YF + + A++Y H+ G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH-------------TACGTPNY 181
HRDLKP+NLL+ S G +K++DFGLS I L CGTP Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 216
+APEV+ +GY G+ D W+ G+IL+ + G +PF
Sbjct: 183 IAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-31
Identities = 83/283 (29%), Positives = 139/283 (49%), Gaps = 33/283 (11%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ + + + +G G F++V A + G VA+K V ++ K +EI +K +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI---AKHGRL-KEDEARRYFQQLINAVD 127
HPNVIK ++ IVLE D G+L I K RL E +YF QL +A++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
+ HSR V HRD+KP N+ + + GV+K+ D GL + H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKVSTFHFLSVYGESYKKCT 245
++ GY+ + SD+WS G +L+ + A PF D+ NL +L +K+ + + + Y
Sbjct: 179 HENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY---- 233
Query: 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 288
S ++L+ ++P+P+ R I+
Sbjct: 234 --------------------SEELRQLVNMCINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 70/221 (31%), Positives = 123/221 (55%), Gaps = 6/221 (2%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIV--DRDQVLRHKMVEQIKREISTMKLIKH 72
+ LG+ LG+G+F +V + +TG +A+K V D + K V ++ EI +K + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 73 PNVIKIIEVM--ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+++ + + + I +E + GG + D++ +G L E+ R+Y +Q++ V Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL-LHTACGTPNYVAPEVLND 189
S + HRD+K N+L DS G +K+ DFG S Q + G + + GTP +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVST 230
+GY GR +D+WS G + ++ P+ E MA K++T
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-31
Identities = 83/274 (30%), Positives = 133/274 (48%), Gaps = 38/274 (13%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77
+ LG+GSF KV A+ T F AIK + +D VL VE E + L +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ +K ++ V+E+++GG+L I + A Y ++I + + HS+G+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
DLK +N+LLD+ G +KI+DFG+ + + D T CGTP+Y+APE+L + Y +
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177
Query: 198 DVWSCGVILFVLMAGFLPF---DESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254
D WS GV+L+ ++ G PF DE L Q
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEEL------------------------------FQS 207
Query: 255 CRADFSC-PSWFSSGAKKLIKRILDPNPDTRMTI 287
R D C P W + AK ++ ++ P+ R+ +
Sbjct: 208 IRMDNPCYPRWLTREAKDILVKLFVREPERRLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 88/305 (28%), Positives = 149/305 (48%), Gaps = 46/305 (15%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIK-----IVDRDQVLRHKMVEQIKREISTMK- 68
Y++ +GEG+F++V A++ +TG + AIK +QV REI ++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-------REIQALRR 53
Query: 69 LIKHPNVIKIIEVMASKT--KIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINA 125
L HPN++++IEV+ + ++ +V E +D L++ I R L E + Y QL+ +
Sbjct: 54 LSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG-LSAISQQVREDGLLHTA-CGTPNYVA 183
+D+ H G+FHRD+KPEN+L+ +LK++DFG I + +T T Y A
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSK-----PPYTEYISTRWYRA 166
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH-FLSVYGESYK 242
PE L GY G D+W+ G + F +++ F F +N + +++ H L
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVL 223
Query: 243 KCTNKYSYTLQICRADFSCPSWFSSGAKK-----------LIKRILDPNPDTRMTISQML 291
K K +++ PS +G +K L+K++L +PD R+T Q L
Sbjct: 224 KKFRKSR------HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277
Query: 292 EDEWF 296
+F
Sbjct: 278 RHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 73/247 (29%), Positives = 120/247 (48%), Gaps = 34/247 (13%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E + +G G+F +V+ + +TG A+KI+ + +L + V I+ E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
V+K+ K +Y+++EF+ GG++ + K L E+E + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 135 FHRDLKPENLLLDSYGVLKISDFGL---------------------------------SA 161
HRD+KP+NLLLDS G +K+SDFGL A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL 221
+ + L + GTP+Y+APEV GY+ + D WS GVI++ ++ G+ PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 222 MALYRKV 228
Y+KV
Sbjct: 242 QETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 4e-31
Identities = 73/209 (34%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLI 70
G +EL +GEG++ KV A++ +TG VAIKI+D + E+IK E + + K
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 71 KHPNVIKIIEVMASKT------KIYIVLEFIDGG---ELFDKIAKHG-RLKEDEARRYFQ 120
HPN+ K ++++V+E GG +L + K G RLKE+ +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
+ + + Y H V HRD+K +N+LL +K+ DFG+SA Q G +T GTP
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPY 178
Query: 181 YVAPEVLN-----DKGYDGRASDVWSCGV 204
++APEV+ D YD R SDVWS G+
Sbjct: 179 WMAPEVIACDEQPDASYDAR-SDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 85/308 (27%), Positives = 138/308 (44%), Gaps = 63/308 (20%)
Query: 23 EGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK-------REISTMKLIKHPNV 75
EG++ V A++ +TG+ VA+K + KM ++ + REI+ + ++HPN+
Sbjct: 15 EGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLREINILLKLQHPNI 66
Query: 76 IKIIEVMASKT--KIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSR 132
+ + EV+ KIY+V+E+++ +L + + E + QL++ V + H
Sbjct: 67 VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-----------Y 181
+ HRDLK NLLL++ G+LKI DFGL+ RE G+P Y
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLA------RE-------YGSPLKPYTQLVVTLWY 172
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKVST------- 230
APE+L A D+WS G I L+ F + L +++ + T
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232
Query: 231 -FHFLSVYGESYKKCT-NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 288
F L KK T KY Y R F S +G L+ R+L +P R++
Sbjct: 233 GFSELP----GAKKKTFTKYPYNQ--LRKKFPALSLSDNGF-DLLNRLLTYDPAKRISAE 285
Query: 289 QMLEDEWF 296
L+ +F
Sbjct: 286 DALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 85/280 (30%), Positives = 135/280 (48%), Gaps = 32/280 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y + R +GEGSF + ++V + A+K + R VE ++E + +KHP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSA-VEDSRKEAVLLAKMKHP 58
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIA-KHGRL-KEDEARRYFQQLINAVDYCHS 131
N++ E + +YIV+E+ DGG+L KI + G+L ED ++F Q+ V + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
+ V HRD+K +N+ L G +K+ DFG + + T GTP YV PE+ +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMP 176
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
Y+ + SD+WS G IL+ L PF ++ L KV SYK + YSY
Sbjct: 177 YNNK-SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------GSYKPLPSHYSYE 227
Query: 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 291
L+ LIK++ NP +R + + +L
Sbjct: 228 LRS-----------------LIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 69/194 (35%), Positives = 110/194 (56%), Gaps = 8/194 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+GEG++ V +N +TG VA+K + R + + REIS +K ++HPN++ + +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 81 VMASKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
V+ ++++Y++ EF+ D + D + K + + + Y Q++ + +CHSR V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 139 LKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
LKP+NLL+D+ GV+K++DFGL+ A VR H T Y APEVL
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVRV--YTHEVV-TLWYRAPEVLLGSPRYSTPV 183
Query: 198 DVWSCGVILFVLMA 211
D+WS G I F MA
Sbjct: 184 DIWSIGTI-FAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 35/217 (16%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--------RE 63
V KYE +G+G+F +V A++ +T VA+K V ++E K RE
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV---------LMENEKEGFPITALRE 61
Query: 64 ISTMKLIKHPNVIKIIEVMASKTK--------IYIVLEFID---GGELFDKIAKHGRLKE 112
I ++L+KH NV+ +IE+ +K Y+V EF + G L +K K
Sbjct: 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTL 118
Query: 113 DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGL 171
E ++ + L+N + Y H + HRD+K N+L+ G+LK++DFGL+ A S
Sbjct: 119 SEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178
Query: 172 LHTA-CGTPNYVAPEV-LNDKGYDGRASDVWSCGVIL 206
+T T Y PE+ L ++ Y G D+W G I+
Sbjct: 179 RYTNRVVTLWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 75/243 (30%), Positives = 113/243 (46%), Gaps = 46/243 (18%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+TLG G+F +V A+ V+T A+K + + VL V +K E + + V+++
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
K +Y V+++I GG++ + + G ED AR Y +L AV+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 139 LKPENLLLDSYGVLKISDFGLSA------------ISQQVREDG---------------- 170
+KP+N+L+D G +K++DFGL VR+D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 171 -----------------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF 213
L H+ GTPNY+APEVL GY + D WS GVIL+ ++ G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 214 LPF 216
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 76/243 (31%), Positives = 114/243 (46%), Gaps = 46/243 (18%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+TLG G+F +V A V+T A+K + + VL V +K E + + V+K+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
K +Y V+++I GG++ + + E AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 139 LKPENLLLDSYGVLKISDFGL---------SAISQQ---VREDG---------------- 170
+KP+N+L+D G +K++DFGL S Q+ +R+D
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 171 -----------------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF 213
L H+ GTPNY+APEVL KGY + D WS GVILF ++ G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 214 LPF 216
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 8e-30
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 19 RTLGEGSFAKVKFAK---NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+ LGEG+F +V K VA+K + D + + +E MK + HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNV 58
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLI-------NAV 126
++++ V + +Y+VLE+++GG+L D + K + + + L+ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---A 183
+Y S+ HRDL N L+ V+KISDFGL S+ V +D G + A
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGL---SRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 184 PEVLNDKGYDGRASDVWSCGVILF 207
PE L D + SDVWS GV+L+
Sbjct: 176 PESLKDGIFT-SKSDVWSFGVLLW 198
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 79/285 (27%), Positives = 125/285 (43%), Gaps = 34/285 (11%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
LG G+ V + TG +A+K + + + +QI RE+ + P ++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGF 64
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHS-RGVF 135
+ I I +E++DGG L DKI K GR+ E + ++ + Y H +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR 195
HRD+KP N+L++S G +K+ DFG+S Q V + L T GT +Y+APE + Y +
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS--GQLV--NSLAKTFVGTSSYMAPERIQGNDYSVK 179
Query: 196 ASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS--VYGESYKKCTNKYSYTLQ 253
SD+WS G+ L L G P+ N F L V + + K+S Q
Sbjct: 180 -SDIWSLGLSLIELATGRFPYPPENDPPD----GIFELLQYIVNEPPPRLPSGKFSPDFQ 234
Query: 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
DF + L +P R + ++LE + KK
Sbjct: 235 ----DF-------------VNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-29
Identities = 89/291 (30%), Positives = 146/291 (50%), Gaps = 49/291 (16%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVD--RDQVLRHKMVEQIKREISTMKLIKH 72
+E+ LG+G+F KV A+N ETG A K++D ++ L MVE I + H
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVE-----IDILASCDH 61
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHS 131
PN++K+++ + ++I++EF GG + + + R L E + R +Q + A++Y H
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV--REDGLLHTACGTPNYVAPEVL-- 187
+ HRDLK N+L G +K++DFG+SA + + R D + GTP ++APEV+
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMC 177
Query: 188 ---NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244
D+ YD +A DVWS G+ L + P E N M +
Sbjct: 178 ETSKDRPYDYKA-DVWSLGITLIEMAQIEPPHHELNPMRVL------------------- 217
Query: 245 TNKYSYTLQICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
L+I +++ + PS +SS K +K+ L+ N D R T +Q+L+
Sbjct: 218 -------LKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 75/298 (25%), Positives = 137/298 (45%), Gaps = 58/298 (19%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG+G +V + TG A+K++D+ ++++ V+++ E + + HP + +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 79 IEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFH 136
++T + +V+++ GGELF + L E+ AR Y +++ A++Y H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 137 RDLKPENLLLDSYGVLKISDFGLS--------AISQQVR------------------EDG 170
RDLKPEN+LL G + +SDF LS +S+ +R E
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 171 LLHTAC-GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVS 229
+ GT Y+APEV++ G+ A D W+ G++L+ ++ G PF SN +
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSNRDETFS--- 242
Query: 230 TFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS--WFSSGAKKLIKRILDPNPDTRM 285
I + + + P SS A+ LI+++L +P R+
Sbjct: 243 -----------------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRL 277
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 64/207 (30%), Positives = 114/207 (55%), Gaps = 13/207 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH- 72
+ EL +G G++ V K+V TG VA+KI++ D V I+RE++ + ++
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQS 59
Query: 73 --PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
PN+ K +++I++E+ +GG + + K G + E ++++ A+ Y H
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIH 118
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND- 189
GV HRD+K N+L+ + G +K+ DFG++A+ Q T GTP ++APEV+ +
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEG 176
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPF 216
K YD +A D+WS G+ ++ + G P+
Sbjct: 177 KYYDTKA-DIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 91/327 (27%), Positives = 146/327 (44%), Gaps = 57/327 (17%)
Query: 12 VGKYE-LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
V ++E L R +GEG++ V A++ +G+ VA+K V D R + REI+ + +
Sbjct: 6 VTEFEKLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNL 63
Query: 71 KHPNVIKIIEVMASK--TKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
+HPN++++ EV+ K I++V+E+ D L D + E + + QL+ +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT--PFSESQVKCLMLQLLRGL 121
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-----Y 181
Y H + HRDLK NLLL G LKI+DFGL+ R G L TP Y
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA------RTYG-LPAKPMTPKVVTLWY 174
Query: 182 VAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLP----FDESNLMAL---------- 224
APE+L Y A D+W+ G IL L+A LP ++ +L+
Sbjct: 175 RAPELLLGCTTYT-TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233
Query: 225 --YRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPD 282
+ + ++ + Y +K+ W S +L+ +L +P
Sbjct: 234 PGFSDLPLVGKFTLPKQPYNNLKHKF--------------PWLSEAGLRLLNFLLMYDPK 279
Query: 283 TRMTISQMLEDEWFKKGYKPPHFDKEE 309
R T + LE +FK+ KP + E
Sbjct: 280 KRATAEEALESSYFKE--KPLPCEPEM 304
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 96/341 (28%), Positives = 155/341 (45%), Gaps = 49/341 (14%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKHP 73
Y+ +GEG++ V A + TG VAIK + H+ Q REI ++ KH
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI---SPFEHQTFCQRTLREIKILRRFKHE 63
Query: 74 NVIKIIEVMASKT-----KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
N+I I++++ + +YIV E ++ +L+ K+ K L D + + Q++ + Y
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKY 121
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS-QQVREDGLLHTACGTPNYVAPEV- 186
HS V HRDLKP NLLL++ LKI DFGL+ I+ + G L T Y APE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPF------DESNLMALYRKVSTFHFLSVYG-- 238
LN KGY +A D+WS G IL +++ F + N L V G
Sbjct: 182 LNSKGYT-KAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN-----------LILGVLGTP 229
Query: 239 --ESYKKCTN----KYSYTLQIC-RADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQ 289
E + Y +L + ++ P+ A L+ ++L NP R+T+ +
Sbjct: 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHKRITVEE 288
Query: 290 MLEDEWFKKGYKP---PHFDKEEEVNLDDVDAIFNDSKENL 327
L + ++ + P P ++ + + D + KE L
Sbjct: 289 ALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDL---PKEKL 326
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 90/305 (29%), Positives = 144/305 (47%), Gaps = 43/305 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIV---DRDQVLRHKMVEQIKREISTMKLI 70
KYE +GEG++ V AKN ET + VA+K V D D+ + + REI +K +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKEL 56
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
KH N++++ +V+ S K+ +V E+ D + FD + +G + + + + QL+ + +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVL 187
CHS V HRDLKP+NLL++ G LK++DFGL+ A VR T Y P+VL
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDVL 171
Query: 188 -NDKGYDGRASDVWSCGVILFVLMAGFLPF-----DESNLMALYRKVST--------FHF 233
K Y + D+WS G I L P + L ++R + T
Sbjct: 172 FGAKLYS-TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230
Query: 234 LSVYGE--SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 291
L Y Y T+ + P S+G + L++ +L NP R++ + L
Sbjct: 231 LPDYKPYPMYPATTSLVNVV----------PKLNSTG-RDLLQNLLVCNPVQRISAEEAL 279
Query: 292 EDEWF 296
+ +F
Sbjct: 280 QHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 74/209 (35%), Positives = 119/209 (56%), Gaps = 12/209 (5%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVD-RDQVLRHKMVEQIKREISTMKLIKHPNVIKII 79
+GEGS V A TG VA+K +D R Q R E + E+ M+ H NV+ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR----ELLFNEVVIMRDYHHENVVDMY 85
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
++++V+EF++GG L D I H R+ E++ ++ A+ Y H++GV HRD+
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDI 144
Query: 140 KPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
K +++LL S G +K+SDFG A +S++V + L GTP ++APEV++ Y G D
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL---VGTPYWMAPEVISRLPY-GTEVD 200
Query: 199 VWSCGVILFVLMAGFLP-FDESNLMALYR 226
+WS G+++ ++ G P F+E L A+ R
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRR 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 71/213 (33%), Positives = 116/213 (54%), Gaps = 8/213 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY +G+G+ V A +V TG VAIK ++ Q + E I EI M+ KHP
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHP 76
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ ++ ++++V+E++ GG L D + + E + ++ + A+++ HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 135
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+K +N+LL G +K++DFG A Q E T GTP ++APEV+ K Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 194 GRASDVWSCGVILFVLMAGFLPF-DESNLMALY 225
G D+WS G++ ++ G P+ +E+ L ALY
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 67/258 (25%), Positives = 120/258 (46%), Gaps = 46/258 (17%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ +G+G+F +V+ + +TG A+K + + ++ + + +K E + P V+ +
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
+Y+++EF+ GG+L + K+ ED R Y + + A++ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 139 LKPENLLLDSYGVLKISDFGLS---------AISQQVREDG------------------- 170
+KP+N+L+D G +K+SDFGLS A Q++ +
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 171 -----------------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF 213
+ ++ GTP+Y+APE+ +GY G+ D WS G I+F + G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 214 LPFDESNLMALYRKVSTF 231
PF N YRK+ +
Sbjct: 246 PPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 85/278 (30%), Positives = 129/278 (46%), Gaps = 40/278 (14%)
Query: 33 KNVETGDFVAIKIVDRDQVLRHKMV--------EQIKREISTMKLIKHPNVIKIIEVMAS 84
+N T FVA + D + + K V + E+ + H ++K + S
Sbjct: 77 RNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136
Query: 85 KTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
K+ +++E+ GG+L +I + H +E E F Q++ A+D HSR + HRDLK
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK 196
Query: 141 PENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 199
N+ L G++K+ DFG S S V D + + CGTP Y+APE+ K Y +A D+
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAPELWERKRYSKKA-DM 254
Query: 200 WSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADF 259
WS GVIL+ L+ PF + + ++V +YG KY
Sbjct: 255 WSLGVILYELLTLHRPFKGPSQREIMQQV-------LYG--------KYD---------- 289
Query: 260 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
P SSG K L+ +L NP R T Q+L E+ K
Sbjct: 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 92/341 (26%), Positives = 165/341 (48%), Gaps = 45/341 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLRHKMVEQIKREISTMKLIKH 72
+Y+ +G G++ +V A + +TG VAIK + R Q H ++ RE+ +K + H
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH--AKRTYRELRLLKHMDH 73
Query: 73 PNVIKIIEVMASKT------KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
NVI +++V + +Y+V + G +L + I K +L +D + Q++ +
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGL 131
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE-DGLLHTACGTPNYVAPE 185
Y HS G+ HRDLKP N+ ++ LKI DFGL+ R D + T Y APE
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA------RHTDDEMTGYVATRWYRAPE 185
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG----ESY 241
++ + + + D+WS G I+ L+ G F S+ + +++ +++ G E
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI-----MNLVGTPDEELL 240
Query: 242 KKCTNK----YSYTL-QICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295
+K +++ Y +L Q+ + DF S + A L++++L +PD R+T ++ L +
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 296 FKKGYKPPHFDKEEEVNLDDVDAIFNDSKENL---VTEKKE 333
+ D E+E V ++ S E+ V E KE
Sbjct: 301 LA-----EYHDPEDE----PVAPPYDQSFESRDLTVDEWKE 332
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 67/228 (29%), Positives = 121/228 (53%), Gaps = 18/228 (7%)
Query: 15 YELGRTLGEGSFAKV-KFAKNVETGDFVAIKIVD-------RDQVLRHKMVEQIKREIST 66
Y + LG G+F V K K + +A+K ++ +D+ R K + I E++
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 67 MK-LIKHPNVIKIIEVMASKTKIYIVLEFIDG---GELFDKIA-KHGRLKEDEARRYFQQ 121
+K ++HPN+++ + ++YIV++ I+G GE F+ + K R E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 122 LINAVDYCH-SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
++ A+ Y H + + HRDL P N++L + I+DFGL ++Q + + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL---AKQKQPESKLTSVVGTIL 178
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
Y PE++ ++ Y G +DVW+ G IL+ + PF +N+++L K+
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 64/221 (28%), Positives = 119/221 (53%), Gaps = 10/221 (4%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ + +G G+F +V K A+KI+++ ++L+ + E + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRG 133
+ + + +Y+V+++ GG+L ++K RL ED AR Y +++ A+D H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEVL---- 187
HRD+KP+N+L+D G ++++DFG ++ EDG + + A GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
+ KG G D WS GV ++ ++ G PF +L+ Y K+
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 1e-26
Identities = 69/213 (32%), Positives = 118/213 (55%), Gaps = 8/213 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY +G+G+ V A ++ TG VAIK ++ Q + ++ I EI M+ K+P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKNP 76
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ ++ ++++V+E++ GG L D + + + E + ++ + A+D+ HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQ 135
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+K +N+LL G +K++DFG A Q E T GTP ++APEV+ K Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 194 GRASDVWSCGVILFVLMAGFLPF-DESNLMALY 225
G D+WS G++ ++ G P+ +E+ L ALY
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 77/252 (30%), Positives = 131/252 (51%), Gaps = 37/252 (14%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
M K +R+ +YE+ + +G G F +V K+ T +F K + + L+ + Q+
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQL 59
Query: 61 KREISTMKLIKHPNVIKIIEVMASKT--KIYIVLEFIDGGELFDKIAK----HGRLKEDE 114
E++ M+ +KH N+++ I+ +K K+YI++EF D G+L I K G+++E
Sbjct: 60 VIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119
Query: 115 ARRYFQQLINAVDYCHS-------RGVFHRDLKPENLLLDS-----------------YG 150
+QL++A+ YCH+ V HRDLKP+N+ L +
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 151 VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL--NDKGYDGRASDVWSCGVILFV 208
+ KI DFGLS + + + + H+ GTP Y +PE+L K YD + SD+W+ G I++
Sbjct: 180 IAKIGDFGLS---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYE 235
Query: 209 LMAGFLPFDESN 220
L +G PF ++N
Sbjct: 236 LCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 33/210 (15%)
Query: 19 RTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQ----IKREISTMKLI 70
+ LGEG F KV+ + TG+ VA+K L H EQ +REI ++ +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFEREIEILRTL 63
Query: 71 KHPNVIKIIEVM--ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR--RYFQQLINAV 126
H N++K V + +++E++ G L D + +H R + + R + Q+ +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGM 122
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ------VREDGLLHTACGTP- 179
DY S+ HRDL N+L++S ++KISDFGL+ + + V+E G P
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES------PI 176
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILFVL 209
+ APE L + ASDVWS GV L+ L
Sbjct: 177 FWYAPECLRTSKFS-SASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 95/344 (27%), Positives = 163/344 (47%), Gaps = 42/344 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIK-IVD--RDQVLRHKMVEQIKREISTMK-L 69
KYE+ + LG+G++ V A + T + VA+K I D R+ ++ REI ++ L
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT----DAQRTFREIMFLQEL 63
Query: 70 IKHPNVIKIIEVMASK--TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
HPN++K++ V+ ++ IY+V E+++ +L I + L++ R QL+ A+
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIMYQLLKALK 121
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ--QVREDGLLHTACGTPNYVAP 184
Y HS V HRDLKP N+LL+S +K++DFGL+ ++S+ + E+ +L T Y AP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH----FLSVYGES 240
E+L + D+WS G IL ++ G L+ ST + + V G
Sbjct: 182 EILLGSTRYTKGVDMWSVGCILGEMLLG---------KPLFPGTSTLNQLEKIIEVIGPP 232
Query: 241 YKKCTN--KYSYTLQI-----CRADFSCPSWF---SSGAKKLIKRILDPNPDTRMTISQM 290
+ K + + R S A L+K++L NP+ R+T +
Sbjct: 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292
Query: 291 LEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEK 334
LE + + + P +E V + +D+ + V E + K
Sbjct: 293 LEHPYVAQFHNP----SDEPVLPYPITIPLDDNVKLSVAEYRNK 332
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 65/206 (31%), Positives = 111/206 (53%), Gaps = 10/206 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G+GSF +V + T VAIKI+D ++ +E I++EI+ + P V K
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
TK++I++E++ GG D + + G L E + ++++ +DY HS HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 141 PENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
N+LL +G +K++DFG++ Q++ + + GTP ++APEV+ YD +A D
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQSAYDSKA-D 183
Query: 199 VWSCGVILFVLMAGFLPFDESNLMAL 224
+WS G+ L G P E + M +
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKV 209
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 72/209 (34%), Positives = 121/209 (57%), Gaps = 12/209 (5%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVD-RDQVLRHKMVEQIKREISTMKLIKHPNVIKII 79
+GEGS V A+ +G VA+K++D R Q R E + E+ M+ +H NV+++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR----ELLFNEVVIMRDYQHQNVVEMY 84
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
+ ++++++EF+ GG L D I RL E++ + ++ A+ Y HS+GV HRD+
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDI 143
Query: 140 KPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
K +++LL G +K+SDFG A IS+ V + L GTP ++APEV++ Y G D
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAPEVISRTPY-GTEVD 199
Query: 199 VWSCGVILFVLMAGFLP-FDESNLMALYR 226
+WS G+++ ++ G P F +S + A+ R
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQAMKR 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-26
Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIK-IVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKII 79
LG+G++ V A+++ T +AIK I +RD + V+ + EI+ +KH N+++ +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 80 EVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEA--RRYFQQLINAVDYCHSRGVFH 136
+ I +E + GG L + +K G LK++E Y +Q++ + Y H + H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 137 RDLKPENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND--KGYD 193
RD+K +N+L+++Y GV+KISDFG S + + T GT Y+APEV++ +GY
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTS--KRLAGINPCTETFTGTLQYMAPEVIDKGPRGY- 188
Query: 194 GRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252
G +D+WS G + + G PF E A KV F
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF--------------------- 227
Query: 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295
+ P S+ AK I R +P+PD R + +L+D +
Sbjct: 228 ---KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 69/213 (32%), Positives = 118/213 (55%), Gaps = 8/213 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY +G+G+ V A +V TG VAIK ++ + + E I EI MK +K+P
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNP 76
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ ++ ++++V+E++ GG L D + + + E + ++ + A+++ H+
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLHANQ 135
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+K +N+LL G +K++DFG A Q E T GTP ++APEV+ K Y
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 194 GRASDVWSCGVILFVLMAGFLPF-DESNLMALY 225
G D+WS G++ ++ G P+ +E+ L ALY
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-26
Identities = 61/198 (30%), Positives = 105/198 (53%), Gaps = 6/198 (3%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG+G F +V + TG A K +D+ ++ + K + E ++ + ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFHRD 138
+K + +V+ ++GG+L I G EAR F Q+I +++ H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
LKPEN+LLD +G ++ISD GL+ +++ + GTP Y+APEVL + YD D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV-D 176
Query: 199 VWSCGVILFVLMAGFLPF 216
++ G L+ ++AG PF
Sbjct: 177 WFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 71/216 (32%), Positives = 115/216 (53%), Gaps = 12/216 (5%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+EL + +G G++ V A+NV TG+ AIK++ + +V+Q EI MK KH N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSN 67
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++ + K++I +EF GG L D G L E + ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEV--LNDKG 191
HRD+K N+LL G +K++DFG+SA I+ + + + GTP ++APEV + KG
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR---KSFIGTPYWMAPEVAAVERKG 184
Query: 192 YDGRASDVWSCGVILFVLMAGFLP--FDESNLMALY 225
+ D+W+ G I + +A P FD + AL+
Sbjct: 185 GYNQLCDIWAVG-ITAIELAELQPPMFDLHPMRALF 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 78/290 (26%), Positives = 136/290 (46%), Gaps = 35/290 (12%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G+GSF +V + T VAIKI+D ++ +E I++EI+ + P V K
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
TK++I++E++ GG D + + G E + ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 141 PENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
N+LL G +K++DFG++ Q++ + T GTP ++APEV+ YD +A D
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIQQSAYDSKA-D 183
Query: 199 VWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRAD 258
+WS G+ L G P + + M + + + ++ GE
Sbjct: 184 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE------------------- 224
Query: 259 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
FS K+ I L+ +P R T ++L+ ++ K K + E
Sbjct: 225 ------FSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-25
Identities = 77/288 (26%), Positives = 135/288 (46%), Gaps = 35/288 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--LRHKMVEQIKREISTMKLIK 71
+Y L + LG+GSF V K+ + +K++ V L Q +E + +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIA--KHG--RLKEDEARRYFQQLINAVD 127
HP ++K + I+ E+ +G +L K+ KH L E++ +F QL+ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
Y H R + HRDLK +N+ L + +LKI DFG+S + + L T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEAL 177
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247
+GYD + SD+WS G IL+ + F+ N +++ ++ V G +
Sbjct: 178 KHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-------VEGPTP------ 223
Query: 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295
S P +S +++ +L+ +P R + +++L + +
Sbjct: 224 ------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 73/211 (34%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIK--------IVDRDQVLRHKMVEQIKREIS 65
KY + +G G++ V AKN ET + VAIK +D + LR EI
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR---------EIK 56
Query: 66 TMKLIKHPNVIKIIEVMASKTK-----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
++ + H NVI I ++M + +YIV E +D +L I L +D + +
Sbjct: 57 LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLY 115
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
QL+ + Y HS V HRDLKP NLLL++ LKI DFGL+ + + + + T
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEYVVTRW 173
Query: 181 YVAPEV-LNDKGYDGRASDVWSCGVILFVLM 210
Y APE+ LN Y A DVWS G I L+
Sbjct: 174 YRAPELLLNCSEY-TTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 91/306 (29%), Positives = 145/306 (47%), Gaps = 42/306 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+YE +GEG++ V A++ T + +A+K + +Q I REIS +K ++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHG 61
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARR------YFQQLINAVD 127
N++++ +V+ S+ ++Y+V E++D D + KH D A+ Y Q++ +
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLD----LD-LKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 128 YCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPE 185
YCHS V HRDLKP+NLL+D LK++DFGL+ A VR H T Y APE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVV-TLWYRAPE 173
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKVSTFHFLSV-YGESYK 242
+L + D+WS G I F M P +S + L++ F L E++
Sbjct: 174 ILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFK---IFRILGTPNEETWP 229
Query: 243 KCTNKYSYTLQICRADFSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQML 291
T+ Y ++ F P W L+ ++L +P R+T L
Sbjct: 230 GVTSLPDY-----KSAF--PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282
Query: 292 EDEWFK 297
E E+FK
Sbjct: 283 EHEYFK 288
|
Length = 294 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 68/221 (30%), Positives = 122/221 (55%), Gaps = 10/221 (4%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ + +G G+F +V K TG A+KI+++ ++L+ + E +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRG 133
+ + + +Y+V+++ GG+L ++K RL ED AR Y +++ A+D H G
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEVL---- 187
HRD+KP+N+LLD G ++++DFG S + ++ DG + + A GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
+ KG G D WS GV ++ ++ G PF +L+ Y K+
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 69/207 (33%), Positives = 117/207 (56%), Gaps = 12/207 (5%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVD-RDQVLRHKMVEQIKREISTMKLIKHPNVIKII 79
+GEGS V A +G VA+K +D R Q R E + E+ M+ +H NV+++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR----ELLFNEVVIMRDYQHENVVEMY 83
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
++++V+EF++GG L D I H R+ E++ ++ A+ H++GV HRD+
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 140 KPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
K +++LL G +K+SDFG A +S++V L GTP ++APE+++ Y G D
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPELISRLPY-GPEVD 198
Query: 199 VWSCGVILFVLMAGFLP-FDESNLMAL 224
+WS G+++ ++ G P F+E L A+
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAM 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 80/230 (34%), Positives = 119/230 (51%), Gaps = 22/230 (9%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR----EISTMKL 69
KY + R LG G+ V AK V G+ A+K+VD + M E K E+ +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDME-----GMSEADKNRAQAEVCCLLN 87
Query: 70 IKHPNVIKIIEVMASKTK--------IYIVLEFIDGGELFDKI---AKHGR-LKEDEARR 117
+++K E A K I +VL++ + G+L +I AK R +E EA
Sbjct: 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
F Q++ AV + HS+ + HRD+K N+LL S G++K+ DFG S + D + T CG
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227
TP YVAPE+ K Y +A D++S GV+L+ L+ PFD N+ + K
Sbjct: 208 TPYYVAPEIWRRKPYSKKA-DMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 69/213 (32%), Positives = 117/213 (54%), Gaps = 8/213 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY +G+G+ V A +V TG VAI+ ++ Q + E I EI M+ K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNP 77
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ ++ ++++V+E++ GG L D + + + E + ++ + A+++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQ 136
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+K +N+LL G +K++DFG A Q E T GTP ++APEV+ K Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 194 GRASDVWSCGVILFVLMAGFLPF-DESNLMALY 225
G D+WS G++ ++ G P+ +E+ L ALY
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 10/204 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G+GSF +V + T + VAIKI+D ++ +E I++EI+ + P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140
TK++I++E++ GG D + K G L+E ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 141 PENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 198
N+LL G +K++DFG++ Q++ + T GTP ++APEV+ YD +A D
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIKQSAYDFKA-D 183
Query: 199 VWSCGVILFVLMAGFLPFDESNLM 222
+WS G+ L G P + + M
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPM 207
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 70/210 (33%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-----IKREISTMK 68
YE +GEG++ KV A++ TG VA+K R +M E+ REIS ++
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT------RLEMDEEGIPPTALREISLLQ 55
Query: 69 LIKH-PNVIKIIEVMASKTK-----IYIVLEFIDGGELFDKIAKHGR-----LKEDEARR 117
++ ++++++V + K +Y+V E++D +L + +GR L +
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLS-AISQQVREDGLLHTA 175
+ QL+ V +CH GV HRDLKP+NLL+D G+LKI+D GL A S V+ H
Sbjct: 115 FMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEI 172
Query: 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVI 205
T Y APEVL + D+WS G I
Sbjct: 173 V-TLWYRAPEVLLGSTHYSTPVDIWSVGCI 201
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 89/294 (30%), Positives = 128/294 (43%), Gaps = 40/294 (13%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
EL R LGEG+ V + TG A+K + D + +QI RE+ K K P +
Sbjct: 5 ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYI 61
Query: 76 IKIIE--VMASKTKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDY 128
+K + S + I I +E+ +GG L D I K GR+ E + + ++ + Y
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLS--AISQQVREDGLLHTACGTPNYVAPEV 186
HSR + HRD+KP N+LL G +K+ DFG+S ++ T GT Y+APE
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG------TFTGTSFYMAPER 174
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMALYRKVSTFHFLSVYGESYKK 243
+ K Y SDVWS G+ L + PF E L + E
Sbjct: 175 IQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI--------------ELLSY 219
Query: 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
N + L+ + W S K IK+ L+ +P R T MLE W K
Sbjct: 220 IVNMPNPELKDEPGNGI--KW-SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 63/202 (31%), Positives = 108/202 (53%), Gaps = 9/202 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH---PNVIK 77
+G G F +V + +TG A+K +D+ ++ + E + L+ P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ + K+ +L+ ++GG+L +++HG E E R Y ++I +++ H+R V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND-KGYDGRA 196
DLKP N+LLD +G ++ISD GL+ + + H + GT Y+APEVL YD A
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSA 177
Query: 197 SDVWSCGVILFVLMAGFLPFDE 218
D +S G +LF L+ G PF +
Sbjct: 178 -DWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 66/222 (29%), Positives = 110/222 (49%), Gaps = 34/222 (15%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REIS 65
+++ YE+ LGEG+F +V A+ ++TG VA+K ++L H + REI
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIK 59
Query: 66 TMKLIKHPNVIKIIEVMASKTK--------IYIVLEFID---GGELFDKIAKHGRLKEDE 114
+K +KHPNV+ +I++ + +Y+V ++D G L + K L E +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQ 116
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI----SQQVREDG 170
+ Y QL+ ++Y H + HRD+K N+L+D+ G+LKI+DFGL+ + G
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 171 LLHTACGTPN-----YVAPE-VLNDKGYDGRASDVWSCGVIL 206
T T Y PE +L ++ Y A D+W G +
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIK-IVDRDQVLRHKMVEQIKREISTMKLIKH 72
+Y+ +G G++ V A + +G VAIK I V + ++ RE+ ++ KH
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFKH 63
Query: 73 PNVIKIIEVMASKTK----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
N+I I +++ +Y+V++ + +L I L E+ R + QL+ + Y
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKY 122
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGL--SAISQQVREDGLLHTACGTPNYVAPEV 186
HS V HRDLKP NLL++ L+I DFG+ S + T Y APE+
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 187 LNDKGYDGRASDVWSCGVIL 206
L A D+WS G I
Sbjct: 183 LLSLPEYTTAIDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 83/306 (27%), Positives = 145/306 (47%), Gaps = 32/306 (10%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
V K+++ +GEG++ +V A++ +TG+ VA+K V D + I REI ++ +
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI-REIKILRQLN 64
Query: 72 HPNVIKIIEVMASKTK----------IYIVLEFIDG---GELFDKIAKHGRLKEDEARRY 118
H N++ + E++ K Y+V E++D G L + ED + +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT-ACG 177
+QL+ ++YCH + HRD+K N+LL++ G +K++DFGL+ + E+ +T
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPYTNKVI 179
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA---LYRKVSTFHFL 234
T Y PE+L + G A DVWSCG IL L F + +A L ++
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 235 SVYGE-----SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 289
+V+ + + K Y ++ R +F S+ + A L+ +L +P R T +
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRL-REEF---SFIPTPALDLLDHMLTLDPSKRCTAEE 295
Query: 290 MLEDEW 295
L W
Sbjct: 296 ALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 67/202 (33%), Positives = 112/202 (55%), Gaps = 13/202 (6%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK-REISTMKLIKH---PNVI 76
+G G F +V + +TG A+K +D+ ++ + K E + E + L+ P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFH 136
+ + K+ +L+ ++GG+L +++HG E E R Y ++I +++ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG--YDG 194
RDLKP N+LLD +G ++ISD GL+ + + H + GT Y+APEVL KG YD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQ-KGVAYDS 175
Query: 195 RASDVWSCGVILFVLMAGFLPF 216
A D +S G +LF L+ G PF
Sbjct: 176 SA-DWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-24
Identities = 75/238 (31%), Positives = 121/238 (50%), Gaps = 22/238 (9%)
Query: 3 VKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR 62
+ + A R G +EL +G G++ +V ++V+TG AIK++D + E+IK
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKL 61
Query: 63 EISTMKLIKH-PNVIKIIEVMASKT------KIYIVLEFIDGGELFD--KIAKHGRLKED 113
EI+ +K H N+ K+ ++++V+EF G + D K K LKED
Sbjct: 62 EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121
Query: 114 EARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173
++++ + + H+ V HRD+K +N+LL +K+ DFG+SA Q R G +
Sbjct: 122 WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRN 179
Query: 174 TACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALY 225
T GTP ++APEV+ D YD R SD+WS G+ + G P D + AL+
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALF 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 63/221 (28%), Positives = 118/221 (53%), Gaps = 10/221 (4%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ + +G G+F +V K T A+KI+++ ++L+ + E + +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRG 133
+ + + +Y+V+++ GG+L ++K RL ED AR Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEVL---- 187
HRD+KP+N+LLD G ++++DFG ++ +DG + + A GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCL---KMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
+ G G D WS GV ++ ++ G PF +L+ Y K+
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 65/201 (32%), Positives = 108/201 (53%), Gaps = 7/201 (3%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
K+E+ +GEG++ V ++ ET + VAIK +D ++ E RE+ ++ +K
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
N++++ E + K+Y+V E+++ EL +++ + ++ R Y QLI A+ +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHK 118
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
+ HRD+KPENLL+ VLK+ DFG A + + T Y +PE+L
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGF-ARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 192 YDGRASDVWSCGVILFVLMAG 212
Y G+A D+WS G IL L G
Sbjct: 178 Y-GKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 44/140 (31%), Positives = 82/140 (58%)
Query: 24 GSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA 83
G+F KV + A+K+V + ++ MV Q++ E + L K P ++ + +
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 84 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 143
S +Y+V+E++ GG++ + +G E+ A +Y ++ A+DY H G+ HRDLKP+N
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134
Query: 144 LLLDSYGVLKISDFGLSAIS 163
+L+ + G +K++DFGLS ++
Sbjct: 135 MLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 68/217 (31%), Positives = 117/217 (53%), Gaps = 14/217 (6%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
YEL + +G G++ V A+N+ TG+ A+KI+ + +++Q EI +K KH N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCN 67
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++ S+ K++I +E+ GG L D G L E + ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVL---NDK 190
HRD+K N+LL G +K++DFG++A I+ + + + GTP ++APEV +
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR---KSFIGTPYWMAPEVAAVEKNG 184
Query: 191 GYDGRASDVWSCGVILFVLMAGFLP--FDESNLMALY 225
GY+ + D+W+ G I + +A P FD + AL+
Sbjct: 185 GYN-QLCDIWAVG-ITAIELAELQPPMFDLHPMRALF 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIK-IVDRDQVLRHKMVEQIKREISTMKLIKHPNVIK 77
R LG GS V A + + VA+K IV D + V+ REI ++ + H N++K
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVK 66
Query: 78 IIEVMASKTK--------------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
+ EV+ +YIV E+++ + + G L E+ AR + QL+
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLL 124
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAI-SQQVREDGLLHTACGTPNY 181
+ Y HS V HRDLKP N+ +++ VLKI DFGL+ I G L T Y
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM 222
+P +L +A D+W+ G I ++ G F ++ +
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R +G GSF V FA++V T + VAIK + ++ + I +E+ ++ ++HPN I+
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ ++V+E+ G D + H + L+E E + + Y HS HR
Sbjct: 81 KGCYLREHTAWLVMEYCLGSAS-DILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR 139
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL--NDKG-YDG 194
D+K N+LL G +K++DFG +++ ++ GTP ++APEV+ D+G YDG
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLM-ALY 225
+ DVWS G+ L P N M ALY
Sbjct: 194 KV-DVWSLGITCIELAERKPPLFNMNAMSALY 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 1e-23
Identities = 31/58 (53%), Positives = 43/58 (74%)
Query: 338 MNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK 395
+NAF+LIS + L LFE++ K+ETRFTS++P +EI+SK+EE AK LGF V+K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 16/194 (8%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+LG T+G+G F V G VA+K + D + E S M ++HPN+
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNL 62
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRG 133
++++ V+ +YIV E++ G L D + GR + + + + ++Y +
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGY 192
HRDL N+L+ V K+SDFGL+ + Q ++ G L P + APE L +K +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTAPEALREKKF 176
Query: 193 DGRASDVWSCGVIL 206
+ SDVWS G++L
Sbjct: 177 STK-SDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 81/321 (25%), Positives = 128/321 (39%), Gaps = 46/321 (14%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIV-----DRDQVLRHKMVEQIK------REIS 65
G LGEG++ KV+ A + TG VAIK V D ++V RE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
M IKH N++ +++V I +V++ + +L + + RL E + + Q++N
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPN-- 180
++ H HRDL P N+ ++S G+ KI+DFGL+ T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 181 -------YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKVS 229
Y APE+L A D+WS G I L+ G F N L ++ +
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 230 T--------FHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNP 281
T L +Y E + D A L++ +L NP
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDD----------AIDLLQSLLKLNP 301
Query: 282 DTRMTISQMLEDEWFKKGYKP 302
R++ + L+ E+FK P
Sbjct: 302 LERISAKEALKHEYFKSDPLP 322
|
Length = 335 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 4e-23
Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 18/204 (8%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-- 71
+YE +G G++ V A++ +G FVA+K V R Q + RE++ +K ++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 72 -HPNVIKIIEVMAS-----KTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLI 123
HPN++++++V A+ +TK+ +V E +D DK+ G L + + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFL 118
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI-SQQVREDGLLHTACGTPNYV 182
+D+ H+ + HRDLKPEN+L+ S G +K++DFGL+ I S Q+ ++ T Y
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----YR 174
Query: 183 APEVLNDKGYDGRASDVWSCGVIL 206
APEVL Y D+WS G I
Sbjct: 175 APEVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 10/186 (5%)
Query: 36 ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKII-EVMASKTKIYIVLEF 94
TG VAIK++ D + +RE + + HPN++ ++ A ++ V E+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--- 151
+ G L + +A G L E R Q+++A+ H++G+ HRDLKP+N+++ GV
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 152 LKISDFGLSAISQQVREDGLL-----HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 206
K+ DFG+ + VR+ + GTP Y APE L + SD+++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP-NSDLYAWGLIF 179
Query: 207 FVLMAG 212
+ G
Sbjct: 180 LECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 65/209 (31%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH-KMVEQIKREISTMKLIKH 72
+Y++ +G+GS+ V A + TG+ VAIK ++ V H +I REI ++L++H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN--DVFEHVSDATRILREIKLLRLLRH 58
Query: 73 PNVIKIIEVMASKTK-----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
P++++I +M ++ IY+V E ++ +L I + L + + + QL+ A+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEV 186
Y H+ VFHRDLKP+N+L ++ LKI DFGL+ ++ + T T Y APE+
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 187 LNDKGYDGR---ASDVWSCGVILFVLMAG 212
+ + A D+WS G I ++ G
Sbjct: 178 CG--SFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 74/234 (31%), Positives = 118/234 (50%), Gaps = 31/234 (13%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVD--RDQVLRHKMVEQIKREISTMK-L 69
+E+ T+G+G++ KV N + G A+KI+D D + E+I+ E + ++ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD------VDEEIEAEYNILQSL 75
Query: 70 IKHPNVIKIIEVMASKTK-----IYIVLEFIDGG---ELFDKIAKHG-RLKEDEARRYFQ 120
HPNV+K + K +++VLE +GG EL + G RL E
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGT 178
+ + + H+ + HRD+K N+LL + G +K+ DFG+SA S ++R + T+ GT
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGT 191
Query: 179 PNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLP-FDESNLMALYR 226
P ++APEV+ D YD R DVWS G+ L G P FD + L++
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARC-DVWSLGITAIELGDGDPPLFDMHPVKTLFK 244
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 6/200 (3%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R LG+G F +V + TG A K +++ ++ + K E ++ + V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFH 136
+K + +VL ++GG+L I G DE R F ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
RDLKPEN+LLD YG ++ISD GL+ ++ E + GT Y+APEV+ ++ Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 197 SDVWSCGVILFVLMAGFLPF 216
D W G +++ ++ G PF
Sbjct: 182 PDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 4e-22
Identities = 63/197 (31%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKI--VDRDQVLRHKMVEQIKREISTMKLIKHPNVI 76
+G+G+F V + ++ VA+K L+ K ++ E +K HPN++
Sbjct: 1 EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ----EAEILKQYDHPNIV 55
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVF 135
K+I V K IYIV+E + GG L + K RL + + ++Y S+
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG----TP-NYVAPEVLNDK 190
HRDL N L+ VLKISDFG+S E+G ++T P + APE LN
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 191 GYDGRASDVWSCGVILF 207
Y SDVWS G++L+
Sbjct: 171 RYTS-ESDVWSYGILLW 186
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 4e-22
Identities = 59/200 (29%), Positives = 103/200 (51%), Gaps = 6/200 (3%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R LG+G F +V + TG A K +++ ++ + K E ++ + V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFH 136
+K + +VL ++GG+L I G +E+ A Y +++ ++ H +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
RDLKPEN+LLD YG ++ISD GL+ ++ E + GT Y+APEVLN++ Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRY-TLS 181
Query: 197 SDVWSCGVILFVLMAGFLPF 216
D W G +++ ++ G PF
Sbjct: 182 PDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 52/145 (35%), Positives = 81/145 (55%), Gaps = 12/145 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REISTMKLIKHPNVI 76
LGEGS+A V ++ TG VA+K +R + E RE S +K +KH N++
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK------EIRLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVF 135
+ +++ +K + +V E++D +L + G L R + QL+ + YCH R V
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125
Query: 136 HRDLKPENLLLDSYGVLKISDFGLS 160
HRDLKP+NLL+ G LK++DFGL+
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 8e-22
Identities = 74/230 (32%), Positives = 121/230 (52%), Gaps = 27/230 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKHP 73
+E+ T+G+G++ KV N + G A+KI+D H + E+I+ E + +K L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP----IHDIDEEIEAEYNILKALSDHP 75
Query: 74 NVIKIIEVMASKT-----KIYIVLEFIDGGELFDKIA---KHG-RLKEDEARRYFQQLIN 124
NV+K + K ++++VLE +GG + D + K G R++E + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYV 182
+ + H HRD+K N+LL + G +K+ DFG+SA S ++R + T+ GTP ++
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTPFWM 191
Query: 183 APEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYR 226
APEV+ D YD R DVWS G+ L G P + + M AL++
Sbjct: 192 APEVIACEQQLDSTYDARC-DVWSLGITAIELGDGDPPLADLHPMRALFK 240
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 59/198 (29%), Positives = 106/198 (53%), Gaps = 11/198 (5%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH--KMVEQIKREISTMKLIKH 72
Y R +G+GS+ +V ++ G IK ++ R K EQ E + +KH
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKH 58
Query: 73 PNVIKIIEVMASKT-KIYIVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYC 129
PN++ E + +YIV+ F +GG+L+ K+ K L E++ +F Q+ A+ Y
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
H + + HRDLK +N+ L ++K+ D G++ + + + + T GTP Y++PE+ ++
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSN 176
Query: 190 KGYDGRASDVWSCGVILF 207
K Y+ + SDVW+ G ++
Sbjct: 177 KPYNYK-SDVWALGCCVY 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-21
Identities = 72/232 (31%), Positives = 117/232 (50%), Gaps = 22/232 (9%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
R G +EL +G G++ +V ++V+TG AIK++D + E+IK+EI+ +K
Sbjct: 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLK 57
Query: 69 LIKH-PNVIKIIEVMASKT------KIYIVLEFIDGGELFDKI--AKHGRLKEDEARRYF 119
H N+ K ++++V+EF G + D I K LKE+
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
++++ + + H V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTP 175
Query: 180 NYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALY 225
++APEV+ D YD + SD+WS G+ + G P D + AL+
Sbjct: 176 YWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALF 226
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 14 KYELGRTLGEGSFAKV--KFAKNVETGDF---VAIKIVDRDQVLRHKMVEQIKREISTMK 68
K L R LG+GSF V AK V G+ VAIK V+ + +R ++ + E S MK
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR--------RYFQ 120
+V++++ V+++ +V+E + G+L + R + + ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQ 123
Query: 121 ---QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQ--VREDG--LL 172
++ + + Y ++ HRDL N ++ +KI DFG++ I + R+ G LL
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 173 HTACGTP-NYVAPEVLNDKGYDGRASDVWSCGVILF 207
P ++APE L D G SDVWS GV+L+
Sbjct: 184 ------PVRWMAPESLKD-GVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 4e-21
Identities = 70/205 (34%), Positives = 111/205 (54%), Gaps = 19/205 (9%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGD-FVAIKIVDRDQVLRHKMVEQIKREISTMKLIK- 71
+YE +GEG++ KV A++++ G FVA+K V R Q M RE++ ++ ++
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 72 --HPNVIKIIEVMA-----SKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQL 122
HPNV+++ +V +TK+ +V E +D DK+ + G + + + QL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQL 119
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI-SQQVREDGLLHTACGTPNY 181
+ +D+ HS V HRDLKP+N+L+ S G +K++DFGL+ I S Q+ L + T Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWY 175
Query: 182 VAPEVLNDKGYDGRASDVWSCGVIL 206
APEVL Y D+WS G I
Sbjct: 176 RAPEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 5e-21
Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 18/221 (8%)
Query: 15 YELGRTLGEGSFAKV---KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ L R LG G F +V + V VAIKI+ D +L+ + ++E+ +K ++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR----VAIKILKSDDLLKQQD---FQKEVQALKRLR 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQ-QLINAVDYC 129
H ++I + V + +YI+ E ++ G L + G++ + Q+ + Y
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLN 188
+ HRDL N+L+ V K++DFGL+ + ++ED L + P + APE +
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 189 DKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKV 228
+ + SDVWS G++L+ + G +P+ N +Y ++
Sbjct: 178 HGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-21
Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 12/210 (5%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+ YE LGEGS+A V K+ G VA+K++ R Q I RE S +K +
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAI-REASLLKGL 60
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYC 129
KH N++ + +++ +K + +V E++ +L + KH G L + + + QL+ + Y
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG---TPNYVAPEV 186
H R + HRDLKP+NLL+ G LK++DFGL A ++ V HT T Y P+V
Sbjct: 120 HQRYILHRDLKPQNLLISDTGELKLADFGL-ARAKSVPS----HTYSNEVVTLWYRPPDV 174
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPF 216
L D+W G I ++ G F
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIK- 71
YEL + LG+G++ V A+N ET + VAIK + V K++ KR + +KL++
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITN--VFSKKIL--AKRALRELKLLRH 57
Query: 72 ---HPNVIKIIE---VMASK-TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF-QQLI 123
H N+ + + V ++Y+ E ++ +I + G+ D + F Q++
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ-QVREDGLLHTACGTPNY 181
+ Y HS V HRDLKP NLL+++ LKI DFGL+ S+ G + T Y
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 182 VAPEV-LNDKGYDGRASDVWSCGVILFVLMAG 212
APE+ L+ + Y +A DVWS G IL L+
Sbjct: 176 RAPEIMLSFQSYT-KAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 8e-21
Identities = 68/205 (33%), Positives = 109/205 (53%), Gaps = 23/205 (11%)
Query: 19 RTLGEGSFAKVKF----AKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
R LGEG F KV N TG+ VA+K + R+ ++ K+EI+ +K + H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHEN 67
Query: 75 VIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
++K + + + +++E++ G L D + KH +L + + QQ+ + Y HS+
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTPNY-VAPE 185
HRDL N+LLD+ ++KI DFGL+ A+ + +VREDG +P + A E
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAVE 180
Query: 186 VLNDKGYDGRASDVWSCGVILFVLM 210
L + + ASDVWS GV L+ L+
Sbjct: 181 CLKENKF-SYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 63/192 (32%), Positives = 95/192 (49%), Gaps = 12/192 (6%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G G+F +V + VA+K R+ L + + +E +K HPN++++I
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RE-TLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
V K IYIV+E + GG+ + G RLK E + + ++Y S+ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN----YVAPEVLNDKGYDGR 195
N L+ VLKISDFG+S + EDG+ + G + APE LN Y
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 196 ASDVWSCGVILF 207
SDVWS G++L+
Sbjct: 177 -SDVWSFGILLW 187
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 13/210 (6%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G GSF V FA N T + VA+K + ++ + I +E+ ++ +KHPN I+
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
+ ++V+E+ G D + H + L+E E + + Y HS + HRD+
Sbjct: 89 CYLKEHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL--NDKG-YDGRA 196
K N+LL G +K++DFG ++ S ++ GTP ++APEV+ D+G YDG+
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 197 SDVWSCGVILFVLMAGFLPFDESNLM-ALY 225
DVWS G+ L P N M ALY
Sbjct: 202 -DVWSLGITCIELAERKPPLFNMNAMSALY 230
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 86/339 (25%), Positives = 159/339 (46%), Gaps = 41/339 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLRHKMVEQIKREISTMKLIKH 72
+Y+ +G G++ V A + VA+K + R Q L H + RE+ +K +KH
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH--ARRTYRELRLLKHMKH 73
Query: 73 PNVIKIIEVMASKT------KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
NVI +++V T ++Y+V + G + I K +L ++ + QL+ +
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGL 131
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
Y HS G+ HRDLKP N+ ++ L+I DFGL ++Q ++ + A T Y APE+
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL---ARQADDEMTGYVA--TRWYRAPEI 186
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG----ESYK 242
+ + + + D+WS G I+ L+ G F ++ + +++ + V G E K
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI-----MEVVGTPSPEVLK 241
Query: 243 KCTNKYSYTL-----QICRADFSCPSWFSSG---AKKLIKRILDPNPDTRMTISQMLEDE 294
K +++++ + + D F A L++++L + D R++ S+ L
Sbjct: 242 KISSEHARKYIQSLPHMPQQDLK--KIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299
Query: 295 WFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKE 333
+F + + P + E E D ++KE + E KE
Sbjct: 300 YFSQYHDP---EDEPEAEPYDESP---ENKERTIEEWKE 332
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 1e-20
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 13/212 (6%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R +G GSF V FA++V T + VAIK + ++ + I +E+ ++ IKHPN I+
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ ++V+E+ G D + H + L+E E + + Y HS + HR
Sbjct: 91 KGCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV---LNDKGYDG 194
D+K N+LL G +K++DFG ++I+ ++ GTP ++APEV +++ YDG
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDG 203
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLM-ALY 225
+ DVWS G+ L P N M ALY
Sbjct: 204 KV-DVWSLGITCIELAERKPPLFNMNAMSALY 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 73/301 (24%), Positives = 135/301 (44%), Gaps = 23/301 (7%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+G+ + V AK+ T VA+K ++ D + ++ +++EI T + ++HPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLD-SCSKEDLKLLQQEIITSRQLQHPN 60
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHS 131
++ + +++Y+V + G D + H G L E + ++NA+DY HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDF--GLSAISQQVRE---DGLLHTACGTPNYVAPEV 186
+G HR +K ++LL G + +S +S I R+ ++ +++PEV
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 187 L--NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY-RKV--STFHFL--SVYGE 239
L N +GY+ + SD++S G+ L G +PF + + KV + L S Y
Sbjct: 180 LQQNLQGYNEK-SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238
Query: 240 SYKKCTNKYSYTLQIC-RADFSCPS--WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296
+ S R P FS + ++ L +P++R + SQ+L +F
Sbjct: 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298
Query: 297 K 297
K
Sbjct: 299 K 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 6/202 (2%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R LG+G F +V + TG A K +++ ++ + K E ++ + V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFH 136
+K + +VL ++GG+L I G +E R F ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
RDLKPEN+LLD +G ++ISD GL+ V E + GT Y+APEV+ ++ Y +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FS 181
Query: 197 SDVWSCGVILFVLMAGFLPFDE 218
D W+ G +L+ ++AG PF +
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 88/338 (26%), Positives = 156/338 (46%), Gaps = 37/338 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y + +G G++ V A + TG VAIK + R ++ RE+ +K +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHE 74
Query: 74 NVIKIIEVMASKTKI------YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
NVI +++V + Y+V+ F+ G K+ KH +L ED + Q++ +
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
Y H+ G+ HRDLKP NL ++ LKI DFGL+ + D + T Y APEV+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVI 187
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247
+ + + D+WS G I+ ++ G F + + ++ + V G K+ K
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI-----MKVTGTPSKEFVQK 242
Query: 248 --------YSYTL-QICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
Y L + + DF S + A +++++L + ++R+T ++ L +F+
Sbjct: 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
Query: 298 KGYKPPHFDKEEEV-----NLDDVDAIFNDSKENLVTE 330
+ + P + E E + D+VD + K TE
Sbjct: 303 EFHDP---EDETEAPPYDDSFDEVDQSLEEWKRLTFTE 337
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
LG G+ V K++ TG +A K+V + + +QI RE+ M + P ++
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSF 68
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSR-GVFH 136
++ I + +EF+D G L D+I K G + + + ++ + Y ++ + H
Sbjct: 69 YGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127
Query: 137 RDLKPENLLLDSYGVLKISDFGLS-----AISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
RD+KP N+L++S G +K+ DFG+S +I+ T GT Y++PE +
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIAD---------TFVGTSTYMSPERIQGGK 178
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESN 220
Y + SDVWS G+ + L G PF SN
Sbjct: 179 YTVK-SDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 63/194 (32%), Positives = 98/194 (50%), Gaps = 18/194 (9%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRD--QVLRHKMVEQIKREISTMKLIKHPNVIKI 78
LG+G+F +V F ++ VA+K D Q L+ K + + + +K HPN++K+
Sbjct: 3 LGKGNFGEV-FKGTLKDKTPVAVKTCKEDLPQELKIKFLSEAR----ILKQYDHPNIVKL 57
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
I V + IYIV+E + GG+ + K LK + ++ + Y S+ HR
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN----YVAPEVLNDKGYD 193
DL N L+ VLKISDFG+S +ED ++++ G + APE LN Y
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 194 GRASDVWSCGVILF 207
SDVWS G++L+
Sbjct: 173 SE-SDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 8e-20
Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 13/212 (6%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R +G GSF V FA++V + VAIK + ++ + I +E+ ++ ++HPN I+
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHR 137
+ ++V+E+ G D + H + L+E E + + Y HS + HR
Sbjct: 81 RGCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV---LNDKGYDG 194
D+K N+LL G++K+ DFG ++I + GTP ++APEV +++ YDG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLM-ALY 225
+ DVWS G+ L P N M ALY
Sbjct: 194 KV-DVWSLGITCIELAERKPPLFNMNAMSALY 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ +G G+F V A++ TG VAIK + + ++ RE+ +K ++H N+I +
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 79 IEVMAS-KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
++ S IY V E + G ++ L++ + + Q++ + Y HS GV HR
Sbjct: 75 SDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHR 132
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRA 196
DLKP N+L++ LKI DFGL+ I Q + G + T Y APE+ L + YD
Sbjct: 133 DLKPSNILINENCDLKICDFGLARI-QDPQMTGYVSTR----YYRAPEIMLTWQKYD-VE 186
Query: 197 SDVWSCGVILFVLMAG 212
D+WS G I ++ G
Sbjct: 187 VDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 85/329 (25%), Positives = 152/329 (46%), Gaps = 33/329 (10%)
Query: 2 SVKVPASR-TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLRHKMVEQ 59
SV+V S T + +Y+ + +G G+ V A + G VA+K + R Q H ++
Sbjct: 9 SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH--AKR 66
Query: 60 IKREISTMKLIKHPNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKED 113
RE+ +K + H N+I ++ V + +Y+V+E +D L I H L +
Sbjct: 67 AYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI--HMELDHE 123
Query: 114 EARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173
Q++ + + HS G+ HRDLKP N+++ S LKI DFGL ++ + ++
Sbjct: 124 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTACTNFMMT 180
Query: 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV----- 228
T Y APEV+ GY D+WS G I+ L+ G + F ++ + + KV
Sbjct: 181 PYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239
Query: 229 -STFHFLSVYGESYKK-CTNKYSY---TLQICRADFSCPS------WFSSGAKKLIKRIL 277
+ F++ + + N+ Y + + D+ PS +S A+ L+ ++L
Sbjct: 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKML 299
Query: 278 DPNPDTRMTISQMLEDEWFKKGYKPPHFD 306
+PD R+++ + L + Y P +
Sbjct: 300 VIDPDKRISVDEALRHPYITVWYDPAEAE 328
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 72/271 (26%), Positives = 128/271 (47%), Gaps = 33/271 (12%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG+G F +V + TG A K +++ ++ + K E E + + ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 81 VMASKTKIYIVLEFIDGGEL----FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFH 136
+KT + +V+ ++GG+L ++ ++ E A Y Q+I+ +++ H R + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 137 RDLKPENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
RDLKPEN+LLD+ G ++ISD GL+ Q + G GTP ++APE+L + YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY----AGTPGFMAPELLQGEEYD- 175
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254
+ D ++ GV L+ ++A PF GE K NK +I
Sbjct: 176 FSVDYFALGVTLYEMIAARGPF------------------RARGE---KVENK-ELKQRI 213
Query: 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRM 285
+ P FS +K + +L +P+ R+
Sbjct: 214 LNDSVTYPDKFSPASKSFCEALLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 18/200 (9%)
Query: 21 LGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQI---KREISTMKLIKHP 73
LG+G+F V+ + TG+ VA+K L+H E + +REI +K ++H
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVK------KLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 74 NVIKIIEVM--ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCH 130
N++K V A + + +V+E++ G L D + KH RL + Y Q+ ++Y
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY-VAPEVLND 189
S+ HRDL N+L++S +KI DFGL+ + Q +E + +P + APE L +
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 190 KGYDGRASDVWSCGVILFVL 209
+ ASDVWS GV+L+ L
Sbjct: 186 SKFS-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 89/333 (26%), Positives = 157/333 (47%), Gaps = 31/333 (9%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLRHKMVEQIKREISTMKLIKH 72
+Y+ +G G++ V A + +TG VA+K + R Q + H ++ RE+ +K +KH
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYRELRLLKHMKH 75
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
NVI +++V +Y+V + G + I K +L +D + Q++ +
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
Y HS + HRDLKP NL ++ LKI DFGL+ D + T Y APE+
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEI 188
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKVSTFHFLSVYGESYK 242
+ + + + D+WS G I+ L+ G F ++ L + R V T + S +
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248
Query: 243 KCTNKYSYTLQICRADFSCPSWF---SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299
N Q+ + +F+ + F + A L++++L + D R+T +Q L +F +
Sbjct: 249 SARNYIQSLTQMPKMNFA--NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ- 305
Query: 300 YKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKK 332
+ D ++E D D F +S++ L+ E K
Sbjct: 306 ----YHDPDDEPVADPYDQSF-ESRDLLIDEWK 333
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 4e-19
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKII 79
LG G+ V A ++ T +A+K++ D + ++ +QI E+ + P +I
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV--ELQKQIMSELEILYKCDSPYIIGFY 65
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
+ +I I EF+DGG L + ++ E R ++ + Y S + HRD+
Sbjct: 66 GAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 199
KP N+L+++ G +K+ DFG+S +Q V + + T GT Y+APE ++ + Y G SDV
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVS--TQLV--NSIAKTYVGTNAYMAPERISGEQY-GIHSDV 176
Query: 200 WSCGVILFVLMAGFLPF 216
WS G+ L G P+
Sbjct: 177 WSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-19
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 15/221 (6%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG G F V K VAIK ++ + +E+ K M + HP ++++
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQL 64
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
V + +YIV EF++ G L + + + G+L +D Q + ++Y HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDG 194
DL N L+ S GV+K+SDFG+ ++ V +D ++ G + PEV N Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGM---TRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 195 RASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVSTFHFL 234
+ SDVWS GV+++ V G +PF++ + + +S L
Sbjct: 181 K-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 74/301 (24%), Positives = 127/301 (42%), Gaps = 40/301 (13%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG+G++ V + TG +A+K + + L QI E+ + P ++
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 81 VMASKTKIYIVLEFIDGG---ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFH 136
+ +Y+ +E++D G +L+ + ED RR ++ + + + H
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
RD+KP N+L++ G +K+ DFG+S L T G +Y+APE + G +
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSG----NLVASLAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 197 -----SDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
SDVWS G+ + + G P+ E+Y N ++
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPP--------------------ETY---ANIFAQL 219
Query: 252 LQICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEE 310
I D + PS +S A+ + + L+ P+ R T +Q+LE W K YK D E
Sbjct: 220 SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK-YKNADVDMAEW 278
Query: 311 V 311
V
Sbjct: 279 V 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 68/269 (25%), Positives = 117/269 (43%), Gaps = 28/269 (10%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
R LG+G F +V + TG A K +++ ++ + K E ++ + V+ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFH 136
+K + +VL ++GG+L I G DE R F +L ++ + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
RDLKPEN+LLD G ++ISD GL+ Q+ E + GT Y+APEV+N++ Y +
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKY-TFS 181
Query: 197 SDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICR 256
D W G +++ ++ G PF K+ + ++
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF----------------------RKRKERVKREEVDRRVKE 219
Query: 257 ADFSCPSWFSSGAKKLIKRILDPNPDTRM 285
FS AK + + +L NP R+
Sbjct: 220 DQEEYSEKFSEDAKSICRMLLTKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 20/200 (10%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REISTMKLIKHPNVI 76
LGEGS+A V + G VA+K V+ K E + RE S +K +KH N++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALK------VISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVF 135
+ +++ +K + V E++ +L + +H G L R + QL+ + Y H + +
Sbjct: 67 LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 136 HRDLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
HRDLKP+NLL+ G LK++DFGL+ +I Q ++ T Y P+VL
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-----TLWYRPPDVLLGATD 180
Query: 193 DGRASDVWSCGVILFVLMAG 212
A D+W G I ++ G
Sbjct: 181 YSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 8e-19
Identities = 78/284 (27%), Positives = 133/284 (46%), Gaps = 25/284 (8%)
Query: 19 RTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
R LGEG F KV+ + TG+ VA+K + + H + +K+EI ++ + H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 67
Query: 75 VIKI--IEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHS 131
++K I I +++EF+ G L + + ++ ++ + +Y Q+ +DY S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY-VAPEVL-ND 189
R HRDL N+L++S +KI DFGL+ + +E + +P + APE L
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT-NKY 248
K Y ASDVWS GV L+ L+ ES+ M L FL + G ++ + T +
Sbjct: 188 KFY--IASDVWSFGVTLYELLT--YCDSESSPMTL--------FLKMIGPTHGQMTVTRL 235
Query: 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
L+ + P +L+++ + P R T ++E
Sbjct: 236 VRVLEEGKR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 9e-19
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 21 LGEGSFAKVKFAK-NVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIK 77
LG+GSF V+ + + G VA+K + D++ +++ +E + M + H N+I+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIR 60
Query: 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR--------RYFQQLINAVDYC 129
+ V+ + + +V E G L D RL++D Y Q+ N + Y
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLD------RLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLN 188
S+ HRDL N+LL S +KI DFGL Q + ++ P + APE L
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 189 DKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ + ASDVW GV L+ + G P+
Sbjct: 174 TRTFS-HASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 84/332 (25%), Positives = 137/332 (41%), Gaps = 65/332 (19%)
Query: 14 KYELGRTLGEGSFAKVKFA--KNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
KYE+ +G G++ +V A KN + G AIK D+ + + REI+ ++ +K
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 72 HPNVIKIIEVMASKT--KIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQ------- 120
H NV+ ++EV +Y++ ++ + D +I K R R
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHR---QAKRVSIPPSMVKSL 113
Query: 121 --QLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAISQQ-----VRED 169
Q++N V Y HS V HRDLKP N+L+ GV+KI D GL+ + D
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 170 GLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYR 226
++ T Y APE+ L + Y +A D+W+ G I L+ F E+ + +
Sbjct: 174 PVVVTIW----YRAPELLLGARHYT-KAIDIWAIGCIFAELLTLEPIFKGREAKI----K 224
Query: 227 KVSTFH------FLSVYG-------ESYKKCTNKYSYTLQICRADFSCPS---WF----- 265
K + F V G KK + + S W
Sbjct: 225 KSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKK 284
Query: 266 -SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296
S L++++L+ +P R+T + LE +F
Sbjct: 285 PDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 59/198 (29%), Positives = 104/198 (52%), Gaps = 16/198 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--REISTMKLIKHPNVIKI 78
LGEG++A V ++ T + VA+K + L H+ RE+S +K +KH N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ-QLINAVDYCHSRGVFHR 137
+++ ++ + +V E++D +L + G L + F QL+ + YCH R + HR
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 138 DLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
DLKP+NLL++ G LK++DFGL+ ++ + + ++ T Y P+VL
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLLGSTEYS 182
Query: 195 RASDVWSCGVILFVLMAG 212
D+W G IL+ + G
Sbjct: 183 TPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 15/221 (6%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+ LG G F VK+ K D VAIK++ + + +E+ K M + H ++++
Sbjct: 10 KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAK----VMMKLSHEKLVQL 64
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHR 137
V + IYIV E++ G L + + +HG R + + + + + Y S+ HR
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDG 194
DL N L+D G +K+SDFGL S+ V +D ++ G+ + PEVL +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGL---SRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 195 RASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVSTFHFL 234
+ SDVW+ GV+++ V G +P++ N KVS L
Sbjct: 181 K-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL 220
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR-EISTMKLIKHPNVIKII 79
LG+G F +V + TG A K +D+ + L+ K E++ E ++ + P ++ +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR-LKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR--RYFQQLINAVDYCHSRGVFHR 137
SKT + +V+ ++GG+L I G + R Y Q+ + + HS + +R
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 197
D+KPEN+LLD G ++SD GL+ ++++ + GT Y+APE+L ++ Y
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYS-YPV 175
Query: 198 DVWSCGVILFVLMAGFLPF 216
D ++ G ++ ++AG PF
Sbjct: 176 DWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMV---------EQIKREIST 66
E R +G G+F V + G VA+K KM +++ RE+
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALK----------KMPNVFQNLVSCKRVFRELKM 52
Query: 67 MKLIKHPNVIKIIEVMASK-----TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQ 121
+ KH NV+ ++++ +IY+V E + +L I L D + + Q
Sbjct: 53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQ 111
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY 181
++ + Y HS G+ HRD+KP NLL++S VLKI DFGL A ++ E + T Y
Sbjct: 112 ILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGL-ARVEEPDESKHMTQEVVTQYY 170
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN 220
APE+L + A D+WS G I L+ + F +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 8 SRTRVGKYELGRTLGEGSFAKV-----KFAKNVETGDFVAIKI--VDRDQVLRHKMVEQI 60
R + LGR +GEG F V +N + VA+K +R K ++
Sbjct: 4 QREDI---TLGRCIGEGQFGDVYQGVYMSPENEKIA--VAVKTCKNCTSPSVREKFLQ-- 56
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYF 119
E M+ HP+++K+I V+ ++ ++IV+E GEL + + L Y
Sbjct: 57 --EAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
QL A+ Y S+ HRD+ N+L+ S +K+ DFGLS + ED + A
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS----RYLEDESYYKASKGK 169
Query: 180 ---NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
++APE +N + + ASDVW GV ++ +LM G PF
Sbjct: 170 LPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLRHKMVEQIKREISTMKLIKH 72
+Y+ + +G G+ V A + TG VAIK + R Q + H ++ RE+ MKL+ H
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH--AKRAYRELVLMKLVNH 74
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYF-QQLI 123
N+I ++ V + +Y+V+E +D ++ H R+ Y Q++
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS------YLLYQML 128
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
+ + HS G+ HRDLKP N+++ S LKI DFGL+ + ++ T Y A
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRA 185
Query: 184 PEVLNDKGYDGRASDVWSCGVIL 206
PEV+ GY D+WS G I+
Sbjct: 186 PEVILGMGYKENV-DIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 4e-18
Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 45/236 (19%)
Query: 53 RHKMVEQIKREISTMKLIKH--PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRL 110
+ + + I I H PN++ + + + S+ +++VL+ +GG+L+ I+K +
Sbjct: 28 KSSEYSRERLTI-----IPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNI 82
Query: 111 KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG-LSAISQQVRED 169
E+ +R+ +++ A+D H G+ RDL P N+LLD G ++++ F S + +
Sbjct: 83 PEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE 142
Query: 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVS 229
+ + C APEV + A D WS G ILF L+ G L
Sbjct: 143 AVENMYC------APEV-GGISEETEACDWWSLGAILFELLTG---------KTLV---- 182
Query: 230 TFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 285
E + N ++ TL I P W S A+ L++++L NP R+
Sbjct: 183 ---------ECHPSGINTHT-TLNI-------PEWVSEEARSLLQQLLQFNPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 90/327 (27%), Positives = 150/327 (45%), Gaps = 35/327 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y + +G G++ V A + TG+ VAIK + R ++ RE++ +K ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHE 74
Query: 74 NVIKIIEVMASKT------KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
NVI +++V S Y+V+ ++ KI H L ED+ + Q++ +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLCGLK 131
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
Y HS G+ HRDLKP NL ++ LKI DFGL+ D + T Y APEV+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVI 186
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY-----K 242
+ + + D+WS G I+ ++ G F + + ++ V G +
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI--LKVTGVPGPEFVQKLED 244
Query: 243 KCTNKYSYTL-QICRADFSC--PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299
K Y +L + R DFS P S A L++++L+ + D R+T ++ LE +F
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPK-ASPQAVDLLEKMLELDVDKRLTATEALEHPYFD-- 301
Query: 300 YKPPHFDKEEEVNLDDVDAIFNDSKEN 326
D +EE ++DS EN
Sbjct: 302 ---SFRDADEETEQQP----YDDSLEN 321
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 7e-18
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
K LG +GEG F V + TG VA+K + D V +E E + M + H
Sbjct: 7 KLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNIKCD-VTAQAFLE----ETAVMTKLHHK 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR--RYFQQLINAVDYCHS 131
N+++++ V+ +YIV+E + G L + + GR + ++ + ++Y S
Sbjct: 60 NLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
+ + HRDL N+L+ GV K+SDFGL+ + ++ L + APE L K
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKK 173
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPFDESNL 221
+ + SDVWS GV+L+ V G P+ + +L
Sbjct: 174 FSSK-SDVWSYGVLLWEVFSYGRAPYPKMSL 203
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 9e-18
Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 20/226 (8%)
Query: 15 YELGRT-------LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
+E+ RT LG G + +V + VA+K + D + VE+ +E + M
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVM 56
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ--QLINA 125
K IKHPN+++++ V + YI+ EF+ G L D + + R + + + Q+ +A
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL-HTACGTP-NYVA 183
++Y + HRDL N L+ ++K++DFGLS + + D H P + A
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTA 173
Query: 184 PEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKV 228
PE L + + SDVW+ GV+L+ + G P+ +L +Y +
Sbjct: 174 PESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--REISTMKLIKHPNVIKI 78
LGEG++A V ++ T + VA+K + L H+ RE+S +K +KH N++ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRL-KEDEARRYFQQLINAVDYCHSRGVFHR 137
+++ ++ + +V E++D +L + G + + QL+ ++YCH R V HR
Sbjct: 70 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 138 DLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
DLKP+NLL++ G LK++DFGL+ +I + + ++ T Y P++L
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPDILLGSTDYS 183
Query: 195 RASDVWSCGVILFVLMAG 212
D+W G I + + G
Sbjct: 184 TQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVI 76
+ LG G F V K D VAIK++ + +E+ K M + HPN++
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAK----VMMKLSHPNLV 62
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVF 135
++ V + I+IV E++ G L + + + G+L + + A++Y S G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY----VAPEVLNDKG 191
HRDL N L+ V+K+SDFGL ++ V +D +T+ + PEV +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGL---ARYVLDDQ--YTSSQGTKFPVKWAPPEVFDYSR 177
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPFD 217
+ + SDVWS GV+++ V G +P++
Sbjct: 178 FSSK-SDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 14/157 (8%)
Query: 67 MKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
MK +PN IK+ + + +++++I G+LFD + K G+L E E ++ +QL+ A+
Sbjct: 65 MK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGV-LKISDFGLSAI--SQQVREDGLLHTACGTPNYVA 183
+ H + H D+K EN+L D + + D+GL I + + GT +Y +
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--------GTLDYFS 174
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN 220
PE + YD + D W+ GV+ + L+ G PF E
Sbjct: 175 PEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 59/235 (25%), Positives = 112/235 (47%), Gaps = 34/235 (14%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ +Y++ R +G+G +V A + VA+K + D + ++ RE +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR------------RYF 119
HP ++ + + + +Y + +I+G L + K KE ++ F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED---------- 169
++ ++Y HS+GV HRDLKP+N+LL +G + I D+G AI +++ E+
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA-AIFKKLEEEDLLDIDVDER 178
Query: 170 GLLHTA-------CGTPNYVAPEVLNDKGYDGRAS-DVWSCGVILFVLMAGFLPF 216
+ +++ GTP+Y+APE L G S D+++ GVIL+ ++ P+
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--REISTMKLIKHPNVIKI 78
LGEG++A V ++ T + VA+K + L H+ RE+S +K +KH N++ +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKE-DEARRYFQQLINAVDYCHSRGVFHR 137
+++ + + +V E++D +L + G + + + Q++ + YCH R V HR
Sbjct: 70 HDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 138 DLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
DLKP+NLL++ G LK++DFGL+ ++ + + ++ T Y P+VL
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLLGSSEYS 183
Query: 195 RASDVWSCGVILFVLMAG 212
D+W G I F + +G
Sbjct: 184 TQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 19 RTLGEGSFAKV---KFAKNVETGDFVAIKIV-------DRDQVLRHKMVEQIKREISTMK 68
+ +G G F +V + + VAIK + R L E S M
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLT---------EASIMG 60
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN---- 124
HPN+I++ V+ + I+ E+++ G L DK L+E++ + QL+
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRG 114
Query: 125 ---AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG-TP- 179
+ Y HRDL N+L++S V K+SDFGLS + + T G P
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPI 172
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILFVLMA 211
+ APE + + + ASDVWS G++++ +M+
Sbjct: 173 RWTAPEAIAYRKFT-SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+L +T+G+G F V G+ VA+K + D + E S M ++H N+
Sbjct: 9 KLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNL 61
Query: 76 IKIIEVMAS-KTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSR 132
++++ V+ K +YIV E++ G L D + GR L D ++ + A++Y +
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
HRDL N+L+ V K+SDFGL+ + ++ G L + APE L +K +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKF 176
Query: 193 DGRASDVWSCGVILFVLMA-GFLPF 216
+ SDVWS G++L+ + + G +P+
Sbjct: 177 STK-SDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
Y + +TL GS +V A D V +KI + L M+ ++ + HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAML---------LQNVNHPS 118
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRG 133
VI++ + + S +VL +L+ + K L D+A +Q++ + Y H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ HRD+K EN+ ++ + I D G A V L A GT APEVL Y+
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLG--AAQFPVVAPAFLGLA-GTVETNAPEVLARDKYN 234
Query: 194 GRASDVWSCGVILFVLMA 211
+A D+WS G++LF ++A
Sbjct: 235 SKA-DIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 61/237 (25%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDF-----VAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ LG+ LGEG+F +V A+ V + VA+K++ D K + + E+ MK
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMK 70
Query: 69 LI-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKED-EARR--------- 117
+I KH N+I ++ V + +Y+V+E+ A HG L++ ARR
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEY----------AAHGNLRDFLRARRPPGEYASPD 120
Query: 118 ----------------YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161
+ Q+ +++ S+ HRDL N+L+ V+KI+DFGL
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGL-- 178
Query: 162 ISQQVRE--------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210
++ + +G L ++APE L D+ Y SDVWS GV+L+ +
Sbjct: 179 -ARDIHHIDYYRKTTNGRLPV-----KWMAPEALFDRVYT-HQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG G+ V ++ +G +A K++ + ++ + QI RE+ + P ++
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG------- 133
S +I I +E +DGG L D++ K EA+R ++++ V RG
Sbjct: 71 AFYSDGEISICMEHMDGGSL-DQVLK-------EAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 134 --VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
+ HRD+KP N+L++S G +K+ DFG+S Q + D + ++ GT +Y++PE L
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTH 178
Query: 192 YDGRASDVWSCGVILFVLMAGFLPF---DESNLMALY 225
Y + SD+WS G+ L L G P D L A++
Sbjct: 179 YSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 37/210 (17%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH-KM-VEQIKREISTMKLIKHPN 74
L R LG G F +V T VA+K L+ M E +E MK ++H
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK-VAVK------TLKPGTMSPEAFLQEAQIMKKLRHDK 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARR-YFQQLI-------NAV 126
++++ V + + IYIV E++ G L D LK E ++ QL+ +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVA 183
Y SR HRDL N+L+ V KI+DFGL+ ++ ED G + A
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLA----RLIEDDEYTAREGAKFPIKWTA 172
Query: 184 PEVLNDKGYDGR---ASDVWSCGVILFVLM 210
PE N Y GR SDVWS G++L ++
Sbjct: 173 PEAAN---Y-GRFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 8/196 (4%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG G+ V + +G +A K++ + ++ + QI RE+ + P ++
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDL 139
S +I I +E +DGG L + K GR+ E + +I + Y + + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 199
KP N+L++S G +K+ DFG+S Q + D + ++ GT +Y++PE L Y + SD+
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYSVQ-SDI 185
Query: 200 WSCGVILFVLMAGFLP 215
WS G+ L + G P
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI--KH--PNVI 76
+G G+ +V + +TG +A+K Q+ R E+ KR + + ++ H P ++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSR-G 133
K + + ++I +E + DK+ K G + ED + ++ A+ Y + G
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT-ACGTPNYVAPEVL----- 187
V HRD+KP N+LLD+ G +K+ DFG+S + V D T + G Y+APE +
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG--RLV--DSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESN 220
N K YD RA DVWS G+ L L G P+
Sbjct: 192 NPK-YDIRA-DVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 23/214 (10%)
Query: 15 YELGRTLGEGSFAKVKFAK-NVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ LGR LG+G F V+ A+ E G F VA+K++ D + +E+ RE + MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD-IFSSSDIEEFLREAACMKEFD 59
Query: 72 HPNVIKIIEV-MASKTK-----IYIVLEFIDGGEL--FDKIAKHGR----LKEDEARRYF 119
HPNVIK+I V + S+ K ++L F+ G+L F +++ G L R+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
+ + ++Y S+ HRDL N +L+ + ++DFGL S+++ C +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL---SKKIYSGDYYRQGCASK 176
Query: 180 ---NYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210
++A E L D Y SDVW+ GV ++ +M
Sbjct: 177 LPVKWLALESLADNVYTTH-SDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 23/254 (9%)
Query: 55 KMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKED- 113
+ Q++ EI + + H N++KI E++ S+ Y++ + D +L+ + +D
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDR 263
Query: 114 ----EARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169
+ R +QL+ AV+Y H + + HRD+K EN+ L+ G + + DFG + ++ RE
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE- 322
Query: 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKV 228
+ GT +PE+L GY +D+WSCG+IL +++ F P + + +
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381
Query: 229 STFHFLSVYGESYKK--CTNKYSY--TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTR 284
LSV E + C + Y + +I A S P LI+ + P D
Sbjct: 382 KIIDSLSVCDEEFPDPPC-KLFDYIDSAEIDHAGHSVPP--------LIRNLGLP-ADFE 431
Query: 285 MTISQMLEDEWFKK 298
+ +ML +W +
Sbjct: 432 YPLVKMLTFDWHLR 445
|
Length = 501 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 84/348 (24%), Positives = 153/348 (43%), Gaps = 38/348 (10%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
T + +Y+ + +G G+ V A + VAIK + R ++ RE+ MK
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 79
Query: 70 IKHPNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQ 121
+ H N+I ++ V + +YIV+E +D + + +++ D R + Q
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-----NLCQVIQMELDHERMSYLLYQ 134
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY 181
++ + + HS G+ HRDLKP N+++ S LKI DFGL ++ ++ T Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 191
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV---------STFH 232
APEV+ GY D+WS G I+ ++ G + F ++ + + KV
Sbjct: 192 RAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250
Query: 233 FLSVYGESYKKCTNKYS-YTLQICRADFSCPS------WFSSGAKKLIKRILDPNPDTRM 285
L +Y + KY+ Y+ + D P+ +S A+ L+ ++L + R+
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 286 TISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKE 333
++ + L+ + Y P E E + D +E+ + E KE
Sbjct: 311 SVDEALQHPYINVWYDP----SEAEAPPPKIPDKQLDEREHTIEEWKE 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 63/213 (29%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIK-----IVDRDQVLRHKMVEQIKREISTMKLIKHP 73
LG G++ V ++V TG +A+K + ++Q +++ + +IS M+ + P
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ---KRLLMDL--DIS-MRSVDCP 60
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGG--ELFDKIAKHG-RLKEDEARRYFQQLINAVDYCH 130
+ + + ++I +E +D + + K+ G + ED + ++ A++Y H
Sbjct: 61 YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 131 SR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPE--- 185
S+ V HRD+KP N+L++ G +K+ DFG+S V D + T G Y+APE
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISG--YLV--DSVAKTIDAGCKPYMAPERIN 176
Query: 186 -VLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217
LN KGYD + SDVWS G+ + L G P+D
Sbjct: 177 PELNQKGYDVK-SDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 21 LGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKR----EISTMKLIKHP 73
+G G F +V + G FVAIK L+ E+ +R E S M HP
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIK------TLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI-------NAV 126
N+I + V+ + I+ EF++ G L D L++++ + QL+ +
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGAL-DSF-----LRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVA 183
Y HRDL N+L++S V K+SDFGLS + D ++ G + A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPF-DESN 220
PE + + + ASDVWS G++++ +M+ G P+ D SN
Sbjct: 180 PEAIAYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 19 RTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKR----EISTMKLIK 71
+ +G G F +V + G VAIK L+ E+ +R E S M
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIK------TLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCH 130
HPN+I + V+ + IV E+++ G L + KH G+ + + + + + Y
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLND 189
G HRDL N+L++S V K+SDFGLS + + E P + APE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 190 KGYDGRASDVWSCGVILFVLMA 211
+ + ASDVWS G++++ +M+
Sbjct: 184 RKFTS-ASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 77/308 (25%), Positives = 130/308 (42%), Gaps = 65/308 (21%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGD-------FVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
LG+ LGEG F +V A+ + VA+K++ D K + + E+ MK+
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 79
Query: 70 I-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY---------- 118
I KH N+I ++ +Y+++E+ G L + + R + Y
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYCYNPTQVPEE 135
Query: 119 ---FQQLIN-------AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168
F+ L++ ++Y S+ HRDL N+L+ V+KI+DFGL+ +
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-- 193
Query: 169 DGLLHTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALY 225
D T G ++APE L D+ Y SDVWS GV+L+ + G P+ + L+
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
Query: 226 RKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 285
+ + H + + CTN+ ++ C W + P R
Sbjct: 253 KLLKEGHRM----DKPSNCTNELYMMMRDC--------WHAV-------------PSQRP 287
Query: 286 TISQMLED 293
T Q++ED
Sbjct: 288 TFKQLVED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
+G G F V +E VAIK + R+ + E E M + HP ++++
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTI-REGAMSE---EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 81 VMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
V ++ I +V EF++ G L D + A+ G+ ++ + + Y S V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDGRA 196
N L+ V+K+SDFG++ D ++ GT + +PEV + Y +
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVL----DDQYTSSTGTKFPVKWSSPEVFSFSKYSSK- 181
Query: 197 SDVWSCGVILF-VLMAGFLPFD 217
SDVWS GV+++ V G P++
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 75/317 (23%), Positives = 139/317 (43%), Gaps = 34/317 (10%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
T + +Y+ + +G G+ V A + VAIK + R ++ RE+ MK
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 70 IKHPNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQ 121
+ H N+I ++ V + +Y+V+E +D + + +++ D R + Q
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-----NLCQVIQMELDHERMSYLLYQ 127
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY 181
++ + + HS G+ HRDLKP N+++ S LKI DFGL ++ ++ T Y
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 184
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV---------STFH 232
APEV+ GY D+WS G I+ ++ + F + + + KV
Sbjct: 185 RAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 233 FLSVYGESYKKCTNKYS-------YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 285
L +Y + KY+ + + AD +S A+ L+ ++L +P R+
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 286 TISQMLEDEWFKKGYKP 302
++ + L+ + Y P
Sbjct: 304 SVDEALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 17/216 (7%)
Query: 16 ELGRTLGEG--SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
EL +G G V A+ TG++V ++ ++ + ++MV ++ E+ KL HP
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINL-EACTNEMVTFLQGELHVSKLFNHP 59
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHS 131
N++ + ++++V F+ G D I H + E Q ++ A+DY H
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY-------VAP 184
G HR +K ++L+ G + +S GL + + L P Y ++P
Sbjct: 120 MGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177
Query: 185 EVL--NDKGYDGRASDVWSCGVILFVLMAGFLPFDE 218
EVL N +GYD + SD++S G+ L G +PF +
Sbjct: 178 EVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 19 RTLGEGSFAKV-------KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ LG G+F V K K VE VA+K + ++ + K ++ RE S M +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVE----VAVKTLKQEHIAAGK--KEFLREASVMAQLD 54
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
HP ++++I V + + +V+E G L + K + + + Q+ + Y S
Sbjct: 55 HPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLS----AISQQVREDGLLHTACGTP-NYVAPEV 186
+ HRDL N+LL + KISDFG+S A S R TA P + APE
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPEC 169
Query: 187 LNDKGYDGRASDVWSCGVIL 206
+N + + SDVWS GV L
Sbjct: 170 INYGKFSSK-SDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 31/222 (13%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
ELG G G KV + +G +A K++ + ++ + QI RE+ + P +
Sbjct: 8 ELGAGNG-GVVTKVL---HRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYI 61
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG-- 133
+ S +I I +E +DGG L D++ K +A R + ++ + RG
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSL-DQVLK-------KAGRIPENILGKISIAVLRGLT 113
Query: 134 -------VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
+ HRD+KP N+L++S G +K+ DFG+S Q + D + ++ GT +Y++PE
Sbjct: 114 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPER 169
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMALY 225
L Y + SD+WS G+ L + G P D L A++
Sbjct: 170 LQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 12/212 (5%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDF----VAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ E + LG G+F V + G+ VAIK++ + K ++I E M
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVD 127
+ HP+V++++ + S + ++ + + G L D + H + + Q+ +
Sbjct: 65 SVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEV 186
Y + + HRDL N+L+ + +KI+DFGL+ + V E P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LDVDEKEYHAEGGKVPIKWMALES 182
Query: 187 LNDKGYDGRASDVWSCGVILFVLMA-GFLPFD 217
+ + Y + SDVWS GV ++ LM G P++
Sbjct: 183 ILHRIYTHK-SDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+L + LG G F +V A N T VA+K + + VE E + MK ++H
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSM----SVEAFLAEANVMKTLQHDK 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARR--------YFQQLINAV 126
++K+ V+ +K IYI+ EF+ G L D LK DE + + Q+ +
Sbjct: 63 LVKLHAVV-TKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGM 115
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI---SQQVREDGLLHTACGTPNYVA 183
+ R HRDL+ N+L+ + V KI+DFGL+ + ++ +G A + A
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG----AKFPIKWTA 171
Query: 184 PEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
PE +N + + SDVWS G++L ++ G +P+
Sbjct: 172 PEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 36/269 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNV-------ETGDFVAIKIVDRDQVLRHKMVEQIKREIST 66
K LG+ LGEG F +V A+ + + VA+K++ D K + + E+
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEM 73
Query: 67 MKLI-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKED---------EAR 116
MK+I KH N+I ++ +Y+++E+ G L + + + + +
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 117 RYFQQLIN-------AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169
F+ L++ ++Y S+ HRDL N+L+ V+KI+DFGL+ + D
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI--D 191
Query: 170 GLLHTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYR 226
T G ++APE L D+ Y + SDVWS GV+++ + G P+ + L++
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250
Query: 227 KVSTFHFLSVYGESYKKCTNKYSYTLQIC 255
+ H + + CTN+ ++ C
Sbjct: 251 LLKEGHRM----DKPANCTNELYMMMRDC 275
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 17 LGRTLGEGSFAKVKFAK-NVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
LG+ LGEG F V + + + G VA+K + D + + +E+ E + MK HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFDHP 61
Query: 74 NVIKIIEV---MASKTKI---YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AV 126
NV+K+I V +S KI ++L F+ G+L + + RL + Q L+ V
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFMV 120
Query: 127 D------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS--AISQQVREDGLLHTACGT 178
D Y +R HRDL N +L + ++DFGLS S G A
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG--RIAKMP 178
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210
++A E L D+ Y + SDVW+ GV ++ +
Sbjct: 179 VKWIAIESLADRVYTSK-SDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 17 LGRTLGEGSFAKVKFAK-------NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
LG+ LGEG F +V A+ + VA+K++ + K + + E+ MKL
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKL 73
Query: 70 I-KHPNVIKIIEVMASKTKIYIVLEFIDGGEL---------------FDKIAKH-GRLKE 112
I KH N+I ++ V + +Y+++E+ G L FD +L
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 113 DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172
+ Q+ ++Y SR HRDL N+L+ V+KI+DFGL+ + D
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI--DYYK 191
Query: 173 HTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILF 207
T+ G ++APE L D+ Y SDVWS G++++
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 18/196 (9%)
Query: 21 LGEGSFAKVK--FAKNVETGDFVAIKIV---DRDQVLRHKMVEQIKREISTMKLIKHPNV 75
LG G+F VK K ++ VA+KI+ + D L+ +++ RE + M+ + +P +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELL----REANVMQQLDNPYI 58
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVF 135
+++I + +++ + +V+E + G L + K+ + E Q+ + Y
Sbjct: 59 VRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP----NYVAPEVLNDKG 191
HRDL N+LL + KISDFGL S+ + D + A + APE +N
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGL---SKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 192 YDGRASDVWSCGVILF 207
+ + SDVWS GV+++
Sbjct: 175 FSSK-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 81/315 (25%), Positives = 136/315 (43%), Gaps = 64/315 (20%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNV-------ETGDFVAIKIVDRDQVLRHKMVEQI 60
SRTR+ LG+ LGEG F +V A+ + VA+K++ D K + +
Sbjct: 10 SRTRL---TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDL 64
Query: 61 KREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDGGEL-----------FDKIAKHG 108
E+ MK+I KH N+I ++ +Y+++E+ G L D
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 109 RLKEDEARRYFQQLIN-------AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161
+L E++ F+ L++ ++Y S+ HRDL N+L+ V+KI+DFGL+
Sbjct: 125 KLPEEQLT--FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 162 ISQQVREDGLLHTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDE 218
+ D T G ++APE L D+ Y SDVWS GV+L+ + G P+
Sbjct: 183 DVHNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 219 SNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILD 278
+ L++ + H + + CT++ ++ C W +
Sbjct: 240 IPVEELFKLLKEGHRM----DKPANCTHELYMIMREC--------WHAV----------- 276
Query: 279 PNPDTRMTISQMLED 293
P R T Q++ED
Sbjct: 277 --PSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 16 ELGRTLGEGSFAKV-KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+L R LG G F +V + N T VA+K + + + E MK ++HP
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTM----DPKDFLAEAQIMKKLRHPK 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
+I++ V + IYIV E + G L + + LK + Q+ + + Y ++
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL-LHTACGTP-NYVAPEVLNDK 190
HRDL N+L+ + K++DFGL+ + ++ED P + APE
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARV---IKEDIYEAREGAKFPIKWTAPEAALYN 179
Query: 191 GYDGRASDVWSCGVILFVLMA-GFLPF 216
+ + SDVWS G++L ++ G +P+
Sbjct: 180 RFSIK-SDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-13
Identities = 26/94 (27%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 363 VKRETRFTSQRPPNEIMSKIEEAAKPLGFN--VRKGNYKMKLQG--DKTGRKGQLSVATE 418
K E S+ P+EI I + + G N R N+ + + D E
Sbjct: 2 KKWELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIE 61
Query: 419 VFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGL 452
V+EV P L +V+ +K G T F K K L
Sbjct: 62 VYEVGPGLFMVDFKKKTGSTKTFTKLATKIQIKL 95
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIK----IVD-RDQVLRHKMVEQIKREI-STMKLIKHPN 74
+G G+F V + +G +A+K VD ++Q +++ ++ M+ P
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ-------KRLLMDLDVVMRSSDCPY 64
Query: 75 VIKIIEVMASKTKIYIVLEFIDGG-ELFDKIA---KHGRLKEDEARRYFQQLINAVDYCH 130
++K + + +I +E +D + F K + E+ + + A++Y
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 131 SR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVLN 188
+ HRD+KP N+LLD G +K+ DFG IS Q+ D + T G Y+APE ++
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQL-VDSIAKTRDAGCRPYMAPERID 180
Query: 189 ---DKGYDGRASDVWSCGVILFVLMAGFLPFDESN 220
GYD R SDVWS G+ L+ + G P+ + N
Sbjct: 181 PSARDGYDVR-SDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 16 ELGRTLGEGSFAKVKFA-KNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+L + LG G F +V N T VA+K + + V+ E + MK ++H
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTM----SVQAFLEEANLMKTLQHDK 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
++++ V+ + IYI+ E++ G L D K + G++ + + Q+ + Y +
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLND 189
HRDL+ N+L+ + KI+DFGL+ +V ED G + APE +N
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAINF 178
Query: 190 KGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ + SDVWS G++L+ ++ G +P+
Sbjct: 179 GSFTIK-SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
+R+ Y+LG +G GSF V A ++T + VAIK V +D ++ RE+ M
Sbjct: 61 NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-------RELLIM 113
Query: 68 KLIKHPNVIKIIE------VMASKTKIY--IVLEFIDGGELFDKIAKHGRLKEDE----- 114
K + H N+I + + ++ I+ +V+EFI + K KH
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALPLFL 171
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQQVREDGLLH 173
+ Y QL A+ Y HS+ + HRDLKP+NLL+D + LK+ DFG SA + + + +
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVSY 230
Query: 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 216
+ Y APE++ D+WS G I+ ++ G+ F
Sbjct: 231 IC--SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 36/228 (15%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDF-----VAIKIVDRDQVLRHKMVEQIKREISTMK 68
LG+TLGEG F KV A VA+K++ + + E + +K
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR--DLLSEFNLLK 58
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL----------------FDKIAKHGRLKE 112
+ HP+VIK+ + + +++E+ G L D L
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 113 DEAR--------RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164
+ R + Q+ + Y + HRDL N+L+ +KISDFGLS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RD 176
Query: 165 QVREDGLLHTACG-TP-NYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210
ED + + G P ++A E L D Y + SDVWS GV+L+ ++
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 51/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 21 LGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
LGEG+F KV + + VAIK + + K+ ++ ++E M ++HPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNI 70
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYF 119
+ ++ V + ++ E++ G+L + + ++ L +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
Q+ ++Y S HRDL N L+ +KISDFGLS + +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 180 NYVAPEVLNDKGYDGR---ASDVWSCGVILFVLMA-GFLPF 216
++ PE + G+ SD+WS GV+L+ + + G P+
Sbjct: 191 RWMPPEAI----LYGKFTTESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REISTMKL 69
+YE G +G G++ V AK + D DRD L+ I REI+ ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKD-------DRDYALKQIEGTGISMSACREIALLRE 54
Query: 70 IKHPNVIKIIEVMASKT--KIYIVLEFIDGGELFDKIAKHGRLKEDE---------ARRY 118
+KHPNVI + +V S K++++ ++ + +L+ I H K ++ +
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAI-SQQVREDGLLH 173
Q+++ + Y H+ V HRDLKP N+L+ G +KI+D G + + + ++ L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210
T Y APE+L + +A D+W+ G I L+
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 32/231 (13%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-----TMKLIKHPNV 75
+GEG+F +V A + G + I ++L+ E R+ + KL HPN+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAI----KMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA----------------RRYF 119
I ++ ++ +YI +E+ G L D + K L+ D A ++
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
+ + Y + HRDL N+L+ KI+DFGLS + E + T P
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVYVKKTMGRLP 181
Query: 180 -NYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKV 228
++A E LN Y + SDVWS GV+L+ +++ G P+ LY K+
Sbjct: 182 VRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 16 ELGRTLGEGSFAKVKFAKNV-ETGDFV--AIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
L R LG G+F +V GD V + + + + E M H
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY-FQQLIN-AVD--- 127
N++++I V + +I+LE + GG+L + R + + + L+ A D
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 128 ---YCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSA---ISQQVREDGLLHTACGT 178
Y HRD+ N LL G V KI+DFG++ + R+ G A
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG---RAMLP 184
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPF 216
++ PE D G +DVWS GV+L+ + + G++P+
Sbjct: 185 IKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 3e-11
Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 36/261 (13%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-----TMKLIKHPNV 75
+GEG+F +V A+ + G +++ + ++ + R+ + KL HPN+
Sbjct: 3 IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA----------------RRYF 119
I ++ + +Y+ +E+ G L D + K L+ D A +
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
+ +DY + HRDL N+L+ V KI+DFGLS + +E + T P
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRLP 174
Query: 180 -NYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVY 237
++A E LN Y SDVWS GV+L+ +++ G P+ LY K+ + L
Sbjct: 175 VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL--- 230
Query: 238 GESYKKCTNKYSYTLQICRAD 258
E C ++ ++ C +
Sbjct: 231 -EKPLNCDDEVYDLMRQCWRE 250
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 1/88 (1%)
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
+QL++A+DY H G+ HRD+K EN+L++ + + DFG + ++ + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF 207
+ APEVL Y + D+WS G+++F
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+L + LG G F +V + VAIK + + + E E + MK ++HP
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHTK---VAIKSLKQGSM----SPEAFLAEANLMKQLQHP 61
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHS 131
++++ V+ ++ IYI+ E+++ G L D K + +L ++ Q+ + +
Sbjct: 62 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAI---SQQVREDGLLHTACGTPNYVAPEVLN 188
+ HRDL+ N+L+ KI+DFGL+ + ++ +G A + APE +N
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG----AKFPIKWTAPEAIN 176
Query: 189 DKGYDGRASDVWSCGVIL 206
G SDVWS G++L
Sbjct: 177 -YGTFTIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 64/263 (24%), Positives = 108/263 (41%), Gaps = 40/263 (15%)
Query: 19 RTLGEGSFAKV-----KFAKNVETGDF-VAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
LG G+F +V +G VA+K + + + K ++ +E M H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNH 58
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD---- 127
PN++K++ V YI++E ++GG+L + + ++L++ +D
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 128 --YCHSRGVFHRDLKPENLLLDSYG-----VLKISDFGL-----SAISQQVREDGLLHTA 175
Y HRDL N L+ G V+KI DFGL + + +GLL
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV- 177
Query: 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVSTFHFL 234
++APE L D G SDVWS GV+++ +L G P+ N +
Sbjct: 178 ----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALN------NQEVLQHV 226
Query: 235 SVYG--ESYKKCTNKYSYTLQIC 255
+ G + + C +K + C
Sbjct: 227 TAGGRLQKPENCPDKIYQLMTNC 249
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 17/165 (10%)
Query: 62 REISTMKLIKHPNVIKIIEVMASKT--KIYIVLEFIDGGELFDKIAKHGRLKEDE----- 114
REI+ ++ +KHPNVI + +V S + K++++ ++ + +L+ I H K ++
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQL 105
Query: 115 ----ARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAI-SQQ 165
+ Q+++ + Y H+ V HRDLKP N+L+ G +KI+D G + + +
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210
++ L T Y APE+L + +A D+W+ G I L+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 17/168 (10%)
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQL 122
E S M H N+I++ V+ I+ E+++ G L DK L++ + QL
Sbjct: 56 EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKY-----LRDHDGEFSSYQL 109
Query: 123 IN-------AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175
+ + Y HRDL N+L++S K+SDFGLS + + E +
Sbjct: 110 VGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG 169
Query: 176 CGTP-NYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPF-DESN 220
P + APE + + + ASDVWS G++++ +M+ G P+ D SN
Sbjct: 170 GKIPIRWTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSFGERPYWDMSN 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH----KMVEQIKREISTMKLIKHPN 74
+ LG G+F V + G+ V I + + LR K ++I E M + +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 70
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ----QLINAVDYCH 130
V +++ + + T + ++ + + G L D + +H K++ +Y Q+ ++Y
Sbjct: 71 VCRLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG-TP-NYVAPEVLN 188
R + HRDL N+L+ + +KI+DFGL+ + ++ H G P ++A E +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWMALESIL 184
Query: 189 DKGYDGRASDVWSCGVILFVLMA-GFLPFD 217
+ Y SDVWS GV ++ LM G P+D
Sbjct: 185 HRIYT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 66/316 (20%), Positives = 128/316 (40%), Gaps = 40/316 (12%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
E+GR G + V A++ TG V ++I D + + + ++ E+ +HPN+
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61
Query: 76 IKIIEVMASKTKIYIVLEFIDGG---ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
+ V + + ++++ F+ G L G + E + ++Y H
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY-------VAPE 185
G HR++K ++L+ G++ +S GLS + VR P + ++PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 186 VLNDK--GYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTFHF----LSVYG 238
+L GY+ + SD++S G+ L G +PF D L +K+ + ++ +
Sbjct: 179 LLRQDLYGYNVK-SDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237
Query: 239 ESYKKCTNKYS----------------YTLQICRADFSCPSWFSSGAKKLIKRILDPNPD 282
+ N S T+ R FS + L++ L +P+
Sbjct: 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPE 297
Query: 283 TRMTISQMLEDEWFKK 298
R + S +L +FK+
Sbjct: 298 KRPSASSLLSHAFFKQ 313
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 30/230 (13%)
Query: 21 LGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVI 76
+GEG+F +V A+ + G D ++ + H+ E+ + KL HPN+I
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 71
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA---------RRYFQQLIN--- 124
++ + +Y+ +E+ G L D + K L+ D A QQL++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 125 ----AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP- 179
+DY + HRDL N+L+ V KI+DFGLS Q+V + T P
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVY---VKKTMGRLPV 187
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKV 228
++A E LN Y SDVWS GV+L+ ++ G P+ LY K+
Sbjct: 188 RWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMV---- 57
S PAS R+ +Y + +L GS +V FV K R K++
Sbjct: 82 SSSDPASVVRM-QYNILSSLTPGSEGEV----------FVCTK---HGDEQRKKVIVKAV 127
Query: 58 ---EQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDE 114
+ REI +K I H +I +I K+ + +V+ +LF + + G L ++
Sbjct: 128 TGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQ 186
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT 174
A ++L+ A+ Y H RG+ HRD+K EN+ LD + DFG + + +
Sbjct: 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 216
GT +PE+L Y + +D+WS G++LF + +
Sbjct: 247 WSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 47/235 (20%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH--KMVEQIKREISTMKLI 70
++++ LGEG+F KV A + + ++ A+KIV R+ K K EI M+ +
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV------RNVPKYTRDAKIEIQFMEKV 182
Query: 71 KHPNV------IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI- 123
+ + +KI ++T ++ G L D I KHG R+ Q+I
Sbjct: 183 RQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH----RHLAQIIF 238
Query: 124 ---NAVDYCHSR-GVFHRDLKPENLLLDSYGV----------------LKISDFGLSAIS 163
A+DY H+ + H DLKPEN+L+++ ++I D G
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE 298
Query: 164 QQVREDGLLHTA-CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217
+ R TA T +Y +PEV+ G+ ++D+WS G I++ L G L +D
Sbjct: 299 RHSR------TAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR---EI 64
SR RV +L L EG+F ++ + ++ + V V H Q+ E
Sbjct: 4 SRDRVTLSDL---LQEGTFGRIFYGILIDE-KPGKEEEVFVKTVKDHASEIQVTLLLQES 59
Query: 65 STMKLIKHPNVIKIIEVMASKT-KIYIVLEFIDGGEL--FDKIAKHGRLKEDEARRYFQ- 120
+ + H N++ I+ V +++ +++ G L F + + G +A Q
Sbjct: 60 CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119
Query: 121 -----QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175
Q+ + Y H RGV H+D+ N ++D +KI+D +A+S+ + H
Sbjct: 120 VHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDY-HCL 175
Query: 176 CGTPN----YVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDE 218
N ++A E L +K Y ASDVWS GV+L+ LM G P+ E
Sbjct: 176 GDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 45/217 (20%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDF----------VAIKIVDRDQVLRHKMVEQIKREIS 65
G+TLG G+F KV VE + VA+K++ + E + E+
Sbjct: 38 SFGKTLGAGAFGKV-----VEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELK 90
Query: 66 TM-KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI--AKHGRLKEDEARRYFQQL 122
M L H N++ ++ I ++ E+ G+L + + + L ++ + Q+
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
+ + S+ HRDL N+LL ++KI DFGL ++ + D NYV
Sbjct: 151 AKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL---ARDIMNDS---------NYV 198
Query: 183 ------------APEVLNDKGYDGRASDVWSCGVILF 207
APE + + Y SDVWS G++L+
Sbjct: 199 VKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLW 234
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
LG+TLGEG F V + + VA+K + R +M E E MK HPN
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM-EDFLSEAVCMKEFDHPN 61
Query: 75 VIKIIEV--MASKTKIY----IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI----- 123
V+++I V +++ Y ++L F+ G+L + + RL + Q L+
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTD 120
Query: 124 --NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTP 179
+ ++Y S+ HRDL N +L+ + ++DFGLS + G + A
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI--AKMPV 178
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF 207
++A E L D+ Y + SDVWS GV ++
Sbjct: 179 KWIAIESLADRVYTTK-SDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+L + LG G F +V N T VA+K + + +E E MK ++H
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLE----EAQIMKKLRHDK 62
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGR-LKEDEARRYFQQLINAVDYCHSR 132
++++ V+ S+ IYIV E++ G L D + GR LK Q+ + Y
Sbjct: 63 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
HRDL+ N+L+ V KI+DFGL+ + + E A + APE
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEA----AL 176
Query: 193 DGR---ASDVWSCGVILFVLMA-GFLPFDESN 220
GR SDVWS G++L L+ G +P+ N
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG+G F +V T VAIK + + M E +E MK ++H ++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 81 VMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138
V+ S+ IYIV EF+ G L D K LK + Q+ + + Y HRD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR--- 195
L+ N+L+ V KI+DFGL+ + + E A + APE GR
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEA----ALYGRFTI 182
Query: 196 ASDVWSCGVILFVLMA-GFLPF 216
SDVWS G++L L+ G +P+
Sbjct: 183 KSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 12/165 (7%)
Query: 58 EQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGR-LKEDEA 115
E +E MK ++H ++++ V+ S+ IYIV E++ G L D + + G+ L+ +
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL 104
Query: 116 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175
Q+ + + Y HRDL+ N+L+ V K++DFGL+ + + E A
Sbjct: 105 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGA 163
Query: 176 CGTPNYVAPEVLNDKGYDGR---ASDVWSCGVILFVLMA-GFLPF 216
+ APE GR SDVWS G++L L G +P+
Sbjct: 164 KFPIKWTAPEA----ALYGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 13 GKYELGRTLGEGSFAKVKFAKN---VETGDF--VAIKIVDRDQVLRHKMVEQIKREISTM 67
E R +G+G+F +V A+ + F VA+K++ + + +RE + M
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALM 62
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL------------------FDKIAKHGR 109
HPN++K++ V A + ++ E++ G+L K G
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 110 ----LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS----- 160
L E +Q+ + Y R HRDL N L+ V+KI+DFGLS
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPF 216
A + E+ + ++ PE + Y SDVW+ GV+L+ + + G P+
Sbjct: 183 ADYYKASENDAIPI-----RWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 53/292 (18%)
Query: 20 TLGEGSFAKVKFAK---NVETGD--FVAIKIVDRDQVLRHKMVEQI----KREISTMKLI 70
TLG G F +V AK E G V +K L+ E + +RE+ + +
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVK------ALQKTKDENLQSEFRRELDMFRKL 65
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGEL--FDKIAKHGRLKEDEARRYFQQLINAVDY 128
H NV++++ + Y++LE+ D G+L F + K K +Q + A+
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV-ALCT 124
Query: 129 CHSRGV--------FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
+ G+ HRDL N L+ S +K+S LS E L A
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLR 183
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVSTFHFLSVYGE 239
++APE + + + + SDVWS GV+++ V G LPF
Sbjct: 184 WLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPF----------------------- 219
Query: 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 291
Y + LQ + + P S KL+ R NP R + S+++
Sbjct: 220 -YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 6/203 (2%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDR--DQVLRHKMVEQIKREISTMKLIKHPNVI 76
+ LG G+F V V G+ V I + + ++ K + E M + HP+++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVF 135
+++ V S T I +V + + G L D + +H + + Q+ + Y R +
Sbjct: 73 RLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR 195
HRDL N+L+ S +KI+DFGL+ + + ++ ++A E ++ + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT-H 190
Query: 196 ASDVWSCGVILFVLMA-GFLPFD 217
SDVWS GV ++ LM G P+D
Sbjct: 191 QSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 48/203 (23%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 27 AKVKFAKNVETGDFVAI-----KIVDRD------QVLRHKMVEQIKR----EISTMKLIK 71
+K + + TG F + K+ + LR ++ +R E T+
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD 64
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCH 130
H N++++ V+ + IV E++ G L + KH G+L + L + + Y
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN--YVAPEVLN 188
G H+ L +L++S V KIS F Q+ + + + T G + APE +
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRL---QEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 189 DKGYDGRASDVWSCGVILFVLMA 211
+ ASDVWS G++++ +M+
Sbjct: 182 -YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 14 KYELGRTLGEGSFAKV--KFAKNVETGDF---VAIKIVDRDQVLRHKMVEQIKREISTMK 68
K L R LG+GSF V A+++ G+ VA+K V+ LR ++ + E S MK
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELF--------DKIAKHGRLKE--DEARRY 118
+V++++ V++ +V+E + G+L + GR E +
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--------DG 170
++ + + Y +++ HRDL N ++ +KI DFG+ ++ + E G
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM---TRDIYETDYYRKGGKG 181
Query: 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207
LL ++APE L D G +SD+WS GV+L+
Sbjct: 182 LLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 17 LGRTLGEGSFAKV---KFAKNVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
L R LGEG+F KV + D VA+K + ++ + +RE + +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASN-DARKDFEREAELLTNFQ 66
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI--------------AKHGRLKEDEARR 117
H N++K V +V E+++ G+L + + G L + +
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160
Q+ + + Y S+ HRDL N L+ V+KI DFG+S
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 17 LGRTLGEGSFAKVKFAK--NVE-TGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
L R LGEG+F KV A+ N+ T D VA+K + +D L + + +RE + ++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAAR--KDFQREAELLTNLQ 65
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEA 115
H +++K V + +V E++ G+L + HG L +
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 116 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA---ISQQVREDGLL 172
Q+ + + Y S+ HRDL N L+ + ++KI DFG+S + R G
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-- 183
Query: 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207
HT ++ PE + + + SDVWS GVIL+
Sbjct: 184 HTMLPI-RWMPPESIMYRKFTTE-SDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 17 LGRTLGEGSFAKVKFAK--NV---ETGDFVAIKIV-DRDQVLRHKMVEQIKREISTMKLI 70
L R LGEG+F KV A+ N+ + VA+K + D R + RE + +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR----KDFHREAELLTNL 64
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-------------RLKEDEARR 117
+H +++K V + +V E++ G+L + HG L + +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA---ISQQVREDGLLHT 174
QQ+ + Y S+ HRDL N L+ ++KI DFG+S + R G HT
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HT 182
Query: 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207
++ PE + + + SDVWS GV+L+
Sbjct: 183 MLPI-RWMPPESIMYRKFTTE-SDVWSLGVVLW 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 19/220 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH-KMVEQIKREISTMKLIKHPNVIKII 79
+G G F KV G A +V + +E+ + + HPNV++ +
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 80 EVMASKTKIYIVLEFIDGGEL-----FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+VLEF G+L ++ ++D +R ++ + + + H
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC-GTP-NYVAPEVLNDKGY 192
H DL N L + +KI D+GL+ +Q ED + C P ++APE++ +G
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGLAL--EQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 193 D------GRASDVWSCGVILFVLM-AGFLPF-DESNLMAL 224
D + S++WS GV ++ L A P+ D S+ L
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 19 RTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
R +G+G F V +++ A+K ++R + + VEQ +E MK HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 76 IKIIEVMASKTKI-YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ-QLINAVDYCHSRG 133
+ ++ + +VL ++ G+L + I + F Q+ ++Y S+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTP-NYVAPEVLNDKG 191
HRDL N +LD +K++DFGL+ I + HT P ++A E L +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 192 YDGRASDVWSCGVILFVLM 210
+ + SDVWS GV+L+ LM
Sbjct: 179 FTTK-SDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 55/237 (23%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 21 LGEGSFAKVK----FAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVI 76
LGE +F K+ + ++ VAIK + + + ++E S M + HPN++
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ--WGEFQQEASLMAELHHPNIV 70
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIA-------------KHGRLKEDEARRYFQ--- 120
++ V+ + + ++ E+++ G+L + + + G +K F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 121 -QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL-----SAISQQVREDGLLHT 174
Q+ ++Y S H+DL N+L+ +KISD GL SA +V+ LL
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLP---FDESNLMALYRK 227
++ PE + + SD+WS GV+L+ + + G P F ++ + RK
Sbjct: 191 -----RWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH----KMVEQIKREISTMKLIKHPN 74
+ LG G+F V K + D +KI +VLR K ++I E M + P
Sbjct: 13 KVLGSGAFGTV--YKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRG 133
V +++ + + T + +V + + G L D + ++ R+ + + Q+ + Y
Sbjct: 71 VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGY 192
+ HRDL N+L+ S +KI+DFGL+ + + E P ++A E + + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARL-LDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 193 DGRASDVWSCGVILFVLMA-GFLPFD 217
SDVWS GV ++ LM G P+D
Sbjct: 189 T-HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 37/150 (24%), Positives = 69/150 (46%), Gaps = 3/150 (2%)
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQL 122
E ++ I HP++I++ ++L +L+ +A + + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
+ A+ Y H + HRD+K EN+ ++ G + + DFG + + + A GT
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIATN 250
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAG 212
APE+L Y G A D+WS G++LF +
Sbjct: 251 APELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 36/102 (35%), Positives = 51/102 (50%), Gaps = 25/102 (24%)
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
Y Q+ +++ SR HRDL N+LL V+KI DFGL ++ + +D
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL---ARDIYKD-------- 226
Query: 178 TPNYV------------APEVLNDKGYDGRASDVWSCGVILF 207
P+YV APE + DK Y + SDVWS GV+L+
Sbjct: 227 -PDYVRKGDARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 21 LGEGSFAKVK---FAKNVETGDFVAIKI--VDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
LG G+F VK + + D VAIK+ + ++ +R +M+ RE M + +P +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQID-VAIKVLKNENEKSVRDEMM----REAEIMHQLDNPYI 57
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+++I V ++ + +V+E GG L + K + Q+ + Y +
Sbjct: 58 VRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGYD 193
HRDL N+LL + KISDFGLS +A P + APE +N + +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 194 GRASDVWSCGVILF 207
R SDVWS G+ ++
Sbjct: 177 SR-SDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 47/200 (23%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS----TMKLIKHP 73
+ LG G F V + GD +IKI + ++ + Q +EI+ M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGD--SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSR 132
+++++ + + +V + G L D + +H L + Q+ + Y
Sbjct: 70 YIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKG 191
+ HR+L N+LL S +++I+DFG++ + + ++ TP ++A E +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYP-DDKKYFYSEHKTPIKWMALESILFGR 187
Query: 192 YDGRASDVWSCGVILFVLMA 211
Y SDVWS GV ++ +M+
Sbjct: 188 YT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 40/220 (18%)
Query: 14 KYELGRTLGEGSFAKV--KFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
K + R LG+GSF V AK V E VAIK V+ +R ++ + E S MK
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ-------- 120
+V++++ V++ +++E + G+L + L+ + Q
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS---LRPEMENNPVQAPPSLKKM 121
Query: 121 -----QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE------- 168
++ + + Y ++ HRDL N ++ +KI DFG+ ++ + E
Sbjct: 122 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM---TRDIYETDYYRKG 178
Query: 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207
GLL +++PE L D G SDVWS GV+L+
Sbjct: 179 GKGLLPV-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 36/102 (35%), Positives = 51/102 (50%), Gaps = 25/102 (24%)
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
Y Q+ +++ SR HRDL N+LL V+KI DFGL ++ + +D
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL---ARDIYKD-------- 227
Query: 178 TPNYV------------APEVLNDKGYDGRASDVWSCGVILF 207
P+YV APE + DK Y + SDVWS GV+L+
Sbjct: 228 -PDYVRKGSARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLW 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 36/174 (20%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD--------QVLRHKMVEQIK----REI 64
L LGEG F +V + +F+ + D ++LR + + + +EI
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ---- 120
M +K+PN+I+++ V S + ++ E+++ G+L + L + E F
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL------NQFLSQREIESTFTHANN 122
Query: 121 --------------QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160
Q+ + + Y S HRDL N L+ ++ +KI+DFG+S
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 39/175 (22%), Positives = 70/175 (40%), Gaps = 29/175 (16%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDF----------------VAIKIVDRDQVLRHKM 56
LGEG F +V + DF VA+K++ R +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAR 63
Query: 57 VEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH----GRLKE 112
+ +K E+ + + PN+ +++ V + +++E+++ G+L + KH L
Sbjct: 64 EDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 113 DEARRYFQQLIN-------AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160
+ F L+ + Y S HRDL N L+ +KI+DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 35/170 (20%)
Query: 21 LGEGSFAKV---------KFAKNVETGD-------FVAIKIV--DRDQVLRHKMVEQIKR 62
LGEG F +V KF + D VA+K++ D ++ R+ + +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL----K 68
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA------- 115
EI M +K PN+I+++ V + + ++ E+++ G+L +++H +E
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQEAAEKADVVTI 127
Query: 116 -----RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160
Q+ + + Y S HRDL N L+ +KI+DFG+S
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 25/102 (24%)
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
Y Q+ +++ SR HRDL N+LL V+KI DFGL ++ + +D
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL---ARDIYKD-------- 232
Query: 178 TPNYV------------APEVLNDKGYDGRASDVWSCGVILF 207
P+YV APE + D+ Y + SDVWS GV+L+
Sbjct: 233 -PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLW 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 14/112 (12%)
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 139
++M SK Y V ++ G + K + + +Q++ A+D HS G+ HRD+
Sbjct: 224 DLMQSKEFPYNVEPYLLGK--VQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281
Query: 140 KPENLLLD-SYGVLKISDFGLSA-----ISQQVREDGLLHTACGTPNYVAPE 185
KP+N++ G KI D G +A I+ +E L P Y APE
Sbjct: 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL------DPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 51/232 (21%)
Query: 21 LGEGSFAKV--------------KFAKNVETGD--FVAIKIV--DRDQVLRHKMVEQIKR 62
LGEG F +V +F NV G VA+KI+ D ++ R+ ++++K
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK- 71
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR------ 116
+ +K PN+I+++ V + + ++ E+++ G+L ++ L + E
Sbjct: 72 ---ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVP 127
Query: 117 --------------RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA- 161
Q+ + + Y S HRDL N L+ +KI+DFG+S
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 162 --ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLM 210
R G A ++A E + G ASDVW+ GV L+ +LM
Sbjct: 188 LYAGDYYRIQG---RAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 25/176 (14%)
Query: 54 HKMVEQIKR-------EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAK 106
+V++I EI+ M ++HPN++K+I + S+ Y++ E+I+G L + +
Sbjct: 717 QFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN 776
Query: 107 HGRLKEDEARRYFQQLINAVDYCH---SRGVFHRDLKPENLLLDSYGV--LKISDFGLSA 161
L + R+ + A+ + H S V +L PE +++D L++S GL
Sbjct: 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLC 833
Query: 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217
+ YVAPE K + SD++ G+IL L+ G P D
Sbjct: 834 TDT---------KCFISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 21 LGEGSFAKVKFAKNV-----ETGDFVAIKIV-DRDQVLRHKMVEQIKREISTMKLIKHPN 74
LGEG+F KV A+ + VA+K + + + R + +RE + +++H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAELLTVLQHQH 68
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQ---------- 120
+++ V + +V E++ G+L + HG L E Q
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 121 -QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA---ISQQVREDGLLHTAC 176
Q+ + + Y S HRDL N L+ V+KI DFG+S + R G
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207
++ PE + + + SD+WS GV+L+
Sbjct: 189 ---RWMPPESILYRKFTTE-SDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 53/201 (26%)
Query: 110 LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169
L D+ R+ Q+ +D+ S+ HRD+ N+LL V KI DFGL ++ + D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGL---ARDIMND 265
Query: 170 GLLHTACGTPNYV------------APEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPF 216
NYV APE + D Y + SDVWS G++L+ + + G P+
Sbjct: 266 S---------NYVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPY 315
Query: 217 DESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRI 276
+ + K F + Y Q+ R DF+ P +S ++K
Sbjct: 316 PG---ILVNSK-----FYKMVKRGY-----------QMSRPDFAPPEIYS-----IMKMC 351
Query: 277 LDPNPDTRMT---ISQMLEDE 294
+ P R T ISQ+++ +
Sbjct: 352 WNLEPTERPTFSQISQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 25/109 (22%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 58 EQIKREISTMKLIKHPNVI--KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA 115
+RE++ ++L+ + K++ S Y+++E+I+G L + KED A
Sbjct: 36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV---SEEEKEDIA 92
Query: 116 RRYFQQL--INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162
+ + L ++ + + H DL P N+L+D +L I D+ +
Sbjct: 93 EQLAELLAKLHQLP---LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 25/218 (11%)
Query: 21 LGEGSFAKVK----FAKNV-ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
LGE F KV F E VAIK + +D+ + E+ K E ++HPN+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKI---AKHGRLKEDEARRYFQQLINAVDYCH-- 130
+ ++ V+ + + ++ + +L + + + H + + + + + D+ H
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 131 -----------SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
S V H+DL N+L+ +KISD GL L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+++PE + G SD+WS GV+L+ V G P+
Sbjct: 191 RWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 22/44 (50%), Positives = 29/44 (65%), Gaps = 2/44 (4%)
Query: 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DES 219
GTP+Y+APE+L K + G A D W+ GV LF + G PF DE+
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDET 584
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 43/203 (21%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-LRHKMVEQIKREISTMKLIKHPNVIKII 79
+G G F KV ++ + T VA +V + K + ++ ++++HPN+++ +
Sbjct: 3 IGNGWFGKVLLSE-IYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKED----EARRYFQQLINAVDYCHSRGVF 135
+V E+ + G+L +++ + + +R ++ V + H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL--HTACGTPNYVAPEVLNDKGYD 193
H DL N L S +K+ D+G+ + +ED + C ++APE++ + +
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGP--SRYKEDYIETEDDKCVPLRWLAPELVGEF-HG 178
Query: 194 G-------RASDVWSCGVILFVL 209
G + S+VW+ GV L+ L
Sbjct: 179 GLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-- 178
Q+ +++ S+ HRDL N+LL ++KI DFGL ++ + D + T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGL---ARDIMHDSNYVSKGSTFL 301
Query: 179 -PNYVAPEVLNDKGYDGRASDVWSCGVILF 207
++APE + D Y SDVWS G++L+
Sbjct: 302 PVKWMAPESIFDNLYT-TLSDVWSYGILLW 330
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--REISTMKLIKHPNVI 76
+ +G G F KV V +G + ++V ++ + + EQ+K E + ++H N++
Sbjct: 1 KEIGNGWFGKV-ILGEVNSG-YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA------RRYFQQLINAVDYCH 130
+ + T +V+EF G+L + R E +R ++ + + H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDL-KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-------YVA 183
H DL N LL + +KI D+GLS + +ED + TP+ ++A
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYV-----TPDQLWVPLRWIA 170
Query: 184 PEVLNDKGYD------GRASDVWSCGVILFVL 209
PE++++ + + S+VWS GV ++ L
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 18/39 (46%), Positives = 26/39 (66%)
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 158
+Q++ + H G+ HRD+KPENLL+ G +KI DFG
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 8/102 (7%)
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-- 178
Q+ N +++ S+ HRDL N+L+ ++KI DFGL ++ + D + T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGL---ARDIMRDSNYISKGSTFL 303
Query: 179 P-NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDE 218
P ++APE + + Y SDVWS G++L+ + G P+ E
Sbjct: 304 PLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 25/103 (24%)
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
Q+ + + S+ HRDL N+LL + KI DFGL ++ +R D N
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL---ARDIRNDS---------N 269
Query: 181 YV------------APEVLNDKGYDGRASDVWSCGVILFVLMA 211
YV APE + + Y SDVWS G++L+ + +
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 40/195 (20%), Positives = 73/195 (37%), Gaps = 68/195 (34%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK--------LIKH 72
+ S A+V A +++G+ VA+K V R + E+I+ ++ ++ L
Sbjct: 133 IASASIAQVHRAV-LKSGEEVAVK------VQRPGIRERIEADLKLLRRLARLIKRLPPG 185
Query: 73 PNVIKIIEVMA--SKT------------------------------KIY--------IVL 92
+ ++EV+ K K+Y + +
Sbjct: 186 GRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTM 245
Query: 93 EFIDGGEL--FDKIAKHGR----LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 146
E+IDG ++ + G L E R + +QL+ G FH D P N+L+
Sbjct: 246 EWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR-------DGFFHADPHPGNILV 298
Query: 147 DSYGVLKISDFGLSA 161
S G + + DFG+
Sbjct: 299 RSDGRIVLLDFGIVG 313
|
Length = 517 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.001
Identities = 24/79 (30%), Positives = 38/79 (48%), Gaps = 5/79 (6%)
Query: 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149
IV+E+I+G L D I E +++ V HS G+ H DL N++L
Sbjct: 76 IVMEYIEGEPLKDLINS----NGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGG 131
Query: 150 GVLKISDFGLSAISQQVRE 168
+ I DFGL+ S+ + +
Sbjct: 132 KIYLI-DFGLAEFSKDLED 149
|
Length = 211 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 34/210 (16%)
Query: 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR------HKMVEQIKREISTMKLIKH 72
LG+G+F + D + V+ H+ S M + H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGEL--FDKIAKHG---RLKEDEARRYFQQLINAVD 127
+++K+ V I +V E++ G L F K+ K D A +QL +A+
Sbjct: 61 KHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVA----KQLASALH 115
Query: 128 YCHSRGVFHRDLKPENLLLDSYGV-------LKISDFG--LSAISQQVREDGLLHTACGT 178
Y + + H ++ +N+L+ YG+ +K+SD G ++ +S++ R + +
Sbjct: 116 YLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI------- 168
Query: 179 PNYVAPEVL-NDKGYDGRASDVWSCGVILF 207
P ++APE + N + A+D WS G L
Sbjct: 169 P-WIAPECIRNGQASLTIAADKWSFGTTLL 197
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.56 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.23 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.03 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.96 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.88 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.86 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.74 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.66 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.57 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.57 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.25 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.24 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.19 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.16 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 98.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.08 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.07 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.84 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.76 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.76 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.62 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.59 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.56 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.55 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.55 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.44 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.27 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.23 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.1 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.03 | |
| PLN02236 | 344 | choline kinase | 96.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.87 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.66 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.63 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.6 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.28 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.96 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.64 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.6 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.47 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.32 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.65 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.64 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.37 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.31 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-66 Score=486.02 Aligned_cols=260 Identities=40% Similarity=0.742 Sum_probs=228.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHH----HHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK----MVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
.-..|.+.+.||+|+||.|.+|..++||+.||||++++....... ....+.+|++||++|+|||||+++++|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 446799999999999999999999999999999999876654311 2345789999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC---CceEEeccccchhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKISDFGLSAIS 163 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~---g~lkl~DFGla~~~ 163 (468)
..||||||++||+|++++..++.+.|+..+.+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|++.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999766 78999999999975
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCC--CCCChhhHHHHHHHHHHHhhCCCCCCCchHHH-HHHhhcccccccccccc
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESNLMA-LYRKVSTFHFLSVYGES 240 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~--~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (468)
. +...+.|.||||.|+|||++.+.+ +++.++||||+||+||.+|+|.+||.+..... +.++
T Consensus 330 g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ------------- 393 (475)
T KOG0615|consen 330 G---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ------------- 393 (475)
T ss_pred c---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH-------------
Confidence 4 456788999999999999998665 44568999999999999999999998765443 4454
Q ss_pred hhhhccccccccccccccCCCC--CC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 241 YKKCTNKYSYTLQICRADFSCP--SW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~--~~--~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
+.++.+.+. .| +|.++++||.+||..||++|||++|+|+||||+..
T Consensus 394 -------------I~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 394 -------------ILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred -------------HhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 344444432 23 79999999999999999999999999999999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-64 Score=495.74 Aligned_cols=264 Identities=37% Similarity=0.701 Sum_probs=248.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|..++.||+|+|+.||.+++..+|+.||+|+|.+..+.+....+.+.+||+|++.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 45999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
|+|+.++|..+++..+.++|.+|+.|++||+.||.|||+++|+|||||..|+|++++.+|||+|||||+..... ....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~--~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD--GERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc--cccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987653 2346
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
.+.||||.|+||||+...++ +..+||||+||+||.||.|++||...+..+.+.+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~------------------------- 229 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNK------------------------- 229 (592)
T ss_pred ceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHH-------------------------
Confidence 78999999999999998887 5999999999999999999999999999999998
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCCC
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 305 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~~~~ 305 (468)
+...++.+|..+|.++++||.+||++||.+|||++++|.|+||++++.|...
T Consensus 230 -Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~l 281 (592)
T KOG0575|consen 230 -IKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARL 281 (592)
T ss_pred -HHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCC
Confidence 5667889999999999999999999999999999999999999887765443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-63 Score=494.45 Aligned_cols=261 Identities=62% Similarity=1.062 Sum_probs=244.6
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH--HHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCC
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH--KMVEQIKREISTMKLIK-HPNVIKIIEVMASKT 86 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~ 86 (468)
...++|.+++.||+|+||+|++|.+..+|+.||+|++++...... ...+.+.+|+.+++.++ ||||+++++++...+
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 578899999999999999999999999999999998877533211 35678889999999999 999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC-CceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~-g~lkl~DFGla~~~~~ 165 (468)
.+|+|||||.||+|++++...+++.|..++.+|+||++||+|||++||+||||||||||+|.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999998764
Q ss_pred hhcCCcccccCCCCCcCCccccccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.....+.+.||||.|+|||++.+.. |.+.++|||||||+||.|++|..||+..+...++.+
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k----------------- 234 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK----------------- 234 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-----------------
Confidence 3567889999999999999999988 999999999999999999999999999998888887
Q ss_pred ccccccccccccccCCCCCCC-CHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 245 TNKYSYTLQICRADFSCPSWF-SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
+..+.+.+|.|+ |+++.+|+++||..||.+|+|+.+|++||||+.
T Consensus 235 ---------i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 235 ---------IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---------HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 677889999999 999999999999999999999999999999997
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-64 Score=499.21 Aligned_cols=265 Identities=46% Similarity=0.848 Sum_probs=249.0
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
....+|.|+++++||.|+-|.|.+|++..||+.+|||+|.+.....+.....|.+||-||+.+.||||+++|+++++..+
T Consensus 7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH 86 (786)
T ss_pred ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence 34578999999999999999999999999999999999987744444556789999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+|+||++||+||+++...++++|.++.++|+||+.|+.|||..+|+||||||+|+|+|..+++||+|||+|.+-.
T Consensus 87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--- 163 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV--- 163 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998632
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
++.++.+.||+|.|.|||++.|.+|+|.++||||||||||.||+|.+||++.+...++.+
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlK-------------------- 223 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLK-------------------- 223 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHH--------------------
Confidence 466889999999999999999999999999999999999999999999999999988888
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
.+++.|.+|..+|+++++||++||+.||++|+|.+||++|||+.....
T Consensus 224 ------V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 224 ------VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred ------HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 678999999999999999999999999999999999999999987543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-61 Score=436.32 Aligned_cols=257 Identities=38% Similarity=0.760 Sum_probs=245.5
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..+.+|+..++||.|+||.|.+++++.+|..+|+|++++..+.+.+..+...+|.++|+.+.||.++++++.+.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 67889999999999999999999999999999999999999988889999999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||||.+||+|+.++.+.++|++..++.|+.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998543
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
+...+.||||.|+|||++..++|. .++|.|||||++|||++|.+||...++..++++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K---------------------- 252 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK---------------------- 252 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH----------------------
Confidence 336789999999999999999985 999999999999999999999999999999998
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
|..+++.+|+.+++++++||+++|+.|-.+|. ..++|..||||+.
T Consensus 253 ----I~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 253 ----ILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred ----HHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 77899999999999999999999999999994 5789999999984
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-60 Score=448.88 Aligned_cols=260 Identities=36% Similarity=0.718 Sum_probs=240.5
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...+.|++++.||+|+||+|++++.+.+++.+|+|++++..+...+..+.+..|..||..++||.||+++..|+++.++|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 55788999999999999999999999999999999999999888888899999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+|+||+.||+|+-++++.+.|+|+.++.|+..|+.||.|||++||+||||||||||+|.+|+++|+||||++.... .+
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999985433 23
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
....+.|||+.|||||++.+.+|+ .++|.||||+++|+|++|.+||.+.+...+++++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I--------------------- 237 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI--------------------- 237 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH---------------------
Confidence 445678999999999999999996 9999999999999999999999999999999885
Q ss_pred ccccccccc-CCCCCCCCHHHHHHHHHhcCCCCCCCC----CHHHHhcCccccc
Q 012228 250 YTLQICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRM----TISQMLEDEWFKK 298 (468)
Q Consensus 250 ~~~~~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~R~----t~~eil~hpwf~~ 298 (468)
..+. ...|..++.++++||+++|..||.+|. ++.+|.+||||..
T Consensus 238 -----~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 238 -----LKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred -----hcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 3344 334555899999999999999999996 7899999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-59 Score=442.73 Aligned_cols=265 Identities=35% Similarity=0.648 Sum_probs=238.6
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
+...+++|.+.+.||+|+||+||+|+++.++..||||.|.+.+. ..+..+.+..||.||+.++|||||.++++...++.
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 45678999999999999999999999999999999999988765 44567889999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC------CceEEeccccch
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY------GVLKISDFGLSA 161 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~------g~lkl~DFGla~ 161 (468)
+|+|||||.||+|.++|...++++|..++.++.||+.||++||+++|+||||||+||||+.. -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999865 458999999999
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
.+. ......+.||+|.|||||++..+.|+ .|+|+||+|+|||+|++|+.||+..+..+++..+...
T Consensus 164 ~L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~---------- 229 (429)
T KOG0595|consen 164 FLQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG---------- 229 (429)
T ss_pred hCC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc----------
Confidence 765 35567899999999999999988997 8999999999999999999999999999998865321
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
...-...+.++++...+|+...|..||..|.+..+-+.|++.....
T Consensus 230 -------------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 230 -------------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred -------------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 1112234455788889999999999999999999999999997643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-59 Score=454.82 Aligned_cols=263 Identities=36% Similarity=0.671 Sum_probs=243.3
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (468)
.....+|.+++.||+|+|++|++|+++.+++.||||++.+..+.+++-.+.+.+|-.+|.+| .||.|++|+..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567899999999999999999999999999999999999988888888999999999999 79999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+|+||+++|+|.++|.+-+.|+|.-+++|+.||+.||+|||++|||||||||||||+|++|++||+|||.|+++....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999875432
Q ss_pred cC---------Cc--ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccc
Q 012228 168 ED---------GL--LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSV 236 (468)
Q Consensus 168 ~~---------~~--~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~ 236 (468)
.. .. ..+..||..|++||++..... +..+|||+||||||.|++|.+||.+.+.--++++
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk--------- 298 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK--------- 298 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHH---------
Confidence 22 11 145789999999999987655 6899999999999999999999999998888888
Q ss_pred cccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 237 YGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
|...++.+|+.+++.+++||+++|..||++|+|++||.+||||..
T Consensus 299 -----------------I~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 299 -----------------IQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred -----------------HHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 566788999999999999999999999999999999999999985
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-58 Score=429.73 Aligned_cols=257 Identities=28% Similarity=0.495 Sum_probs=229.6
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE-EEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK-IYI 90 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~l 90 (468)
..+.+.++.||+|+.|+||+|+++.|++.+|+|+|.... +....+++.+|+++++.++||+||.+|+.|.++.. ++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 346788899999999999999999999999999995432 44567899999999999999999999999999994 999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+||||+||+|.+.+..-++++|.....++.++++||.|||+ ++|+||||||+|||++..|.+||||||.++.+..
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn---- 231 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN---- 231 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh----
Confidence 99999999999999998999999999999999999999995 8999999999999999999999999999987643
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc-----hHHHHHHhhcccccccccccchhhh
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-----NLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
....+..||..|||||.+.+..| +.++||||||+.++|+++|+.||... +..+++..|
T Consensus 232 S~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---------------- 294 (364)
T KOG0581|consen 232 SIANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---------------- 294 (364)
T ss_pred hhcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH----------------
Confidence 26678999999999999999888 58999999999999999999999875 455555553
Q ss_pred ccccccccccccccCCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 245 TNKYSYTLQICRADFSCPSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~-~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
........|.. +|+++++|+..||++||.+|||+.|+++|||+++..
T Consensus 295 ---------v~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 295 ---------VDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ---------hcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 12244456665 999999999999999999999999999999999754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-58 Score=431.34 Aligned_cols=260 Identities=42% Similarity=0.762 Sum_probs=244.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
-.+|++.++||.|+||+|.+|.....|+.||||.|+++.+..+...-.|++||+||..|+||||+.+|++|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46799999999999999999999999999999999999998888888999999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|||..+|+|.++|...+.++|.+++++|+||++|+.|||.++++|||||.+|||+|.++++||+||||+..+.. ...
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---~kf 208 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---KKF 208 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc---ccH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987654 567
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
+.+.||+|-|.+||++.|.+|.|+.+|-|||||+||.|+.|..||++.+...+.++
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ------------------------ 264 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ------------------------ 264 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH------------------------
Confidence 89999999999999999999999999999999999999999999999999888887
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
|.++.+.-|+ -+.++.-||+.||-.||++|.|+++|-.|=|..=++.
T Consensus 265 --Is~GaYrEP~-~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 265 --ISRGAYREPE-TPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred --hhcccccCCC-CCchHHHHHHHHHhcCcccchhHHHHhhhheeecccc
Confidence 4555555554 4778999999999999999999999999999875554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-58 Score=417.13 Aligned_cols=282 Identities=27% Similarity=0.424 Sum_probs=226.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|+.+.++|+|+||+|++|+++.||+.||||++-... .+....+-..|||++|+.|+|||+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 468999999999999999999999999999999985322 2233456678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
+|||+.--|.++-....+++++.++.|++|++.|+.|||+++++||||||||||++.+|.+||||||+|+.+.. +...
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~ 157 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDN 157 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccch
Confidence 99999844544445556899999999999999999999999999999999999999999999999999998764 4556
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
.+.+..|.||+|||++.+...+|.++||||+||++.||++|.+.|.+.+..+....|... .+.+.+.-.+.....++.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~kt--LG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKT--LGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHH--HcccCHHHHHHhccCCce
Confidence 778999999999999999777789999999999999999999999998765554444321 111111111111111111
Q ss_pred cccccccCCCC-------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 252 LQICRADFSCP-------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 252 ~~~~~~~~~~~-------~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.-+.-.....+ +.++..+.+|+++||..||.+|+|.+|+|.||||..
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 11111111111 225778999999999999999999999999999953
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-57 Score=438.80 Aligned_cols=267 Identities=34% Similarity=0.670 Sum_probs=238.5
Q ss_pred CCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
++....+++|++++.||+|+||.||+|+.+.||+.+|+|++++....+.+.++.++.|-++|...++|+||+||..|.+.
T Consensus 134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred ccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 34466788999999999999999999999999999999999998888888899999999999999999999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
.++||||||++||++..++...+.|+|+.+++|+.+++.|++-||+.|++||||||+|+|||..|++||+||||++.+..
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999864322
Q ss_pred hh-------------------c-C-------------------------CcccccCCCCCcCCccccccCCCCCChhhHH
Q 012228 166 VR-------------------E-D-------------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVW 200 (468)
Q Consensus 166 ~~-------------------~-~-------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiW 200 (468)
.. . + .......|||.|+||||+.+++| +..+|+|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwW 372 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWW 372 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHH
Confidence 00 0 0 01123469999999999999998 5999999
Q ss_pred HHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCC--CCHHHHHHHHHhcC
Q 012228 201 SCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILD 278 (468)
Q Consensus 201 SlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~Ll~~~L~ 278 (468)
|||||+||||.|.+||.+.++.+.++++..+ +..+.+|.. .+++++|||.+||.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw------------------------r~~l~fP~~~~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNW------------------------RETLKFPEEVDLSDEAKDLITRLLC 428 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH------------------------hhhccCCCcCcccHHHHHHHHHHhc
Confidence 9999999999999999999999999997532 223344433 68999999999999
Q ss_pred CCCCCCCC---HHHHhcCccccc
Q 012228 279 PNPDTRMT---ISQMLEDEWFKK 298 (468)
Q Consensus 279 ~dP~~R~t---~~eil~hpwf~~ 298 (468)
||++|.. ++||.+||||+.
T Consensus 429 -d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 429 -DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred -CHHHhcCcccHHHHhcCCcccc
Confidence 9999995 999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-57 Score=435.96 Aligned_cols=283 Identities=32% Similarity=0.513 Sum_probs=233.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--CEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKI 88 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 88 (468)
....|+.+++||+|+||.||+|++..+|+.||+|.+..+... .+......|||.||++|+||||++|.++..+. ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 456799999999999999999999999999999999877543 34566788999999999999999999998776 689
Q ss_pred EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|||+|||+. ||..++... -.|++.+++.||+||+.||+|||++||+|||||..|||||.+|++||+|||||+++...
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~- 271 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS- 271 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC-
Confidence 999999998 888888764 47999999999999999999999999999999999999999999999999999977653
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
....++...-|+||+|||++.|..-|+.++|+||+||||.||++|++.|.+.+..+.+.+|.. ..+.+.+.++. ..+
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk--lcGSP~e~~W~-~~k 348 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK--LCGSPTEDYWP-VSK 348 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH--HhCCCChhccc-ccc
Confidence 334477888999999999999988889999999999999999999999999988877777642 22222222221 111
Q ss_pred cccccccccccCCC-------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 248 YSYTLQICRADFSC-------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 248 ~~~~~~~~~~~~~~-------~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.+.. ...+...+. -..+++.+.+|+.+||..||.+|.||.++|+|+||+...
T Consensus 349 LP~~-~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 349 LPHA-TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred CCcc-cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 1100 011111111 123789999999999999999999999999999996543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-56 Score=398.46 Aligned_cols=284 Identities=31% Similarity=0.453 Sum_probs=230.7
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|...+.||+|+||+||+|++..||+.||||.|...+.. ++......|||+.|+.++||||+.++++|.+.+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 5789999999999999999999999999999999876543 334556789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||++. +|...|.... .++..+++.|+.+++.||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+... +..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p--~~~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP--NRI 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC--Ccc
Confidence 99987 9998887654 5899999999999999999999999999999999999999999999999999987653 333
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccc-ccchhhhcccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY-GESYKKCTNKYSY 250 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 250 (468)
.+...-|.||+|||++.|...++..+||||.|||+.||+.|.+-|.+.+..+....+... .+.+ ...|.+...-..+
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~--LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRA--LGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHH--cCCCCcccCccccccccH
Confidence 444578999999999999888899999999999999999999999998877666665321 1111 1112111111111
Q ss_pred cc--ccccc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 251 TL--QICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 251 ~~--~~~~~-~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
.. +.... .-..-+..+.++.+|+.+||..||.+|+|+.|+|+|+||+..+.|
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 10 00000 001223368889999999999999999999999999999985443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-57 Score=403.88 Aligned_cols=257 Identities=34% Similarity=0.706 Sum_probs=231.2
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
.-+.|++.+.||+|.|+.|+++.+..+|+.+|+|+|+....... ..+.+.+|++|-+.|+||||+++.+.+.+....||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 44679999999999999999999999999999999987766554 57889999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec---cCCceEEeccccchhhhhhh
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~---~~g~lkl~DFGla~~~~~~~ 167 (468)
|+|+++|++|+.-|..+.-++|..+-.+++||+.||.|||.+||+|||+||+|+|+- ....+||+|||+|....
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--- 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--- 164 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---
Confidence 999999999998888878899999999999999999999999999999999999995 34469999999998654
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.........|||.|+|||++...+| +.++|||+||||||-||.|.+||.+.+...+++.|
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I------------------- 224 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI------------------- 224 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH-------------------
Confidence 3345667889999999999998888 59999999999999999999999999999999885
Q ss_pred cccccccccccCCCC--CC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 248 YSYTLQICRADFSCP--SW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~--~~--~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
..+.+.+| .| +++++++|+++||..||.+|+|+.|+|+|||+.+
T Consensus 225 -------~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 225 -------KAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred -------hccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 33444333 33 8999999999999999999999999999999985
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-55 Score=422.49 Aligned_cols=269 Identities=36% Similarity=0.676 Sum_probs=231.8
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHH-----------HHHHHHHHHHHHhcCCCCCee
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK-----------MVEQIKREISTMKLIKHPNVI 76 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~i~~Ei~il~~l~hpnIv 76 (468)
....+.+|++++.||+|.||+|.+|++..+++.||||++.+....+.. ..+.+++||.||++|.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 345678999999999999999999999999999999999875544321 246899999999999999999
Q ss_pred EEEEEEEeC--CEEEEEEEccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceE
Q 012228 77 KIIEVMASK--TKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (468)
Q Consensus 77 ~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lk 153 (468)
+|+++..++ +++|||+|||..|.+...-. +.. +++.+|+.|+++++.||+|||.+||+||||||.|+|++++|++|
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 999999665 67999999999988754433 334 99999999999999999999999999999999999999999999
Q ss_pred Eeccccchhhhhh---hcCCcccccCCCCCcCCcccccc---CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHh
Q 012228 154 ISDFGLSAISQQV---REDGLLHTACGTPNYVAPEVLND---KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227 (468)
Q Consensus 154 l~DFGla~~~~~~---~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~ 227 (468)
|+|||.+..+... +.+..+....|||.|+|||.+.+ ..|.+.+.||||+||+||.|+.|+.||-+....+++.+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999998765332 12234556889999999999877 56789999999999999999999999999999999998
Q ss_pred hcccccccccccchhhhccccccccccccccCCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 012228 228 VSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303 (468)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~~ 303 (468)
| ....+.+|.. +...+++||.+||.+||.+|+++.+|..|||.......+
T Consensus 331 I--------------------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 331 I--------------------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred H--------------------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 5 3344445544 789999999999999999999999999999999875543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-56 Score=432.24 Aligned_cols=258 Identities=32% Similarity=0.610 Sum_probs=238.2
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|.+.+.||+|+||.||+|+.+.+.+.||||.+++.. ..++....+.+|++|++.|+|||||.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 578999999999999999999999999999999998754 3455688899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
+|||.| +|+.++..++.++|+.++.++.||++||.|||+++|.|||+||.|||++..|.+|+||||+|+.... +...
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 9999999999999999999999999999999999999999999999999999999999999997654 3456
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
++...|||.|||||++.+.+|+ ..+|+||+|||+|||++|++||-..+..++.+.
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~------------------------ 211 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKS------------------------ 211 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHH------------------------
Confidence 7778899999999999999886 899999999999999999999999888888777
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
|...+...|...|..+.+||+.+|.+||.+|+|..+++.|||.+...
T Consensus 212 --I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 212 --ILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred --HhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 44556667778999999999999999999999999999999998643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-56 Score=427.53 Aligned_cols=284 Identities=31% Similarity=0.488 Sum_probs=228.8
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCC-
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKT- 86 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~- 86 (468)
...+.+|.+.++||.|+||.||+|+.+.+|+.||||.+++.-..-+ .... .||+..|++|+ |||||++.+++.+.+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~n-LREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHH-HHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 3467899999999999999999999999999999999976433222 2222 49999999999 999999999998877
Q ss_pred EEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
.+|+|||||+. .|++++..++ .|++..++.|+.||+.||+|+|.+|+.|||+||||||+..+..+||+|||+|+-...
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999986 9999998765 599999999999999999999999999999999999999999999999999985443
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccc---cccccchh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFL---SVYGESYK 242 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~ 242 (468)
...++.+..|+||+|||++...++|+.++||||+|||++|+++-++.|.+.+..+...+|...-.. ..|.+. .
T Consensus 163 ---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg-~ 238 (538)
T KOG0661|consen 163 ---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG-Y 238 (538)
T ss_pred ---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH-H
Confidence 445778899999999999999999999999999999999999999999998877666665421111 011110 0
Q ss_pred hhcccccccccccc---ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 243 KCTNKYSYTLQICR---ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 243 ~~~~~~~~~~~~~~---~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
+......+.+..+. -...+|. .++++.+||.+||.+||.+||||.|+|+||||+...
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 00000000000000 0111223 789999999999999999999999999999999754
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-55 Score=410.28 Aligned_cols=286 Identities=29% Similarity=0.452 Sum_probs=230.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-----CCE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-----KTK 87 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-----~~~ 87 (468)
.+|...+.||+|+||.|+.|.++.+|+.||||.+... ..+.-..++..||+++|++++|+||+.+.+++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4566689999999999999999999999999998632 3344467888999999999999999999999855 467
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+|+|+|+. +|...|.....++++.++.++.||+.||+|+|+.||+||||||.|+|++.+..+||||||+|+......
T Consensus 101 vYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 9999999965 899988887779999999999999999999999999999999999999999999999999999775444
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch-hhhcc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY-KKCTN 246 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 246 (468)
..+.++.+..|.||+|||++....-++.++||||+||||.||++|++.|.+.+..+.++.+... .+.+.+.. ....+
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~--lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL--LGTPSEEDLQKIRS 257 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh--cCCCCHHHHHHhcc
Confidence 4566788999999999999877666689999999999999999999999999877776665432 11111111 11110
Q ss_pred c--ccccc---ccccccC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 247 K--YSYTL---QICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 247 ~--~~~~~---~~~~~~~-~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
. ..+.. +..+..+ ..-+..++.+.+|+.+||..||.+|+|++|+|+||||.....|
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 0 00100 0111111 1113478999999999999999999999999999999875543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-55 Score=435.96 Aligned_cols=260 Identities=30% Similarity=0.603 Sum_probs=241.0
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTK 87 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 87 (468)
...+.+|.+.+.||+|+||+|++|..+.+++.+|||+++++.+.....++..+.|-+|+...+ ||.+++++..|.++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 556789999999999999999999999999999999999999988888999999999999886 9999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+||||+.||++ .++...+.|+|..++.|+..++.||+|||++||+|||||.+|||+|.+|.+||+|||+++-. ..
T Consensus 444 l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--MG 520 (694)
T ss_pred EEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--CC
Confidence 9999999999994 44555688999999999999999999999999999999999999999999999999999743 33
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
......|.||||.|+|||++.+..| +.++|.|||||+||+||.|+.||.+.+.++++..
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds-------------------- 579 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS-------------------- 579 (694)
T ss_pred CCCccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------------------
Confidence 4456789999999999999999988 5999999999999999999999999999999988
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI-----SQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~-----~eil~hpwf~~ 298 (468)
|...+..+|.|+|.++.++++++|..||++|..+ ++|.+||||+.
T Consensus 580 ------I~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 580 ------IVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred ------HhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 5667888999999999999999999999999965 78999999985
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-55 Score=402.86 Aligned_cols=287 Identities=27% Similarity=0.395 Sum_probs=229.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CCEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKI 88 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 88 (468)
.++.|+.+..|++|+||.||+|+++.|++.||+|.++.+.- +.+.--.-.|||++|.+++|||||.+.++... -+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 46779999999999999999999999999999999987653 23333345699999999999999999998754 4679
Q ss_pred EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|||||||+. +|...+.... +|.+.+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+-+...
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 999999998 9999998766 7999999999999999999999999999999999999999999999999999976542
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccc---ccccccc-chhh
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH---FLSVYGE-SYKK 243 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~---~~~~~~~-~~~~ 243 (468)
-..++...-|.||+|||++.+..-++.++|+||+|||+.||+++.+.|.+.+..+...+|...- ....|+. .-..
T Consensus 231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3346677889999999999998888899999999999999999999999988776666654211 0111110 0000
Q ss_pred hcccccc---ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 244 CTNKYSY---TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 244 ~~~~~~~---~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
..+.... .....+..|..-. ++....+|+..+|..||.+|+||+|+|+|+||...+.|
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred hhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 0000000 0001112222211 67999999999999999999999999999999986543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-56 Score=401.98 Aligned_cols=256 Identities=31% Similarity=0.585 Sum_probs=224.6
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEE-EEEeCC
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE-VMASKT 86 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~-~~~~~~ 86 (468)
+......|+|.+.||+|+||+||++++..+|..||.|.|.-... +.+..+.+..||.+|+.|+|||||++++ .+...+
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 45566779999999999999999999999999999999985543 4456788999999999999999999998 344444
Q ss_pred -EEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCCeeeccCCceEEecc
Q 012228 87 -KIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHS--RG--VFHRDLKPENLLLDSYGVLKISDF 157 (468)
Q Consensus 87 -~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~--~g--ivHrDlKp~NILl~~~g~lkl~DF 157 (468)
-++||||||++|+|..+|+. ...++|..++.++.||+.||..||+ .. |+||||||.||+++.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 48999999999999998864 3469999999999999999999999 44 999999999999999999999999
Q ss_pred ccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccc
Q 012228 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237 (468)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 237 (468)
||++.+.. .....++..|||.||+||++.+.+|+ .++||||+||++|||++-.+||.+.+..++.++
T Consensus 173 GL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~K---------- 239 (375)
T KOG0591|consen 173 GLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKK---------- 239 (375)
T ss_pred hhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHH----------
Confidence 99998765 33456778999999999999999996 999999999999999999999999999988888
Q ss_pred ccchhhhccccccccccccccCC-CC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 238 GESYKKCTNKYSYTLQICRADFS-CP-SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
|..++++ +| ..+|.++..||..|+..||..||+. +|++.+
T Consensus 240 ----------------I~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~d 281 (375)
T KOG0591|consen 240 ----------------IEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQD 281 (375)
T ss_pred ----------------HHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence 5556665 56 5589999999999999999999997 666653
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=419.72 Aligned_cols=263 Identities=40% Similarity=0.760 Sum_probs=240.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
.+.|=|.+.++||+|.|++|.+|++.-+|+.||||+|++.+... -....+.+|++.|+.++|||||+||++..+...+|
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 34567999999999999999999999999999999999876533 34567899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee-ccCCceEEeccccchhhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL-DSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl-~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+|+-++|+|+++|.++. ++.|+.+++||.||+.|+.|||+..+|||||||+||.+ ..-|-+||+|||++..+.+
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-- 171 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-- 171 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC--
Confidence 9999999999999987764 79999999999999999999999999999999999876 5679999999999987654
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
...+.+.||+..|-|||++.|..|+.+++||||||||||-|+||++||...+..+.+-.
T Consensus 172 -G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm-------------------- 230 (864)
T KOG4717|consen 172 -GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM-------------------- 230 (864)
T ss_pred -cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh--------------------
Confidence 45688999999999999999999999999999999999999999999998877766555
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
|....+..|..+|.++++||..||..||++|.|.++|..|+|++..-.+
T Consensus 231 ------ImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 231 ------IMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred ------hhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 5667788999999999999999999999999999999999999976544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-55 Score=385.89 Aligned_cols=258 Identities=36% Similarity=0.709 Sum_probs=242.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
-.+++|++++.||+|.||.||+|+.++++-.||+|++.+..+...+...++.+|++|...|+||||+++|++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 35788999999999999999999999999999999999999888888889999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 90 IVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~--~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+++||+..|+|+..+. ...++++..+..|+.|++.|+.|||..+|+||||||+|+|++.+|.+||+|||-+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 9999999999999998 66789999999999999999999999999999999999999999999999999876432
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.+.-.+.|||..|.|||...+..++ ..+|+|++|++.|+++.|.+||...+..+.+++
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr-------------------- 233 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR-------------------- 233 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH--------------------
Confidence 3445789999999999999999987 899999999999999999999999998889988
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
+.+.++.+|+.++.++.|||.+||..+|.+|.+..|++.|||...
T Consensus 234 ------I~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 234 ------IRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ------HHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 556778889999999999999999999999999999999999875
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=415.47 Aligned_cols=261 Identities=39% Similarity=0.733 Sum_probs=232.3
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKI 88 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 88 (468)
.....|++++.||+|.||.||.|+++.||+.+|+|++.+.........+.+.+|+.||+++. |||||.++++|++.+.+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34457999999999999999999999999999999998877655445678999999999998 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc----CCceEEeccccchhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS----YGVLKISDFGLSAISQ 164 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~----~g~lkl~DFGla~~~~ 164 (468)
|+|||+|.||+|++.|... .++|..+..+++|++.|++|||+.||+||||||+|+|+.. ++.+|++|||+|....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999999887 5999999999999999999999999999999999999963 3579999999998765
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
. .....+.||||.|+|||++...+| +..+||||+||++|.|++|.+||.+.+.......+..
T Consensus 191 ~---~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~-------------- 252 (382)
T KOG0032|consen 191 P---GERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR-------------- 252 (382)
T ss_pred C---CceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc--------------
Confidence 4 456889999999999999988787 5999999999999999999999999887777665432
Q ss_pred ccccccccccccccCCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 245 TNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~--~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
....+..++| +|..+.+||++||..||.+|+|+.++|+|||++..
T Consensus 253 ----------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 253 ----------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ----------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 1123344444 79999999999999999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=406.59 Aligned_cols=262 Identities=31% Similarity=0.563 Sum_probs=220.8
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC--EEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--KIY 89 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~ 89 (468)
..+|..++.||+|+||.||++.+.++|+.+|+|.+...... ..+.+.+|+.+|+.++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 45699999999999999999999999999999999876322 2678999999999999999999999754444 699
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-CCceEEeccccchhhhhh-
Q 012228 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQV- 166 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~~~~~- 166 (468)
++|||++||+|.+++...+ .++|+.++.|.+|++.||+|||++||+||||||+|||++. +|.+||+|||+|......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999887 7999999999999999999999999999999999999999 799999999999865531
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCC-chHHHHHHhhcccccccccccchhhhc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
..........|||.|||||++........++||||+||++.||+||..||.. ....+..-.+.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig---------------- 236 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG---------------- 236 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh----------------
Confidence 1122334578999999999998633334599999999999999999999987 33332222211
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.......+|.++|.++++||.+||..||++||||+++|+|||.+...
T Consensus 237 --------~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 237 --------REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred --------ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 11122367888999999999999999999999999999999998654
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-54 Score=388.04 Aligned_cols=260 Identities=36% Similarity=0.645 Sum_probs=227.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh-----hHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMKLIK-HPNVIKIIEVMASK 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~ 85 (468)
...|.-.+.||.|..++|..+.++.+|..+|+|+|...... .....+.-.+|+.||+++. ||||+++.++|+++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35688889999999999999999999999999998642211 2335666789999999995 99999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..+++|+|+|+.|+||+++.....++|...+.+|+||+.|++|||.++|+||||||+|||+|++-++||+|||+|+....
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999986654
Q ss_pred hhcCCcccccCCCCCcCCccccccC-----CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (468)
...+...||||+|.|||.+... +-++..+|+|+||||+|-||.|.+||......-+.+.+..
T Consensus 176 ---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime---------- 242 (411)
T KOG0599|consen 176 ---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME---------- 242 (411)
T ss_pred ---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh----------
Confidence 4457889999999999998643 2236899999999999999999999988877777666421
Q ss_pred hhhhccccccccccccccCCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 241 YKKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.+-.+..|+| +|..+++||++||+.||.+|+|++|+|+||||.+
T Consensus 243 --------------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 243 --------------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred --------------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 2233445666 7999999999999999999999999999999964
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-52 Score=411.03 Aligned_cols=260 Identities=37% Similarity=0.744 Sum_probs=232.5
Q ss_pred CCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
.....+++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence 34456789999999999999999999999999999999998765544445677899999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.+|+||||+.||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~- 170 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD- 170 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999875422
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..
T Consensus 171 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~------------------- 226 (329)
T PTZ00263 171 ----RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK------------------- 226 (329)
T ss_pred ----CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH-------------------
Confidence 1235689999999999988777 5899999999999999999999988877666655
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
+..+.+.+|.+++..+.+||.+||+.||.+|++ ++++++||||+.
T Consensus 227 -------i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 227 -------ILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred -------HhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 333456678889999999999999999999997 799999999975
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-52 Score=392.31 Aligned_cols=283 Identities=27% Similarity=0.411 Sum_probs=226.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-eeEEEEEEEeCC----
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKT---- 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 86 (468)
+..|+.+++||+|+||+||+|+++.+|+.||+|+++.+... ++......+|+.+|+.|+|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 56688889999999999999999999999999999875432 334556789999999999999 999999998877
Q ss_pred --EEEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccc
Q 012228 87 --KIYIVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (468)
Q Consensus 87 --~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla 160 (468)
.+++||||++. +|..++.... .++...++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999987 9999988765 5888999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (468)
+.+.- +...++...+|.+|+|||++.+..+++..+||||+|||++||+++++.|.+.+..+....+.. ..+.+++.
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~--~lGtP~e~ 243 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR--LLGTPNEK 243 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH--HcCCCCcc
Confidence 86542 233466788999999999999997788999999999999999999999999887665555432 22222111
Q ss_pred -hhhhcccccccc--cccc---ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 241 -YKKCTNKYSYTL--QICR---ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 241 -~~~~~~~~~~~~--~~~~---~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
|.....-..+.. .... .-...-+..++++.+|+.+||+.+|.+|+|+..+|+||||....
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 111110000000 0000 00011112346899999999999999999999999999998654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=401.16 Aligned_cols=254 Identities=31% Similarity=0.637 Sum_probs=226.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997655444445677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||+++|+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875432 12
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i------------------------ 210 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI------------------------ 210 (291)
T ss_pred ccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------------------
Confidence 35679999999999988776 58999999999999999999999988777666653
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
......+|..+++.+.+||++||+.||.+|++ ++++++||||+.
T Consensus 211 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 211 --LAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred --HhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 23445567778999999999999999999995 999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=414.36 Aligned_cols=263 Identities=43% Similarity=0.796 Sum_probs=243.0
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
...++.|.+.++||.|.|++|.+|++..++..||||++++...... ..+.+.+|+.+|+.|+|||||+++.+++....+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 3468899999999999999999999999999999999998765444 345589999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||+.+|++++++.+++++.+..++.+|.|+++|++|||+++|+|||||++||||+.+-++||+|||++..+. .
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999775 3
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
...+.+.||+|.|.|||++.+..|+++.+|+||+|++||.|++|.+||++.+..++...
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r--------------------- 266 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR--------------------- 266 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch---------------------
Confidence 56788999999999999999999999999999999999999999999999887766554
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
...+.+.+|-.++.++.+||+++|.++|.+|+++++++.|.|......
T Consensus 267 -----vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 267 -----VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred -----heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 445677788889999999999999999999999999999999976543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=404.46 Aligned_cols=251 Identities=33% Similarity=0.639 Sum_probs=222.2
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 98 (468)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445667789999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCC
Q 012228 99 ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178 (468)
Q Consensus 99 ~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 178 (468)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 9999999888999999999999999999999999999999999999999999999999999874221 12234457899
Q ss_pred CCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccccccc
Q 012228 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRAD 258 (468)
Q Consensus 179 ~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (468)
+.|+|||++.+..| +.++||||+||++|+|++|..||...+.......+ ....
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~--------------------------~~~~ 211 (323)
T cd05571 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------------------------LMEE 211 (323)
T ss_pred ccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH--------------------------HcCC
Confidence 99999999988777 58999999999999999999999887776665552 2334
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 259 FSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 259 ~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
..+|..+++++.+||.+||..||++|| ++.++++||||..
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 556777899999999999999999999 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=389.32 Aligned_cols=267 Identities=28% Similarity=0.486 Sum_probs=232.8
Q ss_pred CCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
.+.+......|++++.||.|.-|+||+|....++..+|+|++++......+-..++..|-.||+.++||.+..||..|++
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 34556667789999999999999999999999999999999999888766678889999999999999999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
+...|+|||||+||+|....++. +.|++..+++|+..++.||+|||-.|||+||||||||||-++|++.|+||.|+..
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999999999988764 4699999999999999999999999999999999999999999999999999643
Q ss_pred hhh-----------------------------h---h-c---------------------CCcccccCCCCCcCCccccc
Q 012228 163 SQQ-----------------------------V---R-E---------------------DGLLHTACGTPNYVAPEVLN 188 (468)
Q Consensus 163 ~~~-----------------------------~---~-~---------------------~~~~~~~~gt~~y~APEvl~ 188 (468)
... . . . +.......||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 210 0 0 0 00112345899999999999
Q ss_pred cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCC--CCC
Q 012228 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS--WFS 266 (468)
Q Consensus 189 ~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s 266 (468)
|.+. +.++|+|+|||+|||||.|..||.+.+..+.+..+. .....+|. .++
T Consensus 309 G~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv--------------------------~~~l~Fp~~~~vs 361 (459)
T KOG0610|consen 309 GEGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV--------------------------GQPLKFPEEPEVS 361 (459)
T ss_pred cCCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh--------------------------cCCCcCCCCCcch
Confidence 9988 589999999999999999999999998888877742 33344443 478
Q ss_pred HHHHHHHHHhcCCCCCCCCC----HHHHhcCccccc
Q 012228 267 SGAKKLIKRILDPNPDTRMT----ISQMLEDEWFKK 298 (468)
Q Consensus 267 ~~~~~Ll~~~L~~dP~~R~t----~~eil~hpwf~~ 298 (468)
..++|||+++|.+||.+|+. |+||.+||||+.
T Consensus 362 ~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 362 SAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred hHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 99999999999999999999 999999999985
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-51 Score=403.42 Aligned_cols=257 Identities=31% Similarity=0.620 Sum_probs=228.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCC-CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETG-DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
...++|++.+.||+|+||.||+|.+..++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 35678999999999999999999976654 68999999876554445567788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||+.||+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~--- 183 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--- 183 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC---
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....++.+
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i-------------------- 240 (340)
T PTZ00426 184 --RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI-------------------- 240 (340)
T ss_pred --CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH--------------------
Confidence 2345689999999999987766 58999999999999999999999988777666653
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
..+...+|..+++.+.+||++||+.||.+|+ |++++++||||..
T Consensus 241 ------~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 241 ------LEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred ------hcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 3344556777899999999999999999996 8999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-52 Score=406.83 Aligned_cols=259 Identities=28% Similarity=0.518 Sum_probs=229.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
-...|....+||+|+.|.||.|....+++.||||.+++....+ .+.+.+|+.+|+..+|+|||++++.|.-.+.+|+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 3457999999999999999999999999999999998765433 4678899999999999999999999988899999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||++||+|.+.+.. ..++|.++..+++.++.||+|||.+||+|||||.+|||++.+|.+||+|||++....... .
T Consensus 348 VMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~ 424 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--S 424 (550)
T ss_pred EEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc--C
Confidence 9999999999998876 459999999999999999999999999999999999999999999999999988655422 2
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
.-.+..|||.|||||++..+.| ++++||||||++++||+-|++||-..++...+..+..
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-------------------- 483 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------------------- 483 (550)
T ss_pred ccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh--------------------
Confidence 4567889999999999998888 6999999999999999999999987666555554432
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.....+..|+.+|+.+++||.+||+.||.+|+||.|+|+||||+..
T Consensus 484 ---ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 484 ---NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred ---cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 3455667788899999999999999999999999999999999643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=385.19 Aligned_cols=272 Identities=31% Similarity=0.525 Sum_probs=227.4
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...+.|++...||.|..++||+|+...+++.||||+++.+++... .+.+.+|+..|+.++||||++++..|..++.+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 446789999999999999999999999999999999999887654 789999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+||.||.+|++++.+... .+++|..+..++++++.||.|||++|.+|||||+.||||+.+|.|||+|||.+..+...+
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999999764 369999999999999999999999999999999999999999999999999876543322
Q ss_pred cCC--cccccCCCCCcCCccccc--cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHH-Hhhcccccccccccchh
Q 012228 168 EDG--LLHTACGTPNYVAPEVLN--DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY-RKVSTFHFLSVYGESYK 242 (468)
Q Consensus 168 ~~~--~~~~~~gt~~y~APEvl~--~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (468)
... ...+..|||+|||||++. ..+|+ .|+||||+|++..||.+|..||....+.++. .++........
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~------ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL------ 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc------
Confidence 211 126678999999999954 34675 9999999999999999999999987766543 33221110000
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
....+......++..++.++..||+.||.+|||++++|+|+||++...
T Consensus 254 -----------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 254 -----------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred -----------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 011111122236789999999999999999999999999999997543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=403.65 Aligned_cols=260 Identities=31% Similarity=0.584 Sum_probs=222.2
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455678889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc----
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE---- 168 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 168 (468)
|||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875422100
Q ss_pred -----------------------------CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc
Q 012228 169 -----------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES 219 (468)
Q Consensus 169 -----------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~ 219 (468)
.......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0112346899999999999887775 8999999999999999999999988
Q ss_pred hHHHHHHhhcccccccccccchhhhccccccccccccccCCCCC--CCCHHHHHHHHHhcCCCCC---CCCCHHHHhcCc
Q 012228 220 NLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS--WFSSGAKKLIKRILDPNPD---TRMTISQMLEDE 294 (468)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Ll~~~L~~dP~---~R~t~~eil~hp 294 (468)
+..+.+.++... .....+|+ .+++++.+||.+|+. +|. .||+++|+++||
T Consensus 240 ~~~~~~~~i~~~------------------------~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp 294 (363)
T cd05628 240 TPQETYKKVMNW------------------------KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNP 294 (363)
T ss_pred CHHHHHHHHHcC------------------------cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCC
Confidence 877776664321 11222333 368999999999876 444 458999999999
Q ss_pred cccc
Q 012228 295 WFKK 298 (468)
Q Consensus 295 wf~~ 298 (468)
||+.
T Consensus 295 ~f~~ 298 (363)
T cd05628 295 FFEG 298 (363)
T ss_pred CCCC
Confidence 9975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=396.37 Aligned_cols=250 Identities=33% Similarity=0.638 Sum_probs=220.8
Q ss_pred eeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCH
Q 012228 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (468)
Q Consensus 21 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 100 (468)
||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999865544444566788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCC
Q 012228 101 FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180 (468)
Q Consensus 101 ~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 180 (468)
.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 99999888999999999999999999999999999999999999999999999999999875322 1223345789999
Q ss_pred cCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCC
Q 012228 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFS 260 (468)
Q Consensus 181 y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (468)
|+|||++.+..+ +.++||||+||++|+|++|..||...+..+.+..+ ......
T Consensus 159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~--------------------------~~~~~~ 211 (312)
T cd05585 159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--------------------------LQEPLR 211 (312)
T ss_pred cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH--------------------------HcCCCC
Confidence 999999988777 58999999999999999999999888777666552 334456
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCcccccC
Q 012228 261 CPSWFSSGAKKLIKRILDPNPDTRM---TISQMLEDEWFKKG 299 (468)
Q Consensus 261 ~~~~~s~~~~~Ll~~~L~~dP~~R~---t~~eil~hpwf~~~ 299 (468)
+|..+++++.+||.+||..||.+|| ++.+++.||||.+.
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 6777899999999999999999997 57999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=385.15 Aligned_cols=278 Identities=29% Similarity=0.435 Sum_probs=218.8
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--C---
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--T--- 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~--- 86 (468)
.=.|.-.+.+|.|+||.||.|....+++.||||.+-.++-.+ .+|+.+|+.++|||||++..+|... +
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 345999999999999999999999999999999986544322 2899999999999999999888542 2
Q ss_pred EEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-CCceEEeccccch
Q 012228 87 KIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSA 161 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~-~g~lkl~DFGla~ 161 (468)
...+||||++. +|.+.+.. +.+++.-.++-|++||++||.|||+.||+||||||+|+|+|. +|.+||||||.|+
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 34699999986 89888874 578999999999999999999999999999999999999995 4999999999999
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc-
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES- 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 240 (468)
....... ..++..|+.|+|||++.|...++.+.||||+||++.||+.|++.|.+.+..+....+... .+.+..+
T Consensus 175 ~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~--lG~Pt~e~ 249 (364)
T KOG0658|consen 175 VLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV--LGTPTRED 249 (364)
T ss_pred eeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH--hCCCCHHH
Confidence 8765333 356778999999999999888889999999999999999999999998766655554321 1111111
Q ss_pred hhhhcccc-c-cccccccccC--CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 241 YKKCTNKY-S-YTLQICRADF--SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 241 ~~~~~~~~-~-~~~~~~~~~~--~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
.......+ . ...++..... -+....++++.+|+.++|..+|.+|.|+.|++.||||..-..+
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 01110000 0 0001111111 1334478999999999999999999999999999999865443
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=397.09 Aligned_cols=251 Identities=34% Similarity=0.650 Sum_probs=221.7
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 98 (468)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445677889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCC
Q 012228 99 ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178 (468)
Q Consensus 99 ~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 178 (468)
+|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 9999998888899999999999999999999999999999999999999999999999999874321 12234457899
Q ss_pred CCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccccccc
Q 012228 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRAD 258 (468)
Q Consensus 179 ~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (468)
+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+.... +....
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~--------------------------~~~~~ 211 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL--------------------------ILMED 211 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHH--------------------------hccCC
Confidence 99999999987776 5899999999999999999999988776666554 23344
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 259 FSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 259 ~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
..+|..+++++.+||++||..||.+|+ ++.++++||||..
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 566777899999999999999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-50 Score=396.88 Aligned_cols=262 Identities=29% Similarity=0.539 Sum_probs=225.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998765444445667889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875432 33
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+.+..+......
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------------ 216 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET------------------ 216 (333)
T ss_pred CCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc------------------
Confidence 46789999999999988766 48999999999999999999999988877666554321100
Q ss_pred ccccccCCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 253 QICRADFSC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 253 ~~~~~~~~~-~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
........ ...++.++.+||.+||..+|.+|||++++++||||...
T Consensus 217 -~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 217 -LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred -ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 00000000 02368999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=387.67 Aligned_cols=280 Identities=24% Similarity=0.404 Sum_probs=218.3
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
.+++|++.+.||+|+||+||+|.+..++..||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 568899999999999999999999999999999998654321 123457799999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 91 VLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||+++ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~ 157 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PT 157 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CC
Confidence 9999986 8998887654 479999999999999999999999999999999999999999999999999875332 12
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc-
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY- 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 248 (468)
.......+|+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+....+...... .....+.......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGT-PTEETWPGITSNEE 236 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChHHhhccccchh
Confidence 23345678999999999876554568999999999999999999999887766554443211000 0000010000000
Q ss_pred --ccccc--cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 249 --SYTLQ--ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 249 --~~~~~--~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
..... .........+.++.++++||++||++||.+|||++|+++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00000 0001111223478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=402.22 Aligned_cols=260 Identities=31% Similarity=0.630 Sum_probs=222.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444455677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC---
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED--- 169 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~--- 169 (468)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998653221100
Q ss_pred ---------------------------------CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCC
Q 012228 170 ---------------------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 216 (468)
Q Consensus 170 ---------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf 216 (468)
....+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence 01123579999999999988777 58999999999999999999999
Q ss_pred CCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCC--CCCHHHHHHHHHhcCCCCCCCCC---HHHHh
Q 012228 217 DESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS--WFSSGAKKLIKRILDPNPDTRMT---ISQML 291 (468)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Ll~~~L~~dP~~R~t---~~eil 291 (468)
...+..+....+... ...+..|. .+++++.+||++||. +|.+|++ +++++
T Consensus 240 ~~~~~~~~~~~i~~~------------------------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 240 CSDNPQETYRKIINW------------------------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred CCCCHHHHHHHHHcC------------------------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 988776665553211 11122222 368999999999997 9999998 99999
Q ss_pred cCccccc
Q 012228 292 EDEWFKK 298 (468)
Q Consensus 292 ~hpwf~~ 298 (468)
+||||+.
T Consensus 295 ~h~~~~~ 301 (364)
T cd05599 295 SHPFFKG 301 (364)
T ss_pred cCCCcCC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-50 Score=394.35 Aligned_cols=251 Identities=33% Similarity=0.644 Sum_probs=220.9
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 98 (468)
+.||+|+||.||+|.+..+|..||+|++.............+.+|+.+++.++||||+++++.+...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445667789999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCC
Q 012228 99 ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178 (468)
Q Consensus 99 ~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 178 (468)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 9999998888899999999999999999999999999999999999999999999999999864221 12223456899
Q ss_pred CCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccccccc
Q 012228 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRAD 258 (468)
Q Consensus 179 ~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (468)
+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+ ....
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~--------------------------~~~~ 211 (323)
T cd05595 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--------------------------LMEE 211 (323)
T ss_pred cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------------------------hcCC
Confidence 99999999987777 58999999999999999999999888776665552 2334
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 259 FSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 259 ~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
..+|..+++++.+||.+||+.||.+|+ ++.++++||||.+
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 456677899999999999999999998 9999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=402.16 Aligned_cols=260 Identities=31% Similarity=0.504 Sum_probs=220.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987665555567789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc-----
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE----- 168 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~----- 168 (468)
||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 999999999999888999999999999999999999999999999999999999999999999999754311000
Q ss_pred ----------------------------------------CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHH
Q 012228 169 ----------------------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFV 208 (468)
Q Consensus 169 ----------------------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ 208 (468)
.....+.+||+.|+|||++.+..| +.++||||+||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHHH
Confidence 001234579999999999988777 489999999999999
Q ss_pred HhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCC--CCCHHHHHHHHHhcC--CCCCCC
Q 012228 209 LMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS--WFSSGAKKLIKRILD--PNPDTR 284 (468)
Q Consensus 209 ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Ll~~~L~--~dP~~R 284 (468)
|++|..||...+..+....+.. .......|. .+++++.+||.+||. .+|..|
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~------------------------~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVIN------------------------WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHc------------------------cccccCCCCCCCCCHHHHHHHHHHccCcccccCC
Confidence 9999999988776555444311 111222333 478999999999664 455569
Q ss_pred CCHHHHhcCccccc
Q 012228 285 MTISQMLEDEWFKK 298 (468)
Q Consensus 285 ~t~~eil~hpwf~~ 298 (468)
+|++++++||||+.
T Consensus 297 ~~~~~~l~hp~f~~ 310 (381)
T cd05626 297 NGADDIKAHPFFSE 310 (381)
T ss_pred CCHHHHhcCcccCC
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-52 Score=379.94 Aligned_cols=261 Identities=33% Similarity=0.637 Sum_probs=241.1
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
...++.|+.++.||+|+||+|.+++.+.+|+.+|||+++++-+........-..|-++|+..+||.+..+...|...+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 34678999999999999999999999999999999999988877666677777899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||+.||+|+-++.....++|+.++.|...|++||.|||+++||+||||.+|+|+|.+|++||+|||+++- ....
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~~ 321 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIKY 321 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--cccc
Confidence 99999999999999999988999999999999999999999999999999999999999999999999999863 2233
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.....+.||||.|+|||++....| +.++|.|.+||++|+|+||++||...+...++..
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL--------------------- 379 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL--------------------- 379 (516)
T ss_pred cceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHH---------------------
Confidence 456778999999999999998888 6999999999999999999999999998888877
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
|...++.+|..++++++.||..+|.+||.+|. .+.||.+|+||..
T Consensus 380 -----Il~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 380 -----ILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred -----HHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 55678899999999999999999999999998 5889999999975
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-50 Score=402.73 Aligned_cols=260 Identities=32% Similarity=0.569 Sum_probs=221.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
..|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765544555678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh-----
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR----- 167 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~----- 167 (468)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999975321100
Q ss_pred ----------------------------------------cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHH
Q 012228 168 ----------------------------------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207 (468)
Q Consensus 168 ----------------------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~ 207 (468)
......+.+||+.|+|||++.+..|. .++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00011245799999999999888875 8999999999999
Q ss_pred HHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCC--CCCCHHHHHHHHHhcCCCCCCCC
Q 012228 208 VLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCP--SWFSSGAKKLIKRILDPNPDTRM 285 (468)
Q Consensus 208 ~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Ll~~~L~~dP~~R~ 285 (468)
+|++|.+||...+..+....+.. .......| ..+++++.+||.+|+ .||.+|+
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~------------------------~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~ 294 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVIN------------------------WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRL 294 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHc------------------------cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcC
Confidence 99999999998776655444321 11122222 347999999999987 5999999
Q ss_pred C---HHHHhcCccccc
Q 012228 286 T---ISQMLEDEWFKK 298 (468)
Q Consensus 286 t---~~eil~hpwf~~ 298 (468)
+ ++++++||||+.
T Consensus 295 ~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 295 GKNGADEIKAHPFFKT 310 (382)
T ss_pred CCCCHHHHhcCCCcCC
Confidence 8 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=393.58 Aligned_cols=251 Identities=33% Similarity=0.648 Sum_probs=220.9
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||+||+|.++.+++.||+|++.+.........+.+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444566777899988876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 99999999888999999999999999999999999999999999999999999999999999864321 1223445689
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+.+..+ ...
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i--------------------------~~~ 211 (320)
T cd05590 159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--------------------------LND 211 (320)
T ss_pred CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH--------------------------hcC
Confidence 999999999987766 58999999999999999999999988877766653 334
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRMTI------SQMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~------~eil~hpwf~~ 298 (468)
....|.+++.++.+||++||+.||.+|+++ +++++||||+.
T Consensus 212 ~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 212 EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 456677899999999999999999999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=391.59 Aligned_cols=256 Identities=31% Similarity=0.589 Sum_probs=224.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC-CCeeEEEEEEEeCCEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-PNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~ 92 (468)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.++..++| ++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999987654444456778899999999976 46889999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864221 12234
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+.+..+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------------------------ 213 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI------------------------ 213 (324)
T ss_pred eeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------------------------
Confidence 45789999999999988777 58999999999999999999999988877666653
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI-----SQMLEDEWFKK 298 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~-----~eil~hpwf~~ 298 (468)
.......|..++.++.+|+++||..||.+|+++ +++++||||+.
T Consensus 214 --~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 214 --MEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred --HcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 233445667789999999999999999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=401.70 Aligned_cols=260 Identities=29% Similarity=0.596 Sum_probs=220.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++++.||+|+||+||+|.+..+++.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997765444455678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC---
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED--- 169 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~--- 169 (468)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998632210000
Q ss_pred ------------------------------------------CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHH
Q 012228 170 ------------------------------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207 (468)
Q Consensus 170 ------------------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~ 207 (468)
......+||+.|+|||++.+..+ +.++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 00113579999999999988777 58999999999999
Q ss_pred HHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCC--CCCHHHHHHHHHhcCCCCCCC-
Q 012228 208 VLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS--WFSSGAKKLIKRILDPNPDTR- 284 (468)
Q Consensus 208 ~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Ll~~~L~~dP~~R- 284 (468)
+|++|.+||...+..+.+..+... ...+.+|. .++.++.+||.+||. +|.+|
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~------------------------~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINW------------------------RETLYFPDDIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHcc------------------------CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcC
Confidence 999999999887776665554211 11222333 378999999999998 67765
Q ss_pred --CCHHHHhcCccccc
Q 012228 285 --MTISQMLEDEWFKK 298 (468)
Q Consensus 285 --~t~~eil~hpwf~~ 298 (468)
+|+.++++||||+.
T Consensus 295 ~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 295 GRGGAHEIKSHPFFRG 310 (377)
T ss_pred CCCCHHHHhcCCCcCC
Confidence 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=384.65 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=217.7
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+.+..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999986654433344567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|+++|+|.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 99999998887543 3689999999999999999999999999999999999999999999999999875422 122
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~--------------------- 215 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR--------------------- 215 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---------------------
Confidence 345679999999999988777 4899999999999999999999987543221111100
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
.+.......+..++.++.+||++||+.||.+||| ++++++||||..
T Consensus 216 -~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 216 -RVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred -HhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 0122233455568999999999999999999997 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=401.66 Aligned_cols=262 Identities=30% Similarity=0.529 Sum_probs=220.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997655444445677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh-----
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR----- 167 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~----- 167 (468)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999975331100
Q ss_pred ------------------------------------cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh
Q 012228 168 ------------------------------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA 211 (468)
Q Consensus 168 ------------------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~ 211 (468)
........+||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence 0001124579999999999988777 589999999999999999
Q ss_pred CCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC---CHH
Q 012228 212 GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM---TIS 288 (468)
Q Consensus 212 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~---t~~ 288 (468)
|..||...+..+....+... ...........+++++.+||.+|+ .+|.+|+ |+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~----------------------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 240 GQPPFLADTPAETQLKVINW----------------------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred CCCCCCCCCHHHHHHHHhcc----------------------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 99999988766554443210 001111222347899999999977 5999999 999
Q ss_pred HHhcCccccc
Q 012228 289 QMLEDEWFKK 298 (468)
Q Consensus 289 eil~hpwf~~ 298 (468)
++++||||+.
T Consensus 297 ell~h~~~~~ 306 (376)
T cd05598 297 EIKAHPFFKG 306 (376)
T ss_pred HHhCCCCcCC
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=392.32 Aligned_cols=251 Identities=33% Similarity=0.616 Sum_probs=221.5
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444556677899998866 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|...+...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 99999999888999999999999999999999999999999999999999999999999999874322 2223445689
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+.+.. +...
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~--------------------------i~~~ 211 (321)
T cd05591 159 TPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES--------------------------ILHD 211 (321)
T ss_pred CccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHH--------------------------HHcC
Confidence 999999999987777 5899999999999999999999998887777666 3334
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCC-------CHHHHhcCccccc
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRM-------TISQMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-------t~~eil~hpwf~~ 298 (468)
....|.+++.++.+||.+||+.||++|+ +++++++||||..
T Consensus 212 ~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 212 DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 5567778999999999999999999999 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=389.48 Aligned_cols=254 Identities=29% Similarity=0.561 Sum_probs=219.7
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHH---hcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM---KLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999866544444456777777765 466799999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|||++||+|...+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCc
Confidence 999999999988754 5799999999999999999999999999999999999999999999999999864322 1223
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
..+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i----------------------- 213 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI----------------------- 213 (324)
T ss_pred ccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------------------
Confidence 346789999999999988776 58999999999999999999999988776665552
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
.......|..++..+.+||.+||+.||.+|| ++.++++||||+.
T Consensus 214 ---~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 214 ---VNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred ---HhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 2334456677899999999999999999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=393.07 Aligned_cols=251 Identities=34% Similarity=0.647 Sum_probs=220.4
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 98 (468)
+.||+|+||.||+|.+..+|..||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445567789999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 99 ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 99 ~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
+|..++.....+++..+..++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 999999888889999999999999999999997 7999999999999999999999999999864321 1223345689
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+ ...
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i--------------------------~~~ 211 (325)
T cd05594 159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------------------------LME 211 (325)
T ss_pred CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHH--------------------------hcC
Confidence 999999999987777 58999999999999999999999888776665552 233
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
...+|..+++++.+||.+||+.||++|+ ++.++++||||..
T Consensus 212 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 212 EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 4456677899999999999999999997 9999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=388.44 Aligned_cols=251 Identities=30% Similarity=0.600 Sum_probs=217.6
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||.||+|.++.+|+.||+|++.+.........+.+..|..++..+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999865433333455677888888755 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 99999998888999999999999999999999999999999999999999999999999999864221 1223456789
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+....+ ...
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~--------------------------~~~ 211 (316)
T cd05620 159 TPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI--------------------------RVD 211 (316)
T ss_pred CcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------------------------HhC
Confidence 999999999988777 48999999999999999999999988776665553 223
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCCH-HHHhcCccccc
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRMTI-SQMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~-~eil~hpwf~~ 298 (468)
....|.+++.++.+||++||..||.+|+++ +++++||||+.
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 212 TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 345677899999999999999999999998 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-49 Score=384.46 Aligned_cols=283 Identities=24% Similarity=0.394 Sum_probs=213.0
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++.+.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 457899999999999999999999999999999998754321 123456789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 91 VLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||+.+ +|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 157 (303)
T cd07869 81 VFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PS 157 (303)
T ss_pred EEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CC
Confidence 9999964 787777654 5689999999999999999999999999999999999999999999999999864322 12
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH-HHHHHhhcc---cccccccccchhhhc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKVST---FHFLSVYGESYKKCT 245 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~~ 245 (468)
......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+... .+....+.. ......+.... ...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH-SLP 236 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh-hcc
Confidence 2334567899999999987665556899999999999999999999986432 222221110 00000000000 000
Q ss_pred ccccccccc-ccccC---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 246 NKYSYTLQI-CRADF---SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 246 ~~~~~~~~~-~~~~~---~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
......... ..... .....+++.+.+||.+||+.||++|||++|+++||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000000000 00000 0011246789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=395.35 Aligned_cols=265 Identities=28% Similarity=0.520 Sum_probs=225.0
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
.....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34556789999999999999999999999999999999976544444445667899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999999998865 468999999999999999999999999999999999999999999999999987543211
Q ss_pred cCCcccccCCCCCcCCccccccCC---CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.......+||+.|+|||++.+.. +.+.++||||+||++|+|++|..||.+.+....+..+..
T Consensus 197 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~-------------- 261 (370)
T cd05596 197 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD-------------- 261 (370)
T ss_pred -cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc--------------
Confidence 11234568999999999987543 346899999999999999999999998877666665421
Q ss_pred ccccccccccccccCCCCC--CCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012228 245 TNKYSYTLQICRADFSCPS--WFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 298 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~--~~s~~~~~Ll~~~L~~dP~~--R~t~~eil~hpwf~~ 298 (468)
....+.+|. .+|.++.+||++||+.+|.+ |+|++++++||||+.
T Consensus 262 ----------~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 262 ----------HKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred ----------CCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 111223333 47999999999999999998 999999999999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=389.29 Aligned_cols=251 Identities=30% Similarity=0.609 Sum_probs=216.5
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554444566788999999988 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999864211 2223456789
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH---------HHHHhhcccccccccccchhhhcccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---------ALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
|+.|+|||++.+..+ +.++|+||+||++|+|++|..||+..... ...+.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------------- 216 (329)
T cd05588 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------------------- 216 (329)
T ss_pred CccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH---------------------
Confidence 999999999988777 48999999999999999999999642211 01111
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCccccc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT------ISQMLEDEWFKK 298 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t------~~eil~hpwf~~ 298 (468)
+.......|..++..+.+||++||+.||.+|+| ++++++||||..
T Consensus 217 -----~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 217 -----ILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred -----HHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 333455677889999999999999999999997 789999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-49 Score=387.04 Aligned_cols=256 Identities=31% Similarity=0.590 Sum_probs=224.2
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+ .||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876544444456677888888877 4899999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||+++|+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999864321 12233
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+...+...+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i------------------------ 213 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------------------------ 213 (323)
T ss_pred ccCCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH------------------------
Confidence 45789999999999988777 48999999999999999999999988877776653
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI-----SQMLEDEWFKK 298 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~-----~eil~hpwf~~ 298 (468)
......+|..++.++.+|+.+||+.||.+|+++ .++++||||+.
T Consensus 214 --~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 214 --MEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred --HhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 334455677789999999999999999999984 89999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=394.49 Aligned_cols=260 Identities=30% Similarity=0.626 Sum_probs=224.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765544445677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh-----
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR----- 167 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~----- 167 (468)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999987654322
Q ss_pred ----------------------cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHH
Q 012228 168 ----------------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY 225 (468)
Q Consensus 168 ----------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~ 225 (468)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 0012345679999999999988776 58999999999999999999999988766665
Q ss_pred HhhcccccccccccchhhhccccccccccccccCCCCC--CCCHHHHHHHHHhcCCCCCCCCC-HHHHhcCccccc
Q 012228 226 RKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS--WFSSGAKKLIKRILDPNPDTRMT-ISQMLEDEWFKK 298 (468)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Ll~~~L~~dP~~R~t-~~eil~hpwf~~ 298 (468)
..+... ......|. .+++++.+||.+||. ||.+|++ ++++++||||+.
T Consensus 240 ~~i~~~------------------------~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINW------------------------KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhcc------------------------CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 554211 11222222 269999999999997 9999999 999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=391.04 Aligned_cols=256 Identities=30% Similarity=0.493 Sum_probs=225.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
..|...+.||+|+||.||+|.+..+++.||||+++.+.... .++.+.+|+.+|..+++|||.++|+.|..+..+|++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 45888899999999999999999999999999999876433 5788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
|||.||++.+.+.....++|..+..++++++.|+.|||.++.+|||||+.|||+..+|.+|++|||.|........ .-
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--RR 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999876544322 23
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
.+..|||.||||||+.+.+|+ .++||||||++.+||++|.+||....++.....
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------------------- 222 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------------------- 222 (467)
T ss_pred ccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------------------
Confidence 788999999999999988886 899999999999999999999988765322111
Q ss_pred cccc-ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 253 QICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 253 ~~~~-~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
|.+ ....+...+|+.+++|+..||++||+.||||.++|+|+|.+..
T Consensus 223 -Ipk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 223 -IPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred -ccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 222 2222333589999999999999999999999999999999874
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=386.15 Aligned_cols=251 Identities=33% Similarity=0.648 Sum_probs=216.8
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||+||+|.+..+++.||+|++.+.........+....|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999875543333455566777777654 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 99999999888999999999999999999999999999999999999999999999999999874322 1223445789
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+ ...
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i--------------------------~~~ 211 (316)
T cd05592 159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--------------------------LND 211 (316)
T ss_pred CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------------------HcC
Confidence 999999999988776 58999999999999999999999988776666553 223
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCCH-HHHhcCccccc
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRMTI-SQMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~-~eil~hpwf~~ 298 (468)
....|.+++.++.+||.+||+.||.+||++ .++++||||..
T Consensus 212 ~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 212 RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 345677789999999999999999999986 48889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=394.12 Aligned_cols=260 Identities=31% Similarity=0.611 Sum_probs=222.6
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
+.|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999998655444455678889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc----
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE---- 168 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 168 (468)
|||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864321100
Q ss_pred -----------------------------CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc
Q 012228 169 -----------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES 219 (468)
Q Consensus 169 -----------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~ 219 (468)
.......+||+.|+|||++.+..+. .++||||+||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0112245899999999999888774 8999999999999999999999988
Q ss_pred hHHHHHHhhcccccccccccchhhhccccccccccccccCCCCC--CCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCc
Q 012228 220 NLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS--WFSSGAKKLIKRILDPNPDTRM---TISQMLEDE 294 (468)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Ll~~~L~~dP~~R~---t~~eil~hp 294 (468)
+....+..+... ...+.+|+ .+++++.+||.+|+. ||.+|+ +++++++||
T Consensus 240 ~~~~~~~~i~~~------------------------~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 240 TPQETYRKVMNW------------------------KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHP 294 (360)
T ss_pred CHHHHHHHHHcC------------------------CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCC
Confidence 877766654211 11222333 278999999999875 999999 489999999
Q ss_pred cccc
Q 012228 295 WFKK 298 (468)
Q Consensus 295 wf~~ 298 (468)
||+.
T Consensus 295 ~f~~ 298 (360)
T cd05627 295 FFEG 298 (360)
T ss_pred CCCC
Confidence 9985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-49 Score=393.74 Aligned_cols=263 Identities=29% Similarity=0.550 Sum_probs=222.4
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999997654444444567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|....... .
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~ 197 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-M 197 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-c
Confidence 99999999999998865 468999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CcccccCCCCCcCCccccccCC---CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~---~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
....+.+||+.|+|||++.+.+ +++.++||||+||++|+|++|..||...+....+..+..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~---------------- 261 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD---------------- 261 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------
Confidence 1234678999999999987643 346899999999999999999999998877666655421
Q ss_pred ccccccccccccCCCCC--CCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012228 247 KYSYTLQICRADFSCPS--WFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 298 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~--~~s~~~~~Ll~~~L~~dP~~--R~t~~eil~hpwf~~ 298 (468)
....+..|. .++..+++|+.+||..+|.+ |+|++++++||||+.
T Consensus 262 --------~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 262 --------HKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred --------CCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 111223333 36899999999999866654 899999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=368.28 Aligned_cols=259 Identities=36% Similarity=0.659 Sum_probs=218.8
Q ss_pred CCccccCeEEE-eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEe-
Q 012228 8 SRTRVGKYELG-RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMAS- 84 (468)
Q Consensus 8 ~~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~- 84 (468)
.....++|.+- ++||-|-.|+|-.+.++.||+.+|+|++.- ....++|++++-..+ |||||.++++|++
T Consensus 56 ~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 56 EYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred cccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 34567888885 579999999999999999999999998742 134568999877775 9999999999865
Q ss_pred ---CCEEEEEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc---CCceEEec
Q 012228 85 ---KTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISD 156 (468)
Q Consensus 85 ---~~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~---~g~lkl~D 156 (468)
...+.+|||.++||+||+.|+.++. |+|.++..+++||..|+.|||+.+|+||||||||+|... +..+||+|
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence 3568899999999999999998775 999999999999999999999999999999999999974 45799999
Q ss_pred cccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH----HHHHHhhcccc
Q 012228 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKVSTFH 232 (468)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~----~~~~~~~~~~~ 232 (468)
||+|+.... ...+.+.|-||.|+|||++...+|+ ..+|+||+||++|.||||++||-...- ..+..+
T Consensus 208 fGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~r----- 278 (400)
T KOG0604|consen 208 FGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRR----- 278 (400)
T ss_pred cccccccCC---CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhH-----
Confidence 999986432 4568899999999999999888886 899999999999999999999954321 112222
Q ss_pred cccccccchhhhccccccccccccccCCC--CCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCC
Q 012228 233 FLSVYGESYKKCTNKYSYTLQICRADFSC--PSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304 (468)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~~~ 304 (468)
|..+.+.+ |+| +|.+++++|+++|..+|.+|.|+++++.|||..+...-+.
T Consensus 279 ---------------------I~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~ 333 (400)
T KOG0604|consen 279 ---------------------IRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQ 333 (400)
T ss_pred ---------------------hhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCC
Confidence 44444444 456 8999999999999999999999999999999987654433
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=385.63 Aligned_cols=251 Identities=33% Similarity=0.655 Sum_probs=220.1
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444566778899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 99999999888999999999999999999999999999999999999999999999999999864221 1222345689
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+ ...
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i--------------------------~~~ 211 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI--------------------------LED 211 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH--------------------------HcC
Confidence 9999999999887774 8999999999999999999999988776665552 233
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRMTI-----SQMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~-----~eil~hpwf~~ 298 (468)
....|..++..+.+||++||..||++|||+ .++++||||+.
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 212 EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 445566789999999999999999999999 99999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-49 Score=386.39 Aligned_cols=252 Identities=34% Similarity=0.668 Sum_probs=219.1
Q ss_pred EeeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhhh-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 18 GRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLR-HKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
++.||+|+||.||+|.+. .+++.||+|++.+..... ......+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 578899999998654322 2334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
|++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999864322 222334
Q ss_pred ccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccc
Q 012228 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253 (468)
Q Consensus 174 ~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (468)
..+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......
T Consensus 159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~-------------------------- 211 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK-------------------------- 211 (323)
T ss_pred ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH--------------------------
Confidence 5689999999999987766 5899999999999999999999998876655554
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 254 ~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
+.......|+.+++.+.+||.+||+.||++|| +++++++||||+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 212 ILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 33345567778999999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-49 Score=387.29 Aligned_cols=251 Identities=32% Similarity=0.609 Sum_probs=216.6
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHH-HHhcCCCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||+||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++.+.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998655433333455556655 56889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 99999999888999999999999999999999999999999999999999999999999999864321 2223445689
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+++..+ ...
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i--------------------------~~~ 211 (323)
T cd05575 159 TPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--------------------------LNK 211 (323)
T ss_pred ChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHH--------------------------HcC
Confidence 999999999988776 48999999999999999999999988777766653 223
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRMTI----SQMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~----~eil~hpwf~~ 298 (468)
....++.++..+.+||++||+.||.+||++ .++++||||..
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 212 PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 344556689999999999999999999998 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=379.82 Aligned_cols=279 Identities=27% Similarity=0.410 Sum_probs=216.3
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999975432 2234567789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... .....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc-ccccc
Confidence 99999777666555667999999999999999999999999999999999999999999999999998764321 11223
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc-hhhhccccc--
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES-YKKCTNKYS-- 249 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-- 249 (468)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||...+..+....+.... ...... .........
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL--GPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh--CCCCHHHHHhhhccchhc
Confidence 34679999999999988776 589999999999999999999998765443332221100 000000 000000000
Q ss_pred -ccccc----ccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 250 -YTLQI----CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 250 -~~~~~----~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
..... ..........+|.++.+||++||++||++|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000 000011122378899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=386.65 Aligned_cols=258 Identities=31% Similarity=0.611 Sum_probs=218.4
Q ss_pred CeEEEeeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhh-hHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKI 88 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 88 (468)
+|++++.||+|+||+||+|++. .++..||+|++.+.... .....+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 47899999999765432 2234567889999999995 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch----HHHHHHhhcccccccccccchhhh
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||.... .......
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~----------------- 222 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR----------------- 222 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH-----------------
Confidence 1223356899999999999876655789999999999999999999996432 1222221
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
+.......|..+++.+.+||.+||+.||++|| +++++++||||+.
T Consensus 223 ---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 223 ---------ILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred ---------HhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 22334455667899999999999999999999 8889999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=389.40 Aligned_cols=262 Identities=29% Similarity=0.514 Sum_probs=221.7
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|++.+.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46999999999999999999999999999999998765544445677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||+++|+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-cee
Confidence 999999999999876 679999999999999999999999999999999999999999999999999987543211 112
Q ss_pred ccccCCCCCcCCcccccc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 172 LHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~-----~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
....+||+.|+|||++.. ....+.++||||+||++|+|++|..||...+....+..+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--------------- 224 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--------------- 224 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---------------
Confidence 234579999999999863 233468999999999999999999999887766655553211
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.....++..+.+++++.+||++||. ||.+|||++++++||||..
T Consensus 225 -------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 225 -------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred -------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 0001122233478999999999998 9999999999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=383.84 Aligned_cols=251 Identities=31% Similarity=0.601 Sum_probs=216.7
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||+||+|++..+++.||+|++.+.........+....|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999865433333345667788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|.+.+.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 99999998888899999999999999999999999999999999999999999999999999864221 1222345679
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+..+.+ ...
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i--------------------------~~~ 211 (316)
T cd05619 159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--------------------------RMD 211 (316)
T ss_pred CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------------------HhC
Confidence 999999999988776 58999999999999999999999988776666553 122
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH-HHhcCccccc
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRMTIS-QMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~-eil~hpwf~~ 298 (468)
....|.+++.++.+||.+||+.||.+||++. ++++||||+.
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 212 NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 3345677899999999999999999999996 8999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=383.41 Aligned_cols=256 Identities=31% Similarity=0.592 Sum_probs=223.0
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+..|+.+++.+. ||+|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4789999999999999999999999999999998765444445567788999998886 578889999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999874322 11223
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.....+.+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------------------------ 213 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI------------------------ 213 (323)
T ss_pred cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------------------------
Confidence 45679999999999987776 58999999999999999999999988776666653
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
.......|..++.++.+|+.+||..||.+|++ .+++++||||+.
T Consensus 214 --~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 214 --MEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred --HhCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 33445566778999999999999999999997 478999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=385.23 Aligned_cols=251 Identities=31% Similarity=0.608 Sum_probs=215.0
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544444566788999998776 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999999874321 1223345789
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch---------HHHHHHhhcccccccccccchhhhcccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---------LMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.... .....+.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------------- 216 (329)
T cd05618 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------------------- 216 (329)
T ss_pred CccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH---------------------
Confidence 999999999988777 489999999999999999999995321 0111111
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCccccc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT------ISQMLEDEWFKK 298 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t------~~eil~hpwf~~ 298 (468)
+.......|..++..+.+||++||+.||.+|+| ++++++||||+.
T Consensus 217 -----i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 217 -----ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred -----HhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 233455677789999999999999999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=383.24 Aligned_cols=281 Identities=28% Similarity=0.456 Sum_probs=213.5
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-----CEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-----TKI 88 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 88 (468)
+|++.+.||+|+||.||+|++..+|..||||.+..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999864321 222345678999999999999999999988543 358
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+|||||. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999996 58999998888899999999999999999999999999999999999999999999999999875432211
Q ss_pred -CCcccccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc-hhhh
Q 012228 169 -DGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES-YKKC 244 (468)
Q Consensus 169 -~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 244 (468)
.......+||+.|+|||++.+ ..+ +.++||||+||++|+|++|.+||.+.+.......+.... +..... ....
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~i 235 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL--GTPSPETISRV 235 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh--CCCCHHHHHHh
Confidence 122345679999999999865 344 689999999999999999999998776544333221100 000000 0000
Q ss_pred cccc--cccccccc-ccCC---CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 245 TNKY--SYTLQICR-ADFS---CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 245 ~~~~--~~~~~~~~-~~~~---~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.... ........ .... ..+.+++.+.+||.+||+.||++|||++++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 0000 00000000 0000 112367889999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=388.65 Aligned_cols=267 Identities=30% Similarity=0.523 Sum_probs=222.9
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
.....++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34456899999999999999999999999999999999976544444445668899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~- 195 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE- 195 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-
Confidence 9999999999999998865 46899999999999999999999999999999999999999999999999998754321
Q ss_pred cCCcccccCCCCCcCCccccccCC---CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
......+.+||+.|+|||++.+.. +++.++||||+||++|+|++|..||...+....+..+...
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------- 262 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH------------- 262 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------
Confidence 111234678999999999987543 3468999999999999999999999988877666654210
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 298 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~--R~t~~eil~hpwf~~ 298 (468)
.....++.+..++..+.+||.+||..++.+ |++++++++||||++
T Consensus 263 ---------~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 263 ---------KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred ---------CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 001112223358999999999999854443 789999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=387.03 Aligned_cols=250 Identities=30% Similarity=0.590 Sum_probs=214.1
Q ss_pred eeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC---CCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI---KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 21 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
||+|+||+||+|++..+|+.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765544433445556777777665 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 99999999888999999999999999999999999999999999999999999999999999864322 2223456789
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|+.|+|||++.+...++.++||||+||++|+|++|..||...+..+.+..+. .+
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~--------------------------~~ 212 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA--------------------------FG 212 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH--------------------------cC
Confidence 9999999999766545689999999999999999999999888777666532 22
Q ss_pred cCCCCC-CCCHHHHHHHHHhcCCCCCCCC----CHHHHhcCccccc
Q 012228 258 DFSCPS-WFSSGAKKLIKRILDPNPDTRM----TISQMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~-~~s~~~~~Ll~~~L~~dP~~R~----t~~eil~hpwf~~ 298 (468)
...+|. .+++++.+||++||..||.+|| +++++++||||..
T Consensus 213 ~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 213 KVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 233333 3789999999999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=383.74 Aligned_cols=251 Identities=32% Similarity=0.583 Sum_probs=215.7
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHH-HHhcCCCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433334455666665 46789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|...+...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 99999999888999999999999999999999999999999999999999999999999999864221 1223345789
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|+.|+|||++.+..+. .++||||+||++|+|++|..||...+..++++.+ ...
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~--------------------------~~~ 211 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI--------------------------LHK 211 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHH--------------------------HcC
Confidence 9999999999887774 8999999999999999999999988777766653 223
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRMTI----SQMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~----~eil~hpwf~~ 298 (468)
....++..+..+.++|++||..||.+||++ .++++||||..
T Consensus 212 ~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 212 PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 334455688999999999999999999987 58999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=377.64 Aligned_cols=282 Identities=23% Similarity=0.366 Sum_probs=223.2
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++.+.||+|+||.||+|++..+|..+|+|++.... .....+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999997542 23345678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 999999999999999888899999999999999999999986 699999999999999999999999999875432
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh------
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK------ 243 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 243 (468)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..++...+.........+.....
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 22345679999999999988776 58999999999999999999999887766554433221110000000000
Q ss_pred -------hccc-c------cccccccc-ccCCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 244 -------CTNK-Y------SYTLQICR-ADFSC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 244 -------~~~~-~------~~~~~~~~-~~~~~-~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.... . .....+.. ..... ...+++++++||.+||..||++|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000 0 00000000 01111 12378899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=381.40 Aligned_cols=251 Identities=32% Similarity=0.607 Sum_probs=216.4
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHH-HHhcCCCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765444344455666655 67889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 99999998888899999999999999999999999999999999999999999999999999874321 2223445689
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+ ...
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--------------------------~~~ 211 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI--------------------------LHK 211 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH--------------------------hcC
Confidence 9999999999877764 8999999999999999999999988776666553 233
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRMTI----SQMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~----~eil~hpwf~~ 298 (468)
....|+..+..+.++|.+||+.||.+|+++ .++++|+||..
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 212 PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 455666789999999999999999999976 49999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=380.77 Aligned_cols=251 Identities=29% Similarity=0.604 Sum_probs=216.5
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555555667788999999888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 99999998888999999999999999999999999999999999999999999999999999864221 1223456789
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch-------HHHHHHhhcccccccccccchhhhcccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-------LMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.... .....+.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~----------------------- 214 (327)
T cd05617 159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV----------------------- 214 (327)
T ss_pred CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH-----------------------
Confidence 999999999988777 589999999999999999999996421 1111111
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCccccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT------ISQMLEDEWFKK 298 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t------~~eil~hpwf~~ 298 (468)
+.......|..++..+.++|.+||+.||.+|++ ++++++||||+.
T Consensus 215 ---~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 215 ---ILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred ---HHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 233445567778999999999999999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=372.38 Aligned_cols=253 Identities=26% Similarity=0.456 Sum_probs=211.4
Q ss_pred eeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCH
Q 012228 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (468)
Q Consensus 21 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 100 (468)
||+|+||+||+|.+..+|+.||+|++.+.........+.+..|+.+++.++||||+++.+++...+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999765544444456778999999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccC
Q 012228 101 FDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176 (468)
Q Consensus 101 ~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 176 (468)
...+.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 887743 346999999999999999999999999999999999999999999999999998754321 12233467
Q ss_pred CCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccccc
Q 012228 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICR 256 (468)
Q Consensus 177 gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (468)
||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+.. .+..
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~----------------------~~~~ 215 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----------------------RILN 215 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH----------------------hhcc
Confidence 99999999999887774 899999999999999999999976432111111000 0222
Q ss_pred ccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 257 ADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 257 ~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
.....+..++..+.+|+.+||+.||++|| |++++++||||+.
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 216 DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 33445666899999999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=381.11 Aligned_cols=251 Identities=32% Similarity=0.622 Sum_probs=215.0
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHH-HHhcCCCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998654433333344555554 56888999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 99999999888899999999999999999999999999999999999999999999999999874322 2233456789
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|+.|+|||++.+..++ .++||||+||++|+|++|..||...+..+.+..+ ...
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--------------------------~~~ 211 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--------------------------LNK 211 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHH--------------------------HhC
Confidence 9999999999887764 8999999999999999999999988777666553 222
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH----HHhcCccccc
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRMTIS----QMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~----eil~hpwf~~ 298 (468)
....++.+++.+.+||.+||+.||.+|+++. ++++|+||..
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 212 PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 3345566899999999999999999999876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=378.43 Aligned_cols=261 Identities=28% Similarity=0.523 Sum_probs=217.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444445667889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence 99999999999976 4579999999999999999999999999999999999999999999999999986543211 111
Q ss_pred ccccCCCCCcCCcccccc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 172 LHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~----~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
....+||+.|+|||++.+ ....+.++||||+||++|+|++|..||...+..+.+..+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~---------------- 223 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------------- 223 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC----------------
Confidence 223579999999999863 334468999999999999999999999887766665553210
Q ss_pred cccccccccccCCC---CCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012228 248 YSYTLQICRADFSC---PSWFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~---~~~~s~~~~~Ll~~~L~~dP~~--R~t~~eil~hpwf~~ 298 (468)
...+.. ...++..+++||++||..++++ |++++++++||||..
T Consensus 224 --------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 224 --------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred --------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 011111 2347899999999999765544 889999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=383.69 Aligned_cols=258 Identities=29% Similarity=0.526 Sum_probs=233.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE-EE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK-IY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~ 89 (468)
.++.|.+++.+|+|+||.+++++++..+..+++|.|+....... ......+|+.+++++.|||||.+.+.|..++. +|
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 46789999999999999999999999999999999988765433 34578899999999999999999999988888 99
Q ss_pred EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|||+||+||+|.+.|.... .++|+.+..||.|++.||.|||+++|+|||||+.|||++.++.+||+|||+|+.....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~- 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE- 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc-
Confidence 9999999999999997655 5899999999999999999999999999999999999999999999999999987652
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.....+..|||.|+.||++.+.+|. .++|||||||++|||++-+++|.+.+...+..++
T Consensus 160 -~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki------------------- 218 (426)
T KOG0589|consen 160 -DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI------------------- 218 (426)
T ss_pred -hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHH-------------------
Confidence 2366788999999999999999995 9999999999999999999999999999888874
Q ss_pred cccccccccc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 248 YSYTLQICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~-~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.+. -.+.|..++.+++.|++.||..+|..||++.++|.+|....
T Consensus 219 -------~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 219 -------NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred -------hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 333 35678889999999999999999999999999999988874
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=381.61 Aligned_cols=250 Identities=32% Similarity=0.641 Sum_probs=217.5
Q ss_pred eeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEcc
Q 012228 19 RTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 95 (468)
+.||+|+||.||++.+. .+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++.+.+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999999873 57899999999865432 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccccc
Q 012228 96 DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175 (468)
Q Consensus 96 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 175 (468)
++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceecc
Confidence 9999999998888899999999999999999999999999999999999999999999999999875432 11233457
Q ss_pred CCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccc
Q 012228 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQIC 255 (468)
Q Consensus 176 ~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (468)
+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+.... +.
T Consensus 159 ~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~--------------------------i~ 211 (318)
T cd05582 159 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM--------------------------IL 211 (318)
T ss_pred cCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHH--------------------------HH
Confidence 89999999999987776 5899999999999999999999998876666555 23
Q ss_pred cccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 256 RADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 256 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
......|..+++.+.+||++||+.||.+||| +++++.||||+.
T Consensus 212 ~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 212 KAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred cCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 3445567778999999999999999999999 778999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=369.92 Aligned_cols=259 Identities=24% Similarity=0.439 Sum_probs=217.9
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976544333334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|+++|+|.+.+... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 99999999887653 4599999999999999999999999999999999999999999999999999875432 122
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
....+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-------------------- 216 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-------------------- 216 (285)
T ss_pred cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH--------------------
Confidence 234679999999999987666 58899999999999999999999876543322221100
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
+.......+..++..+.+|+.+||..||.+|| +++++++||||..
T Consensus 217 --~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 217 --VKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred --hhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 11222334556899999999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=392.58 Aligned_cols=276 Identities=26% Similarity=0.340 Sum_probs=209.7
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC------
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK------ 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 85 (468)
.++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 467999999999999999999999999999999886432 1234799999999999999999887432
Q ss_pred --CEEEEEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC-ceEEeccc
Q 012228 86 --TKIYIVLEFIDGGELFDKIA----KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFG 158 (468)
Q Consensus 86 --~~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g-~lkl~DFG 158 (468)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 247799999986 6766654 345799999999999999999999999999999999999999665 79999999
Q ss_pred cchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccc
Q 012228 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
+|+.... .......+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+....+...... ...
T Consensus 217 la~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-p~~ 292 (440)
T PTZ00036 217 SAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT-PTE 292 (440)
T ss_pred cchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CCH
Confidence 9985432 122345678999999999877655579999999999999999999999987655444433211000 000
Q ss_pred cchhhhcccccc---c-cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 239 ESYKKCTNKYSY---T-LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 239 ~~~~~~~~~~~~---~-~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.........+.. . .........+|...|.++++||.+||+.||.+|||+.|+|+||||...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 000000000000 0 000001112455578999999999999999999999999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=375.85 Aligned_cols=250 Identities=29% Similarity=0.478 Sum_probs=213.6
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCE-EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-EEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDF-VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-KIYI 90 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~-vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~l 90 (468)
....+.+.||+|+||+||+|.. .|+. ||+|++......... .+.+.+|+.+|.+++|||||++++++.++. .+++
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 3455667799999999999998 4555 999999765543333 778999999999999999999999999888 7999
Q ss_pred EEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCCeeeccCC-ceEEeccccchhhhhh
Q 012228 91 VLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRG-VFHRDLKPENLLLDSYG-VLKISDFGLSAISQQV 166 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~yLH~~g-ivHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~ 166 (468)
||||+++|+|.+++.. ...++...+..++.||+.|++|||+++ |+||||||+|||++.++ ++||||||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999999988 578999999999999999999999999 99999999999999998 9999999999865432
Q ss_pred hcCCcccccCCCCCcCCccccc--cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 167 REDGLLHTACGTPNYVAPEVLN--DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~--~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
. ...+...||+.|||||++. +..| +.++||||+|++||||+||..||......+....+.
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~--------------- 259 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV--------------- 259 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH---------------
Confidence 1 2334478999999999999 4566 599999999999999999999999887654444321
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......+|...++.+..|+..||..||.+||+..+|+.
T Consensus 260 ---------~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 260 ---------VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ---------hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 233445556668999999999999999999999999875
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=373.15 Aligned_cols=284 Identities=23% Similarity=0.396 Sum_probs=219.0
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..+++|++.+.||+|+||+||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 4568899999999999999999999999999999998754321 12345678999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+||||+++ +|.+.+...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-- 157 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP-- 157 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC--
Confidence 99999986 8888776544 5899999999999999999999999999999999999999999999999998753221
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc-
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK- 247 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 247 (468)
........+|+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...... .....+......
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGT-PTEETWPGISSND 236 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CCHHHHhhhcchh
Confidence 122334578999999999876555568999999999999999999999887765544433211000 000001000000
Q ss_pred ----cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 248 ----YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 248 ----~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
...............+.++.++.+||.+||..||.+|||++|+++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 0000000000111223478899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=384.43 Aligned_cols=279 Identities=19% Similarity=0.258 Sum_probs=211.4
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.|+||||+++++++......|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 44689999999999999999999999999999997532 235689999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||++. ++|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... ..
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~ 238 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN 238 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence 999996 5899999888889999999999999999999999999999999999999999999999999987532211 12
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch-------HHHHHHhhcc-ccc-ccccccch
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-------LMALYRKVST-FHF-LSVYGESY 241 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-------~~~~~~~~~~-~~~-~~~~~~~~ 241 (468)
.....+||+.|+|||++.+..| +.++||||+||++|+|++|..||-..+ .......+.. ... ........
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 3345689999999999988776 589999999999999999998874321 1111111110 000 00000000
Q ss_pred -hhhccccccccc-cccccCCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 242 -KKCTNKYSYTLQ-ICRADFSCPS-----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 242 -~~~~~~~~~~~~-~~~~~~~~~~-----~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
............ ........+. .++.++.+||.+||+.||.+|||++|+|+||||+....
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 000000000000 0000011111 24678999999999999999999999999999987543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=385.44 Aligned_cols=275 Identities=29% Similarity=0.444 Sum_probs=219.6
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-C-----CCeeEEEEEEEe
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-H-----PNVIKIIEVMAS 84 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-h-----pnIv~l~~~~~~ 84 (468)
...+|.|.+.||+|+||.|-+|.+.+|++.||||+++... ....+...|+.||..|+ | -|+|+++++|..
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 3458999999999999999999999999999999997653 24567779999999997 4 489999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC--CceEEeccccc
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY--GVLKISDFGLS 160 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~--g~lkl~DFGla 160 (468)
.+++|||+|+++- +|.++++.+. +++...++.+++||+.||.+||+.||||+|||||||||... ..+||+|||.|
T Consensus 260 r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 260 RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999999965 9999998775 68999999999999999999999999999999999999743 47999999999
Q ss_pred hhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (468)
+...+ ...+++.++.|+|||++.|.+|+ .+.||||||||++||++|.+.|.+.+..+.+..|.... +.++..
T Consensus 339 c~~~q-----~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l--G~Pp~~ 410 (586)
T KOG0667|consen 339 CFESQ-----RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL--GLPPPK 410 (586)
T ss_pred cccCC-----cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh--CCCCHH
Confidence 86432 23488999999999999999996 89999999999999999999999998777666654211 111100
Q ss_pred --------hhhhcc--cccc-----c-------------cccccccCCCCC----C-------CCHHHHHHHHHhcCCCC
Q 012228 241 --------YKKCTN--KYSY-----T-------------LQICRADFSCPS----W-------FSSGAKKLIKRILDPNP 281 (468)
Q Consensus 241 --------~~~~~~--~~~~-----~-------------~~~~~~~~~~~~----~-------~s~~~~~Ll~~~L~~dP 281 (468)
...+.. ...+ . ..........|+ + -...+.+||++||.+||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 000000 0000 0 000011222221 1 13567999999999999
Q ss_pred CCCCCHHHHhcCccccc
Q 012228 282 DTRMTISQMLEDEWFKK 298 (468)
Q Consensus 282 ~~R~t~~eil~hpwf~~ 298 (468)
.+|+|+.++|+||||+.
T Consensus 491 ~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 491 AERITPAQALNHPFLTG 507 (586)
T ss_pred hhcCCHHHHhcCccccc
Confidence 99999999999999985
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=377.83 Aligned_cols=283 Identities=26% Similarity=0.430 Sum_probs=215.7
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC---
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--- 86 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--- 86 (468)
..+++|++.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 457899999999999999999999999999999999975432 2234567789999999999999999999986543
Q ss_pred ---EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 87 ---KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 87 ---~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
.+|+||||+++ +|.+.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999976 5666664 35899999999999999999999999999999999999999999999999998743
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch--
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY-- 241 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 241 (468)
.. ........||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+..... .....+
T Consensus 174 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~ 247 (359)
T cd07876 174 CT---NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG--TPSAEFMN 247 (359)
T ss_pred cc---CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC--CCcHHHHH
Confidence 22 2233456789999999999887774 889999999999999999999988765444333211100 000000
Q ss_pred ------hhh---cccccc-c------cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 242 ------KKC---TNKYSY-T------LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 242 ------~~~---~~~~~~-~------~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
... ...... . .+........+...++.+++||.+||..||++|||+.|+|+||||+..+.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 000 000000 0 000000011122257789999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=392.55 Aligned_cols=261 Identities=31% Similarity=0.486 Sum_probs=222.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT---- 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 86 (468)
..++|++.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..++|+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 457899999999999999999999999999999999765432 334567889999999999999999998775432
Q ss_pred ----EEEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccc
Q 012228 87 ----KIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 158 (468)
Q Consensus 87 ----~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFG 158 (468)
.+++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 378999999999999988643 468999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccc
Q 012228 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
+++............+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+....+.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~--------- 258 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL--------- 258 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh---------
Confidence 9876543323334456789999999999988777 489999999999999999999999887766655531
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.......|+.+++++.+|+.+||..||.+|||+.++++|||++.
T Consensus 259 ----------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 259 ----------------AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ----------------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 11122356678999999999999999999999999999999875
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=374.95 Aligned_cols=261 Identities=27% Similarity=0.511 Sum_probs=218.5
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||.||++.++.+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444444566889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999976 467999999999999999999999999999999999999999999999999998643221 1112
Q ss_pred ccccCCCCCcCCcccccc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 172 LHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~----~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
....+||+.|+|||++.+ ...++.++||||+||++|+|++|..||...+..+.+..+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---------------- 223 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------------- 223 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC----------------
Confidence 234689999999999863 333468999999999999999999999988877766664211
Q ss_pred cccccccccccCCCC---CCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012228 248 YSYTLQICRADFSCP---SWFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~---~~~s~~~~~Ll~~~L~~dP~~--R~t~~eil~hpwf~~ 298 (468)
...+..| ..+++++.+||++||..+|.+ |+|++++++||||+.
T Consensus 224 --------~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 224 --------KERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred --------CccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 0111122 347899999999999765555 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=380.38 Aligned_cols=260 Identities=28% Similarity=0.459 Sum_probs=212.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..+.|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 4678999999999999999999999999999999986532 23345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||+++|+|.+. ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 223 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MD 223 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--cc
Confidence 9999999998643 34678888999999999999999999999999999999999999999999998765331 11
Q ss_pred cccccCCCCCcCCcccccc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 171 LLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~----~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
......||+.|+|||++.. ..+.+.++|||||||++|+|++|..||......+........
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~--------------- 288 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI--------------- 288 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---------------
Confidence 2345679999999999743 345567999999999999999999999743221111110000
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
........+..++.++.+||.+||..||++|||+.|+++||||.+..
T Consensus 289 -------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 289 -------CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred -------hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 11122234456889999999999999999999999999999998753
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=382.87 Aligned_cols=283 Identities=25% Similarity=0.399 Sum_probs=220.2
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-----EE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-----KI 88 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 88 (468)
+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4789999999999999999999999999999986432 12223567889999999999999999999998776 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 99999997 489998888888999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccccc---ch---h
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE---SY---K 242 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~---~ 242 (468)
........+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+.......+........... .. .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 22234456899999999998766557899999999999999999999998876665554432111000000 00 0
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
................+......++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 000000000000011112334468899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=389.19 Aligned_cols=259 Identities=30% Similarity=0.470 Sum_probs=220.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCC-CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVET-GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
....|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++||||+++++++...+.+|
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 344599999999999999999999877 7889999875432 233456788999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 90 IVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
+||||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999999887753 34689999999999999999999999999999999999999999999999999986543
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
..........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+....+..
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~--------------- 285 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY--------------- 285 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------
Confidence 222223456789999999999988766 5899999999999999999999998877666555311
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
......|..++.++.+||.+||..||++|||+++++.|||++.
T Consensus 286 ----------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 286 ----------GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ----------CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 1112344558899999999999999999999999999999974
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=328.45 Aligned_cols=281 Identities=29% Similarity=0.465 Sum_probs=224.3
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|.-.++||+|+||+|++|++..+++.||+|.++.+.- +++......+||.+++.|+|.|||+++++..++..+.+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 467788999999999999999999999999999987643 3344567789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|||.. +|..+... ++.++.+.++.++.|++.||.|||++++.|||+||.|+|++.+|.+|++|||+|+-+.- +-..
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi--pvrc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVRC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC--ceEe
Confidence 99976 88777765 45699999999999999999999999999999999999999999999999999986543 1223
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHh-hCCCCCCCchHHHHHHhhccccccccc-ccchhhhccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM-AGFLPFDESNLMALYRKVSTFHFLSVY-GESYKKCTNKYS 249 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll-~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 249 (468)
.+...-|.+|++|.++.+.+.++...|+||.|||+.|+. +|.+.|.+.+..+...++.. ..+.+ .++|.....-..
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~--~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR--LLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH--HhCCCccccCCccccCCC
Confidence 344567999999999999888889999999999999998 58899999998877777642 12111 112222111111
Q ss_pred ccc-ccccccC---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 250 YTL-QICRADF---SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 250 ~~~-~~~~~~~---~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
+.. .+..... .+-+.++...++|++++|.-+|.+|++++.+++||||...
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 100 0000000 1122356778999999999999999999999999999753
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=373.10 Aligned_cols=261 Identities=28% Similarity=0.491 Sum_probs=218.0
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654444444566889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999987 4679999999999999999999999999999999999999999999999999987543211 111
Q ss_pred ccccCCCCCcCCccccccC----CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 172 LHTACGTPNYVAPEVLNDK----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~----~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
....+||+.|+|||++.+. ...+.++||||+||++|+|++|..||...+..+.+..+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---------------- 223 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------------- 223 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC----------------
Confidence 2346799999999998652 23368999999999999999999999887776665553210
Q ss_pred cccccccccccCCCC---CCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012228 248 YSYTLQICRADFSCP---SWFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~---~~~s~~~~~Ll~~~L~~dP~~--R~t~~eil~hpwf~~ 298 (468)
...+..| ..++.++.+||.+||..++.+ |++++++++||||+.
T Consensus 224 --------~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 224 --------EERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred --------CCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 1112222 236899999999999976655 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=371.02 Aligned_cols=280 Identities=24% Similarity=0.378 Sum_probs=220.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
-++|++.++||+|+||.||+|.+..++..+|+|++.... .....+.+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 478999999999999999999999999999999987542 223456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||+.+|+|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++..... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----~ 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 157 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----h
Confidence 99999999999999888899999999999999999999985 799999999999999999999999999875432 1
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch-----hh--
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY-----KK-- 243 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~-- 243 (468)
.....+||+.|+|||++.+..+ +.++|+||+||++|+|++|..||............... ......... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCP-VEGDPAESETSPRPRPPG 235 (333)
T ss_pred ccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCc-ccCCccccccCcccCCcc
Confidence 2234579999999999987666 58999999999999999999999877654443322110 000000000 00
Q ss_pred -----hccccc-------ccccc-ccccCCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 244 -----CTNKYS-------YTLQI-CRADFSCP-SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 244 -----~~~~~~-------~~~~~-~~~~~~~~-~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
...... ....+ .......+ ..++.++++||.+||+.||++|||+.|+++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000000 00000 00111111 2367899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=365.53 Aligned_cols=277 Identities=28% Similarity=0.413 Sum_probs=209.5
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcC-CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC---CCCCeeEEEEEEE-----
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVE-TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI---KHPNVIKIIEVMA----- 83 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~----- 83 (468)
.+|++.+.||+|+||+||+|++.. ++..||+|.+....... .......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999864 56889999987543222 2234456788777766 6999999999885
Q ss_pred eCCEEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 84 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 84 ~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
....+++||||+.+ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 34568999999974 898888653 358999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
.... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+..+....+........ ...+
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~-~~~~ 233 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG-EEDW 233 (290)
T ss_pred eccC---CcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC-hhhc
Confidence 5432 123345679999999999987776 4899999999999999999999998876666555432111000 0011
Q ss_pred hhhccccccccc-ccc-ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 242 KKCTNKYSYTLQ-ICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 242 ~~~~~~~~~~~~-~~~-~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
............ ... ......+.++..+.+|+.+||+.||++|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 000000000000 000 0001223478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=362.22 Aligned_cols=254 Identities=37% Similarity=0.742 Sum_probs=225.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997665544455678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|.|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999998889999999999999999999999999999999999999999999999999998754321 3
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
...+|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.....+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------------------ 210 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI------------------------ 210 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------------------
Confidence 45679999999999877665 58899999999999999999999887765555542
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
..+....|..++..+.++|.+||..||.+|+ +++++++||||+.
T Consensus 211 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 211 --LEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred --hcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 2344556677899999999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=355.85 Aligned_cols=259 Identities=30% Similarity=0.532 Sum_probs=219.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh--hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
+.|++.+.||+|++|.||.|.+..+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+....|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4699999999999999999999999999999998654322 12235678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC-
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED- 169 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~- 169 (468)
|+||++|++|.+.+...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998754322111
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
.......|++.|+|||++.+..+ +.++||||+||++|+|++|..||...+.........
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-------------------- 220 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-------------------- 220 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh--------------------
Confidence 11134568899999999988765 589999999999999999999998765544333321
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
........|..++..+.+||.+||..+|.+|||+.++++||||
T Consensus 221 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 221 ----TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ----ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 1112334556689999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=354.41 Aligned_cols=272 Identities=33% Similarity=0.597 Sum_probs=219.1
Q ss_pred eEE-EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEEEE
Q 012228 15 YEL-GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 15 y~i-~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 92 (468)
|++ .+.||+|+||.|-.+++..+|..||||+|++.. .....++.+|++++..++ |+||+.|+++|+++..+|+||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 444 468999999999999999999999999998864 335678999999999996 999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC---ceEEeccccchhhhhh---
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQV--- 166 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g---~lkl~DFGla~~~~~~--- 166 (468)
|-+.||.|..+|.++..|+|.+|..+.++|+.||.|||.+||.||||||+|||..... -+|||||.|+.-....
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999999999999999999999999999999999999999999999999999997544 5899999987542211
Q ss_pred --hcCCcccccCCCCCcCCccccc----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc
Q 012228 167 --REDGLLHTACGTPNYVAPEVLN----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 167 --~~~~~~~~~~gt~~y~APEvl~----~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (468)
.....+.+.||+..|||||+.. ...++...+|.||||||||.||+|++||.+.--.+ --+.-++.
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d---------CGWdrGe~ 306 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD---------CGWDRGEV 306 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---------CCccCCCc
Confidence 1123456789999999999863 23444599999999999999999999996531100 00000011
Q ss_pred hhhhccccccccccccccCCCCC--C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 241 YKKCTNKYSYTLQICRADFSCPS--W--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~--~--~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
...|.+. ..-.|..+.+.+|. | +|.++++|++.+|..|+.+|.++.++++|||++...
T Consensus 307 Cr~CQ~~--LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 307 CRVCQNK--LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred cHHHHHH--HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 1111000 01125667777775 3 899999999999999999999999999999998653
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-48 Score=367.29 Aligned_cols=260 Identities=29% Similarity=0.493 Sum_probs=229.3
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
......|+..+.||+|+||.||-++-+.||+.+|+|.+++..+...+-.....+|-.||.+++.+.||.+-..|++++.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 34566799999999999999999999999999999999988887766667788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
|+||..|.||+|.-+|.+.+ .|+|..++.|+.+|+.||++||+.+||+|||||+|||+|+.|+++|+|+|||.-+..
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~- 339 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE- 339 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC-
Confidence 99999999999998888877 799999999999999999999999999999999999999999999999999986543
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH----HHHHHhhcccccccccccchh
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~ 242 (468)
........||.+|||||++.+..|+ .++|.||+||+||+|+.|..||..... +++-+.
T Consensus 340 --g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr--------------- 401 (591)
T KOG0986|consen 340 --GKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR--------------- 401 (591)
T ss_pred --CCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH---------------
Confidence 3344556899999999999988874 899999999999999999999975432 122222
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
+......+|..+|+++++|.+.+|..||++|. +++++.+||||+.
T Consensus 402 -----------~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 402 -----------TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred -----------HhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 33344556778999999999999999999998 4679999999986
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=359.61 Aligned_cols=257 Identities=37% Similarity=0.657 Sum_probs=213.5
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
|++++.||+|+||+||+|.+..+++.||+|++........ ......+|+.+++.++||||+++++++.+....|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999987654333 233445699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccc
Q 012228 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT 174 (468)
Q Consensus 95 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 174 (468)
+.+++|.+++...+.+++..+..++.|++.||++||++||+|+||||+||+++.++.++|+|||.+... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 999999999998889999999999999999999999999999999999999999999999999998643 112334556
Q ss_pred cCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch---HHHHHHhhcccccccccccchhhhccccccc
Q 012228 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 175 ~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
.++++.|+|||++......+.++||||||+++++|++|..||.... .............
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------ 219 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL------------------ 219 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH------------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc------------------
Confidence 7899999999998833444699999999999999999999999873 2222222110000
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
..........+..+.++|.+||+.||++|||+.++++||||
T Consensus 220 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 220 ----PSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ----HHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ----cccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00000011123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=363.60 Aligned_cols=284 Identities=22% Similarity=0.381 Sum_probs=219.6
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..+++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 4578899999999999999999999999999999998754321 12345678999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+||||+++ +|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~ 157 (301)
T cd07873 81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--P 157 (301)
T ss_pred EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--C
Confidence 99999975 888887654 4689999999999999999999999999999999999999999999999999875322 1
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
........+++.|+|||++.+....+.++||||+||++|+|++|.+||...+..+....+...... .....+.......
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGT-PTEETWPGILSNE 236 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CChhhchhhhccc
Confidence 122334567899999999877665578999999999999999999999987766554433211000 0001111100000
Q ss_pred ccc-ccccc----ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 249 SYT-LQICR----ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 249 ~~~-~~~~~----~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
... ..... ......+.+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000 00000 0011223478899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=373.91 Aligned_cols=285 Identities=26% Similarity=0.415 Sum_probs=216.8
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC----
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK---- 85 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 85 (468)
...++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 356899999999999999999999999999999999875432 223356678999999999999999999987543
Q ss_pred --CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 86 --TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 86 --~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 457999999976 77777653 5889999999999999999999999999999999999999999999999998754
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc------cc
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS------VY 237 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~------~~ 237 (468)
.. ........||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+.+.++....... ..
T Consensus 177 ~~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 177 GT---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred CC---CCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 22 223345679999999999988777 489999999999999999999999887666555442210000 00
Q ss_pred ccchhhh---cccccc-cc--c----cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 238 GESYKKC---TNKYSY-TL--Q----ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 238 ~~~~~~~---~~~~~~-~~--~----~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
....... ...... .. . ............+..+++||.+||+.||.+|||+.++|+||||...+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 327 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 327 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence 0000000 000000 00 0 0000011112246789999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=353.47 Aligned_cols=287 Identities=28% Similarity=0.414 Sum_probs=217.2
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCC----EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-CC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-KT 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~ 86 (468)
+..|++.+.||+|+||.||+|..++++. .+|||.+..++- ..+.....-|||.+++.++|||++.+..++.+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 4579999999999999999997765543 689999865432 12344567799999999999999999999877 78
Q ss_pred EEEEEEEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC----CceEEecc
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY----GVLKISDF 157 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~-----~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~----g~lkl~DF 157 (468)
.+||++||++. +|++.|..+. .++...++.+++||+.|+.|||++-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 89999999998 9999887543 48999999999999999999999999999999999999877 89999999
Q ss_pred ccchhhhhhhc-CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH---------HHHHh
Q 012228 158 GLSAISQQVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---------ALYRK 227 (468)
Q Consensus 158 Gla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~---------~~~~~ 227 (468)
|+|+++...-. -.......-|.+|+|||++.|...++.++|+||.|||+.||++-.+.|.+.... +...+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99998765322 223455677999999999999998899999999999999999999888654311 11111
Q ss_pred hcccccccccc-cchhhhcccccc--ccccccccC----CCCCC------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 012228 228 VSTFHFLSVYG-ESYKKCTNKYSY--TLQICRADF----SCPSW------FSSGAKKLIKRILDPNPDTRMTISQMLEDE 294 (468)
Q Consensus 228 ~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~----~~~~~------~s~~~~~Ll~~~L~~dP~~R~t~~eil~hp 294 (468)
| ++..+.+. ..|.....-.++ .....+... .++.| -++.+.+||.+||+.||.+|+|++++|+|+
T Consensus 261 I--f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 261 I--FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred H--HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1 11111111 111111111111 110111111 11122 256699999999999999999999999999
Q ss_pred ccccCCCC
Q 012228 295 WFKKGYKP 302 (468)
Q Consensus 295 wf~~~~~~ 302 (468)
||+....|
T Consensus 339 yF~~d~lp 346 (438)
T KOG0666|consen 339 YFTEDPLP 346 (438)
T ss_pred ccccCCCC
Confidence 99987554
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=386.48 Aligned_cols=276 Identities=26% Similarity=0.354 Sum_probs=206.7
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC------CCCeeEEEEEEEeC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK------HPNVIKIIEVMASK 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~------hpnIv~l~~~~~~~ 85 (468)
.++|++.+.||+|+||+||+|.+..+++.||||+++.... .......|+.+++.++ |++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 4689999999999999999999999999999999964321 2234556777776665 45689999988765
Q ss_pred -CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCC-------------
Q 012228 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYG------------- 150 (468)
Q Consensus 86 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g------------- 150 (468)
.++|+|||++ |++|.+++...+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999998 66999999888899999999999999999999998 5999999999999998765
Q ss_pred ---ceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHh
Q 012228 151 ---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227 (468)
Q Consensus 151 ---~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~ 227 (468)
.+||+|||++.... ......+||+.|+|||++.+..| +.++|||||||++|+|++|++||++.+..+....
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875321 22346789999999999998877 4899999999999999999999988775554443
Q ss_pred hcccccccccccchhh---------hccccccc---------cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 012228 228 VSTFHFLSVYGESYKK---------CTNKYSYT---------LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 289 (468)
Q Consensus 228 ~~~~~~~~~~~~~~~~---------~~~~~~~~---------~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~e 289 (468)
+... .......+.. ........ ..............++.+.+||.+||++||.+|||++|
T Consensus 357 i~~~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 357 MEKT--LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHH--cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 3211 0000011100 00000000 00000000000012467889999999999999999999
Q ss_pred HhcCcccccCC
Q 012228 290 MLEDEWFKKGY 300 (468)
Q Consensus 290 il~hpwf~~~~ 300 (468)
+|+||||++.+
T Consensus 435 ~L~Hp~~~~~~ 445 (467)
T PTZ00284 435 MTTHPYVLKYY 445 (467)
T ss_pred HhcCccccccC
Confidence 99999998743
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=402.58 Aligned_cols=262 Identities=30% Similarity=0.545 Sum_probs=232.4
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++++.||+|+||.|.+++++.+++.||+|++++-...+......+..|-.+|..-+.+-|++++..|.+++++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 45689999999999999999999999999999999987554444445678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||++||+|..++.+.++++|+.|++|...++.||.-||+.|.|||||||+|||+|..|++||+|||.+-.+...+ .-
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~V 231 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-TV 231 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC-cE
Confidence 99999999999999998899999999999999999999999999999999999999999999999999876554322 22
Q ss_pred cccccCCCCCcCCccccc----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 171 LLHTACGTPNYVAPEVLN----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~----~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
......|||.|++||++. +.+.+|+.+|.||+||++|||+.|..||-..+..+.|.+|.
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm----------------- 294 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM----------------- 294 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh-----------------
Confidence 355688999999999985 33567899999999999999999999999999999999964
Q ss_pred ccccccccccccCCCC--CCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 012228 247 KYSYTLQICRADFSCP--SWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKK 298 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~--~~~s~~~~~Ll~~~L~~dP~~R~t---~~eil~hpwf~~ 298 (468)
.....+.+| ..+|.++++||+++|. +|+.|.. ++++..||||..
T Consensus 295 -------~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 295 -------NHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred -------chhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 234456667 4489999999999886 7899998 999999999986
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=371.56 Aligned_cols=284 Identities=25% Similarity=0.396 Sum_probs=215.6
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC----
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK---- 85 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 85 (468)
...++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 357899999999999999999999999999999999875432 223456778999999999999999999988543
Q ss_pred --CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 86 --TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 86 --~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999976 67666643 5899999999999999999999999999999999999999999999999998753
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccc------ccc
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFL------SVY 237 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~------~~~ 237 (468)
.. ........||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+.+..+...... ...
T Consensus 170 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 170 GT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred CC---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 22 2233456799999999999887774 8999999999999999999999887655443332111000 000
Q ss_pred ccchhhhcccccc-c---------cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 238 GESYKKCTNKYSY-T---------LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 238 ~~~~~~~~~~~~~-~---------~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
............. . ..........+...+.++.+||.+||..||++|||+.|+|+||||...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0000000000000 0 00000011122235678999999999999999999999999999986554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=360.75 Aligned_cols=275 Identities=27% Similarity=0.416 Sum_probs=208.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC---CCCCeeEEEEEEEe-----C
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI---KHPNVIKIIEVMAS-----K 85 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 85 (468)
+|++.+.||+|+||+||+|.++.+|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6999999999999999999999999999999987542211 1223455777777665 69999999998854 3
Q ss_pred CEEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
..+++||||+.+ +|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999985 888888654 35899999999999999999999999999999999999999999999999998765
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccc---cccccc
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFL---SVYGES 240 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~ 240 (468)
.. ........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||...+......++...... ..+...
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SC---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cC---cccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 32 122345678999999999987776 58999999999999999999999877655544443221000 000000
Q ss_pred hhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
... .................+.++..+.+||.+||++||.+|||+.+++.||||
T Consensus 235 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTL--PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccc--cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 000000000000111223468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=360.88 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=214.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999876544433344567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 94 FIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|+.|++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 999999998886433 589999999999999999999999999999999999999999999999999865322 112
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.............. .
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~-------------~------- 216 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-------------L------- 216 (285)
T ss_pred ccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh-------------h-------
Confidence 234579999999999987776 5899999999999999999999986432111111000 0
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
........+..+++++.+|+.+||+.||.+||| ++|+++||||++
T Consensus 217 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 217 --VKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred --hhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 001111234557899999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=371.27 Aligned_cols=282 Identities=24% Similarity=0.388 Sum_probs=214.6
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (468)
..++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45789999999999999999999999999999999875432 222345677999999999999999999987543
Q ss_pred -CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 86 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
..+|++||++ +++|.+++. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 4579999998 668887765 4679999999999999999999999999999999999999999999999999987543
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
. .....+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+......... ......
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 243 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP-EVLKKI 243 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH-HHHHhc
Confidence 2 2345679999999999987555578999999999999999999999887655544443211000000 000000
Q ss_pred ccccc--c--cc-cccccc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 245 TNKYS--Y--TL-QICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 245 ~~~~~--~--~~-~~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
..... + .. ...... .......++.+.+||.+||..||.+|||+.|+++||||.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 00000 0 00 000000 0011235778999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=357.02 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=217.9
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+.+++.+...+..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999976554444445567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|+.+++|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 99999998887643 3699999999999999999999999999999999999999999999999999865322 122
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
.....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...........+...
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~-------------------- 216 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR-------------------- 216 (285)
T ss_pred ccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--------------------
Confidence 345679999999999987776 58999999999999999999999876543332221100
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
........+..++..+.+|+.+||+.||++||| +.++++|+||+.
T Consensus 217 --~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 217 --VLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred --hhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 112223345557889999999999999999999 889999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=356.83 Aligned_cols=248 Identities=26% Similarity=0.454 Sum_probs=205.7
Q ss_pred eeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCH
Q 012228 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (468)
Q Consensus 21 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 100 (468)
||+|+||.||++.++.+|+.||+|.+.............+..|+.+++.++||||+++++++.+...+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443333344566799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCC
Q 012228 101 FDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178 (468)
Q Consensus 101 ~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 178 (468)
.+.+.... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++..... ........|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 98876543 588999999999999999999999999999999999999999999999999875432 1223346799
Q ss_pred CCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH----HHHHHhhcccccccccccchhhhcccccccccc
Q 012228 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254 (468)
Q Consensus 179 ~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (468)
+.|+|||++.+..+ +.++|+||+||++|+|++|..||..... .+.....
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~-------------------------- 210 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT-------------------------- 210 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh--------------------------
Confidence 99999999988776 5899999999999999999999975432 1111110
Q ss_pred ccccCCC-CCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 012228 255 CRADFSC-PSWFSSGAKKLIKRILDPNPDTRMTI----SQMLEDEWFKK 298 (468)
Q Consensus 255 ~~~~~~~-~~~~s~~~~~Ll~~~L~~dP~~R~t~----~eil~hpwf~~ 298 (468)
....... ...+++++.+|+++||+.||.+|||+ ++++.||||+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 211 LEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred hccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 0111111 13478999999999999999999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=365.89 Aligned_cols=271 Identities=25% Similarity=0.391 Sum_probs=197.5
Q ss_pred EeeeeecCCeEEEEEEEc--CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CCEEEEEEE
Q 012228 18 GRTLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKIYIVLE 93 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 93 (468)
+++||+|+||+||+|+++ .++..||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 578999999999999975 4678999999865432 2346789999999999999999999854 467899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee----ccCCceEEeccccc
Q 012228 94 FIDGGELFDKIAKH---------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLS 160 (468)
Q Consensus 94 ~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl----~~~g~lkl~DFGla 160 (468)
|+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 888877532 258999999999999999999999999999999999999 45679999999999
Q ss_pred hhhhhhh-cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH---------HHHHhhcc
Q 012228 161 AISQQVR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---------ALYRKVST 230 (468)
Q Consensus 161 ~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~---------~~~~~~~~ 230 (468)
....... ........+||+.|+|||++.+...++.++||||+||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 7653321 1122345688999999999987665578999999999999999999999754311 11111110
Q ss_pred ccccccc-ccchhhhccc--ccccc-cccccc---------C-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 231 FHFLSVY-GESYKKCTNK--YSYTL-QICRAD---------F-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 231 ~~~~~~~-~~~~~~~~~~--~~~~~-~~~~~~---------~-~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
. .... ...+...... ..... ...... . ......+..+.+||++||+.||.+|||++|+|+||||
T Consensus 240 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 V--MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred h--cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0000 0000000000 00000 000000 0 0011246779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=393.11 Aligned_cols=270 Identities=31% Similarity=0.506 Sum_probs=221.5
Q ss_pred CCCCCCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEE
Q 012228 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80 (468)
Q Consensus 1 ~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~ 80 (468)
|..++..+...+++|++++.||+|+||+||+|.+..++..||+|++...... ......+.+|+.+|+.|+|||||++++
T Consensus 1 Mp~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d 79 (1021)
T PTZ00266 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYID 79 (1021)
T ss_pred CCccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence 6778888899999999999999999999999999999999999999765432 334567889999999999999999999
Q ss_pred EEEe--CCEEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCCeeec
Q 012228 81 VMAS--KTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSR-------GVFHRDLKPENLLLD 147 (468)
Q Consensus 81 ~~~~--~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~-------givHrDlKp~NILl~ 147 (468)
+|.+ ...+||||||+++|+|.++|.. .+.+++..++.++.||+.||.|||+. +|+||||||+||||+
T Consensus 80 ~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 8854 4679999999999999998865 35799999999999999999999985 499999999999996
Q ss_pred c-----------------CCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccC-CCCCChhhHHHHHHHHHHH
Q 012228 148 S-----------------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVL 209 (468)
Q Consensus 148 ~-----------------~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiWSlGvil~~l 209 (468)
. .+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence 4 34589999999875432 2223456799999999998643 3346899999999999999
Q ss_pred hhCCCCCCCchHH-HHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 012228 210 MAGFLPFDESNLM-ALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 288 (468)
Q Consensus 210 l~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~ 288 (468)
++|..||...+.. .+...+. ..........+.++.+||..||..+|.+|||+.
T Consensus 237 LTGk~PF~~~~~~~qli~~lk--------------------------~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~ 290 (1021)
T PTZ00266 237 CSGKTPFHKANNFSQLISELK--------------------------RGPDLPIKGKSKELNILIKNLLNLSAKERPSAL 290 (1021)
T ss_pred HHCCCCCCcCCcHHHHHHHHh--------------------------cCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHH
Confidence 9999999765432 2222211 111111123688999999999999999999999
Q ss_pred HHhcCcccccCC
Q 012228 289 QMLEDEWFKKGY 300 (468)
Q Consensus 289 eil~hpwf~~~~ 300 (468)
|+|.|||++...
T Consensus 291 QlL~h~~ik~i~ 302 (1021)
T PTZ00266 291 QCLGYQIIKNVG 302 (1021)
T ss_pred HHhccHHHhhcC
Confidence 999999998643
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=355.51 Aligned_cols=255 Identities=29% Similarity=0.484 Sum_probs=221.6
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
|.++++||+|+||.||+|.++.+|+.+|||.+..+. ..+.+.+||.||++++.|++|++|+.|.....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 788999999999999999999999999999986542 467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 95 IDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 95 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
|..|++.+.+..+ ..++|.++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|..+... -..-.
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRN 187 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhC
Confidence 9999999998765 46999999999999999999999999999999999999999999999999998755432 12235
Q ss_pred ccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccc
Q 012228 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253 (468)
Q Consensus 174 ~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (468)
+..|||.|||||++..-+|+ .++||||||++..+|..|++||....+....-.+..
T Consensus 188 TVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT----------------------- 243 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT----------------------- 243 (502)
T ss_pred ccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-----------------------
Confidence 78899999999999999997 789999999999999999999987654322111100
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 254 ~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.....+.-|+.+|.++.+++++||.++|++|.|+.++++|||.++..
T Consensus 244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 12234455666899999999999999999999999999999998754
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=345.98 Aligned_cols=254 Identities=25% Similarity=0.515 Sum_probs=214.8
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-CCEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-KTKIYIVL 92 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~ 92 (468)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999999999999999754432 2345678899999999999999999998864 45689999
Q ss_pred EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 93 EFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 93 E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||+++++|.+.+... ..+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--cCC
Confidence 999999999998763 3589999999999999999999999999999999999999999999999999875532 122
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
......+++.|+|||++.+..+ +.++|+||+||++++|++|..||...+.......+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-------------------- 216 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-------------------- 216 (257)
T ss_pred ccccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------------------
Confidence 3345678999999999987766 4899999999999999999999988765554433211
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
......+..+++.+.+++.+||+.||.+|||+.++++||||
T Consensus 217 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 -----GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01112345588999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=366.35 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=202.2
Q ss_pred cCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeC-
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK- 85 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~- 85 (468)
++|++++.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 68999999999999999999852 455789999986432 222356788999999999 899999999988664
Q ss_pred CEEEEEEEccCCCCHHHHHHhc----------------------------------------------------------
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH---------------------------------------------------------- 107 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~---------------------------------------------------------- 107 (468)
..+|+||||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999998753
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCC
Q 012228 108 ----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183 (468)
Q Consensus 108 ----~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 183 (468)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 2377888999999999999999999999999999999999999999999999975432111111223446788999
Q ss_pred ccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCC
Q 012228 184 PEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCP 262 (468)
Q Consensus 184 PEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (468)
||++.+..+ +.++||||+||++|+|++ |..||......+...... ........|
T Consensus 245 PE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~------------------------~~~~~~~~~ 299 (338)
T cd05102 245 PESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL------------------------KDGTRMRAP 299 (338)
T ss_pred cHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH------------------------hcCCCCCCC
Confidence 999987776 589999999999999997 999998754322221110 111122345
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 263 SWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 263 ~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
...++.+.+|+.+||..||.+|||+.++++
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 300 ENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=349.45 Aligned_cols=257 Identities=28% Similarity=0.548 Sum_probs=217.1
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh------hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL------RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
+|.+++.||+|+||.||+|.+..+++.+|+|.+...... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588999999999999999999999999999988653221 22345678999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
.++||||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987654211
Q ss_pred c----CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 168 E----DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 168 ~----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
. ........|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------- 225 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-------------- 225 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh--------------
Confidence 1 111223468899999999987766 488999999999999999999998765443332211
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.......|..++..+.++|++||+.||.+|||+.++++||||
T Consensus 226 -----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 226 -----------ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -----------ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 111223445578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=376.09 Aligned_cols=258 Identities=30% Similarity=0.484 Sum_probs=225.3
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
+.|.|+..||.|+||+||+|.++.++-..|.|+|... .+...+.+.-||.||..++||+||+|++.|..++.+||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 3588999999999999999999999999999999643 3456788889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|+|.||-....+.. ...+++++++.+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.+...... ...
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qk 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQK 186 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH--Hhh
Confidence 99999988776654 457999999999999999999999999999999999999999999999999998654322 223
Q ss_pred ccccCCCCCcCCccccc-----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 172 LHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~-----~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
-.+..|||+|||||+.. ..+|+ .++||||||++|.+|..+.+|....+++..+-++...
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--------------- 250 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--------------- 250 (1187)
T ss_pred hccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---------------
Confidence 45788999999999974 45676 8999999999999999999999999988777775432
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
....+..|..++..+.|+|.+||.+||..||+++++|+||||++.
T Consensus 251 --------ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 251 --------EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred --------CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 123345677789999999999999999999999999999999854
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=371.96 Aligned_cols=278 Identities=23% Similarity=0.344 Sum_probs=211.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEc--CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..+|++++.||+|+||.||+|... .++..||+|.+.... ...+|+.+|+.++||||+++++++.....+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 457999999999999999999864 456789999886432 2458999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+|||++. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9999996 589999987788999999999999999999999999999999999999999999999999998755432222
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH---HHHHHhhcc-cc--cccccccchhh
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---MALYRKVST-FH--FLSVYGESYKK 243 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~---~~~~~~~~~-~~--~~~~~~~~~~~ 243 (468)
.......||+.|+|||++.+..|. .++||||+||++|+|++|..||.+... ...+..+.. .. ...........
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 223356799999999999887774 899999999999999999999966432 111111110 00 00000000000
Q ss_pred hccccccccccccccCCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 244 CTNKYSYTLQICRADFSCPS-----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
............+..+..|+ .++.++.+||++||..||.+|||+.++|.||||++.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00000000001111122222 257789999999999999999999999999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=356.94 Aligned_cols=261 Identities=32% Similarity=0.597 Sum_probs=235.1
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (468)
..+..+|..+..||+|+||+|-+|..+.+.+.+|||+++++-+.+....+--..|-++|... +-|.+++++..|.+-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 34567899999999999999999999999999999999988776655556556777888777 47899999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+||||+.||+|.-.|++-+++.|..|..|+..|+-||-|||++||++||||.+|||+|.+|++||+|||+++-. .-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn--i~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc--cc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998632 22
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
......+.||||.|+|||++..++| +.++|.||+||+|||||+|++||++.+..++++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a-------------------- 561 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA-------------------- 561 (683)
T ss_pred CCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------------------
Confidence 3345668999999999999999888 6999999999999999999999999999999988
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI-----SQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~-----~eil~hpwf~~ 298 (468)
|......+|..+|.++.++.+.+|.+.|.+|... ++|.+||||+.
T Consensus 562 ------I~ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 562 ------IMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred ------HHHccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 4556677888899999999999999999999864 68999999985
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.96 Aligned_cols=280 Identities=24% Similarity=0.391 Sum_probs=219.6
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36999999999999999999999999999999986532 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||++|++|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 999999999999988889999999999999999999998 5999999999999999999999999999864322 22
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc---cc-
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT---NK- 247 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~- 247 (468)
....+|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+......................... ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345678999999999877665 5899999999999999999999987765444333221111000000000000 00
Q ss_pred ------cccccc-cccccCCCCC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 248 ------YSYTLQ-ICRADFSCPS-WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 248 ------~~~~~~-~~~~~~~~~~-~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
...... ........|. .++.++.+|+.+||..||++|||+.++++||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000000 0011111222 268899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.67 Aligned_cols=258 Identities=29% Similarity=0.528 Sum_probs=215.2
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh---hhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV---LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
+|++++.||+|+||.||+|.+ .+|+.+|+|.+..... ........+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999987 5789999999865422 122345678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh---
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR--- 167 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~--- 167 (468)
||||++|++|.+++...+.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987543211
Q ss_pred -cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 168 -EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 168 -~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.........|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------------- 222 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---------------- 222 (265)
T ss_pred cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh----------------
Confidence 1122334568999999999987766 4899999999999999999999987554332222110
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
........+..++.++.++|++||..+|.+|||+.++++||||
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 223 -------HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -------ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0011123445588999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=351.82 Aligned_cols=278 Identities=25% Similarity=0.426 Sum_probs=211.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||+|++|.||+|.+..++..||+|.+..... .....+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999865432 22234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 94 FIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 94 ~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|+. ++|.+++... ..+++..++.++.||+.||+|||++|++||||||+|||++.+|.+||+|||++...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 998 4888887543 46899999999999999999999999999999999999999999999999998754321 12
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
......+++.|+|||++.+....+.++|+||+||++|+|++|.+||.+.+.......+..... ......+........+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG-TPTEDVWPGVTSLPDY 235 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC-CCChhhhhcchhhHHH
Confidence 223446789999999987655556899999999999999999999987654332222110000 0000000000000000
Q ss_pred c--c-ccccc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 251 T--L-QICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 251 ~--~-~~~~~-~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
. . ..... .......+++++.+||++||+.||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 0 00000 001123378999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=352.04 Aligned_cols=259 Identities=32% Similarity=0.482 Sum_probs=217.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||.|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 56999999999999999999999899999999986542 334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... ...
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--ccc
Confidence 999999999998764 46999999999999999999999999999999999999999999999999998654321 112
Q ss_pred ccccCCCCCcCCccccccC----CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 172 LHTACGTPNYVAPEVLNDK----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~----~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.....+++.|+|||++... ...+.++|+||+||++|+|++|..||...+.......+..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------------- 222 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK----------------- 222 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-----------------
Confidence 2345689999999997532 2234789999999999999999999988766554444211
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.....+..+..++.++.+||.+||..||.+|||++++++||||.+.
T Consensus 223 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 223 ------SEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ------CCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 1112233455688999999999999999999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=351.91 Aligned_cols=261 Identities=27% Similarity=0.480 Sum_probs=219.9
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
+....+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++.+...+.+
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 3345679999999999999999999999999999999875432 2346678999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+|+||+++++|.+++.. ..+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~-- 168 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-- 168 (296)
T ss_pred EEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc--
Confidence 999999999999998865 46999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......++++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~------------------ 229 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------------ 229 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------
Confidence 112234578999999999987666 5899999999999999999999988765443322211
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
........+..+++.+.+||++||..||.+|||+.+++.||||+..
T Consensus 230 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 230 -----NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred -----cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 0111223345578999999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=351.55 Aligned_cols=259 Identities=28% Similarity=0.480 Sum_probs=217.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
...+|++.+.||+|+||.||+|++..++..||+|.+...... ..+.+.+|+.+++.++||||+++++.+......|+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 447899999999999999999999999999999998764432 24668899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||++|++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--~~ 171 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QS 171 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc--cc
Confidence 9999999999998864 56899999999999999999999999999999999999999999999999998754321 12
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
......|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+..
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-------------------- 230 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-------------------- 230 (296)
T ss_pred ccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc--------------------
Confidence 2334578999999999987666 5899999999999999999999987664332221100
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
........+..++..+.+|+.+||..||.+|||+.++++||||...
T Consensus 231 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 231 ---NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ---CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 0111223345578899999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=353.41 Aligned_cols=286 Identities=31% Similarity=0.439 Sum_probs=221.9
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh--hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+|++.+.||+|+||.||+|.+..+|+.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765432 122345677899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.+|.++|+|||++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence 9999 889999998766 7999999999999999999999999999999999999999999999999998754332 12
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc-hhhhccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES-YKKCTNKYS 249 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 249 (468)
......+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+..+...++... .+..... +........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA--LGTPTEENWPGVTSLPD 235 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHH--cCCCchhhhhhcccccc
Confidence 2233456889999999876555578999999999999999999999877655544443211 0000000 000000000
Q ss_pred cc---cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCC
Q 012228 250 YT---LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304 (468)
Q Consensus 250 ~~---~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~~~ 304 (468)
.. ..............+..+.+||.+||.+||++|||+.++++||||++...+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 00 00000001112335789999999999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=353.94 Aligned_cols=278 Identities=28% Similarity=0.450 Sum_probs=211.7
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+.+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 59999999999999999999999999999999875432 22234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 94 FIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 94 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
|+++ +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence 9975 78877764 467999999999999999999999999999999999999999999999999998754321 1223
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCC-CCchHHHHHHhhcccccccccccchhhhcccccc-
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY- 250 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 250 (468)
....+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+..+.+..+....... ....+.........
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP-TEESWPGVSKLPDYK 235 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC-ChHHhHHhhhccccc
Confidence 34567899999999877665568999999999999999988885 5555444443332110000 00000000000000
Q ss_pred cccccccc---CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 251 TLQICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 251 ~~~~~~~~---~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
........ ....+.+++++.+||.+||..||.+|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00000000 11223478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=351.81 Aligned_cols=262 Identities=29% Similarity=0.555 Sum_probs=219.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
..|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999987654433344567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh-----
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR----- 167 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~----- 167 (468)
||++|++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.+|.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999986311000
Q ss_pred --------cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccccc
Q 012228 168 --------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 168 --------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (468)
.........+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.+..+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~------- 232 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD------- 232 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------
Confidence 0001123467889999999887666 589999999999999999999998877666555532100
Q ss_pred chhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 012228 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKK 298 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t---~~eil~hpwf~~ 298 (468)
......+..++.++.++|.+||+.||++||| +.++++||||..
T Consensus 233 ----------------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 233 ----------------IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ----------------cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 0001111247889999999999999999998 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=344.96 Aligned_cols=259 Identities=28% Similarity=0.487 Sum_probs=217.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++++.||.|+||+||+|....++..+|+|++....... ....+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999987544322 4677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 93 EFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 93 E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|++++++|.+.+... ..+++..+..++.|++.||+|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999998765443221
Q ss_pred --CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 170 --GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 170 --~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
......+|++.|+|||++......+.++|+||+||++++|++|..||...+....+.+.....
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------- 223 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--------------- 223 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC---------------
Confidence 122445789999999998776445689999999999999999999998776554444322110
Q ss_pred cccccccccccCCC---CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 248 YSYTLQICRADFSC---PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 248 ~~~~~~~~~~~~~~---~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
...+.. ...+++.+.+++.+||..||++|||++++++||||
T Consensus 224 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 224 --------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 001111 12478899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=368.55 Aligned_cols=262 Identities=31% Similarity=0.567 Sum_probs=240.1
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
...+...+++.+||-|+||.|-++..+.....+|+|++++..+.+....+.+..|-+||..++.|.||++|-.|.+...+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 44567788899999999999999998766667999999998888888889999999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
||+||-|-||+|+..+...+.|++..+++|+..+++|++|||++||++|||||+|+++|.+|-+||.|||+|+....
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--- 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--- 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999986543
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.....+.||||.|+|||++.+++.+ .++|.||||+++||||+|.+||.+.+++..|..|...
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG----------------- 634 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG----------------- 634 (732)
T ss_pred CCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-----------------
Confidence 4557899999999999999999997 9999999999999999999999999999998886421
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
-..+.+|..++..+.+||+++...+|.+|.. +.+|.+|.||..
T Consensus 635 -------id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 635 -------IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred -------hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 1234677889999999999999999999996 899999999974
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=348.40 Aligned_cols=253 Identities=28% Similarity=0.556 Sum_probs=220.8
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.+++..|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 59999999999999999999999999999999987655444557789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
|+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC---cccc
Confidence 9999999999988778999999999999999999999999999999999999999999999999998754321 1234
Q ss_pred ccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH---HHHHHhhcccccccccccchhhhcccccc
Q 012228 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---MALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 174 ~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
...|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+. ......
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------------------- 213 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK----------------------- 213 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH-----------------------
Confidence 5678899999999987765 5899999999999999999999987663 222222
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH--HHHhcCccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI--SQMLEDEWF 296 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~--~eil~hpwf 296 (468)
........|+.++..+.++|.+||..||.+||++ .|+++||||
T Consensus 214 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 214 ---QETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ---hccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 1112334556678999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=348.49 Aligned_cols=257 Identities=31% Similarity=0.485 Sum_probs=214.4
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 788999999999999999999999999999986542 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 95 IDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 95 ~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
+++++|...+.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++..... ......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--cccccc
Confidence 999999887764 45799999999999999999999999999999999999999999999999999865422 112233
Q ss_pred ccCCCCCcCCcccccc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 174 TACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 174 ~~~gt~~y~APEvl~~----~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
...+++.|+|||++.. ....+.++|+||+||++|+|++|.+||...+.......+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~------------------- 222 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK------------------- 222 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh-------------------
Confidence 4578999999999842 12235789999999999999999999987765544333211
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
........|..++.++.+||.+||..||.+|||++++++||||+..
T Consensus 223 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 223 ----SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ----cCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 0111223345578999999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=354.23 Aligned_cols=260 Identities=28% Similarity=0.539 Sum_probs=220.2
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++.++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999999999999998765544445677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC-
Q 012228 93 EFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED- 169 (468)
Q Consensus 93 E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~- 169 (468)
||+.|++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 46999999999999999999999999999999999999999999999999998643221100
Q ss_pred --------------------------CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHH
Q 012228 170 --------------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA 223 (468)
Q Consensus 170 --------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~ 223 (468)
.......||..|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468889999999987766 589999999999999999999998877665
Q ss_pred HHHhhcccccccccccchhhhccccccccccccccCCCCC--CCCHHHHHHHHHhcCCCCCCCCC----HHHHhcCcccc
Q 012228 224 LYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS--WFSSGAKKLIKRILDPNPDTRMT----ISQMLEDEWFK 297 (468)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Ll~~~L~~dP~~R~t----~~eil~hpwf~ 297 (468)
.+..+. ......+. .++..+.++|.+||..||++||| ++++++||||+
T Consensus 240 ~~~~~~--------------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~ 293 (316)
T cd05574 240 TFSNIL--------------------------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293 (316)
T ss_pred HHHHHh--------------------------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence 554421 11122222 26899999999999999999999 99999999998
Q ss_pred cC
Q 012228 298 KG 299 (468)
Q Consensus 298 ~~ 299 (468)
..
T Consensus 294 ~~ 295 (316)
T cd05574 294 GV 295 (316)
T ss_pred cC
Confidence 63
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=351.73 Aligned_cols=261 Identities=28% Similarity=0.475 Sum_probs=218.3
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+...+..|
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 3458899999999999999999999999999999999754322 2456789999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++...... .
T Consensus 93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~--~ 169 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--Q 169 (297)
T ss_pred EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC--c
Confidence 99999999999998865 56899999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
.......+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~------------------- 229 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------------- 229 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-------------------
Confidence 22334578999999999987666 5899999999999999999999977553221111000
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
........|..++..+.+|+.+||..||++|||++++++||||+...
T Consensus 230 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 230 ----NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred ----CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 01112223455788999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=340.82 Aligned_cols=254 Identities=29% Similarity=0.466 Sum_probs=217.6
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|.+.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++.+...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999998764433 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 99999999998774 56899999999999999999999999999999999999999999999999998754331 122
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
....+|++.|+|||++.+..+ +.++|+||+||++++|++|..||...+.......+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 215 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--------------------- 215 (256)
T ss_pred hhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------------
Confidence 334578999999999987776 4899999999999999999999988776555444211
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
......+..++.++.+++.+||+.+|++||++.++++|||+
T Consensus 216 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 ----GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ----CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 11112333578899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=347.60 Aligned_cols=279 Identities=28% Similarity=0.397 Sum_probs=214.3
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999864322 1122355779999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||++++.|...+.....+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccc
Confidence 999998888887777789999999999999999999999999999999999999999999999999987653321 122
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc-
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT- 251 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 251 (468)
....++..|+|||++.+....+.++|+||+||++|+|++|..||.+.+..+....+..... ..............+.
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG--DLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC--CCChHHhhhcccccccc
Confidence 3456788999999987655556899999999999999999999987654433222111000 0000000000000000
Q ss_pred -ccccccc--C---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 252 -LQICRAD--F---SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 252 -~~~~~~~--~---~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
....... . ...+.++..+.+|+.+||+.||++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000000 0 0012368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=345.97 Aligned_cols=263 Identities=29% Similarity=0.509 Sum_probs=214.5
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh-------hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-------RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
+|.+.+.||+|+||.||+|.+..+|+.+|+|.+...... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 689999999999999999999999999999998643221 1123457889999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.+++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754332
Q ss_pred hcCCcccccCCCCCcCCccccccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
..........|+..|+|||++.+.. ..+.++|+||+|+++++|++|..||...+.......+....
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 228 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR------------- 228 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc-------------
Confidence 2222234457899999999987654 23589999999999999999999997655433322211000
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
. ...........++..+.++|.+||.+||.+|||++++++||||
T Consensus 229 --~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 229 --S-----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred --c-----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0 0000001122368899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=346.07 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=211.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 4579999999999999999999999999999999865422 2245678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAK 162 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--ccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999998754321 112
Q ss_pred ccccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 172 LHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
.....|++.|+|||.+.. ....+.++|+||+||++|+|++|..||...+.......+....
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~----------------- 225 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN----------------- 225 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC-----------------
Confidence 234568999999999852 2223578999999999999999999996554332211110000
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpw 295 (468)
........+..++..+.+||++||..||++|||++++++|+|
T Consensus 226 ----~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 226 ----FQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ----CCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000111112236889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=348.92 Aligned_cols=259 Identities=31% Similarity=0.466 Sum_probs=215.2
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
-+.|++++.||+|+||.||+|.+..++..+|+|++.... ....+.+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 367999999999999999999999999999999986542 33466788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||++|++|..++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... ...
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TLQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc--ccc
Confidence 999999999887754 45689999999999999999999999999999999999999999999999999764322 111
Q ss_pred cccccCCCCCcCCccccccC----CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 171 LLHTACGTPNYVAPEVLNDK----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~----~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
......+++.|+|||++.+. ...+.++|+||+||++|+|++|..||...+......++..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------------- 229 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---------------- 229 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc----------------
Confidence 22345688999999998532 2225789999999999999999999987665444333211
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
........+..++.++.++|.+||..||++||+++++++||||..
T Consensus 230 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 230 -------SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred -------CCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 011122334457889999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=357.27 Aligned_cols=281 Identities=21% Similarity=0.364 Sum_probs=208.8
Q ss_pred EEeeeeec--CCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 17 LGRTLGEG--SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 17 i~~~LG~G--~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
++++||+| +|++||++.++.+|+.||+|.++..... ....+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56889999 6789999999999999999999765432 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc----
Q 012228 95 IDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE---- 168 (468)
Q Consensus 95 ~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 168 (468)
+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999998653 4589999999999999999999999999999999999999999999999986543211111
Q ss_pred -CCcccccCCCCCcCCccccccC-CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccccc---chhh
Q 012228 169 -DGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE---SYKK 243 (468)
Q Consensus 169 -~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 243 (468)
........++..|+|||++.+. ..++.++||||+||++|+|++|..||....................... ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 0111234577889999998753 2235899999999999999999999986554333222211110000000 0000
Q ss_pred h---ccccccccccc--------------cccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 244 C---TNKYSYTLQIC--------------RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 244 ~---~~~~~~~~~~~--------------~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
. ........... .........+++.+.+||.+||+.||++|||++++++||||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0 00000000000 0000112236789999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=343.96 Aligned_cols=258 Identities=29% Similarity=0.509 Sum_probs=214.1
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh--hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CCEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKIY 89 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 89 (468)
.|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 589999999999999999999999999999998654321 22345678899999999999999999998865 46789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh-c
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR-E 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~-~ 168 (468)
++|||+++++|.+.+...+.+++.....++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999999999999888889999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
........++..|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.........
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~------------------- 222 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA------------------- 222 (266)
T ss_pred CCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh-------------------
Confidence 112233568899999999987666 589999999999999999999998765443333211
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
........|..+++.+.+|+ +||..+|++|||++++++||||+
T Consensus 223 -----~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 223 -----TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -----cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 11122344566788999999 56678999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=347.10 Aligned_cols=256 Identities=28% Similarity=0.493 Sum_probs=218.3
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++.+.+....|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999875432 223456789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||+++++|.+++... .+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||+++...... ...
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence 999999999998865 89999999999999999999999999999999999999999999999999987654321 123
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
....+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+..
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------------------- 212 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK---------------------- 212 (274)
T ss_pred ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----------------------
Confidence 34568899999999987775 5899999999999999999999987665444333211
Q ss_pred ccccccCCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 253 QICRADFSCPSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 253 ~~~~~~~~~~~~-~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
......+.. ++.++.+++.+||..||++|||++++++||||++.
T Consensus 213 ---~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 213 ---NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred ---cCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 111122333 78899999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=347.64 Aligned_cols=280 Identities=29% Similarity=0.423 Sum_probs=217.4
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 599999999999999999999999999999999765432 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 94 FIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 94 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
|+ +++|.+++.. ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-CCcc
Confidence 99 9999998865 3568999999999999999999999999999999999999999999999999987654321 1223
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc--
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY-- 250 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 250 (468)
....|+..|+|||.+.+....+.++||||+||++++|++|.+||.+.+....+..+....... ....+........+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP-NEETWPGLTSLPDYNK 236 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCC-ChHHHhhccCcchhhc
Confidence 456789999999998766655789999999999999999999998776554443332110000 00000000000000
Q ss_pred cccccccc---CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 251 TLQICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 251 ~~~~~~~~---~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
........ ....+..+..+.+||++||..||.+|||++++++||||.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00000000 011123578999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=351.92 Aligned_cols=287 Identities=26% Similarity=0.387 Sum_probs=218.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--CEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKI 88 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 88 (468)
.+++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 5678999999999999999999999999999999987543221 2233456899999999999999999998755 568
Q ss_pred EEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|+||||+.+ +|.+.+.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999975 78887765 3568999999999999999999999999999999999999999999999999987654321
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.......+++.|+|||++.+....+.++||||+||++|+|++|.+||...+..+....+....... ....+......
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (309)
T cd07845 163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP-NESIWPGFSDL 239 (309)
T ss_pred --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC-Chhhchhhhcc
Confidence 222334568889999998765555689999999999999999999999887766655443211000 00000000000
Q ss_pred ccc-ccccccccC----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 248 YSY-TLQICRADF----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 248 ~~~-~~~~~~~~~----~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
... ........+ ....++++.+.+||.+||.+||++|||++++++||||++...|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 000 000000000 0113368899999999999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=346.53 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=211.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++.+...+..|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 3457999999999999999999999999999999987543 2234567899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||+++++|.+++...+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++..... ...
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~~ 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIA 161 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--ccc
Confidence 999999999999998888999999999999999999999999999999999999999999999999999865432 111
Q ss_pred cccccCCCCCcCCccccc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 171 LLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~---~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
......|++.|+|||++. ...+ +.++|+||+||++|+|++|..||................
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~--------------- 225 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN--------------- 225 (267)
T ss_pred ccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC---------------
Confidence 223457899999999974 2334 589999999999999999999996544322221110000
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpw 295 (468)
...........++..+.++|.+||..||++|||++++++|||
T Consensus 226 ------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 226 ------FQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ------CCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000011111236788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=350.04 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=216.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46899999999999999999999999999999986532 2233567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 93 EFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 93 E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
||++|++|..++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999998888763 379999999999999999999997 5999999999999999999999999999865422
Q ss_pred CCcccccCCCCCcCCccccccCCC-----CCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGY-----DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
....+..+++.|+|||.+.+... .+.++|+||+||++|+|++|..||...........+...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------ 222 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI------------ 222 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH------------
Confidence 22345678899999999865432 357899999999999999999999765544333221100
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
........++.++.++.+||.+||..+|++||+++++++||||....
T Consensus 223 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 223 ----------VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred ----------hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 11122334556899999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=343.45 Aligned_cols=250 Identities=35% Similarity=0.664 Sum_probs=216.6
Q ss_pred eeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCH
Q 012228 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (468)
Q Consensus 21 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 100 (468)
||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+++.+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876554444567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCC
Q 012228 101 FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180 (468)
Q Consensus 101 ~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 180 (468)
.+++.....+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... .....++++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 9999888889999999999999999999999999999999999999999999999999987553321 2234578999
Q ss_pred cCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch--HHHHHHhhcccccccccccchhhhcccccccccccccc
Q 012228 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRAD 258 (468)
Q Consensus 181 y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (468)
|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+ ....+..+.. ....
T Consensus 158 ~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------------~~~~ 212 (262)
T cd05572 158 YVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK------------------------GNGK 212 (262)
T ss_pred ccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc------------------------cCCC
Confidence 999999877666 489999999999999999999998766 4444444210 1233
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 259 FSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 259 ~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
...|...++++.++|.+||..||.+||| ++|+++||||+.
T Consensus 213 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 213 LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 4456667899999999999999999999 999999999984
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=345.26 Aligned_cols=255 Identities=28% Similarity=0.423 Sum_probs=208.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeC-----
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK----- 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~----- 85 (468)
-+.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4679999999999999999999999999999999875431 235678999999998 699999999998653
Q ss_pred -CEEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 86 -TKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 86 -~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
..+|+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 5689999999999999998864 3589999999999999999999999999999999999999999999999999875
Q ss_pred hhhhhcCCcccccCCCCCcCCccccccC----CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccc
Q 012228 163 SQQVREDGLLHTACGTPNYVAPEVLNDK----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~APEvl~~~----~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
.... .......+|++.|+|||++.+. ..++.++|+||+||++|+|++|..||..............
T Consensus 161 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~-------- 230 (272)
T cd06637 161 LDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------- 230 (272)
T ss_pred cccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--------
Confidence 4321 1223456799999999998632 1235789999999999999999999976554333222110
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.......+..++..+.+|+.+||..||.+|||+.++++||||
T Consensus 231 ----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 231 ----------------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ----------------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 000111223468899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=340.33 Aligned_cols=254 Identities=29% Similarity=0.568 Sum_probs=217.1
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||+|+||.||++.+..+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999999764332 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 94 FIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|+.+++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++....... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence 999999999987643 58999999999999999999999999999999999999999999999999987543311 11
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
.....|++.|+|||++.+..+ +.++|+||+||++++|++|..||...+..+....+.
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~---------------------- 214 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII---------------------- 214 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh----------------------
Confidence 223458899999999887665 589999999999999999999998777665554431
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.......+..++.++.++|.+||+.+|.+||++.++++||||
T Consensus 215 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 215 ---RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ---cCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 111122455578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=346.80 Aligned_cols=250 Identities=28% Similarity=0.464 Sum_probs=203.0
Q ss_pred eeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHH---hcCCCCCeeEEEEEEEeCCEEEEEEEccC
Q 012228 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM---KLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (468)
Q Consensus 20 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 96 (468)
.||+|+||.||+|.+..+++.+|+|.+.+.............+|..++ ...+||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999999765433222222333444443 34479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccC
Q 012228 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176 (468)
Q Consensus 97 gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 176 (468)
+|+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999999988888999999999999999999999999999999999999999999999999998644321 123457
Q ss_pred CCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHH--HHHhhcccccccccccchhhhcccccccccc
Q 012228 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA--LYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254 (468)
Q Consensus 177 gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (468)
||+.|+|||.+.+....+.++||||+||++|+|++|..||....... ..... .
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-------------------------~ 211 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-------------------------T 211 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-------------------------h
Confidence 99999999998643434589999999999999999999997542211 11110 1
Q ss_pred ccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 255 ~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
.......|+.++.++.++|.+||..||.+|+ |++++++||||+.
T Consensus 212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 212 LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 1223345666899999999999999999999 6999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=345.23 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=209.0
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999987542 2223467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++..... ...
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----ccc
Confidence 99999988654 3578999999999999999999999999999999999999999999999999875432 223
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH-------HHHHhhcccccccccccchhhhc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-------ALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
...+||+.|+|||++.+..+ +.++|+||+||++|+|++|..||...... .....+
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 212 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI----------------- 212 (279)
T ss_pred cCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-----------------
Confidence 45689999999999987776 58999999999999999999999653211 111110
Q ss_pred cccccccccccccCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 246 NKYSYTLQICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~-~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
....... ....+++++.+++.+||..||.+||+++++++||||+..
T Consensus 213 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 213 --------VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred --------hccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0000111 123368899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=345.23 Aligned_cols=262 Identities=28% Similarity=0.518 Sum_probs=216.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh---hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
+|+.++.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999999999999999998753321 12346788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC-ceEEeccccchhhhhhhc-
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVRE- 168 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~~~- 168 (468)
||||+.|++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998776 599999999875543211
Q ss_pred -CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
........|+..|+|||.+.+..+ +.++|+||+||++++|++|..||...+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------- 223 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI---------------- 223 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH----------------
Confidence 111223568899999999987666 58999999999999999999999754422222111000
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
.........|..+++++.+++.+||..||.+|||+.++++||||+
T Consensus 224 -----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 224 -----ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred -----hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 011122345556889999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=347.46 Aligned_cols=280 Identities=25% Similarity=0.438 Sum_probs=209.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
.+++|++.+.||+|++|.||+|.++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 568899999999999999999999999999999998754321 122346689999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 91 VLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++...... .
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~ 157 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--S 157 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--C
Confidence 9999985 899888654 46899999999999999999999999999999999999999999999999998643211 1
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch-HHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......+++.|+|||++.+....+.++||||+||++|+|++|..||.... ..+....+..... ......+.......
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLG-TPTEETWPGVSSNP 236 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcC-CCChhhhhhhhhcc
Confidence 112234578899999998765544689999999999999999999997654 2222222211000 00000000000000
Q ss_pred cc---ccccc--cccCCCCCCCC--HHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 249 SY---TLQIC--RADFSCPSWFS--SGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 249 ~~---~~~~~--~~~~~~~~~~s--~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.. ..... .......+.++ ..+.+++.+||..||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 00000 00000111233 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=353.66 Aligned_cols=272 Identities=25% Similarity=0.374 Sum_probs=196.5
Q ss_pred EeeeeecCCeEEEEEEEcC--CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--eCCEEEEEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVE--TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA--SKTKIYIVLE 93 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~E 93 (468)
+.+||+|+||+||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. ....+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 5689999999999999754 668899999865422 234678999999999999999999884 4567899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee----ccCCceEEeccccc
Q 012228 94 FIDGGELFDKIAKH---------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLS 160 (468)
Q Consensus 94 ~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl----~~~g~lkl~DFGla 160 (468)
|+.+ +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9975 787776532 248899999999999999999999999999999999999 56689999999999
Q ss_pred hhhhhhhc-CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH---------HHHHhhcc
Q 012228 161 AISQQVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---------ALYRKVST 230 (468)
Q Consensus 161 ~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~---------~~~~~~~~ 230 (468)
+....... ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 76533211 112344678999999999987665578999999999999999999999754321 00111000
Q ss_pred cccccccccchhhhcccccc---------cc----ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 231 FHFLSVYGESYKKCTNKYSY---------TL----QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~---------~~----~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
... ......+........+ .. .............+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMG-FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcC-CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0000111110000000 00 00000001112246779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=340.20 Aligned_cols=259 Identities=29% Similarity=0.522 Sum_probs=214.7
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh--hhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--CEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKI 88 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 88 (468)
..|++++.||+|+||.||.|.+..+|..||+|.+..... ......+.+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999999864322 1223467888999999999999999999988663 578
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||+++++|.+++.....+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999875432211
Q ss_pred -CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
........|+..|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.........
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~------------------ 222 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA------------------ 222 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh------------------
Confidence 112334568999999999987666 589999999999999999999997654443332211
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
........|..++..+.++|++||. +|++|||++++++|||+.
T Consensus 223 ------~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 223 ------TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ------cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0111223455678889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=367.38 Aligned_cols=273 Identities=20% Similarity=0.303 Sum_probs=207.2
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
..+|.+.+.||+|+||.||+|.+..+++.||+|.... ....+|+.+|+.++||||+++++++......|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996432 2345899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||++. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99996 5888887654 469999999999999999999999999999999999999999999999999997654322222
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCC-CC-------chHHHHHHhhcccccc-cccc---
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DE-------SNLMALYRKVSTFHFL-SVYG--- 238 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf-~~-------~~~~~~~~~~~~~~~~-~~~~--- 238 (468)
.....+||+.|+|||++.+..+ +.++|||||||+||+|++|..|+ .. .....+.+.+...... ..+.
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2335679999999999988777 48999999999999999987654 22 1122222222211110 0000
Q ss_pred -cch-hhhccccccccccccccCCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 239 -ESY-KKCTNKYSYTLQICRADFSCPS-----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 239 -~~~-~~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
... ......... ........+. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAAR---NRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhc---ccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000 000000000 0011111122 25678999999999999999999999999999974
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=344.95 Aligned_cols=252 Identities=28% Similarity=0.468 Sum_probs=210.7
Q ss_pred eeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCH
Q 012228 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (468)
Q Consensus 21 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 100 (468)
||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765443333455667899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCC
Q 012228 101 FDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178 (468)
Q Consensus 101 ~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 178 (468)
.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 99987766 799999999999999999999999999999999999999999999999999875432 2222345678
Q ss_pred CCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccccccc
Q 012228 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRAD 258 (468)
Q Consensus 179 ~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (468)
..|+|||++.+..+ +.++|+||+||++|+|++|..||...........+.. ......
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------------------~~~~~~ 214 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR----------------------RTLEMA 214 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh----------------------cccccc
Confidence 89999999887765 5899999999999999999999976543111111100 012223
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 259 FSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 259 ~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
...+..+++.+.++|.+||+.||.+|| ++.++++||||.+
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 345556799999999999999999999 8889999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=359.76 Aligned_cols=250 Identities=32% Similarity=0.655 Sum_probs=217.1
Q ss_pred eEE--EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 15 YEL--GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 15 y~i--~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
|++ .+.||.|.||+||-|.++++|+.||||+|++.+.... ...++++|+.||+.+.||.||.+.-.+++++.+++||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 554 3789999999999999999999999999998776544 3478999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC---ceEEeccccchhhhhhh
Q 012228 93 EFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVR 167 (468)
Q Consensus 93 E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g---~lkl~DFGla~~~~~~~ 167 (468)
|-+.| ++.++|.. .++++|...++++.||+.||.|||-+||+|+||||||||+.... .+||||||+|++...
T Consensus 643 EKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-- 719 (888)
T KOG4236|consen 643 EKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-- 719 (888)
T ss_pred hhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--
Confidence 99976 77777654 46899999999999999999999999999999999999997544 699999999998654
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
...-.+..|||.|.|||++..++|+ ..-|+||.|||+|.-|.|..||..... +..+
T Consensus 720 -ksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQ-------------------- 775 (888)
T KOG4236|consen 720 -KSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDED--INDQ-------------------- 775 (888)
T ss_pred -hhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCccc--hhHH--------------------
Confidence 3345678899999999999999997 899999999999999999999976431 2222
Q ss_pred cccccccccccCCCC--CC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 248 YSYTLQICRADFSCP--SW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~--~~--~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
|.+..+.+| +| +++.+.+||..+|+..-.+|.|+++.|.|||++.
T Consensus 776 ------IQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 776 ------IQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred ------hhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 333444444 34 8999999999999999999999999999999986
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=345.37 Aligned_cols=242 Identities=17% Similarity=0.218 Sum_probs=207.2
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----CCEEEEEEEc
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----KTKIYIVLEF 94 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 94 (468)
..||+|++|.||+|.. +|+.||+|.+...........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 789999999976544444446778899999999999999999999876 4578999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 95 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
++||+|.+++.....+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-----~~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----ccc
Confidence 99999999999888899999999999999999999984 999999999999999999999999999875432 123
Q ss_pred ccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 174 TACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 174 ~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
...||+.|+|||++.+ ..+ +.++||||+||++|+|++|..||...+..+.+..+..
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~--------------------- 236 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN--------------------- 236 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---------------------
Confidence 4568999999999976 344 6899999999999999999999998877666655321
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
....+..|...++.+.+|+.+||+.||++|||++++++
T Consensus 237 ---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 237 ---KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ---cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11233445567899999999999999999999999985
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.52 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=215.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++.+.+.+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 579999999999999999999999999999999975432 24578889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence 999999999998776 789999999999999999999999999999999999999999999999999987654321 12
Q ss_pred ccccCCCCCcCCccccccC---CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 172 LHTACGTPNYVAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~---~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.....++..|+|||.+.+. .+ +.++|+||+||++|+|++|..||...+.......+....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~---------------- 220 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN---------------- 220 (262)
T ss_pred cccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------------
Confidence 2345788999999998765 55 489999999999999999999998766444333221100
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpw 295 (468)
........+..++.++.+|+.+||..||..|||+.+++.|+|
T Consensus 221 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 221 -----FPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -----CCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 000111122336788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=345.01 Aligned_cols=250 Identities=28% Similarity=0.463 Sum_probs=205.1
Q ss_pred eeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHH---HHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccC
Q 012228 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE---ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (468)
Q Consensus 20 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~E---i~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 96 (468)
.||+|+||.||+|.+..+++.||+|++.+..............| +.+++...||||+++++++...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999976543222111222233 344555689999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccC
Q 012228 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176 (468)
Q Consensus 97 gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 176 (468)
||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... .....+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcC
Confidence 9999999988888999999999999999999999999999999999999999999999999998754321 223467
Q ss_pred CCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch---HHHHHHhhcccccccccccchhhhccccccccc
Q 012228 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253 (468)
Q Consensus 177 gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (468)
|++.|+|||++.+....+.++||||+||++|+|++|..||.... .......
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------------------- 210 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-------------------------- 210 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH--------------------------
Confidence 99999999998755434689999999999999999999997652 2221111
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCcccccC
Q 012228 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKKG 299 (468)
Q Consensus 254 ~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~~ 299 (468)
........|..+|..+.+++.+||..||.+|| ++.++++||||+..
T Consensus 211 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 211 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 12223445556799999999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=339.11 Aligned_cols=253 Identities=29% Similarity=0.498 Sum_probs=215.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||.||+|.+..++..+|+|.+..... .+.+.+|+.+++.++||||+++++.+.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 579999999999999999999998899999999865421 567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||+.+++|.+++.. ...+++..+..++.|++.|+.|||+.|++||||+|+||+++.++.+||+|||++....... ..
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--cc
Confidence 99999999999875 4468999999999999999999999999999999999999999999999999987654321 12
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
.....++..|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 213 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN--------------------- 213 (256)
T ss_pred cccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---------------------
Confidence 234558899999999987766 5899999999999999999999987654433222110
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
........+..++..+.++|.+||+.||++|||+.++++||||
T Consensus 214 --~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 214 --KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred --CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 1112223344578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=336.40 Aligned_cols=254 Identities=30% Similarity=0.533 Sum_probs=218.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654332 345667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 99999999999765 468999999999999999999999999999999999999999999999999987543321 12
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
.....|++.|+|||.+.+..+ +.++|+||+|+++++|++|..||...+..+....+..
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------------- 215 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--------------------- 215 (256)
T ss_pred ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---------------------
Confidence 345678999999999987765 4889999999999999999999988776665554321
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
......+..++..+.+++.+||..||.+|||+.++++|||+
T Consensus 216 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 216 ----GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ----CCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 11112234578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=348.50 Aligned_cols=259 Identities=22% Similarity=0.331 Sum_probs=205.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcC----------------CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCe
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVE----------------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 75 (468)
-++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999998642 34479999987542 22345678899999999999999
Q ss_pred eEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 012228 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-------------------RLKEDEARRYFQQLINAVDYCHSRGVFH 136 (468)
Q Consensus 76 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-------------------~l~e~~~~~~~~qll~~l~yLH~~givH 136 (468)
+++++++.+.+..|+||||+++|+|.+++.... .++...+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999886532 3577889999999999999999999999
Q ss_pred cCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh--CCC
Q 012228 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--GFL 214 (468)
Q Consensus 137 rDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~--g~~ 214 (468)
|||||+|||++.++.+||+|||+++...............+++.|+|||++.+..+ +.++||||+||++|+|++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999875433221122233456789999999887666 589999999999999986 678
Q ss_pred CCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 012228 215 PFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 291 (468)
Q Consensus 215 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil 291 (468)
||...+..+....+..... . .........|+.++..+.+|+.+||..||++|||+.+|.
T Consensus 241 p~~~~~~~~~~~~~~~~~~-------------~-----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 241 PYGELTDEQVIENAGEFFR-------------D-----QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCcCCHHHHHHHHHHHhh-------------h-----ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 8887665554433211000 0 001111223455789999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=348.35 Aligned_cols=279 Identities=29% Similarity=0.431 Sum_probs=217.0
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999899999999986543222 34566789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||++++.|.........+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 99999888888777677999999999999999999999999999999999999999999999999998754332 1223
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc---
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS--- 249 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 249 (468)
....++..|+|||++.+....+.++||||+||++++|++|.+||...+..+....+...... .............
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN--LIPRHQEIFQKNPLFA 235 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCC--CchhhHHHhccchHhh
Confidence 44568899999999876555568999999999999999999999876644433332210000 0000000000000
Q ss_pred -cc---cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 250 -YT---LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 250 -~~---~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.. ..........++.++..+.+|+.+||..||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 000000011233578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=343.06 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=211.9
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeC-
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK- 85 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~- 85 (468)
-....++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++.+ +|||++++++++...
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 33457889999999999999999999999999999999864321 235677899999998 799999999998653
Q ss_pred ----CEEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecc
Q 012228 86 ----TKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157 (468)
Q Consensus 86 ----~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DF 157 (468)
+..|+||||++||+|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 468999999999999988753 457899999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhhcCCcccccCCCCCcCCccccccCC----CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccc
Q 012228 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG----YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHF 233 (468)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~ 233 (468)
|++....... .......|+..|+|||++.... ..+.++||||+||++|+|++|..||...+.......+..
T Consensus 173 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~--- 247 (291)
T cd06639 173 GVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR--- 247 (291)
T ss_pred ccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---
Confidence 9987543211 1123456899999999986432 135899999999999999999999987654433322211
Q ss_pred ccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
........+..++..+.+||.+||+.||++|||+.++++||||+
T Consensus 248 --------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 --------------------NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------------------CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00111223444678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=358.98 Aligned_cols=271 Identities=23% Similarity=0.352 Sum_probs=201.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|++.+.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++||||+++++++......|+||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4699999999999999999999999999999985432 2346899999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|++.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 137 e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~~ 212 (357)
T PHA03209 137 PHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---APA 212 (357)
T ss_pred EccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Ccc
Confidence 99965 88887765 45699999999999999999999999999999999999999999999999999874322 122
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCC-CCCCchH----------HHHHHhhcccccc-ccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFL-PFDESNL----------MALYRKVSTFHFL-SVYGE 239 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~-Pf~~~~~----------~~~~~~~~~~~~~-~~~~~ 239 (468)
.....||+.|+|||++.+..+ +.++||||+||++|+|+++.. +|..... ..+...+...... ..+..
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 335679999999999988777 589999999999999998544 4443211 1111111100000 00000
Q ss_pred -ch----hhhccccccccccccccCCC--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 240 -SY----KKCTNKYSYTLQICRADFSC--PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 240 -~~----~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.. ........... .....+.. ...++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 292 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLER-QPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCC-CcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00 00000000000 00000000 1135778899999999999999999999999999975
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=345.61 Aligned_cols=257 Identities=36% Similarity=0.664 Sum_probs=223.2
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 91 (468)
.+|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998755544445677889999999998 99999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC--
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED-- 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~-- 169 (468)
||++++++|.+.+...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.+|.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999998889999999999999999999999999999999999999999999999999998765432210
Q ss_pred ----------------CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccc
Q 012228 170 ----------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHF 233 (468)
Q Consensus 170 ----------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~ 233 (468)
.......++..|+|||++.+..+ +.++|+||+|++++++++|..||...+....++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----- 234 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI----- 234 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-----
Confidence 12233457899999999877655 58999999999999999999999987755444442
Q ss_pred ccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccc
Q 012228 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI----SQMLEDEWF 296 (468)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~----~eil~hpwf 296 (468)
.......|..+++.+.+||.+||+.||.+|||+ +++++||||
T Consensus 235 ---------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 235 ---------------------LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred ---------------------HhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 233445666679999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.66 Aligned_cols=260 Identities=27% Similarity=0.423 Sum_probs=210.2
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEE---
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMA--- 83 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~--- 83 (468)
.....++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3446689999999999999999999999999999999876432 1235677899999999 6999999999873
Q ss_pred --eCCEEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecc
Q 012228 84 --SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157 (468)
Q Consensus 84 --~~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DF 157 (468)
..+..|+||||++|++|.+.+.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 45679999999999999987652 346899999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhhcCCcccccCCCCCcCCccccccC----CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccc
Q 012228 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDK----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHF 233 (468)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~----~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~ 233 (468)
|++...... ........|++.|+|||++... ...+.++||||+||++|+|++|..||...+..........
T Consensus 169 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~--- 243 (286)
T cd06638 169 GVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR--- 243 (286)
T ss_pred CceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---
Confidence 998754321 1123345789999999998532 2235899999999999999999999987654333222110
Q ss_pred ccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
........|..++..+.+||.+||+.||++|||+.++++|+||
T Consensus 244 --------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 --------------------NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------------------cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0111222344468899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=344.64 Aligned_cols=255 Identities=22% Similarity=0.366 Sum_probs=213.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCC-----CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETG-----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
.+++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 3568999999999999999999986555 679999986432 223456788999999999999999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~ 149 (468)
...|++|||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999764 457889999999999999999999999999999999999999
Q ss_pred CceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhh
Q 012228 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKV 228 (468)
Q Consensus 150 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~ 228 (468)
+.+||+|||++................+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875433222222334567889999999887766 589999999999999998 99999887776666553
Q ss_pred cccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.. ......|..+|.++.+|+.+||+.||.+|||+.+++++
T Consensus 240 ~~-------------------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RS-------------------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred Hc-------------------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 21 11223456689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.84 Aligned_cols=280 Identities=29% Similarity=0.462 Sum_probs=218.3
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999865432 2234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||++++.+..+......+++..+..++.|++.||.|||++|++|+||+|+||++++++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 9999877777776667799999999999999999999999999999999999999999999999999876543221 133
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc-c-
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS-Y- 250 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~- 250 (468)
....+++.|+|||++.+....+.++|+||+|+++|+|++|.+||...+..+....+..... .............. .
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG--PLPPSHQELFSSNPRFA 236 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC--CCCHHHhhhcccCcccc
Confidence 4567889999999998774456899999999999999999999987654433332211000 00000000000000 0
Q ss_pred ------ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 251 ------TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 251 ------~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
...........+..++.++.+||++||..||++|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000000112344568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=352.24 Aligned_cols=287 Identities=26% Similarity=0.420 Sum_probs=214.6
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (468)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 3478999999999999999999999999999999986422 223455677899999999999999999987544
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..+|+|+||+.+ +|.+.+. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred ceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 358999999975 8887775 46799999999999999999999999999999999999999999999999999875433
Q ss_pred hhc-CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 166 VRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+...... ...+.....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 237 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT-PSQEDLNCI 237 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CCHHHHHHh
Confidence 211 122334678999999998766544468999999999999999999999876654433222110000 000000000
Q ss_pred cccccc-ccc-c-ccccC---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 245 TNKYSY-TLQ-I-CRADF---SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 245 ~~~~~~-~~~-~-~~~~~---~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
...... ... . ..... ...+..++++.+||.+||+.||++|||+.++++||||+....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 000000 000 0 00000 0113358889999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=336.45 Aligned_cols=256 Identities=30% Similarity=0.553 Sum_probs=216.7
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh--hhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+|+..+.||+|+||+||+|.+..+++.||+|.+..... ......+.+.+|+.+++.++||||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58889999999999999999988999999999865432 1223456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
+||+++++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987543321 2
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
.....|++.|+|||.+......+.++|+||+||++|+|++|..||...........+.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---------------------- 215 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG---------------------- 215 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH----------------------
Confidence 3456789999999998765523589999999999999999999997765333322211
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
........++.+++.+.+++.+||..+|.+|||+.+++.|||+
T Consensus 216 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 216 --RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred --hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0011223455688999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=340.55 Aligned_cols=257 Identities=30% Similarity=0.467 Sum_probs=210.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCC---
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT--- 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~--- 86 (468)
..++|++.+.||+|+||.||+|.++.+++.+|+|++..... ..+.+.+|+.+++.+ .||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 35899999999999999999999999999999999875432 245688999999999 6999999999986544
Q ss_pred ---EEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecccc
Q 012228 87 ---KIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 87 ---~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGl 159 (468)
.+|+||||+++++|.+++.. +..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 58999999999999988765 35799999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcCCcccccCCCCCcCCccccccC----CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc
Q 012228 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDK----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~----~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
+...... ........|++.|+|||++... ...+.++||||+||++|+|++|..||...........+..
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----- 232 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR----- 232 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc-----
Confidence 8754321 1223346689999999998542 2235789999999999999999999976554433333211
Q ss_pred ccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
........+..++..+.+||.+||..||++|||+.++++|||+
T Consensus 233 ------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 ------------------NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ------------------cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0011122233368899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=335.45 Aligned_cols=253 Identities=32% Similarity=0.525 Sum_probs=215.9
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||+|+||.||+|.+..+++.+|+|.+....... ...+.+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 5999999999999999999999999999999997654332 346778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC-CceEEeccccchhhhhhhcCC
Q 012228 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~-g~lkl~DFGla~~~~~~~~~~ 170 (468)
|+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence 99999999999764 348999999999999999999999999999999999999855 46899999998754321 2
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~--------------------- 214 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM--------------------- 214 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH---------------------
Confidence 2234568999999999987665 589999999999999999999998877655544421
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.......+..++..+.+++.+||..||.+|||+.++++||||
T Consensus 215 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 215 ----SGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ----hcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 111223455588999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=335.63 Aligned_cols=250 Identities=31% Similarity=0.546 Sum_probs=213.0
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||+|+||.||++.+..+++.+|+|.++.... ....+.+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999875432 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 94 FIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 94 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|+++|+|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence 99999999988643 45899999999999999999999999999999999999999999999999998755332 112
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 214 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------------------- 214 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc---------------------
Confidence 234568999999999987766 5899999999999999999999998776655444211
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......+..++..+.+||.+||+.||.+|||+.+++.-
T Consensus 215 ----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 ----GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122445578899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=347.70 Aligned_cols=261 Identities=28% Similarity=0.471 Sum_probs=217.5
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 44666788999999999999999999999999986533 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||+++++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..... .....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~--~~~~~ 175 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKR 175 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc--ccccC
Confidence 99999999988754 5799999999999999999999999999999999999999999999999999875432 11223
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---------------------- 232 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---------------------- 232 (292)
T ss_pred ceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------------
Confidence 34678999999999987666 5899999999999999999999987665544333211
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~~ 303 (468)
...........++..+.+++.+||..||.+|||++++++||||.....|.
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 233 -NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred -cCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 01111122234688899999999999999999999999999999766554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=359.83 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=204.5
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCC-----CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVET-----GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (468)
.++|++++.||+|+||.||+|++... +..||+|++..... ....+.+.+|+.+++.+ +||||+++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34699999999999999999996543 35799999975432 22356788999999999 899999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhc----------------------------------------------------------
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH---------------------------------------------------------- 107 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~---------------------------------------------------------- 107 (468)
..+|+|||||++|+|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999988542
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccccc
Q 012228 108 ------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175 (468)
Q Consensus 108 ------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 175 (468)
.++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++............+.
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 24788899999999999999999999999999999999999999999999998754321111111223
Q ss_pred CCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccc
Q 012228 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254 (468)
Q Consensus 176 ~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (468)
.+++.|+|||++.+..+ +.++||||+||++|+|++ |..||............. .
T Consensus 275 ~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~------------------------~ 329 (374)
T cd05106 275 RLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV------------------------K 329 (374)
T ss_pred CCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH------------------------H
Confidence 45678999999977666 589999999999999997 999997654332222210 1
Q ss_pred ccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 255 ~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......|...++++.+++.+||+.||.+|||+.++++
T Consensus 330 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 330 RGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred cccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11223345567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=342.39 Aligned_cols=278 Identities=26% Similarity=0.398 Sum_probs=206.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.+.||+|+||.||+|.+..+|..||+|.+...... .....+.+|+.+++.++|+||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999998654321 1233567899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||+. ++|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~ 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQ 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CC
Confidence 99996 577766654 456889999999999999999999999999999999999999999999999998753321 11
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH-HHHHhhccccccccccc-chhhhc--c
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKVSTFHFLSVYGE-SYKKCT--N 246 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~--~ 246 (468)
......+++.|+|||.+.+....+.++||||+||++|+|++|..||...+.. +....+.. ....+.. .+.... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT--VLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH--HcCCCChhhhhhhhhcc
Confidence 2234567899999999876554468899999999999999999999865432 11111100 0000000 000000 0
Q ss_pred cc-ccccccc-cccCC-CCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 247 KY-SYTLQIC-RADFS-CPS--WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 247 ~~-~~~~~~~-~~~~~-~~~--~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.. ....... ..... ... ..+..+.+++.+||..||++|||+.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 0000000 00000 000 136789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=340.75 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=215.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++.+.||+|+||.||+|.+..+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468899999999999999999999999999999876532 234567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 999999999999876 789999999999999999999999 9999999999999999999999999999875533211
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch-----HHHHHHhhcccccccccccchhhhc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-----LMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
....++..|+|||.+.+..+ +.++|+||+||++|+|++|..||...+ ..+..+.+
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 216 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI----------------- 216 (265)
T ss_pred --hcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-----------------
Confidence 12678899999999988766 589999999999999999999997542 22222221
Q ss_pred cccccccccccccCCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 246 NKYSYTLQICRADFSCPSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~-~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
........+.. ++.++.++|.+||..||++|||+.+++.||||++
T Consensus 217 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 217 --------VNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred --------hcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 11111223333 7889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=340.63 Aligned_cols=258 Identities=26% Similarity=0.519 Sum_probs=215.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC---CCCeeEEEEEEEeCCEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK---HPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 90 (468)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+.+|+.+++.++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4888999999999999999999999999999986542 1223567889999999996 9999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--S 156 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--c
Confidence 9999999999998865 579999999999999999999999999999999999999999999999999987654321 2
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
......|+..|+|||.+.+....+.++|+||+||++|+|++|..||...+.......+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------------------- 216 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-------------------- 216 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc--------------------
Confidence 233457899999999987655556899999999999999999999987655433222110
Q ss_pred ccccccccCCCCC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 251 TLQICRADFSCPS-WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 251 ~~~~~~~~~~~~~-~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
......+. .++.++.+++.+||+.||++|||+.+++.||||++...
T Consensus 217 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 217 -----SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred -----CCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 01111222 26789999999999999999999999999999987543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=335.22 Aligned_cols=254 Identities=32% Similarity=0.569 Sum_probs=215.6
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CCEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKIYIV 91 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV 91 (468)
+|++.+.||.|+||.||+|.+..++..||+|.+...... ....+.+.+|+.+++.++||||+++++.+.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999998754432 3345678899999999999999999997753 4678999
Q ss_pred EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 92 LEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCH-----SRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH-----~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
|||+++++|.+++.. ...+++..+..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999875 357999999999999999999999 89999999999999999999999999999886
Q ss_pred hhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchh
Q 012228 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
..... .......+++.|+|||++.+..+ +.++|+||||+++++|++|..||...+.....+.+..
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 224 (265)
T cd08217 160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE------------ 224 (265)
T ss_pred ccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc------------
Confidence 54321 11334578999999999987665 5899999999999999999999998776555544311
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
......+..++..+.+++.+||..+|++|||+.++++|||+
T Consensus 225 -------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 225 -------------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -------------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 11123455678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=361.39 Aligned_cols=245 Identities=35% Similarity=0.609 Sum_probs=213.4
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 88 (468)
.....|.+...+|.|+||.|..+.+..+++..++|++.+... ...+|+.++... +||||+++++++.+..+.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 356789999999999999999999999999999999986521 233777676666 699999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee-ccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL-DSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl-~~~g~lkl~DFGla~~~~~~~ 167 (468)
|+|||++.|+.+.+.+.....+. ..+..|+.||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999999999998866666 8888999999999999999999999999999999 58999999999998865432
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH-HHHHHhhcccccccccccchhhhcc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
+.+.|-|..|+|||++...+|+ +++||||||++||+||+|..||..... .+++.++
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i------------------ 526 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI------------------ 526 (612)
T ss_pred ----hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh------------------
Confidence 5677889999999999988885 999999999999999999999976543 3555552
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
..+.+. .++|..+++||++||+.||.+|+++.+++.||||
T Consensus 527 --------~~~~~s--~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 527 --------QMPKFS--ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --------cCCccc--cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 223222 7799999999999999999999999999999999
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=334.70 Aligned_cols=257 Identities=32% Similarity=0.585 Sum_probs=215.8
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||+|+||.||+|.+..++..||+|.+...... ....+.+.+|+.+++.++||||+++++...+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999765433 3457789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC-c-
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG-L- 171 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~- 171 (468)
|+++++|.+++.....+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999887789999999999999999999999999999999999999999999999999987654322111 1
Q ss_pred ccccCCCCCcCCccccccCC--CCCChhhHHHHHHHHHHHhhCCCCCCCchH-HHHHHhhcccccccccccchhhhcccc
Q 012228 172 LHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~--~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
....++++.|+|||.+.+.. ..+.++||||+|+++++|++|..||...+. ......+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~-------------------- 219 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV-------------------- 219 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHH--------------------
Confidence 22457889999999987654 235899999999999999999999976532 1111111
Q ss_pred ccccccccccCCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 249 SYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~--~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
........|.+ ++..+.+||.+||+.||.+|||+++++.|||+
T Consensus 220 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 220 -----GAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----hcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01112223443 48899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=340.83 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=208.7
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEE-----
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMA----- 83 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~----- 83 (468)
...+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34588999999999999999999999999999999986542 2235678899999998 6999999999984
Q ss_pred -eCCEEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccc
Q 012228 84 -SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (468)
Q Consensus 84 -~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla 160 (468)
..+.+|++|||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 346789999999999999988753 35889999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhcCCcccccCCCCCcCCcccccc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
...... ........|++.|+|||.+.. ..+ +.++|+|||||++|+|++|..||...........+..
T Consensus 169 ~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~----- 240 (282)
T cd06636 169 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----- 240 (282)
T ss_pred hhhhcc--ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh-----
Confidence 754321 122345678999999999863 234 4789999999999999999999976554322221100
Q ss_pred ccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
. ......+..++.++.+||.+||..||.+|||+.++++||||
T Consensus 241 ------------------~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 241 ------------------N-PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ------------------C-CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0 00001122478899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=337.49 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=207.5
Q ss_pred cCeEEEeeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
.+|++.+.||+|+||.||+|.++ ..+..||+|.+.... .......+.+|+.+++.++||||+++++++...+..|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 57999999999999999999875 456789999987543 2233467889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+|++|||.+.......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~- 161 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA- 161 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc-
Confidence 999999999999998764 578999999999999999999999999999999999999999999999999875432111
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
........++..|+|||++.+..+ +.++||||+||++|++++ |..||...+..+....+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~----------------- 223 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED----------------- 223 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-----------------
Confidence 011112335678999999987766 589999999999999775 9999988776665554311
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
....+.|..++..+.+++.+||+.+|.+|||+++|++
T Consensus 224 --------~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 224 --------GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 1122345568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.13 Aligned_cols=277 Identities=26% Similarity=0.432 Sum_probs=212.2
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|++.+.||.|++|.||+|.+..+|+.||||.+..... .......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999865432 22234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 94 FIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 94 ~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|+. ++|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 588888765 346899999999999999999999999999999999999999999999999998754321 122
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccc-cccc-c-cc--cchhhhcc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTF-HFLS-V-YG--ESYKKCTN 246 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~-~~~~-~-~~--~~~~~~~~ 246 (468)
.....+++.|+|||++.+....+.++||||+||++|+|++|..||...+......++... .... . +. ........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 334567889999999877666578999999999999999999999876544333222110 0000 0 00 00000000
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.... ..........+.+++++.++|.+||+.||.+|||++++++||||
T Consensus 237 ~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPK--WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hccc--ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000 00000011123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=345.86 Aligned_cols=286 Identities=24% Similarity=0.372 Sum_probs=211.2
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC--
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-- 86 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-- 86 (468)
...+++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 34578899999999999999999999999999999998654322 122345668999999999999999999886543
Q ss_pred ------EEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecccc
Q 012228 87 ------KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 87 ------~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGl 159 (468)
..|+||||+.+ +|.+.+.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 46999999975 7887776543 689999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcC--CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccc---c
Q 012228 160 SAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHF---L 234 (468)
Q Consensus 160 a~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~---~ 234 (468)
+......... .......++..|+|||.+.+....+.++||||+|+++|+|++|..||.+.+.......+..... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 8755332211 1223456788999999987655446899999999999999999999988765544333221100 0
Q ss_pred cccccc-hhhhccccccccc-cccccCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 235 SVYGES-YKKCTNKYSYTLQ-ICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 235 ~~~~~~-~~~~~~~~~~~~~-~~~~~~~-~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
..+... ............. ....... .+...+..+.+||.+||..||.+|||++++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000000 0000000000000 0000000 111246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=344.70 Aligned_cols=280 Identities=26% Similarity=0.383 Sum_probs=216.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--CEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKIY 89 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 89 (468)
+++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... +..|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 56899999999999999999999999999999999754332 22344567899999999999999999998877 8999
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+||||+.+ +|.+.+.... .+++..+..++.|++.||+|||++|++|+||||+|||++.++.+||+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-- 159 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC--
Confidence 99999985 8988887644 5899999999999999999999999999999999999999999999999998754432
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc--
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN-- 246 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 246 (468)
........+++.|+|||.+.+....+.++|+||+|+++|+|++|..||...+......++..... ...+..+.....
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG-TPTEKIWPGFSELP 238 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCchHHHHHhhccc
Confidence 12233456788999999987765556899999999999999999999998776655554421100 000000100000
Q ss_pred ----ccccccccccccCCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 247 ----KYSYTLQICRADFSCPSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 247 ----~~~~~~~~~~~~~~~~~~-~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
..............++.. +++.+.+||++||+.||++|||+.|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 000000000011123333 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=352.65 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=207.7
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 91 (468)
..|++.+.||.|+.+.||++.... ...||+|.+... ..+...+..+.+||..|.+|+ |.+||+|+++-..++.+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 459999999999999999999854 455666655432 234567888999999999996 99999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCC-HHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKHGRLK-EDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~-e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||-+- +|..++....... ...++.|..|++.|+.++|++||||.||||.|.|+-. |.+||+|||.|........+-
T Consensus 439 mE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 439 MECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred eecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccce
Confidence 999754 9999998876644 3689999999999999999999999999999999875 999999999998765544444
Q ss_pred cccccCCCCCcCCccccccCCC----------CCChhhHHHHHHHHHHHhhCCCCCCCch-HHHHHHhhccccccccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGY----------DGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~----------~~~~~DiWSlGvil~~ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~ 239 (468)
...+.|||+.|||||.+....+ .++++||||||||||+|+.|++||.... ...-+..+.
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~---------- 586 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT---------- 586 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc----------
Confidence 5567899999999999864333 2689999999999999999999997542 111122211
Q ss_pred chhhhccccccccccccccCCCCCCCCHH-HHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 240 SYKKCTNKYSYTLQICRADFSCPSWFSSG-AKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~-~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.....+.+|..-+.. ++++++.||..||++|||+.++|+|||++-
T Consensus 587 --------------~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 587 --------------DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred --------------CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 112233444433333 999999999999999999999999999974
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=357.78 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=203.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEE-----cCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCC
Q 012228 13 GKYELGRTLGEGSFAKVKFAKN-----VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (468)
++|++++.||+|+||+||+|.+ ..++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 4799999999999999999974 34677899999864322 22356788999999999 8999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcC----------------------------------------------------------
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG---------------------------------------------------------- 108 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~---------------------------------------------------------- 108 (468)
..|+|||||+||+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999886432
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 109 -----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 109 -----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 367888999999999999999999999999999999999999999999999875433211111
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHH-HHHhhcccccccccccchhhhccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA-LYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
.....++..|+|||++.+..+ +.++||||+||++|+|++ |..||....... ..+.+.
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~-------------------- 331 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK-------------------- 331 (375)
T ss_pred cCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH--------------------
Confidence 222345678999999987776 589999999999999997 899997654332 222211
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......|...+.++.+|+.+||+.||++|||+.++++.
T Consensus 332 -----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 332 -----EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -----hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 001122344568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=358.46 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=215.3
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
|.-++.||.|+||.||.|++..|.+.||||.+.........-.+.|.+|+..|+.++|||+|.+.++|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56678899999999999999999999999999765444444567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 95 IDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 95 ~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
|-| +-.|++.- ..++.|.++..+..+.+.||+|||+++.+|||||..|||+++.|.|||+|||.|.+..+ ..
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An 180 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN 180 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence 976 66666653 35799999999999999999999999999999999999999999999999999987654 45
Q ss_pred ccCCCCCcCCccccc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 174 TACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 174 ~~~gt~~y~APEvl~---~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
+..|||.||||||+. ...|+ -++||||||++..+|.-.++|+-..+.+....-|...
T Consensus 181 sFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN------------------- 240 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------------- 240 (948)
T ss_pred cccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-------------------
Confidence 788999999999985 23455 7999999999999999999998776655444433211
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
....+. .+.+|..+++|+..||++-|.+|||.+++|+|+|.....
T Consensus 241 ----esPtLq-s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 241 ----ESPTLQ-SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred ----CCCCCC-CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 111111 223689999999999999999999999999999998654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=351.49 Aligned_cols=284 Identities=26% Similarity=0.447 Sum_probs=215.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (468)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 46789999999999999999999999999999999865322 223345677899999999999999999988543
Q ss_pred -CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 86 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999975 888887653 9999999999999999999999999999999999999999999999999987543
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccc------cccc
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFL------SVYG 238 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~------~~~~ 238 (468)
. ........+++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+....+..+...... ....
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 222344578999999999988777 48999999999999999999999877655444443211000 0000
Q ss_pred cchhhhccccc----ccc-cc-ccccC----C-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 239 ESYKKCTNKYS----YTL-QI-CRADF----S-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 239 ~~~~~~~~~~~----~~~-~~-~~~~~----~-~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
........... ... .. ....+ . .+...++.+++||.+||+.||++|||+.|+|+||||+.++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 00000000000 000 00 00000 0 012246779999999999999999999999999999977654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=394.57 Aligned_cols=261 Identities=31% Similarity=0.548 Sum_probs=226.6
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
-+|+-+.+||.|.||.||.|.+..+|+..|+|-+...... ......+.+|..++..|+|||+|++|++=.+.+.++|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3688899999999999999999999999999998765544 456778999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh--cCC
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR--EDG 170 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~--~~~ 170 (468)
|||+||+|.+.++..+-.+|...+.|..|++.|+.|||++|||||||||.|||++.+|.+|++|||.|....... -.+
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999999999999988888999999999999999999999999999999999999999999999999987544321 123
Q ss_pred cccccCCCCCcCCccccccCC--CCCChhhHHHHHHHHHHHhhCCCCCCCchH-HHHHHhhcccccccccccchhhhccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~--~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.+....|||.|||||++.+.. -.+.++|||||||+..||+||+.||...+. ..++..+
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V------------------- 1454 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV------------------- 1454 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-------------------
Confidence 456778999999999997643 236789999999999999999999986542 2233222
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.......+|..+|++..+||.+||..||++|+++.|+|+|.|-+..
T Consensus 1455 ------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1455 ------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 2344566788899999999999999999999999999999988754
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=335.87 Aligned_cols=251 Identities=33% Similarity=0.583 Sum_probs=207.6
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHH-hcCCCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..++ ...+||||+++++++...+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765433222333445555544 455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 99999998888899999999999999999999999999999999999999999999999999874322 234568
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+.... ...
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------~~~ 212 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR----------------------INW 212 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc----------------------cCC
Confidence 899999999987764 589999999999999999999998877666554432100 000
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCccccc
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKK 298 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t---~~eil~hpwf~~ 298 (468)
....+..+++.+.+++.+||+.||++||| ++|++.||||++
T Consensus 213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 11123347899999999999999999995 579999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.38 Aligned_cols=251 Identities=33% Similarity=0.658 Sum_probs=215.4
Q ss_pred eeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCH
Q 012228 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (468)
Q Consensus 21 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 100 (468)
||.|+||.||+|.+..+|+.+|+|++...........+.+.+|+.+++.++||||+++++.+...+..|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999766544445567889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc------CCcccc
Q 012228 101 FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE------DGLLHT 174 (468)
Q Consensus 101 ~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~------~~~~~~ 174 (468)
.+++...+.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998878899999999999999999999999999999999999999999999999999875432211 112234
Q ss_pred cCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccc
Q 012228 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254 (468)
Q Consensus 175 ~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (468)
..+++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+..+....+.
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------------------------- 214 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL------------------------- 214 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------------------------
Confidence 568889999999877665 589999999999999999999998887766655532
Q ss_pred ccccCCCCCC--CCHHHHHHHHHhcCCCCCCCCCH---HHHhcCccccc
Q 012228 255 CRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTI---SQMLEDEWFKK 298 (468)
Q Consensus 255 ~~~~~~~~~~--~s~~~~~Ll~~~L~~dP~~R~t~---~eil~hpwf~~ 298 (468)
......+.. ++..+.+++.+||+.+|.+|||+ .++++||||++
T Consensus 215 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 215 -NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred -cCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 122223333 48999999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=369.63 Aligned_cols=248 Identities=33% Similarity=0.561 Sum_probs=207.1
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEE-EEe---C---
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEV-MAS---K--- 85 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~-~~~---~--- 85 (468)
+++|.+.|.+|+|+.||+|++...|..||+|.+-.. ++...+.+.+||.+|++|+ |+|||.+++. ... .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 478899999999999999999988899999998543 4567889999999999997 9999999993 211 1
Q ss_pred CEEEEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeeccCCceEEeccccch
Q 012228 86 TKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~yLH~~g--ivHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
-.++|.||||.||.|.+++.. ..+|+|.++.+||.|++.||.+||... |+|||||-|||||+.+|+.||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 247899999999999999974 346999999999999999999999998 9999999999999999999999999987
Q ss_pred hhhhhh--cCC--c---ccccCCCCCcCCccccc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccc
Q 012228 162 ISQQVR--EDG--L---LHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTF 231 (468)
Q Consensus 162 ~~~~~~--~~~--~---~~~~~gt~~y~APEvl~---~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~ 231 (468)
-.-... ..+ . --....|+.|+|||++. +.+. ++|+|||+|||+||-|+....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 422111 000 0 01234799999999973 4444 6999999999999999999999987521
Q ss_pred ccccccccchhhhccccccccccccccCCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012228 232 HFLSVYGESYKKCTNKYSYTLQICRADFSCPS--WFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295 (468)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpw 295 (468)
+.|..+.|.+|+ .++..+.+||+.||+.||.+||++-|++.+-+
T Consensus 264 --------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 264 --------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred --------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 127778888887 48999999999999999999999999987543
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=339.63 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=216.0
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
+.|+..+.||.|+||.||+|.+..++..||+|++..... ....+.+.+|+.+++.++||||+++++.+.+.+..|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468889999999999999999999999999999875432 234577889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||++||+|.+++.. +.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence 99999999998865 579999999999999999999999999999999999999999999999999987543211 122
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
....++..|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+.
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------------- 214 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP----------------------- 214 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-----------------------
Confidence 33468889999999987665 589999999999999999999998766544332210
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.......+..++..+.+++.+||..+|++|||+.++++||||.+.
T Consensus 215 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 215 --KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred --cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 011122333467889999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=341.21 Aligned_cols=269 Identities=26% Similarity=0.383 Sum_probs=216.4
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
...+|++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++.+...+.+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3467999999999999999999999999999999986542 23345778899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||+++++|.+++...+.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999999999888889999999999999999999997 69999999999999999999999999998644221
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
.....+|+..|+|||++.+..+ +.++||||+||++|+|++|..||............ ..........
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---------~~~~~~~~~~-- 224 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD---------PMGILDLLQQ-- 224 (284)
T ss_pred -ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh---------hhHHHHHHHH--
Confidence 1234578999999999877665 58999999999999999999999865432100000 0000000000
Q ss_pred cccccccccCCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 250 YTLQICRADFSCPSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~-~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.+.......+.. ++..+.+|+.+||+.||.+|||+.++++||||.+..
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 225 ---IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred ---HhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000111112222 678899999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=346.93 Aligned_cols=280 Identities=26% Similarity=0.402 Sum_probs=208.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcC--CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--CEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVE--TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKIY 89 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 89 (468)
+|++.+.||+|+||.||+|.+.. ++..||+|.+...........+.+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999999764322233346678999999999999999999999888 8899
Q ss_pred EEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc----CCceEEeccccc
Q 012228 90 IVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS----YGVLKISDFGLS 160 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~----~g~lkl~DFGla 160 (468)
+||||+++ +|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999976 677666432 26899999999999999999999999999999999999999 999999999998
Q ss_pred hhhhhhhc-CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHH---------HHHhhcc
Q 012228 161 AISQQVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA---------LYRKVST 230 (468)
Q Consensus 161 ~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~---------~~~~~~~ 230 (468)
........ .......++++.|+|||++.+....+.++||||+||++++|++|.+||...+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 238 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF- 238 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH-
Confidence 86533221 1122345789999999998776555689999999999999999999997654321 000000
Q ss_pred cccccccc-cchhhhcccccccc---ccccc---------cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 231 FHFLSVYG-ESYKKCTNKYSYTL---QICRA---------DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 231 ~~~~~~~~-~~~~~~~~~~~~~~---~~~~~---------~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
....... ..+........+.. ..... .+......+..+.++|.+||+.||++|||+.++++||||
T Consensus 239 -~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 -EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred -HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000000 00000000000000 00000 000111467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=340.62 Aligned_cols=249 Identities=26% Similarity=0.448 Sum_probs=204.1
Q ss_pred cccCeEEEeee--eecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCE
Q 012228 11 RVGKYELGRTL--GEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (468)
Q Consensus 11 ~~~~y~i~~~L--G~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (468)
..+.|++.+.+ |+|+||.||++.++.++..+|+|++....... .|+.....+ +||||+++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 45678887776 99999999999999999999999987543211 122222222 69999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC-ceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~ 166 (468)
.|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 999999999999999998888999999999999999999999999999999999999999988 999999999864322
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHH-Hhhcccccccccccchhhhc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY-RKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (468)
.....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||......... .....
T Consensus 163 -----~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 221 (267)
T PHA03390 163 -----PSCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK--------------- 221 (267)
T ss_pred -----CccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH---------------
Confidence 123468999999999988776 48999999999999999999999755332210 00000
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-HHHHhcCcccc
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-ISQMLEDEWFK 297 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-~~eil~hpwf~ 297 (468)
........++.+++.+.+||.+||+.||.+|++ ++++|+||||+
T Consensus 222 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 222 --------RQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred --------hhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 111223344468999999999999999999996 69999999996
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=351.29 Aligned_cols=286 Identities=24% Similarity=0.380 Sum_probs=217.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE----eCCEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA----SKTKI 88 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~----~~~~~ 88 (468)
.+|++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999875422 2224567788999999999999999999875 34578
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh-
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR- 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~- 167 (468)
|+||||+. |+|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 5899999887889999999999999999999999999999999999999999999999999987543221
Q ss_pred -cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc-hhhhc
Q 012228 168 -EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES-YKKCT 245 (468)
Q Consensus 168 -~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 245 (468)
.........|+..|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+..... ..... .....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g--~~~~~~~~~~~ 240 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG--SPSEEVLNRIG 240 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC--CChhHhhhhhc
Confidence 112223457899999999987654456899999999999999999999988765544333221100 00000 00000
Q ss_pred cc-cccccc--cccccCC---CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 246 NK-YSYTLQ--ICRADFS---CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 246 ~~-~~~~~~--~~~~~~~---~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
.. ...... ....... ..+..+.++.++|++||+.||.+|||+++++.||||.+...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 00 000000 0000111 113368999999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=339.64 Aligned_cols=277 Identities=28% Similarity=0.449 Sum_probs=214.2
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||.|++|.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999875432 1224567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 94 FIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|+++ +|.+++.... .+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||++...... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence 9986 8888876543 5899999999999999999999999999999999999999999999999998754321 11
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+.+..+....+...... .....+.........
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT-PTESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC-CChhhHHHHhcCchh
Confidence 2234567899999999876655578999999999999999999999987766555443211000 000000000000000
Q ss_pred ccccc----cccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 251 TLQIC----RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 251 ~~~~~----~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
..... .......+..+..+.+++.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00000 00011123468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=337.65 Aligned_cols=258 Identities=26% Similarity=0.478 Sum_probs=216.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|...+.||+|++|.||+|.+..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4666789999999999999999999999999986432 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
|++|++|.+++.. .++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... .....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRK 173 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Ccccc
Confidence 9999999999887 67999999999999999999999999999999999999999999999999987654321 11223
Q ss_pred ccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccc
Q 012228 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253 (468)
Q Consensus 174 ~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (468)
...|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+...
T Consensus 174 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---------------------- 230 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---------------------- 230 (285)
T ss_pred cccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc----------------------
Confidence 4568999999999987766 58999999999999999999999877665555443210
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 254 ~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
.......+..++..+.+++.+||..||++|||+.++++||||++...
T Consensus 231 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 231 -LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred -CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 00111122236789999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=332.99 Aligned_cols=256 Identities=31% Similarity=0.524 Sum_probs=218.5
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|++.+.||+|++|.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765321 34577889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||+++++|.+++.....+++..+..++.|++.|++|||+ .|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Cc
Confidence 999999999999888889999999999999999999999 999999999999999999999999999987653321 12
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch---HHHHHHhhcccccccccccchhhhcccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+ ..+....+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------------- 216 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------------------- 216 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-------------------
Confidence 234568899999999877655 589999999999999999999997763 333333221
Q ss_pred ccccccccccCCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 249 SYTLQICRADFSCPSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~-~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.......+.. ++..+.++|.+||..+|++|||+.++++||||+.
T Consensus 217 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 217 ------DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred ------cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 1112233444 7889999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=354.96 Aligned_cols=261 Identities=31% Similarity=0.533 Sum_probs=224.0
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
-|..++.||-|+||+|++++...|...||+|.+++..+...+....++.|-.||...+++.||+||..|.+++++|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 38889999999999999999999999999999998888877788899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC----
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED---- 169 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~---- 169 (468)
|++||++..++.+.+-|+|+.|++|+..|.+|+++.|..|++||||||+|||||.+|++||+||||++-+.-....
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999998764321110
Q ss_pred ------------------------------------CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCC
Q 012228 170 ------------------------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF 213 (468)
Q Consensus 170 ------------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~ 213 (468)
-..+...||+.|+|||++...+|. ..+|.||.|||||+|+.|+
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCC
Confidence 012234599999999999999985 8999999999999999999
Q ss_pred CCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC---HHHH
Q 012228 214 LPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT---ISQM 290 (468)
Q Consensus 214 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t---~~ei 290 (468)
+||...++.+...++..+ .....+..-..+|.++.+||.++.. +++.|.. ++|+
T Consensus 869 ~pf~~~tp~~tq~kv~nw----------------------~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~v 925 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVINW----------------------RNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQV 925 (1034)
T ss_pred CCccCCCCCcceeeeeeh----------------------hhccccccccccCHHHHHHHHHHhc-Chhhhhcccchhhh
Confidence 999887766554443211 1112222233489999999998664 7788874 6789
Q ss_pred hcCccccc
Q 012228 291 LEDEWFKK 298 (468)
Q Consensus 291 l~hpwf~~ 298 (468)
..||||+.
T Consensus 926 KaHpfFkg 933 (1034)
T KOG0608|consen 926 KAHPFFKG 933 (1034)
T ss_pred hcCccccc
Confidence 99999985
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=343.86 Aligned_cols=260 Identities=27% Similarity=0.478 Sum_probs=216.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.-|+....||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 446667789999999999999999999999999865432 23456889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~ 174 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKR 174 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--cccc
Confidence 99999999887754 67999999999999999999999999999999999999999999999999998754321 1122
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
...+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+..+....+..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------------------- 231 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---------------------- 231 (297)
T ss_pred cceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----------------------
Confidence 34678999999999987766 5899999999999999999999987665544443211
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
........+..++..+.++|.+||+.+|.+|||++++++||||.+...|
T Consensus 232 -~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 232 -SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred -cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 0011122233468889999999999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=341.87 Aligned_cols=260 Identities=28% Similarity=0.480 Sum_probs=216.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 3579999999999999999999998899999999986432 2234678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ..
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--~~ 170 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QS 170 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc--cc
Confidence 9999999999998865 46899999999999999999999999999999999999999999999999988754332 12
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
......|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+..
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-------------------- 229 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------------------- 229 (293)
T ss_pred ccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--------------------
Confidence 2334568999999999887666 5899999999999999999999987654322111100
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.....+..+..++..+.+++++||..+|.+|||+++++.||||+...
T Consensus 230 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 230 ---NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ---CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 01111223344688899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=339.08 Aligned_cols=273 Identities=29% Similarity=0.485 Sum_probs=208.6
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeC--CEEEEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASK--TKIYIV 91 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lV 91 (468)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .. ......+|+.+++++. ||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999865321 11 1223457889998885 99999999999887 889999
Q ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||+.+ +|.+.+... ..+++..+..++.|++.||+|||++|++||||||+||+++. +.+||+|||++...... .
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---P 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---C
Confidence 999975 888887753 56899999999999999999999999999999999999999 99999999998754321 2
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc--
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY-- 248 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 248 (468)
......+++.|+|||.+.+..+.+.++||||+||++|+|++|..||.+.+..+....+.... ......+.......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVL--GTPDAEVLKKFRKSRH 231 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHc--CCCCHHHHHhhccccc
Confidence 22345688999999987665666789999999999999999999998877655544432210 00000000000000
Q ss_pred -cccc--ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 249 -SYTL--QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 249 -~~~~--~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.... .....-....+.++..+.+||.+||.+||++|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 00000001123468999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=350.79 Aligned_cols=245 Identities=29% Similarity=0.425 Sum_probs=208.3
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
+.+++.||+|.||+||.|..+ ....||+|.+...... .+.+.+|+.+|++|+|+|||++++++..+..+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 345689999999999999994 3458999999754332 24566999999999999999999999998899999999
Q ss_pred cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 95 IDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 95 ~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
++.|+|.+++.. ...+...+...++.||++|++||+++++|||||-..|||+++++.+||+|||||+..... .-...
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~ 361 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTAS 361 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeec
Confidence 999999999997 446899999999999999999999999999999999999999999999999999943221 11111
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
...--...|.|||.+....+. .++||||+||+|+||+| |+.||.+.+..+..+.+
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l----------------------- 417 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL----------------------- 417 (468)
T ss_pred CCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-----------------------
Confidence 112234569999999988874 89999999999999998 99999999988887775
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 291 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil 291 (468)
......+.|+.+|+++.+++..|+..+|++|||++.+.
T Consensus 418 --e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 418 --ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred --hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 23456778889999999999999999999999998654
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=337.96 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=209.8
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcC-----CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
.++|++.+.||+|+||.||+|..+. .+..||+|.+..... ......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4689999999999999999997642 345799999864432 222345778999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEec
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~D 156 (468)
..|+||||+++|+|.+++.... .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 9999999999999999997532 245678899999999999999999999999999999999999999999
Q ss_pred cccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccccccc
Q 012228 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
||+++...............++..|+|||.+.+..+ +.++|+||+||++|+|++ |..||.+.+..+....+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~------ 235 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM------ 235 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------
Confidence 999875432211111222345778999999887666 589999999999999998 799998877666554421
Q ss_pred ccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc------Cccccc
Q 012228 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE------DEWFKK 298 (468)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~------hpwf~~ 298 (468)
.......+...++.+.+++.+||+.||++|||+.++++ ||||..
T Consensus 236 -------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 236 -------------------DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred -------------------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 11222344556889999999999999999999999987 898863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=359.49 Aligned_cols=252 Identities=29% Similarity=0.497 Sum_probs=217.3
Q ss_pred eeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCC
Q 012228 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGE 99 (468)
Q Consensus 20 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 99 (468)
.||+|+||+||.|+|..|....|||.|.... ....+-+..||.+++.|+|.|||++.+.+..+..+-|.||-.+||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999986432 3356778999999999999999999999999999999999999999
Q ss_pred HHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec-cCCceEEeccccchhhhhhhcCCccccc
Q 012228 100 LFDKIAKH-GRL--KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQQVREDGLLHTA 175 (468)
Q Consensus 100 L~~~i~~~-~~l--~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~-~~g~lkl~DFGla~~~~~~~~~~~~~~~ 175 (468)
|.+++... +++ .|..+.+|.+||++||.|||++.|||||||-+|||++ -.|.+||+|||-++.+.. -+....+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 99999865 456 7899999999999999999999999999999999997 579999999999876543 34455678
Q ss_pred CCCCCcCCccccc-cCCCCCChhhHHHHHHHHHHHhhCCCCCCCc-hHHHHHHhhcccccccccccchhhhccccccccc
Q 012228 176 CGTPNYVAPEVLN-DKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253 (468)
Q Consensus 176 ~gt~~y~APEvl~-~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (468)
.||..|||||++- |..-+|.++|||||||++.||.||++||-.. ++...+-++.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG------------------------ 792 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG------------------------ 792 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc------------------------
Confidence 8999999999995 3334489999999999999999999999653 2222222221
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 254 ~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
..+...++|..+|.+++++|.+|+.+||.+||+|.++|.+||++...
T Consensus 793 myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 793 MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 44566778888999999999999999999999999999999998763
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=335.77 Aligned_cols=256 Identities=27% Similarity=0.473 Sum_probs=215.8
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
-|++.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++.+...+..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 37888999999999999999999999999999865432 2235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
|+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhc
Confidence 9999999998865 578999999999999999999999999999999999999999999999999986543211 1123
Q ss_pred ccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccc
Q 012228 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253 (468)
Q Consensus 174 ~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (468)
...++..|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.
T Consensus 160 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------------ 214 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------------------------ 214 (277)
T ss_pred cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh------------------------
Confidence 3568899999999877665 488999999999999999999998765544333321
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 254 ~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.......+..++.++.+++.+||..+|.+||++.++++||||.+..
T Consensus 215 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 215 -KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred -cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 1111224455789999999999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=330.86 Aligned_cols=262 Identities=29% Similarity=0.583 Sum_probs=231.5
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (468)
...+..|++++.||+|+|++|-+++.++|.+.+|+|+++++-......+..+..|-.+.... +||.+|-++..|.++..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 34567899999999999999999999999999999999988777777788888888887766 69999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+++|.||.+||+|.-+++....++|+.|+.|...|+.||.|||++||++||||.+|+|+|..|++||+|+|+++- ...
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~l~ 403 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GLG 403 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--CCC
Confidence 999999999999998899989999999999999999999999999999999999999999999999999999863 233
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc-------hHHHHHHhhcccccccccccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-------NLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~-------~~~~~~~~~~~~~~~~~~~~~ 240 (468)
.....++.||||.|+|||++.+..| +..+|.|+|||++|+|++|+.||+-- +.++..-++
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv------------ 470 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV------------ 470 (593)
T ss_pred CCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH------------
Confidence 4556788999999999999999888 69999999999999999999999621 122221111
Q ss_pred hhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCccccc
Q 012228 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT------ISQMLEDEWFKK 298 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t------~~eil~hpwf~~ 298 (468)
+....+.+|..+|-.+..+++..|++||.+|.. .+++..|+||+.
T Consensus 471 -------------ilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 471 -------------ILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred -------------HhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 556677889889999999999999999999974 689999999984
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=339.90 Aligned_cols=280 Identities=25% Similarity=0.393 Sum_probs=209.6
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCE----
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTK---- 87 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 87 (468)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999865432 1223456788999999995 6999999999877665
Q ss_pred -EEEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-CCceEEeccccc
Q 012228 88 -IYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLS 160 (468)
Q Consensus 88 -~~lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~-~g~lkl~DFGla 160 (468)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 888887643 35799999999999999999999999999999999999998 899999999998
Q ss_pred hhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (468)
...... ........+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...... .....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 235 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT-PTEQV 235 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC-CChhh
Confidence 754221 112233467889999999876554568999999999999999999999876654443332210000 00000
Q ss_pred hhhhccccccc--ccccccc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 241 YKKCTNKYSYT--LQICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 241 ~~~~~~~~~~~--~~~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
+.......... ....... ....+.++..+.+||.+||.+||.+|||+.+++.||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00000000000 0000000 001123788999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.65 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=213.0
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
...+|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34669999999999999999999999999999999865443334445678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 91 VLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||+.| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---- 167 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---- 167 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC----
Confidence 9999975 77776654 45799999999999999999999999999999999999999999999999999865322
Q ss_pred CcccccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 170 GLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.....+++.|+|||++.+ ....+.++||||+|+++|+|++|..||...+.......+..
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~----------------- 228 (307)
T cd06607 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----------------- 228 (307)
T ss_pred --CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-----------------
Confidence 234568889999999742 23335899999999999999999999987665443332211
Q ss_pred cccccccccccCCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 248 YSYTLQICRADFSC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 248 ~~~~~~~~~~~~~~-~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
...... +..++..+.++|.+||..||++|||+.+++.||||....
T Consensus 229 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 229 --------NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred --------CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 000111 223678899999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=373.59 Aligned_cols=258 Identities=22% Similarity=0.393 Sum_probs=207.7
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 58999999999999999999999999999999999764333344566788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccc
Q 012228 92 LEFIDGGELFDKIAKH-----------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~-----------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla 160 (468)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999988642 23556778899999999999999999999999999999999999999999999
Q ss_pred hhhhhhhc----------------CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHH
Q 012228 161 AISQQVRE----------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMAL 224 (468)
Q Consensus 161 ~~~~~~~~----------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~ 224 (468)
........ .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 76521100 001123579999999999988776 5899999999999999999999987544322
Q ss_pred HHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 225 YRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
...... ...........+++.+.+++.+||..||++|++..+.+.+
T Consensus 240 ~~~~~i-----------------------~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVI-----------------------LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhc-----------------------cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 211000 0000111122478899999999999999999887665544
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=331.93 Aligned_cols=254 Identities=30% Similarity=0.568 Sum_probs=214.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||+|+||.||+|.++.+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+...+..|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5899999999999999999999999999999997653322 234677899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC-ceEEeccccchhhhhhhcCC
Q 012228 94 FIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~~~~~ 170 (468)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||++++++ .+||+|||.+..... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC--Ccc
Confidence 999999999987644 479999999999999999999999999999999999999886 469999999876532 112
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
......|++.|+|||.+.+..+ +.++|+||+||++++|++|..||...+..+....+..
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 216 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------------- 216 (257)
T ss_pred cccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------------
Confidence 2334568999999999877665 5899999999999999999999987766555443211
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
......++.++.++.+++.+||..+|++|||+.++++||||
T Consensus 217 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 -----GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -----ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 01112234578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=332.97 Aligned_cols=254 Identities=31% Similarity=0.528 Sum_probs=210.5
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 47899999999999999999999999999999988654433444566788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 92 LEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999888753 3458999999999999999999999999999999999999999999999999987643311
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch--HHHHHHhhcccccccccccchhhhc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
.......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .......+..
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--------------- 222 (267)
T cd08228 161 --TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ--------------- 222 (267)
T ss_pred --HHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc---------------
Confidence 12234568899999999987776 489999999999999999999996543 2223222110
Q ss_pred cccccccccccccCCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 246 NKYSYTLQICRADFSC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~-~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
...... +..++..+.+++.+||..+|++|||+.++++.
T Consensus 223 ----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 223 ----------CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred ----------CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 011111 22467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.25 Aligned_cols=256 Identities=26% Similarity=0.466 Sum_probs=213.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
+.|+..+.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457778899999999999999999999999999875432 234567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
||+++++|.+++.. +.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhh
Confidence 99999999998864 57899999999999999999999999999999999999999999999999998754321 1112
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
....|+..|+|||.+.+..+ +.++|+||+||++|+|++|..||...........+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------------- 214 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP----------------------- 214 (277)
T ss_pred hcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-----------------------
Confidence 23468889999999987766 489999999999999999999997654433222210
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.......+..++.++.++|.+||..+|++|||+.++++||||...
T Consensus 215 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 215 --KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred --cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 011112233468889999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=331.83 Aligned_cols=289 Identities=25% Similarity=0.386 Sum_probs=222.2
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe------
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------ 84 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 84 (468)
.++.|+-..+||+|.||.|++|+.+++|+.||+|++-.++- +.+.-....+|+.+|..|+|+|++.+++++..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 56778999999999999999999999999999998754332 23344566799999999999999999987633
Q ss_pred --CCEEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 85 --KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 85 --~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
...+|+||.+|+. +|+.++.+. .+++..+++.++.+|+.||.|+|.+.|+|||+||.|+||+.+|.+||+|||+|+
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 2358999999987 899888766 589999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcC--CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcc---cccccc
Q 012228 162 ISQQVRED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVST---FHFLSV 236 (468)
Q Consensus 162 ~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~---~~~~~~ 236 (468)
.+....+. ...+...-|.+|++||.+.|..-++++.|||+.|||+.+|++|.+.+.+.+.......|.. ......
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 76543321 2245567799999999999988889999999999999999999999998876555444321 111111
Q ss_pred cccc-hhhhccccccccccccccCCC------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 237 YGES-YKKCTNKYSYTLQICRADFSC------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~~~~~------~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
|+.. ........+.. ....+.+.. |-.-.+++.+|+.+||..||.+|+++.+++.|.||.+...|
T Consensus 253 WP~~d~lpL~~sie~e-Pl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELE-PLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CCCcccchHHHhccCC-CCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 1110 00000000000 001111110 11135789999999999999999999999999999876543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.28 Aligned_cols=283 Identities=26% Similarity=0.409 Sum_probs=213.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|++.+.||+|++|+||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999865432 222345678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-CCceEEeccccchhhhhhhc
Q 012228 92 LEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~~~~~~~ 168 (468)
|||+++ +|.+.+..... +++..+..++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999965 88887765443 588899999999999999999999999999999999985 567999999998654321
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
........+++.|+|||.+.+....+.++||||+||++|+|++|.+||...+..+...++...... .....+.......
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT-PNEETWPGVTSLP 235 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChhhccccccch
Confidence 112234567899999999876555568999999999999999999999876654443332110000 0000000000000
Q ss_pred ccc--cc--cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 249 SYT--LQ--ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 249 ~~~--~~--~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.+. .. .........+.+++.+.+++.+||+.||++|||+.++++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 000 00 0000001123468899999999999999999999999999999853
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=346.06 Aligned_cols=291 Identities=26% Similarity=0.367 Sum_probs=219.7
Q ss_pred ccccCeEE-EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHH-----------HHHHHHHHHHHHhcCCCCCeeE
Q 012228 10 TRVGKYEL-GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK-----------MVEQIKREISTMKLIKHPNVIK 77 (468)
Q Consensus 10 ~~~~~y~i-~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~i~~Ei~il~~l~hpnIv~ 77 (468)
..-++|.. .+.||+|+||+||+|.+..+++.||+|++......... ....+.+|+.+++.++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 34567875 57799999999999999999999999998654322100 0124679999999999999999
Q ss_pred EEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecc
Q 012228 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157 (468)
Q Consensus 78 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DF 157 (468)
+++++...+..|+||||+. |+|.+++.....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999997 499999988888999999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhh------------hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHH
Q 012228 158 GLSAISQQV------------REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY 225 (468)
Q Consensus 158 Gla~~~~~~------------~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~ 225 (468)
|++...... ..........+++.|+|||.+.+....+.++|+||+||++|+|++|.+||...+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998754310 01112233457889999999877665578999999999999999999999887765554
Q ss_pred Hhhcccccccccccchhhhcc---ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 226 RKVSTFHFLSVYGESYKKCTN---KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
..+...... .....+..... ................+..+..+.++|.+||+.||++|||+++++.||||+....+
T Consensus 244 ~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 244 GRIFELLGT-PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHHhCC-CchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 433211000 00000000000 00000000000011123468889999999999999999999999999999976544
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=337.95 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=209.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcC-----CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++..... ....+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 5679999999999999999998753 467899999865432 224568899999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCce
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG--------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVL 152 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~--------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~l 152 (468)
..|+||||+++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997643 47889999999999999999999999999999999999999999
Q ss_pred EEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccc
Q 012228 153 KISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTF 231 (468)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~ 231 (468)
||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~- 239 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ- 239 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-
Confidence 9999999874322111112233456788999999987776 589999999999999998 9999987766655544311
Q ss_pred ccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 232 HFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+..++..+.+++.+||..||++|||+.|+++
T Consensus 240 ------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 ------------------------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred ------------------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1111234457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=332.89 Aligned_cols=251 Identities=29% Similarity=0.471 Sum_probs=205.8
Q ss_pred EEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccC
Q 012228 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (468)
Q Consensus 17 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 96 (468)
....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+|+||++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 3458999999999999999999999999986543 2235678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-CCceEEeccccchhhhhhhcCCcc
Q 012228 97 GGELFDKIAKH-GRL--KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 97 gg~L~~~i~~~-~~l--~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
+++|.+.+... ..+ ++..+..++.|++.||+|||++||+||||||+||+++. ++.++|+|||++..... .....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--~~~~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCT 166 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc--CCCcc
Confidence 99999998764 445 88899999999999999999999999999999999986 67999999999875432 11223
Q ss_pred cccCCCCCcCCccccccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHH-HHhhcccccccccccchhhhcccccc
Q 012228 173 HTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMAL-YRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~-~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
....|++.|+|||++.+.. ..+.++|+||+|+++|+|++|..||........ ....
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~---------------------- 224 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV---------------------- 224 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh----------------------
Confidence 3346889999999986543 246899999999999999999999975432111 0000
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.........|..+++++.+|+++||+.+|.+|||+.+++.||||
T Consensus 225 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 225 --GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred --hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 01122234566688999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=335.55 Aligned_cols=255 Identities=21% Similarity=0.277 Sum_probs=206.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcC-----CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34679999999999999999998752 456799999864321 22345678999999999999999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEe
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHG----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 155 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~ 155 (468)
+..++||||+++|+|.+++.... .++...+..++.|++.||+|||+.|++||||||+|||+++++.+||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999987532 25678889999999999999999999999999999999999999999
Q ss_pred ccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccc
Q 012228 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFL 234 (468)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~ 234 (468)
|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~----- 235 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM----- 235 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 9999875432111111123456788999999987666 589999999999999998 799998877665554421
Q ss_pred cccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 235 SVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......+...+..+.+++.+||+.||++|||+.+++++
T Consensus 236 --------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 --------------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred --------------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111223445578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=330.67 Aligned_cols=246 Identities=27% Similarity=0.456 Sum_probs=201.4
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 98 (468)
+.||+|+||.||+|++..+++.||+|.+.... .......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999876432 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 99 ELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 99 ~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999987644 589999999999999999999999999999999999999999999999999875332110000111123
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICR 256 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (468)
+..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.......+. ..
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-------------------------~~ 212 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-------------------------QG 212 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-------------------------cC
Confidence 456999999987766 589999999999999997 999997765544433321 11
Q ss_pred ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 257 ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 257 ~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.....+..++..+.+|+.+||+.||++|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 213 VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 122345557899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=318.38 Aligned_cols=254 Identities=29% Similarity=0.498 Sum_probs=208.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-----CCE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-----KTK 87 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-----~~~ 87 (468)
.+|++.+.||+|+|+.|+++.+..++..||+|.+.... .+..+...+||...++++|||+++++++... ...
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 57999999999999999999999999999999997654 3457788999999999999999999886533 345
Q ss_pred EEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeeccCCceEEeccccch
Q 012228 88 IYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~yLH~~g--ivHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
.|++++|...|+|.+.|+.. ..++|.++..||.++++||++||+.. .+||||||.|||+.+.+..+|.|||.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999988753 25999999999999999999999998 9999999999999999999999999987
Q ss_pred hhhhhhcCC-------cccccCCCCCcCCccccccCCCC--CChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccc
Q 012228 162 ISQQVREDG-------LLHTACGTPNYVAPEVLNDKGYD--GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH 232 (468)
Q Consensus 162 ~~~~~~~~~-------~~~~~~gt~~y~APEvl~~~~~~--~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~ 232 (468)
...-.-.+. .......|..|+|||++.-+.+. +.++|||||||+||.|+.|..||+.. +++
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~-----~~~----- 247 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI-----YQQ----- 247 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH-----hhc-----
Confidence 543211111 11223468899999998755443 68999999999999999999999642 111
Q ss_pred cccccccchhhhccccccccccccccCCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 233 FLSVYGESYKKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
-....+-+.++.+.+|.. +|..+.+||+.||+.||.+||++.+++.+
T Consensus 248 --------------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 --------------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred --------------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 011112245556666543 89999999999999999999999999865
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=327.41 Aligned_cols=254 Identities=33% Similarity=0.598 Sum_probs=219.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+++++.++|||++++++++.+.+..|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999765432 2356789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
|+++++|.+++.....+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc--cccc
Confidence 99999999999988899999999999999999999999999999999999999999999999999987654321 1233
Q ss_pred ccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccc
Q 012228 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253 (468)
Q Consensus 174 ~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (468)
...++..|+|||.+.+..+ +.++|+||+|+++++|++|..||...+........
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~------------------------- 211 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI------------------------- 211 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-------------------------
Confidence 4578999999999877664 58999999999999999999999876543333221
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 254 ~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
........+..++..+.+++.+||..+|++|||+.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 212 VQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred hccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 1122233455678999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.82 Aligned_cols=255 Identities=20% Similarity=0.342 Sum_probs=210.3
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEc----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNV----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
.+..|++.+.||+|+||+||+|... .++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3567999999999999999999863 456789999986432 2234567889999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC
Q 012228 87 KIYIVLEFIDGGELFDKIAKH-----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~-----------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~ 149 (468)
..|+||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999988532 237888999999999999999999999999999999999999
Q ss_pred CceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhh
Q 012228 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKV 228 (468)
Q Consensus 150 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~ 228 (468)
+.+||+|||+++...............++..|+|||.+.+..+ +.++|+||+||++|+|++ |..||.+.+.......+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875433221122234456778999999987666 589999999999999998 99999877665554443
Q ss_pred cccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
. .......+..+++.+.+++.+||+.||.+||++.+++++
T Consensus 240 ~-------------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 R-------------------------KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred H-------------------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 1 112233455688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=328.86 Aligned_cols=254 Identities=36% Similarity=0.634 Sum_probs=219.6
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||.|+||.||+|.+..++..||+|++...... ......+.+|+++++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999999999999999764332 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 94 FIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 94 ~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
++++++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999998764 679999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
......+|++.|+|||.+.+..+ +.++|+||+|+++++|++|..||...+..........
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------- 217 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK------------------- 217 (258)
T ss_pred ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-------------------
Confidence 23345678999999999877766 5889999999999999999999988776655554311
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
......|..++..+.+++.+||..+|.+|||+.++++||||
T Consensus 218 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 218 ------GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 11223445678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.39 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=203.6
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHH-HhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIST-MKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.+|++.+.||+|+||.||+|++..+|+.||+|.+....... ....+..|+.+ ++.++||||+++++++...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 36999999999999999999999999999999987643222 22345566665 6777899999999999999999999
Q ss_pred EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 92 LEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
|||++| +|.+.+.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 999974 77766643 34689999999999999999999998 999999999999999999999999999875432
Q ss_pred hcCCcccccCCCCCcCCccccccC---CCCCChhhHHHHHHHHHHHhhCCCCCCCch-HHHHHHhhcccccccccccchh
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~---~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
........|+..|+|||.+.+. ...+.++|+||+||++|+|++|..||.... ..+.....
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------------- 220 (283)
T cd06617 157 --SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-------------- 220 (283)
T ss_pred --ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH--------------
Confidence 1112335688999999988642 123588999999999999999999996432 11111110
Q ss_pred hhccccccccccccccCCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 243 KCTNKYSYTLQICRADFSCP-SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
........| ..+|.++.+||.+||..+|.+|||+.++++||||.+.
T Consensus 221 -----------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 221 -----------VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred -----------HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 111111222 2378999999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=336.47 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=207.6
Q ss_pred cCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
.+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 46999999999999999999863 345679999886532 2345678899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEE
Q 012228 88 IYIVLEFIDGGELFDKIAKHG-------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKI 154 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~-------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl 154 (468)
.|+||||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||+++++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999987543 4899999999999999999999999999999999999999999999
Q ss_pred eccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccccc
Q 012228 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHF 233 (468)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~ 233 (468)
+|||++................+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.......+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~--- 237 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ--- 237 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---
Confidence 99999875432211112233446788999999987666 589999999999999998 9999988776655554321
Q ss_pred ccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+..++.++.+|+.+||+.||.+|||+.++++
T Consensus 238 ----------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 ----------------------GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred ----------------------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1112234457889999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.02 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=209.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcC-----CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3679999999999999999999977 77889999886432 2223456888999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC---ceEEec
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISD 156 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g---~lkl~D 156 (468)
..|+||||++|++|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999987653 488999999999999999999999999999999999998765 599999
Q ss_pred cccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccccccc
Q 012228 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
||+++................++.|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~------ 235 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT------ 235 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------
Confidence 999875422111111112234568999999987766 589999999999999996 999999877665554431
Q ss_pred ccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......|..++..+.+++.+||+.||++|||+.++++|
T Consensus 236 -------------------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 236 -------------------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -------------------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112233455688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=329.48 Aligned_cols=258 Identities=30% Similarity=0.511 Sum_probs=215.0
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh--hhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--CEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKI 88 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 88 (468)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 469999999999999999999999999999999854321 1223456888999999999999999999998764 568
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999875432211
Q ss_pred -CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
........|+..|+|||.+.+..+ +.++|+||+||++|+|++|..||...........+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------------ 222 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA------------------ 222 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH------------------
Confidence 112234568999999999987766 489999999999999999999998765444333321
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
........|..++..+.++|.+||+ +|.+|||+.+++.|||.
T Consensus 223 ------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 223 ------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 1112234566789999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.10 Aligned_cols=253 Identities=21% Similarity=0.342 Sum_probs=208.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCE----EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDF----VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
..+|++.+.||+|+||+||+|.+..+++. ||+|++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 45799999999999999999998766654 8999986432 233456788999999999999999999998764 5
Q ss_pred EEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.++++||+.+|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 789999999999999988744 6899999999999999999999999999999999999999999999999999865432
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
..........++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+....+......
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~---------------- 225 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---------------- 225 (316)
T ss_pred CcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh----------------
Confidence 22111222345678999999987776 489999999999999997 999998876655443321
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......++.++.++.+++.+||..||.+|||+.+++.+
T Consensus 226 ---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 226 ---------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ---------CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112234456678899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=365.82 Aligned_cols=287 Identities=21% Similarity=0.331 Sum_probs=200.4
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCC-CCEEEEEE--------------eechhhhhHHHHHHHHHHHHHHhcCCCC
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVET-GDFVAIKI--------------VDRDQVLRHKMVEQIKREISTMKLIKHP 73 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vAiK~--------------i~~~~~~~~~~~~~i~~Ei~il~~l~hp 73 (468)
....++|++++.||+|+||+||+|..+.. +...+.|. +.+...........+.+|+.+|+.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 33467899999999999999999876532 22233221 1111111222455688999999999999
Q ss_pred CeeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 012228 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 148 (468)
Q Consensus 74 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~ 148 (468)
||+++++++.+.+..|+|+|++.+ +|++++... .......++.++.||+.||+|||++||+||||||+|||++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 999999999999999999999965 787776542 23456778899999999999999999999999999999999
Q ss_pred CCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCC-CCCc--h-HHHH
Q 012228 149 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDES--N-LMAL 224 (468)
Q Consensus 149 ~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~P-f~~~--~-~~~~ 224 (468)
+|.+||+|||+|..+.... .......+||+.|+|||++.+..| +.++||||+||++|+|++|..| |... + ...+
T Consensus 303 ~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999997654321 112234679999999999988877 4899999999999999998754 4322 1 2222
Q ss_pred HHhhcccccc-cccccchhhhccccccccccccccCCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 225 YRKVSTFHFL-SVYGESYKKCTNKYSYTLQICRADFSC-----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 225 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.+.+...... ..+............. ..+....... ...++.++.++|.+||+.||.+|||+.|+|+||||..
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDS-AEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhh-hhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 2222111000 0000000000000000 0000000000 1125678899999999999999999999999999976
Q ss_pred C
Q 012228 299 G 299 (468)
Q Consensus 299 ~ 299 (468)
.
T Consensus 460 ~ 460 (501)
T PHA03210 460 E 460 (501)
T ss_pred C
Confidence 3
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=337.52 Aligned_cols=275 Identities=26% Similarity=0.414 Sum_probs=212.6
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
|++.+.||.|++|.||+|.+..+|..||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999998754322 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 95 IDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 95 ~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
++ ++|.+++.... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 96 58999887765 6899999999999999999999999999999999999999999999999998644321 1122
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchh------hhcc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK------KCTN 246 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 246 (468)
....+++.|+|||++.+....+.++|+||+||++|+|++|.+||...+.......+...... .....+. ....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGT-PDEDVWPGVTSLPDYKP 235 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChHHhhhhhhchhhhh
Confidence 33456889999999876554568999999999999999999999877654433332111000 0000000 0000
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.... ..........+.++..+.++|.+||+.||.+|||++++++||||
T Consensus 236 ~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 236 TFPK--WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hccc--ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0000 00001111234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=326.05 Aligned_cols=257 Identities=32% Similarity=0.583 Sum_probs=218.4
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--CEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKIYIV 91 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV 91 (468)
+|++.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.+++.++||||+++++.+... +.+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999999999999998765432 33467889999999999999999999999988 899999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
+||+++++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999876544222112
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch-HHHHHHhhcccccccccccchhhhcccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
.....++..|+|||.+.+..+ +.++|+||+|+++++|++|..||...+ .......+.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 217 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG--------------------- 217 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc---------------------
Confidence 345678999999999877665 589999999999999999999998765 221111110
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
........|...+..+.++|.+||..||.+|||+.++++||||
T Consensus 218 ---~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 218 ---SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ---ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 1112233455578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=346.24 Aligned_cols=282 Identities=27% Similarity=0.377 Sum_probs=212.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC------
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK------ 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 85 (468)
.++|++.+.||.|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 4789999999999999999999999999999999865432 2356788999999999999999999876543
Q ss_pred --------CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec-cCCceEEec
Q 012228 86 --------TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISD 156 (468)
Q Consensus 86 --------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~-~~g~lkl~D 156 (468)
...|+||||+++ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 358999999975 88887754 5799999999999999999999999999999999999998 456789999
Q ss_pred cccchhhhhhhc-CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc
Q 012228 157 FGLSAISQQVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 157 FGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
||++........ ........++..|+|||++.+....+.++||||+||++|+|++|..||...+...............
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875432111 1122334688999999987665555689999999999999999999998776555444432111000
Q ss_pred ccccchhhhccccccccc-----cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 236 VYGESYKKCTNKYSYTLQ-----ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
. ................ .........+.++.++.+||.+||+.||.+|||++++++||||+..
T Consensus 239 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 R-EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred C-hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0000000000000000 0000001123478899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=345.97 Aligned_cols=284 Identities=29% Similarity=0.384 Sum_probs=216.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-----C
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-----T 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 86 (468)
..+|++.+.||+|+||+||+|.+..++..||||.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 4589999999999999999999999999999999865322 222345677899999999999999999987544 3
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.+|+||||+. ++|.+.+...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999996 589999988888999999999999999999999999999999999999999999999999998754321
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
........++..|+|||.+.+....+.++||||+||++|+|++|..||.+.+.......+...... ...........
T Consensus 162 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 238 (337)
T cd07858 162 --GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS-PSEEDLGFIRN 238 (337)
T ss_pred --cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC-CChHHhhhcCc
Confidence 123345578999999999875444568999999999999999999999877654433322110000 00000000000
Q ss_pred --ccccccccc---cc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 247 --KYSYTLQIC---RA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 247 --~~~~~~~~~---~~-~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
...+..... .. .....+.+++++.+||++||+.||++|||++++++||||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000000 00 0011234789999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=329.08 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=212.1
Q ss_pred eeeeecCCeEEEEEEEcCC---CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEcc
Q 012228 19 RTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 95 (468)
+.||+|+||.||+|.+... +..||+|++....... ..+.+.+|+.+++.++||||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999999866 8899999997654322 4678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 96 DGGELFDKIAKH---------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 96 ~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 77999999999999999999999999999999999999999999999999998865432
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
..........+++.|+|||.+....+ +.++||||+||++|+|++ |..||...+..+..+.+..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------------- 222 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------------- 222 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------------
Confidence 21122344567889999999887665 589999999999999998 6999998877666665321
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......|..+|+++.+++.+||..||.+|||+.+++++
T Consensus 223 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 ----------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ----------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 22334566689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=343.19 Aligned_cols=281 Identities=25% Similarity=0.380 Sum_probs=215.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT---- 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 86 (468)
..++|++.+.||+|+||.||+|.+..+|..||+|.+.+.. ........+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 4678999999999999999999999999999999986532 22234556889999999999999999999987653
Q ss_pred --EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 87 --KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 87 --~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
.+|+||||+ |++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 469999999 6688877764 679999999999999999999999999999999999999999999999999987532
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
. ......+++.|+|||.+.+....+.++|+||+||++|+|++|..||...+.......+....... ...+...
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~ 242 (343)
T cd07880 170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP--SKEFVQK 242 (343)
T ss_pred c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC--CHHHHHh
Confidence 2 12345678999999998765445789999999999999999999998776554444332111000 0000000
Q ss_pred ccc---cccccc---ccccc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 245 TNK---YSYTLQ---ICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 245 ~~~---~~~~~~---~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
... ..+... ..... ....+.+++.+.++|.+||..||++|||+.+++.||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 000 000000 00000 1123457889999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=328.47 Aligned_cols=247 Identities=38% Similarity=0.724 Sum_probs=217.3
Q ss_pred eeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCH
Q 012228 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (468)
Q Consensus 21 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 100 (468)
||+|+||.||++.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999876655544567889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCC
Q 012228 101 FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180 (468)
Q Consensus 101 ~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 180 (468)
.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 9999988889999999999999999999999999999999999999999999999999987543311 22345678899
Q ss_pred cCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCC
Q 012228 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFS 260 (468)
Q Consensus 181 y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (468)
|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.....+.+ ....+.
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~--------------------------~~~~~~ 211 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--------------------------LKDPLR 211 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------------------------hcCCCC
Confidence 999999877665 58899999999999999999999887765555442 224456
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCH---HHHhcCccc
Q 012228 261 CPSWFSSGAKKLIKRILDPNPDTRMTI---SQMLEDEWF 296 (468)
Q Consensus 261 ~~~~~s~~~~~Ll~~~L~~dP~~R~t~---~eil~hpwf 296 (468)
.|..++..+.+++++||..||++|||+ +++++||||
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 666779999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=328.02 Aligned_cols=253 Identities=32% Similarity=0.571 Sum_probs=210.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.+++.++|+||+++++.+...+..++|
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 36899999999999999999999999999999998754443444467788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 92 LEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~- 159 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC-
Confidence 999999999998864 345899999999999999999999999999999999999999999999999998754321
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch--HHHHHHhhcccccccccccchhhhc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
........+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.... .......+.
T Consensus 160 -~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------------- 221 (267)
T cd08224 160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---------------- 221 (267)
T ss_pred -CcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh----------------
Confidence 122334578999999999987777 489999999999999999999996543 222222211
Q ss_pred cccccccccccccCCCCC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 246 NKYSYTLQICRADFSCPS-WFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~-~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......|. .++..+.++|.+||..+|++|||+.++++
T Consensus 222 ---------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 222 ---------KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---------cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 001112222 47889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=331.73 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=210.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCC-----CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETG-----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
..+|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 468999999999999999999986443 789999986442 2223456789999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEec
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~D 156 (468)
..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 9999999999999999986532 367889999999999999999999999999999999999999999999
Q ss_pred cccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccccccc
Q 012228 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+..+.+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~------ 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI------ 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh------
Confidence 999875543222122334557889999999877665 589999999999999998 999998877666555431
Q ss_pred ccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......|..++..+.+++.+||+.+|++|||+.++++
T Consensus 236 -------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 -------------------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred -------------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11233445567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=334.48 Aligned_cols=259 Identities=31% Similarity=0.586 Sum_probs=214.6
Q ss_pred CeEEEeeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhh-hHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 88 (468)
.|++.+.||.|+||.||.|.+. .+|..||+|++...... .....+.+.+|+.+++.+ +||||+++++.+.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999985 47899999998754332 222356778999999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++...... .
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-E 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc-c
Confidence 999999999999999998888999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CCcccccCCCCCcCCccccccC-CCCCChhhHHHHHHHHHHHhhCCCCCCCchH----HHHHHhhcccccccccccchhh
Q 012228 169 DGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
.......+|+..|+|||.+.+. ...+.++||||+|+++|+|++|..||..... ..+...
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---------------- 223 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR---------------- 223 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH----------------
Confidence 1223356789999999998653 2346889999999999999999999964321 122111
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCcccccC
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKKG 299 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~~ 299 (468)
........|..+++.+.+|+++||..||++|| ++++++.||||++.
T Consensus 224 ----------~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 224 ----------ILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred ----------hhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 12223344556889999999999999999997 89999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=331.75 Aligned_cols=262 Identities=31% Similarity=0.448 Sum_probs=209.3
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CCEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKIYI 90 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 90 (468)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++.++||||+++++++.+ .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999875432 2345678899999999999999999998854 447899
Q ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 91 VLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887643 345899999999999999999999999999999999999999999999999998654321
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch-----HHHHHHhhcccccccccccch
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-----LMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~ 241 (468)
......++..|+|||.+.+..+ +.++|+||+||++|+|++|..||.... ..+....+.....
T Consensus 159 ----~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 225 (287)
T cd06621 159 ----LAGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-------- 225 (287)
T ss_pred ----ccccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc--------
Confidence 1224567889999999987766 489999999999999999999998652 1222221110000
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
. ...........+++.+.++|.+||..||.+|||+.|+++||||++..
T Consensus 226 -------~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 226 -------P----ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred -------h----hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 0 00000000012467899999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.33 Aligned_cols=255 Identities=28% Similarity=0.466 Sum_probs=210.3
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCC-----CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEe
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVET-----GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS 84 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 84 (468)
..++|++.+.||+|+||.||++..... ...+|+|.+..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 346799999999999999999998643 36899999875432 23456688999999999 79999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 012228 85 KTKIYIVLEFIDGGELFDKIAK----------------HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 148 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~----------------~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~ 148 (468)
...+|++|||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 9999999999999999999864 245889999999999999999999999999999999999999
Q ss_pred CCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHh
Q 012228 149 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRK 227 (468)
Q Consensus 149 ~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~ 227 (468)
++.+||+|||+++...............++..|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+..+.
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 99999999999886543221111222335678999999877666 589999999999999997 9999988777666655
Q ss_pred hcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 228 VSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
+.. ......+...+..+.+|+.+||..||++|||+.+++++
T Consensus 247 ~~~-------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKE-------------------------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHc-------------------------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 321 11223455578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=338.28 Aligned_cols=281 Identities=27% Similarity=0.432 Sum_probs=212.6
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC--CC----CeeEEEEE
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--HP----NVIKIIEV 81 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--hp----nIv~l~~~ 81 (468)
+....++|.++++||+|+||.|-.+.+..++..||+|+++.-. ...+..+-||++|+++. -| -+|.+.++
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3445688999999999999999999999999999999996432 24466778999999994 23 37888899
Q ss_pred EEeCCEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-----------
Q 012228 82 MASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS----------- 148 (468)
Q Consensus 82 ~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~----------- 148 (468)
|.-.+++|+|+|.+ |-++++++.+++ +++.++++.+.+||+.+++|||+.+++|.||||||||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999999999 449999998866 5889999999999999999999999999999999999932
Q ss_pred ---------CCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc
Q 012228 149 ---------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES 219 (468)
Q Consensus 149 ---------~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~ 219 (468)
+..++|+|||.|+.-.. .-++...|..|+|||++.+-+|. .++||||+||||+||++|...|...
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred ccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccC
Confidence 23589999999985332 22567889999999999999995 8999999999999999999999765
Q ss_pred hHH---HHHHhhcccccccccccc------------hhhhcccc--ccccccccccCCC---CCCCCHHHHHHHHHhcCC
Q 012228 220 NLM---ALYRKVSTFHFLSVYGES------------YKKCTNKY--SYTLQICRADFSC---PSWFSSGAKKLIKRILDP 279 (468)
Q Consensus 220 ~~~---~~~~~~~~~~~~~~~~~~------------~~~~~~~~--~~~~~~~~~~~~~---~~~~s~~~~~Ll~~~L~~ 279 (468)
+.. ++++.+......-..... |.+..... .+....+.....+ ...-..++.+||++||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 533 355655432111000000 00000000 0000001000000 000124588999999999
Q ss_pred CCCCCCCHHHHhcCcccccC
Q 012228 280 NPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 280 dP~~R~t~~eil~hpwf~~~ 299 (468)
||.+|+|+.|+|.||||+..
T Consensus 393 DP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFARL 412 (415)
T ss_pred CccccccHHHHhcCHHhhcC
Confidence 99999999999999999854
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=328.76 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=209.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCC---CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
++|++.+.||+|+||+||+|....+ ...||+|.+.... .......+.+|+.+++.++||||+++++.+...+..|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 5799999999999999999998654 4579999986543 2334566889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+||||+++++|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999999998764 4689999999999999999999999999999999999999999999999999986642111
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~----------------- 223 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED----------------- 223 (266)
T ss_pred ceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-----------------
Confidence 111112345678999999987666 589999999999999997 9999987666555544321
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus 224 --------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 224 --------GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11122344578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=337.75 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=206.4
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCE--EEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeC
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (468)
.....+|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 34567899999999999999999999877765 566665432 2233456788999999999 899999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~ 149 (468)
+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999987543 47899999999999999999999999999999999999999
Q ss_pred CceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhh
Q 012228 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKV 228 (468)
Q Consensus 150 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~ 228 (468)
+.+||+|||++........ .....++..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+..+....+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred CcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 9999999999863221110 111234567999999877665 589999999999999998 99999877666555442
Q ss_pred cccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.. ......+..+++++.+|+.+||+.+|++|||+++++++
T Consensus 237 ~~-------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 PQ-------------------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hc-------------------------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 00112233468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=337.12 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=209.3
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcC-------CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVE-------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEV 81 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~ 81 (468)
...++|.+++.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+ +||||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 345789999999999999999998743 23569999987542 223356788999999999 79999999999
Q ss_pred EEeCCEEEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 012228 82 MASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 145 (468)
Q Consensus 82 ~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NIL 145 (468)
+...+..|+||||+++|+|.+++.... .++...+..++.|++.||+|||++|++||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999997642 4788999999999999999999999999999999999
Q ss_pred eccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHH
Q 012228 146 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMAL 224 (468)
Q Consensus 146 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~ 224 (468)
++.++.+||+|||++................+++.|+|||++.+..+ +.++|+||+||++|+|++ |..||...+..+.
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 99999999999999875432111111112234578999999987666 589999999999999998 8999988776665
Q ss_pred HHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 225 YRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
...+.. ......|...+.++.+|+.+||..+|.+|||+.+++++
T Consensus 252 ~~~~~~-------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 252 FKLLKE-------------------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHc-------------------------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 554321 11223455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=331.48 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=205.4
Q ss_pred eEEEeeeeecCCeEEEEEEEcC---CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE----
Q 012228 15 YELGRTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK---- 87 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 87 (468)
|++++.||+|+||.||.|.... ++..||+|.+..+.. .....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 6789999999999999999764 347899999875433 23345678899999999999999999998765443
Q ss_pred --EEEEEEccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecccc
Q 012228 88 --IYIVLEFIDGGELFDKIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 88 --~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGl 159 (468)
.+++|||+++|+|..++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999887542 3589999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccc
Q 012228 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
++...............++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~--------- 229 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR--------- 229 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---------
Confidence 875433211111222345678999999876666 589999999999999999 999998876665554432
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......|..++..+.+++.+||+.||++|||+.+++++
T Consensus 230 ----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 230 ----------------HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------------cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112234456688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=368.87 Aligned_cols=151 Identities=29% Similarity=0.624 Sum_probs=141.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
.+++|++.+.||+|+||+||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++...+.+|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 47899999999999999999999999999999999986655455556788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
||||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=328.34 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=210.5
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
...|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+++.++||||+++++++...+.++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 456999999999999999999999999999999986432 2245678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99999999999987543 5899999999999999999999999999999999999999999999999998754321111
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
......+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+....+..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~------------------ 220 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------------ 220 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC------------------
Confidence 1112234567999999887766 488999999999999998 9999988777666555321
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......+..++.++.+++.+||+.||++|||+.++++.
T Consensus 221 -------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 221 -------GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 11223455688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=337.76 Aligned_cols=285 Identities=27% Similarity=0.459 Sum_probs=214.4
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT- 86 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~- 86 (468)
+...+++|++.+.||+|+||.||+|.++.+|+.||+|.++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 345678999999999999999999999999999999999754322 223356778999999999999999999987655
Q ss_pred ---------EEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEec
Q 012228 87 ---------KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156 (468)
Q Consensus 87 ---------~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~D 156 (468)
.+|+|+||+++ ++...+... ..+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 79999999987 677766653 4699999999999999999999999999999999999999999999999
Q ss_pred cccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccc
Q 012228 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSV 236 (468)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~ 236 (468)
||++........ .......++..|+|||.+.+....+.++||||+||++++|++|.+||...+..+....+...... .
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~-~ 237 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS-P 237 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-C
Confidence 999876543221 12223356788999998876554568999999999999999999999877655444433221000 0
Q ss_pred cccchhhhccccccc-----cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 237 YGESYKKCTNKYSYT-----LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 237 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
....+.......... .......-.....++..+.+|+.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 000000000000000 000000001122368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=349.00 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=203.7
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCC-----CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVET-----GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASK 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~ 85 (468)
-++|++++.||+|+||.||+|.+... +..||+|++.... .....+.+.+|+.+|+.+. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 45788999999999999999987533 3469999986542 2234567889999999996 99999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhc----------------------------------------------------------
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH---------------------------------------------------------- 107 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~---------------------------------------------------------- 107 (468)
+.+|+|||||++|+|.+++...
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999987642
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC
Q 012228 108 --------------------------------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (468)
Q Consensus 108 --------------------------------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~ 149 (468)
..+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 237788889999999999999999999999999999999999
Q ss_pred CceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHH-HHh
Q 012228 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMAL-YRK 227 (468)
Q Consensus 150 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~-~~~ 227 (468)
+.+||+|||+++...............+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||........ +..
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 9999999999875433221112223456788999999987766 589999999999999997 9999976543222 222
Q ss_pred hcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 228 VSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
+. .......+..++..+.+++.+||+.||++|||+.++.+
T Consensus 353 ~~-------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IK-------------------------SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred Hh-------------------------cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 10 11122334557899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=335.51 Aligned_cols=255 Identities=20% Similarity=0.333 Sum_probs=211.0
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCC-----CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVET-----GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
.+.+|++.+.||+|+||+||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 345688999999999999999997543 5789999987543 223456788999999999999999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~ 149 (468)
+..++++||+.+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 247888999999999999999999999999999999999999
Q ss_pred CceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhh
Q 012228 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKV 228 (468)
Q Consensus 150 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~ 228 (468)
+.+||+|||+++...............+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+....+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999875433222222334456789999999877666 589999999999999998 89999887766665553
Q ss_pred cccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.. ......+..++..+.+|+.+||+.+|.+|||+.+|++.
T Consensus 240 ~~-------------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RN-------------------------RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred Hc-------------------------CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 21 11223455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=347.64 Aligned_cols=236 Identities=27% Similarity=0.447 Sum_probs=206.5
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
++.||.|+.|.||+|+. .++.||||+++.- -..+|+-|++|+|||||.+.+++.....+|||||||..
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 57899999999999997 5789999987421 13678889999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 98 g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
|-|...+...+.+.......|..+|+.|+.|||.+.|+|||||.-||||+.+..|||+|||-++..... ......||
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG 273 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG 273 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999998765442 33456899
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRA 257 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (468)
|..|||||++.+.+. +.++||||+||+|||||||..||..-+...+.--+. ...-
T Consensus 274 TVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG------------------------sNsL 328 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG------------------------SNSL 328 (904)
T ss_pred hHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEecc------------------------CCcc
Confidence 999999999998877 499999999999999999999998765433211110 1233
Q ss_pred cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 258 DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 258 ~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.++.|..++..++-||++||+-.|..||++.+||.|
T Consensus 329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 556788899999999999999999999999999998
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.54 Aligned_cols=283 Identities=26% Similarity=0.417 Sum_probs=217.3
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE--
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK-- 87 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 87 (468)
..-++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 356789999999999999999999999999999999865322 22234667889999999999999999988765544
Q ss_pred ----EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 88 ----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 88 ----~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
+|+|+||+ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 5699988875 57999999999999999999999999999999999999999999999999998754
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
.. ......+++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+.... ....+.+..
T Consensus 169 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~ 241 (343)
T cd07851 169 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV--GTPDEELLQ 241 (343)
T ss_pred cc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc--CCCCHHHHh
Confidence 32 13455788999999998765455789999999999999999999998777655544432211 000000000
Q ss_pred hccccc---cccc---cccccC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 244 CTNKYS---YTLQ---ICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 244 ~~~~~~---~~~~---~~~~~~-~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
...... +... .....+ .....++..+.+||.+||+.||.+|||+.++++||||.+...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 000000 0000 000000 1112358899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=330.71 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=203.3
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCC--EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe------CC
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------KT 86 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------~~ 86 (468)
|.+++.||+|+||.||+|.+..++. .+|+|.+..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3578999999999999999987775 699999865432 23346778899999999999999999997633 23
Q ss_pred EEEEEEEccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccc
Q 012228 87 KIYIVLEFIDGGELFDKIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla 160 (468)
..+++|||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999887432 34889999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccccccccccc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (468)
+...............+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||......+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--------- 229 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ--------- 229 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---------
Confidence 86533211111123356778999999987766 589999999999999999 8999988766655554321
Q ss_pred chhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......++.++..+.++|.+||+.||.+|||+.+++++
T Consensus 230 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 230 ----------------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ----------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11223445578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=339.00 Aligned_cols=285 Identities=24% Similarity=0.390 Sum_probs=210.6
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC----
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK---- 85 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 85 (468)
..+++|++.+.||+|+||.||+|.+..+++.+|+|.+....... .......+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 34799999999999999999999999999999999986543222 1234567899999999999999999887443
Q ss_pred ----CEEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccc
Q 012228 86 ----TKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (468)
Q Consensus 86 ----~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla 160 (468)
..+|+||||+.+ +|...+.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 357999999976 67776654 457999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhcC---------CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccc
Q 012228 161 AISQQVRED---------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTF 231 (468)
Q Consensus 161 ~~~~~~~~~---------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~ 231 (468)
......... .......+++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+.......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 754332111 11223457889999999876554568999999999999999999999887765554443211
Q ss_pred ccc-cccc-cchhhhccccc-ccccccccc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 232 HFL-SVYG-ESYKKCTNKYS-YTLQICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 232 ~~~-~~~~-~~~~~~~~~~~-~~~~~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
... .... ..+........ ......... ......+++.+.++|.+||..||.+|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 0000 00000000000 000000000 00012256789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=326.09 Aligned_cols=248 Identities=26% Similarity=0.441 Sum_probs=205.3
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|++.+.||+|+||.||+|..+ .+..+|+|.+...... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 56999999999999999999875 4568999988644322 346788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 999999999998753 4689999999999999999999999999999999999999999999999999875422111 11
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
.....++..|+|||++.+..+ +.++|+||+|+++|+|++ |..||...+..+....+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-------------------- 216 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-------------------- 216 (256)
T ss_pred cCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--------------------
Confidence 112234568999999987766 489999999999999999 9999988876666555321
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......|...+..+.+++.+||..||.+|||++++++
T Consensus 217 -----~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 217 -----GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1112234446788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=332.25 Aligned_cols=278 Identities=28% Similarity=0.470 Sum_probs=213.9
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--CEEEEEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TKIYIVL 92 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 92 (468)
|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++... ...|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999997653 2233445678999999999999999999999888 8999999
Q ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||+++ +|.+.+... ..+++..+..++.|++.||+|||++|++|+||||+||++++++.+||+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 888888765 5799999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc-----
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN----- 246 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 246 (468)
.....++..|+|||.+.+....+.++||||+|+++|+|++|..||...+.......+....... ....+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP-TDENWPGVSKLPWFE 236 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-chhhccccccchhhh
Confidence 3345678899999988765545689999999999999999999998877655544432210000 0000000000
Q ss_pred ccccccccccc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 247 KYSYTLQICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 247 ~~~~~~~~~~~-~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
........... .......++..+.+++++||..||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000000000 000111148899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=334.48 Aligned_cols=259 Identities=26% Similarity=0.469 Sum_probs=213.7
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
|+-..+||+|+||.||++.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 333468999999999999999999999999985432 22356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccc
Q 012228 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT 174 (468)
Q Consensus 95 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 174 (468)
+++++|.+++. ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ......
T Consensus 99 ~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~ 175 (292)
T cd06657 99 LEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKS 175 (292)
T ss_pred CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--cccccc
Confidence 99999988765 457899999999999999999999999999999999999999999999999987643321 111234
Q ss_pred cCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccc
Q 012228 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254 (468)
Q Consensus 175 ~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (468)
..|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.. .
T Consensus 176 ~~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~-----------------------~ 231 (292)
T cd06657 176 LVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-----------------------N 231 (292)
T ss_pred cccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------------------h
Confidence 568999999999876665 5899999999999999999999987665544333211 0
Q ss_pred ccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 012228 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303 (468)
Q Consensus 255 ~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~~ 303 (468)
....+.....+++.+.+++.+||..||.+|||+.++++||||.+...|.
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 232 LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred CCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 0111222234688899999999999999999999999999999877544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=343.66 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=202.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEe-C
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS-K 85 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~-~ 85 (468)
++|++.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.+++++ +||||+++++++.. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 47999999999999999999754 3457899999864322 22346678999999999 79999999998754 4
Q ss_pred CEEEEEEEccCCCCHHHHHHhc----------------------------------------------------------
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH---------------------------------------------------------- 107 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~---------------------------------------------------------- 107 (468)
..++++|||+++|+|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 6789999999999999988542
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCc
Q 012228 108 ---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184 (468)
Q Consensus 108 ---~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 184 (468)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 25788999999999999999999999999999999999999999999999999764321111112234456789999
Q ss_pred cccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCC
Q 012228 185 EVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS 263 (468)
Q Consensus 185 Evl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (468)
|++.+..+. .++||||+||++|+|++ |..||.+....+...... ........|.
T Consensus 245 E~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~------------------------~~~~~~~~~~ 299 (337)
T cd05054 245 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL------------------------KEGTRMRAPE 299 (337)
T ss_pred HHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH------------------------hccCCCCCCc
Confidence 999887774 89999999999999997 999997644322221110 0001122344
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 264 WFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 264 ~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
..++++.+++.+||+.+|++|||+.++++|
T Consensus 300 ~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 300 YATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=342.08 Aligned_cols=285 Identities=27% Similarity=0.387 Sum_probs=221.5
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-----EE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-----KI 88 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 88 (468)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999999999999999987532 12234567889999999999999999999987765 79
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||+.+ +|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999985 8999998878899999999999999999999999999999999999999999999999999886543211
Q ss_pred -CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
........+++.|+|||++.+....+.++|+||+|+++|+|++|.+||...+..+.+..+......... ..+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~ 237 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE-EDLKFITSE 237 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh-hHhhhcccc
Confidence 012344568999999999987744468999999999999999999999988876665554321110000 000000000
Q ss_pred c-ccccc--ccccc---CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 248 Y-SYTLQ--ICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 248 ~-~~~~~--~~~~~---~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
. ..... ..... ....+.++..+.+||.+||++||.+|||+++++.||||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0 00000 00000 0112336889999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=332.01 Aligned_cols=259 Identities=29% Similarity=0.493 Sum_probs=218.9
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
.....|++.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++.+...+..|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 355679999999999999999999998999999999975432 3566789999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 9999999999999998876 89999999999999999999999999999999999999999999999999976543221
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......+++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~------------------ 230 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT------------------ 230 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------
Confidence 12234457889999999887766 5899999999999999999999987665544333211
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
........+..++..+.++|.+||+.+|.+|||+.++++||||++
T Consensus 231 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 231 -----KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred -----cCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 001111222336889999999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=329.56 Aligned_cols=254 Identities=30% Similarity=0.548 Sum_probs=209.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|++.+.||+|+||.||+|++..++..+|+|.+.............+.+|+.+++.++||||+++++.+...+..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 46899999999999999999999999999999988764444444556788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 92 LEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|||++|++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence 999999999998863 346899999999999999999999999999999999999999999999999998754321
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH--HHHHHhhcccccccccccchhhhc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL--MALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
.......+|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+... ......+..
T Consensus 160 -~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------- 222 (267)
T cd08229 160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--------------- 222 (267)
T ss_pred -CcccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc---------------
Confidence 122344678999999999987766 4889999999999999999999975432 122222100
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......+..++..+.+++.+||..||.+|||+.++++
T Consensus 223 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 223 ---------CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ---------CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 00000112347889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=334.19 Aligned_cols=260 Identities=26% Similarity=0.451 Sum_probs=213.2
Q ss_pred CCCCccccCeEEEeeeeecCCeEEEEEEEc-------CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeE
Q 012228 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNV-------ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIK 77 (468)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~ 77 (468)
|.......+|++++.||+|+||.||+|+.. ..+..||+|.+.... .......+.+|+.+++.+ +||||++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchh
Confidence 445566778999999999999999999753 234579999986432 223456788999999999 7999999
Q ss_pred EEEEEEeCCEEEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 012228 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 141 (468)
Q Consensus 78 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp 141 (468)
+++++......|+||||+.+|+|.+++... ..++...+..++.|++.||.|||++||+||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999999999999999999999998763 2467788999999999999999999999999999
Q ss_pred CCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCch
Q 012228 142 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESN 220 (468)
Q Consensus 142 ~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~ 220 (468)
+|||++.++.+||+|||+++...............+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999875533222222233456778999999987666 488999999999999998 899998887
Q ss_pred HHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 221 LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
..++...+.. ......+..++..+.+|+.+||..+|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKE-------------------------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHc-------------------------CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 7776665321 11122344578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=340.94 Aligned_cols=281 Identities=18% Similarity=0.317 Sum_probs=206.5
Q ss_pred eeeeec--CCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccC
Q 012228 19 RTLGEG--SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (468)
Q Consensus 19 ~~LG~G--~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 96 (468)
..||.| +||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 9999999999999999999998764332 2345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC----
Q 012228 97 GGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG---- 170 (468)
Q Consensus 97 gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~---- 170 (468)
+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+|++|||.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999988764 358999999999999999999999999999999999999999999999998654332211110
Q ss_pred -cccccCCCCCcCCccccccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch-----hh
Q 012228 171 -LLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY-----KK 243 (468)
Q Consensus 171 -~~~~~~gt~~y~APEvl~~~~-~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 243 (468)
......++..|+|||++.+.. ..+.++||||+||++|+|++|..||....................+.... ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011123566799999987642 23689999999999999999999998765443332221111100000000 00
Q ss_pred hcc---ccc-----------cccccccc--cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 244 CTN---KYS-----------YTLQICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 244 ~~~---~~~-----------~~~~~~~~--~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
... ... ........ ....+..+++.+.+||++||..||++|||+.++++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 000 000 00000000 1111223678899999999999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=321.03 Aligned_cols=252 Identities=35% Similarity=0.569 Sum_probs=213.6
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999998999999999976432 245678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 94 FIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 94 ~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
|++|++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998876 5799999999999999999999999999999999999999999999999999876543211 3
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
....++..|+|||.+.+..+ +.++|+||+|+++++|++|..||...+..........
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------------- 211 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---------------------- 211 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------------------
Confidence 45678999999999877664 5899999999999999999999987754333322110
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpw 295 (468)
........+..++..+.++|.+||+.||++|||+.++++|||
T Consensus 212 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 -NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 011111222235889999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=333.31 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=210.2
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|...+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++|||++++++++.+.+..|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 37777899999999999999999999999999976544334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 94 FIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 94 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
|+.| +|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.... ..
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~ 174 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PA 174 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------CC
Confidence 9965 77777754 4568999999999999999999999999999999999999999999999999976321 22
Q ss_pred cccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 173 HTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
....|+..|+|||++.. ....+.++|+||+||++|+|++|..||...+.......+...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------------------- 235 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------------- 235 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------------
Confidence 35678999999999842 233358899999999999999999999876654443332110
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.........++..+.+|+.+||+.+|.+|||+.+++.||||+..
T Consensus 236 -----~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 236 -----DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred -----CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 00001122367789999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=331.44 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=207.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
..++|.+.+.||+|+||.||+|.+. .++..+|+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4567999999999999999999864 3455699998864432 2345688999999999999999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~ 149 (468)
+..++||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997543 38899999999999999999999999999999999999999
Q ss_pred CceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhh
Q 012228 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKV 228 (468)
Q Consensus 150 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~ 228 (468)
+.+||+|||++................+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...+..+....+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999875432211122234556889999999987766 489999999999999998 99999877766554442
Q ss_pred cccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.. ......+..++..+.+++.+||+.||++|||+.++++
T Consensus 239 ~~-------------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQ-------------------------GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hC-------------------------CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 11 1111223446889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=340.66 Aligned_cols=279 Identities=24% Similarity=0.382 Sum_probs=212.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC------
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK------ 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 85 (468)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4789999999999999999999999999999999875422 222345678999999999999999999988543
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
+.+|++++++ |++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 4578999987 6789887754 5799999999999999999999999999999999999999999999999999875322
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc---c---ccc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS---V---YGE 239 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~---~---~~~ 239 (468)
......+++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+....... . ...
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 173 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred -----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 23345789999999998764444689999999999999999999998766544433322111000 0 000
Q ss_pred c-hhhhccccccccccccccC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 240 S-YKKCTNKYSYTLQICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 240 ~-~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
. .......... .....+ ......++++.+||.+||+.||.+|||+.++++||||++...
T Consensus 248 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 248 ESARNYIQSLTQ---MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HhHHHHHHHhcc---cCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0 0000000000 000000 011125888999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=332.86 Aligned_cols=261 Identities=20% Similarity=0.287 Sum_probs=210.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCC----------------CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETG----------------DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~----------------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn 74 (468)
..++|++++.||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999886544 4589999875432 234677889999999999999
Q ss_pred eeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 012228 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 143 (468)
Q Consensus 75 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~N 143 (468)
|+++++++......+++|||+.+++|.+++.... .+++..+..++.|++.||+|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999987765 68999999999999999999999999999999999
Q ss_pred eeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh--CCCCCCCchH
Q 012228 144 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--GFLPFDESNL 221 (468)
Q Consensus 144 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~--g~~Pf~~~~~ 221 (468)
|+++.++.++|+|||++................+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999875433222222334556788999999877665 589999999999999987 7889987665
Q ss_pred HHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 222 MALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.+........... .........+..++.++.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRD------------------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhcccc------------------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 5554443210000 0001112234457899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=324.52 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=205.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.+.||+|+||+||.|... .+..+|+|.+..... ..+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 357999999999999999999875 345699999865432 135678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||+.+|+|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 9999999999998764 3689999999999999999999999999999999999999999999999999875432111 0
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
......++..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+..+....+..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~------------------- 216 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ------------------- 216 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-------------------
Confidence 1111234567999999987666 489999999999999998 9999987766555444311
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......+...+..+.+++.+||..||.+|||+.+++++
T Consensus 217 ------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 217 ------GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 11122334468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=323.00 Aligned_cols=252 Identities=30% Similarity=0.507 Sum_probs=216.4
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+|++.+.||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999999999999998764432 2335667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 94 FIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 94 ~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998866 356899999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
......+++.|+|||.+.+..+ +.++|+||+|+++++|++|..||...+..+....+..
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------- 215 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------------- 215 (256)
T ss_pred -CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------------
Confidence 2334568999999999987766 4899999999999999999999998876655444211
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
......+..++.++.+++.+||..+|++|||+.++++||++
T Consensus 216 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 ------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 11112334578899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=341.14 Aligned_cols=287 Identities=28% Similarity=0.416 Sum_probs=217.5
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeC--
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK-- 85 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~-- 85 (468)
....++|++.+.||+|+||.||+|.+..+|+.+|+|.+..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 4567889999999999999999999998999999998854321 222345677899999999 999999999988643
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
...|+||||+.+ +|...+... .+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred ceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 468999999975 999988765 789999999999999999999999999999999999999999999999999876543
Q ss_pred hhcC---CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchh
Q 012228 166 VRED---GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 166 ~~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
.... .......||+.|+|||++.+....+.++|+||+||++|+|++|..||.+....+...++....... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~ 238 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP-SAEDIE 238 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-CHHHHH
Confidence 2211 233445689999999998765555689999999999999999999998776555444432211000 000000
Q ss_pred hhccccccc-c-ccc----cccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 243 KCTNKYSYT-L-QIC----RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 243 ~~~~~~~~~-~-~~~----~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
......... . ... .......+.++.++.+||.+||+.||.+|||+.++++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000000000 0 000 00011112268899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=332.44 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=205.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 91 (468)
.+|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4577788999999999999999999999999998754322 33567889999999996 99999999999999999999
Q ss_pred EEccCCCCHHHH---HH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 92 LEFIDGGELFDK---IA--KHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 92 ~E~~~gg~L~~~---i~--~~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
|||+.+ ++.++ +. ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999875 44433 22 235799999999999999999999975 999999999999999999999999999875432
Q ss_pred hhcCCcccccCCCCCcCCccccccC--CCCCChhhHHHHHHHHHHHhhCCCCCCCchH-HHHHHhhcccccccccccchh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 242 (468)
........|++.|+|||++.+. ...+.++||||+||++|+|++|..||..... .+.........
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------- 227 (288)
T cd06616 161 ---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD---------- 227 (288)
T ss_pred ---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC----------
Confidence 1122345689999999998766 2446899999999999999999999976541 11111110000
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
........+..++.++.+||.+||+.||++|||++++++||||+.
T Consensus 228 -----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 228 -----------PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred -----------CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 000011112337889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=329.33 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=206.6
Q ss_pred cCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
.+|++.++||+|+||.||+|... .++..+|+|.+.... ....+.+.+|+++++.++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 46889999999999999999743 356689999876432 3345678999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCce
Q 012228 88 IYIVLEFIDGGELFDKIAKHG---------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVL 152 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~---------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~l 152 (468)
.|++|||+++|+|.+++.... .+++..+..++.|++.|++|||++|++||||||+|||+++++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 999999999999999987643 47899999999999999999999999999999999999999999
Q ss_pred EEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccc
Q 012228 153 KISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTF 231 (468)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~ 231 (468)
||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||......+....+.
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-- 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-- 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH--
Confidence 9999999874432111111223345788999999987776 489999999999999998 999997766555444421
Q ss_pred ccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 232 HFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus 239 -----------------------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 -----------------------QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred -----------------------cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11223345568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=333.64 Aligned_cols=253 Identities=27% Similarity=0.444 Sum_probs=206.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcC-------CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVE-------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMA 83 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~ 83 (468)
.++|.+++.||+|+||.||+|.+.. .+..+|+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 3689999999999999999998632 34579999986432 223456788999999999 5999999999999
Q ss_pred eCCEEEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 012228 84 SKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 147 (468)
Q Consensus 84 ~~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~ 147 (468)
..+.+|+||||+.+|+|.+++... ..++...+..++.|++.||.|||++|++||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 999999999999999999999753 2478889999999999999999999999999999999999
Q ss_pred cCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHH
Q 012228 148 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 226 (468)
Q Consensus 148 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~ 226 (468)
.++.+||+|||+++...............+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...+..+.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999975433211111222334568999999987666 589999999999999998 899998877766665
Q ss_pred hhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 227 KVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.+.. ......+..++.++.+|+.+||..||++|||+.++++
T Consensus 248 ~~~~-------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 248 LLRE-------------------------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHc-------------------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5321 1112334557889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=324.00 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=206.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 357999999999999999999975 457899999875432 235678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999999997654 6899999999999999999999999999999999999999999999999998765421111
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......+..|+|||++.+..+ +.++|+||+|+++|+|++ |..||.+.+.......+..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------------ 219 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ------------------ 219 (261)
T ss_pred -ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc------------------
Confidence 1111223457999999887666 589999999999999999 9999988776655544311
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+...+..+.+++.+||+.||.+|||+.++++
T Consensus 220 -------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 220 -------GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -------CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1122334457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=324.42 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=202.5
Q ss_pred eeeeecCCeEEEEEEE--cCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccC
Q 012228 19 RTLGEGSFAKVKFAKN--VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 96 (468)
+.||+|+||.||+|.. ..++..+|+|++..... .....+.+.+|+.+++.++||||+++++++. ....++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 3689999999999965 45778999999865432 2335677889999999999999999999875 456799999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC-Cccccc
Q 012228 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED-GLLHTA 175 (468)
Q Consensus 97 gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~~~~ 175 (468)
+|+|.+++.....+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++......... ......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 9999999988888999999999999999999999999999999999999999999999999998754322111 011223
Q ss_pred CCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccc
Q 012228 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254 (468)
Q Consensus 176 ~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (468)
.+++.|+|||.+....+ +.++|+||+||++|+|++ |..||...+..+....+..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~------------------------ 213 (257)
T cd05116 159 KWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES------------------------ 213 (257)
T ss_pred CCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC------------------------
Confidence 44678999999876655 589999999999999997 9999988776655554321
Q ss_pred ccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 255 ~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......|..+++++.+||.+||+.||.+|||+++|.+
T Consensus 214 -~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 214 -GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 1223456668999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=330.97 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=205.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCC--EEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 89 (468)
++|++.+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.++.++ +||||+++++++...+..|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999987765 46888775321 223456788999999999 6999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceE
Q 012228 90 IVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lk 153 (468)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997542 488899999999999999999999999999999999999999999
Q ss_pred EeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccc
Q 012228 154 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFH 232 (468)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~ 232 (468)
|+|||++....... .......+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+..
T Consensus 160 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-- 233 (297)
T cd05089 160 IADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 233 (297)
T ss_pred ECCcCCCcccccee---ccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc--
Confidence 99999986322110 0111223557999999887766 589999999999999997 9999988777665554311
Q ss_pred cccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 233 FLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......+..++..+.+|+.+||..||.+|||++++++.
T Consensus 234 -----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 234 -----------------------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred -----------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11223445588999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=327.57 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=209.8
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
..+|++++.||.|+||.||+|.+.. +..+|+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3569999999999999999999977 89999999876432 2345688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--V 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--c
Confidence 9999999999999753 35899999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+....+.
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~------------------- 218 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT------------------- 218 (261)
T ss_pred ccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-------------------
Confidence 11223345678999999887666 589999999999999998 899998877666655531
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......+...++.+.+++.+||+.||.+|||+.++++
T Consensus 219 ------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 219 ------AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ------hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11122345567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=327.09 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=206.0
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCC----EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
...+|++.+.||+|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 34679999999999999999999877776 48999986432 223456788999999999999999999988654
Q ss_pred EEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..++++||+++|+|.+.+... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 578999999999999998764 5699999999999999999999999999999999999999999999999999876543
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
...........+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...........+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------------- 226 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-------------- 226 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--------------
Confidence 211111122335678999999987776 489999999999999998 9999987665544433211
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+..++.++.+++.+||..||++|||+.++++
T Consensus 227 -----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 227 -----------GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----------CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1122334557889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.51 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=206.1
Q ss_pred CeEEEeeeeecCCeEEEEEEEcC-----CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ....+.+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999999753 235689998865432 22356788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 012228 89 YIVLEFIDGGELFDKIAKH------------------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 144 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NI 144 (468)
|++|||+.+|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999988642 2478889999999999999999999999999999999
Q ss_pred eeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHH
Q 012228 145 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA 223 (468)
Q Consensus 145 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~ 223 (468)
|+++++.+||+|||+++..............+++..|+|||.+.+..+ +.++||||+|+++++|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999875433221111223456778999999877666 589999999999999998 999998877666
Q ss_pred HHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 224 LYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
+...+.. ......+..++.++.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~-------------------------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKT-------------------------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhC-------------------------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 5554211 1122345567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=331.11 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=206.3
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEe
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS 84 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 84 (468)
..++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++ +||||+++++.+..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 3457999999999999999999852 345689999986542 223456788999999999 79999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
.+..|+||||+.+|+|.+++.... .+++..+..++.|++.||+|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999999987543 389999999999999999999999999999999999999999999999999875
Q ss_pred hhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccch
Q 012228 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
..............+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||......+.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----------- 258 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----------- 258 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH-----------
Confidence 432211111122346788999999987766 589999999999999998 9999987654433322110
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......+...++.+.+|+.+||.++|++|||+.++++
T Consensus 259 -------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 259 -------------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -------------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00112234457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=335.73 Aligned_cols=285 Identities=26% Similarity=0.377 Sum_probs=212.5
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCC--CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEe----CC
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVET--GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS----KT 86 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 86 (468)
+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+.+|+.+++.+ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999887 8999999986432 1222345677899999999 59999999987532 35
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.+|+++||+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6899999996 589999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred hc--CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 167 RE--DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 167 ~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.. ........||+.|+|||.+.+....+.++||||+||++|+|++|.+||...+.......+........ ...+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 237 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD-EETLSRI 237 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC-HHHHHhh
Confidence 11 11233457899999999886644346899999999999999999999987765444433221100000 0000000
Q ss_pred ccccccc----c-ccccccC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 245 TNKYSYT----L-QICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 245 ~~~~~~~----~-~~~~~~~-~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
....... . ......+ ...+..+..+.+|+.+||+.||.+|||+.+++.||||++.-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 0000000 0 0000000 111235789999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=326.85 Aligned_cols=254 Identities=19% Similarity=0.338 Sum_probs=205.4
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCE----EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDF----VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
..++|++.+.||+|+||+||+|.+..+++. +|+|.+.... .......+..|+.+++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 346899999999999999999999877764 6777764321 2233467788999999999999999999875 45
Q ss_pred EEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..++++||+++|+|.+++... +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 578999999999999999764 5689999999999999999999999999999999999999999999999999976533
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
...........++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.......+.+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-------------- 226 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-------------- 226 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--------------
Confidence 222222334567788999999987666 589999999999999998 9999988765544333211
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......+...+.++.+++.+||..||++|||+.++++.
T Consensus 227 -----------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 227 -----------GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred -----------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11122334467889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=323.48 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=205.6
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+...+..|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 467999999999999999999974 567799998764322 246788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 9999999999998653 4588999999999999999999999999999999999999999999999999876432111
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......++..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.......+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~------------------ 219 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR------------------ 219 (261)
T ss_pred eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc------------------
Confidence 11122345678999999877666 589999999999999998 9999987766555444211
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
....+.+..++.++.+++.+||..||++|||++++++
T Consensus 220 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 220 -------GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1112233447889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=323.78 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=204.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|++.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 45899999999999999999885 5678999998653322 235678999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||++|++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 999999999998764 4689999999999999999999999999999999999999999999999999875422110 01
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
.....++..|+|||.+.+..+ +.++|+||+||++|+|++ |..||...+..+....+..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------------------- 216 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-------------------- 216 (256)
T ss_pred cCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc--------------------
Confidence 111123457999999987766 589999999999999998 8999987766555444311
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......|..++..+.+++.+||..+|++|||+.++++.
T Consensus 217 -----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 217 -----GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -----CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 11223344578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=331.75 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=211.9
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|...+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.++|||++++++++.+.+..|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 48899999999999999999999999999999875543344456678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 94 FIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 94 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
|+.| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++..... .
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~ 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------A 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------c
Confidence 9975 77777654 45689999999999999999999999999999999999999999999999999764322 2
Q ss_pred cccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 173 HTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
....|++.|+|||.+.. .+..+.++|+||+||++|+|++|..||...+.......+...
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------------------- 239 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------------- 239 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-------------------
Confidence 34578999999999742 233468999999999999999999999876554443332110
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
......+..+++.+.+|+.+||+.+|.+|||+.++++|+|+....
T Consensus 240 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 240 -----ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred -----cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 001111233678899999999999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=337.45 Aligned_cols=277 Identities=28% Similarity=0.438 Sum_probs=210.6
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC------
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK------ 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 85 (468)
..+|.+.+.||+|+||.||+|++..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 4789999999999999999999999999999999875422 222345678999999999999999999998654
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..+|+|+||+.. +|...+ ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 357999999965 776654 34689999999999999999999999999999999999999999999999999874321
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
......+++.|+|||++.+....+.++|+||+||++|+|++|+.||.+.+.......+.... ...........
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 242 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT--GVPGPEFVQKL 242 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--CCCCHHHHHHh
Confidence 12345678999999998765445689999999999999999999999877554444332110 00000000000
Q ss_pred ccc---cc--c-cccccccC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 246 NKY---SY--T-LQICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 246 ~~~---~~--~-~~~~~~~~-~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
... .. . .......+ ...+..+..+.+||.+||+.||.+|||+++++.||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 00 0 00000000 0112367889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=323.37 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=203.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.+.||+|+||.||+|.+..+ ..||+|++...... .+.+.+|+.+++.++||||+++++.+. ....|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 46799999999999999999998655 45999998754321 246789999999999999999999874 4568999
Q ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~-~ 157 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y 157 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-c
Confidence 9999999999999763 358999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......++..|+|||.+.+..+ +.++||||+||++|+|++ |..||......+....+..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~------------------ 218 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------------ 218 (262)
T ss_pred ccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc------------------
Confidence 11223446678999999877666 589999999999999999 8999987766555444211
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+..++..+.+|+.+||+.||++|||+.++++
T Consensus 219 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 219 -------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1112234457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=339.90 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=202.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEE-----cCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEe-
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKN-----VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS- 84 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~- 84 (468)
-++|++++.||+|+||+||+|.+ ..+++.||||++..... ......+.+|+.++..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 35799999999999999999985 35678999999975432 22356788999999999 68999999998755
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcC--------------------------------------------------------
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHG-------------------------------------------------------- 108 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~-------------------------------------------------------- 108 (468)
...+++|||||++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 456899999999999999986531
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 109 -----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 109 -----------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
.++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 367778889999999999999999999999999999999999999999999875432111111223345
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICR 256 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (468)
++.|+|||.+.+..+ +.++||||+||++|+|++ |..||............. ...
T Consensus 244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~------------------------~~~ 298 (343)
T cd05103 244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------------------------KEG 298 (343)
T ss_pred CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH------------------------hcc
Confidence 678999999887766 589999999999999996 999997654322111100 111
Q ss_pred ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 257 ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 257 ~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.....|.+.++++.+++.+||..||.+|||+.++++|
T Consensus 299 ~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 299 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2233455678899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=328.24 Aligned_cols=259 Identities=29% Similarity=0.570 Sum_probs=213.1
Q ss_pred CeEEEeeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhh-hHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 88 (468)
.|++.+.||+|+||.||+|.+. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999998754332 223456788999999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||+.+|+|.+.+.....+++..+..++.|++.||.|||+.|++||||||.||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999987543321
Q ss_pred CCcccccCCCCCcCCccccccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCchH----HHHHHhhcccccccccccchhh
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
.......+|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||..... .+..+.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------- 223 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR---------------- 223 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH----------------
Confidence 11122356899999999987543 245899999999999999999999964321 111111
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCcccccC
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKKG 299 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t---~~eil~hpwf~~~ 299 (468)
........|..++..+.++|.+||+.||++||| +.++|+||||+..
T Consensus 224 ----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 224 ----------ILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred ----------HHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 122334456668899999999999999999998 5677999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.45 Aligned_cols=260 Identities=22% Similarity=0.306 Sum_probs=205.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCC--------------CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETG--------------DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIK 77 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~--------------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~ 77 (468)
-.+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 358999999999999999999875432 358999987542 2234567889999999999999999
Q ss_pred EEEEEEeCCEEEEEEEccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 012228 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHG------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 145 (468)
Q Consensus 78 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NIL 145 (468)
+++++...+..|+||||+.+++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886532 3678889999999999999999999999999999999
Q ss_pred eccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh--CCCCCCCchHHH
Q 012228 146 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--GFLPFDESNLMA 223 (468)
Q Consensus 146 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~--g~~Pf~~~~~~~ 223 (468)
++.++.+||+|||++................+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999875432211111223345678999999887666 589999999999999987 778998766555
Q ss_pred HHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 224 LYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
....+...... . ........++.+++.+.+|+.+||..||++|||++++++
T Consensus 241 ~~~~~~~~~~~------------~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRN------------Q------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhh------------c------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 44432110000 0 001112234457899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=332.43 Aligned_cols=282 Identities=24% Similarity=0.395 Sum_probs=213.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-CCEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-KTKIY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~ 89 (468)
..++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .....+.+.+|+.+++.++||||+++++++.. .+..|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45789999999999999999999999999999999865422 22345678899999999999999999999865 56789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
++|||+. ++|...+.. ..+++..+..++.|++.||+|||++||+||||+|.|||++.++.+||+|||++.....
T Consensus 87 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 87 FVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred EEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 9999994 588877754 5689999999999999999999999999999999999999999999999999874321
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc-c--
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT-N-- 246 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 246 (468)
......+++.|+|||.+.+....+.++|+||+||++|+|++|..||...+.......+... .....+.+.... .
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL--LGTPPDDVINTICSEN 237 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH--hCCCCHHHHHhccchh
Confidence 2234567889999999876444468999999999999999999999876654332222110 000000000000 0
Q ss_pred cccccccc-ccccCC---CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 247 KYSYTLQI-CRADFS---CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 247 ~~~~~~~~-~~~~~~---~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
........ ...... ..+.++..+.++|++||+.+|++|||+++++.||||.....|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00000000 000001 113467899999999999999999999999999999875544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=327.11 Aligned_cols=249 Identities=29% Similarity=0.492 Sum_probs=201.8
Q ss_pred EEEeeeeecCCeEEEEEEEc----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 16 ELGRTLGEGSFAKVKFAKNV----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 16 ~i~~~LG~G~~g~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.+.+.||.|+||.||+|... ..+..|+||.+... ......+.+.+|+++++.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 47899999999999999997 34567999999542 2333467889999999999999999999999988889999
Q ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||++|+|.+++... ..+++.....++.|++.||.|||+++++|+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999987 67999999999999999999999999999999999999999999999999998765221111
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......+...|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+....+.
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~------------------- 219 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK------------------- 219 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH-------------------
T ss_pred ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc-------------------
Confidence 12233456778999999987665 589999999999999999 789998887776665542
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......+..++..+.+++.+||..||.+|||+.++++
T Consensus 220 ------~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 220 ------QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ------TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ------ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11223455568999999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=327.88 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=207.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcC-----CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
..+|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4679999999999999999999753 67889999986543 2234567889999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG----------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 144 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~----------------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NI 144 (468)
..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999987432 367888999999999999999999999999999999
Q ss_pred eeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHH
Q 012228 145 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA 223 (468)
Q Consensus 145 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~ 223 (468)
|++.++.++|+|||++................+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999875432211111223345678999999887776 589999999999999997 888998776665
Q ss_pred HHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 224 LYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
....+.. ......+..++.++.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~-------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRD-------------------------GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhc-------------------------CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 5544311 1122345567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=323.05 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=207.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCC---EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
.+.|++.+.||+|+||.||+|.+..++. .||+|++.... .....+.+..|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4679999999999999999999987665 59999986532 233456789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
++||||+++|+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999988753 468999999999999999999999999999999999999999999999999987543321
Q ss_pred cCCcccccC---CCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 168 EDGLLHTAC---GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 168 ~~~~~~~~~---gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
......... .+..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+..+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~------------- 226 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ------------- 226 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-------------
Confidence 111111111 2457999999987776 589999999999999886 9999988766555444311
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
....+.+..++..+.+++.+||..+|.+|||+++++.
T Consensus 227 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 227 ------------DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ------------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1122334457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=324.06 Aligned_cols=252 Identities=21% Similarity=0.366 Sum_probs=209.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCC----EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
.++|++.+.||+|+||+||+|.++.+|+ .+|+|.+..... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 4689999999999999999999877665 589998865432 2345678899999999999999999999887 78
Q ss_pred EEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999998764 46899999999999999999999999999999999999999999999999999865432
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
..........++..|+|||.+....+ +.++|+||+||++|++++ |..||......+..+.+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------------- 225 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE---------------- 225 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh----------------
Confidence 11111112234568999999876666 489999999999999998 999999887766655532
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......|...+..+.+++.+||..||++|||+.++++
T Consensus 226 ---------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 226 ---------KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ---------CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 12233455567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=320.45 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=201.5
Q ss_pred eeeeecCCeEEEEEEEcCCC---CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEcc
Q 012228 19 RTLGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 95 (468)
+.||+|+||.||+|....++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876544 78999998765432 34567889999999999999999999876 45689999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC-cccc
Q 012228 96 DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG-LLHT 174 (468)
Q Consensus 96 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~~~~ 174 (468)
.+|+|.+++.....+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999988889999999999999999999999999999999999999999999999999987553321110 0111
Q ss_pred cCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccccccc
Q 012228 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253 (468)
Q Consensus 175 ~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (468)
..++..|+|||.+.+..+ +.++||||+||++|+|++ |.+||...+..+....+..
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~----------------------- 213 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES----------------------- 213 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-----------------------
Confidence 123467999999987766 589999999999999997 9999988776555444311
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 254 ~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......|..++..+.++|.+||..||++|||+.++++
T Consensus 214 --~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 214 --GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred --CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1122445668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=326.32 Aligned_cols=275 Identities=29% Similarity=0.448 Sum_probs=209.3
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC---CCCCeeEEEEEEEeCCE----
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI---KHPNVIKIIEVMASKTK---- 87 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 87 (468)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999998999999999975432 222334566788877766 59999999999988776
Q ss_pred -EEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 88 -IYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 88 -~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
+|++|||+.+ +|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8988887643 58999999999999999999999999999999999999999999999999987643
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.. .......+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||...+..+...++........ ...+...
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 233 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPS-EEEWPRN 233 (287)
T ss_pred CC---cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCC-hHhcCCC
Confidence 21 22334457889999999987766 5899999999999999999999998876665555432110000 0000000
Q ss_pred cc--ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 245 TN--KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 245 ~~--~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.. ................+.+++.+.++|.+||+.||.+||++++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 00000000000011112356888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=333.54 Aligned_cols=255 Identities=26% Similarity=0.451 Sum_probs=207.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCC-------CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVET-------GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVM 82 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 82 (468)
...+|++++.||+|+||.||+|.+... +..||+|.+.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 345799999999999999999986432 2368999886432 223456788999999999 799999999999
Q ss_pred EeCCEEEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 012228 83 ASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 146 (468)
Q Consensus 83 ~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl 146 (468)
...+.+|++|||+++|+|.+++.... .++...+..++.|++.||.|||++|++||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 99999999999999999999987532 36778889999999999999999999999999999999
Q ss_pred ccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHH
Q 012228 147 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 225 (468)
Q Consensus 147 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~ 225 (468)
+.++.+||+|||+++...............++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999875433211111222334567999999987766 488999999999999998 89999888776665
Q ss_pred HhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 226 RKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
..+.. ......+..++..+.+|+.+||..+|.+|||+.+++++
T Consensus 247 ~~~~~-------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 247 KLLKE-------------------------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHc-------------------------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 55321 11223344578899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=341.87 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=204.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCC
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKT 86 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~ 86 (468)
.+|.+++.||+|+||.||+|++. .++..||+|++..... ....+.+.+|+.+|..+. ||||+++++++...+
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 46888999999999999999964 3556899999975432 223457889999999997 999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcC----------------------------------------------------------
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG---------------------------------------------------------- 108 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~---------------------------------------------------------- 108 (468)
.+|+|||||.+|+|.+++...+
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999986532
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 012228 109 ----------------------------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 148 (468)
Q Consensus 109 ----------------------------------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~ 148 (468)
.++...+..++.|++.||+|||+.|++||||||+|||++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE 274 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence 2566778889999999999999999999999999999999
Q ss_pred CCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHh
Q 012228 149 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRK 227 (468)
Q Consensus 149 ~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~ 227 (468)
++.+||+|||+++...............+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||......+....
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 99999999999875432211111223457889999999987666 589999999999999998 8999977544333222
Q ss_pred hcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 228 VSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.. ........|..++.++.+|+.+||..+|.+|||++++++.
T Consensus 354 ~~------------------------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 354 AI------------------------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HH------------------------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 10 0111223456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=321.46 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=203.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+...... .+.+.+|+.+++.++||||+++++++. .+..|++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 457999999999999999999875 5667999998754322 245789999999999999999999875 4568999
Q ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence 9999999999998753 3589999999999999999999999999999999999999999999999999875432111
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......++..|+|||.+.+..+ +.++||||||+++|+|++ |.+||...+..+....+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~------------------- 217 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE------------------- 217 (260)
T ss_pred ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------------------
Confidence 11112235567999999877665 589999999999999999 999998876665555431
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......+...+..+.+|+.+||..||.+|||++++.+
T Consensus 218 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 218 ------RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ------cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 11122345557889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=330.34 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=209.7
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
..|+..+.||+|+||.||+|++..+++.+|+|.+.............+.+|+.+++.++|||++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34888899999999999999999999999999987543333344567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||+.| +|.+.+.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------ 167 (308)
T cd06634 95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (308)
T ss_pred EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC------
Confidence 99974 77776654 44689999999999999999999999999999999999999999999999999865322
Q ss_pred ccccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 172 LHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
.....+++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+..+....+..
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------------- 228 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------------- 228 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh-------------------
Confidence 234568899999999752 22235789999999999999999999976554333222110
Q ss_pred cccccccccCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 250 YTLQICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 250 ~~~~~~~~~~~-~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
..... .+..++..+.+||.+||..+|.+|||++++++|||+...
T Consensus 229 ------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 229 ------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ------cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00011 123478889999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.50 Aligned_cols=254 Identities=28% Similarity=0.515 Sum_probs=209.1
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh--hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+|.+.+.||+|+||.||+|.+..++..+++|++...... .......+.+|+.+++.++||||+++++.+.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888887877776542221 112234567899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 92 LEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|||+++++|.+.+.. ...+++..+..++.|++.||.|||++|++|+||||+||+++. +.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999988753 356999999999999999999999999999999999999975 6799999999875432
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~------------------ 218 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV------------------ 218 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH------------------
Confidence 12223345688999999998776664 78999999999999999999998766554444321
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.......+..++.++.++|.+||..||++||++.++++||||
T Consensus 219 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 219 -------EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -------cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 111222344578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=318.32 Aligned_cols=244 Identities=27% Similarity=0.484 Sum_probs=207.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
...|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 45799999999999999999987 478999999975432 356788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~--- 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG--- 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc---
Confidence 99999999999998766 6999999999999999999999999999999999999999999999999998754221
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.....++..|+|||.+.+..+ +.++|+||+|+++++|++ |..||...+.......+..
T Consensus 156 --~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------------------ 214 (256)
T cd05039 156 --QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK------------------ 214 (256)
T ss_pred --cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc------------------
Confidence 113344667999999876665 589999999999999997 9999988776655444211
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+..+++.+.++|.+||..+|++|||+.++++
T Consensus 215 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 215 -------GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -------CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 1122334557899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.72 Aligned_cols=273 Identities=23% Similarity=0.398 Sum_probs=201.8
Q ss_pred CCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCHHHHH
Q 012228 25 SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI 104 (468)
Q Consensus 25 ~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 104 (468)
++|.||.+++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..|++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445667777777999999999976532 2335678999999999999999999999999999999999999999999998
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc-----CCcccccCC
Q 012228 105 AKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE-----DGLLHTACG 177 (468)
Q Consensus 105 ~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~-----~~~~~~~~g 177 (468)
... ..+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||.+........ ........+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 763 4689999999999999999999999999999999999999999999999998764322111 112233457
Q ss_pred CCCcCCccccccC--CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHH-HHhhcccccccccccch-----hhhccc--
Q 012228 178 TPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNLMAL-YRKVSTFHFLSVYGESY-----KKCTNK-- 247 (468)
Q Consensus 178 t~~y~APEvl~~~--~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~-----~~~~~~-- 247 (468)
+..|+|||++.+. .| +.++|+||+||++|+|++|..||........ ..++.... ........ ......
T Consensus 171 ~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T cd08216 171 NLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTV-PCLLDKSTYPLYEDSMSQSRS 248 (314)
T ss_pred cccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-ccccccCchhhhcCCcCcccc
Confidence 8899999998753 34 5899999999999999999999986543322 22211100 00000000 000000
Q ss_pred -cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 248 -YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 248 -~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
..............+..++.++.+|+.+||..||++|||+.++++||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00000001111222233577899999999999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=321.55 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=207.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCC---EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
.++|++++.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3679999999999999999999875544 79999986533 223456788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999998764 468999999999999999999999999999999999999999999999999987654321
Q ss_pred cCC-cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 168 EDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 168 ~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
... ......++..|+|||.+.+..+ +.++|+||+||++|++++ |..||...+..+....+..
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~--------------- 224 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE--------------- 224 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC---------------
Confidence 111 0111223567999999987666 589999999999999886 9999987766555444321
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
....+.+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus 225 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 225 ----------GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ----------CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0112233447889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=327.71 Aligned_cols=277 Identities=30% Similarity=0.456 Sum_probs=214.5
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999997653 2233456677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 95 IDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 95 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
+.+ +|.+.+... ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.+||+|||++...... .....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence 985 899999876 57999999999999999999999999999999999999999999999999998754331 11233
Q ss_pred ccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc--ccc
Q 012228 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY--SYT 251 (468)
Q Consensus 174 ~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 251 (468)
...++..|+|||.+.+....+.++|+||+||++++|++|.+||...+......++...... .....+....... ...
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGT-PTEESWPGVTKLPDYKPT 235 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCC-CcHHHHHhhccccccccc
Confidence 4556788999999877644568999999999999999999999887765554443211000 0000010000000 000
Q ss_pred ccc--ccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 252 LQI--CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 252 ~~~--~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
... ....-...+.++..+.++|++||..||++|||+++++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 000 000001112247889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=327.23 Aligned_cols=259 Identities=21% Similarity=0.342 Sum_probs=204.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcC----------------CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCee
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVE----------------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVI 76 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv 76 (468)
++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .....+.+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 579999999999999999986532 34579999986542 233456788999999999999999
Q ss_pred EEEEEEEeCCEEEEEEEccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 012228 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 145 (468)
Q Consensus 77 ~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NIL 145 (468)
++++++...+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999987643 3667789999999999999999999999999999999
Q ss_pred eccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh--CCCCCCCchHHH
Q 012228 146 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--GFLPFDESNLMA 223 (468)
Q Consensus 146 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~--g~~Pf~~~~~~~ 223 (468)
++.++.++|+|||++................+++.|+|||...+..+ +.++|+||+||++|+|++ |..||...+..+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999875432211111223345678999998877666 589999999999999998 789998766555
Q ss_pred HHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 224 LYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......... . . .........+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~---------~----~-----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIENTGEFF---------R----D-----QGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHH---------h----h-----ccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 443321100 0 0 0011122334557889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=327.21 Aligned_cols=277 Identities=31% Similarity=0.453 Sum_probs=214.1
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
|++.+.||+|++|.||+|.+..+|+.+|+|.+...... ......+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998754322 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 95 IDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 95 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
+++ +|.+.+... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 976 888877663 579999999999999999999999999999999999999999999999999987554321 1223
Q ss_pred ccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc-ccccc
Q 012228 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK-YSYTL 252 (468)
Q Consensus 174 ~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 252 (468)
...++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+...++...... .....+...... .....
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGT-PDPEVWPKFTSLARNYKF 235 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CchHhcccchhhhhhhhh
Confidence 3557889999999887644568999999999999999999999887765554443211000 000000000000 00000
Q ss_pred ccccc----cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 253 QICRA----DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 253 ~~~~~----~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
..... .....+.++.++.++|.+||.+||.+||++++++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00000 001123368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=318.91 Aligned_cols=229 Identities=26% Similarity=0.428 Sum_probs=193.5
Q ss_pred cCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCHHHH
Q 012228 24 GSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDK 103 (468)
Q Consensus 24 G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 103 (468)
|+||+||+|++..+++.||+|.+.+... ..+|...+....||||+++++++.+.+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999975431 22344445556799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCC
Q 012228 104 IAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183 (468)
Q Consensus 104 i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 183 (468)
+.....+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||++..... ......++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 98888899999999999999999999999999999999999999999999999998764432 1234456788999
Q ss_pred ccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCC
Q 012228 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS 263 (468)
Q Consensus 184 PEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (468)
||.+.+..+ +.++|+||+||++|+|++|..||...... . .....+..|.
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----------------------------~~~~~~~~~~ 199 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSG-I-----------------------------NTHTTLNIPE 199 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchh-c-----------------------------ccccccCCcc
Confidence 999877666 58999999999999999999887543110 0 0112234677
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccc
Q 012228 264 WFSSGAKKLIKRILDPNPDTRMTI-----SQMLEDEWF 296 (468)
Q Consensus 264 ~~s~~~~~Ll~~~L~~dP~~R~t~-----~eil~hpwf 296 (468)
++++.+.+||.+||+.||++|||+ +++++||||
T Consensus 200 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 200 WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 789999999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=319.22 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=203.7
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
-.+|+++++||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.++||||+++++++. .+..|++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 357999999999999999999864 6788999998754322 356789999999999999999999874 4668999
Q ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 157 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-Y 157 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-c
Confidence 9999999999998653 358999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......++..|+|||++.+..+ +.++||||+|+++|+|++ |.+||.+.+..+....+..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------------ 218 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER------------------ 218 (260)
T ss_pred ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc------------------
Confidence 11122345678999999877665 589999999999999998 9999988776655544311
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+...+.++.+++.+||..||++|||++++++
T Consensus 219 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 219 -------GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1112334457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=318.35 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=202.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..|+|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 46799999999999999999988654 4699998865332 2356778999999999999999999875 4568999
Q ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||+.+|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-Y 157 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-c
Confidence 99999999999997643 47899999999999999999999999999999999999999999999999987543211 1
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+....+....+..
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------------ 218 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER------------------ 218 (260)
T ss_pred cccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------------
Confidence 11122345678999999877665 589999999999999999 9999988766555444211
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+..++..+.+++++||..||.+|||++++++
T Consensus 219 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 219 -------GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -------CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1122344557899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=318.61 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=207.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCC---EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
...|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++.++||||+++.+++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3478999999999999999999976665 79999986542 122356788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|+||||+++++|.+++... +.+++..+..++.|++.|++|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999998764 578999999999999999999999999999999999999999999999999987553321
Q ss_pred cCCcc-cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 168 EDGLL-HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 168 ~~~~~-~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
..... .....++.|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+....+..
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~--------------- 225 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND--------------- 225 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc---------------
Confidence 11111 11223457999999987766 589999999999999997 9999987766655554321
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
....+.+...+..+.+++.+||..+|++||++.++++
T Consensus 226 ----------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 226 ----------GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ----------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1112223346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=316.54 Aligned_cols=245 Identities=26% Similarity=0.396 Sum_probs=202.6
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 98 (468)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++.+.+..|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999977 999999998754332 34567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 99 ELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 99 ~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
+|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999998653 4689999999999999999999999999999999999999999999999999875432111111112334
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICR 256 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (468)
+..|+|||.+.+..+ +.++|+||+||++|+|++ |..||...........+.. .
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-------------------------~ 211 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-------------------------G 211 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-------------------------C
Confidence 567999999877665 589999999999999998 8999987765554444211 1
Q ss_pred ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 257 ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 257 ~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.....|..++..+.+++.+||..+|.+|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 212 YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 122344557899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=317.68 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=204.2
Q ss_pred eeeeecCCeEEEEEEEcC-CCC--EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEcc
Q 012228 19 RTLGEGSFAKVKFAKNVE-TGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 95 (468)
+.||+|++|.||+|.+.. ++. .||+|.+...... ...+.+.+|+.+++.++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999765543 456788999999999999999999999988 8899999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC-Ccc
Q 012228 96 DGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED-GLL 172 (468)
Q Consensus 96 ~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~ 172 (468)
++|+|.+.+.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999998764 6899999999999999999999999999999999999999999999999998765432111 111
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
....++..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+..+....+..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------------------- 215 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK--------------------- 215 (257)
T ss_pred cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---------------------
Confidence 23457789999999887776 588999999999999998 9999987776665554321
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......+..++..+.+++.+||..+|++|||+.++++
T Consensus 216 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 216 ---EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ---cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 11122234457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=317.37 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=206.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++.+.||+|+||.||+|.+. ++..||+|.+...... .+.+.+|+.+++.++||||+++++++......|+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3468999999999999999999975 5578999998754322 3568899999999999999999999999899999
Q ss_pred EEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 91 VLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
||||+++++|.+++.... .++...+..++.|++.|+.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999999997643 689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.......++..|+|||.+.+..+ +.++|+||+||++|+|++ |..||.+.+.......+..
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~----------------- 219 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER----------------- 219 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------------
Confidence 11112234568999999987665 589999999999999998 9999988766655554311
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+...+.++.+++.+||..||.+|||++++++
T Consensus 220 --------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 220 --------GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1122334446889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=310.24 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=205.0
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 92 (468)
..+.+..||.|+.|.|++++.+.+|...|||.+.+.. +....++|...+.++.+.. +|+||+.+++|..+..+++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3456778999999999999999999999999997654 3345678888888877765 999999999999999999999
Q ss_pred EccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 93 EFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 93 E~~~gg~L~~~i~--~~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|.|.. -.+.+. -.++++|..+-++...++.||.||.++ ||+|||+||+|||+|+.|++||||||.+..+.. .
T Consensus 171 elMs~--C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---S 245 (391)
T KOG0983|consen 171 ELMST--CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---S 245 (391)
T ss_pred HHHHH--HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec---c
Confidence 99853 233322 235699999999999999999999865 899999999999999999999999999876533 1
Q ss_pred CcccccCCCCCcCCccccc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCch-HHHHHHhhcccccccccccchhhhc
Q 012228 170 GLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~---~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
...+...|.+.|||||.+. ...|+ ..+||||||+.|+||.||..||.+.+ ..+.+.++..
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--------------- 309 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--------------- 309 (391)
T ss_pred cccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---------------
Confidence 2234467999999999985 33565 88999999999999999999998843 2333333321
Q ss_pred cccccccccccccCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 246 NKYSYTLQICRADFSCP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~--~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.....+| ..+|+++++|+..||++|+.+||...++|+|||....
T Consensus 310 ----------~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 310 ----------EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred ----------cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 1111222 2389999999999999999999999999999999753
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.84 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=207.3
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcC----CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-C
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVE----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-K 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~ 85 (468)
.-.+|++.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34679999999999999999999875 35789999886432 33346778899999999999999999998755 5
Q ss_pred CEEEEEEEccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecc
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH--------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~--------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DF 157 (468)
...++++||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 7789999999999999998653 35899999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccc
Q 012228 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSV 236 (468)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~ 236 (468)
|+++.+.............++..|+|||.+.+..+ +.++||||+||++|++++ |..||...+..++...+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD------ 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc------
Confidence 99875432111111123346678999999987766 589999999999999998 9999988776655444211
Q ss_pred cccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 237 YGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
...+..+..+++++.+++.+||..||++|||+.++++
T Consensus 235 -------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 -------------------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -------------------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1122234457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=324.07 Aligned_cols=275 Identities=30% Similarity=0.457 Sum_probs=209.9
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEEEEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 93 (468)
|++.+.||+|+||+||+|....+++.||||.+....... ......+|+..++.++ ||||+++++++...+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 788999999999999999999999999999986543211 1223457999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 94 FIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|+ +|+|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---CCC
Confidence 99 779999887765 789999999999999999999999999999999999999999999999999875432 122
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccc---cccccchhhhcccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFL---SVYGESYKKCTNKY 248 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 248 (468)
.....++..|+|||++.+....+.++|+||+|+++++|++|.+||...+..+...++...... ..+.... ......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 233 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY-KLASKL 233 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh-hhhccc
Confidence 334568899999999865554568999999999999999999999877655544433211000 0000000 000000
Q ss_pred cccccc-cccc-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 249 SYTLQI-CRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 249 ~~~~~~-~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
...... .... ....+..+..+.+||++||..||.+|||++|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000000 0000 01112237889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=340.96 Aligned_cols=256 Identities=27% Similarity=0.504 Sum_probs=215.1
Q ss_pred cCeE-EEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh-hhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE--E
Q 012228 13 GKYE-LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK--I 88 (468)
Q Consensus 13 ~~y~-i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~--~ 88 (468)
|+|- ....||+|+|-+||+|.|..+|-.||=--+....+ ......+.+..|+.+|+.|+|||||++|+.+.+..+ +
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 4443 34689999999999999999999988433332222 234457899999999999999999999999987765 8
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeecc-CCceEEeccccchhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDS-YGVLKISDFGLSAISQQ 165 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~g--ivHrDlKp~NILl~~-~g~lkl~DFGla~~~~~ 165 (468)
.+|+|++.+|+|..|+.+.++++...++.|++||+.||.|||++. |+|||||-+||+|++ .|.|||+|+|||++...
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 899999999999999999999999999999999999999999995 999999999999984 68999999999998654
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCC-chHHHHHHhhcccccccccccchhhh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
. ......|||.|||||++. ..|+ ..+||||||+.+.||+|+.+||.. .++.++|+++....
T Consensus 199 s----~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi------------ 260 (632)
T KOG0584|consen 199 S----HAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI------------ 260 (632)
T ss_pred c----ccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC------------
Confidence 2 234578999999999987 4675 999999999999999999999976 46888888875321
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
... .+..--.+++++||.+||.. .+.|+|+.|+|+||||...
T Consensus 261 ----------KP~--sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 261 ----------KPA--ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----------CHH--HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 100 11111368899999999999 9999999999999999874
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.86 Aligned_cols=244 Identities=23% Similarity=0.353 Sum_probs=198.6
Q ss_pred eeeecCCeEEEEEEEc--CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCC
Q 012228 20 TLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG 97 (468)
Q Consensus 20 ~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 97 (468)
.||+|+||.||+|... .++..||+|++.... .....+.+.+|+.+++.++||||+++++++. ....|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999875 445679999986542 2334567889999999999999999999875 4578999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC-ccccc
Q 012228 98 GELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG-LLHTA 175 (468)
Q Consensus 98 g~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~~~~~ 175 (468)
|+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999875 4578999999999999999999999999999999999999999999999999987543221111 11112
Q ss_pred CCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccc
Q 012228 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254 (468)
Q Consensus 176 ~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (468)
.+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......+....+.
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~------------------------- 212 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE------------------------- 212 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------------------------
Confidence 33578999999887666 589999999999999996 999998876655544431
Q ss_pred ccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 255 ~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......|+..++++.+++.+||..||++||++.++.+
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 213 QGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11223456668999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.39 Aligned_cols=244 Identities=27% Similarity=0.475 Sum_probs=203.4
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-EeCCEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVM-ASKTKIY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~ 89 (468)
...+|++.+.||+|+||.||++.. .|..||+|.+.... ..+.+.+|+.+++.++|||++++++++ ...+..|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 346899999999999999999976 47889999986432 245678999999999999999999975 4567799
Q ss_pred EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-- 154 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 154 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc--
Confidence 9999999999999987654 388999999999999999999999999999999999999999999999999874322
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
......++..|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+....+..
T Consensus 155 ---~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~---------------- 214 (256)
T cd05082 155 ---TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---------------- 214 (256)
T ss_pred ---cCCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc----------------
Confidence 1123445678999999887666 489999999999999997 9999987776655544311
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......++.+++.+.+++.+||..||++|||+.++++
T Consensus 215 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 215 ---------GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112334557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=316.72 Aligned_cols=249 Identities=29% Similarity=0.453 Sum_probs=208.3
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCC----CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETG----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
+++.+.||+|+||.||+|.+..++ ..||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357899999999999999998766 8999999865432 2245788899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 91 VLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+|||+++++|.+.+..... +++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999876554 99999999999999999999999999999999999999999999999999876543211
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.. .....+++.|+|||.+.+..+ +.++|+||+||++++|++ |.+||...+.....+.+..
T Consensus 159 ~~-~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~----------------- 219 (258)
T smart00219 159 YK-KKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK----------------- 219 (258)
T ss_pred cc-cccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------------
Confidence 11 111236789999999866555 589999999999999998 8999988776666555321
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+..++.++.+++.+||..||.+|||+.++++
T Consensus 220 --------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 220 --------GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --------CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 1122344558999999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=322.44 Aligned_cols=239 Identities=22% Similarity=0.320 Sum_probs=195.7
Q ss_pred eeeeecCCeEEEEEEEcCCCCE-------EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 19 RTLGEGSFAKVKFAKNVETGDF-------VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~-------vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+.||+|+||.||+|.+...+.. +|+|.+.... ....+.+..|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 4699999999999998765543 8888875432 23456788899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc--------eEEeccccchh
Q 012228 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--------LKISDFGLSAI 162 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~--------lkl~DFGla~~ 162 (468)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999987765 69999998764
Q ss_pred hhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCchHHHHHHhhcccccccccccch
Q 012228 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
... .....+++.|+|||++.+....+.++||||+||++|+|++| ..||...+.......
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------------- 217 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------------- 217 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH--------------
Confidence 322 23456889999999998755556899999999999999998 577766554432221
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......|...+.++.+|+.+||+.||++|||++++++.
T Consensus 218 -------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 218 -------------YEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -------------HHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 111223444567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=319.28 Aligned_cols=243 Identities=26% Similarity=0.394 Sum_probs=197.8
Q ss_pred eeeeecCCeEEEEEEEcCCCC--EEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEEEcc
Q 012228 19 RTLGEGSFAKVKFAKNVETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFI 95 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 95 (468)
+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999988776 46888876322 223456788999999999 7999999999999999999999999
Q ss_pred CCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecccc
Q 012228 96 DGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 96 ~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGl 159 (468)
++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999987543 478999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccc
Q 012228 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
+....... .......++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+..+.+..
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-------- 226 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-------- 226 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC--------
Confidence 85322111 1112234567999999877666 589999999999999997 9999987766655554311
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+...+.++.+|+.+||..||.+|||+.++++
T Consensus 227 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 227 -----------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -----------------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0111233446889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=323.02 Aligned_cols=261 Identities=22% Similarity=0.375 Sum_probs=206.6
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKI 88 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 88 (468)
...+.|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.++..+. ||||+++++++.+....
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 4567899999999999999999999989999999999754321 22445667777666664 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
|+||||+.+ .|.+.+.. ...+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||++......
T Consensus 90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999999865 67766655 4578999999999999999999997 59999999999999999999999999998754321
Q ss_pred hcCCcccccCCCCCcCCccccccCC---CCCChhhHHHHHHHHHHHhhCCCCCCCchH-HHHHHhhcccccccccccchh
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 242 (468)
.......+++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||..... .+....+..
T Consensus 169 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------------ 233 (296)
T cd06618 169 ---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ------------ 233 (296)
T ss_pred ---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc------------
Confidence 1122345788999999987543 235789999999999999999999976432 222222110
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
...........++.++.+|+.+||..||.+|||++++++||||+..
T Consensus 234 -----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 234 -----------EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred -----------CCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 0001111122368899999999999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=319.77 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=207.5
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcC-----CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
.+|++.+.||+|+||.||+|+.+. +.+.+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 679999999999999999999754 34679999886532 22245678899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccc
Q 012228 88 IYIVLEFIDGGELFDKIAKHG---------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 158 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~---------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFG 158 (468)
.|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999998765 68999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccccccccc
Q 012228 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVY 237 (468)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 237 (468)
++...... .........++..|+|||.+.+..+ +.++||||+|+++|+|++ |..||...........+..
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~------- 233 (275)
T cd05046 163 LSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA------- 233 (275)
T ss_pred cccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc-------
Confidence 98643211 1112223456778999999877665 488999999999999998 8899977655544443211
Q ss_pred ccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......+..++..+.+++.+||..||.+|||+.+++.+
T Consensus 234 -----------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 234 -----------------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -----------------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 111122344578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=317.33 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=204.7
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCC---CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
-.+|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 35699999999999999999997644 3469999886432 12345678899999999999999999998875 457
Q ss_pred EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 89999999999999997644 58999999999999999999999999999999999999999999999999987543221
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
. .......+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+..+....+.
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~----------------- 222 (270)
T cd05056 162 Y-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE----------------- 222 (270)
T ss_pred c-eecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-----------------
Confidence 1 11112334568999999877666 589999999999999986 999998876655444321
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......++.++..+.+++.+||..+|.+|||+.+++..
T Consensus 223 --------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 223 --------NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred --------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112223455678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=317.30 Aligned_cols=239 Identities=20% Similarity=0.290 Sum_probs=192.1
Q ss_pred eeeeecCCeEEEEEEEcCC------------CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 19 RTLGEGSFAKVKFAKNVET------------GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~------------~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
+.||+|+||.||+|..... ...||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4689999999999985322 2358889876432 234556788999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc-------eEEeccc
Q 012228 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-------LKISDFG 158 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~-------lkl~DFG 158 (468)
..++||||+++|+|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++. +|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998888753 56899999999999999999999999999999999999987664 8999999
Q ss_pred cchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHh-hCCCCCCCchHHHHHHhhccccccccc
Q 012228 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM-AGFLPFDESNLMALYRKVSTFHFLSVY 237 (468)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll-~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 237 (468)
++..... .....++..|+|||.+.+....+.++||||+||++|+|+ .|..||......+.....
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--------- 222 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY--------- 222 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---------
Confidence 9864321 223567889999999875555568999999999999998 589999776543332211
Q ss_pred ccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
..........+.++.+|+.+||+.||.+||++.+|+++
T Consensus 223 ------------------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 223 ------------------EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ------------------hcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 11111222246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=338.55 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=209.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
+...++..||+|+||+||+|.+-. .||||+++.+....+ ..+.+++|+.++++-+|.||+-+.+++..+.. .||+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 456788999999999999999844 599999988766544 78899999999999999999999999988887 9999
Q ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
.+|+|-+|..++.-. ..|.....+.|++|++.|+.|||.++|+|||||..|||+.+++.|||+||||++..........
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q 546 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ 546 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence 999999999988643 4689999999999999999999999999999999999999999999999999987655444445
Q ss_pred ccccCCCCCcCCccccccC--CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 172 LHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~--~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
+....|...|||||++... ..+++.+||||+||++|||++|.+||...+.+++.-.+
T Consensus 547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV--------------------- 605 (678)
T KOG0193|consen 547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV--------------------- 605 (678)
T ss_pred cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe---------------------
Confidence 6667788999999998632 33479999999999999999999999865554432221
Q ss_pred cccccccccC-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 250 YTLQICRADF-----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 250 ~~~~~~~~~~-----~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.++.. ..-...+.++++|+..||.+++++||+..+||.
T Consensus 606 -----GrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 606 -----GRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -----cccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 12211 111235679999999999999999999999986
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=358.86 Aligned_cols=256 Identities=31% Similarity=0.511 Sum_probs=200.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-------
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------- 84 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------- 84 (468)
...|+.++.||+|+||.||+++++-+|..||||.|.... .......+.+|+..|.+|+|||||+++..+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 356788899999999999999999999999999998754 34456789999999999999999999864310
Q ss_pred ------------------------------------------------C-------------------------------
Q 012228 85 ------------------------------------------------K------------------------------- 85 (468)
Q Consensus 85 ------------------------------------------------~------------------------------- 85 (468)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CEEEEEEEccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 012228 86 ---------------------------------TKIYIVLEFIDGGELFDKIAKHGRL-KEDEARRYFQQLINAVDYCHS 131 (468)
Q Consensus 86 ---------------------------------~~~~lV~E~~~gg~L~~~i~~~~~l-~e~~~~~~~~qll~~l~yLH~ 131 (468)
..+||-||||+...|.+++..+... ..+.++++|+||++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0179999999986666666554443 478999999999999999999
Q ss_pred CCccccCCCCCCeeeccCCceEEeccccchhhh----h------------hhcCCcccccCCCCCcCCccccccCC--CC
Q 012228 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ----Q------------VREDGLLHTACGTPNYVAPEVLNDKG--YD 193 (468)
Q Consensus 132 ~givHrDlKp~NILl~~~g~lkl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~APEvl~~~~--~~ 193 (468)
+||+||||||.||++|+++.|||+|||+|+... . ...++..+...||-.|+|||++.+.. .+
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999998722 0 01122456678999999999998766 34
Q ss_pred CChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCC----CCHHH
Q 012228 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW----FSSGA 269 (468)
Q Consensus 194 ~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~s~~~ 269 (468)
+.|+|+||||||||||+. ||... ++....+.. ...+.++.|+. --+.-
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~-----------------------LR~g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTS--MERASILTN-----------------------LRKGSIPEPADFFDPEHPEE 847 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHh-----------------------cccCCCCCCcccccccchHH
Confidence 599999999999999984 56432 222222111 22333333322 13456
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 270 KKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 270 ~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
..+|+.||+.||++||||.|+|++.||.
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 7899999999999999999999999996
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=320.21 Aligned_cols=265 Identities=26% Similarity=0.359 Sum_probs=201.7
Q ss_pred ccCe-EEEeeeeecCCeEEEEEE----EcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--
Q 012228 12 VGKY-ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-- 84 (468)
Q Consensus 12 ~~~y-~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-- 84 (468)
.++| ++.+.||+|+||+||++. ...++..||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3566 999999999999998865 335788999999875422 2234567899999999999999999998765
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
...+|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 3468999999999999999876 469999999999999999999999999999999999999999999999999987653
Q ss_pred hhhcCC-cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH--HHHHhhcccccccccccch
Q 012228 165 QVREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM--ALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 165 ~~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 241 (468)
...... ......++..|+|||.+.+..+ +.++||||+||++|+|++|..||...... +...... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~----~~~~~~~~ 233 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ----GQMTVVRL 233 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccc----cccchhhh
Confidence 321111 1122345677999999877666 58999999999999999999999764321 1111000 00000000
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
... .........+..++..+.+++.+||..||++|||++++++
T Consensus 234 ~~~--------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 234 IEL--------LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhh--------hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000 0011122345567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=313.43 Aligned_cols=250 Identities=23% Similarity=0.398 Sum_probs=206.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
..+|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 357999999999999999999885 4778999998654332 24577899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||+++++|.+++... +.++++.+..++.|++.|++|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-cc
Confidence 9999999999998764 468999999999999999999999999999999999999999999999999987442211 01
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
......++..|+|||.+.+..+ +.++|+||+|+++|+|++ |..||...........+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------------- 216 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA------------------- 216 (256)
T ss_pred ccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-------------------
Confidence 1112234678999999987666 589999999999999998 9999988776655554311
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......|...+..+.+|+.+||..+|++|||+.+++++
T Consensus 217 ------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 217 ------GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 01112244468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=312.00 Aligned_cols=244 Identities=28% Similarity=0.458 Sum_probs=200.0
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG 98 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 98 (468)
+.||+|+||.||+|.. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4689999999999986 468899999986542 2223456889999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 99 ELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 99 ~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc-ccccCCCCCC
Confidence 999988754 45899999999999999999999999999999999999999999999999998643211 0111112344
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICR 256 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (468)
++.|+|||++.+..+ +.++||||+|+++|+|++ |..||...........+.. .
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-------------------------~ 210 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-------------------------G 210 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-------------------------C
Confidence 677999999877665 589999999999999998 9999987766554444211 1
Q ss_pred ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 257 ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 257 ~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.....+..++..+.+++.+||..+|++|||+.++++
T Consensus 211 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 211 YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 122344557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=323.50 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=205.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCC----EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
..++|+..+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 34679999999999999999999987776 468888764322 22344678999999999999999999998654
Q ss_pred EEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4679999999999999987654 589999999999999999999999999999999999999999999999999986543
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
...........++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.........+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~--------------- 225 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE--------------- 225 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---------------
Confidence 221111223446778999999887666 589999999999999997 999998765444333221
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
....+..++..+..+.+++.+||..||++|||++++++.
T Consensus 226 ----------~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 226 ----------KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ----------CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111223344578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=317.31 Aligned_cols=251 Identities=20% Similarity=0.254 Sum_probs=192.0
Q ss_pred eeeeecCCeEEEEEEEcC--CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccC
Q 012228 19 RTLGEGSFAKVKFAKNVE--TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 96 (468)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 469999999999997532 44578888875432 22334567899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 97 GGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 97 gg~L~~~i~~~~-----~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
+|+|.+++.... ..++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999987643 246788899999999999999999999999999999999999999999999864322111111
Q ss_pred ccccCCCCCcCCccccccC------CCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 172 LHTACGTPNYVAPEVLNDK------GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~------~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.....+++.|+|||++... ...+.++||||+||++|+|++ |..||......+..........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~----------- 227 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD----------- 227 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC-----------
Confidence 1233456789999997532 233689999999999999998 8899987665444333211000
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
..-.....+..++....+++..|+ .||++|||++++++
T Consensus 228 ---------~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 228 ---------IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ---------ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 000111223447888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=318.56 Aligned_cols=238 Identities=23% Similarity=0.298 Sum_probs=191.2
Q ss_pred eeeecCCeEEEEEEEcCC------------------------CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCe
Q 012228 20 TLGEGSFAKVKFAKNVET------------------------GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75 (468)
Q Consensus 20 ~LG~G~~g~V~~a~~~~~------------------------~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 75 (468)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999985321 2358899886432 2234567889999999999999
Q ss_pred eEEEEEEEeCCEEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC----
Q 012228 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---- 150 (468)
Q Consensus 76 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g---- 150 (468)
+++++++...+..|+||||+++|+|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999988865 45789999999999999999999999999999999999998654
Q ss_pred ---ceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHh-hCCCCCCCchHHHHHH
Q 012228 151 ---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM-AGFLPFDESNLMALYR 226 (468)
Q Consensus 151 ---~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll-~g~~Pf~~~~~~~~~~ 226 (468)
.+|++|||++..... .....++..|+|||.+.+....+.++||||+||++|+|+ +|..||......+...
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998753221 123457889999999876544468999999999999985 7999998765443322
Q ss_pred hhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 227 KVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.. ......|...++.+.++|.+||+.+|++|||+.+++++
T Consensus 233 ~~---------------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FY---------------------------EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH---------------------------HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 11 01112333356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=318.25 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=200.2
Q ss_pred eeeeecCCeEEEEEEEcCCC------CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 19 RTLGEGSFAKVKFAKNVETG------DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
+.||+|+||.||+|.+.... ..+|+|.+..... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46899999999999986544 6899998864321 223556889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC-----ceEEeccccc
Q 012228 93 EFIDGGELFDKIAKH-------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-----VLKISDFGLS 160 (468)
Q Consensus 93 E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g-----~lkl~DFGla 160 (468)
||+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 3478899999999999999999999999999999999999877 8999999998
Q ss_pred hhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccccccccccc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (468)
................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~---------- 227 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT---------- 227 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh----------
Confidence 75432211111223345788999999987666 589999999999999998 999998776655544421
Q ss_pred chhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
....+..+..+|..+.+||.+||..+|.+|||+.++++
T Consensus 228 ---------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 228 ---------------AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ---------------cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11223345557899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=316.55 Aligned_cols=251 Identities=18% Similarity=0.209 Sum_probs=192.8
Q ss_pred eeeeecCCeEEEEEEEc--CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccC
Q 012228 19 RTLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 96 (468)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 3556799998865432 2233468889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 97 GGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 97 gg~L~~~i~~~~-----~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
+|+|.+++.... ..++..+..++.|++.|++|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999987532 356778889999999999999999999999999999999999999999999864322111111
Q ss_pred ccccCCCCCcCCccccccCC------CCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 172 LHTACGTPNYVAPEVLNDKG------YDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~------~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
....++++.|+|||++.+.. ..+.++||||+||++|+|++ |..||...+..+..........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------- 227 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ----------- 227 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc-----------
Confidence 22356788999999986432 13579999999999999996 9999987655443322110000
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
............+..+.+++++|+ .+|++|||+++++.
T Consensus 228 ---------~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 228 ---------LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---------CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000111112236788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=311.92 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=203.2
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 4578999999999999999999864 55679999886432 124568899999999999999999999887 77899
Q ss_pred EEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 91 VLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+|||+++++|.+++... ..++...+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 156 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE- 156 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-
Confidence 99999999999999763 357888999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
........++..|+|||++.+..+ +.++|+||+||++|++++ |..||...+.......+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~----------------- 218 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER----------------- 218 (260)
T ss_pred cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----------------
Confidence 111112235567999999977655 589999999999999998 9999988766555444211
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+...+.++.+++.+||+.||++|||+.++++
T Consensus 219 --------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 219 --------GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred --------CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1112233457889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=318.86 Aligned_cols=267 Identities=25% Similarity=0.395 Sum_probs=201.9
Q ss_pred CeEEEeeeeecCCeEEEEEEE----cCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--CE
Q 012228 14 KYELGRTLGEGSFAKVKFAKN----VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TK 87 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 87 (468)
-|++.+.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 378999999999999999984 4578899999986442 233456789999999999999999999998775 67
Q ss_pred EEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.|+||||++|++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 899999999999999987653 5899999999999999999999999999999999999999999999999998765332
Q ss_pred hcC-CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 167 RED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 167 ~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
... .......++..|+|||++.+..+ +.++||||+||++|+|+++..|+....... ........ .. .......
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~-~~~~~~~~--~~--~~~~~~~ 236 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLF-LKMIGPTH--GQ--MTVTRLV 236 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchh-hhhccccc--cc--ccHHHHH
Confidence 111 11224557778999999887666 589999999999999999877654321110 00000000 00 0000000
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
. .. ........+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus 237 ~----~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 R----VL-EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred H----HH-HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 00 0011223345588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=312.26 Aligned_cols=247 Identities=25% Similarity=0.362 Sum_probs=195.3
Q ss_pred eeeeecCCeEEEEEEEcC---CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-eCCEEEEEEEc
Q 012228 19 RTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA-SKTKIYIVLEF 94 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 94 (468)
+.||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998753 34579999885422 2334567889999999999999999999765 45668999999
Q ss_pred cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc--CCc
Q 012228 95 IDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--DGL 171 (468)
Q Consensus 95 ~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~--~~~ 171 (468)
+.+|+|.+++.... .+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+++....... ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 99999999987643 467788889999999999999999999999999999999999999999999875432110 011
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
.....+++.|+|||.+.+..+ +.++||||+||++|+|++ |.+||...+..+....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~--------------------- 216 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL--------------------- 216 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---------------------
Confidence 123346778999999887766 589999999999999999 577787766555444321
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......+..++..+.+++.+||..+|++|||+.++++.
T Consensus 217 ----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 217 ----QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred ----cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 111223344578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=316.28 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=202.6
Q ss_pred eEEEeeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-----
Q 012228 15 YELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT----- 86 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----- 86 (468)
|.+.++||+|+||.||+|... .++..||+|++..+.. .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999864 4678999999865432 2334667889999999999999999999886532
Q ss_pred -EEEEEEEccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecccc
Q 012228 87 -KIYIVLEFIDGGELFDKIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 87 -~~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGl 159 (468)
..++++||+.+|+|.+++... ..++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999998876532 2478999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccc
Q 012228 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
++...............+++.|++||.+.+..+ +.++|||||||++|+|++ |.+||...+..+.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~--------- 229 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI--------- 229 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH---------
Confidence 875432111111223345678999999887666 489999999999999999 899998877665554431
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......++..+..+.+++.+||..+|++|||+.+++++
T Consensus 230 ----------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 230 ----------------KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ----------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112233445678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=332.67 Aligned_cols=251 Identities=29% Similarity=0.462 Sum_probs=210.8
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCC---E-EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGD---F-VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~---~-vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
+-.+.++||+|+||.||+|..+..+. . ||+|...............+.+|.++|+.++|||||++||+.....-+|
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34556999999999999999875422 3 8999987543334456788999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+|||+|.||+|.+++...+. ++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++.....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~-- 315 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY-- 315 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce--
Confidence 99999999999999998874 999999999999999999999999999999999999999999999999998743211
Q ss_pred CCcccccC-CCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 169 DGLLHTAC-GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 169 ~~~~~~~~-gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
......+ -...|+|||.+....| +.++||||+||++||+++ |..||.+....+...++..
T Consensus 316 -~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~---------------- 377 (474)
T KOG0194|consen 316 -VMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK---------------- 377 (474)
T ss_pred -eeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh----------------
Confidence 1111122 4568999999988766 599999999999999998 8899999998888777521
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......|...+..+..++.+|+..||++|||+.++.+
T Consensus 378 --------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 378 --------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 11223445567889999999999999999999999875
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=315.95 Aligned_cols=267 Identities=25% Similarity=0.380 Sum_probs=201.4
Q ss_pred cCeEEEeeeeecCCeEEEEEE----EcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CC
Q 012228 13 GKYELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KT 86 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~ 86 (468)
.+|++.+.||+|+||.||+|. +..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 479999999999999999998 44678899999986542 2345678899999999999999999998643 45
Q ss_pred EEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
.+|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999998764 4689999999999999999999999999999999999999999999999999886533
Q ss_pred hhcCCcc-cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 166 VREDGLL-HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~~~~~~-~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
....... ....++..|+|||.+.+..+ +.++||||+||++++|++|..|+...... ....+................
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHHHHHH
Confidence 1111011 11223456999999987666 58999999999999999998877554321 111111100000000000000
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
. .....+..+..++.++.+|+.+||..+|++|||+.++++
T Consensus 239 ~--------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 L--------KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred H--------hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 011122344567899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=340.68 Aligned_cols=264 Identities=27% Similarity=0.446 Sum_probs=203.0
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT---- 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 86 (468)
..+-|..-+.||+|+||.||+++++.+|+.||||.++.... ....+..-+|+++|++|+|||||+++++=++..
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 34678889999999999999999999999999999976442 234677889999999999999999999865544
Q ss_pred --EEEEEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec--cCC--ceEEecc
Q 012228 87 --KIYIVLEFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYG--VLKISDF 157 (468)
Q Consensus 87 --~~~lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~--~~g--~lkl~DF 157 (468)
.-.+|||||.||+|+..+... .+++|.+...++..+..||.|||++||+||||||+||++- .+| .-||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 457999999999999998653 4799999999999999999999999999999999999983 223 5799999
Q ss_pred ccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH-----HHHHHhhcccc
Q 012228 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-----MALYRKVSTFH 232 (468)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~-----~~~~~~~~~~~ 232 (468)
|.|+-... +....+..||+.|.+||++..+++++..+|.||+||++|++.||..||..... .-++..+....
T Consensus 169 G~Arel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 169 GAARELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred cccccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 99986654 44778899999999999998766778999999999999999999999964321 12222222111
Q ss_pred cccccccchhhhccccccccccccccCCCCCCCCHH----HHHHHHHhcCCCCCCCC
Q 012228 233 FLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSG----AKKLIKRILDPNPDTRM 285 (468)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~----~~~Ll~~~L~~dP~~R~ 285 (468)
..-..+.....+. .-.....+++|..+++. +-..|..||..+|.+|.
T Consensus 246 ~~v~i~~~~~eNg------pv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 246 SGVAIGAQEEENG------PVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CceeEeeecccCC------ceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1000111111100 00123344455445544 45678889999999999
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=310.75 Aligned_cols=243 Identities=26% Similarity=0.475 Sum_probs=201.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 346899999999999999999864 78899999986432 235678999999999999999999998654 4799
Q ss_pred EEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 91 VLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999997654 4799999999999999999999999999999999999999999999999998743221
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
......+..|+|||.+.+..+ +.++|+||+||++|+|++ |..||...+..+....+..
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----------------- 212 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK----------------- 212 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-----------------
Confidence 122334568999999877666 589999999999999997 9999988776655444211
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+..++..+.+++.+||+.+|.+|||+.++++
T Consensus 213 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 213 --------GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --------CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1112233457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.42 Aligned_cols=236 Identities=20% Similarity=0.276 Sum_probs=191.6
Q ss_pred eeeeecCCeEEEEEEEcCCC----------CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 19 RTLGEGSFAKVKFAKNVETG----------DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~----------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
+.||+|+||.||+|.+..++ ..+++|.+..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46999999999999998776 3478887654321 14677899999999999999999999887 778
Q ss_pred EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC-------ceEEeccccc
Q 012228 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-------VLKISDFGLS 160 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g-------~lkl~DFGla 160 (468)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 799999999999999999999999999999999999999888 7999999998
Q ss_pred hhhhhhhcCCcccccCCCCCcCCccccccC-CCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
..... .....++..|+|||.+.+. ...+.++||||+||++++|++ |..||...+..+......
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~--------- 220 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ--------- 220 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---------
Confidence 75432 2234567789999998766 344689999999999999999 688887765332222210
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......+ ....+.+++.+||..||.+|||+.++++
T Consensus 221 ----------------~~~~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 221 ----------------DQHRLPMP--DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ----------------cCCCCCCC--CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00111111 2378999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=316.92 Aligned_cols=279 Identities=25% Similarity=0.444 Sum_probs=203.2
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-----C---CCeeEEEEEEE-
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-----H---PNVIKIIEVMA- 83 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----h---pnIv~l~~~~~- 83 (468)
++|.+.++||.|.|++||+|.|..+.+.||+|+++... ...+....||.+|+.++ | .+||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 89999999999999999999999999999999997543 35677889999999884 2 47999999984
Q ss_pred ---eCCEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccC--------
Q 012228 84 ---SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSY-------- 149 (468)
Q Consensus 84 ---~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~-------- 149 (468)
++.++|||+|++ |..|..+|.... +++...++.|++|++.||.|||.. ||+|.||||+|||+..+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence 467899999999 558999988654 699999999999999999999976 99999999999999110
Q ss_pred ---C----------------------------------------------------------------------------
Q 012228 150 ---G---------------------------------------------------------------------------- 150 (468)
Q Consensus 150 ---g---------------------------------------------------------------------------- 150 (468)
+
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence 0
Q ss_pred -------------------------------------------------------------------------------c
Q 012228 151 -------------------------------------------------------------------------------V 151 (468)
Q Consensus 151 -------------------------------------------------------------------------------~ 151 (468)
.
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 1
Q ss_pred eEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch----------H
Q 012228 152 LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----------L 221 (468)
Q Consensus 152 lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~----------~ 221 (468)
+||+|||-|+.... ..+.-..|..|+||||+.+.+|. ..+||||++|++|||+||...|+..+ .
T Consensus 393 vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~-~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 393 VKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYS-TSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred EEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCC-CchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 33444444332211 12233468889999999999995 89999999999999999999996432 1
Q ss_pred HHHHHhhccccccccc-ccchhhhcccccccccc-----------ccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 012228 222 MALYRKVSTFHFLSVY-GESYKKCTNKYSYTLQI-----------CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 289 (468)
Q Consensus 222 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~e 289 (468)
..+............. +.-...+.+.......| ....+.++..-..++.+||.-||+.+|++||||.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 1111111111111111 11112222221111111 12223333333567889999999999999999999
Q ss_pred HhcCcccccCCCC
Q 012228 290 MLEDEWFKKGYKP 302 (468)
Q Consensus 290 il~hpwf~~~~~~ 302 (468)
+|+|||+.....|
T Consensus 547 cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 547 CLKHPWLNPVAGP 559 (590)
T ss_pred HhcCccccCCCCC
Confidence 9999999976554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=296.97 Aligned_cols=276 Identities=22% Similarity=0.424 Sum_probs=209.2
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCC--E
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKT--K 87 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~--~ 87 (468)
..++|++.+++|+|.|+.|+.|++..+++.++||+++.-+ .+.|.+||.||+.|+ ||||++++++..++. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 4678999999999999999999999999999999986432 356889999999997 999999999987764 4
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-CCceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~~~~~ 166 (468)
..+|+||....+...+. ..++...++.|+.+|+.||.|||++||+|||+||.|+++|. .-.++|+|+|+|.+..+.
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 67999999886654443 45899999999999999999999999999999999999995 557999999999876542
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCC-CCchHHHHHHhhccc----c-------cc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTF----H-------FL 234 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf-~~~~~~~~~~~~~~~----~-------~~ 234 (468)
. ...-...+..|--||++-.-.++..+-|+||+||+|..|+..+-|| .+.+..+..-++... + +.
T Consensus 187 ~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 187 K---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred c---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 2 2445667889999999987776678999999999999999999997 343332222222211 0 00
Q ss_pred cccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 235 SVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
..+++.+...........+..-..-.-....++++.+||.++|..|-.+|+|+.|++.||||..
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1122222222211111111000000001115799999999999999999999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=311.22 Aligned_cols=279 Identities=24% Similarity=0.425 Sum_probs=221.3
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-----EEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-----KIY 89 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~ 89 (468)
.+--+.||.|+||+||.+.|..+|+.||+|++..- ..+--..+.+.+|+++|...+|.|++...++....+ .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34568899999999999999999999999988532 222334678889999999999999999999886543 478
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+++|++.. +|...|.....++.+.++-+++||+.||+|||+.||.||||||.|+|++.+..+||||||+|+.-+.. ..
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d-~~ 211 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR-DR 211 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-hh
Confidence 99999976 99999999999999999999999999999999999999999999999999999999999999965442 23
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
..++...-|..|+|||++.|...++.++||||.|||+.||+..+..|...++.+..+.+...-...........|..
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG--- 288 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG--- 288 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh---
Confidence 34555667889999999999888889999999999999999999999998887777766532111111111111111
Q ss_pred cccccccccCCCCC-----------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 250 YTLQICRADFSCPS-----------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 250 ~~~~~~~~~~~~~~-----------~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
....+.++....|. .-..++..++.+||.+||.+|++.++++.|++..++
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 11112222222222 223578899999999999999999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=309.98 Aligned_cols=288 Identities=28% Similarity=0.440 Sum_probs=222.8
Q ss_pred CCCCCC--CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEE
Q 012228 3 VKVPAS--RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80 (468)
Q Consensus 3 ~~~~~~--~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~ 80 (468)
+.+|.+ .+.-.+|.-++.+|.|+- .|..|-|.-.+++||+|.+.... ......++..+|..++..++|+||++++.
T Consensus 5 ~~i~~~s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n 82 (369)
T KOG0665|consen 5 VEIPDSSTFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLN 82 (369)
T ss_pred EEcCCCcceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeee
Confidence 344442 334467888999999999 88899999999999999987652 22334677889999999999999999999
Q ss_pred EEEeC------CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEE
Q 012228 81 VMASK------TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKI 154 (468)
Q Consensus 81 ~~~~~------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl 154 (468)
+|.-. ...|+|||+++. +|...+. -.++-+.+..++.|.+.|++|||+.||+||||||+||++..++.+||
T Consensus 83 ~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi 159 (369)
T KOG0665|consen 83 VFTPQKTLEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKI 159 (369)
T ss_pred ccCccccHHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheee
Confidence 98543 458999999976 8888877 45788899999999999999999999999999999999999999999
Q ss_pred eccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccc
Q 012228 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFL 234 (468)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~ 234 (468)
.|||+|+.-. .+-.++.+..|..|+|||++.+.+| ...+||||+|||+.+|++|...|.+.+..+.+.++.. ..
T Consensus 160 ~dfg~ar~e~---~~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~--~l 233 (369)
T KOG0665|consen 160 LDFGLARTED---TDFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIE--QL 233 (369)
T ss_pred ccchhhcccC---cccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHH--Hh
Confidence 9999997432 2235677889999999999999986 5899999999999999999999999887766666532 12
Q ss_pred cccccchhh-----------hccccccc-c------ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 235 SVYGESYKK-----------CTNKYSYT-L------QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 235 ~~~~~~~~~-----------~~~~~~~~-~------~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
+.+++++.+ ..+++... + .........++.-+..+++|+.+||..||++|+|++++|+|||+
T Consensus 234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 222222211 11111110 0 00001111111234679999999999999999999999999999
Q ss_pred ccCCC
Q 012228 297 KKGYK 301 (468)
Q Consensus 297 ~~~~~ 301 (468)
+-++.
T Consensus 314 ~vw~~ 318 (369)
T KOG0665|consen 314 KVWYD 318 (369)
T ss_pred eeecc
Confidence 85543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=340.86 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=213.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcC-----CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
.-++.+.||+|+||+||+|+... ....||||.++... .....+.++||++++..|+|||||+|++++..++-+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 45677899999999999998643 33569999987543 333678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcC----------C----CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEE
Q 012228 89 YIVLEFIDGGELFDKIAKHG----------R----LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKI 154 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~----------~----l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl 154 (468)
|||+|||..|||.+++..+. . ++..+...++.||+.|++||-++.+|||||-..|+||.++-.|||
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence 99999999999999987543 2 778899999999999999999999999999999999999999999
Q ss_pred eccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccccc
Q 012228 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHF 233 (468)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~ 233 (468)
+||||++.......-.......-...|||||.+...++ +.++||||+||+|||+++ |.-||.+.+.++..+.+.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~---- 719 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR---- 719 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH----
Confidence 99999986443222111212233568999999998888 589999999999999997 999999998888877753
Q ss_pred ccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 012228 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 291 (468)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil 291 (468)
.+.-+.+|+.+|.++.+|+..||+.+|++|||+.||-
T Consensus 720 ---------------------~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 720 ---------------------AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred ---------------------cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 2334678999999999999999999999999999984
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=309.55 Aligned_cols=251 Identities=27% Similarity=0.523 Sum_probs=205.9
Q ss_pred CeEEEeeeeecCCeEEEEEEEcC-CCCEEEEEEeechhh-------hhHHHHHHHHHHHHHHhc-CCCCCeeEEEEEEEe
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVE-TGDFVAIKIVDRDQV-------LRHKMVEQIKREISTMKL-IKHPNVIKIIEVMAS 84 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~-------~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~ 84 (468)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 788999998853221 122345667789988865 789999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCceEEecccc
Q 012228 85 KTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~lkl~DFGl 159 (468)
.+..|+||||++|++|.+.+.. ...+++..++.++.|++.||.|||+ .|++|+||+|+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999888743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred chhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccccc
Q 012228 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (468)
+...... .......|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+...
T Consensus 161 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-------- 228 (269)
T cd08528 161 AKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA-------- 228 (269)
T ss_pred eeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhc--------
Confidence 8754332 13445678999999999987665 68999999999999999999999877655444432110
Q ss_pred chhhhccccccccccccccCCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 240 SYKKCTNKYSYTLQICRADFSCP-SWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
...+.+ ..+++.+.+++.+||+.||++|||+.|+.++
T Consensus 229 -----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 229 -----------------VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -----------------cCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 001111 2478899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=308.51 Aligned_cols=251 Identities=18% Similarity=0.262 Sum_probs=192.0
Q ss_pred eeeeecCCeEEEEEEEcCC--CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccC
Q 012228 19 RTLGEGSFAKVKFAKNVET--GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 96 (468)
+.||+|+||+||+|..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999976433 33566777654322 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 97 GGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 97 gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
+|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999998754 23667788999999999999999999999999999999999999999999997532211111122
Q ss_pred cccCCCCCcCCccccccCC------CCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 173 HTACGTPNYVAPEVLNDKG------YDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~------~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
...++++.|+|||++.... ..+.++||||+||++|+|++ |..||...+..+.+..+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~------------ 226 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ------------ 226 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc------------
Confidence 3467889999999985321 12578999999999999996 6789987666555444311100
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
..-.....+..+++.+.+++..|+ .+|.+|||++++++
T Consensus 227 --------~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 227 --------VKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred --------cccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 000111223347888999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=318.97 Aligned_cols=267 Identities=29% Similarity=0.460 Sum_probs=221.9
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhh----HHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR----HKMVEQIKREISTMKLIKHPNVIKIIEVMA- 83 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~----~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~- 83 (468)
++.-.+|-++..||+|+|+.||+|.+....++||+|+-...+..+ .+..+..-+|.+|++.|+||-||++|++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 445678999999999999999999999999999999965443332 234567789999999999999999999995
Q ss_pred eCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCCeeec---cCCceEEeccc
Q 012228 84 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--GVFHRDLKPENLLLD---SYGVLKISDFG 158 (468)
Q Consensus 84 ~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~--givHrDlKp~NILl~---~~g~lkl~DFG 158 (468)
+.+.+|-|+|||+|.+|.-++..+.-++|.+|+.|+-||+.||.||.+. -|+|-||||.|||+- ..|.+||+|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 4567999999999999999999999999999999999999999999987 599999999999994 46789999999
Q ss_pred cchhhhhhhcC-----CcccccCCCCCcCCccccc-c--CCCCCChhhHHHHHHHHHHHhhCCCCCCCch-HHHHHHhhc
Q 012228 159 LSAISQQVRED-----GLLHTACGTPNYVAPEVLN-D--KGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKVS 229 (468)
Q Consensus 159 la~~~~~~~~~-----~~~~~~~gt~~y~APEvl~-~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-~~~~~~~~~ 229 (468)
|++++.....+ .+.....||.||++||.+. + .+-.+.++||||+|||+|.++.|+.||.... ..++++.-+
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99988654332 1334467999999999874 2 3344789999999999999999999997653 333333321
Q ss_pred ccccccccccchhhhccccccccccccccCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 230 TFHFLSVYGESYKKCTNKYSYTLQICRADFSCP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
. +...+..+| +-+++++++||++||.+--++|+.+.++-.||||.-
T Consensus 699 I-----------------------lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 699 I-----------------------LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred h-----------------------hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 1 334445555 448999999999999999999999999999999974
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=311.44 Aligned_cols=263 Identities=15% Similarity=0.168 Sum_probs=193.0
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCC---CCEEEEEEeechhhh--hHH-H-----HHHHHHHHHHHhcCCCCCeeE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVL--RHK-M-----VEQIKREISTMKLIKHPNVIK 77 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~--~~~-~-----~~~i~~Ei~il~~l~hpnIv~ 77 (468)
...-++|++.+.||+|+||+||+|.+..+ +..+|+|+....... .+. . ......++..++.+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 33446899999999999999999999877 677888875432211 000 0 111223445566778999999
Q ss_pred EEEEEEeCC----EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceE
Q 012228 78 IIEVMASKT----KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (468)
Q Consensus 78 l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lk 153 (468)
+++...... ..++++|++.. ++.+.+......++..+..++.|++.||+|||++||+||||||+|||++.++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 998765443 35788888754 6767766655678999999999999999999999999999999999999999999
Q ss_pred Eeccccchhhhhhhc-----CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH-HHHHHh
Q 012228 154 ISDFGLSAISQQVRE-----DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRK 227 (468)
Q Consensus 154 l~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~-~~~~~~ 227 (468)
|+|||+|+.+..... ........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+... ......
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 999999976532111 111233579999999999988777 5999999999999999999999987632 222111
Q ss_pred hcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 228 VSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.... . ...+..+.... +..+..+.+++..|+..+|++||+++++++
T Consensus 246 ~~~~-~-----------------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCD-F-----------------IKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHH-H-----------------HHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1000 0 00011222222 235788999999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=311.15 Aligned_cols=267 Identities=24% Similarity=0.370 Sum_probs=203.3
Q ss_pred cCeEEEeeeeecCCeEEEEEEEc----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CC
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNV----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KT 86 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~ 86 (468)
..|++.+.||+|+||.||+|... .++..+|+|++...... ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 46888999999999999999964 35789999999755332 346778999999999999999999999877 56
Q ss_pred EEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..|+||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 7999999999999999997654 589999999999999999999999999999999999999999999999999876542
Q ss_pred hhcCC-cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 166 VREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
..... ......++..|+|||.+.+..+ +.++||||+||++++|++|..||......... ...... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~----~~~~~~~~ 235 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQ----GQMIVTRL 235 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhcc-cccccc----ccccHHHH
Confidence 11110 1112344567999999877665 58899999999999999999998664322110 000000 00000000
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.... ........+..++.++.+|+.+||..||.+|||+.++++
T Consensus 236 ~~~~-----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 236 LELL-----KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHH-----HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 011122334457789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.33 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=213.1
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCC-CC----EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVET-GD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~-~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
.-++.+.||+|+||.||.|..... |. .||+|.+.+. .+......+.+|..+|+.++|||||+++++..+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 467889999999999999998643 32 3888888654 3455678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 89 YIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
+|++|||+||+|..+|++.. .++......++.|++.|++||+++++|||||-..|+||+....+||+|||+|+
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 99999999999999998862 48899999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccc
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (468)
..........-....-...|||||.+....+ +.++|||||||+|||+++ |..||.+.+..+.+..+
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------------ 917 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------------ 917 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------------
Confidence 4332111111111122357999999998666 689999999999999997 99999998877766543
Q ss_pred hhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
...+.+..|+.++..+.+++..||+.+|++||++..|++
T Consensus 918 -------------~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 918 -------------LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -------------HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 345678889999999999999999999999999999997
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=338.40 Aligned_cols=277 Identities=19% Similarity=0.255 Sum_probs=184.1
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCC----CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEE---
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVET----GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEV--- 81 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~--- 81 (468)
....++|++.+.||+|+||.||+|.+..+ +..||+|.+...... +....| .++...+.++..+...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 34568999999999999999999999988 999999987543211 111111 1112222222222211
Q ss_pred ---EEeCCEEEEEEEccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 012228 82 ---MASKTKIYIVLEFIDGGELFDKIAKHGR--------------------LKEDEARRYFQQLINAVDYCHSRGVFHRD 138 (468)
Q Consensus 82 ---~~~~~~~~lV~E~~~gg~L~~~i~~~~~--------------------l~e~~~~~~~~qll~~l~yLH~~givHrD 138 (468)
......+++||||+.+++|.+++..... ..+..+..++.||+.||+|||++||+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2456679999999999999998875421 12345678999999999999999999999
Q ss_pred CCCCCeeecc-CCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCC---------------------CCCh
Q 012228 139 LKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY---------------------DGRA 196 (468)
Q Consensus 139 lKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~---------------------~~~~ 196 (468)
|||+|||++. ++.+||+|||+|+..... ........++|+.|+|||.+....+ .+.+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 9999999985 689999999999754321 1223456789999999997643221 1245
Q ss_pred hhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHh
Q 012228 197 SDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRI 276 (468)
Q Consensus 197 ~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~ 276 (468)
+||||+||+||+|+++..|++... ......+...... ...|....... ........+......+..+.+||.+|
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYD---LVAWRKLVEPR--ASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCc---HHHHHHhhccc--cchhhhhhhhhccccchHHHHHHHHH
Confidence 699999999999999877765431 2222221110000 00000000000 00000111222222355677999999
Q ss_pred cCCCCCCCCCHHHHhcCcccccC
Q 012228 277 LDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 277 L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
|+.||.+|||+.++|+||||+..
T Consensus 434 L~~dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 434 MRFKGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred ccCCcccCCCHHHHhCCcCcCCC
Confidence 99999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=324.34 Aligned_cols=285 Identities=25% Similarity=0.395 Sum_probs=218.5
Q ss_pred CCCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC------CCCeeE
Q 012228 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK------HPNVIK 77 (468)
Q Consensus 4 ~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~------hpnIv~ 77 (468)
+|.-+..+-++|.+....|+|-||+|..|.+...|..||||+|....+ +.+.=.+|+.||++|+ --|+++
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 344455566789999999999999999999999999999999976432 4455679999999996 348999
Q ss_pred EEEEEEeCCEEEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC-CceE
Q 012228 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLK 153 (468)
Q Consensus 78 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~-g~lk 153 (468)
|+..|...+++|||+|.+.- .|.+.+..-+ +|....++.|++||+.||..|-..||+|.||||.|||+++. ..+|
T Consensus 499 l~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceee
Confidence 99999999999999999854 8888887655 58899999999999999999999999999999999999864 5689
Q ss_pred EeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccc
Q 012228 154 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHF 233 (468)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~ 233 (468)
|||||.|..... ...+.+.-+..|+|||++.|.+|+ .+.|+||+||.||||+||+..|.+.+..+++........
T Consensus 578 LCDfGSA~~~~e----neitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 578 LCDFGSASFASE----NEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eccCcccccccc----ccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 999999875432 335566678899999999999997 899999999999999999999999887666554321110
Q ss_pred --c--cccccch----------------hhhcccccccc-----------ccccccCCCCCC---CCHHHHHHHHHhcCC
Q 012228 234 --L--SVYGESY----------------KKCTNKYSYTL-----------QICRADFSCPSW---FSSGAKKLIKRILDP 279 (468)
Q Consensus 234 --~--~~~~~~~----------------~~~~~~~~~~~-----------~~~~~~~~~~~~---~s~~~~~Ll~~~L~~ 279 (468)
+ ..-...+ ........... ....+...+|.. .-..+.+||.+||..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 0 0000000 00000000000 000001111111 235688999999999
Q ss_pred CCCCCCCHHHHhcCccccc
Q 012228 280 NPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 280 dP~~R~t~~eil~hpwf~~ 298 (468)
||++|+|+.|+|+||||+.
T Consensus 733 dP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 733 DPEKRITVNQALKHPFITE 751 (752)
T ss_pred ChhhcCCHHHHhcCCcccC
Confidence 9999999999999999974
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=329.81 Aligned_cols=266 Identities=27% Similarity=0.441 Sum_probs=222.8
Q ss_pred CCCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEE
Q 012228 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVM 82 (468)
Q Consensus 4 ~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~ 82 (468)
.+.......+.|++..+||.|.+|.||++.++.+|+.+|+|+.+...- ..+.++-|.+||+.+. |||++.++++|
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 334445566789999999999999999999999999999999876532 3467889999999885 99999999998
Q ss_pred Ee-----CCEEEEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEe
Q 012228 83 AS-----KTKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 155 (468)
Q Consensus 83 ~~-----~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~ 155 (468)
.- ++.+|||||||.||+..|+++. ..++.|+.+..+++.++.|+.+||++.++|||||-.|||++.+|.|||+
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEe
Confidence 43 5789999999999999998875 4579999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhhhcCCcccccCCCCCcCCccccccC-----CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcc
Q 012228 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVST 230 (468)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~ 230 (468)
|||.+...... .+.-.+..|||.|||||++... .|+ ..+|+||||++..||..|.+|+...-+...+-++..
T Consensus 166 DFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR 242 (953)
T KOG0587|consen 166 DFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 242 (953)
T ss_pred eeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCC
Confidence 99998765442 3345678899999999999643 343 689999999999999999999987766544333211
Q ss_pred cccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 231 FHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.....+..|..++.++.++|..||.+|-.+||+..++|+|||.+..
T Consensus 243 -----------------------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 243 -----------------------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred -----------------------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 1122334455689999999999999999999999999999999843
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=313.57 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=196.0
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-EEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-KIYIV 91 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lV 91 (468)
..|.-...||+|+||.||+|... +|..||||.+....... ...+.+|+.++.+++|||+|+|++++.+.+ ..++|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 56777789999999999999985 45899999876543221 344999999999999999999999999988 59999
Q ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 92 LEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRG---VFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~g---ivHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
+||++.|+|.+++.... .+++....+|+.+++.||+|||+.. |+||||||+|||+|++++.||+|||+|......
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999999999998765 7899999999999999999999864 999999999999999999999999999643321
Q ss_pred hcCCccccc-CCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch------HHHHHHhhccccccccccc
Q 012228 167 REDGLLHTA-CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN------LMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 167 ~~~~~~~~~-~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~------~~~~~~~~~~~~~~~~~~~ 239 (468)
.....+. .||.+|+|||.+..... +.++||||+||+|.||++|+.|.+... ..+.......
T Consensus 231 --~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~--------- 298 (361)
T KOG1187|consen 231 --DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE--------- 298 (361)
T ss_pred --ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH---------
Confidence 1222223 89999999999876444 689999999999999999998887542 1111100000
Q ss_pred chhhhccccccccccccccCC---CCC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 240 SYKKCTNKYSYTLQICRADFS---CPS-WFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~---~~~-~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.. ....+....+. .+. ..-..+..+..+|++.+|..||++.|+++
T Consensus 299 -------~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 299 -------EG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -------Cc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 00 00001111111 110 01123567788999999999999999754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=292.32 Aligned_cols=250 Identities=25% Similarity=0.436 Sum_probs=200.5
Q ss_pred EEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHH-hcCCCCCeeEEEEEEEeCCEEEEEEEcc
Q 012228 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (468)
Q Consensus 17 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 95 (468)
-+..||.|+||+|++..++.+|+..|||.|+.... ++..+++..|.... +.-++||||++|+....+...||.||+|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 35679999999999999999999999999987664 34467788888764 4557999999999999999999999999
Q ss_pred CCCCHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 96 DGGELFDKI-----AKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 96 ~gg~L~~~i-----~~~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+- +|..+. .....++|..+-.+....+.||.||-.. .|+|||+||+|||+|..|.+||||||.+..+.. .
T Consensus 146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---S 221 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---S 221 (361)
T ss_pred hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH---H
Confidence 64 443221 2345799999999999999999999865 899999999999999999999999999865432 1
Q ss_pred CcccccCCCCCcCCccccc--cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 170 GLLHTACGTPNYVAPEVLN--DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~--~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
-..+.-.|..+|||||.+. +.+|+ ..+|+||||++|||+.||..|+.+.+. .+.++..
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~----------------- 281 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQ----------------- 281 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHH-----------------
Confidence 1223457899999999985 34576 899999999999999999999987542 2222211
Q ss_pred cccccccccccC---CCCC---CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 248 YSYTLQICRADF---SCPS---WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~---~~~~---~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
...+++ ..+. .++..+..+|..||.+|-+.||...+++++||++.
T Consensus 282 ------Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 282 ------VVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred ------HHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 111111 1121 27889999999999999999999999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=287.93 Aligned_cols=240 Identities=46% Similarity=0.848 Sum_probs=204.1
Q ss_pred CCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCHHHHH
Q 012228 25 SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI 104 (468)
Q Consensus 25 ~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 104 (468)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..++.++|+||+++++.+......++++|++.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998999999999876443221 578889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCc
Q 012228 105 AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184 (468)
Q Consensus 105 ~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 184 (468)
.....++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+...... .......++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence 87777999999999999999999999999999999999999999999999999998765432 134456788999999
Q ss_pred cccccCCCCCChhhHHHHHHHHHHHhhCCCCCCC-chHHHHHHhhcccccccccccchhhhccccccccccccccCCCC-
Q 012228 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCP- 262 (468)
Q Consensus 185 Evl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 262 (468)
|.+.+..+ +.++||||+|+++++|++|..||.. .+.....+... .......
T Consensus 156 E~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------------------------~~~~~~~~ 208 (244)
T smart00220 156 EVLLGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG--------------------------KPKPPFPP 208 (244)
T ss_pred HHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh--------------------------ccCCCCcc
Confidence 99987666 4799999999999999999999987 44444444321 1111111
Q ss_pred CC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 263 SW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 263 ~~--~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.+ ++.++.+++.+||..||++||++.++++||||
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 11 78899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=312.93 Aligned_cols=275 Identities=21% Similarity=0.247 Sum_probs=189.7
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEc----------------CCCCEEEEEEeechhhhhH-H----------HHHHHHH
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNV----------------ETGDFVAIKIVDRDQVLRH-K----------MVEQIKR 62 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~----------------~~~~~vAiK~i~~~~~~~~-~----------~~~~i~~ 62 (468)
...++|++.++||+|+||+||+|... ..++.||||.+........ . ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34678999999999999999999752 3456799999864321110 0 1122335
Q ss_pred HHHHHhcCCCCCe-----eEEEEEEEe--------CCEEEEEEEccCCCCHHHHHHhcC---------------------
Q 012228 63 EISTMKLIKHPNV-----IKIIEVMAS--------KTKIYIVLEFIDGGELFDKIAKHG--------------------- 108 (468)
Q Consensus 63 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~~~--------------------- 108 (468)
|+.++.+++|.++ +++++++.. ....|+||||+++|+|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766554 666666542 356899999999999999886421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCcc
Q 012228 109 ---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185 (468)
Q Consensus 109 ---~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 185 (468)
.++...++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ........+|+.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChh
Confidence 23567789999999999999999999999999999999999999999999986543211 11111233589999999
Q ss_pred ccccCC--------------------CC-CChhhHHHHHHHHHHHhhCCC-CCCCchHHHHHHhhcccccccccccchhh
Q 012228 186 VLNDKG--------------------YD-GRASDVWSCGVILFVLMAGFL-PFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 186 vl~~~~--------------------~~-~~~~DiWSlGvil~~ll~g~~-Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
++.... |. ..+.|+||+||++++|++|.+ ||................ ...|..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~-----~~~~r~ 455 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDND-----LNRWRM 455 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccch-----HHHHHh
Confidence 975422 11 134799999999999999986 776432211110000000 000000
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCC---CCCCCHHHHhcCccccc
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNP---DTRMTISQMLEDEWFKK 298 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP---~~R~t~~eil~hpwf~~ 298 (468)
. .....++......++.+++|+.+||..+| .+|+|++|+|+||||..
T Consensus 456 ~--------~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 Y--------KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred h--------cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0 01112233334478999999999999876 68999999999999964
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=311.14 Aligned_cols=203 Identities=31% Similarity=0.600 Sum_probs=186.4
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHH-----HHHHHHHHHHHhcCC---CCCeeEEEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKM-----VEQIKREISTMKLIK---HPNVIKIIEVM 82 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~-----~~~i~~Ei~il~~l~---hpnIv~l~~~~ 82 (468)
....|...+.||+|+||.|++|+++.+...|+||.|.++++.-... ...+-.||.||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4567999999999999999999999999999999999887764433 335778999999997 99999999999
Q ss_pred EeCCEEEEEEEcc-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 83 ASKTKIYIVLEFI-DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 83 ~~~~~~~lV~E~~-~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
++.+++|++||.- +|.+||++|+....++|.+++.+|+|++.|+++||++||+|||||-+|+.++.+|-+||+|||.|.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 9999999999976 567999999999999999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCC
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~ 217 (468)
.. .++......||..|.|||++.|.+|-|.+-|||++|++||-++....||-
T Consensus 719 ~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 YT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 54 35667889999999999999999999999999999999999999888874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.46 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=217.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcC-CCC--EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVE-TGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
++..+.+.||+|+||+|+.|.+.. +|+ .||||++..+.... ....+.+|+.+|.+|+|||+|+||++..+ ..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 456678999999999999999874 343 58999998765443 57789999999999999999999999987 6788
Q ss_pred EEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
||||+|++|+|.+.+.+. ..|.......|+.||+.|+.||.+++.|||||-..|+|+-....||||||||.+-+....
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999999999873 358889999999999999999999999999999999999999999999999988665422
Q ss_pred cCCcccc-cCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 168 EDGLLHT-ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 168 ~~~~~~~-~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
....+.. ..-...|+|||.+....+ +.++|+|++||++|||++ |+.||.+.....+++++
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i----------------- 328 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI----------------- 328 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc-----------------
Confidence 2111111 123457999999988777 489999999999999997 89999999988888875
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
..+..+.-|+.+|.++.+++..||..+|.+|||+..|.+.-+...
T Consensus 329 --------D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 329 --------DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred --------cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 334566778889999999999999999999999999987655544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=302.62 Aligned_cols=244 Identities=27% Similarity=0.453 Sum_probs=201.5
Q ss_pred EEEeeeeecCCeEEEEEEEcCC--CC--EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 16 ELGRTLGEGSFAKVKFAKNVET--GD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 16 ~i~~~LG~G~~g~V~~a~~~~~--~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.+.+.||.|-||.||.|..... |+ .||||..+.+... ...+.+..|..+|+.++|||||++++++.+ .-+|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 3457899999999999997532 33 5899988664322 236789999999999999999999999865 458999
Q ss_pred EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||+++-|+|..+++.+. .++......|+.||+.||.|||+.+.|||||-..|||+.....+||+|||+++......
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~--- 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA--- 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc---
Confidence 99999999999998754 68999999999999999999999999999999999999999999999999999765422
Q ss_pred cccccCC--CCCcCCccccccCCCCCChhhHHHHHHHHHHHh-hCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 171 LLHTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM-AGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 171 ~~~~~~g--t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll-~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
......| ..-|||||.+.-..+ +.++|||.|||.+||++ .|.-||.+-...+....+
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i------------------- 605 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI------------------- 605 (974)
T ss_pred hhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------------------
Confidence 1222223 346999999976666 58999999999999987 599999876543332221
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 291 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil 291 (468)
.....+++|+.+|+.+..|+.+||.+||.+||++.+|.
T Consensus 606 ------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 606 ------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 23457789999999999999999999999999988764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=300.74 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=208.2
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.-.++++||+|-||.|.++.-. .+..||+|+++.... ....+.+.+||++|.+|+|||||++++++..++-+|+|+|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3567899999999999999873 468999999976543 2346789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 94 FIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|++.|+|.+++.++.. .......+++.||++|++||.+.++|||||.+.|+|+|+++++||+|||+++-+.....-..
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999999999998753 34456667999999999999999999999999999999999999999999985432211111
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHh--hCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM--AGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll--~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
-....-...|||||.+...++ +.++|+|++|+++||++ |..-||...+.++..+......
T Consensus 696 qgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~----------------- 757 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFF----------------- 757 (807)
T ss_pred ecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhc-----------------
Confidence 112233568999999887777 58999999999999974 7899998877766655432110
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
..+-...-+..|+-++..+.+|+.+|+..|-++|||.+++-.
T Consensus 758 -~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 758 -RDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -CCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 001122344567789999999999999999999999999854
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=295.17 Aligned_cols=243 Identities=26% Similarity=0.445 Sum_probs=210.3
Q ss_pred EEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEcc
Q 012228 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFI 95 (468)
Q Consensus 16 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 95 (468)
....+||-|.||.||.|.+++..-.||||.++.+.. ..+.+..|..+|+.++|||+|+|++++..+.-+|||+|||
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 346789999999999999999999999999865432 3677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 96 DGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 96 ~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
..|.|.+++....+ ++.-....++.||.+|++||..++++||||-..|+|+.++..+|++||||++++.. ...+
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg----DTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG----DTYT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC----Ccee
Confidence 99999999987664 67777888899999999999999999999999999999999999999999998643 2223
Q ss_pred ccCC---CCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 174 TACG---TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 174 ~~~g---t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
...| ..-|.|||.+.-..+ +.++|||+|||+|||+.| |..||.+.+..+.|..+..
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk------------------- 481 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK------------------- 481 (1157)
T ss_pred cccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-------------------
Confidence 3333 446999999987666 489999999999999997 9999999998888776532
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......|+.+++.+..|++.||+++|.+||+++||-+
T Consensus 482 ------gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 482 ------GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred ------cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 2344567889999999999999999999999998743
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=290.62 Aligned_cols=280 Identities=27% Similarity=0.425 Sum_probs=207.1
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcC---CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKT 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~ 86 (468)
....|.++++||+|+|++||+|.+.. ..+.||+|.+..... ...+..|+++|..+. +.||+++.+.+..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44669999999999999999999987 788999999865432 356889999999996 999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec-cCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~-~~g~lkl~DFGla~~~~~ 165 (468)
.+.+||||.+..+..++.. .++-.+++.|++.++.||+++|.+||+||||||.|+|.+ ..+.-.|+|||+|...+.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 9999999999987777764 477999999999999999999999999999999999998 567889999999973211
Q ss_pred hh------c-------------------------CC-----------cccccCCCCCcCCccccccCCCCCChhhHHHHH
Q 012228 166 VR------E-------------------------DG-----------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 203 (468)
Q Consensus 166 ~~------~-------------------------~~-----------~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlG 203 (468)
.. . .+ .-....|||+|+|||++...+-.++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 00 001234999999999999888888999999999
Q ss_pred HHHHHHhhCCCCCCCch--HHHHHHhhcccc---------ccc---ccccch----hhhccccccc--cccccccC----
Q 012228 204 VILFVLMAGFLPFDESN--LMALYRKVSTFH---------FLS---VYGESY----KKCTNKYSYT--LQICRADF---- 259 (468)
Q Consensus 204 vil~~ll~g~~Pf~~~~--~~~~~~~~~~~~---------~~~---~~~~~~----~~~~~~~~~~--~~~~~~~~---- 259 (468)
||+..++++..||-... ...+......+. ..+ .+..++ ......+... ..+...+.
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999999984321 111111111000 000 011000 0000000000 00111011
Q ss_pred --CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 260 --SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 260 --~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.....++..+.+|+.+||..||.+|+|++++|+||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 111225779999999999999999999999999999973
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=308.40 Aligned_cols=244 Identities=30% Similarity=0.426 Sum_probs=193.3
Q ss_pred EeeeeecCCeE-EEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEEEEEcc
Q 012228 18 GRTLGEGSFAK-VKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVLEFI 95 (468)
Q Consensus 18 ~~~LG~G~~g~-V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 95 (468)
.+.+|.|+.|+ ||+|.. .|+.||||.+-.+ ....+.+||..|+.-+ |||||++|+.-.+....||+.|+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 46789999986 899998 6789999977432 3456789999999985 999999999999999999999999
Q ss_pred CCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc---CC--ceEEeccccchhhhhh
Q 012228 96 DGGELFDKIAKHGR----LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YG--VLKISDFGLSAISQQV 166 (468)
Q Consensus 96 ~gg~L~~~i~~~~~----l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~---~g--~lkl~DFGla~~~~~~ 166 (468)
.. +|.++++.+.. ......+..+.|+++||++||+.+|+||||||.||||+. ++ .++|+|||+++.....
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 76 99999988521 112456788999999999999999999999999999975 34 6899999999876442
Q ss_pred hc-CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 167 RE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 167 ~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.. -....+..||-+|+|||++..... +.++||+|+||++|+.++| ..||...-..+. .
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--N----------------- 724 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--N----------------- 724 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHhhh--h-----------------
Confidence 22 223556789999999999987665 4799999999999998885 999976532211 1
Q ss_pred ccccccccccccccCCC---CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 245 TNKYSYTLQICRADFSC---PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~---~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
|.++.+.. .+.-..++.+||.+||.+||..||||.++|.||+|-..
T Consensus 725 ---------Il~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 725 ---------ILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred ---------hhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 11121111 11112289999999999999999999999999999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=306.09 Aligned_cols=261 Identities=26% Similarity=0.433 Sum_probs=218.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
-.+|++...+|.|+||.||+|+++.+++..|+|+++.+.- .....+.+||-+++.++|||||.+++.|.....+|++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 3579999999999999999999999999999999987643 3467788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||||.||+|.+...-.+.++|.++.+..+..+.|++|||++|-+|||||-.|||+++.|.+|++|||.+...... -..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAK 168 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh--hhh
Confidence 999999999999888899999999999999999999999999999999999999999999999999997644321 122
Q ss_pred ccccCCCCCcCCccccc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 172 LHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~---~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.....|||.|||||+-. ..+| ...+|||++|+...++---++|--..-+......+.+..
T Consensus 169 rksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~---------------- 231 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG---------------- 231 (829)
T ss_pred hhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccC----------------
Confidence 34678999999999853 3455 499999999999999988777754444333332222110
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
........+..+++.+.+|++.+|.++|++|||++.+|.|||....
T Consensus 232 -----~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 232 -----FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred -----CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 1112223344478899999999999999999999999999998754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=302.59 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=214.9
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCC---EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
-.|.+.||.|.||.||+|+.+..|+ .||||.++... .++....+..|..||-+.+||||++|.++.....-+.||
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 4678999999999999999987774 59999997544 445677899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
+|||+.|+|..++.. +++|+..+...+++.|+.|++||-++|.|||||-..|||++.+-..|++||||+++..... ..
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~-~~ 787 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EA 787 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-Cc
Confidence 999999999999865 4679999999999999999999999999999999999999999999999999999775533 22
Q ss_pred cccccCC--CCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 171 LLHTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 171 ~~~~~~g--t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
..++.-| ...|.|||.+...++ +.++|+||+||+|||.++ |..||...+..+..+.+.
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe------------------ 848 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE------------------ 848 (996)
T ss_pred cccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHH------------------
Confidence 2333333 357999999988777 589999999999999875 999998887777776652
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
..-.++.|..+|..+..|+..||++|-.+||++.||+.+
T Consensus 849 -------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 849 -------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred -------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 223445566789999999999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=326.48 Aligned_cols=250 Identities=21% Similarity=0.304 Sum_probs=189.2
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
..|...+.||+|+||.||+|.+..++..||+|.+...... ...|+.++++++|||||++++++.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3466678999999999999999999999999998643211 125688999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH---SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH---~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||+++|+|.+++. .+++..+..++.|++.|++||| +.+|+||||||+||+++.++..+++ ||.+.....
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999999999985 3899999999999999999999 6699999999999999998888876 665443211
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch-----HHHHHHhhcccccccccccchhhh
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-----LMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.....||+.|+|||++.+..| +.++||||+||++|||++|+.||+... ..+..+..... ......
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 904 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD-------CHLDMW 904 (968)
T ss_pred --CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc-------cchhhe
Confidence 123468899999999987776 589999999999999999999995421 11111000000 000000
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
...........+.....++.+++.+||+.||++|||++|+++.
T Consensus 905 ------~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 905 ------IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ------eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000011111111123457889999999999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=251.15 Aligned_cols=204 Identities=25% Similarity=0.494 Sum_probs=169.3
Q ss_pred EEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEEEcc
Q 012228 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFI 95 (468)
Q Consensus 17 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 95 (468)
.+..||+|+||.|-+.++..+|...|+|.+...- +.+...++.+|+.+..+. .+|.+|.+|+.+.....+|+.||.|
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 4568999999999999999999999999996532 234466778899885554 6999999999999999999999999
Q ss_pred CCCCHHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 96 DGGELFD----KIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 96 ~gg~L~~----~i~~~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
+. +|.. .+...+.++|..+-+++..++.||.|||++ .|+|||+||+|||++..|.+||||||.+..+.. .
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d----S 202 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD----S 202 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh----h
Confidence 75 5543 345667899999999999999999999987 899999999999999999999999999876533 2
Q ss_pred cccc-cCCCCCcCCccccc----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCc-hHHHHHHhh
Q 012228 171 LLHT-ACGTPNYVAPEVLN----DKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKV 228 (468)
Q Consensus 171 ~~~~-~~gt~~y~APEvl~----~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~-~~~~~~~~~ 228 (468)
...+ ..|...|+|||.+. .++| +-++||||||+.++||.+++.||+.. ++.++++++
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 2223 56888999999975 3356 48999999999999999999999753 455555544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=270.09 Aligned_cols=249 Identities=23% Similarity=0.425 Sum_probs=192.0
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHh--cCCCCCeeEEEEEEEeC---
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK--LIKHPNVIKIIEVMASK--- 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~--~l~hpnIv~l~~~~~~~--- 85 (468)
.-.+-.+.+.||+|.||.||+|.. .|+.||||++.... .....+|.+|.+ .|+|+||+.++..-..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 446788999999999999999998 68999999996431 245667777776 55999999999875333
Q ss_pred -CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCCeeeccCCceEEec
Q 012228 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------GVFHRDLKPENLLLDSYGVLKISD 156 (468)
Q Consensus 86 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~--------givHrDlKp~NILl~~~g~lkl~D 156 (468)
..+|+|++|-+.|+|+|++.. ..++.+...+++..+++||++||.. .|+|||||+.|||+..+|..-|+|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 358999999999999999987 7899999999999999999999963 499999999999999999999999
Q ss_pred cccchhhhhhhc--CCcccccCCCCCcCCccccccCCC----C-CChhhHHHHHHHHHHHhhC----------CCCCCC-
Q 012228 157 FGLSAISQQVRE--DGLLHTACGTPNYVAPEVLNDKGY----D-GRASDVWSCGVILFVLMAG----------FLPFDE- 218 (468)
Q Consensus 157 FGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~----~-~~~~DiWSlGvil~~ll~g----------~~Pf~~- 218 (468)
+|||-....... +-.....+||..|||||++...-. . -..+||||+|.++||++.. ++||.+
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 999975443211 223466899999999999864321 1 1568999999999999753 567642
Q ss_pred ----chHHHHHHhhcccccccccccchhhhccccccccccccccCCCCC-CCCH----HHHHHHHHhcCCCCCCCCCHHH
Q 012228 219 ----SNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS-WFSS----GAKKLIKRILDPNPDTRMTISQ 289 (468)
Q Consensus 219 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~----~~~~Ll~~~L~~dP~~R~t~~e 289 (468)
++.+++.+.+. +.+.....|. |-+. .+..|++.|+..||.-|.|+--
T Consensus 440 Vp~DPs~eeMrkVVC------------------------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALr 495 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVC------------------------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALR 495 (513)
T ss_pred CCCCCCHHHHhccee------------------------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHH
Confidence 33444433321 2223334443 3332 3567899999999999999976
Q ss_pred Hhc
Q 012228 290 MLE 292 (468)
Q Consensus 290 il~ 292 (468)
|.+
T Consensus 496 iKK 498 (513)
T KOG2052|consen 496 IKK 498 (513)
T ss_pred HHH
Confidence 653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=274.99 Aligned_cols=246 Identities=24% Similarity=0.336 Sum_probs=193.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC--CCCCeeEEEEEEEeCC---
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI--KHPNVIKIIEVMASKT--- 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l--~hpnIv~l~~~~~~~~--- 86 (468)
+..-++.+.||+|.||+||+|.. +++.||||++... ..+.+..|-+|.+.. +|+||+++++.-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 45577889999999999999997 5699999999643 235566777776654 7999999998865555
Q ss_pred -EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCCeeeccCCceEEec
Q 012228 87 -KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR---------GVFHRDLKPENLLLDSYGVLKISD 156 (468)
Q Consensus 87 -~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~---------givHrDlKp~NILl~~~g~lkl~D 156 (468)
.++||+||.+.|+|.+++.. ..++.....+++..++.||+|||+. .|+|||||+.|||+..+++.-|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 79999999999999999986 5799999999999999999999973 599999999999999999999999
Q ss_pred cccchhhhhhhcCCcccccCCCCCcCCccccccCCCCC-----ChhhHHHHHHHHHHHhhCCC------------CCC--
Q 012228 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG-----RASDVWSCGVILFVLMAGFL------------PFD-- 217 (468)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~-----~~~DiWSlGvil~~ll~g~~------------Pf~-- 217 (468)
||||..+......+......||..|||||++.+.-.-. ...||||+|.+||||++.-. ||.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99999888766666667789999999999997653321 46899999999999987533 232
Q ss_pred ---CchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHH
Q 012228 218 ---ESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW-----FSSGAKKLIKRILDPNPDTRMTISQ 289 (468)
Q Consensus 218 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~s~~~~~Ll~~~L~~dP~~R~t~~e 289 (468)
.++.+++...+. ..+....+|.. ....+.+.+..|++.||+.|+|+.=
T Consensus 440 vG~hPt~e~mq~~VV------------------------~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVV------------------------RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred hcCCCCHHHHHHHHH------------------------hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 122222222221 11222222221 2456889999999999999999964
Q ss_pred H
Q 012228 290 M 290 (468)
Q Consensus 290 i 290 (468)
+
T Consensus 496 v 496 (534)
T KOG3653|consen 496 V 496 (534)
T ss_pred H
Confidence 4
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=290.16 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=203.5
Q ss_pred EEEeeeeecCCeEEEEEEEcC---C----CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCE
Q 012228 16 ELGRTLGEGSFAKVKFAKNVE---T----GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTK 87 (468)
Q Consensus 16 ~i~~~LG~G~~g~V~~a~~~~---~----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 87 (468)
.+.+.||+|+||.|++|.-.. . ...||+|....... ....+.+..|+++|+.+. ||||+.+.+.+.....
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 456699999999999998541 1 34699999865432 245788999999999995 9999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc
Q 012228 88 IYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV 151 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~ 151 (468)
+++|+|||..|+|.+++...+ .++......++.||+.|++||++..++||||-..|||+..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998766 3888999999999999999999999999999999999999999
Q ss_pred eEEeccccchhhhhhhcCCcccccCCCC--CcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCch-HHHHHHh
Q 012228 152 LKISDFGLSAISQQVREDGLLHTACGTP--NYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESN-LMALYRK 227 (468)
Q Consensus 152 lkl~DFGla~~~~~~~~~~~~~~~~gt~--~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~-~~~~~~~ 227 (468)
+||+|||+|+........ ......|+. .|||||.+....| +.++||||+||+|||+++ |..||.+.. ..++++.
T Consensus 457 ~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 999999999853321111 111122223 4999999998666 589999999999999997 899998744 4444443
Q ss_pred hcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 228 VSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
+ ........|..++.++.++++.|++.+|++||+..++.+
T Consensus 535 l-------------------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 L-------------------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred H-------------------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 2 223455678889999999999999999999999999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=285.08 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=210.5
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCC----EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
.+..++||+|+||+||+|...-.|+ +||||++...... +....+..|.-+|.+|+|||+++|+++..... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3456899999999999999865555 5899998755432 23567889999999999999999999987766 889
Q ss_pred EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 91 VLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|++|+++|.|.++++.++ .+.......|..||++|+.|||.++++||||-..|||+..-..+||.|||+|+........
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 999999999999997654 6889999999999999999999999999999999999999999999999999987765443
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......-.+.|+|=|.+....| +.++||||+||++||++| |..|+++....++-..+
T Consensus 855 y~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-------------------- 913 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------------------- 913 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH--------------------
Confidence 33333334567899998887777 599999999999999997 99999998877765553
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.....++.|+..+-++.-++.+||-.|+..||+++++..
T Consensus 914 -----e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 914 -----EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -----hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 223457889999999999999999999999999988754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=254.34 Aligned_cols=257 Identities=28% Similarity=0.485 Sum_probs=199.6
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEE-EEeCCEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEV-MASKTKI 88 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~-~~~~~~~ 88 (468)
..+.|.|.+.||+|.||++.+|.++.++..+++|.+.+... ....+.+|...--.|. |.||+.-|++ |++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 45789999999999999999999999999999999987643 2466888988766675 9999998876 6777888
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec--cCCceEEeccccchhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~--~~g~lkl~DFGla~~~~~~ 166 (468)
.+++|||+-|+|.+-+.. .++.|...+.++.||++|+.|+|++++||||||.+||||- +.-.+||||||+.+....
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 899999999999998876 5799999999999999999999999999999999999993 334899999999764321
Q ss_pred hcCCcccccCCCCCcCCccccccC---CC-CCChhhHHHHHHHHHHHhhCCCCCCCchHHH-HHHhhcccccccccccch
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDK---GY-DGRASDVWSCGVILFVLMAGFLPFDESNLMA-LYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~---~~-~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (468)
.....--+..|.|||+.... .+ ..+.+|+|.+|+|+|.+|+|.+||......+ .+-. |
T Consensus 176 ----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~-------------~ 238 (378)
T KOG1345|consen 176 ----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE-------------W 238 (378)
T ss_pred ----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH-------------H
Confidence 22233356789999986432 11 2467899999999999999999997443211 0110 0
Q ss_pred hhhccccccccccccccCCCCC---CCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCcccccC
Q 012228 242 KKCTNKYSYTLQICRADFSCPS---WFSSGAKKLIKRILDPNPDTR---MTISQMLEDEWFKKG 299 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~Ll~~~L~~dP~~R---~t~~eil~hpwf~~~ 299 (468)
..+ ..+.....|. .+|+.+..+.++-|..+|++| .++.......|....
T Consensus 239 ~~w---------~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 239 EQW---------LKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred HHH---------hcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 000 1111222332 279999999999999999999 666667777887653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=244.54 Aligned_cols=213 Identities=44% Similarity=0.801 Sum_probs=185.7
Q ss_pred eeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCH
Q 012228 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGEL 100 (468)
Q Consensus 21 LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 100 (468)
||+|++|.||++.+..+++.+++|++....... ..+.+.+|+.+++.++|++|+++++++......+++||++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997654221 346788999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-CCceEEeccccchhhhhhhcCCcccccCCC
Q 012228 101 FDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGT 178 (468)
Q Consensus 101 ~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 178 (468)
.+++... ..++...+..++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999876 57899999999999999999999999999999999999999 89999999999875433211 13345678
Q ss_pred CCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccccccc
Q 012228 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRAD 258 (468)
Q Consensus 179 ~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (468)
..|++||.+......+.++|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8999999987753446899999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 012228 259 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 294 (468)
Q Consensus 259 ~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hp 294 (468)
..+.+++.+||..||++|||+.++++|+
T Consensus 188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1366899999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=300.33 Aligned_cols=270 Identities=33% Similarity=0.521 Sum_probs=216.5
Q ss_pred ccCe-EEEeeeeecCCeEEEEEEEcCCCCEEEEEEeech---hhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 12 VGKY-ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD---QVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 12 ~~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
...| .-...+|.|++|.|+.+......+.++.|..... ..........+..|+.+-..+.|||++.....+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 3446 4578899999999998888877777777765421 11122223347888889999999999887777666666
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
++-+||||++ +|+.++...+.+...++..+++||+.||+|+|+.||.|||+||+|++++.+|.+||+|||.+.++....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6666999999 999999988899999999999999999999999999999999999999999999999999999887766
Q ss_pred cC--CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHH-Hhhcccccccccccchhhh
Q 012228 168 ED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY-RKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 168 ~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (468)
+. ......+|+.+|+|||++.+..|+...+||||+|++++.|.+|+.||..+...+.. ...
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~---------------- 538 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN---------------- 538 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh----------------
Confidence 65 56677899999999999999999999999999999999999999999765433221 000
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.......+..+.......++...+.+|.+||++||.+|+|+++|++.+||+...
T Consensus 539 --~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 539 --NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred --ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 000001122233333344788999999999999999999999999999998754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=246.00 Aligned_cols=210 Identities=46% Similarity=0.816 Sum_probs=180.9
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67899999999999999999988999999999765432 2467888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 95 IDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 95 ~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
+++++|.+++..... +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||++....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence 999999999988776 8999999999999999999999999999999999999999999999999987654322 11234
Q ss_pred ccCCCCCcCCcccc-ccCCCCCChhhHHHHHHHHHHHhhCCCCCCC-ch-HHHHHHhh
Q 012228 174 TACGTPNYVAPEVL-NDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SN-LMALYRKV 228 (468)
Q Consensus 174 ~~~gt~~y~APEvl-~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~-~~-~~~~~~~~ 228 (468)
...++..|++||.+ ....+ +.++|+||+|+++++|++|..||.. .+ ...+.+.+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 56788899999998 44445 4699999999999999999999977 44 33555553
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=295.16 Aligned_cols=201 Identities=20% Similarity=0.259 Sum_probs=146.0
Q ss_pred CCC-CCeeEEEEEE-------EeCCEEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 012228 70 IKH-PNVIKIIEVM-------ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140 (468)
Q Consensus 70 l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlK 140 (468)
++| +||+++++.+ .....++++||++ +++|.+++.. ...+++.++..+++||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 5777777776 2334678889987 4599999975 3469999999999999999999999999999999
Q ss_pred CCCeeecc-------------------CCceEEeccccchhhhhhhc--------------CCcccccCCCCCcCCcccc
Q 012228 141 PENLLLDS-------------------YGVLKISDFGLSAISQQVRE--------------DGLLHTACGTPNYVAPEVL 187 (468)
Q Consensus 141 p~NILl~~-------------------~g~lkl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~APEvl 187 (468)
|+||||+. ++.+||+|||+++....... .......+||++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999954 44566667776653211000 0001124689999999999
Q ss_pred ccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCH
Q 012228 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSS 267 (468)
Q Consensus 188 ~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 267 (468)
.+..| +.++||||+||+||||++|.+|+..... ....+... ... ..+....+
T Consensus 188 ~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~----------------------~~~---~~~~~~~~ 239 (793)
T PLN00181 188 NGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR----------------------VLP---PQILLNWP 239 (793)
T ss_pred ccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh----------------------hcC---hhhhhcCH
Confidence 88887 5899999999999999999988764321 11111000 000 00001245
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 268 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 268 ~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
...+++.+||.+||.+|||+.|+++||||.+.
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 57789999999999999999999999999763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=234.59 Aligned_cols=252 Identities=22% Similarity=0.271 Sum_probs=204.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCC-----CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-EeCC
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETG-----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVM-ASKT 86 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~-~~~~ 86 (468)
.++++...+-+|+||.||.|+..... +.|-+|.++... .+-....+..|-..+..+.|||+..+.++. ++..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 46788889999999999999765322 335566653221 222466788899999999999999999986 4456
Q ss_pred EEEEEEEccCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccc
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG--------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 158 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~--------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFG 158 (468)
.-+.++.+..-|.|..++...+ .++..+...++.|+..|++|||++||+|.||-..|++||+.-.+||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 6788889998899998887322 36677788899999999999999999999999999999999999999999
Q ss_pred cchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccccccccc
Q 012228 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVY 237 (468)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 237 (468)
+++.+-+......-........||+||.+....|. .++|+||+||+||||++ |+.|+...++.++...+.
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-------- 512 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-------- 512 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh--------
Confidence 99876554443333444566789999999988885 89999999999999997 999999999998877652
Q ss_pred ccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
....+..|-.+|+++...+..||..+|++||+.+|+..
T Consensus 513 -----------------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 513 -----------------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -----------------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 23345567778999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-27 Score=230.67 Aligned_cols=261 Identities=35% Similarity=0.631 Sum_probs=210.8
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC-CeeEEEEEEEeCCEEEEEEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP-NVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~E 93 (468)
|.+.+.||.|+||.||++.+. ..+|+|.+.............+.+|+.++..+.|+ +|+++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999997 88999999766544433577889999999999988 79999999988888999999
Q ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC-ceEEeccccchhhhhhhcC
Q 012228 94 FIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVRED 169 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~~~~ 169 (468)
++.++++.+.+.... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998877765 799999999999999999999999999999999999999988 7999999998754432221
Q ss_pred C----cccccCCCCCcCCccccccC--CCCCChhhHHHHHHHHHHHhhCCCCCCCchH----HHHHHhhccccccccccc
Q 012228 170 G----LLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 170 ~----~~~~~~gt~~y~APEvl~~~--~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~----~~~~~~~~~~~~~~~~~~ 239 (468)
. .....+||+.|+|||.+.+. .+.....|+||+|++++++++|..||..... ......+......
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----- 233 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP----- 233 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-----
Confidence 1 34678899999999999874 4556899999999999999999999877653 3333322111000
Q ss_pred chhhhccccccccccccccCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 240 SYKKCTNKYSYTLQICRADFSCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
....... ......+.+++.+++..+|..|.+..+...++|....
T Consensus 234 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 ----------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ----------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000 1123578999999999999999999999999777653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=241.38 Aligned_cols=170 Identities=19% Similarity=0.221 Sum_probs=135.3
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcC-CCCEEEEEEeechhh--hhHHHHHHHHHHHHHHhcCCCCCeeE-EEEEEEe
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVE-TGDFVAIKIVDRDQV--LRHKMVEQIKREISTMKLIKHPNVIK-IIEVMAS 84 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~hpnIv~-l~~~~~~ 84 (468)
+...++|++.+.||+|+||+||+|++.. +++.+|||++..... ........+.+|+.+|+.++|+||+. +++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4567889999999999999999999876 778889998753211 12234567899999999999999985 5442
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCCeeeccCCceEEeccccchhh
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL-KPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDl-Kp~NILl~~~g~lkl~DFGla~~~ 163 (468)
+..|+||||++|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.+
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 45799999999999963 211 11 1568899999999999999999999 999999999999999999999876
Q ss_pred hhhhcCCc------ccccCCCCCcCCcccccc
Q 012228 164 QQVREDGL------LHTACGTPNYVAPEVLND 189 (468)
Q Consensus 164 ~~~~~~~~------~~~~~gt~~y~APEvl~~ 189 (468)
........ ..+.++++.|+|||.+..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 54332211 246788999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=222.20 Aligned_cols=165 Identities=22% Similarity=0.260 Sum_probs=127.5
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccC
Q 012228 98 GELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176 (468)
Q Consensus 98 g~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 176 (468)
|+|.+++... ..+++..++.++.|++.||+|||+++ ||+|||++.++.+|+ ||++..... ....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence 6899999874 45999999999999999999999999 999999999999999 999875432 1236
Q ss_pred CCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH-HHHHhhcccccccccccchhhhccccccccccc
Q 012228 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKVSTFHFLSVYGESYKKCTNKYSYTLQIC 255 (468)
Q Consensus 177 gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (468)
||+.|+|||++.+..|. .++||||+||++|+|++|..||...... .....+...... ..
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------------~~ 125 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA-------------------DD 125 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc-------------------CC
Confidence 89999999999888774 8999999999999999999999765321 222221100000 00
Q ss_pred cccCCCCCCCCH--HHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 256 RADFSCPSWFSS--GAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 256 ~~~~~~~~~~s~--~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
......+..++. .+.+++.+||..||.+|||+.++++|+|+.
T Consensus 126 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 126 PRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 000011122333 699999999999999999999999999986
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-30 Score=254.55 Aligned_cols=239 Identities=32% Similarity=0.607 Sum_probs=205.6
Q ss_pred eeeecCCeEEEEEEEc---CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEEEEEcc
Q 012228 20 TLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVLEFI 95 (468)
Q Consensus 20 ~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 95 (468)
.+|+|+||.|++++.. ..|..+|+|+..+....... ...-..|-.++..++ ||.+|+++..++.+...|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~-~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD-RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc-ccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 4799999999877643 56778999998765443221 224456777888887 999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccccc
Q 012228 96 DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175 (468)
Q Consensus 96 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 175 (468)
.||+|+..+.....+.+...+.+...++.|++++|+.||+|||+|++||+++.+|++++.|||+++..-... ..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hc
Confidence 999999999998899999999999999999999999999999999999999999999999999988654322 22
Q ss_pred CCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccc
Q 012228 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQIC 255 (468)
Q Consensus 176 ~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (468)
|||..|||||++. ++ ..++|.||+|+++|+|++|..||.. +.... |.
T Consensus 154 cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~--------------------------Il 200 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKR--------------------------IL 200 (612)
T ss_pred ccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHH--------------------------Hh
Confidence 9999999999998 34 4789999999999999999999988 33333 55
Q ss_pred cccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 012228 256 RADFSCPSWFSSGAKKLIKRILDPNPDTRMTI-----SQMLEDEWFKK 298 (468)
Q Consensus 256 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~-----~eil~hpwf~~ 298 (468)
+..+..|..++..+++++..++..+|..|.-. .++++|+||+.
T Consensus 201 ~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 201 KAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred hhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 66778888899999999999999999999865 79999999986
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=259.02 Aligned_cols=262 Identities=33% Similarity=0.544 Sum_probs=223.2
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcC-CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVE-TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 89 (468)
...|.+.+.||+|+|+.|-++.... +...+|.|.+.... ......+++..|..+.+.+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5679999999999999999888754 44567888776543 23345677888999999998 999999999999999999
Q ss_pred EEEEccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCeeeccCC-ceEEeccccchhhhh
Q 012228 90 IVLEFIDGGELFDKI-AKHG-RLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQ 165 (468)
Q Consensus 90 lV~E~~~gg~L~~~i-~~~~-~l~e~~~~~~~~qll~~l~yLH-~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~ 165 (468)
++++|..|+++++.+ ..+. ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ ++|++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 7766 7899999999999999999999 99999999999999999999 999999999998877
Q ss_pred -hhcCCcccccCC-CCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 166 -VREDGLLHTACG-TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 166 -~~~~~~~~~~~g-t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
.+........|| ++.|.|||...+..|.++..|+||+|+++..+++|..||+.........
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~----------------- 240 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY----------------- 240 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-----------------
Confidence 556667778899 9999999999988899999999999999999999999998765432110
Q ss_pred hcccccccccccc-cc--CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 244 CTNKYSYTLQICR-AD--FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 244 ~~~~~~~~~~~~~-~~--~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
..+... .. ...+..++..+.+++.++|..+|..|.+.+++..+||+..
T Consensus 241 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 241 -------SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -------eeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 000111 12 2333447899999999999999999999999999999987
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-25 Score=219.52 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=193.2
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCC-CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC----CCCeeEEEEEE-EeCCE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETG-DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK----HPNVIKIIEVM-ASKTK 87 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~----hpnIv~l~~~~-~~~~~ 87 (468)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+......... ..+..|+.++..+. .+++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998765 6789998765422211 15778899988886 36999999999 57888
Q ss_pred EEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC-----CceEEeccccc
Q 012228 88 IYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-----GVLKISDFGLS 160 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~-----g~lkl~DFGla 160 (468)
-||||+.+ |.+|.++.... +.++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 55999887544 579999999999999999999999999999999999999865 46999999999
Q ss_pred hhhhhhhcCC-------c-ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccc
Q 012228 161 AISQQVREDG-------L-LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH 232 (468)
Q Consensus 161 ~~~~~~~~~~-------~-~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~ 232 (468)
+.+......+ . .....||..|+++.+..+... ++..|+||++.++.+++.|.+||..........+...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~-- 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK-- 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH--
Confidence 8433211111 1 123459999999999888776 6999999999999999999999976553222222110
Q ss_pred cccccccchhhhccccccccccccccC-C-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 233 FLSVYGESYKKCTNKYSYTLQICRADF-S-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
...... . .....+.++..+...+-..+...+|....+...
T Consensus 252 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 252 ---------------------DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred ---------------------HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 000000 0 223345677788887777899999998887665
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=241.55 Aligned_cols=221 Identities=30% Similarity=0.570 Sum_probs=173.6
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
.-.+|..++.+..|+||-||+++++.+.+.+|+ .++++++ +.|. |+.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l--------ilRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL--------ILRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccch--------hhhc--cccccCCccee--------------
Confidence 446799999999999999999999999999999 4554432 1111 44444455555
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc--
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE-- 168 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~-- 168 (468)
|+-...+...+.++.+. +.+++|||+.||+|||+||+|+||+.-|++|++|||++..--....
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 45555666666666555 8899999999999999999999999999999999999764211000
Q ss_pred -----------CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccc
Q 012228 169 -----------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237 (468)
Q Consensus 169 -----------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 237 (468)
.-.-...||||.|+||||+..++| |.++|+|++|+|+|+.+.|..||.+.++++++..+....
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~----- 274 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD----- 274 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh-----
Confidence 001234599999999999999998 699999999999999999999999999999988854321
Q ss_pred ccchhhhccccccccccccccCCCC---CCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCccccc
Q 012228 238 GESYKKCTNKYSYTLQICRADFSCP---SWFSSGAKKLIKRILDPNPDTRM---TISQMLEDEWFKK 298 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~~Ll~~~L~~dP~~R~---t~~eil~hpwf~~ 298 (468)
..+| +-++++++++|.++|+.+|..|. .+-++.+|+||+.
T Consensus 275 ---------------------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 275 ---------------------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred ---------------------ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 1112 22688999999999999999997 4668889999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=199.18 Aligned_cols=142 Identities=23% Similarity=0.272 Sum_probs=113.4
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHH-----------------------HHHHHHHHHHHHhcCCCCC
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK-----------------------MVEQIKREISTMKLIKHPN 74 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------------------~~~~i~~Ei~il~~l~hpn 74 (468)
.+.||+|+||.||+|.+. +|+.||+|+++........ ......+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999996 8999999999754221100 1123456999999998877
Q ss_pred eeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCCeeeccCCceE
Q 012228 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC-HSRGVFHRDLKPENLLLDSYGVLK 153 (468)
Q Consensus 75 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yL-H~~givHrDlKp~NILl~~~g~lk 153 (468)
+.....+... . .+|||||++|+++.........+++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6544333222 2 389999999988776655567899999999999999999999 799999999999999998 48899
Q ss_pred Eeccccchhh
Q 012228 154 ISDFGLSAIS 163 (468)
Q Consensus 154 l~DFGla~~~ 163 (468)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=192.82 Aligned_cols=212 Identities=24% Similarity=0.358 Sum_probs=170.6
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTK 87 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 87 (468)
-...++|+++++||.|+||.+|+|....+|+.||||+-.... . -.++..|..+.+.|+ ...|..+..+..+...
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-K----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-C----CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 346789999999999999999999999999999999865432 1 135678999999997 5788888888888888
Q ss_pred EEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc---CCceEEeccccchhh
Q 012228 88 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFGLSAIS 163 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~---~g~lkl~DFGla~~~ 163 (468)
-.+|||++. -+|.++..-. ..++...+.-++-|++.-++|+|.++.+||||||+|.|..- ...+-++|||+|+.+
T Consensus 86 nvlVMdLLG-PsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLLG-PSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeeccC-ccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 899999984 4787776543 46999999999999999999999999999999999999863 356899999999876
Q ss_pred hhhhcCC-----cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHh
Q 012228 164 QQVREDG-----LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227 (468)
Q Consensus 164 ~~~~~~~-----~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~ 227 (468)
....... .-....||..|.+=-...+... +...|+=|+|.+|..+.-|.+||.+.....-.++
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK 232 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK 232 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence 5433221 1233468999988776665444 5788999999999999999999998665443333
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=200.93 Aligned_cols=174 Identities=13% Similarity=0.199 Sum_probs=135.3
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHH------HHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ------IKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
.-++|++.+.||.|+||.||++.+ ++..+|+|++............. +.+|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 347899999999999999999755 46689999997554333333333 5799999999999999999988664
Q ss_pred C--------CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEec
Q 012228 85 K--------TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156 (468)
Q Consensus 85 ~--------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~D 156 (468)
. +..++||||++|.+|.+.. .+++ ....+++.+|..||+.|++|||+||+|++++.+| ++|+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 3 3579999999999997763 2333 2456999999999999999999999999999988 99999
Q ss_pred cccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHh
Q 012228 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210 (468)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll 210 (468)
||........... ..+.....|. .++|+||||+++..+.
T Consensus 178 fg~~~~~~e~~a~--------------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK--------------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH--------------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 9987643211110 1134455666 7899999999887554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=197.08 Aligned_cols=210 Identities=24% Similarity=0.423 Sum_probs=175.1
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.|+++++||+|+||+.+.|.+.-++++||||.-.+.. ..-++..|.+..+.|. .++|...|.+...+-+-.||+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 6999999999999999999999999999999854322 2457889999999996 899999999988888889999
Q ss_pred EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC-----ceEEeccccchhhhhh
Q 012228 93 EFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-----VLKISDFGLSAISQQV 166 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g-----~lkl~DFGla~~~~~~ 166 (468)
|++. -+|.|+..-.+ +|+...+.-++.|++.-++|+|++..|+|||||+|.||...| .+.|+|||+|+.+...
T Consensus 104 dLLG-PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 104 DLLG-PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhhC-cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 9984 47777776554 699999999999999999999999999999999999997543 5899999999876543
Q ss_pred hcC-----CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc---hHHHHHHhhcc
Q 012228 167 RED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKVST 230 (468)
Q Consensus 167 ~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~---~~~~~~~~~~~ 230 (468)
... .......||..||+=-...|... +...|+=|||-+++..|-|.+||.+. +..+-+++|..
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 221 12234569999999888888766 48899999999999999999999865 45556666654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=202.62 Aligned_cols=234 Identities=27% Similarity=0.371 Sum_probs=152.0
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC----------CCCeeEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK----------HPNVIKIIEVMA 83 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~----------hpnIv~l~~~~~ 83 (468)
....++.||.|+++.||.+++..||+.+|+|+............+.+++|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4678899999999999999999999999999986554333345677777775555532 223444444332
Q ss_pred e---------C---C-----EEEEEEEccCCCCHHHHHH---hcCCC---CHHHH-HHHHHHHHHHHHHHHhCCccccCC
Q 012228 84 S---------K---T-----KIYIVLEFIDGGELFDKIA---KHGRL---KEDEA-RRYFQQLINAVDYCHSRGVFHRDL 139 (468)
Q Consensus 84 ~---------~---~-----~~~lV~E~~~gg~L~~~i~---~~~~l---~e~~~-~~~~~qll~~l~yLH~~givHrDl 139 (468)
- . + +.+++|+-+.+ +|.+.+. ..... ....+ ..+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1 1 23678888754 7777654 33322 12233 344589999999999999999999
Q ss_pred CCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccC-------CCCCChhhHHHHHHHHHHHhhC
Q 012228 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-------GYDGRASDVWSCGVILFVLMAG 212 (468)
Q Consensus 140 Kp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-------~~~~~~~DiWSlGvil~~ll~g 212 (468)
+|+|+|++.+|.+.|+||+....... .......+..|.+||..... ...+.+.|.|+||+++|.|+||
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999987653322 11113355789999986442 1236889999999999999999
Q ss_pred CCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccC-CCCCCCCHHHHHHHHHhcCCCCCCC
Q 012228 213 FLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADF-SCPSWFSSGAKKLIKRILDPNPDTR 284 (468)
Q Consensus 213 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~Ll~~~L~~dP~~R 284 (468)
..||+......... ..+ .+. .+|..++.||++||+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~------------------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPE------------------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSG------------------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccccc------------------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99998754321000 011 122 478999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=193.28 Aligned_cols=142 Identities=22% Similarity=0.253 Sum_probs=115.1
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhh-----------------------HHHHHHHHHHHHHHhcCCCCC
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-----------------------HKMVEQIKREISTMKLIKHPN 74 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~i~~Ei~il~~l~hpn 74 (468)
.+.||+|+||.||+|.+. +|+.||||+++...... .-......+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999987542100 001234568999999999998
Q ss_pred eeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCceE
Q 012228 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLK 153 (468)
Q Consensus 75 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~lk 153 (468)
|.....+.... .|+||||++|+++.........+++..+..++.|++.++.++|+ +||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 86555444333 38999999988665443445678999999999999999999999 9999999999999999 89999
Q ss_pred Eeccccchhh
Q 012228 154 ISDFGLSAIS 163 (468)
Q Consensus 154 l~DFGla~~~ 163 (468)
|+|||+|...
T Consensus 158 liDFG~a~~~ 167 (190)
T cd05145 158 IIDVSQAVEL 167 (190)
T ss_pred EEEcccceec
Confidence 9999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=228.64 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=186.9
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechh-hhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQ-VLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.|...+.||.+.|=+|.+|++. .|. |+||++-+.. ...-....+-..|++ ...++|||++.+.-+......-|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6888999999999999999984 344 9999986543 222222344445666 66678999999998888888889999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhh--hhhhcCC
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS--QQVREDG 170 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~--~~~~~~~ 170 (468)
+|... +|+|.+..+.-+..-+-+.|+.||+.||.-||..||+|+|||.||||++.-+-+.|+||..-+.. ...++..
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99977 99999998888999999999999999999999999999999999999999999999999864321 1111111
Q ss_pred ---cccccCCCCCcCCccccccCC----------CCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccc
Q 012228 171 ---LLHTACGTPNYVAPEVLNDKG----------YDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSV 236 (468)
Q Consensus 171 ---~~~~~~gt~~y~APEvl~~~~----------~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~ 236 (468)
...+...-..|+|||.+.... .-+++.||+|+||+++||++ |.+||.-.....+...- ...
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~-~~~---- 254 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN-ADD---- 254 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC-ccC----
Confidence 223334445799999875422 12578999999999999987 79999754433221110 000
Q ss_pred cccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 237 YGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.+..+..--+...++||..|++.||++|.+|++.|+.
T Consensus 255 --------------------~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 255 --------------------PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred --------------------HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000000024468999999999999999999999985
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-23 Score=196.24 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=176.6
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCC-----------------------------------EEEEEEeechhh-
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGD-----------------------------------FVAIKIVDRDQV- 51 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~-----------------------------------~vAiK~i~~~~~- 51 (468)
+.-++++|+++..||+|..+.||.|.....|. +.|||.+-.-..
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 34467889999999999999999998654211 246776532111
Q ss_pred -hhHHHHHHHHHHHH------HH--------h-------c-CCCCCeeEEEEEEEe------------------------
Q 012228 52 -LRHKMVEQIKREIS------TM--------K-------L-IKHPNVIKIIEVMAS------------------------ 84 (468)
Q Consensus 52 -~~~~~~~~i~~Ei~------il--------~-------~-l~hpnIv~l~~~~~~------------------------ 84 (468)
......+.+.+|.- .+ + + -+|||||++...|.+
T Consensus 232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g 311 (598)
T KOG4158|consen 232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG 311 (598)
T ss_pred CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence 12233444545541 11 1 1 259999999887632
Q ss_pred ---CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec--cCC--ceEEecc
Q 012228 85 ---KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYG--VLKISDF 157 (468)
Q Consensus 85 ---~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~--~~g--~lkl~DF 157 (468)
+..+|+||..... +|..++.. +..+....+-++.|+++|+.|||.+||.|||+|++|||+. +++ .+.|+||
T Consensus 312 ~g~~~tlylvMkrY~~-tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 312 AGEPKTLYLVMKRYRQ-TLREYLWT-RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred cCCCceEEEehhcchh-hHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence 2358999998865 89988875 4577788888999999999999999999999999999994 333 5899999
Q ss_pred ccchhhhhhh----cCCcccccCCCCCcCCccccccCC-----CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhh
Q 012228 158 GLSAISQQVR----EDGLLHTACGTPNYVAPEVLNDKG-----YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228 (468)
Q Consensus 158 Gla~~~~~~~----~~~~~~~~~gt~~y~APEvl~~~~-----~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~ 228 (468)
|.+---...+ ...-.-...|.-.-||||+....+ .+-.++|.|++|.+.||++....||-......+-...
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~ 469 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT 469 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence 9863211100 001112345777899999975322 1126899999999999999999999763221110000
Q ss_pred cccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 012228 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 288 (468)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~ 288 (468)
| -...-...|..+++.+++|+..+|+.||++|+++.
T Consensus 470 ------------Y------------qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 470 ------------Y------------QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ------------h------------hhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 0 11123346777999999999999999999999964
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=181.45 Aligned_cols=191 Identities=14% Similarity=0.182 Sum_probs=142.0
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHH-HHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEEEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKM-VEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~-~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 92 (468)
..+...|++|+||+|+.+.. .+..++.+.+.......... ...+.+|+++|++|. |++|.+++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 45678999999999997775 77888888776544322211 225789999999995 5889999886 4579999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCCeeeccCCceEEeccccchhhhhhhcC--
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL-KPENLLLDSYGVLKISDFGLSAISQQVRED-- 169 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDl-Kp~NILl~~~g~lkl~DFGla~~~~~~~~~-- 169 (468)
||+.|.+|...+.. . ...++.|++.+|+++|++||+|||| ||+|||++.+|.++|+|||+|........-
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999988654321 1 1357889999999999999999999 799999999999999999999854321110
Q ss_pred -----C----cccccCCCCCcCCccccccCCCCC-ChhhHHHHHHHHHHHhhCCCCCCC
Q 012228 170 -----G----LLHTACGTPNYVAPEVLNDKGYDG-RASDVWSCGVILFVLMAGFLPFDE 218 (468)
Q Consensus 170 -----~----~~~~~~gt~~y~APEvl~~~~~~~-~~~DiWSlGvil~~ll~g~~Pf~~ 218 (468)
. .......++.|++|+--.-..-.+ ...+..+.|+-+|.++|+..|+-+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 011223688899998643221112 456777999999999999988754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=183.06 Aligned_cols=134 Identities=20% Similarity=0.268 Sum_probs=108.2
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-----CCCCeeEEEEEEEeCC---EEE
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-----KHPNVIKIIEVMASKT---KIY 89 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 89 (468)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 7667666 6999875432 2346789999999999 5799999999998874 434
Q ss_pred -EEEEc--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCCeeeccC----CceEEeccccc
Q 012228 90 -IVLEF--IDGGELFDKIAKHGRLKEDEARRYFQQLINAV-DYCHSRGVFHRDLKPENLLLDSY----GVLKISDFGLS 160 (468)
Q Consensus 90 -lV~E~--~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l-~yLH~~givHrDlKp~NILl~~~----g~lkl~DFGla 160 (468)
+|||| +.+|+|.+++.. +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 558999999976 457766 35688888877 99999999999999999999743 47999995533
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-22 Score=182.03 Aligned_cols=246 Identities=20% Similarity=0.353 Sum_probs=195.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..++...+..+|.+...|..|+|+.. |..+++|++....... .....+..|.-.|+-..||||+.+++.+..+.++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 34455667788999999999999984 5566778876544432 23456778888899999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeeccCCceEEe--ccccchhh
Q 012228 90 IVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKIS--DFGLSAIS 163 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~yLH~~g--ivHrDlKp~NILl~~~g~lkl~--DFGla~~~ 163 (468)
++..||+-|+|+..+..... .+..++.+++.+++.|++|||+.. |----|.+..+++|++-+.+|+ |--++.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-- 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-- 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--
Confidence 99999999999999976544 678899999999999999999974 4444688899999998776664 322211
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCC--CChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYD--GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~--~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
+ .....-+|.|++||.+..++-+ -.++|+||+++++|||.|...||...++.+.-.++.
T Consensus 342 q-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------ 402 (448)
T KOG0195|consen 342 Q-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------ 402 (448)
T ss_pred e-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------------
Confidence 1 1123457899999999876543 368999999999999999999999888776655532
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 291 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil 291 (468)
...-...+|+.++..+..|+.-|++.||.+||.+..|.
T Consensus 403 ------------leglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 403 ------------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ------------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 33445678999999999999999999999999987654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=183.57 Aligned_cols=144 Identities=23% Similarity=0.258 Sum_probs=115.8
Q ss_pred CeEEEeeeeecCCeEEEEEE-EcCCCCEEEEEEeechhhh---------------------hHHHHHHHHHHHHHHhcCC
Q 012228 14 KYELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVL---------------------RHKMVEQIKREISTMKLIK 71 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~-~~~~~~~vAiK~i~~~~~~---------------------~~~~~~~i~~Ei~il~~l~ 71 (468)
-|++.+.||+|+||.||+|. +..+|+.||+|++...... .......+.+|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38899999999999999999 6679999999998754210 0011234678999999997
Q ss_pred CC--CeeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCCeeecc
Q 012228 72 HP--NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG-VFHRDLKPENLLLDS 148 (468)
Q Consensus 72 hp--nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~g-ivHrDlKp~NILl~~ 148 (468)
+. .+.++++. ...|+||||++|++|.........+....+..++.|++.++++||++| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 33444432 235899999999888776555556777788899999999999999999 99999999999999
Q ss_pred CCceEEeccccchh
Q 012228 149 YGVLKISDFGLSAI 162 (468)
Q Consensus 149 ~g~lkl~DFGla~~ 162 (468)
++.++|+|||.|..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999998764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-21 Score=206.44 Aligned_cols=193 Identities=23% Similarity=0.350 Sum_probs=160.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC---CCCeeEEEEEEEeCCEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK---HPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 89 (468)
..|.|.+.||+|+||+||.|.+.. |+.||+|+=.......-....++ +.+|+ -+.|..+...+.-.+.-+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~------~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQV------MERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHH------HHhhchhhhcchHHHHHHHccCCcce
Confidence 469999999999999999999976 99999998665544432222333 23333 345666666666677789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec-------cCCceEEeccccchh
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-------SYGVLKISDFGLSAI 162 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~-------~~g~lkl~DFGla~~ 162 (468)
+|+||.+.|+|.+++...+.+++..+..+..|++..|+.||..||||+||||+|.||. ..--++|+|||.|..
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 9999999999999999988999999999999999999999999999999999999994 234699999999876
Q ss_pred hhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCC
Q 012228 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF 213 (468)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~ 213 (468)
+.-..........++|-.+-.+|+..|.+|. ..+|.|.++.+++.||.|+
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHH
Confidence 6555444567778999999999999999994 9999999999999999995
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=167.22 Aligned_cols=137 Identities=25% Similarity=0.328 Sum_probs=115.7
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh-----hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
+.||+|++|.||+|.. +|..+++|+....... .......+.+|+.++..+.|++|.....++.+.+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 7788999986532211 11123467899999999999999887777777788899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998865332 8889999999999999999999999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=165.16 Aligned_cols=138 Identities=22% Similarity=0.316 Sum_probs=109.5
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhh-------------------HHHHHHHHHHHHHHhcCCCCC-
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-------------------HKMVEQIKREISTMKLIKHPN- 74 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-------------------~~~~~~i~~Ei~il~~l~hpn- 74 (468)
|.+.+.||+|+||.||+|... +|+.||||++......- ........+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999874 89999999976532100 001123678999999998774
Q ss_pred -eeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceE
Q 012228 75 -VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (468)
Q Consensus 75 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lk 153 (468)
+...++ ....++||||++|++|..... ......++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 444443 244589999999998866532 145677889999999999999999999999999999999999
Q ss_pred Eeccccchhh
Q 012228 154 ISDFGLSAIS 163 (468)
Q Consensus 154 l~DFGla~~~ 163 (468)
|+|||+|...
T Consensus 166 liDfg~~~~~ 175 (198)
T cd05144 166 IIDWPQMVST 175 (198)
T ss_pred EEECCccccC
Confidence 9999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.1e-19 Score=162.57 Aligned_cols=133 Identities=21% Similarity=0.262 Sum_probs=108.3
Q ss_pred eeeecCCeEEEEEEEcCCCCEEEEEEeechhhh-----hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 20 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
.||+|+||.||+|.. +|..+++|........ .......+.+|+.+++.+.|+++....-++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 6788999986432211 111246678999999999988766555555566778999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 95 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
++|++|.+.+..... .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988755321 7899999999999999999999999999999 79999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-19 Score=179.70 Aligned_cols=207 Identities=23% Similarity=0.345 Sum_probs=156.6
Q ss_pred HhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCCCe
Q 012228 67 MKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGV-FHRDLKPENL 144 (468)
Q Consensus 67 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~gi-vHrDlKp~NI 144 (468)
|+.+.|.|+.++++...++..+++|.+||.-|+|.+.+.. ...++......++++++.||+|||+..| +|+.+++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678899999999999999999999999999999999987 4467888888899999999999999866 9999999999
Q ss_pred eeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCC------CCChhhHHHHHHHHHHHhhCCCCCCC
Q 012228 145 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY------DGRASDVWSCGVILFVLMAGFLPFDE 218 (468)
Q Consensus 145 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~------~~~~~DiWSlGvil~~ll~g~~Pf~~ 218 (468)
++|....+||+|||+..+..............-..-|.|||++.+... -+.++||||+|++++++++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876542111111122223456899999976422 25679999999999999999999976
Q ss_pred ch----HHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 219 SN----LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 219 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.. +.++...+..... . ..+........+.+++..++..|+..+|..||+++++..
T Consensus 161 ~~~~~~~~eii~~~~~~~~--------------~-----~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGS--------------N-----PFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCC--------------C-----CcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2333333221000 0 000111100024557999999999999999999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.7e-20 Score=181.97 Aligned_cols=248 Identities=21% Similarity=0.307 Sum_probs=168.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCC---CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEE-------EE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE-------VM 82 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~-------~~ 82 (468)
+.+.+.+..+.++++.+...+-..+ .+-++-+.-+.++ ........+++-.+....|-+..-+.+ .+
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~ 320 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS 320 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence 3456666777777776665544333 2334434333222 123444556666666655444433333 11
Q ss_pred -----EeCCEEEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEE
Q 012228 83 -----ASKTKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKI 154 (468)
Q Consensus 83 -----~~~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl 154 (468)
.....+||.|++|...+|.+++.... ..+......++.|+..|++| +|.+|||+||.||++..++.+||
T Consensus 321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence 11235899999999999999997544 35677899999999999999 99999999999999999999999
Q ss_pred eccccchhhhhhh----cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhc
Q 012228 155 SDFGLSAISQQVR----EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVS 229 (468)
Q Consensus 155 ~DFGla~~~~~~~----~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~ 229 (468)
.|||+.+-..... .....+...||++||+||-+.+..| +.++||||||+||+||+. =..+|........
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d----- 471 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFERIATLTD----- 471 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHHHHHhhhh-----
Confidence 9999987544332 1123455679999999999999888 599999999999999987 2233322111111
Q ss_pred ccccccccccchhhhccccccccccccccCCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 230 TFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
+..+.++-.-+ --+.-..|+.+||...|.+||++.+.-.|+|.
T Consensus 472 ------------------------~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 472 ------------------------IRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ------------------------hhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 11111110001 12345689999999999999988887777775
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=182.28 Aligned_cols=138 Identities=20% Similarity=0.245 Sum_probs=112.0
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh-----hhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-----LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
.|...+.||+|+||+||++.... ..+++|+...... ......+.+.+|+.+++.++|++++....+..+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 35567899999999999998743 3444444321111 1112245688999999999999999888777777788
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
++||||++|++|.+.+. ....++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||+|+.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998875 457789999999999999999999999999999 678999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=155.98 Aligned_cols=137 Identities=26% Similarity=0.370 Sum_probs=100.1
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHH---------------------HHHHHHHHHhcCCCC--C
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE---------------------QIKREISTMKLIKHP--N 74 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~---------------------~i~~Ei~il~~l~hp--n 74 (468)
++.||+|+||.||+|.+. +|+.||||++............ ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999986 8999999998653221111111 124566667666543 3
Q ss_pred eeEEEEEEEeCCEEEEEEEccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCce
Q 012228 75 VIKIIEVMASKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVL 152 (468)
Q Consensus 75 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~l 152 (468)
+.+.++. ...++||||++|+.+.. .+.. ... ...++.++.+++.++.++|+ .||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKD-VRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhh-hhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4455543 23589999999854321 1111 111 17788999999999999999 9999999999999999 8999
Q ss_pred EEeccccchh
Q 012228 153 KISDFGLSAI 162 (468)
Q Consensus 153 kl~DFGla~~ 162 (468)
+|+|||.|..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.5e-19 Score=184.53 Aligned_cols=262 Identities=25% Similarity=0.426 Sum_probs=213.8
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
.....+.+.+-+-.|+++.+..+.-..+|...++|+..+.........+.+.++-+++-...+|-++.....+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 35677888999999999999999998899888888876544433334555666666666667788887766666778899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh---
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV--- 166 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~--- 166 (468)
++++|+.|++|..++.+.+..+++-++.+...+..+++|||+..+.|||++|.|+|...+|..+++|||........
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999843221110
Q ss_pred -hc-------------------------CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch
Q 012228 167 -RE-------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN 220 (468)
Q Consensus 167 -~~-------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~ 220 (468)
.. ........||+.|.|||++.+... +..+|+|+.|+++++.++|.+||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 00 011223468999999999988776 588999999999999999999999999
Q ss_pred HHHHHHhhcccccccccccchhhhccccccccccccccCCCC---CCCCHHHHHHHHHhcCCCCCCCCCHH---HHhcCc
Q 012228 221 LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCP---SWFSSGAKKLIKRILDPNPDTRMTIS---QMLEDE 294 (468)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~~Ll~~~L~~dP~~R~t~~---eil~hp 294 (468)
+...++.+ .+.....| ...+..+++++..+|..+|.+|..+. +...|+
T Consensus 1040 pq~~f~ni--------------------------~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~ 1093 (1205)
T KOG0606|consen 1040 PQQIFENI--------------------------LNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHP 1093 (1205)
T ss_pred hhhhhhcc--------------------------ccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCC
Confidence 88887763 33333333 33789999999999999999999988 899999
Q ss_pred cccc
Q 012228 295 WFKK 298 (468)
Q Consensus 295 wf~~ 298 (468)
||+.
T Consensus 1094 ~~~~ 1097 (1205)
T KOG0606|consen 1094 FFQD 1097 (1205)
T ss_pred ccCC
Confidence 9985
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.5e-17 Score=152.40 Aligned_cols=137 Identities=20% Similarity=0.316 Sum_probs=104.4
Q ss_pred eeee-ecCCeEEEEEEEcCCCCEEEEEEeechhh----hh------HHHHHHHHHHHHHHhcCCCCCe--eEEEEEEEeC
Q 012228 19 RTLG-EGSFAKVKFAKNVETGDFVAIKIVDRDQV----LR------HKMVEQIKREISTMKLIKHPNV--IKIIEVMASK 85 (468)
Q Consensus 19 ~~LG-~G~~g~V~~a~~~~~~~~vAiK~i~~~~~----~~------~~~~~~i~~Ei~il~~l~hpnI--v~l~~~~~~~ 85 (468)
..|| .|+.|+||.+.. .+..+++|.+..... .. ......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4566 777788888876 478899998864321 11 1123567899999999998775 6677664332
Q ss_pred -CE---EEEEEEccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccc
Q 012228 86 -TK---IYIVLEFIDG-GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (468)
Q Consensus 86 -~~---~~lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla 160 (468)
.. .++|||+++| .+|.+++.. ..+++.. +.|++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999997 688888764 4566553 578999999999999999999999999999899999999987
Q ss_pred hh
Q 012228 161 AI 162 (468)
Q Consensus 161 ~~ 162 (468)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 63
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.9e-17 Score=140.98 Aligned_cols=132 Identities=23% Similarity=0.317 Sum_probs=112.6
Q ss_pred EEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC--CCeeEEEEEEEeCCEEEEEEEc
Q 012228 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH--PNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 17 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 94 (468)
+++.||+|.++.||++.... ..+++|.+..... ...+.+|+.+++.+.| +++.+++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999843 7899999865421 3467899999999976 5999999988888889999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCeeeccCCceEEeccccchh
Q 012228 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR---GVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 95 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~---givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
+.|+.+... +......++.+++.+++++|.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998776543 5567778899999999999985 799999999999999999999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-15 Score=154.15 Aligned_cols=256 Identities=20% Similarity=0.228 Sum_probs=192.7
Q ss_pred CeEEEeeeee--cCCeEEEEEEE--cCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEE
Q 012228 14 KYELGRTLGE--GSFAKVKFAKN--VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKI 88 (468)
Q Consensus 14 ~y~i~~~LG~--G~~g~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 88 (468)
.+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.. .........=.+|+...+.++ |+|.++.+..++..+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 4667788999 99999999998 889999999973221 111111222347777777775 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCCeeeccC-CceEEeccccchh
Q 012228 89 YIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLIN----AVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAI 162 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~----~l~yLH~~givHrDlKp~NILl~~~-g~lkl~DFGla~~ 162 (468)
|+-+|+|. .+|..+...... +++..++..+.+... ||.++|+.+++|-|+||.||+...+ ...+++|||+...
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 99999996 588888876665 899999999999999 9999999999999999999999998 8899999999876
Q ss_pred hhhhhcCCc---ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccccc
Q 012228 163 SQQVREDGL---LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 163 ~~~~~~~~~---~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (468)
.....-... ....-|...|++||++.+. ++...||+|+|.++.+..+|..++..... .
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----------------~ 333 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKN-----------------S 333 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCC-----------------C
Confidence 544221111 1122577789999998753 36899999999999999888766643210 0
Q ss_pred chhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.|..+.+.+ ....+-...+.++...+..|++.+|..|++++.++.|++...
T Consensus 334 ~W~~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 334 SWSQLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred Ccccccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 111110000 000111124666777999999999999999999999999874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.3e-15 Score=155.26 Aligned_cols=145 Identities=22% Similarity=0.392 Sum_probs=102.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh-------------------------------hHHHHHHH
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-------------------------------RHKMVEQI 60 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-------------------------------~~~~~~~i 60 (468)
...|+. +.||.|++|.||+|+.+.+|+.||||+++..-.. -.+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 7899999999999999888999999999643100 00122334
Q ss_pred HHHHHHH------hcC----CCCCeeEEEEEEEe-CCEEEEEEEccCCCCHHHH--HHhcC----CCCHHHHHHHHHHHH
Q 012228 61 KREISTM------KLI----KHPNVIKIIEVMAS-KTKIYIVLEFIDGGELFDK--IAKHG----RLKEDEARRYFQQLI 123 (468)
Q Consensus 61 ~~Ei~il------~~l----~hpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~--i~~~~----~l~e~~~~~~~~qll 123 (468)
.+|+..+ .++ .+.+.+.+-.++.+ .+..+|||||++|+.+.+. +...+ .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 4444433 333 24444555455533 4556899999999999764 33333 355666677777765
Q ss_pred HHHHHHHhCCccccCCCCCCeeeccCC----ceEEeccccchhhh
Q 012228 124 NAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGLSAISQ 164 (468)
Q Consensus 124 ~~l~yLH~~givHrDlKp~NILl~~~g----~lkl~DFGla~~~~ 164 (468)
..|++|+|+||.||+++.+| .++++|||++....
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 48999999999999999888 99999999986543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.3e-14 Score=143.14 Aligned_cols=185 Identities=18% Similarity=0.316 Sum_probs=139.3
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|.+ ...+-++.+..-.|..+.++.+|.+...+..+. ...+.+.+-+.-|+.++||||+++++.++....+|+|+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE 89 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE 89 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence 4666 444444444332466678899999998876543 345677888999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH-~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
.+. -|..++.+ ++......-++||+.||.||| +.+++|++|.-..|+++..|..||++|.++........ ..
T Consensus 90 rV~--Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~ 162 (690)
T KOG1243|consen 90 RVR--PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PA 162 (690)
T ss_pred ccc--cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--cc
Confidence 985 35555554 347777788999999999998 56899999999999999999999999998764433221 11
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhC
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG 212 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g 212 (468)
....---.|..|+.+.... -..|.|.|||++++++.|
T Consensus 163 ~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 163 KSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCc
Confidence 1111222467777654333 357999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.1e-14 Score=142.98 Aligned_cols=141 Identities=24% Similarity=0.342 Sum_probs=95.7
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh---h----------------------------HHHHH------HHH
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---R----------------------------HKMVE------QIK 61 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~---~----------------------------~~~~~------~i~ 61 (468)
+.||.|++|.||+|+. .+|+.||||+.+..-.. . ..... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999997 47999999998532100 0 00011 133
Q ss_pred HHHHHHhcC----CCCCeeEEEEEE-EeCCEEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 012228 62 REISTMKLI----KHPNVIKIIEVM-ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLIN-AVDYCHSRGV 134 (468)
Q Consensus 62 ~Ei~il~~l----~hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~-~l~yLH~~gi 134 (468)
+|...+..+ +|.+-+.+-.++ ...+..++||||++|++|.+..... ...+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 455544444 233333333333 2234569999999999998776432 1222 2345555555 4678999999
Q ss_pred cccCCCCCCeeeccCCceEEeccccchhh
Q 012228 135 FHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 135 vHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
+|+|+||.||+++.+|.++++|||++...
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 99999999999999999999999997643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.1e-13 Score=122.80 Aligned_cols=141 Identities=17% Similarity=0.219 Sum_probs=103.7
Q ss_pred EeeeeecCCeEEEEEEEcC------CCCEEEEEEeechhh-------------------hhHHHHH----HHHHHHHHHh
Q 012228 18 GRTLGEGSFAKVKFAKNVE------TGDFVAIKIVDRDQV-------------------LRHKMVE----QIKREISTMK 68 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~------~~~~vAiK~i~~~~~-------------------~~~~~~~----~i~~Ei~il~ 68 (468)
...||.|--+.||.|.... .+..+|+|+.+.... .+..... ..++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998653 357899998632100 0001122 3449999999
Q ss_pred cCC--CCCeeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCCee
Q 012228 69 LIK--HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC-HSRGVFHRDLKPENLL 145 (468)
Q Consensus 69 ~l~--hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yL-H~~givHrDlKp~NIL 145 (468)
++. .-++.+++++ ..-++||||+.++.+..-...+..+++..+..++.|++.+|..| |+.|++|+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 985 3456666654 45689999998755533223334567777888899999999999 8999999999999999
Q ss_pred eccCCceEEeccccchhh
Q 012228 146 LDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 146 l~~~g~lkl~DFGla~~~ 163 (468)
++ ++.+.|+|||.|...
T Consensus 158 ~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EE-CCcEEEEECCCceeC
Confidence 97 478999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.2e-14 Score=144.58 Aligned_cols=252 Identities=19% Similarity=0.176 Sum_probs=187.7
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEc-CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNV-ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTK 87 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 87 (468)
...++|..+..||.|.|+.|+..... .++..|++|...+.-......+ .-..|+-+...+. |.+++..+..+.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34678999999999999999988755 6778899998754332222212 2346666666664 9999999988888888
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC-CceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~-g~lkl~DFGla~~~~~~ 166 (468)
.|+=.|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.++.+.-.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 89999999999887776555678999999999999999999999999999999999999876 78899999998642110
Q ss_pred hcCCcccccCCCCCcC-CccccccCCCCCChhhHHHHHHHHHHHhhCCCC-CCCchHHHHHHhhcccccccccccchhhh
Q 012228 167 REDGLLHTACGTPNYV-APEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~-APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.....+.-++. .+|++.....+..++|++|+|.-+.+.++|... +......
T Consensus 421 -----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---------------------- 473 (524)
T KOG0601|consen 421 -----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---------------------- 473 (524)
T ss_pred -----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce----------------------
Confidence 11112233344 355554444446899999999999999887533 2221110
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
.+..+.....+..+.+++.+.+.++.+++..|+.+.++..|+=|-
T Consensus 474 --------~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 474 --------TIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred --------eeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 134454555555568899999999999999999999999887664
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.6e-13 Score=119.68 Aligned_cols=127 Identities=21% Similarity=0.275 Sum_probs=96.0
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCe-eEEEEEEEeCCEEEEEEEccC
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV-IKIIEVMASKTKIYIVLEFID 96 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~ 96 (468)
.+.|+.|.++.||++.. .+..|++|+...... ......+|+.+++.+.+.++ .+++.... ...++|||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999987 478899998754321 12245689999998865444 34554433 33579999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCCeeeccCCceEEeccccch
Q 012228 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV-----FHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 97 gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~gi-----vHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
|.++... ......++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.|.
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9877542 11123467899999999999985 9999999999999 6789999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.5e-13 Score=97.87 Aligned_cols=62 Identities=56% Similarity=0.883 Sum_probs=49.0
Q ss_pred CCCCCChhhhhhcCCCCCCccchhhhcc-cccccceeeecCChhHHHHHHHHHhcccCceEEe
Q 012228 334 KPVSMNAFELISRTKSFSLENLFEKQTG-LVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK 395 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~ 395 (468)
+|..+|||++|++|+++||+++|+.... .+++.+||+|..|++.|+++||++++.+|+.|++
T Consensus 1 ~p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 1 KPKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp --EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CCccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 3678999999999999999999987544 3678999999999999999999999999999875
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.3e-12 Score=122.23 Aligned_cols=202 Identities=16% Similarity=0.289 Sum_probs=139.2
Q ss_pred HhcCCCCCeeEEEEEEEeC-----CEEEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--cc
Q 012228 67 MKLIKHPNVIKIIEVMASK-----TKIYIVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRG--VF 135 (468)
Q Consensus 67 l~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~~l~yLH~~g--iv 135 (468)
+-.+-|.|||+++.++.+. ....++.||+..|+|..++++.. .+.....++|+-||++||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 3445699999999988554 45889999999999999887543 5888999999999999999999984 99
Q ss_pred ccCCCCCCeeeccCCceEEeccccchhhhhhhcC--CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCC
Q 012228 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF 213 (468)
Q Consensus 136 HrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~ 213 (468)
|+++.-+-|++..+|-+||.--.....-...... .......+-++|.|||.=..... +.++|||++|....+|..|.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILE 279 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHhe
Confidence 9999999999999999998632221111110000 01112346788999996433333 46899999999999998876
Q ss_pred CCCCC-chHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 214 LPFDE-SNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 214 ~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.--.. .+....... +.+.-+... ...-+.++.+||+..|..||++.+++.
T Consensus 280 iq~tnseS~~~~ee~--------------------------ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 280 IQSTNSESKVEVEEN--------------------------IANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eccCCCcceeehhhh--------------------------hhhheeecc---CccccCcCcccccCCCCCCcchhhhhc
Confidence 54221 111000000 000000000 112346899999999999999999999
Q ss_pred Cccccc
Q 012228 293 DEWFKK 298 (468)
Q Consensus 293 hpwf~~ 298 (468)
||-+-+
T Consensus 331 Hpllfe 336 (458)
T KOG1266|consen 331 HPLLFE 336 (458)
T ss_pred Cceeee
Confidence 998753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.4e-11 Score=105.99 Aligned_cols=134 Identities=21% Similarity=0.260 Sum_probs=99.7
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHH-----HHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK-----MVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
..+++|+-+.++.+.. -|..+++|.=..+...... ..+.-.+|..++..++--.|-..+=+..+++...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999865 4455677753222211111 23456789999999875555554445556777889999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
|.+|-.|.+.+... ...+++.+-.-+.-||..||+|+||.++||++.+.+ +.++||||+.+
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888765 255667777778889999999999999999998744 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.7e-11 Score=116.85 Aligned_cols=212 Identities=18% Similarity=0.237 Sum_probs=157.7
Q ss_pred CCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----CCEEEEEEEccCC-CC
Q 012228 25 SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----KTKIYIVLEFIDG-GE 99 (468)
Q Consensus 25 ~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~g-g~ 99 (468)
--.+.|+|....+|..|++|.++-.+... ......-+++++++.|+|+|.+.+++.+ +..+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 34678999999999999999995443222 2223356778999999999999999863 4569999999875 57
Q ss_pred HHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 100 LFDKIAKH---------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 100 L~~~i~~~---------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
|.++.-.. ...+|..+|.|+.||..||.++|+.|..-+-|.|.+||++++-+++|+..|..-+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 87764321 247889999999999999999999999999999999999998899999888755433
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCC-CCCchHHHH-HHhhcccccccccccchh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDESNLMAL-YRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~P-f~~~~~~~~-~~~~~~~~~~~~~~~~~~ 242 (468)
... -|-+.+. .+-|.=.||.+++.|.||..- |......+. ...
T Consensus 445 ~d~----------------~~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~--------------- 489 (655)
T KOG3741|consen 445 EDP----------------TEPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR--------------- 489 (655)
T ss_pred CCC----------------CcchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------------
Confidence 211 0222222 456999999999999999432 221111111 111
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
+-+.+|.++++++.-+...++.+ -++.+++.|
T Consensus 490 ------------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 490 ------------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 11237889999999999999988 889999877
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.5e-10 Score=100.66 Aligned_cols=144 Identities=23% Similarity=0.247 Sum_probs=107.7
Q ss_pred EEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh-----hhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-----LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 17 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
....|-+|+-+.|+.+.. .|+.+.||.-..... ...-...+..+|+++|.++.--.|.-..=++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567888999999999987 788888886432211 1111345678999999998755555555556666777899
Q ss_pred EEccCC-CCHHHHHHhcC-CCCHHHH-HHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC---ceEEeccccchh
Q 012228 92 LEFIDG-GELFDKIAKHG-RLKEDEA-RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAI 162 (468)
Q Consensus 92 ~E~~~g-g~L~~~i~~~~-~l~e~~~-~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g---~lkl~DFGla~~ 162 (468)
|||.+| -++.+++.... .-.++.. ..+++++-+.+.-||.++|+|+||..+||++..+| .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 36667765533 2233333 78899999999999999999999999999997655 358999999764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.8e-11 Score=111.39 Aligned_cols=140 Identities=21% Similarity=0.332 Sum_probs=107.0
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC--CCeeEEEEEEEeC---CEEEEEEE
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH--PNVIKIIEVMASK---TKIYIVLE 93 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lV~E 93 (468)
+.||.|..+.||++... +|+.+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 57899999999999874 3688999997654321 124567899999999975 4457777776553 36789999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS------------------------------------------ 131 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~------------------------------------------ 131 (468)
|++|+++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999887665432 456777777788888888888874
Q ss_pred --------------CCccccCCCCCCeeecc--CCceEEeccccchh
Q 012228 132 --------------RGVFHRDLKPENLLLDS--YGVLKISDFGLSAI 162 (468)
Q Consensus 132 --------------~givHrDlKp~NILl~~--~g~lkl~DFGla~~ 162 (468)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24689999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.2e-09 Score=98.16 Aligned_cols=127 Identities=27% Similarity=0.349 Sum_probs=84.6
Q ss_pred EEEEEEEcCCCCEEEEEEeechh-----------------------hhhHHHHHHHHHHHHHHhcCCCC--CeeEEEEEE
Q 012228 28 KVKFAKNVETGDFVAIKIVDRDQ-----------------------VLRHKMVEQIKREISTMKLIKHP--NVIKIIEVM 82 (468)
Q Consensus 28 ~V~~a~~~~~~~~vAiK~i~~~~-----------------------~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~ 82 (468)
.||.|.. ..|..+|+|+..... ....-......+|.++|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4888987 567899999863210 01111245678999999999755 566676553
Q ss_pred EeCCEEEEEEEccC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCCeeeccCCceEEecccc
Q 012228 83 ASKTKIYIVLEFID--GGELFDKIAKHGRLKEDEARRYFQQLINAVDY-CHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 83 ~~~~~~~lV~E~~~--gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~y-LH~~givHrDlKp~NILl~~~g~lkl~DFGl 159 (468)
. -++||||++ |..+..+... .++.+....++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred --C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2 379999998 6455433322 22356677788888886665 579999999999999999986 999999998
Q ss_pred chh
Q 012228 160 SAI 162 (468)
Q Consensus 160 a~~ 162 (468)
|..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.8e-11 Score=122.31 Aligned_cols=157 Identities=21% Similarity=0.360 Sum_probs=113.8
Q ss_pred HHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhhhhhhc------C-CcccccCCCCCcCCccccccCCC
Q 012228 121 QLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE------D-GLLHTACGTPNYVAPEVLNDKGY 192 (468)
Q Consensus 121 qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~------~-~~~~~~~gt~~y~APEvl~~~~~ 192 (468)
+...|+.|+|.. ++||++|.|++|.++.+|..||+.|+++........ + ....-......|.|||++.+. .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-T 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-c
Confidence 344899999976 899999999999999999999999998754322100 0 000011245679999999874 4
Q ss_pred CCChhhHHHHHHHHHHHh-hCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHH
Q 012228 193 DGRASDVWSCGVILFVLM-AGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKK 271 (468)
Q Consensus 193 ~~~~~DiWSlGvil~~ll-~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 271 (468)
.+.++|++|+||++|.+. .|+..+........+...... ...+.+..+..+++++++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~----------------------~~~~~~~~s~~~p~el~~ 243 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL----------------------LNAGAFGYSNNLPSELRE 243 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc----------------------cccccccccccCcHHHHH
Confidence 478999999999999999 566666554332222221000 112223334568999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 272 LIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 272 Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
=|.++|..++..||++.+++..|||....
T Consensus 244 ~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 244 SLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHhcCCcccCcchhhhhcccccCCch
Confidence 99999999999999999999999998743
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.5e-09 Score=98.93 Aligned_cols=132 Identities=17% Similarity=0.105 Sum_probs=92.1
Q ss_pred EEEEEEEcCCCCEEEEEEeechhhh---hH-----HHHHHHHHHHHHHhcCCCCCe--eEEEEEEEe-----CCEEEEEE
Q 012228 28 KVKFAKNVETGDFVAIKIVDRDQVL---RH-----KMVEQIKREISTMKLIKHPNV--IKIIEVMAS-----KTKIYIVL 92 (468)
Q Consensus 28 ~V~~a~~~~~~~~vAiK~i~~~~~~---~~-----~~~~~i~~Ei~il~~l~hpnI--v~l~~~~~~-----~~~~~lV~ 92 (468)
.|..+.. .|+.|.||........ +. .......+|+..+..|..-+| ..++.+.+. ...-++||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3445543 5678999976332211 00 001136789988887742222 223333332 23568999
Q ss_pred EccCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-------CCceEEeccccch
Q 012228 93 EFIDGG-ELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-------YGVLKISDFGLSA 161 (468)
Q Consensus 93 E~~~gg-~L~~~i~~--~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~-------~g~lkl~DFGla~ 161 (468)
|++++. +|.+++.. ....++.....++.++...+.-||+.||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999885 78888754 345677788899999999999999999999999999999975 4679999999864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.5e-09 Score=98.99 Aligned_cols=137 Identities=24% Similarity=0.353 Sum_probs=105.0
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh-------hh------------HHHHHHHHHHHHHHhcCCCC--
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-------LR------------HKMVEQIKREISTMKLIKHP-- 73 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-------~~------------~~~~~~i~~Ei~il~~l~hp-- 73 (468)
+.++..||-|--|.||.|.+. .|..+|+|.=+.... .+ .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 457899999999999999985 799999997321100 00 01234678999999999754
Q ss_pred CeeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceE
Q 012228 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (468)
Q Consensus 74 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lk 153 (468)
.+.+.+++ +...+|||+.+|-.|... +++.+.+..++..|+.-+.-+-..||+|+|+.+-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 67777764 556899999999766432 224566667777777777777799999999999999999999999
Q ss_pred Eeccccch
Q 012228 154 ISDFGLSA 161 (468)
Q Consensus 154 l~DFGla~ 161 (468)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.2e-08 Score=95.43 Aligned_cols=246 Identities=17% Similarity=0.202 Sum_probs=151.5
Q ss_pred EEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEE------EEeCCE-
Q 012228 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEV------MASKTK- 87 (468)
Q Consensus 16 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~------~~~~~~- 87 (468)
..++.||+|+-+.+|-.-. -+. .+.|+......-.. . +.+..|... .||-+-.=+.+ ..+...
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch--hhc-hhheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 3568899999999985433 122 34588876543221 1 222233333 46644331111 122223
Q ss_pred EEEEEEccCCCCHHHHHH-h------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccc
Q 012228 88 IYIVLEFIDGGELFDKIA-K------HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~-~------~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla 160 (468)
+-+.|..+.|..--..+. . ......+.+.+..+.|+.+.+.||++|.+-+|+.++|+|+++++.+.|.|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 778899887753222221 1 123667888999999999999999999999999999999999999999986543
Q ss_pred hhhhhhhcCCcccccCCCCCcCCccccc-----cCCCCCChhhHHHHHHHHHHHhhC-CCCCCCchHH-----HHHHhhc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLM-----ALYRKVS 229 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiWSlGvil~~ll~g-~~Pf~~~~~~-----~~~~~~~ 229 (468)
.+. .++....-..|.+.|.+||.-. +..- +...|.|.||+++|++|.| ..||.+.... ...-.|.
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 221 1222233456899999999754 2233 4678999999999999876 9999764210 0000111
Q ss_pred ccccccccccchhhhccccccccccccccC---CCCCC--CCHHHHHHHHHhcCC--CCCCCCCHHH
Q 012228 230 TFHFLSVYGESYKKCTNKYSYTLQICRADF---SCPSW--FSSGAKKLIKRILDP--NPDTRMTISQ 289 (468)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--~s~~~~~Ll~~~L~~--dP~~R~t~~e 289 (468)
... +.+..+-..+.. ..++| ++++++.|..+|+.. ++.-|||++.
T Consensus 241 ~g~---------------f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 241 HGR---------------FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cce---------------eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 100 011111111111 11223 789999999999975 3668999853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.3e-08 Score=89.46 Aligned_cols=105 Identities=20% Similarity=0.392 Sum_probs=82.9
Q ss_pred HHHHHHHHHHhcCCCC--CeeEEEEEEEeC----CEEEEEEEccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 012228 58 EQIKREISTMKLIKHP--NVIKIIEVMASK----TKIYIVLEFIDGG-ELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130 (468)
Q Consensus 58 ~~i~~Ei~il~~l~hp--nIv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH 130 (468)
....+|...+..|..- ...+.+.+.+.. ...++|+|++++. +|.+++......+......++.++...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 3577888888777422 233344444332 2458999999884 79998887566788889999999999999999
Q ss_pred hCCccccCCCCCCeeeccCC---ceEEeccccchh
Q 012228 131 SRGVFHRDLKPENLLLDSYG---VLKISDFGLSAI 162 (468)
Q Consensus 131 ~~givHrDlKp~NILl~~~g---~lkl~DFGla~~ 162 (468)
++||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.2e-09 Score=110.92 Aligned_cols=246 Identities=18% Similarity=0.200 Sum_probs=171.7
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-eeEEEEEEEeCCEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKIYIV 91 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV 91 (468)
.-|....-+++|+++++++.+...+...+ .+++... ..+.-++++|.+++||| .+..++-+..+...+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34667788899999999999987666655 6766432 34557889999999999 77777777788889999
Q ss_pred EEccCCC--CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg--~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
++++.++ .....-.....+.+.+.....+.-..+++++|+.--+||| ||+..+ +..|..||+.+..+....
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 9999887 2222222222355555666677778899999998889999 777765 888999999876543321
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
...+..+|+.++|||+.....++ ...|.|++|+--.+|.-|.+|-..+-.. ... .+... +
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~---------~g~~p----~--- 445 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPM---------IGNGP----N--- 445 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCccc--cCC---------CCCCC----C---
Confidence 34567899999999999888886 7889999998777787787776542110 000 00000 0
Q ss_pred cccccccccCCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 250 YTLQICRADFSC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 250 ~~~~~~~~~~~~-~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
...... ..|-+..-.++-..|+..-|..|+....++.|.+|....
T Consensus 446 ------s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 446 ------SPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred ------ccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 000000 011111112467789999999999999999999998653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.2e-07 Score=86.09 Aligned_cols=139 Identities=18% Similarity=0.268 Sum_probs=90.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHH------HHHHHHHHhcCCC---CCeeEEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ------IKREISTMKLIKH---PNVIKIIEVM 82 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------i~~Ei~il~~l~h---pnIv~l~~~~ 82 (468)
-++|.+.+.+-......|.+..- +|..+++|.........+..... ..+++..+..++. .....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 36788888888777777766654 67889999875433222222221 2344444444432 2222222222
Q ss_pred -----EeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecc
Q 012228 83 -----ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157 (468)
Q Consensus 83 -----~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DF 157 (468)
.-....+|+|||++|.+|.+... ++++ +...+..++.-||+.|++|+|.+|.|++++.+ .++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 22244679999999987765432 3332 44567788999999999999999999999964 4999999
Q ss_pred ccch
Q 012228 158 GLSA 161 (468)
Q Consensus 158 Gla~ 161 (468)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8644
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.6e-07 Score=84.87 Aligned_cols=139 Identities=22% Similarity=0.273 Sum_probs=98.1
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH---------------------HHHHHHHHHHHHHhcCC--CCC
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---------------------KMVEQIKREISTMKLIK--HPN 74 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---------------------~~~~~i~~Ei~il~~l~--hpn 74 (468)
...|..|--+.||+|.. .++..+|+|++......-. -......+|+..|+++. +=.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34677788889999987 5789999999854222111 11234567888888874 444
Q ss_pred eeEEEEEEEeCCEEEEEEEccCCCCH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCce
Q 012228 75 VIKIIEVMASKTKIYIVLEFIDGGEL-FDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVL 152 (468)
Q Consensus 75 Iv~l~~~~~~~~~~~lV~E~~~gg~L-~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~l 152 (468)
+.+.+.+.. -.+|||++..... .-.+ ++-++..+++..+..+++..+.-|-. .|+||+||+.-|||+. +|.+
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 455555442 3689999865311 1111 12234455799999999999999887 8999999999999999 7999
Q ss_pred EEeccccchhh
Q 012228 153 KISDFGLSAIS 163 (468)
Q Consensus 153 kl~DFGla~~~ 163 (468)
.|+|||-|...
T Consensus 206 ~iID~~QaV~~ 216 (268)
T COG1718 206 YIIDVSQAVTI 216 (268)
T ss_pred EEEECcccccc
Confidence 99999987643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.57 E-value=7e-07 Score=96.97 Aligned_cols=204 Identities=20% Similarity=0.234 Sum_probs=146.3
Q ss_pred HHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE----EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 012228 57 VEQIKREISTMKLIKHPNVIKIIEVMASKTKI----YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132 (468)
Q Consensus 57 ~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~----~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~ 132 (468)
+....-|+..+..+.|+|++.++.+....... .+..|+|.+-++...+..-+..+.+.++.+..++++|++|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 44455677778888999999999887554332 34457899999999999999999999999999999999999999
Q ss_pred CccccCCCCC---CeeeccCCceEEe--ccccchhhhhhhcCCcccccCCCCCcCCccccccCCCC-CChhhHHHHHHHH
Q 012228 133 GVFHRDLKPE---NLLLDSYGVLKIS--DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD-GRASDVWSCGVIL 206 (468)
Q Consensus 133 givHrDlKp~---NILl~~~g~lkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~-~~~~DiWSlGvil 206 (468)
...|.-+... +--.+..+.+.++ ||+.+...... ........+..+.|||......+. +...|+|.+|.++
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~---~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN---EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCc---ccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 6666555544 4444566677777 88876644332 122233446678888887655543 2346999999999
Q ss_pred HHHhhCCCCCCCch-HHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 012228 207 FVLMAGFLPFDESN-LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 285 (468)
Q Consensus 207 ~~ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~ 285 (468)
..+..|..+-.... .... .+........+++.+|+.-++++|+
T Consensus 383 ~~~~~~~~i~~~~~~~~~~------------------------------------l~~~~~~~~~d~~~~~~~~~~~~Rl 426 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVPVSL------------------------------------LDVLSTSELLDALPKCLDEDSEERL 426 (1351)
T ss_pred hhhhhcCcccccccchhhh------------------------------------hccccchhhhhhhhhhcchhhhhcc
Confidence 99988765432211 1000 0111122677899999999999999
Q ss_pred CHHHHhcCcccccC
Q 012228 286 TISQMLEDEWFKKG 299 (468)
Q Consensus 286 t~~eil~hpwf~~~ 299 (468)
++.+++.|+|.+..
T Consensus 427 ~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 427 SALELLTHPFLRFP 440 (1351)
T ss_pred chhhhhhchhcccc
Confidence 99999999998753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.3e-07 Score=80.80 Aligned_cols=138 Identities=18% Similarity=0.183 Sum_probs=97.4
Q ss_pred eecCCeEEEEEEEcCCCCEEEEEEeechhhh--h-HHHHHHHHHHHHHHhcCCC--CCeeEEE--EEEEeC--CEEEEEE
Q 012228 22 GEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--R-HKMVEQIKREISTMKLIKH--PNVIKII--EVMASK--TKIYIVL 92 (468)
Q Consensus 22 G~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~-~~~~~~i~~Ei~il~~l~h--pnIv~l~--~~~~~~--~~~~lV~ 92 (468)
|+|+-|.|+.... .|..+-+|.-...-.. . ..-...+.+|+..++.|.. -.+.++. +....+ -.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688888888765 3446777765311000 0 1124578899999998852 2244443 222222 2357999
Q ss_pred EccCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc--eEEeccccch
Q 012228 93 EFIDG-GELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--LKISDFGLSA 161 (468)
Q Consensus 93 E~~~g-g~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~--lkl~DFGla~ 161 (468)
|-++| -+|.+++... .+.++.....++.++...+.-||+.|+.|+|+-+.|||++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97764 4888887653 34577888899999999999999999999999999999987777 9999998655
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.5e-07 Score=83.00 Aligned_cols=133 Identities=15% Similarity=0.161 Sum_probs=83.2
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC--CeeEEEEEEEeCCEEEEEEEccC
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP--NVIKIIEVMASKTKIYIVLEFID 96 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~lV~E~~~ 96 (468)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..- .+.+.+++....+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999973 24567889875422 124568999999988633 34677777777888899999999
Q ss_pred CCC-HH--------------HHH-------Hhc--CCCCHHH-HHHHHHHH----------HH-HHHHHH----hCCccc
Q 012228 97 GGE-LF--------------DKI-------AKH--GRLKEDE-ARRYFQQL----------IN-AVDYCH----SRGVFH 136 (468)
Q Consensus 97 gg~-L~--------------~~i-------~~~--~~l~e~~-~~~~~~ql----------l~-~l~yLH----~~givH 136 (468)
|.. +. ..+ ..- ...+... ...+..++ .. ..++|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11 111 100 0111110 01111111 11 112222 124789
Q ss_pred cCCCCCCeeeccCCceEEeccccch
Q 012228 137 RDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 137 rDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999865
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.2e-06 Score=79.81 Aligned_cols=137 Identities=21% Similarity=0.310 Sum_probs=82.0
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC--CeeEEEEEE---EeCCEEEEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP--NVIKIIEVM---ASKTKIYIVL 92 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lV~ 92 (468)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999999854 58999997643 2346677899998888532 345666533 2334579999
Q ss_pred EccCCCCHHH----------------HH---Hhc----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 012228 93 EFIDGGELFD----------------KI---AKH----GRLKEDE------ARRY---------------FQQLIN-AVD 127 (468)
Q Consensus 93 E~~~gg~L~~----------------~i---~~~----~~l~e~~------~~~~---------------~~qll~-~l~ 127 (468)
++++|..+.. .+ ... ..+.... .... ...+.. .++
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 11 111 0111000 0000 011122 233
Q ss_pred HHH-------hCCccccCCCCCCeeec-cCCceEEeccccch
Q 012228 128 YCH-------SRGVFHRDLKPENLLLD-SYGVLKISDFGLSA 161 (468)
Q Consensus 128 yLH-------~~givHrDlKp~NILl~-~~g~lkl~DFGla~ 161 (468)
.++ ...++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333 24699999999999999 66777899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.1e-07 Score=93.13 Aligned_cols=136 Identities=24% Similarity=0.379 Sum_probs=88.0
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh---------------------------h----HHHHHH------HH
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---------------------------R----HKMVEQ------IK 61 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~---------------------------~----~~~~~~------i~ 61 (468)
..|+.+|-|.||.|+.+ +|+.||||+.+..-.. - ....+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56889999999999985 5999999996431000 0 001112 23
Q ss_pred HHHHHHhcCC-----CCCeeEEEEEEEeCCEEEEEEEccCCCCHHHH--HHhcCCCCHH-----HHHHHHHHHHHHHHHH
Q 012228 62 REISTMKLIK-----HPNVIKIIEVMASKTKIYIVLEFIDGGELFDK--IAKHGRLKED-----EARRYFQQLINAVDYC 129 (468)
Q Consensus 62 ~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~--i~~~~~l~e~-----~~~~~~~qll~~l~yL 129 (468)
+|...+.+++ .|++.-..=+.+-.+.-.|+|||++|-.+.+. +.. .+++.. -++.++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~------ 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL------ 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHH------
Confidence 4444444442 33333222223334566899999999877766 343 445533 2333333333
Q ss_pred HhCCccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 130 H~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
..|+.|.|.+|.||+++.+|.+-+.|||+....
T Consensus 283 -~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 283 -RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred -hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 389999999999999999999999999997644
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.25 E-value=8.3e-06 Score=76.95 Aligned_cols=134 Identities=16% Similarity=0.143 Sum_probs=82.2
Q ss_pred eeecCC-eEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEEEEEccCCC
Q 012228 21 LGEGSF-AKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYIVLEFIDGG 98 (468)
Q Consensus 21 LG~G~~-g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 98 (468)
|-.|.. +.||++.. .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 344555 78999875 34678889875432 234668999988884 444667777777667789999999987
Q ss_pred CHHHHH-------------------HhcC----CCCHH------HHHHHHH----------------HHHHHHHHH----
Q 012228 99 ELFDKI-------------------AKHG----RLKED------EARRYFQ----------------QLINAVDYC---- 129 (468)
Q Consensus 99 ~L~~~i-------------------~~~~----~l~e~------~~~~~~~----------------qll~~l~yL---- 129 (468)
.|.... ..-. .+... .....+. .+...++.|
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 664321 0000 01100 0000000 011111222
Q ss_pred ---HhCCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 130 ---HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 130 ---H~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
....++|+|+.|.|||+++++.+.|+||+.|..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123489999999999999977788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1e-07 Score=105.26 Aligned_cols=257 Identities=16% Similarity=0.077 Sum_probs=169.7
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh--hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--CE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--TK 87 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 87 (468)
+..|++.=.+|-|.++.-..-+.+.. -+.+|+...-... .+...+....|..-++...|+++...+.-.... ..
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 34455555555555543222221111 2344544321111 111234445566666677899998877655432 34
Q ss_pred EEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCCeeeccCCceEEeccc
Q 012228 88 IYIVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKISDFG 158 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~~l~yLH~~g-----ivHrDlKp~NILl~~~g~lkl~DFG 158 (468)
-|.+++||.+|.+++.|.++- .+.+.-+.....+.+.+..-+|+.. .+|+++|+-|.+|..+-++|++++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 689999999999999987642 3555666666677788888888652 7899999999999999999999999
Q ss_pred cchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccc
Q 012228 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
+.++..+. ........+++.|++|++...-.+. .++|+|+.|+.+|....|..+|-......+...+
T Consensus 1386 LdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgii---------- 1452 (2724)
T KOG1826|consen 1386 LDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYFIFFLQPALKGII---------- 1452 (2724)
T ss_pred cccccCch--HhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcc----------
Confidence 99843321 2234456788899999998877774 5699999999999999999888654433322221
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
........+-..|.++-.....+|-+.-..||.-...+.-+.|--
T Consensus 1453 ---------------dn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1453 ---------------DNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred ---------------cccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 112222333334666666677777777788898888888777653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=9.1e-06 Score=70.89 Aligned_cols=129 Identities=20% Similarity=0.273 Sum_probs=90.9
Q ss_pred EEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeE-EEEEEEeCCEEEEEEEc
Q 012228 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIK-IIEVMASKTKIYIVLEF 94 (468)
Q Consensus 16 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~-l~~~~~~~~~~~lV~E~ 94 (468)
++.+.||+|++|.||++.. .|..+|+|+-..+. ....+..|.++|..+.-.++.. +|.+.. .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 3467899999999999998 56699999876543 2457889999999998666643 444432 2455999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCCeeeccCCceEEeccccchh
Q 012228 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK-PENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 95 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlK-p~NILl~~~g~lkl~DFGla~~ 162 (468)
+.|-.|.+.-... + ++-...+++.---|-..||-|..|. |...++-.++.+.|+||..|+.
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9997775543311 1 2233445555445677899999997 5555555556999999999874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.9e-05 Score=87.46 Aligned_cols=80 Identities=14% Similarity=0.291 Sum_probs=56.4
Q ss_pred EeeeeecCCeEEEEEEEcCCC--CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCe--eEEEEEEEeC---CEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVETG--DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNV--IKIIEVMASK---TKIY 89 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~~ 89 (468)
.+.|+.|.+..+|+......+ ..+++|+........ ....+.+|+.+|+.+. |+++ .+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 677899999999998765432 467777754322111 1346779999999995 6665 7777776654 4578
Q ss_pred EEEEccCCCC
Q 012228 90 IVLEFIDGGE 99 (468)
Q Consensus 90 lV~E~~~gg~ 99 (468)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999999854
|
|
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.09 E-value=1e-05 Score=54.70 Aligned_cols=43 Identities=19% Similarity=0.346 Sum_probs=37.8
Q ss_pred CceEEEEEEEEEe-CCeEEEEEEEcCCCchhHHHHHHHHHhccc
Q 012228 411 GQLSVATEVFEVA-PTLHIVEVRKTGGDTLEFHKFYKKFSSGLK 453 (468)
Q Consensus 411 ~~l~~~~~i~~~~-~~~~~vdf~~~~Gd~le~~~~~~~~~~~l~ 453 (468)
..+.|.+||+++. .+++.|+|+|.+||.+.|++++.+|...|+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~ 46 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR 46 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence 4588999999998 899999999999999999999999988774
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.08 E-value=5.1e-05 Score=68.37 Aligned_cols=128 Identities=23% Similarity=0.292 Sum_probs=90.9
Q ss_pred cCeEEEeeeeecCC-eEEEEEEEcCCCCEEEEEEeec----------hhhhh-H-------HHHHHHHHHHHHHhcCC--
Q 012228 13 GKYELGRTLGEGSF-AKVKFAKNVETGDFVAIKIVDR----------DQVLR-H-------KMVEQIKREISTMKLIK-- 71 (468)
Q Consensus 13 ~~y~i~~~LG~G~~-g~V~~a~~~~~~~~vAiK~i~~----------~~~~~-~-------~~~~~i~~Ei~il~~l~-- 71 (468)
..++.++.||.|+- |.||++.. .|..||+|++.. +.... . .....+..|.+..-+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67899999999999 99999997 778999999321 00000 0 12345677877766664
Q ss_pred -CCCe--eEEEEEEEeC------------------CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 012228 72 -HPNV--IKIIEVMASK------------------TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130 (468)
Q Consensus 72 -hpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH 130 (468)
+.++ |++++++.-. ....||.||.+... .+.. .-+.++.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 5566 9999987221 12467888876533 2222 33457778888899
Q ss_pred hCCccccCCCCCCeeeccCCceEEeccccc
Q 012228 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (468)
Q Consensus 131 ~~givHrDlKp~NILl~~~g~lkl~DFGla 160 (468)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999987 3489999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.07 E-value=9.5e-05 Score=67.09 Aligned_cols=133 Identities=21% Similarity=0.280 Sum_probs=93.9
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhh-------------hhHHHHHHHHHHHHHHhcCC------CCCeeEEE
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-------------LRHKMVEQIKREISTMKLIK------HPNVIKII 79 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-------------~~~~~~~~i~~Ei~il~~l~------hpnIv~l~ 79 (468)
..||+|+.=.||.- ......+||++..... .......+..+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56899999888843 2345578899876540 01112455667777666665 88999999
Q ss_pred EEEEeCCEEEEEEEccCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC---
Q 012228 80 EVMASKTKIYIVLEFIDG------GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG--- 150 (468)
Q Consensus 80 ~~~~~~~~~~lV~E~~~g------g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g--- 150 (468)
++.+++...-+|+|.... -+|.+++.. +.+++ . +...|-.-.+||-+++|+.+|++|.||++..++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998632 267777744 45666 3 333444556788999999999999999996432
Q ss_pred -ceEEec-ccc
Q 012228 151 -VLKISD-FGL 159 (468)
Q Consensus 151 -~lkl~D-FGl 159 (468)
.+.|+| ||-
T Consensus 159 ~~lvlIDG~G~ 169 (199)
T PF10707_consen 159 FRLVLIDGLGE 169 (199)
T ss_pred eEEEEEeCCCC
Confidence 477777 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.87 E-value=6e-05 Score=70.70 Aligned_cols=72 Identities=10% Similarity=0.109 Sum_probs=43.7
Q ss_pred eeeeecCCe-EEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC---CeeEEEEEEEeC---CEEEEE
Q 012228 19 RTLGEGSFA-KVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP---NVIKIIEVMASK---TKIYIV 91 (468)
Q Consensus 19 ~~LG~G~~g-~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~lV 91 (468)
+.|+.|+.. .||+.. ..+++|+..... ....+.+|..+++.|... .+.++++..... ...|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 456766666 488752 356778754321 234688999999887531 233444433322 235889
Q ss_pred EEccCCCCH
Q 012228 92 LEFIDGGEL 100 (468)
Q Consensus 92 ~E~~~gg~L 100 (468)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999998655
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00033 Score=70.45 Aligned_cols=79 Identities=19% Similarity=0.216 Sum_probs=54.5
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh---h--HHHHHHHHHHHHHHhcCC---CCCeeEEEEEEEeCCEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---R--HKMVEQIKREISTMKLIK---HPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~---~--~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 89 (468)
.+.||.|.+..||++.+...++.++||.-.. ... . .-..+....|.+.|+.+. ..++.+++.+ ++...+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p-~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALP-YVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCc-ccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 4689999999999999864446899997431 110 0 012456677888888763 3467777776 445678
Q ss_pred EEEEccCCCC
Q 012228 90 IVLEFIDGGE 99 (468)
Q Consensus 90 lV~E~~~gg~ 99 (468)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998743
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00017 Score=74.55 Aligned_cols=139 Identities=23% Similarity=0.369 Sum_probs=85.0
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhh-----------------------------HHHHHHHHHHHHHH--
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-----------------------------HKMVEQIKREISTM-- 67 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-----------------------------~~~~~~i~~Ei~il-- 67 (468)
+.||.-+.|.|++|+.+. |+.||||+-+.. +.+ ++..+.+..|+..+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 678999999999999865 999999985321 100 01123333333332
Q ss_pred --------hcCCCCC---eeEEEEEEE-eCCEEEEEEEccCCCCHHH--HHHhcCCCCHHHHHHHHHHHHHHH-HHHHhC
Q 012228 68 --------KLIKHPN---VIKIIEVMA-SKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAV-DYCHSR 132 (468)
Q Consensus 68 --------~~l~hpn---Iv~l~~~~~-~~~~~~lV~E~~~gg~L~~--~i~~~~~l~e~~~~~~~~qll~~l-~yLH~~ 132 (468)
+.+.|-+ -|.+=.+|. -.....|+||||+|.-+.+ .|.+. +++...+. ..+..+. +-|=..
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~---~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDIL---NKLVEAYLEQIFKT 320 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHH---HHHHHHHHHHHHhc
Confidence 2223444 122223332 2345689999999975544 44443 34444332 2222221 122346
Q ss_pred CccccCCCCCCeeecc----CCceEEeccccchhh
Q 012228 133 GVFHRDLKPENLLLDS----YGVLKISDFGLSAIS 163 (468)
Q Consensus 133 givHrDlKp~NILl~~----~g~lkl~DFGla~~~ 163 (468)
|++|.|=+|.||+++. ++.+.+-|||+....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 8999999999999983 678999999997644
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00028 Score=66.02 Aligned_cols=75 Identities=21% Similarity=0.305 Sum_probs=47.7
Q ss_pred EeeeeecCCeEEEEEEEcC-CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-eeEEEEEEEeCCEEEEEEEcc
Q 012228 18 GRTLGEGSFAKVKFAKNVE-TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKIYIVLEFI 95 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~ 95 (468)
++.|..|-...+|++.... .++.|++|+...... ..-...+|+.+++.+...+ ..+++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4667778888999987543 357888997653211 1122347888888885333 344444332 2 3799999
Q ss_pred CCCCH
Q 012228 96 DGGEL 100 (468)
Q Consensus 96 ~gg~L 100 (468)
+|..+
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00012 Score=71.13 Aligned_cols=136 Identities=17% Similarity=0.207 Sum_probs=82.3
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC--CeeEEEE------EEEeCCEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP--NVIKIIE------VMASKTKIY 89 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~~ 89 (468)
.+.|..|....+|+... ++..+++|+.... ....+..|+.++..|.+. .+.+++. +....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56777888889998865 3457888987531 124566788888877432 2444443 123345678
Q ss_pred EEEEccCCCCHHH--------------HHHhc-CCCCH--------HHHH------------HHHHHHHHHHHHHHh---
Q 012228 90 IVLEFIDGGELFD--------------KIAKH-GRLKE--------DEAR------------RYFQQLINAVDYCHS--- 131 (468)
Q Consensus 90 lV~E~~~gg~L~~--------------~i~~~-~~l~e--------~~~~------------~~~~qll~~l~yLH~--- 131 (468)
+|+++++|..+.. .+... ..+.. .... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999865411 01100 00000 0000 011112233444443
Q ss_pred ----CCccccCCCCCCeeeccCCceEEeccccch
Q 012228 132 ----RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 132 ----~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
.+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999997778999999865
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00013 Score=69.25 Aligned_cols=133 Identities=17% Similarity=0.210 Sum_probs=76.2
Q ss_pred eeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCe-eEEEEEEEeCCEEEEEEEccCCC
Q 012228 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV-IKIIEVMASKTKIYIVLEFIDGG 98 (468)
Q Consensus 20 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg 98 (468)
.+..|-...+|+.. .+++.+++|...... ....-...+|..+++.+...++ .+++... . -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence 34567888899887 356788888754321 1110124678889888863322 3333332 2 26899999986
Q ss_pred CHHH--------------H---HHhcC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCccccCC
Q 012228 99 ELFD--------------K---IAKHG----RLKE-DEARRYFQQL---------INAVDYCHS--------RGVFHRDL 139 (468)
Q Consensus 99 ~L~~--------------~---i~~~~----~l~e-~~~~~~~~ql---------l~~l~yLH~--------~givHrDl 139 (468)
.+.. . +.... +++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5421 1 11110 1111 2222332222 111222211 25899999
Q ss_pred CCCCeeeccCCceEEeccccchh
Q 012228 140 KPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 140 Kp~NILl~~~g~lkl~DFGla~~ 162 (468)
.|.||++++++ +.|+||+.|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00042 Score=67.38 Aligned_cols=141 Identities=24% Similarity=0.288 Sum_probs=96.7
Q ss_pred EEeeeeecCCeEEEEEEEcCCCCEEEEEEeech--------------------hh--hhHHH-HHHHHHHHHHHhcCCCC
Q 012228 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD--------------------QV--LRHKM-VEQIKREISTMKLIKHP 73 (468)
Q Consensus 17 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~--------------------~~--~~~~~-~~~i~~Ei~il~~l~hp 73 (468)
+-..|..|--+.||.|.. .+|+.+|||++.-. .+ ...++ .-...+|++.|++|+..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445677888899999987 67888999986310 00 01112 23467899999888644
Q ss_pred CeeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCce
Q 012228 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVL 152 (468)
Q Consensus 74 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~l 152 (468)
.|...--++. ..-.|||+++....--.=...+..++...+..+.+|++.-+.-|-+ .+.||.||.--|+|+-+ |.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEE
Confidence 4322211111 1236899999642221112234568888999999999999988765 58999999999999976 899
Q ss_pred EEeccccch
Q 012228 153 KISDFGLSA 161 (468)
Q Consensus 153 kl~DFGla~ 161 (468)
.|+|-+-+-
T Consensus 304 yiIDVSQSV 312 (520)
T KOG2270|consen 304 YIIDVSQSV 312 (520)
T ss_pred EEEEccccc
Confidence 999988654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00097 Score=64.85 Aligned_cols=77 Identities=12% Similarity=0.085 Sum_probs=53.5
Q ss_pred EEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC---CCeeEEEEEEEe---CCEEEE
Q 012228 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH---PNVIKIIEVMAS---KTKIYI 90 (468)
Q Consensus 17 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~l 90 (468)
-.+.||.|..+.||..... ++ .+.+|..+. .. ....+..|...|+.|.- -.+.++++++.. .+.-++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-QG-NPMPLMARS-FS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcC-CC-CEEEEEecc-cc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3567999999999998652 23 467777432 10 12467789999988852 356777776644 366899
Q ss_pred EEEccCCCCH
Q 012228 91 VLEFIDGGEL 100 (468)
Q Consensus 91 V~E~~~gg~L 100 (468)
|||+++|+.+
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.56 E-value=8e-05 Score=71.10 Aligned_cols=135 Identities=18% Similarity=0.294 Sum_probs=96.5
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh-----hHH--------------HHHHHHHHHHHHhcCCC--C
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHK--------------MVEQIKREISTMKLIKH--P 73 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~--------------~~~~i~~Ei~il~~l~h--p 73 (468)
|.+++.||-|.-+.||.+.+ ..|.+.++|+-+..... +.. ..-...+|...|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67899999999999999988 57889999974221110 000 11235688888888852 2
Q ss_pred CeeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceE
Q 012228 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (468)
Q Consensus 74 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lk 153 (468)
-+.+.++ .+..++|||++.|..|...-. ...+..+...++.-+--|-.+|++|+|..--||++++++.++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 3444444 356789999999866643321 223445556667777788999999999999999999999999
Q ss_pred Eeccccc
Q 012228 154 ISDFGLS 160 (468)
Q Consensus 154 l~DFGla 160 (468)
++||--.
T Consensus 243 vIDFPQm 249 (465)
T KOG2268|consen 243 VIDFPQM 249 (465)
T ss_pred EeechHh
Confidence 9999743
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00024 Score=64.07 Aligned_cols=99 Identities=16% Similarity=0.281 Sum_probs=79.9
Q ss_pred HHHHHHHhcCCC-CCeeEEEEEEEeCCEEEEEEEccCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 012228 61 KREISTMKLIKH-PNVIKIIEVMASKTKIYIVLEFIDGGELFDK---IAKHGRLKEDEARRYFQQLINAVDYCHS---RG 133 (468)
Q Consensus 61 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~---i~~~~~l~e~~~~~~~~qll~~l~yLH~---~g 133 (468)
..|.-+++.+.+ +++.+++|.+- -++|.||...+++... +..-...+......++.+++..+++++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 368888999975 69999999873 3678999987766432 1111246888999999999999999998 45
Q ss_pred ccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 134 VFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 134 ivHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
+.-.|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999887644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00091 Score=65.42 Aligned_cols=139 Identities=19% Similarity=0.258 Sum_probs=80.5
Q ss_pred EEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC--CeeEEEEE------EEeCCE
Q 012228 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP--NVIKIIEV------MASKTK 87 (468)
Q Consensus 16 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~------~~~~~~ 87 (468)
.-.+.++.|....+|++.. .+| .+++|+..... . .+.+..|++++..|... .+.+++.. ....+.
T Consensus 25 ~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eeccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 3356777887789998864 334 57789875421 1 23355677777776422 23343331 122456
Q ss_pred EEEEEEccCCCCHH-----------HH---HHh-cCCCC--------HHH-----HH----------HHHHHHHHHHHHH
Q 012228 88 IYIVLEFIDGGELF-----------DK---IAK-HGRLK--------EDE-----AR----------RYFQQLINAVDYC 129 (468)
Q Consensus 88 ~~lV~E~~~gg~L~-----------~~---i~~-~~~l~--------e~~-----~~----------~~~~qll~~l~yL 129 (468)
.+++|||++|..+. .. +.. ...++ ... .. .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999885421 00 110 00110 000 00 0011223345555
Q ss_pred Hh-------CCccccCCCCCCeeeccCCceEEeccccch
Q 012228 130 HS-------RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 130 H~-------~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
.. .+++|+|+.+.||+++.++...|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 42 589999999999999998877899999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.003 Score=62.10 Aligned_cols=30 Identities=33% Similarity=0.537 Sum_probs=26.1
Q ss_pred CCccccCCCCCCeeeccCCceEEeccccch
Q 012228 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 132 ~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
.|+||+|+.|.|||++++...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999976556899999865
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0021 Score=63.33 Aligned_cols=77 Identities=17% Similarity=0.130 Sum_probs=49.2
Q ss_pred eeeecCCeEEEEEEEcCCCCEEEEEEeec-hhh-hh--HHHHHHHHHHHHHHhcCC--CC-CeeEEEEEEEeCCEEEEEE
Q 012228 20 TLGEGSFAKVKFAKNVETGDFVAIKIVDR-DQV-LR--HKMVEQIKREISTMKLIK--HP-NVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 20 ~LG~G~~g~V~~a~~~~~~~~vAiK~i~~-~~~-~~--~~~~~~i~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV~ 92 (468)
.||.|....||++.+...++.|+||--.. -.. .. .-..++..-|...|+... .| .+.++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999854446899996321 010 00 112455667888887764 34 45555544 455567999
Q ss_pred EccCCC
Q 012228 93 EFIDGG 98 (468)
Q Consensus 93 E~~~gg 98 (468)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0019 Score=62.88 Aligned_cols=75 Identities=15% Similarity=0.146 Sum_probs=46.9
Q ss_pred EeeeeecCCeEEEEEEEcC------CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-eeEEEEEEEeCCEEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVE------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKIYI 90 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~l 90 (468)
++.|..|-...+|++.... +++.+++|+...... ......+|..+++.+...+ ..+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3456667777899887543 367899999754321 1234568888888885322 2344544432 35
Q ss_pred EEEccCCCCH
Q 012228 91 VLEFIDGGEL 100 (468)
Q Consensus 91 V~E~~~gg~L 100 (468)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999888654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0037 Score=60.78 Aligned_cols=141 Identities=16% Similarity=0.226 Sum_probs=84.3
Q ss_pred EEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC--CCeeEEEEEEEeCC--EEEEE
Q 012228 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH--PNVIKIIEVMASKT--KIYIV 91 (468)
Q Consensus 16 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~--~~~lV 91 (468)
.+++.+-.|..-.+|...+ +++.+++. ... ............+|..+++.+.- --+...++.+.++. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 3444443344444555555 37888888 321 11122245567788888888753 23333444444444 66999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHH-HHHHHHHHHHh---------------------------------------
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQ-QLINAVDYCHS--------------------------------------- 131 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~-qll~~l~yLH~--------------------------------------- 131 (468)
|++++|..+.+.. .+......+.. .+...|.-||+
T Consensus 104 ~~~veGe~~~~~~-----~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 104 MEWVEGEVVWSAL-----PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred EEEecceeccCcC-----CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 9999984332211 11111122222 55555555554
Q ss_pred -------------------CCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 132 -------------------RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 132 -------------------~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..++|+|+.+.|++++..+-+=+.||+++.+-.+
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 2589999999999999988899999999886433
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0026 Score=64.54 Aligned_cols=175 Identities=22% Similarity=0.249 Sum_probs=107.7
Q ss_pred HHHHHHHHHHhcCCCCCeeEEEEEEEeC-CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 012228 58 EQIKREISTMKLIKHPNVIKIIEVMASK-TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFH 136 (468)
Q Consensus 58 ~~i~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givH 136 (468)
.++.-...+++.+.|+|.-..+++.... ....+|||++.- +|.+....+. +-..... .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~-l~~~s~~--------------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN-LKDESLL--------------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc-cchhhhc--------------ccccce
Confidence 3455667888999999999999887543 457899999964 8888876643 2111111 222222
Q ss_pred cCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCC
Q 012228 137 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 216 (468)
Q Consensus 137 rDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf 216 (468)
- +.++++| .+++. | |- ..++++||||+|.++.++..|...|
T Consensus 91 ~------------~~~~~td-~~~t~------------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 91 L------------NIIYITD-HFLTK------------------Y--PS------PIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred e------------hhhhccc-ccccc------------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHH
Confidence 1 2333444 11110 0 11 1125899999999999999998888
Q ss_pred CCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 217 DESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
......+....+.+......-... ..... .+--.++.....++.+|+-..|..||...++++|+-|
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~-------------~a~e~-~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~ 197 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLS-------------TAMEH-LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSF 197 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHH-------------HHHHH-HHHHhhhHhHHHHhccCCccccccccchhHHhcCccH
Confidence 776655555444322111000000 00000 0001146667889999999999999999999999999
Q ss_pred ccCCC
Q 012228 297 KKGYK 301 (468)
Q Consensus 297 ~~~~~ 301 (468)
...+.
T Consensus 198 ~ev~~ 202 (725)
T KOG1093|consen 198 TEVYK 202 (725)
T ss_pred HHHHh
Confidence 87643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0052 Score=61.08 Aligned_cols=137 Identities=18% Similarity=0.248 Sum_probs=78.3
Q ss_pred EeeeeecCCeEEEEEEEcC----CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCe-eEEEEEEEeCCEEEEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVE----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV-IKIIEVMASKTKIYIVL 92 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~ 92 (468)
...|-.|-.-.+|++.... +++.|++|+..... ...+++ .+|..+++.+..-++ .++++.+... .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 3445447888899987432 34689999875432 112222 578888888863333 3445555332 578
Q ss_pred EccCCCCHHHH----------H-------HhcC----C-C-CHHHHHHHHHHHH-----------------HHHHHH---
Q 012228 93 EFIDGGELFDK----------I-------AKHG----R-L-KEDEARRYFQQLI-----------------NAVDYC--- 129 (468)
Q Consensus 93 E~~~gg~L~~~----------i-------~~~~----~-l-~e~~~~~~~~qll-----------------~~l~yL--- 129 (468)
||++|..|... + .... . . ..+.+..+..++. ..+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 88877554211 0 1100 0 1 1223333332221 111111
Q ss_pred -H----hCCccccCCCCCCeeecc-CCceEEeccccchh
Q 012228 130 -H----SRGVFHRDLKPENLLLDS-YGVLKISDFGLSAI 162 (468)
Q Consensus 130 -H----~~givHrDlKp~NILl~~-~g~lkl~DFGla~~ 162 (468)
. ...++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 235899999999999986 47899999998763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0053 Score=59.03 Aligned_cols=30 Identities=23% Similarity=0.422 Sum_probs=25.5
Q ss_pred CccccCCCCCCeeeccCCc-eEEeccccchh
Q 012228 133 GVFHRDLKPENLLLDSYGV-LKISDFGLSAI 162 (468)
Q Consensus 133 givHrDlKp~NILl~~~g~-lkl~DFGla~~ 162 (468)
.++|+|++|.|||+++++. .-|.||+.+.+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.019 Score=57.78 Aligned_cols=77 Identities=13% Similarity=0.104 Sum_probs=50.6
Q ss_pred EEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh-hhH---HHHHHHHHHHHHHhcCC---CCCeeEEEEEEEeCCEEE
Q 012228 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-LRH---KMVEQIKREISTMKLIK---HPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 17 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 89 (468)
-.+.||.|....||+..+ .+..++||.-..... ... ....+...|...|+.+. ..++.+++.+.. +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 367889999999999887 345688887431110 000 12344556677776664 347778887765 4457
Q ss_pred EEEEccCC
Q 012228 90 IVLEFIDG 97 (468)
Q Consensus 90 lV~E~~~g 97 (468)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.02 Score=55.87 Aligned_cols=29 Identities=31% Similarity=0.544 Sum_probs=25.6
Q ss_pred CCccccCCCCCCeeeccCCceEEeccccch
Q 012228 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 132 ~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999998 778999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.011 Score=59.11 Aligned_cols=78 Identities=17% Similarity=0.181 Sum_probs=51.9
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeec-hhhhh--HHHHHHHHHHHHHHhcCC--CC-CeeEEEEEEEeCCEEEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDR-DQVLR--HKMVEQIKREISTMKLIK--HP-NVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~-~~~~~--~~~~~~i~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV 91 (468)
.+.||.|.-..||++.+...+..|+||--.. -+... .-..++..-|..+|+... .| ++.++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6788999999999999854456799886321 00100 112566778888888764 34 55666654 55566789
Q ss_pred EEccCC
Q 012228 92 LEFIDG 97 (468)
Q Consensus 92 ~E~~~g 97 (468)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999865
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.02 Score=56.52 Aligned_cols=140 Identities=16% Similarity=0.285 Sum_probs=77.1
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCC---CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCe-eEEEEEEEeCCEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV-IKIIEVMASKTKIY 89 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 89 (468)
..++ +.|..|-.-.+|++..... +..|++|+..... ...+ .-.+|..+++.+..-++ .++++++.. .
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~--G-- 86 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVI-DRERELQAIKYLSAAGFGAKLLGVFGN--G-- 86 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEe-chHHHHHHHHHHHhcCCCCceeEEeCC--c--
Confidence 3344 4444477778898875432 3478899875321 1111 12478888888864444 345555532 2
Q ss_pred EEEEccCCCCHHH----------HH-------HhcC-C----CC-HHHHHHHHHHH----------------------HH
Q 012228 90 IVLEFIDGGELFD----------KI-------AKHG-R----LK-EDEARRYFQQL----------------------IN 124 (468)
Q Consensus 90 lV~E~~~gg~L~~----------~i-------~~~~-~----l~-e~~~~~~~~ql----------------------l~ 124 (468)
+|.+|++|..|.. .+ .... . .+ ...+..++.++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 4888887754411 11 1101 0 11 12233333222 11
Q ss_pred HHHH----HHhCC----ccccCCCCCCeeecc-CCceEEeccccchh
Q 012228 125 AVDY----CHSRG----VFHRDLKPENLLLDS-YGVLKISDFGLSAI 162 (468)
Q Consensus 125 ~l~y----LH~~g----ivHrDlKp~NILl~~-~g~lkl~DFGla~~ 162 (468)
-+.. +...+ .+|+|+.|.|||+++ ++.++++||..|..
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1111 11222 799999999999975 57899999998753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.12 Score=50.40 Aligned_cols=29 Identities=17% Similarity=0.154 Sum_probs=27.1
Q ss_pred CccccCCCCCCeeeccCCceEEeccccch
Q 012228 133 GVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 133 givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
++||+|+.+.|+|+++++.+.++||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999865
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.062 Score=54.09 Aligned_cols=75 Identities=21% Similarity=0.256 Sum_probs=43.6
Q ss_pred EeeeeecCCeEEEEEEEcCC-CCE-----EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC-CeeEEEEEEEeCCEEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVET-GDF-----VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP-NVIKIIEVMASKTKIYI 90 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~-~~~-----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~l 90 (468)
.+.|..|-...+|++..... +.. |.+++... .....-.-.+|+.+++.|... .-.++++.+.. ++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 44554588889999975432 222 44443211 111111224789999999644 44556666643 68
Q ss_pred EEEccCCCCH
Q 012228 91 VLEFIDGGEL 100 (468)
Q Consensus 91 V~E~~~gg~L 100 (468)
+.||++|..|
T Consensus 127 l~efIeGr~l 136 (383)
T PTZ00384 127 IQEWVEGNTM 136 (383)
T ss_pred EEEEeccccC
Confidence 9999988654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.07 Score=51.49 Aligned_cols=74 Identities=16% Similarity=0.223 Sum_probs=46.7
Q ss_pred EEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC---CCCeeEEEEEEEeCCEEEEEEE
Q 012228 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK---HPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 17 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E 93 (468)
-.+.+|.|....+|... .+++.+.+|+-.... ...+..|..-|+.|. .-.+.+.+.+....+.-|+|||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 35678889999999887 578889999876221 234567777777773 4457788888877777799999
Q ss_pred ccCCC
Q 012228 94 FIDGG 98 (468)
Q Consensus 94 ~~~gg 98 (468)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 98765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.043 Score=53.78 Aligned_cols=85 Identities=22% Similarity=0.334 Sum_probs=61.1
Q ss_pred CCCeeEEEEEE-EeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccC
Q 012228 72 HPNVIKIIEVM-ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSY 149 (468)
Q Consensus 72 hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~ 149 (468)
.++..+.+-+- ......|++|++- |+.| ..+. .-..+++..++++.+..++-+..+ ..-|||+.-.||||+ +
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~i-s~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~ 357 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPI-SIIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E 357 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Ccee-eeee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence 44444444443 2234567888875 3333 2222 235678888999998888887765 689999999999999 8
Q ss_pred CceEEeccccchh
Q 012228 150 GVLKISDFGLSAI 162 (468)
Q Consensus 150 g~lkl~DFGla~~ 162 (468)
|++.|+||-+++.
T Consensus 358 GnvtLIDfklsRl 370 (488)
T COG5072 358 GNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEeeeeec
Confidence 9999999999984
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.42 Score=47.12 Aligned_cols=70 Identities=14% Similarity=0.065 Sum_probs=41.1
Q ss_pred cCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC--CeeEEE---E--EEEeCCEEEEEEEccC
Q 012228 24 GSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP--NVIKII---E--VMASKTKIYIVLEFID 96 (468)
Q Consensus 24 G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~---~--~~~~~~~~~lV~E~~~ 96 (468)
|.-..||.... .+|..+++|+.+.... ....+..|+..+..|... .++... + +...++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 34456888875 4567899998753321 234566788777766311 122211 1 1233566788999998
Q ss_pred CC
Q 012228 97 GG 98 (468)
Q Consensus 97 gg 98 (468)
|.
T Consensus 111 G~ 112 (325)
T PRK11768 111 GR 112 (325)
T ss_pred CC
Confidence 75
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.53 Score=53.66 Aligned_cols=31 Identities=29% Similarity=0.439 Sum_probs=26.3
Q ss_pred CCccccCCCCCCeeeccCC--ceE-Eeccccchh
Q 012228 132 RGVFHRDLKPENLLLDSYG--VLK-ISDFGLSAI 162 (468)
Q Consensus 132 ~givHrDlKp~NILl~~~g--~lk-l~DFGla~~ 162 (468)
.++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999775 555 999998754
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.17 Score=48.88 Aligned_cols=74 Identities=15% Similarity=0.091 Sum_probs=44.5
Q ss_pred eecCCeEEEEEEEcC----CC----CEEEEEEeechhhhhH--HHHHHHHHHHHHHhcCC-------------CCCeeEE
Q 012228 22 GEGSFAKVKFAKNVE----TG----DFVAIKIVDRDQVLRH--KMVEQIKREISTMKLIK-------------HPNVIKI 78 (468)
Q Consensus 22 G~G~~g~V~~a~~~~----~~----~~vAiK~i~~~~~~~~--~~~~~i~~Ei~il~~l~-------------hpnIv~l 78 (468)
|.|-.|.+|++.-.. ++ ..++||.......... .....+.+|+.+.+.+- .....++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 677778888776532 22 2488888752222221 12456778887776551 1234566
Q ss_pred EEEEEeCCEEEEEEEcc
Q 012228 79 IEVMASKTKIYIVLEFI 95 (468)
Q Consensus 79 ~~~~~~~~~~~lV~E~~ 95 (468)
+....++...+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 66655556788999865
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.12 Score=51.37 Aligned_cols=60 Identities=18% Similarity=0.196 Sum_probs=42.6
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCCeeecc
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY-CHSRGVFHRDLKPENLLLDS 148 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~y-LH~~givHrDlKp~NILl~~ 148 (468)
..|+-+|..|.++..++.. ...+|+..+.++.--..|+-- +--.+.+|.|++|.||++--
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 4567778888888877765 345666666666555555443 34568999999999999953
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.31 E-value=0.17 Score=46.26 Aligned_cols=84 Identities=18% Similarity=0.242 Sum_probs=56.4
Q ss_pred HHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--Cccc
Q 012228 59 QIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--GVFH 136 (468)
Q Consensus 59 ~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~--givH 136 (468)
.+..+.+++.++. .|+++..- +.-.+-+++|+|-.... ... .++.-=+.+|.-.|+. +.+|
T Consensus 104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~~~----N~i~agi~~L~~fH~~~~~~lH 166 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------NFS----NFITAGIKDLMDFHSENQHCLH 166 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------chh----HHHHHhHHHHHHhhccCCCeec
Confidence 3467777777654 57777732 44457799999953211 000 0111114567778843 7999
Q ss_pred cCCCCCCeeeccCCceEEecccc
Q 012228 137 RDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 137 rDlKp~NILl~~~g~lkl~DFGl 159 (468)
+|-.|+||+-|..|.+||.|=+.
T Consensus 167 GD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 167 GDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999764
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 468 | ||||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-66 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-66 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-66 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-66 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-66 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-65 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-65 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-64 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-62 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-61 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-61 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-61 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-61 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-60 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-60 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-60 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-59 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-58 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-58 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-51 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-51 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-51 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-50 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-50 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-47 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-46 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-46 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-46 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-46 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-46 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-46 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-46 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-46 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-46 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-46 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-46 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-46 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-46 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-46 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-46 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-46 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-45 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-45 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-45 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-45 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-45 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-45 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-45 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-45 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-45 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-45 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-45 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-45 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-45 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-45 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-45 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-44 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-44 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-44 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-44 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-44 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-44 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-44 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-44 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-44 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-44 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-44 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-44 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-44 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-44 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-44 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-44 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-44 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-44 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-44 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-44 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-44 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-44 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-44 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-44 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-44 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-44 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-44 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-44 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-44 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-43 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-43 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-43 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-42 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-42 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-42 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-42 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-42 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-42 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-42 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-42 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-42 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-41 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-41 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-41 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-41 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-41 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-41 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-41 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-41 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-41 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-41 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-41 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-41 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-41 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-41 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-41 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-41 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-41 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-41 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-41 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-41 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-41 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-41 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-41 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-41 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-41 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-41 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-40 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-40 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-40 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-40 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-40 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-40 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-40 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-40 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-40 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-40 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-40 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-40 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-40 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-40 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-40 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-40 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-40 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-40 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-40 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-40 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-40 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-39 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-39 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-39 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-39 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-39 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-39 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-39 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-39 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-39 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-39 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-39 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-39 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-39 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-39 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-39 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-39 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-39 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-39 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-39 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-39 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-39 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-39 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-39 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-39 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-39 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-39 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-38 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-38 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-38 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-38 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-38 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-38 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-38 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-38 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-37 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-37 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-37 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-37 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-37 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-37 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-37 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-37 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-37 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-37 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-37 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-37 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-37 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-37 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-37 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-37 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-37 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-37 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-37 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-37 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-37 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-37 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-37 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-36 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-36 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-36 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-36 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-36 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-36 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-36 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-36 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-36 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-35 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-35 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-35 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-35 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-35 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-35 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-35 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-35 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-35 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-35 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-35 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-35 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-35 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-35 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-35 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-35 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-35 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-35 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-35 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-34 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-34 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-34 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-34 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-34 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-34 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-34 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-34 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-34 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-34 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-34 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-34 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-34 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-34 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-34 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-34 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-34 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-34 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-34 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-34 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-34 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-34 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-34 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-34 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-34 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-34 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-34 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-34 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-34 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-33 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-33 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-33 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-33 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-33 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-33 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-33 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-33 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 2e-32 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-32 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-31 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-31 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-31 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-31 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-31 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-31 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-31 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-31 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-31 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-31 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-31 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-31 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-31 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-31 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-31 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-31 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-30 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-30 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-30 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-30 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-30 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-30 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-30 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-30 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-29 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-29 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-29 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-29 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-28 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-28 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-28 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-28 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-28 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-28 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-28 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-28 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-28 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-28 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-28 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-28 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-28 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-28 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-28 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-28 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-28 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-28 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-28 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-28 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-28 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-28 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-28 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-28 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-28 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-28 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-28 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-28 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-28 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-28 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-28 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-28 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-28 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-28 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-27 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-27 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-27 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-27 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-27 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-27 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-27 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-27 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-27 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-27 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-27 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-27 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-26 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-26 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-26 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-26 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-25 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-25 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-25 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-25 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-24 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-24 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-24 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-24 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-24 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-24 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-24 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-24 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-24 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-24 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-24 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-24 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-24 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-24 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-23 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-23 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-23 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-23 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-23 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-23 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-23 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-23 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-23 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-23 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-23 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-23 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-23 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-23 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-23 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-23 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-23 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-23 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-23 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-23 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-23 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-23 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-23 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-23 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-23 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-23 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-23 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-23 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-23 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-23 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-23 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-23 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-23 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-23 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-23 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-23 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-23 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-23 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-23 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-23 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-23 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-22 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-22 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-21 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-21 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-21 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-21 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-20 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-20 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-20 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-20 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-20 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-20 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-20 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-20 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-20 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-20 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-20 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-20 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-20 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-20 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-20 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-20 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-20 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-20 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-20 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-20 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-19 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-19 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-19 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-19 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-19 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-19 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-19 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-19 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-19 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-19 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-19 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-19 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-19 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-19 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-19 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-19 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-19 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-19 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-19 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-19 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-19 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-19 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-19 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-19 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-19 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-19 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-19 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-19 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-19 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-19 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-19 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-19 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-19 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-19 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-19 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-19 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-19 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-19 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-19 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-19 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-19 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-19 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-19 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-19 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-19 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-19 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-19 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-19 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-19 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-19 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-19 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-19 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-19 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-19 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-19 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-19 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-19 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-18 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-18 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-18 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-18 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-18 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-18 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-17 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-17 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-17 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 7e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-17 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-17 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-17 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-16 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-16 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-14 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-12 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-12 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-11 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 9e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-11 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-11 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 9e-11 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-11 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 9e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-11 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-11 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-11 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-11 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-09 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 8e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 |
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 532 bits (1373), Expect = 0.0
Identities = 146/494 (29%), Positives = 246/494 (49%), Gaps = 89/494 (18%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
R ++G Y LG TLG G+F KVK K+ TG VA+KI++R ++ +V +I+REI +
Sbjct: 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
KL +HP++IK+ +V+++ + I++V+E++ GGELFD I K+GRL E E+RR FQQ+++ VD
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
YCH V HRDLKPEN+LLD++ KI+DFGLS + + + L T+CG+PNY APEV+
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVI 187
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247
+ + Y G D+WS GVIL+ L+ G LPFD+ ++ L++K
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK-------------------- 227
Query: 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDK 307
IC F P + + L+K +L +P R TI + E EWFK+ F +
Sbjct: 228 ------ICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPE 281
Query: 308 EEEVNLDDVD--------------------AIFNDSKEN--------LVTEKKEKPVSMN 339
+ + +D ++N + ++ ++ ++ + +
Sbjct: 282 DPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKD 341
Query: 340 AFELISRTKSFSLEN-----------------------------LFEKQTGLVKRE--TR 368
+ S SF ++ K G+ K +
Sbjct: 342 FYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLG 401
Query: 369 FTSQRPPNEIMSKIEEAAKPLGFNVRKGN-YKMKLQGDKTGRKGQLSVATEVFEVAPTLH 427
SQ PN+IM+++ A K L + + N Y ++++ ++ ++++V +
Sbjct: 402 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTY 461
Query: 428 IVEVRKTGGDTLEF 441
+++ R + LE
Sbjct: 462 LLDFRSIDDEILEV 475
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 478 bits (1232), Expect = e-170
Identities = 124/298 (41%), Positives = 182/298 (61%), Gaps = 29/298 (9%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
R ++G Y LG TLG G+F KVK ++ TG VA+KI++R ++ +V +IKREI +
Sbjct: 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
KL +HP++IK+ +V+++ T ++V+E++ GGELFD I KHGR++E EARR FQQ+++AVD
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
YCH V HRDLKPEN+LLD++ KI+DFGLS + + + L T+CG+PNY APEV+
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVI 182
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247
+ + Y G D+WSCGVIL+ L+ G LPFD+ ++ L++K
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK-------------------- 222
Query: 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 305
I F P + + L+ +L +P R TI + E EWFK+ F
Sbjct: 223 ------IRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-168
Identities = 127/353 (35%), Positives = 194/353 (54%), Gaps = 39/353 (11%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
+ S+ +G Y + TLGEGSF KVK A + +T VA+K + R + + M +++REI
Sbjct: 1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
S +KL++HP++IK+ +V+ + T I +V+E+ GGELFD I + R+ EDE RR+FQQ+I
Sbjct: 61 SYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
A++YCH + HRDLKPENLLLD +KI+DFGLS I + + L T+CG+PNY AP
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAP 176
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244
EV+N K Y G DVWSCG++L+V++ G LPFD+ + L++K
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------------- 219
Query: 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
+ + P + S GA+ LI+R++ +P R+TI ++ D WF
Sbjct: 220 ---------VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYL 270
Query: 305 FDKEEEVN-------LDDVDAIFNDSKENLVT--EKKEKPVSMNAFELISRTK 348
EE + + S++ +V E A+ L+ +
Sbjct: 271 RPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEALRSDENNEVKEAYNLLHENQ 323
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 472 bits (1218), Expect = e-168
Identities = 105/293 (35%), Positives = 151/293 (51%), Gaps = 31/293 (10%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
V ++L +TLGEG++ +V+ A N T + VA+KIVD + + E IK+EI K++
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
H NV+K Y+ LE+ GGELFD+I + E +A+R+F QL+ V Y H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
G+ HRD+KPENLLLD LKISDFGL+ + + + LL+ CGT YVAPE+L +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
+ DVWSCG++L ++AG LP+D+ S+ Y
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----------------------- 220
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301
W S L+ +IL NP R+TI + +D W+ K K
Sbjct: 221 ---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 475 bits (1224), Expect = e-167
Identities = 108/367 (29%), Positives = 171/367 (46%), Gaps = 37/367 (10%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+Y+ + +G G+F + ++ T + VA+K ++R + E ++REI + +
Sbjct: 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSL 73
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+HPN+++ EV+ + T + I++E+ GGEL+++I GR EDEAR +FQQL++ V YCH
Sbjct: 74 RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 131 SRGVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
S + HRDLK EN LLD LKI DFG S S + GTP Y+APEVL
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLL 190
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248
+ YDG+ +DVWSCGV L+V++ G PF++ YRK
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ------------------ 232
Query: 249 SYTLQICRADFSCPS--WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFD 306
+I +S P S LI RI +P TR++I ++ WF K +
Sbjct: 233 ----RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMN 288
Query: 307 KEEEV-NLDDVDAIFNDSKENL-VTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVK 364
+ + + + + + P N T + L++ + +
Sbjct: 289 ESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDS--E 346
Query: 365 RETRFTS 371
E S
Sbjct: 347 SEIDIDS 353
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 472 bits (1218), Expect = e-167
Identities = 105/318 (33%), Positives = 151/318 (47%), Gaps = 31/318 (9%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
V ++L +TLGEG++ +V+ A N T + VA+KIVD + + E IK+EI K++
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
H NV+K Y+ LE+ GGELFD+I + E +A+R+F QL+ V Y H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
G+ HRD+KPENLLLD LKISDFGL+ + + + LL+ CGT YVAPE+L +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
+ DVWSCG++L ++AG LP+D+ S+ Y
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----------------------- 220
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
W S L+ +IL NP R+TI + +D W+ K K
Sbjct: 221 ---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPR 277
Query: 309 EEVNLDDVDAIFNDSKEN 326
Sbjct: 278 VTSGGVSESPSGFSKHIQ 295
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 471 bits (1214), Expect = e-167
Identities = 94/313 (30%), Positives = 154/313 (49%), Gaps = 33/313 (10%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE-QIKREISTMKL 69
+GKY +G LGEGS+ KVK + ET A+KI+ + ++ R E +K+EI ++
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 70 IKHPNVIKIIEVM--ASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINA 125
++H NVI++++V+ K K+Y+V+E+ G E+ D + R +A YF QLI+
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDG 121
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
++Y HS+G+ H+D+KP NLLL + G LKIS G++ D T+ G+P + PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 186 VLND-KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244
+ N + G D+WS GV L+ + G PF+ N+ L+
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN----------------- 224
Query: 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
I + ++ P L+K +L+ P R +I Q+ + WF+K + P
Sbjct: 225 ---------IGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE 275
Query: 305 FDKEEEVNLDDVD 317
+ D D
Sbjct: 276 APVPIPPSPDTKD 288
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 451 bits (1163), Expect = e-159
Identities = 94/307 (30%), Positives = 144/307 (46%), Gaps = 32/307 (10%)
Query: 2 SVKVPASRT---RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE 58
+ ++P +Y GR LG+G FAK + +T + A KIV + +L+ E
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 59 QIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY 118
++ EIS + + H +V+ +++VLE L + + L E EAR Y
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
+Q++ Y H V HRDLK NL L+ +KI DFGL+ + + CGT
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGT 178
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238
PNY+APEVL+ KG+ DVWS G I++ L+ G PF+ S L Y +
Sbjct: 179 PNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLR----------- 226
Query: 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
I + ++S P + A LI+++L +P R TI+++L DE+F
Sbjct: 227 ---------------IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271
Query: 299 GYKPPHF 305
GY P
Sbjct: 272 GYIPARL 278
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 450 bits (1160), Expect = e-158
Identities = 93/293 (31%), Positives = 140/293 (47%), Gaps = 29/293 (9%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+Y GR LG+G FAK + +T + A KIV + +L+ E++ EIS + +
Sbjct: 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 98
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
H +V+ +++VLE L + + L E EAR Y +Q++ Y H
Sbjct: 99 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 158
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
V HRDLK NL L+ +KI DFGL+ + + CGTPNY+APEVL+ K
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKK 216
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
G+ DVWS G I++ L+ G PF+ S L Y +
Sbjct: 217 GHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLR----------------------- 252
Query: 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303
I + ++S P + A LI+++L +P R TI+++L DE+F GY P
Sbjct: 253 ---IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 442 bits (1140), Expect = e-156
Identities = 90/300 (30%), Positives = 150/300 (50%), Gaps = 30/300 (10%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
++ +++G LG+GSFA V A+++ TG VAIK++D+ + + MV++++ E+
Sbjct: 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVD 127
+KHP+++++ +Y+VLE GE+ + E+EAR + Q+I +
Sbjct: 67 QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
Y HS G+ HRDL NLLL +KI+DFGL+ + +T CGTPNY++PE+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIA 184
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247
+ G SDVWS G + + L+ G PFD + K
Sbjct: 185 TRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-------------------- 223
Query: 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDK 307
+ AD+ PS+ S AK LI ++L NP R+++S +L+ + + D+
Sbjct: 224 ------VVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 440 bits (1135), Expect = e-154
Identities = 122/328 (37%), Positives = 184/328 (56%), Gaps = 30/328 (9%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
+ +G Y L +T+G+G+FAKVK A+++ TG VAIKI+D+ Q L ++++ RE+
Sbjct: 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVR 66
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
MK++ HPN++K+ EV+ ++ +Y+++E+ GGE+FD + HGR+KE EAR F+Q+++A
Sbjct: 67 IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 126
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
V YCH + + HRDLK ENLLLD+ +KI+DFG S + G L CG P Y APE
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDAFCGAPPYAAPE 183
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245
+ K YDG DVWS GVIL+ L++G LPFD NL L +
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER------------------ 225
Query: 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 305
+ R + P + S+ + L+KR L NP R T+ Q+++D W G++
Sbjct: 226 --------VLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 277
Query: 306 DKEEEVNLDDVDAIFNDSKENLVTEKKE 333
E LD D D + ++E
Sbjct: 278 KPFVEPELDISDQKRIDIMVGMGYSQEE 305
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 438 bits (1129), Expect = e-154
Identities = 93/326 (28%), Positives = 158/326 (48%), Gaps = 58/326 (17%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK------ 55
S ++ +Y L +G+GS+ VK A N + A+K++ + +++R
Sbjct: 2 SSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 56 -----------------MVEQIKREISTMKLIKHPNVIKIIEVM--ASKTKIYIVLEFID 96
+EQ+ +EI+ +K + HPNV+K++EV+ ++ +Y+V E ++
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVN 121
Query: 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156
G + + + L ED+AR YFQ LI ++Y H + + HRD+KP NLL+ G +KI+D
Sbjct: 122 QGPVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFL 214
FG+S + D LL GTP ++APE L++ K + G+A DVW+ GV L+ + G
Sbjct: 181 FGVSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
Query: 215 PFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW--FSSGAKKL 272
PF + +M L+ K I P + K L
Sbjct: 239 PFMDERIMCLHSK--------------------------IKSQALEFPDQPDIAEDLKDL 272
Query: 273 IKRILDPNPDTRMTISQMLEDEWFKK 298
I R+LD NP++R+ + ++ W +
Sbjct: 273 ITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 436 bits (1124), Expect = e-153
Identities = 91/309 (29%), Positives = 160/309 (51%), Gaps = 34/309 (11%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
++P + + +++GR LG+G F V A+ + +A+K++ + Q+ + + Q++RE
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
I ++HPN++++ + +IY++LEF GEL+ ++ KHGR E + + ++L
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA 124
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
+A+ YCH R V HRD+KPENLL+ G LKI+DFG S + +R T CGT +Y+
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLP 180
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243
PE++ K +D + D+W GV+ + + G PFD + +R+
Sbjct: 181 PEMIEGKTHDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHRR---------------- 223
Query: 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK-- 301
I D P + S G+K LI ++L +P R+ + ++E W K +
Sbjct: 224 ----------IVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273
Query: 302 -PPHFDKEE 309
PP + +
Sbjct: 274 LPPVYQSTQ 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 428 bits (1102), Expect = e-150
Identities = 88/305 (28%), Positives = 155/305 (50%), Gaps = 31/305 (10%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
+ + +E+GR LG+G F V A+ ++ +A+K++ + Q+ + + Q++RE+
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
++HPN++++ T++Y++LE+ G ++ ++ K + E Y +L NA
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
+ YCHS+ V HRD+KPENLLL S G LKI+DFG S + R CGT +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245
++ + +D + D+WS GV+ + + G PF+ + Y++
Sbjct: 178 MIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKR------------------ 218
Query: 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 305
I R +F+ P + + GA+ LI R+L NP R + ++LE W P
Sbjct: 219 --------ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270
Query: 306 DKEEE 310
+ +E
Sbjct: 271 CQNKE 275
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 422 bits (1087), Expect = e-147
Identities = 87/346 (25%), Positives = 146/346 (42%), Gaps = 42/346 (12%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE-----QI 60
KY LG G+F V A + E V +K + +++VL +E ++
Sbjct: 17 ACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF-IDGGELFDKIAKHGRLKEDEARRYF 119
EI+ + ++H N+IK++++ ++ +V+E G +LF I +H RL E A F
Sbjct: 77 TLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
+QL++AV Y + + HRD+K EN+++ +K+ DFG +A + L +T CGT
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFCGTI 193
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE 239
Y APEVL Y G ++WS GV L+ L+ PF E +
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEE------------ 235
Query: 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299
A P S L+ +L P P+ R T+ +++ D W +
Sbjct: 236 --------------TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281
Query: 300 YKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELIS 345
+ EE ++ ++ + L + A EL
Sbjct: 282 VNLADYTWEEVFRVNKPESGVLSAAS-LEMGNRSLSDVAQAQELCG 326
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 414 bits (1067), Expect = e-144
Identities = 83/311 (26%), Positives = 139/311 (44%), Gaps = 45/311 (14%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ---IKREIS 65
+Y LG LG+G F V + VAIK++ R++VL + E++
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 66 TMKLI----KHPNVIKIIEVMASKTKIYIVLEF-IDGGELFDKIAKHGRLKEDEARRYFQ 120
+ + HP VI++++ ++ +VLE + +LFD I + G L E +R +F
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTP 179
Q++ A+ +CHSRGV HRD+K EN+L+D G K+ DFG A+ D GT
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYTDFDGTR 202
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE 239
Y PE ++ Y + VWS G++L+ ++ G +PF+
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------------- 243
Query: 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299
+I A+ P+ S LI+R L P P +R ++ ++L D W +
Sbjct: 244 -------------EILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290
Query: 300 YKPPHFDKEEE 310
+ + +
Sbjct: 291 AEDVPLNPSKG 301
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 410 bits (1057), Expect = e-143
Identities = 82/317 (25%), Positives = 136/317 (42%), Gaps = 43/317 (13%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMV---EQIKR 62
+Y++G LG G F V V VAIK V++D++ + ++
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 63 EISTMKLIKH--PNVIKIIEVMASKTKIYIVLEFIDG-GELFDKIAKHGRLKEDEARRYF 119
E+ +K + VI++++ ++LE + +LFD I + G L+E+ AR +F
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGT 178
Q++ AV +CH+ GV HRD+K EN+L+D G LK+ DFG A+ + D + GT
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGT 211
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238
Y PE + Y GR++ VWS G++L+ ++ G +PF+
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------------ 253
Query: 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
+I R SS + LI+ L P R T ++ W +
Sbjct: 254 --------------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299
Query: 299 GYKPPHFDKEEEVNLDD 315
P + +L
Sbjct: 300 VLLPQETAEIHLHSLSP 316
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-135
Identities = 65/336 (19%), Positives = 136/336 (40%), Gaps = 38/336 (11%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK----- 55
++ V + Y + RTL +G F K+ + + F A+K ++ + + +
Sbjct: 19 LNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKS 76
Query: 56 ---------MVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAK 106
+ K E+ + IK+ + ++ + ++YI+ E+++ +
Sbjct: 77 NNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY 136
Query: 107 HGRLK--------EDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDF 157
L + + ++N+ Y H+ + + HRD+KP N+L+D G +K+SDF
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDF 196
Query: 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPF 216
G S D + + GT ++ PE +++ Y+G D+WS G+ L+V+ +PF
Sbjct: 197 GESEY----MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252
Query: 217 -DESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKR 275
+ +L+ L+ + + + ++ S+ +K
Sbjct: 253 SLKISLVELFNNI-------RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL 305
Query: 276 ILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 311
L NP R+T L+ EW + +E+
Sbjct: 306 FLRKNPAERITSEDALKHEWLADTNIEDLREFSKEL 341
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 347 bits (890), Expect = e-113
Identities = 93/446 (20%), Positives = 163/446 (36%), Gaps = 35/446 (7%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
G +E+ LG G F V + +TG+ VAIK ++ L K E+ EI MK +
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL 69
Query: 71 KHPNVIKIIEVMASKTKI------YIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQ 121
HPNV+ EV K+ + +E+ +GG+L + + LKE R
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGT 178
+ +A+ Y H + HRDLKPEN++L + KI D G + + + L GT
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEFVGT 186
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTFHFLSVY 237
Y+APE+L K Y D WS G + F + GF PF + + KV +
Sbjct: 187 LQYLAPELLEQKKYTVTV-DYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
K+S L + ++ ++ +L + R T Q F+
Sbjct: 246 VYDDLTGAVKFSSVLPTPN---HLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
Query: 298 KGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAF-ELISRTKSFSLEN-L 355
+ + + ++ N + T + ++ + + E
Sbjct: 303 AL---------DSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQE 353
Query: 356 FEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSV 415
+ +GL + +Q + + + L F + + SV
Sbjct: 354 LLQASGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRK--TVYEPQISLPAHPESV 411
Query: 416 ATEVFEVAPTLHIVEVRKTGGDTLEF 441
+ + + L +R+ G +
Sbjct: 412 SIVLQDPKRPLTYTHLRRVWGQIWQT 437
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-108
Identities = 105/305 (34%), Positives = 155/305 (50%), Gaps = 41/305 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMK 68
+Y + +TLG G+ +VK A +T VAIKI+ + + ++ EI +K
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
+ HP +IKI ++ YIVLE ++GGELFDK+ + RLKE + YF Q++ AV Y
Sbjct: 71 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 129 CHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
H G+ HRDLKPEN+LL S ++KI+DFG S I + E L+ T CGTP Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 186
Query: 186 VLNDKGYD--GRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTFHFLSVYGESYK 242
VL G RA D WS GVILF+ ++G+ PF + ++L ++++ +
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY--------- 237
Query: 243 KCTNKYSYTLQICRADFSCPSWF--SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300
+F W S A L+K++L +P R T + L W +
Sbjct: 238 ---------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282
Query: 301 KPPHF 305
F
Sbjct: 283 MKRKF 287
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-107
Identities = 73/324 (22%), Positives = 130/324 (40%), Gaps = 62/324 (19%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E LG+G+F +V A+N + AIK + + + + I E+ + + H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQ 62
Query: 74 NVIKIIEV-------------MASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYF 119
V++ + K+ ++I +E+ + G L+D I + DE R F
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ------------VR 167
+Q++ A+ Y HS+G+ HRDLKP N+ +D +KI DFGL+ +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227
L +A GT YVA EVL+ G+ D++S G+I F ++ + + +K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKK 240
Query: 228 VSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWF----SSGAKKLIKRILDPNPDT 283
+ P F KK+I+ ++D +P+
Sbjct: 241 --------------------------LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNK 274
Query: 284 RMTISQMLEDEWFKKGYKPPHFDK 307
R +L W ++ +
Sbjct: 275 RPGARTLLNSGWLPVKHQDEVIKE 298
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-104
Identities = 103/298 (34%), Positives = 154/298 (51%), Gaps = 41/298 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMK 68
+Y + +TLG G+ +VK A +T VAI+I+ + + ++ EI +K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
+ HP +IKI ++ YIVLE ++GGELFDK+ + RLKE + YF Q++ AV Y
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 129 CHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
H G+ HRDLKPEN+LL S ++KI+DFG S I + E L+ T CGTP Y+APE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 311
Query: 186 VLNDKGYD--GRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTFHFLSVYGESYK 242
VL G RA D WS GVILF+ ++G+ PF + ++L ++++ +
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY--------- 362
Query: 243 KCTNKYSYTLQICRADFSCPSWF--SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
+F W S A L+K++L +P R T + L W +
Sbjct: 363 ---------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-104
Identities = 64/312 (20%), Positives = 121/312 (38%), Gaps = 28/312 (8%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ L LG+G+ A V ++ +TGD AIK+ + L + V+ RE +K + H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKN 68
Query: 75 VIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYC 129
++K+ + T +++EF G L+ + + L E E + ++ +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 130 HSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
G+ HR++KP N++ D V K++DFG + + +D + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPD 185
Query: 186 VL--------NDKGYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKVSTFHF 233
+ + K Y D+WS GV + G LPF + K+ T
Sbjct: 186 MYERAVLRKDHQKKYGATV-DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293
K ++ + + S ++ IL+ + + Q +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSC-SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 294 EWFKKGYKPPHF 305
H
Sbjct: 304 TSDILHRGNSHH 315
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-104
Identities = 90/305 (29%), Positives = 156/305 (51%), Gaps = 35/305 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y++ LG+G+F+ V+ + TG A KI++ + L + ++++RE + ++HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 65
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++++ + + ++ Y+V + + GGELF+ I E +A QQ++ ++ YCHS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HR+LKPENLLL S +K++DFGL+ V + H GTP Y++PEVL
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y + D+W+CGVIL++L+ G+ PF + + LY ++ +
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY----------------- 224
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK-PPHFDK 307
D+ P W + AK LI +L NP R+T Q L+ W + +
Sbjct: 225 -------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHR 277
Query: 308 EEEVN 312
++ V+
Sbjct: 278 QDTVD 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-103
Identities = 68/303 (22%), Positives = 128/303 (42%), Gaps = 43/303 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y + + +G G +KV N E AIK V+ ++ ++ ++ + EI+ + ++
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 86
Query: 74 N--VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
+ +I++ + + IY+V+E +L + K + E + Y++ ++ AV H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
G+ H DLKP N L+ G+LK+ DFG++ Q + + GT NY+ PE + D
Sbjct: 146 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 192 YD----------GRASDVWSCGVILFVLMAGFLPFDE--SNLMALYRKVSTFHFLSVYGE 239
SDVWS G IL+ + G PF + + + L+ + H
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH------- 257
Query: 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299
+ P + ++K L +P R++I ++L + +
Sbjct: 258 ------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
Query: 300 YKP 302
P
Sbjct: 300 THP 302
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-103
Identities = 100/295 (33%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y L T+G GS+ +VK A T A K + + V + V++ K+EI MK + HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHP 66
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N+I++ E T IY+V+E GGELF+++ +E +A R + +++AV YCH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
V HRDLKPEN L + LK+ DFGL+A + ++ T GTP YV+P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVLE-G 182
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y G D WS GV+++VL+ G+ PF + K+ F
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF----------------- 224
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303
F W S A+ LI+R+L +P R+T Q LE EWF+K
Sbjct: 225 -------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-102
Identities = 71/361 (19%), Positives = 138/361 (38%), Gaps = 29/361 (8%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ L LG+G+ A V ++ +TGD AIK+ + L + V+ RE +K + H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKN 68
Query: 75 VIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYC 129
++K+ + T +++EF G L+ + + L E E + ++ +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 130 HSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
G+ HR++KP N++ D V K++DFG + + +D + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPD 185
Query: 186 VL--------NDKGYDGRASDVWSCGVILFVLMAGFLPFDE----SNLMALYRKVSTFHF 233
+ + K Y G D+WS GV + G LPF + K+ T
Sbjct: 186 MYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293
K ++ + + S ++ IL+ + + Q +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSC-SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 294 EWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTE-KKEKPVSMNAFELISRTKSFSL 352
H +++ + ++ K+ + + ELI + L
Sbjct: 304 TSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVL 363
Query: 353 E 353
E
Sbjct: 364 E 364
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 308 bits (790), Expect = e-102
Identities = 92/299 (30%), Positives = 146/299 (48%), Gaps = 42/299 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-----HKMVEQIKREISTMK 68
KY+ +G G + V+ + TG A+KI++ ++ E +RE ++
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 69 -LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
+ HP++I +I+ S + +++V + + GELFD + + L E E R + L+ AV
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
+ H+ + HRDLKPEN+LLD +++SDFG S + L CGTP Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLRELCGTPGYLAPEIL 271
Query: 188 ------NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241
GY G+ D+W+CGVILF L+AG PF + + R + +
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY-------- 322
Query: 242 KKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
FS P W SS K LI R+L +P+ R+T Q L+ +F++
Sbjct: 323 ----------------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 304 bits (782), Expect = e-101
Identities = 87/309 (28%), Positives = 140/309 (45%), Gaps = 45/309 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDR------DQVLRHKMVEQIKREISTM 67
YE LG G + V+ + T A+KI+D ++ E +E+ +
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 68 KLIK-HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
+ + HPN+I++ + + T ++V + + GELFD + + L E E R+ + L+ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
H + HRDLKPEN+LLD +K++DFG S + L CGTP+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYLAPEI 194
Query: 187 L------NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240
+ N GY G+ D+WS GVI++ L+AG PF M + R + + ++
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY------- 246
Query: 241 YKKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
F P W +S K L+ R L P R T + L +F++
Sbjct: 247 -----------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
Query: 299 GYKP--PHF 305
HF
Sbjct: 290 YVVEEVRHF 298
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-100
Identities = 76/369 (20%), Positives = 146/369 (39%), Gaps = 49/369 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y + + +G G +KV N E AIK V+ ++ ++ ++ + EI+ + ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 67
Query: 74 N--VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
+ +I++ + + IY+V+E +L + K + E + Y++ ++ AV H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
G+ H DLKP N L+ G+LK+ DFG++ Q + + GT NY+ PE + D
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 192 YD----------GRASDVWSCGVILFVLMAGFLPFDE--SNLMALYRKVSTFHFLSVYGE 239
SDVWS G IL+ + G PF + + + L+ + H
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH------- 238
Query: 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299
+ P + ++K L +P R++I ++L + +
Sbjct: 239 ------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280
Query: 300 YKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQ 359
P ++ + +++ + LV + A L N +
Sbjct: 281 THPV--NQMAKGTTEEMKYVLG----QLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSK 334
Query: 360 TGLVKRETR 368
T KR +
Sbjct: 335 TFEKKRGKK 343
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-100
Identities = 75/370 (20%), Positives = 145/370 (39%), Gaps = 49/370 (13%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
Y + + +G G +KV N E AIK V+ ++ ++ ++ + EI+ + ++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQ 113
Query: 73 PN--VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+ +I++ + + IY+V+E +L + K + E + Y++ ++ AV H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
G+ H DLKP N L+ G+LK+ DFG++ Q + + G NY+ PE + D
Sbjct: 173 QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 191 GYD----------GRASDVWSCGVILFVLMAGFLPFDE--SNLMALYRKVSTFHFLSVYG 238
SDVWS G IL+ + G PF + + + L+ + H
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH------ 285
Query: 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
+ P + ++K L +P R++I ++L + +
Sbjct: 286 -------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326
Query: 299 GYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEK 358
P ++ + +++ + LV + A L N
Sbjct: 327 QTHP--VNQMAKGTTEEMKYVLG----QLVGLNSPNSILKAAKTLYEHYSGGESHNSSSS 380
Query: 359 QTGLVKRETR 368
+T KR +
Sbjct: 381 KTFEKKRGKK 390
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-100
Identities = 89/303 (29%), Positives = 153/303 (50%), Gaps = 34/303 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y++ LG+G+F+ V+ + TG A KI++ + L + ++++RE + ++HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 88
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++++ + + ++ Y+V + + GGELF+ I E +A QQ++ ++ YCHS G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HR+LKPENLLL S +K++DFGL+ V + H GTP Y++PEVL
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y + D+W+CGVIL++L+ G+ PF + + LY ++ +
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY----------------- 247
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
D+ P W + AK LI +L NP R+T Q L+ W +
Sbjct: 248 -------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHR 300
Query: 309 EEV 311
++
Sbjct: 301 QDT 303
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-100
Identities = 99/290 (34%), Positives = 150/290 (51%), Gaps = 35/290 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y + LG+GSF +V K+ T A+K++++ ++K I RE+ +K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++K+ E++ + YIV E GGELFD+I K R E +A R +Q+ + + Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPEN+LL+S +KI DFGLS +++ + GT Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y DVWS GVIL++L++G PF N + ++V T +
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY----------------- 239
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
F P W S AK LI+++L +P R+T +Q LE W +K
Sbjct: 240 -------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = e-100
Identities = 99/296 (33%), Positives = 148/296 (50%), Gaps = 37/296 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ LG G+F++V K TG A+K + + R +E EI+ +K IKH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHE 66
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ + ++ S T Y+V++ + GGELFD+I + G E +A QQ+++AV Y H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPENLL + + I+DFGLS + ++G++ TACGTP YVAPEVL K
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAPEVLAQK 182
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y +A D WS GVI ++L+ G+ PF E L+ K+ ++
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY----------------- 224
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
+F P W S AK I +L+ +P+ R T + L W
Sbjct: 225 -------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHR 273
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = e-100
Identities = 90/294 (30%), Positives = 146/294 (49%), Gaps = 39/294 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ R LG G+F V + +G IK +++D+ +EQI+ EI +K + HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHP 80
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKI----AKHGRLKEDEARRYFQQLINAVDYC 129
N+IKI EV +YIV+E +GGEL ++I A+ L E +Q++NA+ Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 130 HSRGVFHRDLKPENLLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
HS+ V H+DLKPEN+L + +KI DFGL+ + + D A GT Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEV 197
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246
+ D+WS GV+++ L+ G LPF ++L + +K +
Sbjct: 198 FK-RDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP------------- 242
Query: 247 KYSYTLQICRADFSCPSWF-SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299
+++ + A L+K++L +P+ R + +Q+L EWFK+
Sbjct: 243 -----------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 1e-96
Identities = 92/303 (30%), Positives = 153/303 (50%), Gaps = 33/303 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y+L LG+G+F+ V+ V G A I++ ++ ++++RE +L+KHP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHP 70
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++++ + ++ + Y++ + + GGELF+ I E +A QQ++ AV +CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
V HR+LKPENLLL S +K++DFGL+ + E GTP Y++PEVL
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKD 188
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y G+ D+W+CGVIL++L+ G+ PF + + LY+++ Y
Sbjct: 189 PY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI---------------KAGAY-- 230
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
DF P W + AK LI ++L NP R+T ++ L+ W
Sbjct: 231 -------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHR 283
Query: 309 EEV 311
+E
Sbjct: 284 QET 286
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 5e-96
Identities = 97/291 (33%), Positives = 146/291 (50%), Gaps = 39/291 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E+ LG G+ + V K T A+K++ + + ++ EI + + HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLSHP 108
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N+IK+ E+ + T+I +VLE + GGELFD+I + G E +A +Q++ AV Y H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 134 VFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPENLL + LKI+DFGLS I V L+ T CGTP Y APE+L
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249
Y G D+WS G+I ++L+ GF PF DE ++R++ +
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY---------------- 268
Query: 250 YTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
F P W S AK L+++++ +P R+T Q L+ W
Sbjct: 269 --------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 6e-95
Identities = 95/294 (32%), Positives = 151/294 (51%), Gaps = 37/294 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---RHKMVEQIKREISTMKLI 70
YE+G LG G FA V+ + TG A K + + ++ R E+I+RE++ ++ I
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+HPN+I + ++ +KT + ++LE + GGELFD +A+ L EDEA ++ +Q+++ V Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 131 SRGVFHRDLKPENLLLDSYGV----LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
S+ + H DLKPEN++L V +K+ DFG++ + GTP +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEI 182
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246
+N + G +D+WS GVI ++L++G PF +S
Sbjct: 183 VNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISA---------------- 225
Query: 247 KYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
DF + S AK I+R+L +P RMTI+Q LE W K
Sbjct: 226 --------VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 7e-95
Identities = 96/302 (31%), Positives = 152/302 (50%), Gaps = 41/302 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIK 71
YEL +G+G F+ V+ N ETG A+KIVD + E +KRE S ++K
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLK----EDEARRYFQQLINAVD 127
HP++++++E +S +Y+V EF+DG +L +I K E A Y +Q++ A+
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 128 YCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDG-LLHTACGTPNYVA 183
YCH + HRD+KP +LL S +K+ FG++ Q+ E G + GTP+++A
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMA 201
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243
PEV+ + Y G+ DVW CGVILF+L++G LPF + L+ +
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGI--------------- 244
Query: 244 CTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301
KY + W S AK L++R+L +P R+T+ + L W K+ +
Sbjct: 245 IKGKY---------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295
Query: 302 PP 303
Sbjct: 296 YA 297
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 2e-94
Identities = 99/290 (34%), Positives = 150/290 (51%), Gaps = 35/290 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y + LG+GSF +V K+ T A+K++++ ++K I RE+ +K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++K+ E++ + YIV E GGELFD+I K R E +A R +Q+ + + Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 134 VFHRDLKPENLLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPEN+LL+S +KI DFGLS +++ + GT Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y DVWS GVIL++L++G PF N + ++V T +
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY----------------- 239
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
F P W S AK LI+++L +P R+T +Q LE W +K
Sbjct: 240 -------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 1e-93
Identities = 107/351 (30%), Positives = 172/351 (49%), Gaps = 40/351 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y+ R LG+GSF +V K+ TG A+K++ + QV + E + RE+ +K + HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++K+ E K Y+V E GGELFD+I R E +A R +Q+++ + Y H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 134 VFHRDLKPENLLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPENLLL+S ++I DFGLS + GT Y+APEVL+
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDKIGTAYYIAPEVLH-G 202
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y DVWS GVIL++L++G PF+ +N + +KV +
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY----------------- 244
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
F P W S AK LI+++L P R++ L+ EW + + ++
Sbjct: 245 -------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT-----YTKEQ 292
Query: 309 EEVNLDDVDAIFNDSKENLVTEK-KEKPVSMNAFELISRTKSFSLENLFEK 358
V++ +D + ++ T+K + + +L S+ ++ L +F K
Sbjct: 293 ISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHK 343
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 2e-93
Identities = 89/308 (28%), Positives = 142/308 (46%), Gaps = 44/308 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKH 72
YE+ +G GS++ K + T A+KI+D+ + EI + + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQH 75
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
PN+I + +V +Y+V E + GGEL DKI + E EA + V+Y H++
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 133 GVFHRDLKPENLLL----DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
GV HRDLKP N+L + ++I DFG + + E+GLL T C T N+VAPEVL
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVLE 193
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFD---ESNLMALYRKVSTFHFLSVYGESYKKCT 245
+GYD A D+WS GV+L+ ++ G+ PF + + ++ + F
Sbjct: 194 RQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF------------ 240
Query: 246 NKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303
S W S AK L+ ++L +P R+T + +L W + P
Sbjct: 241 ------------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
Query: 304 HFDKEEEV 311
+ +
Sbjct: 289 QYQLNRQD 296
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 3e-93
Identities = 90/334 (26%), Positives = 141/334 (42%), Gaps = 73/334 (21%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--LRHKMVEQIKREISTMKLIK 71
KY L +G+GS+ V+ A +T AIKI++++++ + K VE+IK E+ MK +
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR---------------------- 109
HPN+ ++ EV + I +V+E GG L DK+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 110 ------------------LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS--Y 149
+E +Q+ +A+ Y H++G+ HRD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 150 GVLKISDFGLSAI--SQQVREDGLLHTACGTPNYVAPEVLNDKGYD-GRASDVWSCGVIL 206
+K+ DFGLS E + T GTP +VAPEVLN G D WS GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 207 FVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW-- 264
+L+ G +PF N +V + F P++
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLN------------------------KKLCFENPNYNV 302
Query: 265 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
S A+ L+ +L+ N D R + L+ W +
Sbjct: 303 LSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 4e-93
Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 37/307 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---RHKMVEQIKREISTMKLI 70
Y++G LG G FA VK + TG A K + + Q R E+I+RE+S ++ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
H NVI + +V ++T + ++LE + GGELFD +A+ L E+EA + +Q+++ V+Y H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 131 SRGVFHRDLKPENLLLDS----YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
++ + H DLKPEN++L +K+ DFGL+ + + GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEI 189
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246
+N + G +D+WS GVI ++L++G PF +++
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITS---------------- 232
Query: 247 KYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
DF + S AK I+++L R+TI + L W
Sbjct: 233 --------VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284
Query: 305 FDKEEEV 311
+ E V
Sbjct: 285 MVRRESV 291
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 5e-93
Identities = 98/306 (32%), Positives = 146/306 (47%), Gaps = 37/306 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKM---VEQIKREISTMKLI 70
Y+ G LG G FA VK + TG A K + + + + E I+RE+S +K I
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+HPNVI + EV +KT + ++LE + GGELFD +A+ L E+EA + +Q++N V Y H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 131 SRGVFHRDLKPENLLLDSY----GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
S + H DLKPEN++L +KI DFGL+ + GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAPEI 188
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246
+N + G +D+WS GVI ++L++G PF VS
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA---------------- 231
Query: 247 KYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
+F + S+ AK I+R+L +P RMTI L+ W K
Sbjct: 232 --------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283
Query: 305 FDKEEE 310
++
Sbjct: 284 LSRKAS 289
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 5e-92
Identities = 110/391 (28%), Positives = 175/391 (44%), Gaps = 54/391 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y+ + LG G++ +V ++ T AIKI+ + + ++ E++ +KL+ HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDHP 96
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++K+ + K Y+V+E GGELFD+I + E +A +Q+++ V Y H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 134 VFHRDLKPENLLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPENLLL+S ++KI DFGLSA+ + GT Y+APEVL K
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVLR-K 212
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y DVWS GVILF+L+AG+ PF + RKV +
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY----------------- 254
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
F P W S GAK LIK++L + R++ Q LE W K+ E
Sbjct: 255 -------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307
Query: 309 EEVNLDDVDAI--FNDSK-----------ENLVTEKKEKPVSMNAFELISRTKS--FSLE 353
+ ++ + F +S+ L ++ +E + F I + +
Sbjct: 308 LPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQ-EETKELTDIFRHIDKNGDGQLDRQ 366
Query: 354 NLFEKQTGLVKRETRFTSQRPPNEIMSKIEE 384
L + G K + +I S+++
Sbjct: 367 ELID---GYSKLSGEEVAVFDLPQIESEVDA 394
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 6e-92
Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 37/307 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---RHKMVEQIKREISTMKLI 70
Y++G LG G FA VK + TG A K + + Q R E+I+RE+S ++ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
HPN+I + +V ++T + ++LE + GGELFD +A+ L E+EA + +Q+++ V+Y H
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 131 SRGVFHRDLKPENLLLDS----YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
++ + H DLKPEN++L +K+ DFGL+ + + GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEI 189
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246
+N + G +D+WS GVI ++L++G PF ++
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITA---------------- 232
Query: 247 KYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
DF + S AK I+++L R+TI + L W
Sbjct: 233 --------VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQA 284
Query: 305 FDKEEEV 311
+ E V
Sbjct: 285 MVRRESV 291
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 3e-91
Identities = 94/302 (31%), Positives = 154/302 (50%), Gaps = 41/302 (13%)
Query: 14 KYELG---RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
Y+L + LGEGSF+ + + ++ A+KI+ + +M ++EI+ +KL
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLC 62
Query: 71 K-HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ HPN++K+ EV + ++V+E ++GGELF++I K E EA ++L++AV +
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 130 HSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
H GV HRDLKPENLL +KI DFG + + ++ L T C T +Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTFHFLSVYGESYKKCT 245
LN GYD + D+WS GVIL+ +++G +PF + V
Sbjct: 181 LNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK------------- 226
Query: 246 NKYSYTLQICRA--DFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301
+I + F +W S AK LI+ +L +P+ R+ +S + +EW + G +
Sbjct: 227 -------KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279
Query: 302 PP 303
Sbjct: 280 LS 281
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 5e-91
Identities = 97/306 (31%), Positives = 145/306 (47%), Gaps = 44/306 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKM----------VEQIKRE 63
Y R LG G++ +V K AIK++ + Q + + E+I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
IS +K + HPN+IK+ +V K Y+V EF +GGELF++I + E +A +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
+ + Y H + HRD+KPEN+LL++ +KI DFGLS+ +D L GT
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTAY 213
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240
Y+APEVL K Y DVWSCGVI+++L+ G+ PF N + +KV +
Sbjct: 214 YIAPEVLK-KKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY------- 264
Query: 241 YKKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
F W S AK+LIK +L + + R T + L W KK
Sbjct: 265 -----------------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307
Query: 299 GYKPPH 304
+
Sbjct: 308 YANNIN 313
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 1e-89
Identities = 89/303 (29%), Positives = 145/303 (47%), Gaps = 30/303 (9%)
Query: 14 KYELGR-TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIK 71
Y+L LGEG+ A+V+ N+ T A+KI+++ + ++ RE+ +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQG 69
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
H NV+++IE + + Y+V E + GG + I K E EA Q + +A+D+ H+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 132 RGVFHRDLKPENLLLDSYG---VLKISDFGLSAI-----SQQVREDGLLHTACGTPNYVA 183
+G+ HRDLKPEN+L + +KI DF L + L T CG+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 184 PEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238
PEV+ YD R D+WS GVIL++L++G+ PF G
Sbjct: 190 PEVVEAFSEEASIYDKRC-DLWSLGVILYILLSGYPPFVGRC---------GSDCGWDRG 239
Query: 239 ESYKKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296
E+ C N ++Q + +F W S AK LI ++L + R++ +Q+L+ W
Sbjct: 240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299
Query: 297 KKG 299
+
Sbjct: 300 QGC 302
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 2e-89
Identities = 85/310 (27%), Positives = 135/310 (43%), Gaps = 38/310 (12%)
Query: 14 KYEL-GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
Y L + LG G FA V+ + TG A K + + + +I EI+ ++L K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKS 87
Query: 73 -PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYC 129
P VI + EV + ++I ++LE+ GGE+F + E++ R +Q++ V Y
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 130 HSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
H + H DLKP+N+LL G +KI DFG+S + L GTP Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLAPEI 204
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246
LN A+D+W+ G+I ++L+ PF + Y +S
Sbjct: 205 LNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ---------------- 247
Query: 247 KYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
D+S ++ S A I+ +L NP+ R T L W ++
Sbjct: 248 --------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299
Query: 305 FDKEEEVNLD 314
F EE +
Sbjct: 300 FHPEETSSSS 309
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 4e-89
Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 37/295 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY + LG G F V + K V + +K+EIS + + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSR 132
N++ + E S ++ ++ EFI G ++F++I L E E Y Q+ A+ + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 133 GVFHRDLKPENLLLDSY--GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ H D++PEN++ + +KI +FG ++Q++ P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQ---ARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
A+D+WS G +++VL++G PF + + +
Sbjct: 179 VV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY----------------- 220
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303
F ++ S A + R+L +RMT S+ L+ W K+ +
Sbjct: 221 -------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 8e-89
Identities = 92/325 (28%), Positives = 152/325 (46%), Gaps = 46/325 (14%)
Query: 14 KYELGR-TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIK 71
Y+L + LG G KV + TG A+K++ + ++E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDHHWQASG 80
Query: 72 HPNVIKIIEV----MASKTKIYIVLEFIDGGELFDKIAKHGRLK--EDEARRYFQQLINA 125
P+++ I++V K + I++E ++GGELF +I + G E EA + + A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
+ + HS + HRD+KPENLL S VLK++DFG + + L T C TP YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYV 196
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242
APEVL + YD ++ D+WS GVI+++L+ GF PF Y + +
Sbjct: 197 APEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPF--------------------YSNTGQ 235
Query: 243 KCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300
+ +++ + F P W S AK+LI+ +L +P R+TI+Q + W +
Sbjct: 236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295
Query: 301 KPPHFDKEEEVNLDDVDAIFNDSKE 325
P L + +++ KE
Sbjct: 296 VVPQTPLHTARVLQEDKDHWDEVKE 320
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 2e-88
Identities = 97/374 (25%), Positives = 163/374 (43%), Gaps = 54/374 (14%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKHP 73
+ LG G KV N T + A+K++ + +RE+ + P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115
Query: 74 NVIKIIEV----MASKTKIYIVLEFIDGGELFDKIAKHGRLK--EDEARRYFQQLINAVD 127
++++I++V A + + IV+E +DGGELF +I G E EA + + A+
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 128 YCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
Y HS + HRD+KPENLL S +LK++DFG +++ L T C TP YVAP
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKETTSHNSLTTPCYTPYYVAP 232
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244
EVL + YD ++ D+WS GVI+++L+ G+ PF Y
Sbjct: 233 EVLGPEKYD-KSCDMWSLGVIMYILLCGYPPF--------------------YSNHGLAI 271
Query: 245 TNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
+ +++ + +F P W S K LI+ +L P RMTI++ + W + K
Sbjct: 272 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331
Query: 303 PHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFE-KQTG 361
P + L + + + KE+ S A + + ++ + +
Sbjct: 332 P------QTPLHTSRVL--KEDKERWEDVKEEMTSALATMRVDY-EQIKIKKIEDASNPL 382
Query: 362 LVKRETRFTSQRPP 375
L+KR + +
Sbjct: 383 LLKRRKKARALEAA 396
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 275 bits (704), Expect = 2e-86
Identities = 91/386 (23%), Positives = 156/386 (40%), Gaps = 47/386 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y++ LG G+F V TG+ A K V E +++EI TM +++HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHP 214
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSR 132
++ + + ++ ++ EF+ GGELF+K+ +H ++ EDEA Y +Q+ + + H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 133 GVFHRDLKPENLLLDSYGV--LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
H DLKPEN++ + LK+ DFGL + + + GT + APEV K
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGL---TAHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
G +D+WS GV+ ++L++G PF N R V + +
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW----------------- 373
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
+ ++ S K I+++L +P+TRMTI Q LE W G P +
Sbjct: 374 -------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426
Query: 309 EEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETR 368
++++ T+ P + IS S + R+
Sbjct: 427 PSSRY-------TKIRDSIKTKYDAWPEPLPPLGRISNYSSLRK----HRPQEYSIRDAF 475
Query: 369 FTSQRPPNEIMSKIEEAAKPLGFNVR 394
+ + K G +
Sbjct: 476 WDRSEAQPRFIVKPYGTEVGEGQSAN 501
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 2e-86
Identities = 85/359 (23%), Positives = 147/359 (40%), Gaps = 47/359 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y++ LG G+F V TG K ++ L +K EIS M + HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHP 108
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSR 132
+I + + K ++ ++LEF+ GGELFD+IA ++ E E Y +Q + + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 133 GVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ H D+KPEN++ ++ +KI DFGL+ + D ++ T + APE+++ +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
G +D+W+ GV+ +VL++G PF + + + V +
Sbjct: 226 PV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW----------------- 267
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
+F ++ S AK IK +L P R+T+ LE W K +
Sbjct: 268 -------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320
Query: 309 EEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRET 367
N ++ + + + P A I R +FS Q +
Sbjct: 321 SSRY--------NKIRQKIKEKYADWPAPQPA---IGRIANFSSLRKHRPQEYQIYDSY 368
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 3e-86
Identities = 48/331 (14%), Positives = 103/331 (31%), Gaps = 79/331 (23%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
R G LG+ A + ETG+ + + + ++Q+K E+ ++L+
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 71 ----------------------KHPNVIKIIEVMASKTKIYIVLEFI-----------DG 97
K P K+I V + ++++ F G
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 98 GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157
L + H L + Q+I + H G+ H L+P +++LD G + ++ F
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLND----------KGYDGRASDVWSCGVILF 207
DG + + + PE+ + + D W+ G++++
Sbjct: 251 EHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 208 VLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSS 267
+ LP + + + F
Sbjct: 305 WIWCADLPITKDAALGGSEWI------------------------------FRSCKNIPQ 334
Query: 268 GAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
+ L++ L + R+ Q +E +++
Sbjct: 335 PVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 2e-85
Identities = 84/306 (27%), Positives = 140/306 (45%), Gaps = 38/306 (12%)
Query: 14 KYELGRT--LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
Y + +T LG G F +V + TG +A KI+ + K E++K EIS M +
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLD 144
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCH 130
H N+I++ + SK I +V+E++DGGELFD+I + L E + + +Q+ + + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 131 SRGVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
+ H DLKPEN+L + +KI DFGL +++ + L GTP ++APEV+N
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGL---ARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248
+D+WS GVI ++L++G PF N + +
Sbjct: 262 YDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW--------------- 305
Query: 249 SYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFD 306
D + S AK+ I ++L R++ S+ L+ W
Sbjct: 306 ---------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLS 356
Query: 307 KEEEVN 312
+++ N
Sbjct: 357 AQKKKN 362
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 6e-85
Identities = 71/309 (22%), Positives = 122/309 (39%), Gaps = 47/309 (15%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y + LGEG F+ V + + G F A+K + + E+ +RE +L HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHRLFNHP 86
Query: 74 NVIKIIEV----MASKTKIYIVLEFIDGGELFDKI----AKHGRLKEDEARRYFQQLINA 125
N+++++ +K + +++L F G L+++I K L ED+ +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI-------SQQVREDGLLHTACGT 178
++ H++G HRDLKP N+LL G + D G S+Q T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 179 PNYVAPEVLNDKGYD--GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSV 236
+Y APE+ + + + +DVWS G +L+ +M G P+D
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-------------- 252
Query: 237 YGESYKKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDE 294
G+S + S P SS +L+ ++ +P R I +L
Sbjct: 253 -GDSVAL----------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
Query: 295 WFKKGYKPP 303
+ P
Sbjct: 302 EALQPPAPG 310
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 5e-83
Identities = 75/318 (23%), Positives = 129/318 (40%), Gaps = 60/318 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKH 72
+ + R L EG FA V A++V +G A+K + + I +E+ MK L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL---SNEEEKNRAIIQEVCFMKKLSGH 85
Query: 73 PNVIKII-------EVMASKTKIYIVLEFIDGGELFDKIAK---HGRLKEDEARRYFQQL 122
PN+++ E + +++L + G+L + + K G L D + F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 123 INAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSAI-------SQQVREDGLLH 173
AV + H + + HRDLK ENLLL + G +K+ DFG + S + L+
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 174 ---TACGTPNYVAPEVLN--DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
T TP Y PE+++ G D+W+ G IL++L PF++ +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----- 260
Query: 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMT 286
I +S P + LI+ +L NP+ R++
Sbjct: 261 -------------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLS 295
Query: 287 ISQMLEDEWFKKGYKPPH 304
I++++ + +
Sbjct: 296 IAEVVHQLQEIAAARNVN 313
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 1e-81
Identities = 82/307 (26%), Positives = 139/307 (45%), Gaps = 42/307 (13%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
+R YE+ T+G GS+ + + + G + K +D + + + E++ ++
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRE 61
Query: 70 IKHPNVIKIIE--VMASKTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLI 123
+KHPN+++ + + + T +YIV+E+ +GG+L I K + L E+ R QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 124 NAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
A+ CH R V HRDLKP N+ LD +K+ DFGL+ I + T GT
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGT 179
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238
P Y++PE +N Y+ + SD+WS G +L+ L A PF + L K
Sbjct: 180 PYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGK----------- 227
Query: 239 ESYKKCTNKYSYTLQICRADFSC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
I F P +S ++I R+L+ R ++ ++LE+
Sbjct: 228 ---------------IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272
Query: 298 KGYKPPH 304
+ + H
Sbjct: 273 EHHHHHH 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 9e-81
Identities = 79/303 (26%), Positives = 141/303 (46%), Gaps = 36/303 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY + +GEGSF K K+ E G IK ++ + + K E+ +RE++ + +KHP
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKI--AKHGRLKEDEARRYFQQLINAVDYCHS 131
N+++ E +YIV+++ +GG+LF +I K +ED+ +F Q+ A+ + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
R + HRD+K +N+ L G +++ DFG++ + L GTP Y++PE+ +K
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKP 201
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
Y+ SD+W+ G +L+ L F+ ++ L K
Sbjct: 202 YN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK------------------------ 236
Query: 252 LQICRADFSC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG---YKPPHFDK 307
I F +S + L+ ++ NP R +++ +LE + K + P
Sbjct: 237 --IISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIA 294
Query: 308 EEE 310
EE
Sbjct: 295 EEF 297
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 3e-79
Identities = 78/270 (28%), Positives = 136/270 (50%), Gaps = 27/270 (10%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
++ G+ LGEGSF+ V A+ + T AIKI+++ +++ V + RE M + HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+K+ K+Y L + GEL I K G E R Y ++++A++Y H +G+
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
HRDLKPEN+LL+ ++I+DFG + + + ++ GT YV+PE+L +K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-C 210
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254
++SD+W+ G I++ L+AG PF N +++K I
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK--------------------------I 244
Query: 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTR 284
+ ++ P F A+ L++++L + R
Sbjct: 245 IKLEYDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 6e-78
Identities = 78/338 (23%), Positives = 120/338 (35%), Gaps = 68/338 (20%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKH 72
+ LG GS V F G VA+K + D + EI + + H
Sbjct: 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDH 68
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINA 125
PNVI+ + +YI LE L D + KE +Q+ +
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGV-------------LKISDFGLSAI--SQQVREDG 170
V + HS + HRDLKP+N+L+ + + ISDFGL S Q
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 171 LLHTACGTPNYVAPEVLNDKGYD------GRASDVWSCGVILFVLM-AGFLPFDESNLMA 223
L+ GT + APE+L + R+ D++S G + + ++ G PF +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK---- 243
Query: 224 LYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNP 281
Y +S + C + A LI +++D +P
Sbjct: 244 -------------YSRESNIIRGIFSLD------EMKCLHDRSLIAEATDLISQMIDHDP 284
Query: 282 DTRMTISQMLEDEWFKKGYKPPHF-----DKEEEVNLD 314
R T ++L F K F D+ E N D
Sbjct: 285 LKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRD 322
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 1e-76
Identities = 80/312 (25%), Positives = 140/312 (44%), Gaps = 37/312 (11%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
+ + + + +G G F++V A + G VA+K V ++ K +EI
Sbjct: 25 DMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEID 84
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQ 121
+K + HPNVIK ++ IVLE D G+L I + + E +YF Q
Sbjct: 85 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY 181
L +A+++ HSR V HRD+KP N+ + + GV+K+ D GL + H+ GTP Y
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYY 202
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKVSTFHFLSVYGE 239
++PE +++ GY+ SD+WS G +L+ + A PF D+ NL +L +K
Sbjct: 203 MSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK------------ 249
Query: 240 SYKKCTNKYSYTLQICRADFSC--PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
I + D+ +S ++L+ ++P+P+ R ++ + +
Sbjct: 250 --------------IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
Query: 298 KGYKPPHFDKEE 309
+
Sbjct: 296 HACTASSLEHHH 307
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 5e-76
Identities = 69/303 (22%), Positives = 118/303 (38%), Gaps = 61/303 (20%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
++ +G G F +V AK+ G IK V + E+ +RE+ + + H N
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVN 65
Query: 75 VIKIIE----------------VMASKTKIYIVLEFIDGGELFDKI--AKHGRLKEDEAR 116
++ + ++I +EF D G L I + +L + A
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 117 RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176
F+Q+ VDY HS+ + +RDLKP N+ L +KI DFGL ++ DG +
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKRTRSK 182
Query: 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVSTFHFLS 235
GT Y++PE ++ + Y + D+++ G+IL +L F+ S R
Sbjct: 183 GTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG------- 234
Query: 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295
F K L++++L P+ R S++L
Sbjct: 235 ------------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270
Query: 296 FKK 298
K
Sbjct: 271 VWK 273
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 7e-75
Identities = 46/318 (14%), Positives = 87/318 (27%), Gaps = 55/318 (17%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
K +L L G + V ++VE + A+K+ +E++ +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 74 NVIKIIEVM--------------------------ASKTKIYIVLEFIDG-----GELFD 102
+ + + + +++ D
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 103 KIAKHGRLKEDEARRYF-QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161
+ + A QLI S+G+ H P+NL + G L + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL- 241
Query: 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLPFDESN 220
+ + Y E LN A + W G+ ++ + FLPF
Sbjct: 242 ----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL-- 295
Query: 221 LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPN 280
T + + S F + K LI R L+ +
Sbjct: 296 --------VTPGIKGSWKRPSLRVPGTDSL-------AFGSCTPLPDFVKTLIGRFLNFD 340
Query: 281 PDTRMTISQMLEDEWFKK 298
R+ + +E F +
Sbjct: 341 RRRRLLPLEAMETPEFLQ 358
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 7e-75
Identities = 83/327 (25%), Positives = 137/327 (41%), Gaps = 65/327 (19%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHP 73
+ LG G KV N T + A+K++ + +RE+ + + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 74 NVIKIIEV----MASKTKIYIVLEFIDGGELFDKIAKHGRLK--EDEARRYFQQLINAVD 127
++++I++V A + + IV+E +DGGELF +I G E EA + + A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 128 YCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
Y HS + HRD+KPENLL S +LK++DFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244
E + YD ++ D+WS GVI+++L+ G+ PF Y
Sbjct: 169 ETTG-EKYD-KSCDMWSLGVIMYILLCGYPPF--------------------YSNHGLAI 206
Query: 245 TNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
+ +++ + +F P W S K LI+ +L P RMTI++ + W + K
Sbjct: 207 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266
Query: 303 PHFDKEEEVNLDDVDAIFNDSKENLVT 329
P L + + D KE + +
Sbjct: 267 PQTPLHTSRVLKEDKERWEDVKEEMTS 293
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 1e-74
Identities = 64/317 (20%), Positives = 119/317 (37%), Gaps = 50/317 (15%)
Query: 8 SRTRVGK--YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
S VGK + LG G+ + + + + VA+K + + RE+
Sbjct: 17 SVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQ 69
Query: 66 TMK-LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLI 123
++ +HPNVI+ + YI +E L + + K E QQ
Sbjct: 70 LLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTT 128
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYG-----VLKISDFGLSA-ISQQVREDGLLHTACG 177
+ + + HS + HRDLKP N+L+ ISDFGL ++ G
Sbjct: 129 SGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 178 TPNYVAPEVLNDKGYD--GRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFL 234
T ++APE+L++ + D++S G + + +++ G PF +S
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--------- 239
Query: 235 SVYGESYKKCTNKYSYTLQICRADFSCPSWF---SSGAKKLIKRILDPNPDTRMTISQML 291
+ + C A++LI++++ +P R + +L
Sbjct: 240 -----------------ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282
Query: 292 EDEWFKKGYKPPHFDKE 308
+ +F K F ++
Sbjct: 283 KHPFFWSLEKQLQFFQD 299
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-72
Identities = 66/315 (20%), Positives = 115/315 (36%), Gaps = 55/315 (17%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E + LG G F V AKN AIK + R E++ RE+ + ++HP
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHP 63
Query: 74 NVIKIIEV------------MASKTKIYIVLEFIDGGELFDKIAKHGRLK---EDEARRY 118
+++ + K +YI ++ L D + ++
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI----------SQQVRE 168
F Q+ AV++ HS+G+ HRDLKP N+ V+K+ DFGL +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
GT Y++PE ++ Y D++S G+ILF L+ F + + V
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLYPF--STQMERVRTLTDV 240
Query: 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 288
K+ + +++ +L P+P R
Sbjct: 241 ---------------RNLKFP----------PLFTQKYPCEYVMVQDMLSPSPMERPEAI 275
Query: 289 QMLEDEWFKKGYKPP 303
++E+ F+ P
Sbjct: 276 NIIENAVFEDLDFPG 290
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 233 bits (594), Expect = 3e-72
Identities = 49/333 (14%), Positives = 101/333 (30%), Gaps = 70/333 (21%)
Query: 3 VKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR 62
R R G LG+ A + ETG+ + + + ++Q+K
Sbjct: 70 ESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 127
Query: 63 EISTMKL----------------------IKHPNVIKIIEVMASKTKIYIVLEFID---- 96
E+ ++L +K P K+I V + ++++ F
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187
Query: 97 -------GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149
G L + H L + Q+I + H G+ H L+P +++LD
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 247
Query: 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD----GRASDVWSCGVI 205
G + ++ F + + P A +L + A D W+ G+
Sbjct: 248 GGVFLTGFEH-LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 206 LFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWF 265
++ + LP + + + F
Sbjct: 307 IYWIWCADLPNTDDAALGGSEWI------------------------------FRSCKNI 336
Query: 266 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
+ L++ L + R+ Q +E +++
Sbjct: 337 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 4e-72
Identities = 98/342 (28%), Positives = 169/342 (49%), Gaps = 66/342 (19%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+++ RTLG GSF +V ++ G + A+K++ ++ V+R K VE E + ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+I++ +I++++++I+GGELF + K R A+ Y ++ A++Y HS+ +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RDLKPEN+LLD G +KI+DFG + + +T CGTP+Y+APEV++ K Y
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY-N 181
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254
++ D WS G++++ ++AG+ PF +SN M Y K I
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK--------------------------I 215
Query: 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE-----WFK---------KGY 300
A+ P +F+ K L+ R++ + R+ Q ++ WFK +
Sbjct: 216 LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 275
Query: 301 KPP-------------HFDK--EEEVNL-----DDVDAIFND 322
+ P FDK EE++N D +F D
Sbjct: 276 ETPYEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLFRD 317
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 5e-72
Identities = 94/339 (27%), Positives = 160/339 (47%), Gaps = 63/339 (18%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
++ +TLG GSF +V K+ E+G+ A+KI+D+ +V++ K +E E ++ + P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++K+ + +Y+V+E++ GGE+F + + GR E AR Y Q++ +Y HS +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RDLKPENLL+D G ++++DFG + R G T CGTP +APE++ KGY
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGY-N 216
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254
+A D W+ GV+++ + AG+ PF + +Y K I
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK--------------------------I 250
Query: 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE-----WFK---------KGY 300
PS FSS K L++ +L + R + ++ WF +
Sbjct: 251 VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV 310
Query: 301 KPP------------HFDK--EEEVNL---DDVDAIFND 322
+ P +FD EEE+ + + F +
Sbjct: 311 EAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFTE 349
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 7e-71
Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 36/287 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
++ LG GS+ +V ++ E G A+K ++ S K+ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSR 132
+++ + +Y+ E G L G L E + Y + + A+ + HS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
G+ H D+KP N+ L G K+ DFGL ++ G G P Y+APE+L Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SY 232
Query: 193 DGRASDVWSCGVILFVLMAGF-LPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
A+DV+S G+ + + LP L +
Sbjct: 233 G-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQG------------------------ 267
Query: 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
+F + SS + ++ +L+P+P R T +L ++
Sbjct: 268 --YLPPEF--TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 7e-64
Identities = 76/327 (23%), Positives = 150/327 (45%), Gaps = 57/327 (17%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
E+ R +G+GSF KV + +T A+K +++ + + V + +E+ M+ ++HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVF 135
+ + + +++V++ + GG+L + ++ KE+ + + +L+ A+DY ++ +
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 136 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK---GY 192
HRD+KP+N+LLD +G + I+DF ++A+ + + + T GT Y+APE+ + + GY
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAM---LPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 193 DGRASDVWSCGVILFVLMAGFLPF---DESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249
A D WS GV + L+ G P+ ++ +
Sbjct: 195 -SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---------------------- 231
Query: 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-TISQMLEDEWFK---------KG 299
+ PS +S L+K++L+PNPD R +S + + K
Sbjct: 232 ----FETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKR 287
Query: 300 YKPP--------HFDKE---EEVNLDD 315
P + D EE+ L+
Sbjct: 288 LIPGFIPNKGRLNCDPTFELEEMILES 314
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-63
Identities = 42/312 (13%), Positives = 96/312 (30%), Gaps = 58/312 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ LGEG+FA+V A + + +K+ + Q+ +K
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER---LK 122
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-----LKEDEARRYFQQLI 123
+K + +V E G L + I + + + + +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 124 NAVDYCHSRGVFHRDLKPENLLL-----------DSYGVLKISDFGLSAISQQVREDGLL 172
++ H + H D+KP+N +L D L + D G S + + +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH 232
C T + E+L++K ++ D + ++ ++ G ++ +
Sbjct: 243 TAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE----- 296
Query: 233 FLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
+ R W + +L+ + +L
Sbjct: 297 --------------------GLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLR 331
Query: 293 ---DEWFKKGYK 301
+ F++ Y
Sbjct: 332 QKLKKVFQQHYT 343
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 7e-62
Identities = 92/345 (26%), Positives = 153/345 (44%), Gaps = 58/345 (16%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
++ + LG+G+F KV + TG + A+KI+ ++ ++ V E ++ +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+ + + ++ V+E+ +GGELF +++ E+ AR Y ++++A++Y HSR V
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RD+K ENL+LD G +KI+DFGL + + + + T CGTP Y+APEVL D Y G
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254
RA D W GV+++ +M G LPF + L+ I
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL--------------------------I 217
Query: 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE-----WFK---------KGY 300
+ P S AK L+ +L +P R+ E +F K
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 277
Query: 301 KPP------------HFDKE---EEVNLDDVDAIFNDSKENLVTE 330
PP +FD E + + + D + L
Sbjct: 278 LPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQR 322
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-61
Identities = 89/333 (26%), Positives = 152/333 (45%), Gaps = 54/333 (16%)
Query: 1 MSVKVPASRTRVG--KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE 58
++ + P+ + ++ + L + LG+GSF KV A+ +T F AIK + +D VL VE
Sbjct: 3 LNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE 62
Query: 59 QIKREISTMKL-IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARR 117
E + L +HP + + +K ++ V+E+++GG+L I + A
Sbjct: 63 CTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF 122
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
Y ++I + + HS+G+ +RDLK +N+LLD G +KI+DFG+ + + D +T CG
Sbjct: 123 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCG 180
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237
TP+Y+APE+L + Y + D WS GV+L+ ++ G PF + L+
Sbjct: 181 TPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS---------- 229
Query: 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-TISQMLEDEWF 296
I + P W AK L+ ++ P+ R+ + + F
Sbjct: 230 ----------------IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
Query: 297 K---------KGYKPP------------HFDKE 308
+ K PP +FDKE
Sbjct: 274 REINWEELERKEIDPPFRPKVKSPFDCSNFDKE 306
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-61
Identities = 89/331 (26%), Positives = 147/331 (44%), Gaps = 57/331 (17%)
Query: 6 PASRTRVG--KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
P+S + + +G+GSF KV A++ F A+K++ + +L+ K + I E
Sbjct: 29 PSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE 88
Query: 64 ISTM-KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQL 122
+ + K +KHP ++ + + K+Y VL++I+GGELF + + E AR Y ++
Sbjct: 89 RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI 148
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
+A+ Y HS + +RDLKPEN+LLDS G + ++DFGL + + + T CGTP Y+
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYL 206
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242
APEVL+ + Y R D W G +L+ ++ G PF N +Y
Sbjct: 207 APEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN--------------- 250
Query: 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED----EWFK- 297
I ++ A+ L++ +L + R+ + +F
Sbjct: 251 -----------ILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299
Query: 298 --------KGYKPP------------HFDKE 308
K PP HFD E
Sbjct: 300 INWDDLINKKITPPFNPNVSGPNDLRHFDPE 330
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-61
Identities = 77/271 (28%), Positives = 139/271 (51%), Gaps = 21/271 (7%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHP 73
++L R +G GS+AKV + +T A+K+V ++ V + ++ ++ E + HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++ + ++++++ V+E+++GG+L + + +L E+ AR Y ++ A++Y H RG
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ +RDLK +N+LLDS G +K++D+G+ + +R T CGTPNY+APE+L + Y
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 187
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253
G + D W+ GV++F +MAG PFD +
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-----------DQNTEDYLFQV------ 230
Query: 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTR 284
I P S A ++K L+ +P R
Sbjct: 231 ILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 6e-61
Identities = 89/337 (26%), Positives = 156/337 (46%), Gaps = 59/337 (17%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKV---KFAKNVETGDFVAIKIVDRDQVL-RHKMV 57
SV + R +EL R LG+G + KV + TG A+K++ + ++ K
Sbjct: 6 SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT 65
Query: 58 EQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARR 117
K E + ++ +KHP ++ +I + K+Y++LE++ GGELF ++ + G ED A
Sbjct: 66 AHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF 125
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
Y ++ A+ + H +G+ +RDLKPEN++L+ G +K++DFGL + + + + HT CG
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC--KESIHDGTVTHTFCG 183
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237
T Y+APE+L G+ RA D WS G +++ ++ G PF N K
Sbjct: 184 TIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK---------- 232
Query: 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE--- 294
I + + P + + A+ L+K++L N +R+ E
Sbjct: 233 ----------------ILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276
Query: 295 --WFK---------KGYKPP------------HFDKE 308
+F+ + +PP FD +
Sbjct: 277 HPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSK 313
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-60
Identities = 85/335 (25%), Positives = 155/335 (46%), Gaps = 57/335 (17%)
Query: 2 SVKVPASRTRVG--KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ 59
+R R+ + LG+GSF KV ++ T + A+KI+ +D V++ VE
Sbjct: 7 KFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC 66
Query: 60 IKREISTMKLI-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY 118
E + L K P + ++ + ++Y V+E+++GG+L I + GR KE A Y
Sbjct: 67 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY 126
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
++ + + S+G+ +RDLK +N++LDS G +KI+DFG+ + + + T CGT
Sbjct: 127 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGT 184
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238
P+Y+APE++ + Y G++ D W+ GV+L+ ++AG PF+ + L++
Sbjct: 185 PDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----------- 232
Query: 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE---- 294
I + + P S A + K ++ +P R+ E +
Sbjct: 233 ---------------IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277
Query: 295 -WFK---------KGYKPP-----------HFDKE 308
+F+ K +PP +FD+
Sbjct: 278 AFFRYIDWEKLERKEIQPPYKPKACGRNAENFDRF 312
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-60
Identities = 93/322 (28%), Positives = 154/322 (47%), Gaps = 57/322 (17%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHP 73
+E R LG+GSF KV A+ ETGD A+K++ +D +L+ VE E + L HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+ ++ + +++ V+EF++GG+L I K R E AR Y ++I+A+ + H +G
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ +RDLK +N+LLD G K++DFG+ + + T CGTP+Y+APE+L + Y
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLY- 201
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253
G A D W+ GV+L+ ++ G PF+ N L+
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA-------------------------- 235
Query: 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-TISQMLEDE-----WFK---------K 298
I + P+W A ++K + NP R+ +++Q E +FK +
Sbjct: 236 ILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHR 295
Query: 299 GYKPP------------HFDKE 308
+PP +FD +
Sbjct: 296 QIEPPFRPRIKSREDVSNFDPD 317
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 4e-60
Identities = 76/271 (28%), Positives = 139/271 (51%), Gaps = 21/271 (7%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHP 73
++L R +G GS+AKV + +T A+++V ++ V + ++ ++ E + HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++ + ++++++ V+E+++GG+L + + +L E+ AR Y ++ A++Y H RG
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ +RDLK +N+LLDS G +K++D+G+ + +R T CGTPNY+APE+L + Y
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 230
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253
G + D W+ GV++F +MAG PFD +
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-----------DQNTEDYLFQV------ 273
Query: 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTR 284
I P S A ++K L+ +P R
Sbjct: 274 ILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-60
Identities = 89/339 (26%), Positives = 158/339 (46%), Gaps = 61/339 (17%)
Query: 1 MSVKVPASRTRVG--KYELGRTLGEGSFAKV---KFAKNVETGDFVAIKIVDRDQVLRHK 55
++ V + ++EL + LG+GSF KV K + A+K++ + +
Sbjct: 10 ITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD 69
Query: 56 MVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA 115
V K E + + HP ++K+ ++ K+Y++L+F+ GG+LF +++K E++
Sbjct: 70 RVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV 128
Query: 116 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175
+ Y +L A+D+ HS G+ +RDLKPEN+LLD G +K++DFGLS + + + ++
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSF 186
Query: 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235
CGT Y+APEV+N +G+ +++D WS GV++F ++ G LPF +
Sbjct: 187 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM-------- 237
Query: 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE- 294
I +A P + S A+ L++ + NP R+ +E
Sbjct: 238 ------------------ILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279
Query: 295 ----WFK---------KGYKPP------------HFDKE 308
+F + PP +FD E
Sbjct: 280 KRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDPE 318
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-59
Identities = 90/336 (26%), Positives = 156/336 (46%), Gaps = 56/336 (16%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
K+ R + YE+ + +G G+F +V+ ++ T A+K++ + ++++ E
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
M P V+++ +Y+V+E++ GG+L + + + E AR Y +++
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVV 178
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL--HTACGTPNY 181
A+D HS G HRD+KP+N+LLD G LK++DFG ++ ++G++ TA GTP+Y
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDY 235
Query: 182 VAPEVLNDKGYD---GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238
++PEVL +G D GR D WS GV L+ ++ G PF +L+ Y K+
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI---------- 285
Query: 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEW 295
+K S T F + S AK LI L + + R+ + ++ +
Sbjct: 286 -----MNHKNSLT-------FPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLF 332
Query: 296 FK---------KGYKPP------------HFDKEEE 310
FK + P +FD EE
Sbjct: 333 FKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEE 368
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 4e-59
Identities = 97/337 (28%), Positives = 154/337 (45%), Gaps = 58/337 (17%)
Query: 1 MSVKVPASRTRVGK--YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE 58
M V + + RV +E + LG+G+F KV K TG + A+KI+ ++ ++ V
Sbjct: 134 MEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA 193
Query: 59 QIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY 118
E ++ +HP + + + ++ V+E+ +GGELF +++ ED AR Y
Sbjct: 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 253
Query: 119 FQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
++++A+DY HS + V +RDLK ENL+LD G +KI+DFGL + +++ + T CG
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCG 311
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237
TP Y+APEVL D Y GRA D W GV+++ +M G LPF + L+
Sbjct: 312 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---------- 360
Query: 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE--- 294
I + P AK L+ +L +P R+ E
Sbjct: 361 ----------------ILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404
Query: 295 --WFK---------KGYKPP------------HFDKE 308
+F K PP +FD+E
Sbjct: 405 HRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEE 441
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 1e-58
Identities = 79/340 (23%), Positives = 145/340 (42%), Gaps = 62/340 (18%)
Query: 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
KV R +E+ + +G G+F +V K A+KI+++ ++L+ + E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQL 122
+ + + +Y+V+++ GG+L ++K RL E+ AR Y ++
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL--HTACGTPN 180
+ A+D H HRD+KP+N+L+D G ++++DFG ++ EDG + A GTP+
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPD 241
Query: 181 YVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235
Y++PE+L Y G D WS GV ++ ++ G PF +L+ Y K+
Sbjct: 242 YISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---- 296
Query: 236 VYGESYKKCTNKYSYTLQICRADFSCPSW---FSSGAKKLIKRILDPNPDTRMT---ISQ 289
+ F P+ S AK LI+R++ R+ I
Sbjct: 297 --------------------KERFQFPTQVTDVSENAKDLIRRLICSRE-HRLGQNGIED 335
Query: 290 MLEDEWFK-------KGYKPP------------HFDKEEE 310
+ +F + + P +FD +++
Sbjct: 336 FKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDD 375
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-58
Identities = 80/340 (23%), Positives = 147/340 (43%), Gaps = 56/340 (16%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK 61
V++ R + +E+ + +G G+F++V K +TG A+KI+++ +L+ V +
Sbjct: 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 62 REISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQ 120
E + + ++ + +Y+V+E+ GG+L ++K G R+ + AR Y
Sbjct: 110 EERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA 169
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL--HTACGT 178
+++ A+D H G HRD+KP+N+LLD G ++++DFG ++R DG + A GT
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGT 226
Query: 179 PNYVAPEVLNDKGYD------GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH 232
P+Y++PE+L G G D W+ GV + + G PF + Y K+ +
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY- 285
Query: 233 FLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT---ISQ 289
+ + A+ I+R+L P+TR+
Sbjct: 286 --------------------KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324
Query: 290 MLEDEWFK-------KGYKPP------------HFDKEEE 310
+F + PP +FD E+
Sbjct: 325 FRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVED 364
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 2e-57
Identities = 83/320 (25%), Positives = 151/320 (47%), Gaps = 55/320 (17%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHP 73
+ LG+GSF KV ++ T + A+KI+ +D V++ VE E + L K P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+ ++ + ++Y V+E+++GG+L I + GR KE A Y ++ + + S+G
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ +RDLK +N++LDS G +KI+DFG+ + + + T CGTP+Y+APE++ + Y
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPY- 519
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253
G++ D W+ GV+L+ ++AG PF+ + L++
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-------------------------- 553
Query: 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE-----WFK---------KG 299
I + + P S A + K ++ +P R+ E + +F+ K
Sbjct: 554 IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 613
Query: 300 YKPP-----------HFDKE 308
+PP +FD+
Sbjct: 614 IQPPYKPKASGRNAENFDRF 633
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-57
Identities = 51/310 (16%), Positives = 99/310 (31%), Gaps = 61/310 (19%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
++ +G G F V G AIK + ++ + L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLINAVDYC 129
+V++ A + I E+ +GG L D I+++ R KE E + Q+ + Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 130 HSRGVFHRDLKPENLLLDSYGVL-------------------KISDFGLSAISQQVREDG 170
HS + H D+KP N+ + + KI D G V
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH------VTRIS 185
Query: 171 LLHTACGTPNYVAPEVLN-DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVS 229
G ++A EVL + + +D+++ + + +
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQWH------ 238
Query: 230 TFHFLSVYGESYKKCTNKYSYTLQICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTIS 288
+I + P S +L+K ++ P+P+ R +
Sbjct: 239 -----------------------EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAM 275
Query: 289 QMLEDEWFKK 298
+++
Sbjct: 276 ALVKHSVLLS 285
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-56
Identities = 71/361 (19%), Positives = 123/361 (34%), Gaps = 99/361 (27%)
Query: 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVD-------RDQVLR------ 53
ASR +E + +G G F V AKN AIK + R++V+R
Sbjct: 1 ASRYL-TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA 59
Query: 54 ------------------------------------------HKMVEQIKREISTMKLIK 71
++ +I M
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDE---ARRYFQQLINAVDY 128
N + ++ + K +YI ++ L D + + L++ E F Q+ AV++
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED----------GLLHTACGT 178
HS+G+ HRDLKP N+ V+K+ DFGL Q E+ GT
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238
Y++PE ++ Y D++S G+ILF L+ F E + +
Sbjct: 240 KLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME--RVRIITD----------- 285
Query: 239 ESYKKCTNKYSYTLQICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
+ F + +++ +L P+P R + ++E+ F+
Sbjct: 286 ---------------VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
Query: 298 K 298
Sbjct: 331 N 331
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 8e-56
Identities = 70/352 (19%), Positives = 137/352 (38%), Gaps = 62/352 (17%)
Query: 6 PASRTRVGK--YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
+G+ + R LG G F +V + TG A K +++ ++ + K + E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELF----DKIAKHGRLKEDEARRYF 119
+ + ++ + +KT + +V+ ++GG++ + + +E A Y
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
Q+++ +++ H R + +RDLKPEN+LLD G ++ISD GL+ + GTP
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTP 353
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE 239
++APE+L + Y + D ++ GV L+ ++A PF +++
Sbjct: 354 GFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL----------- 401
Query: 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE----- 294
++ + + P FS +K + +L +P+ R+ D
Sbjct: 402 -KQR----------VLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450
Query: 295 WFK---------KGYKPP-----------------HFDKEEEVNLDDVDAIF 320
F+ PP F + V + D F
Sbjct: 451 LFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTEF 502
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-55
Identities = 84/306 (27%), Positives = 139/306 (45%), Gaps = 42/306 (13%)
Query: 8 SRTRVGKYEL-----GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR 62
S YE LG+G++ V +++ +AIK + + + +
Sbjct: 12 SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHE 68
Query: 63 EISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEA--RRYF 119
EI+ K +KH N+++ + + I I +E + GG L + +K G LK++E Y
Sbjct: 69 EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGT 178
+Q++ + Y H + HRD+K +N+L+++Y GVLKISDFG S + T GT
Sbjct: 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGT 186
Query: 179 PNYVAPEVLN--DKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTFHFLS 235
Y+APE+++ +GY G+A+D+WS G + + G PF + A KV
Sbjct: 187 LQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG------ 239
Query: 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295
K + P S+ AK I + +P+PD R + +L DE+
Sbjct: 240 ---------MFKVHPEI---------PESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281
Query: 296 FKKGYK 301
K K
Sbjct: 282 LKVSSK 287
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-55
Identities = 59/288 (20%), Positives = 104/288 (36%), Gaps = 38/288 (13%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+G GSF +V K+ +TG A+K V + E+ + P
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPR 111
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++ + + + I +E ++GG L I + G L ED A Y Q + ++Y H+R +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 135 FHRDLKPENLLLDSYGVL-KISDFGLSAI---SQQVREDGLLHTACGTPNYVAPEVLNDK 190
H D+K +N+LL S G + DFG + + GT ++APEV+ K
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKVSTFHFLSVYGESYKKCTNKYS 249
D D+WS ++ ++ G P+ + + S
Sbjct: 232 PCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP----------------- 273
Query: 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
P + + I+ L P R + ++
Sbjct: 274 -------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-55
Identities = 78/280 (27%), Positives = 147/280 (52%), Gaps = 39/280 (13%)
Query: 16 ELGRTLGEGSFAKV---KFAKNVETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLIK 71
EL + LG G++ KV + +TG A+K++ + ++ + K E + E ++ I+
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 72 H-PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
P ++ + ++TK++++L++I+GGELF +++ R E E + Y +++ A+++ H
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL--N 188
G+ +RD+K EN+LLDS G + ++DFGLS E + CGT Y+AP+++
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVRGG 235
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPF----DESNLMALYRKVSTFHFLSVYGESYKKC 244
D G+ +A D WS GV+++ L+ G PF ++++ + R+
Sbjct: 236 DSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR----------------- 277
Query: 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTR 284
I +++ P S+ AK LI+R+L +P R
Sbjct: 278 ---------ILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-55
Identities = 78/347 (22%), Positives = 136/347 (39%), Gaps = 61/347 (17%)
Query: 6 PASRTRVGK--YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKRE 63
R V K + R LG+G F +V + TG A K +++ ++ + K E
Sbjct: 175 WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQ 121
++ + V+ + +K + +VL ++GG+L I G+ E A Y +
Sbjct: 235 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY 181
+ ++ H + +RDLKPEN+LLD +G ++ISD GL + V E + GT Y
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL---AVHVPEGQTIKGRVGTVGY 351
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241
+APEV+ ++ Y + D W+ G +L+ ++AG PF + +V
Sbjct: 352 MAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV------------E 398
Query: 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE-----WF 296
+ + FS A+ L ++L +P R+ E F
Sbjct: 399 RL----------VKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 297 K---------KGYKPP--------------HFDKE---EEVNLDDVD 317
K +PP ++ + V L+ D
Sbjct: 449 KKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVELEPTD 495
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-53
Identities = 60/133 (45%), Positives = 94/133 (70%)
Query: 333 EKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFN 392
E P+ MNAFE+I+ ++ +L LF+++ VKR+TRF S+R P+EI++ IE A +GF
Sbjct: 2 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61
Query: 393 VRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGL 452
N+K +L+G + + GQL+V E++EVAP+L +V+VRK G+TLE+HKFYKK S L
Sbjct: 62 SHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKL 121
Query: 453 KDVVWQAEENKEE 465
++++W+A E +
Sbjct: 122 ENIIWRATEGIPK 134
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-53
Identities = 64/295 (21%), Positives = 126/295 (42%), Gaps = 40/295 (13%)
Query: 13 GKYE-LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
G++ +G GSF V + ET VA + ++ + ++ K E +K ++
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 83
Query: 72 HPNVIKII----EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
HPN+++ + K I +V E + G L + + +K R + +Q++ +
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 128 YCHSRG--VFHRDLKPENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
+ H+R + HRDLK +N+ + G +KI D GL+ + + GTP ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAP 199
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTFHFLSVYGESYKK 243
E+ + YD + DV++ G+ + + P+ + N +YR+V++
Sbjct: 200 EMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV----------- 246
Query: 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
S K++I+ + N D R +I +L +F++
Sbjct: 247 -------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-53
Identities = 79/355 (22%), Positives = 138/355 (38%), Gaps = 71/355 (20%)
Query: 4 KVPASRTRVGK--YELGRTLGEGSFAKVKFAKNVETGDFVAIK------IVDRDQVLRHK 55
K + + + R +G G F +V + +TG A+K I +
Sbjct: 178 KNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLA 236
Query: 56 MVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEA 115
+ E + +S + P ++ + + K+ +L+ ++GG+L +++HG E +
Sbjct: 237 LNE--RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM 294
Query: 116 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175
R Y ++I +++ H+R V +RDLKP N+LLD +G ++ISD GL+ H +
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHAS 350
Query: 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235
GT Y+APEVL ++D +S G +LF L+ G PF
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF------------------- 391
Query: 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE- 294
K P FS + L++ +L + + R+ E
Sbjct: 392 -RQHKTKDKHEIDR---MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447
Query: 295 ----WFK---------KGYKPP-----------------HFDKE--EEVNLDDVD 317
+F+ + Y PP FD+E + + L D D
Sbjct: 448 KESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSD 502
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-52
Identities = 85/322 (26%), Positives = 136/322 (42%), Gaps = 52/322 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REISTMKL 69
KYE +GEGS+ V +N +TG VAIK + L + IK REI +K
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVD 127
+KHPN++ ++EV K ++++V E+ D D+ + + E + Q + AV+
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVN 116
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYV---- 182
+CH HRD+KPEN+L+ + V+K+ DFG + ++ + + V
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY----YD-----DEVATRW 167
Query: 183 --APEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKVSTFHFL--- 234
+PE+L D Y G DVW+ G + L++G P S++ LY L
Sbjct: 168 YRSPELLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWPGK-SDVDQLYL---IRKTLGDL 222
Query: 235 ------SVYGESYKKCTNKYSYTLQICRADFS--CPSWFSSGAKKLIKRILDPNPDTRMT 286
Y P+ S A L+K L +P R+T
Sbjct: 223 IPRHQQVFSTNQYFSGVKIPDPE---DMEPLELKFPNI-SYPALGLLKGCLHMDPTERLT 278
Query: 287 ISQMLEDEWFKKGYKPPHFDKE 308
Q+L +F+ + KE
Sbjct: 279 CEQLLHHPYFENIREIEDLAKE 300
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 8e-52
Identities = 87/322 (27%), Positives = 146/322 (45%), Gaps = 48/322 (14%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK-REISTMKLI 70
+ KYE +GEGS+ V +N +TG VAIK KMV++I REI +K +
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQL 81
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
+H N++ ++EV K + Y+V EF+D + + L ++Y Q+IN + +
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGF 139
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYV----- 182
CHS + HRD+KPEN+L+ GV+K+ DFG + ++ + + V
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV----YD-----DEVATRWY 190
Query: 183 -APEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKVST-------- 230
APE+L D Y G+A DVW+ G ++ + G P D S++ LY +
Sbjct: 191 RAPELLVGDVKY-GKAVDVWAIGCLVTEMFMGEPLFPGD-SDIDQLYHIMMCLGNLIPRH 248
Query: 231 ---FHFLSVY-GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT 286
F+ V+ G + + + + L K+ L +PD R
Sbjct: 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLS--------EVVIDLAKKCLHIDPDKRPF 300
Query: 287 ISQMLEDEWFKKGYKPPHFDKE 308
+++L ++F+ F +E
Sbjct: 301 CAELLHHDFFQMDGFAERFSQE 322
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 85/340 (25%), Positives = 146/340 (42%), Gaps = 69/340 (20%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
MSV S T + +Y LGEG++ +V A + T + VAIK + ++ E
Sbjct: 22 MSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI--------RL-EHE 72
Query: 61 K--------REISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKE 112
+ RE+S +K ++H N+I++ V+ +++++ E+ + +L + K+ +
Sbjct: 73 EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM 131
Query: 113 DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-----GVLKISDFGLSAISQQVR 167
+ + QLIN V++CHSR HRDLKP+NLLL VLKI DFGL+ R
Sbjct: 132 RVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------R 185
Query: 168 EDGLLHTACGTPN-----------YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--F 213
A G P Y PE+L + Y + D+WS I ++
Sbjct: 186 -------AFGIPIRQFTHEIITLWYRPPEILLGSRHY-STSVDIWSIACIWAEMLMKTPL 237
Query: 214 LPFDESNLMALYRKVSTFHFLSVYGES----------YKKCTNKYSYTLQICRADFSCPS 263
P D S + L++ F L + ++ +K+ K+ + + +
Sbjct: 238 FPGD-SEIDQLFK---IFEVLGLPDDTTWPGVTALPDWKQSFPKFRG--KTLKRVL--GA 289
Query: 264 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303
L+ +L+ +P R++ LE +F P
Sbjct: 290 LLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 6e-49
Identities = 66/317 (20%), Positives = 121/317 (38%), Gaps = 33/317 (10%)
Query: 13 GKYELGRTLGEG--SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
G YEL +G+G V A+ TG++V ++ ++ + +MV ++ E+ KL
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLF 83
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDY 128
HPN++ + ++++V F+ G D + E Q ++ A+DY
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA-----ISQQVREDGLLHTACGTPNYVA 183
H G HR +K ++L+ G + +S + +Q + +++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 184 PEVL--NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKV------------ 228
PEVL N +GYD ++ D++S G+ L G +PF + L K+
Sbjct: 204 PEVLQQNLQGYDAKS-DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262
Query: 229 -------STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNP 281
+ T FS +++ L NP
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322
Query: 282 DTRMTISQMLEDEWFKK 298
D R + S +L +FK+
Sbjct: 323 DARPSASTLLNHSFFKQ 339
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-49
Identities = 78/295 (26%), Positives = 135/295 (45%), Gaps = 33/295 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ +G+GSF +V + T VAIKI+D ++ +E I++EI+ + P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 81
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
V K TK++I++E++ GG D + + G L E + ++++ +DY HS
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
HRD+K N+LL +G +K++DFG++ Q +T GTP ++APEV+ YD
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253
+A D+WS G+ L G P E + M L+ TL+
Sbjct: 199 KA-DIWSLGITAIELARGEPPHSELHPMKVLF-----------------LIPKNNPPTLE 240
Query: 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
+S K+ ++ L+ P R T ++L+ ++ + K + E
Sbjct: 241 ---------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 286
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 80/330 (24%), Positives = 132/330 (40%), Gaps = 63/330 (19%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK-------- 61
+ +++ LG G++A V N TG +VA+K ++K
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK--------------EVKLDSEEGTP 47
Query: 62 ----REISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGG-----ELFDKIAKHGRLKE 112
REIS MK +KH N++++ +V+ ++ K+ +V EF+D + L+
Sbjct: 48 STAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLEL 107
Query: 113 DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGL 171
+ + + QL+ + +CH + HRDLKP+NLL++ G LK+ DFGL+ A V
Sbjct: 108 NLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN---- 163
Query: 172 LHTACGTPN-----YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMA 223
+ Y AP+VL + Y + D+WSCG IL ++ G P ++
Sbjct: 164 ----TFSSEVVTLWYRAPDVLMGSRTY-STSIDIWSCGCILAEMITGKPLFPGT-NDEEQ 217
Query: 224 LYRKVSTFHFLSVYGES----------YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLI 273
L F + ES Y + +
Sbjct: 218 LKL---IFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFL 274
Query: 274 KRILDPNPDTRMTISQMLEDEWFKKGYKPP 303
+L NPD R++ Q L WF + Y
Sbjct: 275 HGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-48
Identities = 91/332 (27%), Positives = 139/332 (41%), Gaps = 57/332 (17%)
Query: 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
M++ V +R +YE LGEG FA V A++ T VAIK + + +
Sbjct: 1 MALDVK---SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI------KLGHRSEA 51
Query: 61 K--------REISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRL 110
K REI ++ + HPN+I +++ K+ I +V +F++ + L
Sbjct: 52 KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVL 109
Query: 111 KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170
+ Y + ++Y H + HRDLKP NLLLD GVLK++DFGL+
Sbjct: 110 TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA---------- 159
Query: 171 LLHTACGTPN-----------YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPF 216
+ G+PN Y APE+L + Y G D+W+ G IL L+ FLP
Sbjct: 160 ---KSFGSPNRAYTHQVVTRWYRAPELLFGARMY-GVGVDMWAVGCILAELLLRVPFLPG 215
Query: 217 DESNLMALYRKVSTFHFLSVYGES----YKKCTNKYSYTLQICRADFSCPSWFSSGAKKL 272
D S+L L R F L E + ++ S L
Sbjct: 216 D-SDLDQLTR---IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 271
Query: 273 IKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
I+ + NP R+T +Q L+ ++F P
Sbjct: 272 IQGLFLFNPCARITATQALKMKYFSNRPGPTP 303
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-48
Identities = 74/311 (23%), Positives = 129/311 (41%), Gaps = 27/311 (8%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E LG G+ V + +G +A K++ + ++ + QI RE+ + P
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG- 133
++ S +I I +E +DGG L + K GR+ E + +I + Y +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ HRD+KP N+L++S G +K+ DFG+S D + ++ GT +Y++PE L Y
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYS 208
Query: 194 GRASDVWSCGVILFVLMAGFLPF-----DESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248
+ SD+WS G+ L + G P E LM + + + NK+
Sbjct: 209 VQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 249 SYTLQICRADF---------SCPSW----FSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295
+ A F P FS + + + L NP R + Q++ +
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
Query: 296 FKKGYKPPHFD 306
K+ D
Sbjct: 328 IKR-SDAEEVD 337
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-48
Identities = 65/286 (22%), Positives = 123/286 (43%), Gaps = 35/286 (12%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+G+ +G GSF V K + GD VA+K++ + ++ K E+ ++ +H N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWH---GD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++ + + ++ IV ++ +G L+ + A + + + +Q +DY H++
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ HRDLK N+ L +KI DFGL+ + G+ ++APEV+ + +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 194 --GRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
SDV++ G++L+ LM G LP+ +N + V G
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV---------GRGSLS------- 244
Query: 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTR---MTISQMLED 293
+ + +CP K+L+ L D R I +E+
Sbjct: 245 -PDLSKVRSNCPKRM----KRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-47
Identities = 80/298 (26%), Positives = 131/298 (43%), Gaps = 41/298 (13%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ +G GSF V A+ + G VA+KI+ +Q + V + RE++ MK ++HPN
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH---GSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ---QLINAVDYCHS 131
++ + + + IV E++ G L+ + K G ++ + RR + ++Y H+
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 132 RG--VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
R + HR+LK NLL+D +K+ DFGLS + + +A GTP ++APEVL D
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249
+ + SDV+S GVIL+ L P+ N + V
Sbjct: 214 EPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC----------------- 255
Query: 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTR---MTISQMLEDEWFKKGYKPPH 304
L+I P + +I+ P R TI +L K PP+
Sbjct: 256 KRLEI-------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR-PLIKSAVPPPN 305
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-47
Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 57/313 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--------REIS 65
KYE +GEG++ V AKN ET + VA+K V ++ + REI
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV--------RL-DDDDEGVPSSALREIC 53
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLI 123
+K +KH N++++ +V+ S K+ +V EF D + FD +G L + + + QL+
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLL 111
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPN-- 180
+ +CHSR V HRDLKP+NLL++ G LK+++FGL+ A VR C +
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--------CYSAEVV 163
Query: 181 ---YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKVSTFHFL 234
Y P+VL K Y + D+WS G I L P L R F L
Sbjct: 164 TLWYRPPDVLFGAKLY-STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR---IFRLL 219
Query: 235 SVYGES----------YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTR 284
E YK + ++ + L++ +L NP R
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPAT--TSLVNVV---PKLNATGRDLLQNLLKCNPVQR 274
Query: 285 MTISQMLEDEWFK 297
++ + L+ +F
Sbjct: 275 ISAEEALQHPYFS 287
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-47
Identities = 74/294 (25%), Positives = 136/294 (46%), Gaps = 40/294 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ +GEGS V A+ +G VA+K++D + R E + E+ M+ +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHF 102
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
NV+++ + ++++++EF+ GG L D I RL E++ + ++ A+ Y H++G
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+K +++LL G +K+SDFG A Q ++ + GTP ++APEV++ Y
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 194 GRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
D+WS G I+ + M P F +S + A+ R
Sbjct: 220 TEV-DIWSLG-IMVIEMVDGEPPYFSDSPVQAMKR------------------------- 252
Query: 252 LQICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
+ + S + ++R+L +P R T ++L+ + + P
Sbjct: 253 --LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP 304
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-47
Identities = 77/294 (26%), Positives = 134/294 (45%), Gaps = 40/294 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY +G+G+ V A +V TG VAI+ ++ Q + E I EI M+ K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNP 77
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ ++ ++++V+E++ GG L D + + E + ++ + A+++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+K +N+LL G +K++DFG A Q E T GTP ++APEV+ K Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 194 GRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
+ D+WS G I+ + M P +E+ L ALY
Sbjct: 195 PKV-DIWSLG-IMAIEMIEGEPPYLNENPLRALYL------------------------- 227
Query: 252 LQICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
I P S+ + + R L+ + + R + ++L+ ++ K
Sbjct: 228 --IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPL 279
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 76/297 (25%), Positives = 135/297 (45%), Gaps = 33/297 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
YEL +G G+ A V+ A + VAIK ++ ++ ++++ +EI M HPN
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPN 74
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFD--------KIAKHGRLKEDEARRYFQQLINAV 126
++ K ++++V++ + GG + D K G L E ++++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLL--HTACGTPNYVA 183
+Y H G HRD+K N+LL G ++I+DFG+SA ++ T GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 184 PEVL-NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKVSTFHFLSVYGESY 241
PEV+ +GYD +A D+WS G+ L G P+ + M L
Sbjct: 195 PEVMEQVRGYDFKA-DIWSFGITAIELATGAAPYHKYPPMKVLM---------------- 237
Query: 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
+L+ D + +K+I L +P+ R T +++L ++F+K
Sbjct: 238 -LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-46
Identities = 67/317 (21%), Positives = 130/317 (41%), Gaps = 54/317 (17%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
E+G +G+G F +V + + G+ VAI+++D ++ ++ KRE+ + +H N
Sbjct: 36 EIGELIGKGRFGQVYHGRWH---GE-VAIRLIDIER-DNEDQLKAFKREVMAYRQTRHEN 90
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRG 133
V+ + S + I+ G L+ + L ++ R+ Q+++ + Y H++G
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVL--- 187
+ H+DLK +N+ D+ G + I+DFGL + Q R + L G ++APE++
Sbjct: 151 ILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 188 ------NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241
+ + + SDV++ G I + L A PF A+ ++ T ++
Sbjct: 210 SPDTEEDKLPFS-KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL----- 263
Query: 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTR---MTISQMLEDEWFKK 298
+ ++ + R + MLE K
Sbjct: 264 ---------------SQIGMGKEI----SDILLFCWAFEQEERPTFTKLMDMLEK--LPK 302
Query: 299 GYK----PPHFDKEEEV 311
+ P HF K E+
Sbjct: 303 RNRRLSHPGHFWKSAEL 319
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-46
Identities = 71/329 (21%), Positives = 125/329 (37%), Gaps = 76/329 (23%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK------------ 61
Y LGEG++A V K+ T + VA+K +I+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALK--------------EIRLEHEEGAPCTAI 48
Query: 62 REISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYF 119
RE+S +K +KH N++ + +++ ++ + +V E++D + D + + +
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFL 106
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
QL+ + YCH + V HRDLKP+NLL++ G LK++DFGL+ R A P
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA------R-------AKSIP 153
Query: 180 N-----------YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALY 225
Y P++L Y D+W G I + + G P + L+
Sbjct: 154 TKTYDNEVVTLWYRPPDILLGSTDY-STQIDMWGVGCIFYEMATGRPLFPGS-TVEEQLH 211
Query: 226 RKVSTFHFLSVYGES----------YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKR 275
F L E +K Y + + S L+ +
Sbjct: 212 F---IFRILGTPTEETWPGILSNEEFKTYNYP-KYRAEALLSHA---PRLDSDGADLLTK 264
Query: 276 ILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
+L R++ ++ +F + H
Sbjct: 265 LLQFEGRNRISAEDAMKHPFFLSLGERIH 293
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 3e-46
Identities = 81/323 (25%), Positives = 141/323 (43%), Gaps = 68/323 (21%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK------- 61
+ + KY+ +GEG++ V AK+ G VA+K + ++ +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRI--------RL-DAEDEGIPSTA 66
Query: 62 -REISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRY 118
REIS +K + HPN++ +I+V+ S+ + +V EF++ ++ D+ L++ + + Y
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIY 124
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
QL+ V +CH + HRDLKP+NLL++S G LK++DFGL+ R A G
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------R-------AFGI 171
Query: 179 PN-----------YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMAL 224
P Y AP+VL K Y + D+WS G I ++ G P ++ L
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKY-STSVDIWSIGCIFAEMITGKPLFPGV-TDDDQL 229
Query: 225 YRKVSTFHFLSVYGES----------YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIK 274
+ F L +K+ T + + F L+
Sbjct: 230 PK---IFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPW-SSII---PGFCQEGIDLLS 282
Query: 275 RILDPNPDTRMTISQMLEDEWFK 297
+L +P+ R++ + +FK
Sbjct: 283 NMLCFDPNKRISARDAMNHPYFK 305
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 91/318 (28%), Positives = 136/318 (42%), Gaps = 69/318 (21%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--------REIS 65
KY +GEG++ V A+N G+ A+K + ++ E+ REIS
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKI--------RL-EKEDEGIPSTTIREIS 52
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLI 123
+K +KH N++K+ +V+ +K ++ +V E +D +L D G L+ A+ + QL+
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLL 110
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN--- 180
N + YCH R V HRDLKP+NLL++ G LKI+DFGL+ R A G P
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA------R-------AFGIPVRKY 157
Query: 181 --------YVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKVS 229
Y AP+VL K Y D+WS G I ++ G P S L R
Sbjct: 158 THEIVTLWYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGV-SEADQLMR--- 212
Query: 230 TFHFLSVYGES----------YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDP 279
F L Y Y + L+ ++L
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEP--LPWESFL---KGLDESGIDLLSKMLKL 267
Query: 280 NPDTRMTISQMLEDEWFK 297
+P+ R+T Q LE +FK
Sbjct: 268 DPNQRITAKQALEHAYFK 285
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 82/295 (27%), Positives = 134/295 (45%), Gaps = 42/295 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+++ LGEGS+ V A + ETG VAIK V + +++I +EIS M+ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSP 84
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSR 132
+V+K T ++IV+E+ G + D I ++ L EDE Q + ++Y H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
HRD+K N+LL++ G K++DFG++ Q +T GTP ++APEV+ + GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 193 DGRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
+ A D+WS G I + MA P D + A++
Sbjct: 203 NCVA-DIWSLG-ITAIEMAEGKPPYADIHPMRAIF------------------------- 235
Query: 251 TLQICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
I F P +S +K+ L +P+ R T +Q+L+ + +
Sbjct: 236 --MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 81/300 (27%), Positives = 142/300 (47%), Gaps = 45/300 (15%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E+ LG+G+F KV AKN ETG A K+++ +E EI + HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHP 76
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSR 132
++K++ K++I++EF GG + + + L E + + +Q++ A+++ HS+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-----L 187
+ HRDLK N+L+ G ++++DFG+SA + ++ + GTP ++APEV +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKVSTFHFLSVYGESYKKCT 245
D YD +A D+WS G I + MA P + + + L
Sbjct: 195 KDTPYDYKA-DIWSLG-ITLIEMAQIEPPHHELNPMRVLL-------------------- 232
Query: 246 NKYSYTLQICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
+I ++D PS +S + +K LD NP+TR + +Q+LE +
Sbjct: 233 -------KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-45
Identities = 69/288 (23%), Positives = 113/288 (39%), Gaps = 48/288 (16%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
E+ +G G+F V AK VAIK ++ + + E+ + + HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNI 63
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI---NAVDYCHSR 132
+K+ A + +V+E+ +GG L++ + L A + V Y HS
Sbjct: 64 VKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 133 ---GVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
+ HRDLKP NLLL + VLKI DFG + Q + G+ ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFE 176
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248
Y DV+S G+IL+ ++ PFDE A + +
Sbjct: 177 GSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPA----------FRIMWAVHN------ 219
Query: 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTR---MTISQMLED 293
+ + P + L+ R +P R I +++
Sbjct: 220 GTRPPL---IKNLPKPI----ESLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-45
Identities = 62/295 (21%), Positives = 115/295 (38%), Gaps = 47/295 (15%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIV----DRDQVLRHKMVEQIKREISTMKLIK 71
E + +G+G F V + V+ VAIK + + + ++ +RE+ M +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCH 130
HPN++K+ +V+EF+ G+L+ ++ +K R + ++Y
Sbjct: 82 HPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 131 SRG--VFHRDLKPENLLLDSYG-----VLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
++ + HRDL+ N+ L S K++DFGLS S + G ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMA 194
Query: 184 PEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241
PE + + Y +D +S +IL+ ++ G PFDE S +
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE---------YSYGKIKFINMIRE 244
Query: 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTR---MTISQMLED 293
+ I CP + +I+ +P R I + L +
Sbjct: 245 EG------LRPTIPE---DCPPRL----RNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-44
Identities = 81/320 (25%), Positives = 132/320 (41%), Gaps = 51/320 (15%)
Query: 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK----REIST 66
V KYE +G+G+F +V A++ +TG VA+K +VL E REI
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKI 69
Query: 67 MKLIKHPNVIKIIEVMASK--------TKIYIVLEFIDG--GELFDKIAKHGRLKEDEAR 116
++L+KH NV+ +IE+ +K IY+V +F + L + E +
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIK 127
Query: 117 RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTA 175
R Q L+N + Y H + HRD+K N+L+ GVLK++DFGL+ A S +T
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 176 C-GTPNYVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYR----- 226
T Y PE+L ++ Y G D+W G I+ + + + + L
Sbjct: 188 RVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLC 245
Query: 227 ---------KVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRIL 277
V + E Y+K ++ + A LI ++L
Sbjct: 246 GSITPEVWPNVDNY-------ELYEKLELVKGQKRKV-KDRLKAYV-RDPYALDLIDKLL 296
Query: 278 DPNPDTRMTISQMLEDEWFK 297
+P R+ L ++F
Sbjct: 297 VLDPAQRIDSDDALNHDFFW 316
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 62/207 (29%), Positives = 111/207 (53%), Gaps = 6/207 (2%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+Y++ LG G + V A++ VAIK + + + +++ +RE+ + H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
N++ +I+V Y+V+E+I+G L + I HG L D A + Q+++ + + H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC--GTPNYVAPEVLNDK 190
+ HRD+KP+N+L+DS LKI DFG I++ + E L T GT Y +PE +
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFG---IAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFD 217
D +D++S G++L+ ++ G PF+
Sbjct: 188 ATDEC-TDIYSIGIVLYEMLVGEPPFN 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-44
Identities = 52/294 (17%), Positives = 108/294 (36%), Gaps = 55/294 (18%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
L E ++ + G+ + +K++ + + + E +++ HPN
Sbjct: 13 NFLTKLNENHSGELWKGRWQ---GNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 75 VIKIIEVMAS--KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD----- 127
V+ ++ S ++ ++ G L++ + + D+++ + A+D
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA----VKFALDMARGM 124
Query: 128 -YCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
+ H+ + L ++++D +IS + Q P +VAP
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAP 177
Query: 185 EVLNDKGYDG--RASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242
E L K D R++D+WS V+L+ L+ +PF + + M + KV+
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG---------- 227
Query: 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTR---MTISQMLED 293
I P S KL+K ++ +P R I +LE
Sbjct: 228 -------LRPTI-------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 67/302 (22%), Positives = 123/302 (40%), Gaps = 42/302 (13%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIST-MKLIKHP 73
E +G G+ +V + +TG +A+K + R + ++I ++ +K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-R 132
+++ + T ++I +E + K G + E + ++ A+ Y
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL----- 187
GV HRD+KP N+LLD G +K+ DFG+S ++ +D + G Y+APE +
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247
YD R +DVWS G+ L L G P+ + F L+
Sbjct: 202 TKPDYDIR-ADVWSLGISLVELATGQFPYKNCK--------TDFEVLT------------ 240
Query: 248 YSYTLQICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
++ + + FS + +K L + R +++LE + K+ Y+
Sbjct: 241 -----KVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR-YETLE 294
Query: 305 FD 306
D
Sbjct: 295 VD 296
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-44
Identities = 74/329 (22%), Positives = 130/329 (39%), Gaps = 54/329 (16%)
Query: 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIV--DRDQVLRHKMVEQIKRE 63
P +YE +G G++ V A++ +G FVA+K V + RE
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE 61
Query: 64 ISTMKLIK---HPNVIKIIEVMASK-----TKIYIVLEFIDG--GELFDKIAKHGRLKED 113
++ ++ ++ HPNV+++++V A+ K+ +V E +D DK G L +
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAE 120
Query: 114 EARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173
+ +Q + +D+ H+ + HRDLKPEN+L+ S G +K++DFGL+ R
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------R------ 168
Query: 174 TACGTPN----------YVAPEVLNDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNL 221
Y APEVL Y D+WS G I + + S
Sbjct: 169 -IYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGN-SEA 225
Query: 222 MALYRKVSTFHFLSVYGE-------SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIK 274
L + F + + E S + + ++ +L+
Sbjct: 226 DQLGK---IFDLIGLPPEDDWPRDVSLPRGAFP-PRGPRPVQSVV---PEMEESGAQLLL 278
Query: 275 RILDPNPDTRMTISQMLEDEWFKKGYKPP 303
+L NP R++ + L+ + K P
Sbjct: 279 EMLTFNPHKRISAFRALQHSYLHKDEGNP 307
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 14/214 (6%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVD----RDQVLRHKMVEQIKREIS 65
T+ G Y L R +G G V A++ VA+K++ D V R +M +RE
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRM----QREAR 86
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINA 125
T ++ P+V+ I + ++Y+ + I+G +L + + G L A +Q+ +A
Sbjct: 87 TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVA 183
+D H+ G HRD+KPEN+L+ + + DFG I+ ++ L GT Y+A
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFG---IASATTDEKLTQLGNTVGTLYYMA 203
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217
PE ++ R +D+++ +L+ + G P+
Sbjct: 204 PERFSESHATYR-ADIYALTCVLYECLTGSPPYQ 236
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-43
Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 49/294 (16%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDFVAIKIVDRD-QVLRHKMVEQIKREISTMKLIKHP 73
L +G G F KV A GD VA+K D + +E +++E ++KHP
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N+I + V + + +V+EF GG L ++ R+ D + Q+ ++Y H
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 134 ---VFHRDLKPENLLLDSYG--------VLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
+ HRDLK N+L+ +LKI+DFGL+ + +A G ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWM 181
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242
APEV+ + + SDVWS GV+L+ L+ G +PF + +A+ YG +
Sbjct: 182 APEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAV-----------AYGVAMN 229
Query: 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTR---MTISQMLED 293
K L I PS KL++ +P+P +R I L
Sbjct: 230 K------LALPI-------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 63/294 (21%), Positives = 118/294 (40%), Gaps = 43/294 (14%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
G LG+G F + + ETG+ + +K + R + +E+ M+ ++HPNV
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGV 134
+K I V+ ++ + E+I GG L I + + + + + + Y HS +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAI------------SQQVREDGLLHTACGTPNYV 182
HRDL N L+ + ++DFGL+ + S + + +T G P ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242
APE++N + YD DV+S G++L ++ + +G + +
Sbjct: 190 APEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRT-----------MDFGLNVR 237
Query: 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTR---MTISQMLED 293
+CP F + R D +P+ R + + LE
Sbjct: 238 G-----FLDRYCPP---NCPPSFF----PITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 2e-43
Identities = 30/127 (23%), Positives = 54/127 (42%), Gaps = 7/127 (5%)
Query: 334 KPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNV 393
MNAF++IS + F+L LF R RF S ++ ++EE V
Sbjct: 2 GARRMNAFDIISGSPGFNLSGLFGDARK-YDRVERFVSAWTAERVVERLEEIVSAENLTV 60
Query: 394 -RKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYK-KFSSG 451
+K + MK++G +KG ++ E+ ++ L ++EVRK +
Sbjct: 61 AKKETWGMKIEG----QKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPF 116
Query: 452 LKDVVWQ 458
++V +
Sbjct: 117 FVELVHE 123
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 76/311 (24%), Positives = 134/311 (43%), Gaps = 47/311 (15%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIK 71
G +EL +G G++ +V ++V+TG AIK++D + E+IK+EI+ +K
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 72 HPNVIKIIE------VMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLI 123
H N+ ++++V+EF G + D K K LKE+ ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
+ + H V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197
Query: 184 PEVL-----NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKVSTFHFLSVY 237
PEV+ D YD ++ D+WS G+ + G P + + M AL+
Sbjct: 198 PEVIACDENPDATYDFKS-DLWSLGITAIEMAEGAPPLCDMHPMRALF------------ 244
Query: 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
+ L+ +S + I+ L N R Q+++ + +
Sbjct: 245 -----LIPRNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291
Query: 298 KGYKPPHFDKE 308
+
Sbjct: 292 DQPNERQVRIQ 302
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 72/295 (24%), Positives = 126/295 (42%), Gaps = 40/295 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ R +G GSF V FA++V + VAIK + ++ + I +E+ ++ ++HP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N I+ + ++V+E+ G L+E E + + Y HS
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEV---LND 189
+ HRD+K N+LL G++K+ DFG ++ ++ ++ GTP ++APEV +++
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDE 227
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLP--FDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247
YDG+ DVWS G I + +A P F+ + + ALY
Sbjct: 228 GQYDGKV-DVWSLG-ITCIELAERKPPLFNMNAMSALY-----------------HIAQN 268
Query: 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
S LQ +S + + L P R T +L+ + + P
Sbjct: 269 ESPALQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-42
Identities = 93/351 (26%), Positives = 150/351 (42%), Gaps = 63/351 (17%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
R + Y + +G GSF V AK ++G+ VAIK +VL+ K + RE+ M
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKN--RELQIM 101
Query: 68 KLIKHPNVIKIIEVMASKT------KIYIVLEFIDGGELFDKIAKH-----GRLKEDEAR 116
+ + H N++++ S + +VL+++ E ++A+H L +
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVK 159
Query: 117 RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTA 175
Y QL ++ Y HS G+ HRD+KP+NLLLD VLK+ DFG + +
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---------- 209
Query: 176 CGTPN--YV------APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFD-ESNLMALY 225
G PN Y+ APE+ Y + DVWS G +L L+ G F +S + L
Sbjct: 210 -GEPNVSYICSRYYRAPELIFGATDYT-SSIDVWSAGCVLAELLLGQPIFPGDSGVDQL- 266
Query: 226 RKVSTFHFLSVYG----ESYKKCTNKYS-YTL-QICRADFS---CPSWFSSGAKKLIKRI 276
+ V G E ++ Y+ + QI ++ P A L R+
Sbjct: 267 -----VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPR-TPPEAIALCSRL 320
Query: 277 LDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENL 327
L+ P R+T + +F + P + N D A+FN + + L
Sbjct: 321 LEYTPTARLTPLEACAHSFFDELRDP----NVKLPNGRDTPALFNFTTQEL 367
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 75/330 (22%), Positives = 134/330 (40%), Gaps = 68/330 (20%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNV-ETGDFVAIKIVDRDQVLRHKMVEQIK--------R 62
+YE +GEG++ KV A+++ G FVA+K V ++ + + R
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--------RV-QTGEEGMPLSTIR 60
Query: 63 EISTMKLIK---HPNVIKIIEV-----MASKTKIYIVLEFIDG--GELFDKIAKHGRLKE 112
E++ ++ ++ HPNV+++ +V +TK+ +V E +D DK+ + G +
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPT 119
Query: 113 DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172
+ + QL+ +D+ HS V HRDLKP+N+L+ S G +K++DFGL+ R
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------R----- 168
Query: 173 HTACGTPN----------YVAPEVLNDKGYDGRASDVWSCGVILFVLMAG--FLPFDESN 220
Y APEVL Y D+WS G I + S+
Sbjct: 169 --IYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGS-SD 224
Query: 221 LMALYRKVSTFHFL-----SVY-GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIK 274
+ L + + + + +S + Q + K L+
Sbjct: 225 VDQLGK---ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV---TDIDELGKDLLL 278
Query: 275 RILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
+ L NP R++ L +F+ +
Sbjct: 279 KCLTFNPAKRISAYSALSHPYFQDLERCKE 308
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-41
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 8/211 (3%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+YELG LG G ++V A+++ VA+K++ D + +RE + H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 73 PNVIKI----IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
P ++ + + YIV+E++DG L D + G + A A+++
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC--GTPNYVAPEV 186
H G+ HRD+KP N+++ + +K+ DFG+ A + + + TA GT Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGI-ARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217
D R SDV+S G +L+ ++ G PF
Sbjct: 191 ARGDSVDAR-SDVYSLGCVLYEVLTGEPPFT 220
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 74/341 (21%), Positives = 137/341 (40%), Gaps = 47/341 (13%)
Query: 3 VKVPASRTRVG-KYE-LGRTLGEGSFAKVKFA--KNVETGDFVAIKIVDRDQVLRHKMVE 58
VK+ + R RV +E G +G G++ V A K+ + A+K ++ +
Sbjct: 9 VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-- 66
Query: 59 QIKREISTMKLIKHPNVIKIIEVMASKT--KIYIVLEF--------IDGGELFDKIAKHG 108
REI+ ++ +KHPNVI + +V S K++++ ++ I K
Sbjct: 67 ---REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 109 RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY----GVLKISDFGLS-AIS 163
+L + Q+++ + Y H+ V HRDLKP N+L+ G +KI+D G + +
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 164 QQVREDGLLHTACGTPNYVAPEVL-NDKGYDGRASDVWSCGVILFVLMAG---------- 212
++ L T Y APE+L + Y +A D+W+ G I L+
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 213 ---FLPFDESNLMALYRKVST--------FHFLSVYGESYKKCTNKYSYTLQICRADFSC 261
P+ L ++ + + + K + +
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 262 PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
S A L++++L +P R+T Q ++D +F + P
Sbjct: 303 KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLP 343
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-41
Identities = 71/308 (23%), Positives = 139/308 (45%), Gaps = 44/308 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKH 72
Y+L R LG G +++V A N+ + V +KI+ + + IKREI ++ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLRGG 90
Query: 73 PNVIKIIEVM---ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
PN+I + +++ S+T + E ++ + L + + R Y +++ A+DYC
Sbjct: 91 PNIITLADIVKDPVSRTPALVF-EHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYC 146
Query: 130 HSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL- 187
HS G+ HRD+KP N+++D + L++ D+GL+ +E + + + PE+L
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 203
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPF----DESNLMALYRKV----STFHFLSVYG- 238
+ + YD + D+WS G +L ++ PF D + + KV + ++ Y
Sbjct: 204 DYQMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 239 ---ESYKKCTNKYSYTLQICRADFS------CPSWFSSGAKKLIKRILDPNPDTRMTISQ 289
+ ++S R + S A + ++L + +R+T +
Sbjct: 263 ELDPRFNDILGRHS------RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316
Query: 290 MLEDEWFK 297
+E +F
Sbjct: 317 AMEHPYFY 324
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-41
Identities = 65/298 (21%), Positives = 118/298 (39%), Gaps = 44/298 (14%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIST-MKLIKHP 73
+ +G G++ V + +G +A+K + + K +Q+ ++ M+ P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCP 81
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAK------HGRLKEDEARRYFQQLINAVD 127
+++ + + +I +E + FDK K + E+ + + A++
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 128 YCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
+ + HRD+KP N+LLD G +K+ DFG+S Q V A G Y+APE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDA-GCRPYMAPER 196
Query: 187 L----NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM--ALYRKVSTFHFLSVYGES 240
+ + +GYD R SDVWS G+ L+ L G P+ + N + L V G+
Sbjct: 197 IDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQL--------TQVVKGDP 247
Query: 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
+ S FS + L + R ++L+ +
Sbjct: 248 P--------------QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 87/389 (22%), Positives = 142/389 (36%), Gaps = 76/389 (19%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
+YE+ +G GS+ V A + VAIK + R V + + I REI+ + + H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRLNH 111
Query: 73 PNVIKIIEVMASKT-----KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
+V+K+++++ K ++Y+VLE D + L E + L+ V
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPN------ 180
Y HS G+ HRDLKP N L++ +K+ DFGL+ + + L + +
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 181 ------------YV------APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL 221
+V APE+ L + Y A DVWS G I L+ +
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIFAELLNMIKENVAYHA 289
Query: 222 M--ALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI----------CRADF---------- 259
L+ S F + Q+ D
Sbjct: 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKR 349
Query: 260 ---SCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 305
P S+ A L+KR+L NP+ R+TI++ L +FK+
Sbjct: 350 YIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA--- 406
Query: 306 DKEEEVNLDDVDAIFNDSKENLVTEKKEK 334
+ E + V FND + +
Sbjct: 407 -EVETNATEKVRLPFNDWMNMDEPQLRYA 434
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 99/345 (28%), Positives = 148/345 (42%), Gaps = 64/345 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y + +G GSF V AK VE+ + VAIK V +D+ RE+ M+++KHP
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-------RFKNRELQIMRIVKHP 92
Query: 74 NVIKIIEVMAS------KTKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQL 122
NV+ + S + + +VLE++ E + ++H + + Y QL
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVP--ETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGTPN- 180
+ ++ Y HS G+ HRD+KP+NLLLD GVLK+ DFG + I PN
Sbjct: 151 LRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-----------PNV 199
Query: 181 -YV------APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFD-ESNLMALYRKVSTF 231
Y+ APE+ Y D+WS G ++ LM G F ES + L
Sbjct: 200 SYICSRYYRAPELIFGATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQL------V 252
Query: 232 HFLSVYG----ESYKKCTNKYS-YTL-QICRADFS---CPSWFSSGAKKLIKRILDPNPD 282
+ V G E K Y + QI FS P A LI R+L+ P
Sbjct: 253 EIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPR-TPPDAIDLISRLLEYTPS 311
Query: 283 TRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENL 327
R+T + L +F + + N ++ +FN +KE L
Sbjct: 312 ARLTAIEALCHPFFDELRTG----EARMPNGRELPPLFNWTKEEL 352
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-39
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVE-TGDFVAIKIV--DRDQVLRHKMVEQIKREISTMKL 69
G+YE+ + G + A + G V +K + D + E +
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQ----AMAMAERQFLAE 135
Query: 70 IKHPNVIKIIEV-----MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
+ HP++++I YIV+E++ G L +L EA Y +++
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILP 193
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL-SAISQQVREDGLLHTACGTPNYVA 183
A+ Y HS G+ + DLKPEN++L + K+ D G S I+ G GTP + A
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS----FG---YLYGTPGFQA 245
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 217
PE++ + A+D+++ G L L +
Sbjct: 246 PEIV--RTGPTVATDIYTVGRTLAALTLDLPTRN 277
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 63/297 (21%), Positives = 120/297 (40%), Gaps = 46/297 (15%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-TMKLIKHP 73
E LG G++ V+ ++V +G +A+K + + + +++ ++ +M+ + P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDY 128
+ + + ++I +E +D DK K + ED + ++ A+++
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 129 CHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV- 186
HS V HRD+KP N+L+++ G +K+ DFG+S + +D G Y+APE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERI 181
Query: 187 ---LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243
LN KGY + SD+WS G+ + L P+D
Sbjct: 182 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWG-----------TPFQQ------- 222
Query: 244 CTNKYSYTLQICRAD--FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
Q+ FS+ + L N R T ++++ +F
Sbjct: 223 -------LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-39
Identities = 86/349 (24%), Positives = 134/349 (38%), Gaps = 47/349 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
++L LGEG++ V A + TG+ VAIK ++ + REI +K KH
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKH 68
Query: 73 PNVIKIIEVMASKTK-----IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINA 125
N+I I + + +YI+ E + D ++ L +D + + Q + A
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP--NYV- 182
V H V HRDLKP NLL++S LK+ DFGL+ I + D T + +V
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 183 -----APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSV 236
APEV L Y RA DVWSCG IL L F + + +
Sbjct: 185 TRWYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI-----FGI 238
Query: 237 YG-----ESYKKCTNKYSYTL-----QICRADFS--CPSWFSSGAKKLIKRILDPNPDTR 284
G + + + A P + L++R+L +P R
Sbjct: 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKR 297
Query: 285 MTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKE 333
+T + LE + + + P +E + F K+
Sbjct: 298 ITAKEALEHPYLQTYHDP----NDEPEGEPIPPSFFEFDHYKEALTTKD 342
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 79/323 (24%), Positives = 129/323 (39%), Gaps = 53/323 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIK-IVDRDQVLRHKMVEQIKREISTMKLIKH 72
+Y + LG G V A + + VAIK IV D V+ REI ++ + H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS----VKHALREIKIIRRLDH 67
Query: 73 PNVIKIIEVMASKTK--------------IYIVLEFIDGGELFD--KIAKHGRLKEDEAR 116
N++K+ E++ +YIV E+++ D + + G L E+ AR
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEEHAR 123
Query: 117 RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLS-AISQQVREDGLLHT 174
+ QL+ + Y HS V HRDLKP NL +++ VLKI DFGL+ + G L
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 175 ACGTPNYVAPEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH- 232
T Y +P + L+ Y +A D+W+ G I ++ G L+
Sbjct: 184 GLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTG---------KTLFAGAHELEQ 233
Query: 233 ---FLSVYG----ESYKKCTNKYSYTLQ----ICRADFS--CPSWFSSGAKKLIKRILDP 279
L E ++ + ++ + P S A +++IL
Sbjct: 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTF 292
Query: 280 NPDTRMTISQMLEDEWFKKGYKP 302
+P R+T + L + P
Sbjct: 293 SPMDRLTAEEALSHPYMSIYSFP 315
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 75/334 (22%), Positives = 139/334 (41%), Gaps = 35/334 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
+Y+ + +G G+ V A + VAIK + R +++ + RE+ MK + H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--PFQNQTHAKRAYRELVLMKCVNH 83
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
N+I ++ V + +YIV+E +D L I L + Q++ +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGI 140
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
+ HS G+ HRDLKP N+++ S LKI DFGL ++ ++ T Y APEV
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVS------TFHFLSVYGES 240
+ GY D+WS G I+ ++ G + F ++ + + KV F+ +
Sbjct: 198 ILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 241 YKKCTNKYS----------YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQM 290
+ + + AD +S A+ L+ ++L + R+++ +
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 291 LEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSK 324
L+ + Y P + E D ++ +
Sbjct: 317 LQHPYINVWYDP---SEAEAPPPKIPDKQLDERE 347
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 85/411 (20%), Positives = 163/411 (39%), Gaps = 46/411 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
+Y+ + +G G+ V A + VAIK + R +++ + RE+ MK + H
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--PFQNQTHAKRAYRELVLMKCVNH 120
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
N+I ++ V + +Y+V+E +D L I L + Q++ +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGI 177
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
+ HS G+ HRDLKP N+++ S LKI DFGL ++ ++ T Y APEV
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVS------TFHFLSVYGES 240
+ GY D+WS G I+ ++ + F + + + KV F+ +
Sbjct: 235 ILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293
Query: 241 YKKC------TNKYSYTLQICRADFSCPSWF----SSGAKKLIKRILDPNPDTRMTISQM 290
+ ++ + F S +S A+ L+ ++L +P R+++
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 291 LEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDS-------KENLVTE----KKEKPVSMN 339
L+ + Y P + E D ++ KE + E +++ +
Sbjct: 354 LQHPYINVWYDP---AEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVV 410
Query: 340 AFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLG 390
+ + + + + + T Q ++ S +E +A PLG
Sbjct: 411 KGQPSPSGAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSSLEASAGPLG 461
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 83/339 (24%), Positives = 149/339 (43%), Gaps = 57/339 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
Y + +G G++ V A + TG VAIK + R + ++ + RE+ +K ++H
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFAKRAYRELRLLKHMRH 83
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLIN 124
NVI +++V Y+V+ F+ D K+ KH +L ED + Q++
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVYQMLK 139
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV-- 182
+ Y H+ G+ HRDLKP NL ++ LKI DFGL+ R+ T YV
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVT 188
Query: 183 ----APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237
APEV LN Y + D+WS G I+ ++ G F S+ + +++ + V
Sbjct: 189 RWYRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI-----MKVT 242
Query: 238 G----ESYKKCTNKYSYTL-----QICRADFS--CPSWFSSGAKKLIKRILDPNPDTRMT 286
G E ++ + + ++ + DF+ + S A L++++L + + R+T
Sbjct: 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVT 301
Query: 287 ISQMLEDEWFKKGYKP------PHFDKEEEVNLDDVDAI 319
+ L +F+ + +D + +D
Sbjct: 302 AGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEW 340
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 84/339 (24%), Positives = 149/339 (43%), Gaps = 57/339 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
+Y+ +G G++ V A + +TG VA+K + R + + + RE+ +K +KH
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAKRTYRELRLLKHMKH 87
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLIN 124
NVI +++V +Y+V + D I K +L +D + Q++
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV-- 182
+ Y HS + HRDLKP NL ++ LKI DFGL+ R T YV
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA------RHTADEMT-----GYVAT 192
Query: 183 ----APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237
APE+ LN Y+ + D+WS G I+ L+ G F ++ + + + L +
Sbjct: 193 RWYRAPEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI-----LRLV 246
Query: 238 G----ESYKKCTNKYSYTL-----QICRADFS--CPSWFSSGAKKLIKRILDPNPDTRMT 286
G E KK +++ + Q+ + +F+ + A L++++L + D R+T
Sbjct: 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRIT 305
Query: 287 ISQMLEDEWFKKGYKP------PHFDKEEEVNLDDVDAI 319
+Q L +F + + P +D+ E +D
Sbjct: 306 AAQALAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEW 344
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-38
Identities = 85/344 (24%), Positives = 141/344 (40%), Gaps = 62/344 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
+Y +GEG++ V A + VAIK + H+ Q REI + +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRH 84
Query: 73 PNVIKIIEVMASKTK-----IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINA 125
N+I I +++ + T +YIV + ++ D K+ K L D + Q++
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV--- 182
+ Y HS V HRDLKP NLLL++ LKI DFGL+ ++ + T YV
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATR 195
Query: 183 ---APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH----FL 234
APE+ LN KGY ++ D+WS G IL +++ ++ L
Sbjct: 196 WYRAPEIMLNSKGYT-KSIDIWSVGCILAEMLSN---------RPIFPGKHYLDQLNHIL 245
Query: 235 SVYG----ESYKKCTNKYSYTL-----QICRADFSCPSWF---SSGAKKLIKRILDPNPD 282
+ G E N + + ++ F S A L+ ++L NP
Sbjct: 246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN--RLFPNADSKALDLLDKMLTFNPH 303
Query: 283 TRMTISQMLEDEWFKKGYKP-------PHFDKEEEVNLDDVDAI 319
R+ + Q L + ++ Y P F + E++ + +
Sbjct: 304 KRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKL 347
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 56/296 (18%), Positives = 114/296 (38%), Gaps = 30/296 (10%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
L +G+G + +V G+ VA+KI R + + E+ +++H N+
Sbjct: 11 TLLECVGKGRYGEVWRGSW--QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENI 64
Query: 76 IKII----EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
+ I S T+++++ + + G L+D + L R + + + + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123
Query: 132 R--------GVFHRDLKPENLLLDSYGVLKISDFGLSAI--SQQVREDGLLHTACGTPNY 181
+ HRDLK +N+L+ G I+D GL+ + + D + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 182 VAPEVLNDKGYDG-----RASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSV 236
+APEVL++ + D+W+ G++L+ + + + S
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 237 YGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
C ++ + + + KL+K NP R+T ++ +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLA----KLMKECWYQNPSARLTALRIKK 295
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 82/384 (21%), Positives = 141/384 (36%), Gaps = 76/384 (19%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
Y + +G GS+ V A + T VAIK V+R + + + I REI+ + +K
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--MFEDLIDCKRILREITILNRLKS 84
Query: 73 PNVIKIIEVMASKTK-----IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQ-QLIN 124
+I++ +++ +YIVLE D D K+ K +E + L+
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADS----DLKKLFKTPIFLTEEHIKTILYNLLL 140
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP----- 179
++ H G+ HRDLKP N LL+ +K+ DFGL+ ++ +++
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 180 ---------NYV------APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM- 222
++V APE+ L + Y ++ D+WS G I L+
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 223 -ALYRKVSTFHF---------------------LSVYG----ESYKKCTNKYSYTL---- 252
L+ S F ++ G + K
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319
Query: 253 -QICRADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEE 309
+ PS S L++ +L NP+ R+TI Q L+ + K K K E
Sbjct: 320 PHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK----KLE 374
Query: 310 EVNLDDVDAIFNDSKENLVTEKKE 333
+ + F+D T+ +
Sbjct: 375 NFSTKKIILPFDDWMVLSETQLRY 398
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-37
Identities = 92/338 (27%), Positives = 155/338 (45%), Gaps = 56/338 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMKLIKH 72
Y +G G++ V A + +G+ VAIK + R + ++ + RE+ +K ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--PFQSEIFAKRAYRELLLLKHMQH 82
Query: 73 PNVIKIIEVMASKTK------IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
NVI +++V + Y+V+ F+ +L + + E++ + Q++ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---- 182
Y HS GV HRDLKP NL ++ LKI DFGL+ R T YV
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT-----GYVVTRW 188
Query: 183 --APEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG- 238
APEV L+ Y+ + D+WS G I+ ++ G F + + ++ L V G
Sbjct: 189 YRAPEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI-----LKVTGV 242
Query: 239 ---ESYKKCTNKYSYTL-----QICRADFS--CPSWFSSGAKKLIKRILDPNPDTRMTIS 288
E +K +K + + Q R DF+ P S A L++++L+ + D R+T +
Sbjct: 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR-ASPQAADLLEKMLELDVDKRLTAA 301
Query: 289 QMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN 326
Q L +F+ P D EEE + F+DS E+
Sbjct: 302 QALTHPFFE-----PFRDPEEE---TEAQQPFDDSLEH 331
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-37
Identities = 85/379 (22%), Positives = 148/379 (39%), Gaps = 78/379 (20%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY LG+TLG GSF V ++E+G A+K +VL+ RE+ MK++ H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQDPRY--KNRELDIMKVLDHV 60
Query: 74 NVIKIIEVMASKTK--------------------------------------IYIVLEFI 95
N+IK+++ + + +++E++
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 96 DGGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY- 149
+ K+ K + + Y QL AV + HS G+ HRD+KP+NLL++S
Sbjct: 121 P--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSCGVILFV 208
LK+ DFG + + + + C + Y APE+ L Y + D+WS G +
Sbjct: 179 NTLKLCDFGSAKKL--IPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIGCVFGE 234
Query: 209 LMAGFLPFD-ESNLMALYRKVSTFHFLSVYG----ESYKKCTNKYSYTL--QICRADFS- 260
L+ G F E+++ L + + G E + Y+ + D+
Sbjct: 235 LILGKPLFSGETSIDQL------VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288
Query: 261 -CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLD----- 314
P S A L+++IL PD R+ + + +F + + N
Sbjct: 289 ILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQ 348
Query: 315 DVDAIFNDSKENLVTEKKE 333
++ +FN S L
Sbjct: 349 NIPQLFNFSPYELSIIPGN 367
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-36
Identities = 43/229 (18%), Positives = 74/229 (32%), Gaps = 36/229 (15%)
Query: 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREI 64
VP +R G+Y L G + A + VA+ VD VL ++++
Sbjct: 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRT 82
Query: 65 STMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
+ I P V ++++V+ ++ +V E+I GG L + A R Q L
Sbjct: 83 LRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAA 140
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
A D H GV P + + G + ++ +
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD 178
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKVS 229
D+ G L+ L+ P E+ L R +
Sbjct: 179 A--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-36
Identities = 63/304 (20%), Positives = 118/304 (38%), Gaps = 32/304 (10%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
RT + ++ + +G+G + +V K G+ VA+K+ + + EI
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFT----TEEASWFRETEIYQTV 86
Query: 69 LIKHPNVIKII----EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN 124
L++H N++ I + S T++Y++ ++ + G L+D + L + ++
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVS 145
Query: 125 AVDYCHSR--------GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--DGLLHT 174
+ + H+ + HRDLK +N+L+ G I+D GL+ D +T
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 175 ACGTPNYVAPEVL------NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
GT Y+ PEVL N A D++S G+IL+ + + L
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMA-DMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 288
S C K + + C KL+ NP +R+T
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG----KLMTECWAHNPASRLTAL 320
Query: 289 QMLE 292
++ +
Sbjct: 321 RVKK 324
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 78/368 (21%), Positives = 148/368 (40%), Gaps = 60/368 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQ-IKREISTMK-LIK 71
KYEL + LG+G++ V + + TG+ VA+K + ++ Q REI + L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--AFQNSTDAQRTFREIMILTELSG 67
Query: 72 HPNVIKIIEVMASKTK--IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQ-QLINAV 126
H N++ ++ V+ + +Y+V ++++ D + + L E ++Y QLI +
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMET----DLHAVIRANIL-EPVHKQYVVYQLIKVI 122
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN------ 180
Y HS G+ HRD+KP N+LL++ +K++DFGLS +R N
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 181 -------YV------APEV-LNDKGYDGRASDVWSCGVILFVLMAG-------------- 212
YV APE+ L Y + D+WS G IL ++ G
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 213 ----FLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSC---PSWF 265
+ F + + + + E + + + +
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 266 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKE 325
+ A L+ ++L NP+ R++ + L+ + + P EE + ND+ +
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP----NEEPNCDHIITIPINDNVK 357
Query: 326 NLVTEKKE 333
+ + + +
Sbjct: 358 HSIDDYRN 365
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 75/361 (20%), Positives = 143/361 (39%), Gaps = 61/361 (16%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
SR + ++++ R G+G+F V+ K TG VAIK +V++ RE+ M
Sbjct: 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQDPRFR--NRELQIM 70
Query: 68 KLIK---HPNVIKIIEVMASKTK-------IYIVLEFIDGGELFDKIAKHG-----RLKE 112
+ + HPN++++ + + + +V+E++ + + ++
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRRQVAPPP 128
Query: 113 DEARRYFQQLINAVDYCH--SRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQQVRED 169
+ + QLI ++ H S V HRD+KP N+L++ + G LK+ DFG +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP- 187
Query: 170 GLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228
+ C + Y APE+ ++ Y A D+WS G I +M G ++R
Sbjct: 188 -NVAYIC-SRYYRAPELIFGNQHYT-TAVDIWSVGCIFAEMMLG---------EPIFRGD 235
Query: 229 STFHFLS----VYG----ESYKKCTNKYS--YTLQICRADFS-----CPSWFSSGAKKLI 273
++ L V G E +K ++ +S + A L+
Sbjct: 236 NSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295
Query: 274 KRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVD-AIFNDSKENLVTEKK 332
+L P+ RM + L +F + + P + N D+ +F + +
Sbjct: 296 SALLQYLPEERMKPYEALCHPYFDELHDP----ATKLPNNKDLPEDLFRFLPNEIEVMSE 351
Query: 333 E 333
Sbjct: 352 A 352
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 63/297 (21%), Positives = 118/297 (39%), Gaps = 32/297 (10%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
L ++G+G F +V K G+ VA+KI R + + EI +++H N+
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENI 98
Query: 76 IKII----EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
+ I + + T++++V ++ + G LFD + ++ + + + + + + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 157
Query: 132 RGVF--------HRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--DGLLHTACGTPNY 181
V HRDLK +N+L+ G I+D GL+ + D + GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 182 VAPEVLNDKG------YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235
+APEVL+D RA D+++ G++ + + L S
Sbjct: 218 MAPEVLDDSINMKHFESFKRA-DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
V C K I SC + K+++ N R+T ++ +
Sbjct: 277 VEEMRKVVCEQK--LRPNIPNRWQSCEAL--RVMAKIMRECWYANGAARLTALRIKK 329
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 71/342 (20%), Positives = 133/342 (38%), Gaps = 51/342 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIK-IVDRDQVLRHKMVEQ-------IKREIS 65
Y + R + GS+ V + G VAIK + + R + + REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 66 TMKLIKHPNVIKIIEVMASKTK-----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
+ HPN++ + ++ + +Y+V E + +L I + + +YF
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFM 140
Query: 121 -QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
++ + H GV HRDL P N+LL + I DF L +++ D
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL---AREDTADANKTHYVTHR 197
Query: 180 NYVAPEV-LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH----FL 234
Y APE+ + KG+ + D+WS G ++ + AL+R + ++ +
Sbjct: 198 WYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNR---------KALFRGSTFYNQLNKIV 247
Query: 235 SVYG----ESYKKCTNKYSYT-LQICRADFSCPSWF------SSGAKKLIKRILDPNPDT 283
V G E ++ + L+ ++ +W A LI ++L+ NP
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
Query: 284 RMTISQMLEDEWFKKGYKP------PHFDKEEEVNLDDVDAI 319
R++ Q L +F+ + P + ++ DV +
Sbjct: 308 RISTEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDM 349
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 50/225 (22%), Positives = 93/225 (41%), Gaps = 25/225 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+L G F V K ++VA+KI + K Q + E+ ++ +KH
Sbjct: 25 PLQLLEVKARGRFGCVW--KAQLLNEYVAVKIFPI----QDKQSWQNEYEVYSLPGMKHE 78
Query: 74 NVIKII----EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
N+++ I + ++++ F + G L D + + + +E + + + Y
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYL 137
Query: 130 HSR----------GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
H + HRD+K +N+LL + I+DFGL+ + + G H GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 180 NYVAPEVLNDKGYDG----RASDVWSCGVILFVLMAGFLPFDESN 220
Y+APEVL D+++ G++L+ L + D
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 76/334 (22%), Positives = 129/334 (38%), Gaps = 54/334 (16%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+YE+ + +G+GSF +V A + + VA+K+V R+ + Q EI ++ ++
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RN---EKRFHRQAAEEIRILEHLRK 152
Query: 73 ------PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLIN 124
NVI ++E + I + E + L++ I K+ R++ ++
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDGLLHTACGTPNYV 182
+D H + H DLKPEN+LL G +K+ DFG S Q ++T + Y
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYR 266
Query: 183 APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMAL--------------- 224
APEV+ Y D+WS G IL L+ G+ DE + +A
Sbjct: 267 APEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325
Query: 225 -------YRKVSTFHFLSVYGESYKKCTNKYSYTL-QICRADFSCPSWFSSGAKK----- 271
+ +V S + R W ++
Sbjct: 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 272 --LIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303
+K+ L+ +P RMT Q L W ++ P
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 69/337 (20%), Positives = 129/337 (38%), Gaps = 65/337 (19%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK- 71
+Y L R LG G F+ V AK++ VA+KIV D+ E + EI ++ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74
Query: 72 ----------HPNVIKIIEV----MASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEA 115
+++K+++ + + +V E + G L K +H +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV 133
Query: 116 RRYFQQLINAVDYCHSR-GVFHRDLKPENLLLD------SYGVLKISDFGLSAISQQVRE 168
++ +QL+ +DY H R G+ H D+KPEN+L++ + +KI+D G +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-----WY 188
Query: 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYR-- 226
D + T Y +PEVL + +D+WS ++F L+ G F+ + +
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 227 ---------------------KVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWF 265
K + F S + + + L+ + +
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRG--LLRNISKLKFWPLEDVLTEKY--KFS 303
Query: 266 SSGAKK---LIKRILDPNPDTRMTISQMLEDEWFKKG 299
AK+ + +L +P R ++ W K
Sbjct: 304 KDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 59/309 (19%), Positives = 110/309 (35%), Gaps = 45/309 (14%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+L +G G + V VA+K+ ++ ++ I + L++H N+
Sbjct: 16 KLLELIGRGRYGAVYKGS--LDERPVAVKVFSF----ANRQNFINEKNIYRVPLMEHDNI 69
Query: 76 IKII-----EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+ I + + +V+E+ G L ++ H + R + + Y H
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLH 128
Query: 131 S---------RGVFHRDLKPENLLLDSYGVLKISDFGLS------AISQQVREDGLLHTA 175
+ + HRDL N+L+ + G ISDFGLS + + ED +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 176 CGTPNYVAPEVL------NDKGYDGRASDVWSCGVIL---FVLMAGFLPFDESN--LMAL 224
GT Y+APEVL D + D+++ G+I F+ P + MA
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 225 YRKVSTFHFLSVYGESYKKCTNKYSYTL-QICRADFSCPSWFSSGAKKLIKRILDPNPDT 283
+V + + K + + + + I+ D + +
Sbjct: 249 QTEVG--NHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK----ETIEDCWDQDAEA 302
Query: 284 RMTISQMLE 292
R+T E
Sbjct: 303 RLTAQXAEE 311
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK---REISTMKLIKH 72
LG +G G+F +V + VA+K + +E +K H
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-----LPPDLKAKFLQEARILKQYSH 171
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHS 131
PN++++I V K IYIV+E + GG+ + G L+ + ++Y S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY----VAPEVL 187
+ HRDL N L+ VLKISDFG+S + DG+ + G APE L
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 188 NDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
N Y SDVWS G++L+ G P+
Sbjct: 288 NYGRYS-SESDVWSFGILLWETFSLGASPY 316
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 76/336 (22%), Positives = 135/336 (40%), Gaps = 61/336 (18%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+YE+ +G+GSF +V A + ++VAIKI+ ++ + + Q + E+ ++L+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN---KKAFLNQAQIEVRLLELMNK 109
Query: 73 P------NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLIN 124
++ + + + +V E + L+D + + + R++ QQ+
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 125 AVDYCHSR--GVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDGLLHTACGTPN 180
A+ + + + H DLKPEN+LL + +KI DFG S+ + ++ +
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSC----QLGQRIYQYIQSRF 223
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMAL------------- 224
Y +PEVL YD A D+WS G IL + G F +E + M
Sbjct: 224 YRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282
Query: 225 ---------YRKVSTFHFLSVYGESYK-----KCTNKYSYTLQICRADFSCPSWFSSGAK 270
+ K+ + + K T K L + SG
Sbjct: 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342
Query: 271 K--------LIKRILDPNPDTRMTISQMLEDEWFKK 298
LI R+LD +P TR+ L+ +FKK
Sbjct: 343 VADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 62/342 (18%), Positives = 126/342 (36%), Gaps = 73/342 (21%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+ + R +G+G+F +V ++++ + A+K+V R+ K K E +K I++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNI---KKYTRSAKIEADILKKIQN 90
Query: 73 -----PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINA 125
N++K + ++ E + G L++ I ++ ++ + Y +++ A
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT----------A 175
++Y + H DLKPEN+LLD K + + + A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 176 CGTPNYV----------APEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLM 222
+Y APEV+ + G+D +SD+WS G +L L G L F + +
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268
Query: 223 AL----------------YRKVSTFHFL-----------SVYGESYKKCTNKYSYTLQIC 255
A+ + + + + S K I
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328
Query: 256 RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
F + IL +P R + +++L+ ++ +
Sbjct: 329 HELF----------CDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 80/336 (23%), Positives = 134/336 (39%), Gaps = 57/336 (16%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGD-FVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+YE+ TLGEG+F KV + + G VA+KIV ++ + E + EI ++ +
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNV---DRYCEAARSEIQVLEHLN 69
Query: 72 HP------NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLI 123
++++E I IV E + G +D I ++G + D R+ Q+
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGV-------------------LKISDFGLSAISQ 164
+V++ HS + H DLKPEN+L +K+ DFG SA
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SAT-- 185
Query: 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNL 221
+D T T +Y APEV+ G+ + DVWS G IL GF F D
Sbjct: 186 --YDDEHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242
Query: 222 MALYRKV--------------STFHFLSVYGESYKKCTNKY-SYTLQICRADFSCPSWFS 266
+A+ ++ + +Y S + +
Sbjct: 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302
Query: 267 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
LI+++L+ +P R+T+ + L+ +F K
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 15/220 (6%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+ LG G + +V + VA+K + D + + ++ E + MK IKHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNL 278
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRG 133
++++ V + YI+ EF+ G L D + + R + Q+ +A++Y +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDK 190
HR+L N L+ ++K++DFGLS ++ G + APE L
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 191 GYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVS 229
+ SDVW+ GV+L+ + G P+ +L +Y +
Sbjct: 395 KFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 30/208 (14%)
Query: 16 ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIK---REISTMK 68
+ + LG+G+F V+ + TG+ VA+K L+H E ++ REI +K
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK------KLQHSTEEHLRDFEREIEILK 66
Query: 69 LIKHPNVIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINA 125
++H N++K V S + + +++E++ G L D + KH R+ + +Y Q+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTP 179
++Y ++ HRDL N+L+++ +KI DFGL+ + Q +V+E G P
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES------P 180
Query: 180 -NYVAPEVLNDKGYDGRASDVWSCGVIL 206
+ APE L + + ASDVWS GV+L
Sbjct: 181 IFWYAPESLTESKFS-VASDVWSFGVVL 207
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 30/208 (14%)
Query: 16 ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIK---REISTMK 68
+ + LG+G+F V+ + TG+ VA+K L+H E ++ REI +K
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK------KLQHSTEEHLRDFEREIEILK 97
Query: 69 LIKHPNVIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINA 125
++H N++K V S + + +++E++ G L D + KH R+ + +Y Q+
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTP 179
++Y ++ HRDL N+L+++ +KI DFGL+ + Q +V+E G P
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES------P 211
Query: 180 -NYVAPEVLNDKGYDGRASDVWSCGVIL 206
+ APE L + + ASDVWS GV+L
Sbjct: 212 IFWYAPESLTESKFS-VASDVWSFGVVL 238
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 14/212 (6%)
Query: 16 ELGRTLGEGSFAKVKFAK-NVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
L LG+GSF V+ + + +G VA+K + D + + + ++ RE++ M + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHS 131
N+I++ V + +V E G L D++ KH G RY Q+ + Y S
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYV---APEVL 187
+ HRDL NLLL + ++KI DFGL A+ Q D APE L
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAWCAPESL 196
Query: 188 NDKGYDGRASDVWSCGVILF-VLMAGFLPFDE 218
+ + ASD W GV L+ + G P+
Sbjct: 197 KTRTFSH-ASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 16 ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ R LGEG F KV N TG+ VA+K + D +H+ K+EI ++ +
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLY 91
Query: 72 HPNVIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
H ++IK + +V+E++ G L D + +H + + + QQ+ + Y
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYL 150
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTPNYV- 182
H++ HRDL N+LLD+ ++KI DFGL+ A+ + +VREDG P V
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VF 202
Query: 183 --APEVLNDKGYDGRASDVWSCGVIL 206
APE L + + ASDVWS GV L
Sbjct: 203 WYAPECLKEYKFY-YASDVWSFGVTL 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-27
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 23/221 (10%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+L +T+G+G F V G+ VA+K + D + E S M ++H N+
Sbjct: 24 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNL 76
Query: 76 IKIIEV-MASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSR 132
++++ V + K +YIV E++ G L D + GR L D ++ + A++Y
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLND 189
HRDL N+L+ V K+SDFGL+ + ++ G L P V APE L +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEALRE 188
Query: 190 KGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVS 229
K + SDVWS G++L+ + G +P+ L + +V
Sbjct: 189 KKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 73/337 (21%), Positives = 131/337 (38%), Gaps = 57/337 (16%)
Query: 13 GKYELGRTLGEGSFAKV-KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+YE+ LGEG+F KV + + VA+KI+ R+ K E + EI+ +K IK
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RNV---GKYREAARLEINVLKKIK 74
Query: 72 HP------NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLI 123
+ + + + I E + G F+ + ++ R QL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGV-------------------LKISDFGLSAISQ 164
+A+ + H + H DLKPEN+L + ++++DFG SA
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SAT-- 190
Query: 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNL 221
+ T T +Y PEV+ + G+ + DVWS G ILF GF F +
Sbjct: 191 --FDHEHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREH 247
Query: 222 MA------------LYRKVSTFHFLSVYGESYKKCTNKYSYTLQICR---ADFSCPSWFS 266
+ + + + G + + ++ Y + C+ + S
Sbjct: 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307
Query: 267 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303
L++R+L+ +P R+T+++ L +F
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 30/208 (14%)
Query: 16 ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIK---REISTMK 68
+ LG+G+F V+ + TG VA+K L+H +Q + REI +K
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK------QLQHSGPDQQRDFQREIQILK 79
Query: 69 LIKHPNVIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINA 125
+ ++K V + + +V+E++ G L D + +H RL Y Q+
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 126 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ-----VREDGLLHTACGTP 179
++Y SR HRDL N+L++S +KI+DFGL+ + VRE G P
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------P 193
Query: 180 -NYVAPEVLNDKGYDGRASDVWSCGVIL 206
+ APE L+D + R SDVWS GV+L
Sbjct: 194 IFWYAPESLSDNIFS-RQSDVWSFGVVL 220
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 16 ELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
+ R LGEG F KV+ + TG+ VA+K + + H +K+EI ++ +
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLY 81
Query: 72 HPNVIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDY 128
H N++K + I +++EF+ G L + + K+ ++ + +Y Q+ +DY
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTP-NY 181
SR HRDL N+L++S +KI DFGL+ AI V++D P +
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------PVFW 195
Query: 182 VAPEVLNDKGYDGRASDVWSCGVIL 206
APE L + ASDVWS GV L
Sbjct: 196 YAPECLMQSKFY-IASDVWSFGVTL 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+ LG G + +V + VA+K + D + + ++ E + MK IKHPN+
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNL 71
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++++ V + YI+ EF+ G L D + + Q+ +A++Y +
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDK 190
HRDL N L+ ++K++DFGLS ++ G P + APE L
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 191 GYDGRASDVWSCGVILF-VLMAGFLPF 216
+ SDVW+ GV+L+ + G P+
Sbjct: 188 KFS-IKSDVWAFGVLLWEIATYGMSPY 213
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 23/221 (10%)
Query: 16 ELGRTLGEGSFAKVK--FAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+L +T+G+G F V + + VA+K + D + E S M ++H
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK----VAVKCIKND-----ATAQAFLAEASVMTQLRHS 246
Query: 74 NVIKIIEV-MASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCH 130
N+++++ V + K +YIV E++ G L D + GR L D ++ + A++Y
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLND 189
HRDL N+L+ V K+SDFGL+ + ++ G L P + APE L +
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALRE 360
Query: 190 KGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVS 229
K + SDVWS G++L+ + G +P+ L + +V
Sbjct: 361 KKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+L LG G F +V VA+K + + + + E + MK ++H +
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLA----EANLMKQLQHQRL 70
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+++ V ++ IYI+ E+++ G L D K +L ++ Q+ + + R
Sbjct: 71 VRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDK 190
HRDL+ N+L+ KI+DFGL+ ++ ED G P + APE +N
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLA----RLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 191 GYDGRASDVWSCGVILF-VLMAGFLPF 216
+ SDVWS G++L ++ G +P+
Sbjct: 186 TFT-IKSDVWSFGILLTEIVTHGRIPY 211
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 16 ELGRTLGEGSFAKV------KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
+ + LG G+F V + V+ VAIK + K ++I E M
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATS--PKANKEILDEAYVMAS 73
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDY 128
+ +P+V +++ + + + ++ + + G L D + +H + + Q+ ++Y
Sbjct: 74 VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPE 185
R + HRDL N+L+ + +KI+DFGL ++ + + + A G P ++A E
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 186 VLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDE 218
+ + Y SDVWS GV ++ ++ G P+D
Sbjct: 190 SILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDG 222
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 15/219 (6%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
L LG+G F +V T VAIK + + ++ E MK ++H +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKL 241
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRG 133
+++ V S+ IYIV E++ G L D + L+ + Q+ + + Y
Sbjct: 242 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-P-NYVAPEVLNDKG 191
HRDL+ N+L+ V K++DFGL ++ + ++ P + APE
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVS 229
+ SDVWS G++L + G +P+ + +V
Sbjct: 358 FTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 22/229 (9%)
Query: 13 GKYE-------LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS 65
G E L + LG G F VK K D VA+K++ + + + E
Sbjct: 1 GHMELKREEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQ----EAQ 55
Query: 66 TMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLIN 124
TM + HP ++K V + + IYIV E+I G L + + HG+ L+ + +
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCE 115
Query: 125 AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NY 181
+ + S HRDL N L+D +K+SDFG++ + D ++ GT P +
Sbjct: 116 GMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT----RYVLDDQYVSSVGTKFPVKW 171
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVS 229
APEV + Y SDVW+ G++++ V G +P+D + KVS
Sbjct: 172 SAPEVFHYFKYSS-KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 17 LGRTLGEGSFAKVKFA--KNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ LG G+F VK + + VA+KI+ +++ + +++ E + M+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
++++I + +V+E + G L + ++ +K+ Q+ + Y
Sbjct: 80 IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG--------TPNYVAPEV 186
HRDL N+LL + KISDFGLS + +R D + A APE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLS---KALRADENYYKAQTHGKWPVKWY----APEC 191
Query: 187 LNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+N + SDVWS GV+++ G P+
Sbjct: 192 INYYKFSS-KSDVWSFGVLMWEAFSYGQKPY 221
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 15/219 (6%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
L LG+G F +V T VAIK + + ++ E MK ++H +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKL 324
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRG 133
+++ V S+ IYIV E++ G L D + L+ + Q+ + + Y
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-P-NYVAPEVLNDKG 191
HRDL+ N+L+ V K++DFGL ++ + ++ P + APE
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVS 229
+ SDVWS G++L + G +P+ + +V
Sbjct: 441 FTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 26/230 (11%)
Query: 13 GKYE-------LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--RE 63
GK+ + +G G F V + VAIK +R + + E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIK------TIREGAMSEEDFIEE 53
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQL 122
M + HP ++++ V + I +V EF++ G L D + G + +
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P- 179
+ Y V HRDL N L+ V+K+SDFG++ + D ++ GT P
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPV 169
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKV 228
+ +PEV + Y SDVWS GV+++ V G +P++ + + +
Sbjct: 170 KWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 51/224 (22%), Positives = 101/224 (45%), Gaps = 20/224 (8%)
Query: 16 ELGRTLGEGSFAKV------KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
+ + LG G+F V + V+ VAIK + K ++I E M
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATS--PKANKEILDEAYVMAS 73
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDY 128
+ +P+V +++ + + + ++ + + G L D + +H + + Q+ ++Y
Sbjct: 74 VDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPE 185
R + HRDL N+L+ + +KI+DFGL ++ + + + A G P ++A E
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 186 VLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKV 228
+ + Y SDVWS GV ++ ++ G P+D + +
Sbjct: 190 SILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 16 ELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+ + +G G +V + + VAIK + R + E S M
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDV--PVAIKALKAGYTERQR--RDFLSEASIMGQF 107
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYC 129
HPN+I++ V+ IV E+++ G L + H G+ + + + + Y
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEV 186
G HRDL N+L+DS V K+SDFGLS + + + +T G + APE
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAPEA 225
Query: 187 LNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ + + ASDVWS GV+++ VL G P+
Sbjct: 226 IAFRTFSS-ASDVWSFGVVMWEVLAYGERPY 255
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 16 ELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
ELGR +GEG F V +N VAIK + E+ +E TM+
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVR--EKFLQEALTMRQF 73
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYC 129
HP+++K+I V ++ ++I++E GEL + L Y QL A+ Y
Sbjct: 74 DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEV 186
S+ HRD+ N+L+ S +K+ DFGLS + ED + A P ++APE
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS----RYMEDSTYYKASKGKLPIKWMAPES 188
Query: 187 LNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+N + + ASDVW GV ++ +LM G PF
Sbjct: 189 INFRRFTS-ASDVWMFGVCMWEILMHGVKPF 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 34/233 (14%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKM 56
V + S V +G G F V + A+K ++R
Sbjct: 17 HVVIGPSSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKI--HCAVKSLNRI--TDIGE 69
Query: 57 VEQIKREISTMKLIKHPNVIKIIEVMA-SKTKIYIVLEFIDGGELFDKIAKHGR-LKEDE 114
V Q E MK HPNV+ ++ + S+ +VL ++ G+L + I +
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 129
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-------AISQQVR 167
+ Q+ + Y S+ HRDL N +LD +K++DFGL+ S +
Sbjct: 130 LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 168 EDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
L P V A E L + + SDVWS GV+L+ ++ G P+
Sbjct: 190 TGAKL------P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 233
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 17 LGRTLGEGSFAKVKFAK-NVETGDF---VAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+ +G G F +V +G VAIK + + + E M H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSH 105
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHS 131
N+I++ V++ + I+ E+++ G L + + G + + + + Y +
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLN 188
HRDL N+L++S V K+SDFGLS + + E +T G + APE ++
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA--TYTTSGGKIPIRWTAPEAIS 223
Query: 189 DKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ + ASDVWS G++++ V+ G P+
Sbjct: 224 YRKFTS-ASDVWSFGIVMWEVMTYGERPY 251
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+L + LG G F +V A + VA+K + + + E + MK ++H +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 245
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+K+ V +K IYI+ EF+ G L D K + + + + Q+ + + R
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDK 190
HRDL+ N+L+ + V KI+DFGL+ +V ED G + APE +N
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 191 GYDGRASDVWSCGVILF-VLMAGFLPF 216
+ SDVWS G++L ++ G +P+
Sbjct: 361 SFT-IKSDVWSFGILLMEIVTYGRIPY 386
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 16 ELGRTLGEGSFAKV---KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
L R LGEG F +V + + VA+K +D L +K E+ E MK + H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDH 72
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHS 131
P+++K+I ++ + +I++E GEL + ++ LK Y Q+ A+ Y S
Sbjct: 73 PHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLN 188
HRD+ N+L+ S +K+ DFGLS + ED + A T P +++PE +N
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLS----RYIEDEDYYKASVTRLPIKWMSPESIN 187
Query: 189 DKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ + ASDVW V ++ +L G PF
Sbjct: 188 FRRFTT-ASDVWMFAVCMWEILSFGKQPF 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 44/230 (19%), Positives = 96/230 (41%), Gaps = 32/230 (13%)
Query: 16 ELGRTLGEGSFAKV------KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
+ LG G F V ++++ V IK+++ + + + + +
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKI--PVCIKVIEDKSG--RQSFQAVTDHMLAIGS 71
Query: 70 IKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD- 127
+ H ++++++ + + + +V +++ G L D +++ Q L+N V
Sbjct: 72 LDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLD------HVRQHRGALGPQLLLNWGVQI 124
Query: 128 -----YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P- 179
Y G+ HR+L N+LL S ++++DFG+ + + D P
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV---ADLLPPDDKQLLYSEAKTPI 181
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKV 228
++A E ++ Y SDVWS GV ++ ++ G P+ L + +
Sbjct: 182 KWMALESIHFGKYTH-QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 7e-24
Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV 75
+ LG G F VK+ K D VAIK++ + + +E E M + H +
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKL 81
Query: 76 IKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGV 134
+++ V + I+I+ E++ G L + + + R + + + + A++Y S+
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKG 191
HRDL N L++ GV+K+SDFGLS + D ++ G+ P + PEVL
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLS----RYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 197
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPF 216
+ SD+W+ GV+++ + G +P+
Sbjct: 198 FS-SKSDIWAFGVLMWEIYSLGKMPY 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 17 LGRTLGEGSFAKVKFAK-NVETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ + +G G F +V + + + VAIK + + + E S M HP
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSR 132
N+I++ V+ + IV E+++ G L + KH + + + + + + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLND 189
G HRDL N+L++S V K+SDFGL + + E +T G + +PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA--AYTTRGGKIPIRWTSPEAIAY 224
Query: 190 KGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ + ASDVWS G++L+ V+ G P+
Sbjct: 225 RKFTS-ASDVWSYGIVLWEVMSYGERPY 251
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 16 ELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
ELGR +GEG F V +N VAIK + E+ +E TM+
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAM--AVAIKTCKNCTSDSVR--EKFLQEALTMRQF 448
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYC 129
HP+++K+I V ++ ++I++E GEL + L Y QL A+ Y
Sbjct: 449 DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG-TP-NYVAPEVL 187
S+ HRD+ N+L+ S +K+ DFGL S+ + + + G P ++APE +
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 188 NDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
N + + ASDVW GV ++ +LM G PF
Sbjct: 565 NFRRFTS-ASDVWMFGVCMWEILMHGVKPF 593
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 34/233 (14%)
Query: 2 SVKVPASRTRVGKYELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKM 56
V + S V +G G F V + A+K ++R
Sbjct: 81 HVVIGPSSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKI--HCAVKSLNRI--TDIGE 133
Query: 57 VEQIKREISTMKLIKHPNVIKIIEVMA-SKTKIYIVLEFIDGGELFDKIAKHGR-LKEDE 114
V Q E MK HPNV+ ++ + S+ +VL ++ G+L + I +
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 193
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-------AISQQVR 167
+ Q+ + + S+ HRDL N +LD +K++DFGL+ S +
Sbjct: 194 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 168 EDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
L P V A E L + + SDVWS GV+L+ ++ G P+
Sbjct: 254 TGAKL------P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 297
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 36/226 (15%)
Query: 16 ELGRTLGEGSFAKV---KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
LGR LG+G F V + + + VA+K++ + ++ +E+ RE + MK H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDH 84
Query: 73 PNVIKIIEV------MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-A 125
P+V K++ V ++L F+ G+L + R+ E+ Q L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFM 143
Query: 126 VD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHT 174
VD Y SR HRDL N +L + ++DFGLS I L
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL-- 201
Query: 175 ACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
P V A E L D Y SDVW+ GV ++ ++ G P+
Sbjct: 202 ----P--VKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPY 240
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 21/218 (9%)
Query: 14 KYELGRT--------LGEGSFAKVKFAK-NVETGDF-VAIKIVDRDQVLRHKMVEQIKRE 63
K L R LG G+F V+ + VAIK++ + E++ RE
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMRE 60
Query: 64 ISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQL 122
M + +P ++++I V ++ + +V+E GG L + + Q+
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 123 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P- 179
+ Y + HRDL N+LL + KISDFGLS +D P
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPL 177
Query: 180 NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ APE +N + + SDVWS GV ++ L G P+
Sbjct: 178 KWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPY 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-23
Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 34/232 (14%)
Query: 3 VKVPASRTRVGKYELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMV 57
V +P R R +G+G F V AIK + R ++
Sbjct: 14 VLIPHERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRI--QCAIKSLSRITEMQQV-- 66
Query: 58 EQIKREISTMKLIKHPNVIKIIEV-MASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEA 115
E RE M+ + HPNV+ +I + + + +++L ++ G+L I R +
Sbjct: 67 EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL 126
Query: 116 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-------AISQQVRE 168
+ Q+ ++Y + HRDL N +LD +K++DFGL+ S Q
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 169 DGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
L P V A E L + SDVWS GV+L+ +L G P+
Sbjct: 187 HARL------P--VKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPY 229
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 3e-22
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 13/203 (6%)
Query: 21 LGEGSFAKVKFAK-NVETGDF-VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
LG G+F V+ + VAIK++ + E++ RE M + +P ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRL 401
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
I V ++ + +V+E GG L + + Q+ + Y + HR
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDKGYDG 194
+L N+LL + KISDFGLS +D + APE +N + +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 195 RASDVWSCGVILF-VLMAGFLPF 216
SDVWS GV ++ L G P+
Sbjct: 519 -RSDVWSYGVTMWEALSYGQKPY 540
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 34/214 (15%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+ R LG+GSF V AK V + VAIK V+ +R + + E S MK
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMKEF 85
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD---KIAKHGRLKEDEARRYFQQLIN-AV 126
+V++++ V++ +++E + G+L + A ++I A
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 127 D------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTA 175
+ Y ++ HRDL N ++ +KI DFG++ I + GLL
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL--- 202
Query: 176 CGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
P V +PE L D + SDVWS GV+L
Sbjct: 203 ---P--VRWMSPESLKDGVFT-TYSDVWSFGVVL 230
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 61/216 (28%), Positives = 87/216 (40%), Gaps = 38/216 (17%)
Query: 16 ELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
LG+ LGEG F V K VA+K + D + +E+ E + MK
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSL--KVAVKTMKLDNS-SQREIEEFLSEAACMKDF 93
Query: 71 KHPNVIKIIEV-----MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN- 124
HPNVI+++ V K ++L F+ G+L + RL+ Q L+
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKF 152
Query: 125 AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLH 173
VD Y +R HRDL N +L + ++DFGLS I +
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM- 211
Query: 174 TACGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
P V A E L D+ Y SDVW+ GV +
Sbjct: 212 -----P--VKWIAIESLADRVYT-SKSDVWAFGVTM 239
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 71/372 (19%), Positives = 126/372 (33%), Gaps = 99/372 (26%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK- 71
G+Y + R LG G F+ V + +++ FVA+K+V + E EI +K ++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT----ETALDEIRLLKSVRN 92
Query: 72 ----HPNVIKIIEVMAS-------KTKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRY 118
PN +++++ T I +V E + G L I K + L ++
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 119 FQQLINAVDYCHSR-GVFHRDLKPENLLL------------------------------- 146
QQ++ +DY H++ + H D+KPEN+LL
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 147 ------------------DSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-YVAPEVL 187
+KI+D G + + T Y + EVL
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTF-HFLSVYGESYKKCTN 246
GY+ +D+WS + F L G F+ + R + + G+ +K
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 247 KYSYTLQIC------RADFSCPSWFSS---------------GAKKLIKRILDPNPDTRM 285
Y+ + + W G + +L+ P+ R
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 286 TISQMLEDEWFK 297
T ++ L W
Sbjct: 385 TAAECLRHPWLN 396
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 49/214 (22%), Positives = 79/214 (36%), Gaps = 34/214 (15%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
L R LG G+F +V + VA+K + + + E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKF 90
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD-- 127
H N+++ I V +I++E + GG+L + + + L++ A D
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 128 ----YCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLS-AISQQ----VREDGLLHTA 175
Y HRD+ N LL G V KI DFG++ I + +L
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML--- 207
Query: 176 CGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
P V PE + + +D WS GV+L
Sbjct: 208 ---P--VKWMPPEAFMEGIFTS-KTDTWSFGVLL 235
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 51/228 (22%)
Query: 16 ELGRTLGEGSFAKVK--FAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
G+TLG G+F KV A + D VA+K++ L + E + E+ + +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLSYL 83
Query: 71 -KHPNVIKIIEVMASKTKIYIVLEFIDGGEL-----------FDKIAKHGRLKEDEARRY 118
H N++ ++ ++ E+ G+L +++DE
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 119 FQQLI-------NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171
+ L+ + + S+ HRDL N+LL + KI DFGL ++ ++ D
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL---ARDIKNDS- 199
Query: 172 LHTACGTPNYV------------APEVLNDKGYDGRASDVWSCGVILF 207
NYV APE + + Y SDVWS G+ L+
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 39/217 (17%)
Query: 17 LGRTLGEGSFAKVKFAKNVETGDF--VAIKIV--DRDQVLRHKMVEQIKREISTMKLI-K 71
+GEG+F +V A+ + G AIK + + E+ + +
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA----GELEVLCKLGH 84
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY---------FQQL 122
HPN+I ++ + +Y+ +E+ G L D + K L+ D A QQL
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 123 IN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ--QVREDGLLH 173
++ A D Y + HRDL N+L+ V KI+DFGLS + + G L
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL- 203
Query: 174 TACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF 207
P V A E LN Y SDVWS GV+L+
Sbjct: 204 -----P--VRWMAIESLNYSVYT-TNSDVWSYGVLLW 232
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 46/225 (20%), Positives = 82/225 (36%), Gaps = 40/225 (17%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDF-------VAIKIVDRDQVLRHKMVEQIKREISTMK 68
+LG+G+F K+ E GD+ V +K++D+ E S M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMS 67
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVD 127
+ H +++ V + +V EF+ G L + K+ + +QL A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 128 YCHSRGVFHRDLKPENLLLDSYG--------VLKISDFGLSAISQQVREDGLLHTACGTP 179
+ + H ++ +N+LL +K+SD G+ S V
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI---SITVLPK---------- 174
Query: 180 NY-------VAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF 216
+ V PE + + A+D WS G L+ + G P
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 51/216 (23%), Positives = 81/216 (37%), Gaps = 38/216 (17%)
Query: 16 ELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIK--REISTMK 68
L R LG G+F +V N + VA+K + +++ E +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIIS 129
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD 127
H N+++ I V +I+LE + GG+L + + + L++ A D
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 128 ------YCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLS-AISQQ----VREDGLLH 173
Y HRD+ N LL G V KI DFG++ I + +L
Sbjct: 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML- 248
Query: 174 TACGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
P V PE + + +D WS GV+L
Sbjct: 249 -----P--VKWMPPEAFMEGIFTS-KTDTWSFGVLL 276
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 45/222 (20%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIK--REISTMK 68
L R LGEG+F KV N+ VA+K + +D + + RE +
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KD----PTLAARKDFQREAELLT 72
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFD---------KIAKHGRLKEDEARRYF 119
++H +++K V + +V E++ G+L I G+ ++ +
Sbjct: 73 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 120 QQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VR 167
Q+++ A Y S+ HRDL N L+ + ++KI DFG+S + V
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 168 EDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
+L P + PE + + + SDVWS GVIL
Sbjct: 193 GHTML------P--IRWMPPESIMYRKFT-TESDVWSFGVIL 225
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 47/220 (21%), Positives = 82/220 (37%), Gaps = 40/220 (18%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
LGE F KV G+ VAIK + + E+ + E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--EEFRHEAMLRARL 69
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD---------KIAKHGRLKEDEARRYFQQ 121
+HPNV+ ++ V+ + ++ + G+L + + + ++
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 122 LIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VRED 169
++ Y S V H+DL N+L+ +KISD GL + + +
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 170 GLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
LL P + APE + + SD+WS GV+L
Sbjct: 190 SLL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVL 220
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 47/224 (20%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDF-----VAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+ G+TLG G+F KV A G VA+K++ E + E+ M +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 71 -KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRY-------FQQL 122
+H N++ ++ + ++ E+ G+L + + + R+ E + + L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 123 IN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA 175
++ + + S+ HRD+ N+LL + V KI DFGL ++ + D
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMND------ 217
Query: 176 CGTPNYV------------APEVLNDKGYDGRASDVWSCGVILF 207
NY+ APE + D Y SDVWS G++L+
Sbjct: 218 ---SNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 53/219 (24%), Positives = 84/219 (38%), Gaps = 40/219 (18%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
L LGEG+F KV N+ VA+K + ++ + +RE + ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQ--DFQREAELLTML 100
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGEL--------FDKIAKHGRLKEDEARRYFQQL 122
+H ++++ V + +V E++ G+L D G QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 123 IN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDG 170
+ A Y HRDL N L+ V+KI DFG+S I V
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 171 LLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
+L P + PE + + + SDVWS GV+L
Sbjct: 221 ML------P--IRWMPPESILYRKFT-TESDVWSFGVVL 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 60/229 (26%), Positives = 89/229 (38%), Gaps = 48/229 (20%)
Query: 16 ELGRTLGEGSF-----AKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
LG+TLGEG F A K VA+K++ + + + E + +K +
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQV 83
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGEL-----------------FDKIAKHGRLKED 113
HP+VIK+ + + +++E+ G L D
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 114 EARRYFQQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ 165
E LI+ A Y + HRDL N+L+ +KISDFGLS + ++
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 166 ----VREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF 207
R G + P V A E L D Y SDVWS GV+L+
Sbjct: 204 DSYVKRSQGRI------P--VKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 43/224 (19%)
Query: 16 ELGRTLGEGSFAKVKFAK-------NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
LG+ LGEG+F +V A+ + VA+K++ D + + E+ MK
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--SDLVSEMEMMK 95
Query: 69 LI-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD---------KIAKHGRLKEDEARRY 118
+I KH N+I ++ +Y+++E+ G L + + + E +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 119 FQQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----V 166
F+ L++ Y S+ HRDL N+L+ V+KI+DFGL+ I+
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 167 REDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF 207
+G L P V APE L D+ Y SDVWS GV+++
Sbjct: 216 TTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 47/226 (20%)
Query: 16 ELGRTLGEGSFAKV-----KFAKNVETGDF--VAIKIVDRDQVLRHKMVEQIK--REIST 66
LG+ LGEG+F +V + VA+K++ D + E+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEM 127
Query: 67 MKLI-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD---------KIAKHGRLKEDEAR 116
MK+I KH N+I ++ +Y+++E+ G L + + E +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 117 RYFQQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ--- 165
+ L++ A Y S+ HRDL N+L+ V+KI+DFGL+ I
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 166 -VREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF 207
+G L P V APE L D+ Y SDVWS GV+L+
Sbjct: 248 KKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 16 ELGRTLGEGSFAKVKFAK-------NVETGDFVAIKIVDRDQVLRHKMVEQIK--REIST 66
LG+ LGEG F +V A+ + VA+K++ D + E+
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEM 139
Query: 67 MKLI-KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD---------KIAKHGRLKEDEAR 116
MK+I KH N+I ++ +Y+++E+ G L + + + E +
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 117 RYFQQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ--- 165
F+ L++ Y S+ HRDL N+L+ V+KI+DFGL+ I+
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 166 -VREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF 207
+G L P V APE L D+ Y SDVWS GV+++
Sbjct: 260 KKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 42/223 (18%)
Query: 16 ELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+LG+ LG G+F +V A T VA+K++ H + E+ + I
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHI 87
Query: 71 -KHPNVIKIIEV-MASKTKIYIVLEFIDGGELFD---------KIAKHGRLKEDEARRYF 119
H NV+ ++ + +++EF G L K +
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 120 QQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VR 167
+ LI + + SR HRDL N+LL V+KI DFGL+ I + +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 168 EDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVILF 207
D L P + APE + D+ Y SDVWS GV+L+
Sbjct: 208 GDARL------P--LKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 52/228 (22%), Positives = 87/228 (38%), Gaps = 48/228 (21%)
Query: 16 ELGRTLGEGSFAKV--KFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
E R +GEG+F +V A + + VA+K++ + + +RE + M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMAEF 107
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGEL-----------------FDKIAKHGRLKED 113
+PN++K++ V A + ++ E++ G+L D +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 114 EARRYFQQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ 165
+ + A Y R HRDL N L+ V+KI+DFGLS I
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 166 ----VREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCGVIL 206
+ + P + PE + Y SDVW+ GV+L
Sbjct: 228 DYYKADGNDAI------P--IRWMPPESIFYNRYT-TESDVWAYGVVL 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 60/235 (25%)
Query: 16 ELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIV--DRDQVLRHKMVEQIKREISTMK 68
E G+ LG G+F KV A VA+K++ D R ++ E+ M
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM----SELKMMT 103
Query: 69 LI-KHPNVIKIIEVMASKTKIYIVLEFIDGGEL----------------FDKIAKHGRLK 111
+ H N++ ++ IY++ E+ G+L + K +
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 112 EDEARRYFQQLIN-AVD------YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164
ED F+ L+ A + + HRDL N+L+ V+KI DFGL ++
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL---AR 220
Query: 165 QVREDGLLHTACGTPNYV------------APEVLNDKGYDGRASDVWSCGVILF 207
+ D NYV APE L + Y + SDVWS G++L+
Sbjct: 221 DIMSDS---------NYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLW 265
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIK 71
+ +G+ +G G+F +++ KN+ T ++VAIK+ Q+ E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-----QLHLEYRFYKQLGS 63
Query: 72 HPNVIKIIEVMASKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ ++ +VLE + +LFD + LK QLI+ ++Y
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKT--VLMIAIQLISRMEYV 121
Query: 130 HSRGVFHRDLKPENLLLDSYG-----VLKISDFGLS-----AISQQV---REDGLLHTAC 176
HS+ + +RD+KPEN L+ G V+ I DF L+ +++ RE L
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL---T 178
Query: 177 GTPNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLP 215
GT Y++ + G + R D+ + G + + G LP
Sbjct: 179 GTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK- 71
K+ LGR +G GSF ++ N++T + VAIK+ + +H Q+ E ++++
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KH---PQLLYESKIYRILQG 61
Query: 72 HPNVIKIIEVMASKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ + +V++ + +LF+ ++ LK Q+IN V++
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKT--VLMLADQMINRVEFV 119
Query: 130 HSRGVFHRDLKPENLLLDSYG---VLKISDFGLS-----AISQQVREDGLLHTACGTPNY 181
HS+ HRD+KP+N L+ + I DFGL+ + Q GT Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 182 VAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLP 215
+ V G + R D+ S G +L + G LP
Sbjct: 180 AS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 51/229 (22%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRD--QVLRHKMVEQIKREISTMKLIKHPNVIKI 78
+G G F KV + + G VA+K + Q + + + EI T+ +HP+++ +
Sbjct: 47 IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE-----EFETEIETLSFCRHPHLVSL 100
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD------YCHSR 132
I + ++ ++ ++++ G L + +G + + Q+L + Y H+R
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYLHTR 158
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSA---------ISQQVREDGLLHTACGTPNYVA 183
+ HRD+K N+LLD V KI+DFG+S +S V+ GT Y+
Sbjct: 159 AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK---------GTLGYID 209
Query: 184 PE-----VLNDKGYDGRASDVWSCGVILFVLMAG------FLPFDESNL 221
PE L +K SDV+S GV+LF ++ LP + NL
Sbjct: 210 PEYFIKGRLTEK------SDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+Y LGR +G GSF + ++ G+ VAIK+ +H Q+ E K+++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHP---QLHIESKIYKMMQG 63
Query: 73 -PNVIKIIEVMASKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ I A +V+E + +LF+ ++ LK Q+I+ ++Y
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKT--VLLLADQMISRIEYI 121
Query: 130 HSRGVFHRDLKPENLLLDSYG---VLKISDFGLS-----AISQQ---VREDGLLHTACGT 178
HS+ HRD+KP+N L+ ++ I DFGL+ A + Q RE+ L GT
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL---TGT 178
Query: 179 PNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLP 215
Y + + G + R D+ S G +L G LP
Sbjct: 179 ARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 49/220 (22%), Positives = 89/220 (40%), Gaps = 29/220 (13%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIK 71
Y++GR +GEGSF + N+ VAIK R Q++ E T K L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAP---QLRDEYRTYKLLAG 64
Query: 72 HPNVIKIIEVMASKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
+ + +V++ + +L D + +K +Q++ V
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKT--VAMAAKQMLARVQSI 122
Query: 130 HSRGVFHRDLKPENLLLDSYG-----VLKISDFGLS-----AISQQV---REDGLLHTAC 176
H + + +RD+KP+N L+ ++ + DFG+ +++Q RE L
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL---S 179
Query: 177 GTPNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLP 215
GT Y++ + G + R D+ + G + + G LP
Sbjct: 180 GTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 4e-15
Identities = 38/192 (19%), Positives = 59/192 (30%), Gaps = 48/192 (25%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIV-----DRDQVLRHKMVEQIKREISTMK 68
K + +GEG F +V VAIKI+ D K E+I EI K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 69 LI---------KHPNVIKIIEV------------------------------MASKTKIY 89
+ + I + V +++
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDS 148
IVLEF GG +++ A+ QL ++ + HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 149 YGVLKISDFGLS 160
+ K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 53/233 (22%), Positives = 87/233 (37%), Gaps = 68/233 (29%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-HKMVEQIKREISTMKLIKHPNVIKII 79
+GEG F V K VA+K + + ++ +Q +EI M +H N+++++
Sbjct: 39 MGEGGFGVV--YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 80 -------------EVMASKTKIYIVLEFIDGGELFDKIAKHG-----RLK--EDEARRYF 119
M + + L L R K + A
Sbjct: 97 GFSSDGDDLCLVYVYMPNGS-----LLDR----LSCLDGTPPLSWHMRCKIAQGAAN--- 144
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL---------SAISQQVREDG 170
+++ H HRD+K N+LLD KISDFGL + ++ ++
Sbjct: 145 -----GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV--- 196
Query: 171 LLHTACGTPNYVAPE----VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES 219
GT Y+APE + K SD++S GV+L ++ G DE
Sbjct: 197 ------GTTAYMAPEALRGEITPK------SDIYSFGVVLLEIITGLPAVDEH 237
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 43/231 (18%), Positives = 89/231 (38%), Gaps = 36/231 (15%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
++ LG+ +G G F + A + A +V + ++ + E+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE----YQENGPLFSELKFYQRVAK 92
Query: 73 PNVIKIIEVMASKTKI-------------------YIVLEFIDGGELFDKIAKHGRLKED 113
+ IK + ++V+E + G +L ++G K+
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151
Query: 114 EARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLS-----AISQQV 166
+ ++++ ++Y H H D+K NLLL + + ++D+GLS + +
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 167 REDGLLHTACGTPNYVAPEVLND-KGYD-GRASDVWSCGVILFVLMAGFLP 215
++ GT + + L+ KG R SDV G + + G LP
Sbjct: 212 YQENPRKGHNGTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 42/223 (18%)
Query: 21 LGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80
LG G F KV + + G VA+K + ++ ++ Q + E+ + + H N++++
Sbjct: 38 LGRGGFGKV-YKGRLADGTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 94
Query: 81 VMASKTKIYIVLEFIDGG----ELFDKIAKHGRLKEDEARRYFQQLINAV---------- 126
+ T+ +V ++ G L ++ L D +R I A+
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPL--DWPKRQ---RI-ALGSARGLAYLH 148
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH--TA-CGTPNYVA 183
D+C + + HRD+K N+LLD + DFGL+ + + H TA GT ++A
Sbjct: 149 DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRGTIGHIA 203
Query: 184 PE-----VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL 221
PE ++K +DV+ GV+L L+ G FD + L
Sbjct: 204 PEYLSTGKSSEK------TDVFGYGVMLLELITGQRAFDLARL 240
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 36/242 (14%), Positives = 80/242 (33%), Gaps = 55/242 (22%)
Query: 13 GKYELGRTLGEGSF-----AKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
+++G +G+G F A + +++V + +K+ D + E+
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-------GPLFTELKFY 87
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH--------GRLKED---EAR 116
+ P I+ + + ++ G + G +
Sbjct: 88 QRAAKPEQIQKWIRTRKLKYLGVP-KYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 117 RYF---------QQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLS----- 160
+ F ++++ ++Y H H D+K NLLL+ + + + D+GL+
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 161 -----AISQQVREDGLLHTACGTPNYVAPEVLND-KGYD-GRASDVWSCGVILFVLMAGF 213
A + GT + + ++ G R D+ G + + G
Sbjct: 207 EGVHKAYAA--DPKRCH---DGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
Query: 214 LP 215
LP
Sbjct: 259 LP 260
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 35/239 (14%), Positives = 82/239 (34%), Gaps = 49/239 (20%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDF--------VAIKIVDRDQVLRHKMV----EQI 60
+++L + + A T ++K+ +D L ++
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKI----YIVLEFIDGGELFDKIAKHGRLKEDEAR 116
+++ K + ++ I M ++VL + G L + +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-------ALDVSPK 153
Query: 117 RYF---------QQLINAVDYCHSRGVFHRDLKPENLLL--DSYGVLKISDFGLSAI--- 162
+L++A+++ H H ++ EN+ + + + ++ +G +
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 163 -SQQV--RED-GLLHTACGTPNYVAPEVLND-KGYD-GRASDVWSCGVILFVLMAGFLP 215
+ V E H G +++ ++ KG R SD+ S G + + GFLP
Sbjct: 214 SGKHVAYVEGSRSPHE--GDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 2e-09
Identities = 73/495 (14%), Positives = 135/495 (27%), Gaps = 186/495 (37%)
Query: 39 DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH----PNVI----KIIEVMASKTKIYI 90
FV + D K V+ + + I + + I H + + ++ + SK + +
Sbjct: 28 AFVD----NFDC----KDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQE-EM 78
Query: 91 VLEFIDGGE------LFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 144
V +F++ L I R R Y +Q R + D N
Sbjct: 79 VQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ----------RDRLYND----NQ 124
Query: 145 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 204
+ Y V ++ + ++R+ LL L V G
Sbjct: 125 VFAKYNVSRLQPY------LKLRQ-ALLE-------------LRPAKN------VLIDG- 157
Query: 205 ILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRAD-----F 259
+ G G K L +C +
Sbjct: 158 -----VLGS------------------------G--------KTWVALDVCLSYKVQCKM 180
Query: 260 SCP-SWFSSG----AKKLIKRI------LDPN----PDTRMTISQMLEDEWFKKGYKPPH 304
W + + +++ + +DPN D I + +
Sbjct: 181 DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI---QAELRRL 237
Query: 305 FDKEEEVN----LDDV------DAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLEN 354
+ N L +V +A FN S + L+T + K V+ F + T SL+
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNA-FNLSCKILLT-TRFKQVT--DFLSAATTTHISLD- 292
Query: 355 LFEKQTGLVKRET-----RFTSQRP---PNEI-------MSKIEEAAKPLGFNVRKGNYK 399
L E ++ RP P E+ +S I E+ + N+K
Sbjct: 293 --HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRD--GLATWDNWK 348
Query: 400 MKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDV---- 455
+ DK + S+ + E+ K + + S
Sbjct: 349 -HVNCDKLTTIIESSLNVL------------------EPAEYRKMFDRLSVFPPSAHIPT 389
Query: 456 -----VWQAEENKEE 465
+W +
Sbjct: 390 ILLSLIWFDVIKSDV 404
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 1e-08
Identities = 77/514 (14%), Positives = 150/514 (29%), Gaps = 174/514 (33%)
Query: 44 KIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDK 103
++ + V R + ++++ + ++L NV+ I+ + K ++ L+ ++ K
Sbjct: 124 QVFAKYNVSRLQPYLKLRQAL--LELRPAKNVL--IDGVLGSGKTWVALDVCLSYKVQCK 179
Query: 104 IAKH------GRLKEDEAR-RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156
+ E Q+L+ +D + H + ++
Sbjct: 180 MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI---HSIQAELRR 236
Query: 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS----------C---- 202
+ + E+ LL VL +V + C
Sbjct: 237 L----LKSKPYENCLL-------------VL-----L----NVQNAKAWNAFNLSCKILL 270
Query: 203 -----GVILFV------------LMAGFLPFDES-NLMALY------------RKVSTFH 232
V F+ P DE +L+ Y +
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTP-DEVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 233 FLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRI------LDPNPDTRMT 286
LS+ ES + + D W KL I L+P + R
Sbjct: 330 -LSIIAESIRD---------GLATWDN----WKHVNCDKLTTIIESSLNVLEPA-EYR-- 372
Query: 287 ISQMLED-EWFKKGYK-PPH------FDKEEEVNLDDVDAIFNDSKENLVTE-KKEKPVS 337
+M + F P FD + + V+ + S LV + KE +S
Sbjct: 373 --KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS---LVEKQPKESTIS 427
Query: 338 MNAFELISRTKSFSLENLFEKQTGLVKR----ETRFTSQRPPNEI-----------MSKI 382
+ + L + K LEN + +V +T + P + + I
Sbjct: 428 IPSIYLELKVK---LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNI 484
Query: 383 EEAAKPLGFNVRKGNY---KMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTL 439
E + F + ++ + K++ D T S+ +TL
Sbjct: 485 EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL--------------------NTL 524
Query: 440 EFHKFYKKF-----------SSGLKDVVWQAEEN 462
+ KFYK + + + D + + EEN
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLPKIEEN 558
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 1e-06
Identities = 57/363 (15%), Positives = 107/363 (29%), Gaps = 113/363 (31%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVD-RDQV-----LRHKMV-EQI 60
+ + + + T E K K ++ + D +V R ++ E I
Sbjct: 287 THISLDHHSMTLTPDE---VKSLLLK------YLDCRPQDLPREVLTTNPRRLSIIAESI 337
Query: 61 KREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ 120
+ ++T KH N K+ ++ S ++ L+ E R+ F
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIES---------SLN------------VLEPAEYRKMFD 376
Query: 121 QLINAVDYCHSRGVFHRDLK-PENLL------LDSYGVLKISD--FGLSAISQQVRE--- 168
+L VF P LL + V+ + + S + +Q +E
Sbjct: 377 RL----------SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 169 ---DGLLHTACGTPNYVAPEVLNDK---GYDG-RASDVWSC------GVILFVLMAGFLP 215
L N A L+ Y+ + D +
Sbjct: 427 SIPSIYLELKVKLENEYA---LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 216 FDESNLMALYRKVST-FHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGA----- 269
+ M L+R V F FL K I +W +SG+
Sbjct: 484 IEHPERMTLFRMVFLDFRFLE----------QK------IRH---DSTAWNASGSILNTL 524
Query: 270 ---KKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNL------DDVDAIF 320
K I D +P ++ +L+ F + + + +L + +AIF
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILD---FLPKIE-ENLICSKYTDLLRIALMAEDEAIF 580
Query: 321 NDS 323
++
Sbjct: 581 EEA 583
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 25/99 (25%)
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 180
Q+ +++ SR HRDL N+LL V+KI DFGL ++ + +D P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL---ARDIYKD---------PD 248
Query: 181 YV------------APEVLNDKGYDGRASDVWSCGVILF 207
YV APE + D+ Y + SDVWS GV+L+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLW 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 35/171 (20%), Positives = 57/171 (33%), Gaps = 13/171 (7%)
Query: 16 ELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+LG+ LG G+F +V A T VA+K++ H + E+ + I
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHI 82
Query: 71 -KHPNVIKIIEVM-ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
H NV+ ++ + +++EF G L + R K +E Y +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFRQG 138
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
G DLK + S S F V E+
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 3e-07
Identities = 16/86 (18%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 370 TSQRPPNEIMSKIEEAAKPLGFNVR-KGNYKMKLQGDKTGRKGQLSVATEVFEVA-PTLH 427
TS PN++M +I + + K + + + + EV ++ +L+
Sbjct: 34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLN 93
Query: 428 IVEVRKTGGDTLEFHKFYKKFSSGLK 453
V ++ G ++ F K ++ LK
Sbjct: 94 GVRFKRISGTSIAFKNIASKIANELK 119
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 28/165 (16%), Positives = 55/165 (33%), Gaps = 28/165 (16%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKI---------------VDRDQVLRHKMVEQ 59
+G+ +GEG + V + E +K D +
Sbjct: 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 60 IKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF 119
+ E ++ ++ V K+ +++E ID EL+ ++ +
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYR-------VRVENPDEVL 199
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164
++ V + RG+ H DL N+L+ + I DF S
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 243
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 99.98 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.19 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.96 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.89 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.82 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.78 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.65 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.64 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.6 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.58 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.55 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.42 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 98.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.09 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.82 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.67 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.52 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.27 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.18 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.16 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.12 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.89 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.76 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.47 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.28 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.72 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.58 | |
| 3ost_A | 128 | Serine/threonine-protein kinase KCC4; kinase assoc | 85.0 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 81.61 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-70 Score=526.41 Aligned_cols=262 Identities=31% Similarity=0.601 Sum_probs=240.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+++|+.|+|||||++++++.+++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34567999999999999999999999999999999998876655555778999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||||+||+|++++.+.+.++|..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876554445
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
....+.|||+.|+|||++.+..| +.++|||||||+||+|++|.+||.+.+..+++.+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~---------------------- 245 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK---------------------- 245 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----------------------
T ss_pred ccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----------------------
Confidence 56678899999999999998887 5899999999999999999999999988888777
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH------HhcCccccc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ------MLEDEWFKK 298 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~e------il~hpwf~~ 298 (468)
+....+.+|..+|+++++||.+||+.||++|||++| +++||||+.
T Consensus 246 ----i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 246 ----IIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp ----HHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ----HHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 344566778889999999999999999999999998 588999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-69 Score=516.45 Aligned_cols=261 Identities=47% Similarity=0.885 Sum_probs=219.9
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
+..+++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 45689999999999999999999999999999999999877655555567899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||| +|+|++++...+++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 164 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--- 164 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---
Confidence 9999999 679999999999999999999999999999999999999999999999999999999999999986543
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.....+.|||+.|+|||++.+..|++.++||||+||++|+|++|.+||.+.+..++++.
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~--------------------- 223 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKN--------------------- 223 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------------------
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH---------------------
Confidence 23456789999999999999999888999999999999999999999999888877776
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
+..+.+.+|.++|+++++||.+||+.||++|||++|+++||||+..
T Consensus 224 -----i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 224 -----ISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp -----HHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred -----HHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 3445566788899999999999999999999999999999999854
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-66 Score=511.35 Aligned_cols=259 Identities=26% Similarity=0.455 Sum_probs=228.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
..|++++.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999997654322 356789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
|||+||+|++++.. +++++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 227 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 227 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCB
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCcc
Confidence 99999999998876 6799999999999999999999999999999999999999999999999999986543 23345
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
.+.|||+.|+|||++.+..| +.++|||||||+||+|++|.+||.+.+..+.+..+...
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--------------------- 285 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------------- 285 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---------------------
T ss_pred cccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---------------------
Confidence 67899999999999998888 59999999999999999999999998887777665321
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
....+..+..+|+++++||.+||+.||++|||++|+|+||||++...
T Consensus 286 --~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 286 --LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp --SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred --CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 11122334458999999999999999999999999999999997643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-67 Score=512.93 Aligned_cols=261 Identities=28% Similarity=0.548 Sum_probs=225.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.|+|||||++++++.+++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 468999999999999999999999999999999999876543 3356789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 91 VLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|||||+||+|++++...+ .++|..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 999999999999997543 47999999999999999999999999999999999999999999999999998654321
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
....+.|||+.|+|||++.+..|+ .++|||||||+||+|++|.+||.+.+..+++.++..
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~------------------ 239 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS------------------ 239 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------------------
T ss_pred -ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc------------------
Confidence 234567899999999999998885 899999999999999999999999988888777422
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
......+..+|+++.+||.+||+.||++|||++|+|+||||++..
T Consensus 240 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 240 -------GSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp -------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred -------CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 111234566899999999999999999999999999999998643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-66 Score=501.86 Aligned_cols=256 Identities=32% Similarity=0.626 Sum_probs=222.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
++|++++.||+|+||+||+|++. .+++.||||++++...... ....+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 67999999999999999999984 4688999999976543222 1235778999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||||+||+|++++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~ 180 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HE 180 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--CC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999985433 23
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
....+.|||+.|+|||++.+..|+ .++||||+||+||+|++|.+||.+.+..+++..+
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--------------------- 238 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI--------------------- 238 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------------------
T ss_pred ccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH---------------------
Confidence 345678999999999999988885 8999999999999999999999999888887773
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
.+..+.+|..+|+++.+||++||+.||++||| ++|+++||||+.
T Consensus 239 -----~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 239 -----LKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp -----HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred -----HcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 34556778889999999999999999999998 579999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-65 Score=511.93 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=229.3
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
+.|++++.||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.|+|||||+++++|.+.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999997654322 356889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcc
Q 012228 93 EFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLL 172 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 172 (468)
|||+||+|.+++.. +++++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... .....
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 304 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 304 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCB
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCccc
Confidence 99999999998865 6799999999999999999999999999999999999999999999999999986543 23345
Q ss_pred cccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccc
Q 012228 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252 (468)
Q Consensus 173 ~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (468)
.+.|||+.|||||++.+..| +.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---------------------- 361 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---------------------- 361 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----------------------
T ss_pred cccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc----------------------
Confidence 67899999999999998888 5999999999999999999999999888777766532
Q ss_pred ccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 253 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
.....+..+..+|+++++||.+||+.||++|||++|+|+||||++...
T Consensus 362 -~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 362 -NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp -SCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred -CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 111223345568999999999999999999999999999999997543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-64 Score=516.54 Aligned_cols=408 Identities=36% Similarity=0.665 Sum_probs=312.1
Q ss_pred CCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
...+...+++|++++.||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+
T Consensus 8 ~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp -CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34566788999999999999999999999999999999999987654433346788999999999999999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
.+.+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|....
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
. .....+.|||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+...++.+
T Consensus 168 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~----------------- 227 (476)
T 2y94_A 168 D---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----------------- 227 (476)
T ss_dssp T---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH-----------------
T ss_pred c---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH-----------------
Confidence 2 23456789999999999999888877899999999999999999999998877666665
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCCCCCccccCCcc--hh---hhh
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLD--DV---DAI 319 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~~~~~~~~~~~~~--~~---~~~ 319 (468)
+..+.+..|..+++++.+||++||+.||.+|||++++++||||++...+...+........ +. ...
T Consensus 228 ---------i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (476)
T 2y94_A 228 ---------ICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEV 298 (476)
T ss_dssp ---------HHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSC
T ss_pred ---------HhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHH
Confidence 3334556677899999999999999999999999999999999875432221111100000 00 000
Q ss_pred ---hccccccc----cccccCCC------------CC---CChh---------------------hhhhcCCCC------
Q 012228 320 ---FNDSKENL----VTEKKEKP------------VS---MNAF---------------------ELISRTKSF------ 350 (468)
Q Consensus 320 ---~~~~~~~~----~~~~~~~~------------~~---~~~~---------------------~~~~~~~~~------ 350 (468)
+....+.. .......+ .. ...+ ..+..+.+.
T Consensus 299 ~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (476)
T 2y94_A 299 CEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARH 378 (476)
T ss_dssp CCC-------------------------------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCST
T ss_pred HHHcCCCHHHHHHHHhCCCCCCHHHHHHHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccc
Confidence 00000000 00000000 00 0000 000000000
Q ss_pred CCccc--hhh---hcccccccceeeecCChhHHHHHHHHHhcccCceEEe-cCceeEEeeccCCCCCceEEEEEEEEEeC
Q 012228 351 SLENL--FEK---QTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAP 424 (468)
Q Consensus 351 ~~~~~--~~~---~~~~~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~ 424 (468)
.+... ... .+...+++.++.|+.+|.+||.+|..|++.+|+.|+. +.+.|+++...+.....+.|.+++|++++
T Consensus 379 ~~~~~~~~~~~~~~~~~~~w~lgi~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~ 458 (476)
T 2y94_A 379 TLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDS 458 (476)
T ss_dssp TCTTTSSSTTTCSCCCCCCEEESEEECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSS
T ss_pred cccccccccccccccccceeeecCccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecC
Confidence 00000 000 1223578899999999999999999999999999976 67999998765544567789999999999
Q ss_pred CeEEEEEEEcCCCchhH
Q 012228 425 TLHIVEVRKTGGDTLEF 441 (468)
Q Consensus 425 ~~~~vdf~~~~Gd~le~ 441 (468)
+.+||||++..|+.++|
T Consensus 459 ~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 459 RTYLLDFRSIDDEILEV 475 (476)
T ss_dssp SCEEEEEEEECCC----
T ss_pred CcEEEEeeecCCCcccc
Confidence 99999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-64 Score=483.70 Aligned_cols=256 Identities=25% Similarity=0.479 Sum_probs=219.4
Q ss_pred ccCe-EEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----CC
Q 012228 12 VGKY-ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----KT 86 (468)
Q Consensus 12 ~~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~ 86 (468)
-++| ++.+.||+|+||+||+|.+..++..||+|++...... ....+.+.+|+.+|+.|+|||||++++++.+ .+
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 3566 7888999999999999999999999999999865543 3346789999999999999999999999865 35
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeecc-CCceEEeccccchhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDS-YGVLKISDFGLSAIS 163 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~g--ivHrDlKp~NILl~~-~g~lkl~DFGla~~~ 163 (468)
.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 68999999999999999999999999999999999999999999999 999999999999984 799999999999753
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc-hHHHHHHhhcccccccccccchh
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
. .....+.||||.|||||++.+ +| +.++|||||||+||+|++|.+||.+. +...++..+...
T Consensus 183 ~----~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~----------- 245 (290)
T 3fpq_A 183 R----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG----------- 245 (290)
T ss_dssp C----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-----------
T ss_pred C----CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC-----------
Confidence 2 334567899999999999875 46 59999999999999999999999764 444555543211
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
......+...++++.+||.+||+.||++|||++|+|+||||++
T Consensus 246 -------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 246 -------------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -------------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -------------CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0111234457899999999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-64 Score=491.06 Aligned_cols=260 Identities=25% Similarity=0.353 Sum_probs=220.6
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
.++.|++.++||+|+||+||+|+++.+|+.||||+++++... .+|+.+|+.|+|||||++++++.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 346799999999999999999999999999999999865432 379999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC-ceEEeccccchhhhhhhcC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVRED 169 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~~~~ 169 (468)
|||||+||+|++++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+........
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999999999999999999999999999999999999999999999988 5999999999876442221
Q ss_pred C---cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 170 G---LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 170 ~---~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
. ...+.|||+.|||||++.+..|+ .++||||+||+||+|++|.+||.+.+..+++.++...
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--------------- 271 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--------------- 271 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS---------------
T ss_pred cceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC---------------
Confidence 1 22346899999999999998885 8999999999999999999999876654444443210
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH-------------hcCcccccCCCC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQM-------------LEDEWFKKGYKP 302 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~ei-------------l~hpwf~~~~~~ 302 (468)
.......|+.+|+++.+||.+||+.||.+|||+.|+ ++|||+.+...|
T Consensus 272 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 272 --------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp --------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred --------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 001123567799999999999999999999999997 579999765433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-62 Score=493.66 Aligned_cols=286 Identities=25% Similarity=0.343 Sum_probs=228.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe------CC
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------KT 86 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------~~ 86 (468)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.|+|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 579999999999999999999999999999999976433 23345678899999999999999999999754 36
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.+|||||||+ |+|++++...+.+++..++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7999999996 589999999999999999999999999999999999999999999999999999999999999865332
Q ss_pred --hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 167 --REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 167 --~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.......+.|||+.|+|||++.+..+++.++||||+|||+|+|++|.+||.+.+..+.+..+.......... .+...
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~-~~~~~ 290 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA-VIQAV 290 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG-GTC--
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH-Hhhhh
Confidence 223455678999999999999988887899999999999999999999999998877777664321110000 00000
Q ss_pred cccc-ccccccccccC-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 245 TNKY-SYTLQICRADF-----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 245 ~~~~-~~~~~~~~~~~-----~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
.... ........... ...+.+|+++++||.+||..||++|||++|+|+||||++...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 0000 00000000000 012347899999999999999999999999999999987543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-61 Score=504.18 Aligned_cols=260 Identities=26% Similarity=0.462 Sum_probs=226.6
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHH---HHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE---QIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~---~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
...+++|++++.||+|+||+||+|+++.+|+.||||++.+..+....... ..++++.+++.++|||||+++++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 55688999999999999999999999999999999999876554332223 334456777888999999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
+.+|||||||+||+|++++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999986532
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch---HHHHHHhhcccccccccccchh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
....+.||||.|+|||++.+...++.++|||||||+||+|++|.+||.+.+ ..++...
T Consensus 345 ----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~--------------- 405 (689)
T 3v5w_A 345 ----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--------------- 405 (689)
T ss_dssp ----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---------------
T ss_pred ----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---------------
Confidence 335678999999999999754444699999999999999999999997643 2233333
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
+....+.+|..+|+++++||.+||+.||.+|++ ++||++||||+.
T Consensus 406 -----------i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 406 -----------TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp -----------HHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred -----------hcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 334556778889999999999999999999998 799999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=462.78 Aligned_cols=253 Identities=27% Similarity=0.453 Sum_probs=201.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-----
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT----- 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----- 86 (468)
+++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|+.|+|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 467999999999999999999999999999999997653 3334578899999999999999999999986544
Q ss_pred -------EEEEEEEccCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEec
Q 012228 87 -------KIYIVLEFIDGGELFDKIAKHGRL---KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156 (468)
Q Consensus 87 -------~~~lV~E~~~gg~L~~~i~~~~~l---~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~D 156 (468)
.+|+|||||+||+|.+++.....+ ++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 379999999999999999877654 4567899999999999999999999999999999999999999999
Q ss_pred cccchhhhhhhcC----------CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH-HHHH
Q 012228 157 FGLSAISQQVRED----------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALY 225 (468)
Q Consensus 157 FGla~~~~~~~~~----------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~-~~~~ 225 (468)
||+|+........ ...++.|||+.|||||++.+..| +.++|||||||+||+|++ ||..... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 9999876442211 12345789999999999998887 499999999999999996 8865432 1222
Q ss_pred HhhcccccccccccchhhhccccccccccccccCCCCC---CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 226 RKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS---WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
..+. . ..+|+ ..++.+.+||++||+.||++|||+.|+++||||+.
T Consensus 238 ~~~~--------------------------~--~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 238 TDVR--------------------------N--LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHH--------------------------T--TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHh--------------------------c--CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 2211 0 11121 24677899999999999999999999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-60 Score=473.18 Aligned_cols=280 Identities=24% Similarity=0.410 Sum_probs=211.1
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (468)
..++|++++.||+|+||+||+|+++ .+++.||+|.+.+.. ....+.+|+.+|+.+ +|||||++++++.+.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 4578999999999999999999975 467899999986543 134578999999998 6999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC-CceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~-g~lkl~DFGla~~~~~ 165 (468)
++|+|||||+||+|.+++. .+++.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 94 ~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999999999983 59999999999999999999999999999999999999876 8999999999975332
Q ss_pred hh--------------------------cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCC-
Q 012228 166 VR--------------------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE- 218 (468)
Q Consensus 166 ~~--------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~- 218 (468)
.. ......+.|||+.|+|||++.+..+++.++||||+|||+|+|++|..||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 11 112345678999999999998877668999999999999999999999954
Q ss_pred chHHHHHHhhcccccc------------------cccccchhhhc-------ccccc---ccccccccCCCCCCCCHHHH
Q 012228 219 SNLMALYRKVSTFHFL------------------SVYGESYKKCT-------NKYSY---TLQICRADFSCPSWFSSGAK 270 (468)
Q Consensus 219 ~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~-------~~~~~---~~~~~~~~~~~~~~~s~~~~ 270 (468)
.+..+.+..+...... ........... ...+. ..............+|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 3333333332210000 00000000000 00000 00000111122334799999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 271 KLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 271 ~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
+||++||+.||++|+|++|+|+||||++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-60 Score=457.12 Aligned_cols=256 Identities=22% Similarity=0.341 Sum_probs=219.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
-++|.+.+.||+|+||+||+|++. .++..||||+++... ....+.+.+|+.+|++|+|||||++++++.+++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 357999999999999999999875 367889999997542 334678999999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceE
Q 012228 87 KIYIVLEFIDGGELFDKIAKH-------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 153 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~-------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lk 153 (468)
.+|||||||++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++++|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 999999999999999999764 3699999999999999999999999999999999999999999999
Q ss_pred EeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccc
Q 012228 154 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFH 232 (468)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~ 232 (468)
|+|||+|+..............+||+.|+|||++.+..| +.++||||+||+||||+| |..||.+.+..++...+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~-- 245 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ-- 245 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH--
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--
Confidence 999999986544332223344679999999999998887 489999999999999998 9999999888777766421
Q ss_pred cccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 233 FLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
......|..+|+++.+|+.+||+.||++|||++++ |+|+++
T Consensus 246 -----------------------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 246 -----------------------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp -----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred -----------------------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 22345677799999999999999999999999999 567764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-59 Score=490.79 Aligned_cols=264 Identities=33% Similarity=0.604 Sum_probs=230.7
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..+++|++++.||+|+||+||+|+++.+|+.||+|++.+... ...+.+.+|+.+|+.|+|||||++++++.+.+.+|
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 456899999999999999999999999999999999976542 23567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC--CceEEeccccchhhhhh
Q 012228 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY--GVLKISDFGLSAISQQV 166 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~--g~lkl~DFGla~~~~~~ 166 (468)
||||||+||+|++++.. .+.+++.+++.|++||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+....
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~- 309 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 309 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC-
Confidence 99999999999999964 4579999999999999999999999999999999999999854 8999999999986543
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.....+.|||+.|+|||++.+..| +.++||||+||+||+|++|.+||.+.+..+.+..+.....
T Consensus 310 --~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~------------- 373 (573)
T 3uto_A 310 --KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------------- 373 (573)
T ss_dssp --TSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-------------
T ss_pred --CCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC-------------
Confidence 344567899999999999999888 5899999999999999999999999988888777532110
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
......+..+|+++++||++||+.||.+|||++|+|+||||+....+
T Consensus 374 ---------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 374 ---------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp ---------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred ---------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 00111224589999999999999999999999999999999976544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=452.20 Aligned_cols=252 Identities=21% Similarity=0.336 Sum_probs=211.2
Q ss_pred cCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
.+|.+.+.||+|+||+||+|+.. .++..||||+++... ....+.+.+|+.+|++|+|||||++++++.+.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 56999999999999999999864 468899999997542 3346789999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCce
Q 012228 88 IYIVLEFIDGGELFDKIAKH---------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVL 152 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~---------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~l 152 (468)
+|||||||++|+|.+++... +++++.++..++.|++.||+|||+++|+||||||+|||++.++++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 99999999999999999754 358999999999999999999999999999999999999999999
Q ss_pred EEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccc
Q 012228 153 KISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTF 231 (468)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~ 231 (468)
||+|||+|+..............+||+.|+|||++.+..| +.++|||||||+||||+| |..||.+.+..+....+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-- 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-- 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH--
Confidence 9999999986654333334456789999999999998887 599999999999999998 999999988777766642
Q ss_pred ccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 232 HFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......|..+|+++.+|+.+||+.||++|||++|++++
T Consensus 275 -----------------------~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 -----------------------QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp -----------------------HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred -----------------------cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 123455677899999999999999999999999999865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-58 Score=447.39 Aligned_cols=256 Identities=22% Similarity=0.342 Sum_probs=221.2
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
...+.+++.+.||+|+||+||+|... .+++.||||+++... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 34578999999999999999999863 467899999996532 22345678999999999999999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 148 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~ 148 (468)
++.+|||||||++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999999999999653 35899999999999999999999999999999999999999
Q ss_pred CCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHh
Q 012228 149 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRK 227 (468)
Q Consensus 149 ~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~ 227 (468)
++++||+|||+|+............+.+||+.|+|||++.+..| +.++||||+||+||||+| |..||.+.+..++...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987655444445567889999999999998887 599999999999999998 8999999888777766
Q ss_pred hcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 228 VSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
+. .....+.|+.+|+++.+|+.+||+.||++|||+.||+++
T Consensus 260 i~-------------------------~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IR-------------------------NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HH-------------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH-------------------------cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 42 122345677799999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-57 Score=445.98 Aligned_cols=266 Identities=43% Similarity=0.819 Sum_probs=239.1
Q ss_pred CCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
.......+++|++.+.||+|+||+||+|.+..+|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 7 ~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 7 CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp ----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 34556788999999999999999999999999999999999987543 33456778899999999999999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
.+.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||+|....
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred CCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999999999999998999999999999999999999999999999999999999999999999999997543
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
. .......+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+..++...
T Consensus 166 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----------------- 225 (328)
T 3fe3_A 166 V---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----------------- 225 (328)
T ss_dssp S---SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------------
T ss_pred C---CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----------------
Confidence 2 33456789999999999999988888899999999999999999999999988777766
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
+..+.+..|..+|+++.+||++||..||.+|||++|+++||||+...
T Consensus 226 ---------i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 226 ---------VLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp ---------HHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred ---------HHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 33455667778999999999999999999999999999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-58 Score=444.54 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=204.2
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.+++++++.||+|+||+||+|+.. ..||||+++.... .....+.+.+|+.+|++++|||||++++++.. +.+|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 357889999999999999999864 3599999875433 23456789999999999999999999998754 568999
Q ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||+||+|.+++... ..+++.++..++.|++.||+|||++||+||||||+|||+++++++||+|||+|+.........
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999999764 579999999999999999999999999999999999999999999999999998765444444
Q ss_pred cccccCCCCCcCCccccccCC--CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHH-HHhhcccccccccccchhhhccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESNLMAL-YRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~--~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
...+.+||+.|||||++.+.. .++.++|||||||+||||+||..||.+.+.... ...+....
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~--------------- 254 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY--------------- 254 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC---------------
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC---------------
Confidence 556789999999999996432 236899999999999999999999987653332 22211100
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 294 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hp 294 (468)
........++.+|+++.+|+.+||+.||++|||+.|++++-
T Consensus 255 ------~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 255 ------ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp ------CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred ------CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 00011234556899999999999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=442.36 Aligned_cols=264 Identities=45% Similarity=0.860 Sum_probs=232.3
Q ss_pred CCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
-+...+++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 3 i~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT 82 (336)
T ss_dssp -CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 35668899999999999999999999999999999999998654433333467889999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.+|+||||+ +|+|++++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~- 160 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD- 160 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-
T ss_pred EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC-
Confidence 999999999 679999999889999999999999999999999999999999999999999999999999999976543
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.........
T Consensus 161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~------------------- 219 (336)
T 3h4j_B 161 --GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK------------------- 219 (336)
T ss_dssp --SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-------------------
T ss_pred --CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-------------------
Confidence 23456789999999999999888877899999999999999999999976543221111
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
+....+..|..+|+++.+||++||+.||.+|||++|+++||||+...
T Consensus 220 -------i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 220 -------VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp -------CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred -------HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 33445667788999999999999999999999999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-56 Score=441.63 Aligned_cols=261 Identities=34% Similarity=0.653 Sum_probs=229.0
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (468)
...+++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 34678999999999999999999999999999999999876554555567788999999988 69999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-- 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-- 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--
Confidence 999999999999999999989999999999999999999999999999999999999999999999999999874322
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
......+.|||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+++..
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~-------------------- 235 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA-------------------- 235 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------------------
T ss_pred CCccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH--------------------
Confidence 2233456799999999999988777 5899999999999999999999999988887777
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI------SQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~------~eil~hpwf~~ 298 (468)
+......+|.++++++.+||++||+.||.+||++ +++++||||+.
T Consensus 236 ------i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 236 ------ILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp ------HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred ------HHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 3445667788899999999999999999999999 89999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=443.65 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=213.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCC-----CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC-CCeeEEEEEEEeC-
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVET-----GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-PNVIKIIEVMASK- 85 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~~- 85 (468)
++|++++.||+|+||+||+|.+..+ ++.||||.+..... ....+.+.+|+.+|++++| ||||++++++...
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 5799999999999999999998654 35799999975432 2345678999999999975 9999999998664
Q ss_pred CEEEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~ 149 (468)
+.+|||||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++++
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 5799999999999999999753 348999999999999999999999999999999999999999
Q ss_pred CceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHH-HHHHh
Q 012228 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLM-ALYRK 227 (468)
Q Consensus 150 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~-~~~~~ 227 (468)
+++||+|||+|+............+.+||+.|||||++.+..| +.++||||+||+||||+| |..||.+.+.. .+...
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~ 300 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 300 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999986543222223445789999999999998887 599999999999999998 99999876533 23332
Q ss_pred hcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 228 VSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
+ .....+..|..+|+++.+|+.+||+.||++|||++||++|
T Consensus 301 i-------------------------~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 301 L-------------------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp H-------------------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H-------------------------HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 2 1123456677899999999999999999999999999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-55 Score=433.58 Aligned_cols=259 Identities=32% Similarity=0.631 Sum_probs=232.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
.+++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 57899999999999999999999999999999999987654344446678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ...
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~ 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CCC
Confidence 999999999999999888999999999999999999999999999999999999999999999999999875322 223
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
...+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++..+
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---------------------- 217 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---------------------- 217 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----------------------
T ss_pred cccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH----------------------
Confidence 4567899999999999988777 58999999999999999999999988877776663
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
......+|..+++++.+||.+||+.||.+|| +++++++||||+.
T Consensus 218 ----~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 218 ----LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp ----HHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ----HcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 3345567778999999999999999999999 9999999999974
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=426.54 Aligned_cols=257 Identities=33% Similarity=0.710 Sum_probs=232.5
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..+++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45789999999999999999999999999999999998765443344677889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999975432
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
...+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||...+....+..+
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--------------------- 215 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--------------------- 215 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---------------------
T ss_pred -ccccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---------------------
Confidence 2346789999999999988777 58999999999999999999999988877776663
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
......+|+.+++++.+||.+||..||.+|| +++++++||||+.
T Consensus 216 -----~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 216 -----LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp -----HHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred -----HhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 3345567788999999999999999999999 9999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-55 Score=433.70 Aligned_cols=262 Identities=31% Similarity=0.588 Sum_probs=231.7
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCC
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (468)
....+++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 345678999999999999999999999999999999999876543333456788999999876 8999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999874322
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
......+.|||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+++..+
T Consensus 171 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------------------ 230 (345)
T 1xjd_A 171 -GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------------------ 230 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------------------
T ss_pred -CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------------------
Confidence 1233567899999999999988777 59999999999999999999999998887777763
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH-HHhcCccccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS-QMLEDEWFKK 298 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~-eil~hpwf~~ 298 (468)
......+|.++++++.+||.+||..||.+|||+. ++++||||+.
T Consensus 231 --------~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 231 --------RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp --------HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred --------HhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 3344567788999999999999999999999998 9999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=434.80 Aligned_cols=261 Identities=30% Similarity=0.591 Sum_probs=227.0
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (468)
...+++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 34578999999999999999999999999999999999877655555566788999999877 89999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+|||||+||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-- 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--
Confidence 999999999999999999989999999999999999999999999999999999999999999999999999974222
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch---------HHHHHHhhcccccccccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---------LMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~---------~~~~~~~~~~~~~~~~~~ 238 (468)
......+.|||+.|+|||++.+..| +.++|||||||++|+|++|..||.... ...+++.
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~----------- 273 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV----------- 273 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH-----------
T ss_pred CCCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH-----------
Confidence 2334567899999999999998877 599999999999999999999996432 1112222
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI------SQMLEDEWFKK 298 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~------~eil~hpwf~~ 298 (468)
+....+.+|..+|+++.+||++||+.||.+||++ +|+++||||+.
T Consensus 274 ---------------i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 274 ---------------ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp ---------------HHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred ---------------HhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 3445667888899999999999999999999995 79999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-54 Score=425.98 Aligned_cols=261 Identities=30% Similarity=0.590 Sum_probs=229.5
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (468)
...+++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 34678999999999999999999999999999999999877665556677889999999988 89999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999875322
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch---------HHHHHHhhcccccccccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---------LMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~---------~~~~~~~~~~~~~~~~~~ 238 (468)
......+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.... ...+++.
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 230 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV----------- 230 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH-----------
T ss_pred CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH-----------
Confidence 2234567799999999999988777 599999999999999999999997521 1222222
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCccccc
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI------SQMLEDEWFKK 298 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~------~eil~hpwf~~ 298 (468)
+......+|..++.++.+||.+||+.||.+|||+ +++++||||+.
T Consensus 231 ---------------i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 231 ---------------ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp ---------------HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred ---------------HHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 3344556778899999999999999999999995 89999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-54 Score=427.76 Aligned_cols=259 Identities=32% Similarity=0.670 Sum_probs=234.5
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
....+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34578999999999999999999999999999999999987655444456778899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999975432
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
...+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus 194 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------------------- 250 (350)
T 1rdq_E 194 ---RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------- 250 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------------------
T ss_pred ---CcccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH-------------------
Confidence 2346789999999999988777 58999999999999999999999998887777663
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
..+...+|..+++++.+||.+||+.||.+||+ ++++++||||+.
T Consensus 251 -------~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 251 -------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp -------HHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred -------HcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 33455677789999999999999999999998 999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=429.26 Aligned_cols=261 Identities=30% Similarity=0.575 Sum_probs=232.0
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (468)
...+++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 45678999999999999999999999999999999999876554444467788999999988 79999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999874322
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
......+.|||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..++++.+
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------------------- 233 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------------------- 233 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------------------
T ss_pred CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH-------------------
Confidence 2233557899999999999988777 59999999999999999999999998888777763
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
......+|..+|+++.+||.+||..||.+||+ ++++++||||+.
T Consensus 234 -------~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 234 -------MEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp -------HHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred -------HhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 33455677889999999999999999999994 699999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-54 Score=426.93 Aligned_cols=259 Identities=33% Similarity=0.583 Sum_probs=227.2
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH---HHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
...++|++++.||+|+||+||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 455789999999999999999999999999999999986543221 12467889999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC----ceEEeccccchh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGLSAI 162 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g----~lkl~DFGla~~ 162 (468)
.+|+||||++||+|++++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999999999888999999999999999999999999999999999999998777 799999999976
Q ss_pred hhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchh
Q 012228 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
... .......+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+.+..+..
T Consensus 169 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------ 232 (361)
T 2yab_A 169 IED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITA------------ 232 (361)
T ss_dssp CCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT------------
T ss_pred cCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Confidence 543 233456789999999999988777 5999999999999999999999999887777766432
Q ss_pred hhccccccccccccccCCC----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 243 KCTNKYSYTLQICRADFSC----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~----~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
..+.+ +..+|+.+.+||.+||..||.+|||++|+++||||+.
T Consensus 233 --------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 233 --------------VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp --------------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred --------------cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 12222 2347899999999999999999999999999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=427.35 Aligned_cols=264 Identities=26% Similarity=0.523 Sum_probs=231.2
Q ss_pred CCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
......+++|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34566788999999999999999999999999999999999876554444567888999999999999999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
+.+|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999976432
Q ss_pred hhcCCcccccCCCCCcCCccccccC--CCCCChhhHHHHHHHHHHHhhCCCCCCCch---HHHHHHhhcccccccccccc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~ 240 (468)
.....+.+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+ .......
T Consensus 168 ---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------- 231 (384)
T 4fr4_A 168 ---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT------------- 231 (384)
T ss_dssp ---TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-------------
T ss_pred ---CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-------------
Confidence 3345678999999999998742 223689999999999999999999997532 3333332
Q ss_pred hhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-HHHHhcCccccc
Q 012228 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-ISQMLEDEWFKK 298 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-~~eil~hpwf~~ 298 (468)
+.......|..+++.+.+||.+||+.||.+||+ ++++++||||+.
T Consensus 232 -------------~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 232 -------------FETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp -------------HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred -------------HhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 233445677789999999999999999999998 999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=426.87 Aligned_cols=261 Identities=30% Similarity=0.586 Sum_probs=223.8
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHH-HhcCCCCCeeEEEEEEEeCCE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIST-MKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~i-l~~l~hpnIv~l~~~~~~~~~ 87 (468)
....++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3466889999999999999999999999999999999987765554556677788887 577899999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999975322
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
......+.|||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+++..+
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------------------- 251 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI------------------- 251 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH-------------------
T ss_pred CCCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------------------
Confidence 2334567899999999999988777 58999999999999999999999998888777763
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI----SQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~----~eil~hpwf~~ 298 (468)
......+++.++..+.+||.+||+.||.+||++ +++++||||+.
T Consensus 252 -------~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 252 -------LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp -------HHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred -------HhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 334455677899999999999999999999997 69999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-54 Score=421.95 Aligned_cols=265 Identities=38% Similarity=0.653 Sum_probs=224.3
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..+++|++++.||+|+||+||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 4678999999999999999999999999999999999755432 23467889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+|||||+||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999866543344
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH-HHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
......+||+.|+|||++.+..+++.++||||+||++|+|++|..||...+.. ..+....
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~------------------- 222 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------------- 222 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH-------------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-------------------
Confidence 44567889999999999988887778999999999999999999999765432 1111110
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
...........+++.+.+||.+||..||.+|||++|+++||||++..
T Consensus 223 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 223 -----EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp -----TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -----cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 00111112234789999999999999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=411.41 Aligned_cols=261 Identities=27% Similarity=0.478 Sum_probs=226.2
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
+...++|++.+.||+|+||+||+|.+..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++...+.+
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 345678999999999999999999999999999999997654332 45678999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 169 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (297)
T ss_dssp EEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--
Confidence 999999999999999876 47999999999999999999999999999999999999999999999999998754432
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......+||+.|+|||++.+..| +.++||||+||++|+|++|..||...+.......+..
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~------------------ 230 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT------------------ 230 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------------
T ss_pred ccccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------
Confidence 223456789999999999988877 5899999999999999999999988776555443211
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
........+..+++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 231 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 231 -----NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -----HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 1122334455689999999999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-53 Score=407.92 Aligned_cols=284 Identities=28% Similarity=0.435 Sum_probs=222.2
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 4789999999999999999999999999999999976543 233456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||+++ +|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence 999987 5555544 467899999999999999999999999999999999999999999999999999976432 223
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCC-CCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
.....+||+.|+|||++.+...++.++||||+||++|+|++|..| |.+.+..+....+....... ....+........
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP-TEEQWPSMTKLPD 235 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC-CTTTCTTGGGSTT
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC-Chhhhhhhccccc
Confidence 345678999999999998877567999999999999999988777 56666555554442211000 0001110000000
Q ss_pred c----ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 250 Y----TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 250 ~----~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
+ ............+.+++++.+||.+||+.||++|||++|+++||||++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 0 00011112233445899999999999999999999999999999998643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=432.57 Aligned_cols=261 Identities=34% Similarity=0.664 Sum_probs=226.4
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++++.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 3457899999999999999999999999999999999875543 234567899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec---cCCceEEeccccchhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~---~~g~lkl~DFGla~~~~~~ 166 (468)
+|||||+||+|++.+...+.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|.....
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~- 165 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG- 165 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT-
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC-
Confidence 9999999999999999999999999999999999999999999999999999999998 467899999999976543
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
........+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+..+.+..+...
T Consensus 166 -~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------------- 228 (444)
T 3soa_A 166 -EQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG--------------- 228 (444)
T ss_dssp -TCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT---------------
T ss_pred -CCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC---------------
Confidence 2233456789999999999988777 58999999999999999999999998877777664321
Q ss_pred ccccccccccccCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 247 KYSYTLQICRADFSCP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~--~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
...+..+ +.+|+++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 229 ---------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 229 ---------AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp ---------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ---------CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 1111222 347999999999999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=435.98 Aligned_cols=262 Identities=33% Similarity=0.632 Sum_probs=222.9
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
....+++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 34467899999999999999999999999999999999987654444456678899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 301 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK- 301 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC-
Confidence 99999999999999999998999999999999999999999998 9999999999999999999999999999875322
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
........+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+.......+
T Consensus 302 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------------------ 361 (446)
T 4ejn_A 302 -DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------------------ 361 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------------------
T ss_pred -CCcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------------------
Confidence 2233556899999999999988777 59999999999999999999999988877776663
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
......+|..+++++.+||.+||+.||.+|| |++|+++||||+.
T Consensus 362 --------~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 362 --------LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp --------HHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred --------HhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 3345567778999999999999999999999 9999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=430.91 Aligned_cols=265 Identities=30% Similarity=0.524 Sum_probs=227.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 35678999999999999999999999999999999998654433323445789999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...... .
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~ 223 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M 223 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-E
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-c
Confidence 99999999999999875 579999999999999999999999999999999999999999999999999997543311 1
Q ss_pred CcccccCCCCCcCCccccccCC---CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~---~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
....+.+||+.|+|||++.+.+ +++.++|||||||++|+|++|..||.+.+....+.++...
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------------- 288 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--------------- 288 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH---------------
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhc---------------
Confidence 1234679999999999998655 2468999999999999999999999999888877775321
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 298 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~--R~t~~eil~hpwf~~ 298 (468)
.....++.+..+|+++++||++||..+|.+ |++++||++||||+.
T Consensus 289 -------~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 289 -------KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp -------HHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred -------cccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 001122233458999999999999999999 999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=413.14 Aligned_cols=262 Identities=32% Similarity=0.628 Sum_probs=219.6
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhhh-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLR-HKMVEQIKREISTMKLIKHPNVIKIIEVMA 83 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 83 (468)
.....++|++.+.||+|+||.||+|++. .+|+.||+|++.+..... ......+.+|+.+|+.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3456789999999999999999999985 689999999997654322 223556789999999999999999999999
Q ss_pred eCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 84 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 84 ~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
+.+.+|+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999998753
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
.. ........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+
T Consensus 172 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--------------- 233 (327)
T 3a62_A 172 IH--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI--------------- 233 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---------------
T ss_pred cc--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH---------------
Confidence 32 1223456789999999999988777 58999999999999999999999988877666653
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
.......|+.+++++.+||.+||..||.+|| +++++++||||+.
T Consensus 234 -----------~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 234 -----------LKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp -----------HHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred -----------HhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 2344566778999999999999999999999 8899999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=419.42 Aligned_cols=260 Identities=33% Similarity=0.667 Sum_probs=225.9
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3456899999999999999999999999999999999865443 334677899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC---ceEEeccccchhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAISQQV 166 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g---~lkl~DFGla~~~~~~ 166 (468)
+|||||+||+|++.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~- 183 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 183 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT-
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC-
Confidence 9999999999999999888999999999999999999999999999999999999998654 599999999976542
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 184 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~--------------- 245 (362)
T 2bdw_A 184 --SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG--------------- 245 (362)
T ss_dssp --CCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---------------
T ss_pred --CcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC---------------
Confidence 233456789999999999988777 58999999999999999999999988877766654211
Q ss_pred ccccccccccccCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 247 KYSYTLQICRADFSCP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~--~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
...+..+ ..+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus 246 ---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 246 ---------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp ---------CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred ---------CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 0111112 237899999999999999999999999999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=430.31 Aligned_cols=264 Identities=27% Similarity=0.496 Sum_probs=226.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 34578999999999999999999999999999999998654433333445789999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~- 229 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 229 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-
Confidence 99999999999999987 5689999999999999999999999999999999999999999999999999997543211
Q ss_pred CCcccccCCCCCcCCcccccc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 169 DGLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.......+||+.|+|||++.. ...++.++||||+||++|+|++|..||.+.+..+.+.++...
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 296 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH------------- 296 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH-------------
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc-------------
Confidence 112345789999999999872 333468999999999999999999999998888877775321
Q ss_pred ccccccccccccccCCCC---CCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCccccc
Q 012228 245 TNKYSYTLQICRADFSCP---SWFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 298 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~---~~~s~~~~~Ll~~~L~~dP~~--R~t~~eil~hpwf~~ 298 (468)
...+.+| ..+|+++++||++||..+|++ |++++|+++||||+.
T Consensus 297 -----------~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 297 -----------KERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp -----------HHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred -----------cccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 1122333 348999999999999999988 999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=418.29 Aligned_cols=258 Identities=38% Similarity=0.744 Sum_probs=212.1
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++++.||+|+||+||+|++..+++.||+|++....... +.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 4578999999999999999999999999999999997654322 457799999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc--eEEeccccchhhhhhhc
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--LKISDFGLSAISQQVRE 168 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~--lkl~DFGla~~~~~~~~ 168 (468)
|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--- 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 170 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc---
Confidence 9999999999999998889999999999999999999999999999999999999987765 99999999874322
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH----HHHHHhhcccccccccccchhhh
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.......+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+. ......
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~----------------- 233 (361)
T 3uc3_A 171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR----------------- 233 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH-----------------
T ss_pred cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH-----------------
Confidence 22234568999999999999888876669999999999999999999986543 222222
Q ss_pred ccccccccccccccCCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 245 TNKYSYTLQICRADFSCPS--WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~--~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
+.......|. .+++++.+||.+||+.||.+|||++|+++||||.+...
T Consensus 234 ---------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 234 ---------ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp ---------HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred ---------HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 1122223333 47999999999999999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=413.94 Aligned_cols=255 Identities=27% Similarity=0.489 Sum_probs=223.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 4678999999999999999999999999999999997542 234568899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc--CCceEEeccccchhhhhhh
Q 012228 91 VLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~--~g~lkl~DFGla~~~~~~~ 167 (468)
|||||+||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 999999999999997654 6999999999999999999999999999999999999987 78999999999976543
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----------------- 217 (321)
T 1tki_A 157 -GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN----------------- 217 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----------------
T ss_pred -CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHc-----------------
Confidence 233456789999999999987665 5899999999999999999999998887776665422
Q ss_pred cccccccccccCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 248 YSYTLQICRADFSCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~----~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
..+..+ +.+|.++.+||.+||..||.+|||+.|+|+||||++.
T Consensus 218 ---------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 218 ---------AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ---------TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ---------CCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 111211 3479999999999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=401.54 Aligned_cols=261 Identities=32% Similarity=0.676 Sum_probs=229.6
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
...+++|++++.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45678999999999999999999999999999999999765544443456788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||+++|+|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc---
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999864332
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+..+....+
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------------- 219 (279)
T 3fdn_A 162 -SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------------------- 219 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------------------
T ss_pred -ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH--------------------
Confidence 22345689999999999987766 58999999999999999999999988877766653
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.......|..+++.+.+||.+||+.||.+|||++|+++||||+...
T Consensus 220 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 220 ------SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp ------HHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ------HhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 3344556777899999999999999999999999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=408.61 Aligned_cols=289 Identities=26% Similarity=0.389 Sum_probs=219.0
Q ss_pred CCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
........++|++++.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp --CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 3445567899999999999999999999995 599999999975432 22345678899999999999999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
.+.+|+||||+++ +|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 91 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 91 ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 9999999999986 7888776644 5999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
.. ........+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+....... ....+..
T Consensus 170 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~ 246 (311)
T 3niz_A 170 GI--PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP-NPREWPQ 246 (311)
T ss_dssp TS--CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCC-CTTTSGG
T ss_pred CC--CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCC-ChHHhhh
Confidence 32 22334556899999999999876555799999999999999999999998765444433332110000 0000000
Q ss_pred hcc-----ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 244 CTN-----KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 244 ~~~-----~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
... ................+.+++++.+||.+||+.||++|||++|+++||||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 000 00000000000011234478999999999999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=412.01 Aligned_cols=294 Identities=26% Similarity=0.374 Sum_probs=215.5
Q ss_pred CCCCCCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEE
Q 012228 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80 (468)
Q Consensus 1 ~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~ 80 (468)
|+...+.+...+++|++++.||+|+||+||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++
T Consensus 22 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (329)
T 3gbz_A 22 MSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKS 100 (329)
T ss_dssp ----------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEE
T ss_pred ceeccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEE
Confidence 445566777889999999999999999999999999999999999976532 2234566789999999999999999999
Q ss_pred EEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec-----cCCceEEe
Q 012228 81 VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-----SYGVLKIS 155 (468)
Q Consensus 81 ~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~-----~~g~lkl~ 155 (468)
++.+.+.+|+||||++| +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 101 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 101 VIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred EEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEEC
Confidence 99999999999999985 9999999988999999999999999999999999999999999999994 45569999
Q ss_pred ccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc
Q 012228 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
|||+|...... .......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 180 Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 180 DFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257 (329)
T ss_dssp CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99999865432 2234556789999999999876655799999999999999999999999887665555443210000
Q ss_pred ccccchhhhcccccccccc-----ccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 236 VYGESYKKCTNKYSYTLQI-----CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
....+........+.... .......+..+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 258 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 258 -DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp -CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred -chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 000000000000000000 000000122268999999999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=411.26 Aligned_cols=264 Identities=37% Similarity=0.587 Sum_probs=225.4
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH---HHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
....++|++++.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3455789999999999999999999999999999999976543211 1246788999999999999999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC----ceEEeccccch
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGLSA 161 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g----~lkl~DFGla~ 161 (468)
+.+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999999999888999999999999999999999999999999999999999887 89999999997
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
.... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 167 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-------- 234 (326)
T 2y0a_A 167 KIDF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-------- 234 (326)
T ss_dssp ECCT---TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC--------
T ss_pred ECCC---CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC--------
Confidence 6532 223456789999999999987776 5899999999999999999999998877666555321100
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
......++.+++.+.+||.+||..||.+|||++++++||||+.
T Consensus 235 --------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 235 --------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp --------------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred --------------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 0000112347899999999999999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=400.25 Aligned_cols=265 Identities=46% Similarity=0.867 Sum_probs=225.0
Q ss_pred CCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
.+....++|++++.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 45667899999999999999999999999999999999997654433334567889999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
..|+||||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~- 163 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD- 163 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999876432
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.......+||+.|+|||++.+..+.+.++||||+|+++|+|++|..||...+.......+
T Consensus 164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------------------ 223 (276)
T 2h6d_A 164 --GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI------------------ 223 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------------------
T ss_pred --CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh------------------
Confidence 222345679999999999988777678999999999999999999999988776666553
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.......|..++..+.+||.+||+.||.+|||++++++||||++..
T Consensus 224 --------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 224 --------RGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp --------HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred --------hcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 2233445677899999999999999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=406.94 Aligned_cols=265 Identities=34% Similarity=0.670 Sum_probs=217.2
Q ss_pred CCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhh-----------------------HHHHHHHHHH
Q 012228 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-----------------------HKMVEQIKRE 63 (468)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~i~~E 63 (468)
.....+++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 34456789999999999999999999999999999999997654221 1124568899
Q ss_pred HHHHhcCCCCCeeEEEEEEEe--CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 012228 64 ISTMKLIKHPNVIKIIEVMAS--KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 141 (468)
Q Consensus 64 i~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp 141 (468)
+.+++.++||||+++++++.+ ...+|+||||+++++|.+++. ...+++..+..++.||+.||+|||++||+||||||
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 999999999999999999987 578999999999999987643 46799999999999999999999999999999999
Q ss_pred CCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCC--CCChhhHHHHHHHHHHHhhCCCCCCCc
Q 012228 142 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY--DGRASDVWSCGVILFVLMAGFLPFDES 219 (468)
Q Consensus 142 ~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~--~~~~~DiWSlGvil~~ll~g~~Pf~~~ 219 (468)
+|||++.++.+||+|||++..... ........+||+.|+|||++.+... .+.++||||+||++|+|++|..||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999876433 2223456789999999999976543 467899999999999999999999988
Q ss_pred hHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 220 NLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
+.......+.. ....+..++.+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 244 ~~~~~~~~~~~------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 244 RIMCLHSKIKS------------------------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp SHHHHHHHHHH------------------------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred cHHHHHHHHhc------------------------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 76665554321 01112223458999999999999999999999999999999963
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-53 Score=409.21 Aligned_cols=250 Identities=21% Similarity=0.305 Sum_probs=193.5
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC----EE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT----KI 88 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----~~ 88 (468)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.... .......|+..+..++|||||++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 5799999999999999999997 689999999975432 1223346777778899999999999997653 68
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCCeeeccCCceEEeccccc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------GVFHRDLKPENLLLDSYGVLKISDFGLS 160 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~--------givHrDlKp~NILl~~~g~lkl~DFGla 160 (468)
|||||||++|+|.+++.. ..++++.+..++.|++.||+|||++ ||+||||||+|||++.++++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999976 5799999999999999999999987 9999999999999999999999999999
Q ss_pred hhhhhhhc--CCcccccCCCCCcCCccccccCCC-----CCChhhHHHHHHHHHHHhhCCCCCCCchH------------
Q 012228 161 AISQQVRE--DGLLHTACGTPNYVAPEVLNDKGY-----DGRASDVWSCGVILFVLMAGFLPFDESNL------------ 221 (468)
Q Consensus 161 ~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DiWSlGvil~~ll~g~~Pf~~~~~------------ 221 (468)
+....... .....+.+||+.|+|||++.+... ++.++||||+||+||||++|.+||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 86543221 122345689999999999976421 24789999999999999999887754321
Q ss_pred ---HHHHHhhcccccccccccchhhhccccccccccccccCCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 222 ---MALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 222 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
..+...+. .......+|.. .+..+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~------------------------~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVC------------------------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHT------------------------TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHh------------------------cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11111100 00111222222 23468899999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=399.97 Aligned_cols=281 Identities=29% Similarity=0.435 Sum_probs=216.7
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|++++.||+|+||+||+|.+ .+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999999 68999999999754322 22245678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||+++ +|.+.+... +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence 999986 899888764 67999999999999999999999999999999999999999999999999999765321 22
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc--cc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN--KY 248 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 248 (468)
.....+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+....... ....+..... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP-NSKNWPNVTELPKY 234 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGSTTC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCC-Chhhchhhhccccc
Confidence 33456899999999999876655799999999999999999999999877655544432110000 0000000000 00
Q ss_pred ccccc--cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 249 SYTLQ--ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 249 ~~~~~--~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
..... ...........+++++.+||.+||+.||++|||++|+++||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00000 000001123457899999999999999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=446.69 Aligned_cols=260 Identities=30% Similarity=0.574 Sum_probs=234.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 88 (468)
..+++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4578899999999999999999999999999999999876554444567788999999988 699999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... .
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--D 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--T
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--C
Confidence 99999999999999999989999999999999999999999999999999999999999999999999999975322 2
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.....+.+||+.|+|||++.+..| +.++|||||||+||+|++|.+||.+.+..++++.
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~--------------------- 553 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS--------------------- 553 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------------------
T ss_pred CcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHH---------------------
Confidence 234567899999999999988877 5999999999999999999999999988888877
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCccccc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI-----SQMLEDEWFKK 298 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~-----~eil~hpwf~~ 298 (468)
+....+.+|..+++++.+||++||+.||.+||++ +||++||||+.
T Consensus 554 -----i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 554 -----IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp -----HHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred -----HHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 3445567788899999999999999999999998 99999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=424.99 Aligned_cols=263 Identities=27% Similarity=0.499 Sum_probs=224.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 34678999999999999999999999999999999998754433334456889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~- 216 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG- 216 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC-
Confidence 9999999999999998754 79999999999999999999999999999999999999999999999999997543311
Q ss_pred CCcccccCCCCCcCCcccccc------CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchh
Q 012228 169 DGLLHTACGTPNYVAPEVLND------KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~------~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
.......+||+.|+|||++.+ ...++.++||||+||++|+|++|..||.+.+..+.+.++...
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------- 285 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY----------- 285 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH-----------
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------
Confidence 112235689999999999873 223369999999999999999999999998888777765321
Q ss_pred hhccccccccccccccCCC---CCCCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCccccc
Q 012228 243 KCTNKYSYTLQICRADFSC---PSWFSSGAKKLIKRILDPNPDTR---MTISQMLEDEWFKK 298 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~Ll~~~L~~dP~~R---~t~~eil~hpwf~~ 298 (468)
...+.. +..+|+++++||++||. +|.+| ++++|+++||||+.
T Consensus 286 -------------~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 286 -------------KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp -------------HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred -------------ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 011122 34689999999999999 99998 59999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=399.70 Aligned_cols=265 Identities=32% Similarity=0.698 Sum_probs=232.0
Q ss_pred CCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
.|.....+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 6 MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp ----CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 45667788999999999999999999999999999999999976544333345678899999999999999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
.+..|+||||+++|+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999986443
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
. ......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+..+....+
T Consensus 166 ~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---------------- 224 (284)
T 2vgo_A 166 S----LRRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI---------------- 224 (284)
T ss_dssp S----SCBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----------------
T ss_pred c----cccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH----------------
Confidence 2 22345689999999999988776 58999999999999999999999988766655542
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.......|+.++..+.+||.+||..||.+|||++++++||||+...
T Consensus 225 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 225 ----------VNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp ----------HTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ----------hccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 2344556777999999999999999999999999999999998643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=413.93 Aligned_cols=258 Identities=35% Similarity=0.659 Sum_probs=217.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH--HHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH--KMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
.-++|++.+.||+|+||+||+|.++.+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34679999999999999999999999999999999976543211 1246788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc---eEEeccccch
Q 012228 89 YIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFGLSA 161 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~---lkl~DFGla~ 161 (468)
|+|||||+||+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999998877643 25899999999999999999999999999999999999987655 9999999997
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
.... ........+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+. ..+..+.
T Consensus 182 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~------------ 245 (351)
T 3c0i_A 182 QLGE--SGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGII------------ 245 (351)
T ss_dssp ECCT--TSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHH------------
T ss_pred EecC--CCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHH------------
Confidence 6543 1223456789999999999988777 5999999999999999999999988643 3333321
Q ss_pred hhhccccccccccccccCCC----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 242 KKCTNKYSYTLQICRADFSC----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
...+.. +..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 246 --------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 246 --------------KGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp --------------HTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred --------------cCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 111111 1347899999999999999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=420.31 Aligned_cols=286 Identities=24% Similarity=0.380 Sum_probs=213.8
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCC--
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKT-- 86 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~-- 86 (468)
...++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 45689999999999999999999999999999999986542 23344667889999999997 999999999997654
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.+|+|||||++ +|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 79999999985 89888876 68999999999999999999999999999999999999999999999999999754321
Q ss_pred -------------------hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHh
Q 012228 167 -------------------REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227 (468)
Q Consensus 167 -------------------~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~ 227 (468)
.........+||++|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1122345678999999999998755557999999999999999999999999887766665
Q ss_pred hcccccccccccc-hhhhccc------------c-------cccc---ccccccCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 012228 228 VSTFHFLSVYGES-YKKCTNK------------Y-------SYTL---QICRADFSCPSWFSSGAKKLIKRILDPNPDTR 284 (468)
Q Consensus 228 ~~~~~~~~~~~~~-~~~~~~~------------~-------~~~~---~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R 284 (468)
+.... ..+... ....... . .... .........+..+++++.+||.+||+.||.+|
T Consensus 243 i~~~~--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 243 IIGVI--DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHH--CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhc--CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 53210 000000 0000000 0 0000 00000111233578999999999999999999
Q ss_pred CCHHHHhcCcccccCC
Q 012228 285 MTISQMLEDEWFKKGY 300 (468)
Q Consensus 285 ~t~~eil~hpwf~~~~ 300 (468)
||++|+|+||||+...
T Consensus 321 ~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 321 ISANDALKHPFVSIFH 336 (388)
T ss_dssp CCHHHHTTSTTTTTTC
T ss_pred CCHHHHhCCHHHHHhc
Confidence 9999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=415.43 Aligned_cols=289 Identities=22% Similarity=0.379 Sum_probs=220.8
Q ss_pred ccccCeEEEeeeeec--CCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 10 TRVGKYELGRTLGEG--SFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G--~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
...++|++++.||+| +||+||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456889999999999 9999999999999999999999875433 3456788999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
+|+|||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999876 6799999999999999999999999999999999999999999999999999764322
Q ss_pred hhc-----CCcccccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccc
Q 012228 166 VRE-----DGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 166 ~~~-----~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
... .......+||+.|+|||++.+ ..| +.++||||+||++|+|++|..||.+.+.......+..........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 111 122334589999999999987 345 689999999999999999999998765443333222111100000
Q ss_pred cch---h-----------------hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 239 ESY---K-----------------KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 239 ~~~---~-----------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
... . ...................+..+++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 000 0 00000000000001112344558999999999999999999999999999999986
Q ss_pred CC
Q 012228 299 GY 300 (468)
Q Consensus 299 ~~ 300 (468)
..
T Consensus 340 ~~ 341 (389)
T 3gni_B 340 IK 341 (389)
T ss_dssp C-
T ss_pred Hh
Confidence 43
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=433.86 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=227.4
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
....++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 35567899999999999999999999999999999999876554444456788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
|+||||++||+|.+++...+. +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 999999999999999987554 99999999999999999999999999999999999999999999999999975432
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch----HHHHHHhhcccccccccccchh
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
.......+||+.|+|||++.+..| +.++||||+||++|+|++|..||...+ ...+...
T Consensus 339 --~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~--------------- 400 (576)
T 2acx_A 339 --GQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------------- 400 (576)
T ss_dssp --TCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH---------------
T ss_pred --CccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH---------------
Confidence 223456799999999999988777 599999999999999999999998753 2333333
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
+......+|..+|+++.+||.+||+.||.+|| |++|+++||||+.
T Consensus 401 -----------i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 401 -----------VKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp -----------HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred -----------hhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 22234456677999999999999999999999 8999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=396.41 Aligned_cols=264 Identities=35% Similarity=0.588 Sum_probs=233.8
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45678999999999999999999999999999999998765545556678899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+||||+++++|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--c
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998764321 2
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+..+....+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------------------- 227 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--------------------- 227 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---------------------
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------------------
Confidence 22345679999999999987766 58999999999999999999999988766655442
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
.......|..+++.+.+||.+||+.||++|||++++++||||+....|
T Consensus 228 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 228 -----KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp -----HTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred -----hhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 233455667789999999999999999999999999999999976654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=400.76 Aligned_cols=283 Identities=26% Similarity=0.380 Sum_probs=218.8
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 6899999999999999999999999999999999865432 233456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|..... ....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--cccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999976442 2223
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
....+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+...... .............+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD--LIPRHQQVFSTNQYF 236 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS--CCHHHHHHHHTCGGG
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcc--ccccccccccccccc
Confidence 456689999999999987555579999999999999999999999988766554443211000 000000000000000
Q ss_pred --cccccccC-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 252 --LQICRADF-----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 252 --~~~~~~~~-----~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
........ ...+.+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 00000000 0013478999999999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-52 Score=397.65 Aligned_cols=262 Identities=34% Similarity=0.636 Sum_probs=204.6
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
+..+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 34678999999999999999999999999999999999765443333457789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|+||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~- 165 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP- 165 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC-
Confidence 9999999999999999875 56999999999999999999999999999999999999999999999999998754321
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......
T Consensus 166 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------------- 223 (278)
T 3cok_A 166 -HEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-------------------- 223 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------------
T ss_pred -CCcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH--------------------
Confidence 122335679999999999987666 5899999999999999999999987553332222
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
+....+..|..++.++.+||.+||+.||.+|||++++++||||.+.
T Consensus 224 ------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 224 ------VVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ------CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ------HhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 2223445677789999999999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=407.08 Aligned_cols=285 Identities=28% Similarity=0.436 Sum_probs=209.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++++.||+|+||+||+|.+..+|+.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 357899999999999999999999999999999999764321 123567799999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 91 VLEFIDGGELFDKIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
||||++| +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9999985 999988754 359999999999999999999999999999999999999999999999999997653
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
. ........+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+....... ....+...
T Consensus 160 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 236 (317)
T 2pmi_A 160 I--PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP-NESLWPSV 236 (317)
T ss_dssp S--CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC-CTTTCGGG
T ss_pred C--CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-ChhHhhhh
Confidence 2 12234566899999999999876555799999999999999999999999887766655543210000 00000000
Q ss_pred ccccccccccc---------cccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 245 TNKYSYTLQIC---------RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 245 ~~~~~~~~~~~---------~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
.....+...+. ......+..++.++.+||.+||+.||.+|||++|+++||||++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 00000000000 0011123357899999999999999999999999999999997543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=404.42 Aligned_cols=264 Identities=35% Similarity=0.589 Sum_probs=233.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 45689999999999999999999999999999999987655455567788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--TC
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--cc
Confidence 9999999999999998889999999999999999999999999999999999999999999999999998765322 22
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+.+..+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---------------------- 253 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI---------------------- 253 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----------------------
T ss_pred cccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH----------------------
Confidence 3345689999999999987766 58999999999999999999999987766655442
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCCC
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~~ 303 (468)
....+..|..+++.+.+||.+||+.||.+|||++|+++||||+..+.+.
T Consensus 254 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 254 ----KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp ----HHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred ----hcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 2334556777899999999999999999999999999999999876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=429.45 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=227.4
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
....++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 45668899999999999999999999999999999999876554444456788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 89 YIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999998764 369999999999999999999999999999999999999999999999999997643
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch----HHHHHHhhcccccccccccc
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~ 240 (468)
.. .......+||+.|+|||++.+..| +.++|||||||++|+|++|..||...+ ..++.+.
T Consensus 341 ~~--~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~------------- 404 (543)
T 3c4z_A 341 AG--QTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR------------- 404 (543)
T ss_dssp TT--CCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH-------------
T ss_pred CC--CcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH-------------
Confidence 31 222345699999999999998777 599999999999999999999997652 3344433
Q ss_pred hhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
+......+|..+|+.+.+||++||+.||.+||+ ++++++||||+.
T Consensus 405 -------------i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 405 -------------VLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp -------------HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred -------------HhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 233445667789999999999999999999996 589999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=427.76 Aligned_cols=278 Identities=25% Similarity=0.410 Sum_probs=215.2
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (468)
..++|++++.||+|+||+||+|.+..+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4688999999999999999999999999999999997653 2334567888999999999999999999999654
Q ss_pred -CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 86 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
..+|+||||+++ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 468999999987 5777664 359999999999999999999999999999999999999999999999999998643
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc------ccc
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS------VYG 238 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~------~~~ 238 (468)
. .......+||+.|+|||++.+..|. .++||||+||++|+|++|.+||.+.+..+.+..+....... ...
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 3345668999999999999988774 89999999999999999999999988776666553211000 000
Q ss_pred cchhhhccccccccccccccCCCCCC---------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSW---------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
........... ......++.. .++++++||.+||+.||.+|||++|+|+||||+....
T Consensus 292 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 292 PTVRNYVENRP-----KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHHHHTTSC-----CCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhhhhHhhccc-----ccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 00000000000 0000111100 1567999999999999999999999999999997554
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=411.53 Aligned_cols=258 Identities=33% Similarity=0.581 Sum_probs=217.5
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 88 (468)
...++|++.+.||+|+||+||+|.++.+|+.||+|++.+... ...+|+.++.++ +||||+++++++.+.+.+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 446789999999999999999999999999999999976532 134788888877 799999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC----CceEEeccccchhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY----GVLKISDFGLSAISQ 164 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~----g~lkl~DFGla~~~~ 164 (468)
|+|||||+||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+... +.+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999999999998899999999999999999999999999999999999998533 359999999997643
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCC---chHHHHHHhhcccccccccccch
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE---SNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~---~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
. ......+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.. .+..++...+....
T Consensus 172 ~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~--------- 239 (342)
T 2qr7_A 172 A--ENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK--------- 239 (342)
T ss_dssp C--TTCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC---------
T ss_pred C--CCCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC---------
Confidence 3 2234567899999999999987766 4899999999999999999999975 34445554432110
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.......+..+|+++.+||++||..||.+|||+.++++||||...
T Consensus 240 -------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 240 -------------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp -------------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred -------------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 000111234589999999999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=426.78 Aligned_cols=261 Identities=36% Similarity=0.622 Sum_probs=223.8
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH----------HHHHHHHHHHHHHhcCCCCCeeEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH----------KMVEQIKREISTMKLIKHPNVIKI 78 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~----------~~~~~i~~Ei~il~~l~hpnIv~l 78 (468)
....++|++++.||+|+||+||+|.+..+++.||+|++.+...... ...+.+.+|+.+|+.++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3456789999999999999999999999999999999976543211 234678899999999999999999
Q ss_pred EEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC---ceEEe
Q 012228 79 IEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKIS 155 (468)
Q Consensus 79 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g---~lkl~ 155 (468)
++++.+...+|+|||||+||+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999999999989999999999999999999999999999999999999999776 69999
Q ss_pred ccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc
Q 012228 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
|||+|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+..+....+..
T Consensus 192 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----- 261 (504)
T 3q5i_A 192 DFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK----- 261 (504)
T ss_dssp CCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----
T ss_pred ECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-----
Confidence 9999986543 233556789999999999874 45 6899999999999999999999999888877776432
Q ss_pred ccccchhhhccccccccccccccCCC----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 236 VYGESYKKCTNKYSYTLQICRADFSC----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
+.+.+ +..+|+++.+||++||++||.+|||++|+|+||||++..
T Consensus 262 ---------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 262 ---------------------GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp ---------------------CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred ---------------------CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 11111 134799999999999999999999999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=411.36 Aligned_cols=263 Identities=29% Similarity=0.533 Sum_probs=224.8
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
....++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+...+
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 3456789999999999999999999999999999999976432 2245788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc--CCceEEeccccchhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQ 165 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~--~g~lkl~DFGla~~~~~ 165 (468)
|+|||||+||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999999987654 6999999999999999999999999999999999999974 57899999999976432
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~------------- 266 (387)
T 1kob_A 204 ---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD------------- 266 (387)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC-------------
T ss_pred ---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 233456689999999999988776 589999999999999999999999887766665542210
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.......+..+++++.+||.+||..||.+|||++|+++||||+...
T Consensus 267 ---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 267 ---------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp ---------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ---------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 0011122345799999999999999999999999999999998653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=391.61 Aligned_cols=263 Identities=32% Similarity=0.618 Sum_probs=226.8
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 4568899999999999999999999999999999999765543 334677889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc---eEEeccccchhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFGLSAISQQV 166 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~---lkl~DFGla~~~~~~ 166 (468)
+||||++|++|.+.+.....+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~- 160 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 160 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc-
Confidence 99999999999999998899999999999999999999999999999999999999986665 99999999875432
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+....
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-------------- 223 (284)
T 3kk8_A 161 --SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-------------- 223 (284)
T ss_dssp --SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------------
T ss_pred --CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc--------------
Confidence 223445789999999999988776 589999999999999999999999887776666532110
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
..........+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 224 --------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 224 --------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp --------CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred --------ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 001111123478999999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-52 Score=428.73 Aligned_cols=262 Identities=37% Similarity=0.634 Sum_probs=228.2
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999997655433334577899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee---ccCCceEEeccccchhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl---~~~g~lkl~DFGla~~~~~~ 166 (468)
+|||||.||+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 181 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 181 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc-
Confidence 999999999999999998999999999999999999999999999999999999999 5678999999999976532
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+..+....+...
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--------------- 242 (484)
T 3nyv_A 182 --SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG--------------- 242 (484)
T ss_dssp --CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------------
T ss_pred --ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC---------------
Confidence 233456789999999999976 45 58999999999999999999999998887777664321
Q ss_pred ccccccccccccCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 247 KYSYTLQICRADFSCP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~--~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
...+..| ..+|+++.+||++||+.||.+|||++|+|+||||+...
T Consensus 243 ---------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 243 ---------KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp ---------CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred ---------CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 1111222 23799999999999999999999999999999998653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=394.86 Aligned_cols=265 Identities=38% Similarity=0.653 Sum_probs=225.7
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
+.+++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 3578999999999999999999999999999999999765432 24567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+||||+++++|.+++.....+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 99999999999999988788999999999999999999999999999999999999999999999999999765443333
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH-HHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||...+.. ..+..+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------- 222 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------------- 222 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-------------------
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-------------------
Confidence 34556789999999999988777678999999999999999999999875432 1111110
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
........+..+++.+.+||.+||+.||.+|||++|+++||||++..
T Consensus 223 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 223 -----EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp -----TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -----hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 00111122234789999999999999999999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=403.56 Aligned_cols=255 Identities=36% Similarity=0.691 Sum_probs=198.7
Q ss_pred cccCeEEE---eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCC
Q 012228 11 RVGKYELG---RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKT 86 (468)
Q Consensus 11 ~~~~y~i~---~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~ 86 (468)
...+|++. +.||+|+||+||+|.+..+|+.||+|++.+.. ...+.+|+.+++.+. ||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 34678886 78999999999999999999999999997542 345678999999997 999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC---ceEEeccccchhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAIS 163 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g---~lkl~DFGla~~~ 163 (468)
..|+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999999989999999999999999999999999999999999999998766 8999999999754
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH-------HHHHHhhcccccccc
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-------MALYRKVSTFHFLSV 236 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~-------~~~~~~~~~~~~~~~ 236 (468)
.. ........+||+.|+|||++.+..| +.++||||+||++|+|++|..||...+. .+....+
T Consensus 160 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-------- 228 (325)
T 3kn6_A 160 PP--DNQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-------- 228 (325)
T ss_dssp CC------------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH--------
T ss_pred CC--CCCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH--------
Confidence 33 2233456789999999999988777 4899999999999999999999986542 2233332
Q ss_pred cccchhhhccccccccccccccCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 237 YGESYKKCTNKYSYTLQICRADFSCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
..+.+..+ ..+|+++.+||.+||..||.+|||++++++||||+...
T Consensus 229 ------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 229 ------------------KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp ------------------TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred ------------------HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 22222222 23799999999999999999999999999999998653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=390.80 Aligned_cols=256 Identities=38% Similarity=0.666 Sum_probs=224.3
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++.+.||+|+||.||+|.+..++..||+|++....... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 45678999999999999999999999999999999997654322 467889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee---ccCCceEEeccccchhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl---~~~g~lkl~DFGla~~~~~~ 166 (468)
+||||+++++|.+++.....+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~- 161 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP- 161 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT-
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC-
Confidence 999999999999999988899999999999999999999999999999999999999 7889999999999875433
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.......+||+.|+|||++.+. .+.++||||+||++|+|++|..||...+..+....+..
T Consensus 162 --~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------- 221 (277)
T 3f3z_A 162 --GKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE---------------- 221 (277)
T ss_dssp --TSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----------------
T ss_pred --ccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----------------
Confidence 2334567899999999998754 46899999999999999999999998877766655321
Q ss_pred ccccccccccccCCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 247 KYSYTLQICRADFSCPS----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~----~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.....|. .+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 222 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 222 ----------GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ----------CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ----------CCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 2222222 478999999999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=425.16 Aligned_cols=262 Identities=38% Similarity=0.642 Sum_probs=224.7
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++++.||+|+||+||+|.+..+++.||+|++.+..... .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 35578999999999999999999999999999999997654322 23567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec---cCCceEEeccccchhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~---~~g~lkl~DFGla~~~~~~ 166 (468)
+|||||.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 176 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC-
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC-
Confidence 9999999999999999889999999999999999999999999999999999999995 456799999999976533
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.......+||+.|+|||++.+. | +.++||||+||++|+|++|.+||.+.+..+....+...
T Consensus 177 --~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--------------- 237 (486)
T 3mwu_A 177 --NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG--------------- 237 (486)
T ss_dssp --C----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---------------
T ss_pred --CCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------------
Confidence 2334567899999999999763 5 58999999999999999999999998877776664321
Q ss_pred ccccccccccccCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 247 KYSYTLQICRADFSCP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~--~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
...+..| ..+|+++.+||.+||+.||.+|||+.++|+||||++...
T Consensus 238 ---------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 238 ---------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp ---------CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred ---------CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 1111222 237999999999999999999999999999999987543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=405.70 Aligned_cols=283 Identities=24% Similarity=0.397 Sum_probs=215.5
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|++++.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 4789999999999999999999999999999999975432 11222455899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||++| +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence 999985 8988887654 599999999999999999999999999999999999999999999999999875432 122
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc---
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK--- 247 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 247 (468)
.....+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+....... ....+......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP-TEETWPGILSNEEF 234 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGCHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-ChHhchhhhcchhh
Confidence 34456889999999999876555799999999999999999999999988766655543211000 00000000000
Q ss_pred --cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 248 --YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 248 --~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
..+...........++.+++++.+||.+||+.||.+|||++|+|+||||.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 00000000111122345789999999999999999999999999999998653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=415.48 Aligned_cols=286 Identities=27% Similarity=0.353 Sum_probs=213.1
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (468)
..++|++++.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 4578999999999999999999999999999999997542 2334567889999999999999999999999766
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
+.+|+||||+++ +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 679999999975 9999999888899999999999999999999999999999999999999999999999999986543
Q ss_pred hhcC--------------------CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhC-----------CC
Q 012228 166 VRED--------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-----------FL 214 (468)
Q Consensus 166 ~~~~--------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g-----------~~ 214 (468)
.... ......+||++|+|||++.....++.++||||+||++|+|++| .+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2211 2346789999999999975555557999999999999999985 44
Q ss_pred CCCCch-----------------HHHHHHhhcccccccccccchhhhccccccccccccccCC-------CCCCCCHHHH
Q 012228 215 PFDESN-----------------LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFS-------CPSWFSSGAK 270 (468)
Q Consensus 215 Pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~s~~~~ 270 (468)
+|.+.+ ..+....+. ...+.+................+...... ..+.+++++.
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~--~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIF--NIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHH--HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHH--HhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 444332 011111110 00000000000000000000000000000 1134799999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 271 KLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 271 ~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
+||.+||+.||.+|||++|+|+||||+...
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999999999998743
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=421.86 Aligned_cols=285 Identities=27% Similarity=0.357 Sum_probs=202.1
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-----C
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-----K 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-----~ 85 (468)
..++|++++.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++.. .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 3478999999999999999999999999999999996542 233456788999999999999999999999843 3
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..+|+||||+. |+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 130 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 67999999985 59999999888899999999999999999999999999999999999999999999999999986542
Q ss_pred hhc-------------------------CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh---------
Q 012228 166 VRE-------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--------- 211 (468)
Q Consensus 166 ~~~-------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~--------- 211 (468)
... .......+||++|+|||++.....++.++||||+|||||+|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 111 1234567899999999987655545799999999999999998
Q ss_pred --CCCCCCCchHH--------------------HHHHhhcccccccccccc-hhhhcc----cccccc--ccccccCCCC
Q 012228 212 --GFLPFDESNLM--------------------ALYRKVSTFHFLSVYGES-YKKCTN----KYSYTL--QICRADFSCP 262 (468)
Q Consensus 212 --g~~Pf~~~~~~--------------------~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~--~~~~~~~~~~ 262 (468)
|.+||.+.+.. +....+.. ..+..... ...... ...... ..........
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~--~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN--ILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHH--HHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHH--HcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 77777665421 11111100 00000000 000000 000000 0000001122
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 263 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 263 ~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
+..++++.+||++||..||.+|||++|+|+||||+..
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 3468999999999999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=425.17 Aligned_cols=260 Identities=37% Similarity=0.646 Sum_probs=219.7
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
....++|++++.||+|+||+||+|++..++..||+|++.+...... ....+.+|+.+++.++||||+++++++.+...+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 3445679999999999999999999999999999999976543222 245688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC---CceEEeccccchhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKISDFGLSAISQQ 165 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~---g~lkl~DFGla~~~~~ 165 (468)
|+|||||+||+|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.. +.+||+|||+|.....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999999999988999999999999999999999999999999999999999764 4599999999976543
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
.......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+..+....+....
T Consensus 192 ---~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------------- 253 (494)
T 3lij_A 192 ---QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK------------- 253 (494)
T ss_dssp ---TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------------
T ss_pred ---CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 223456789999999999864 45 689999999999999999999999988877776643211
Q ss_pred cccccccccccccCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 246 NKYSYTLQICRADFSCP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~--~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
..+..+ ..+|+.+.+||++||+.||.+|||++++|+||||++
T Consensus 254 -----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 254 -----------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp -----------CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred -----------CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 111112 247999999999999999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=397.47 Aligned_cols=286 Identities=26% Similarity=0.403 Sum_probs=215.6
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhh--HHHHHHHHHHHHHHhcCC---CCCeeEEEEEE
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR--HKMVEQIKREISTMKLIK---HPNVIKIIEVM 82 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~ 82 (468)
+....++|++.+.||+|+||+||+|++..+|+.||+|++....... ......+.+|+.+++.++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 4456789999999999999999999999999999999997543211 111234567777777664 99999999999
Q ss_pred EeCC-----EEEEEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEe
Q 012228 83 ASKT-----KIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 155 (468)
Q Consensus 83 ~~~~-----~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~ 155 (468)
.... .+|+||||+.+ +|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 8765 58999999975 99999987654 9999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc
Q 012228 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
|||+|..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+.......
T Consensus 163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eCccccccCC---CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999976532 233456789999999999988777 589999999999999999999999887766665543211000
Q ss_pred ccccchhhhcc--ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 236 VYGESYKKCTN--KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 236 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
. ...+..... ................+.+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 239 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 239 P-EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp C-TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred C-hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0 000000000 00000000000011224578999999999999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=390.19 Aligned_cols=260 Identities=35% Similarity=0.589 Sum_probs=215.5
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
+...++|++.+.||+|+||+||+|.+..++..||+|++....... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence 345678999999999999999999999999999999997654322 356788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee---ccCCceEEeccccch
Q 012228 89 YIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSA 161 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl---~~~g~lkl~DFGla~ 161 (468)
|+||||+++|+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999999988543 679999999999999999999999999999999999999 456889999999997
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
.... .......+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.+.+..+.........
T Consensus 176 ~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--------- 241 (285)
T 3is5_A 176 LFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE--------- 241 (285)
T ss_dssp C-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred ecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC---------
Confidence 6543 223456789999999999864 44 589999999999999999999999887766655432100
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.........+++++.+||.+||+.||.+|||++|+++||||++
T Consensus 242 --------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 242 --------------PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp --------------CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred --------------cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 0000111237899999999999999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=402.14 Aligned_cols=282 Identities=22% Similarity=0.373 Sum_probs=221.7
Q ss_pred CCCCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-----CCCeeE
Q 012228 3 VKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-----HPNVIK 77 (468)
Q Consensus 3 ~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----hpnIv~ 77 (468)
++...+....++|++.+.||+|+||+||+|++..+++.||+|++.... .......+|+.+++.+. ||||++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 344556667789999999999999999999999999999999997432 23456778999999986 999999
Q ss_pred EEEEEEeCCEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-------
Q 012228 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS------- 148 (468)
Q Consensus 78 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~------- 148 (468)
+++++...+.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 999999999999999999 889999998765 5999999999999999999999999999999999999975
Q ss_pred ------------------CCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHh
Q 012228 149 ------------------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 210 (468)
Q Consensus 149 ------------------~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll 210 (468)
++.+||+|||+|+.... .....+||+.|+|||++.+..| +.++||||+||++|+|+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell 253 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHH
Confidence 78999999999975332 2346789999999999998877 58999999999999999
Q ss_pred hCCCCCCCchHHHHHHhhcccccccccccchh-hhcc-ccccccccccccCCCC--------------------CCCCHH
Q 012228 211 AGFLPFDESNLMALYRKVSTFHFLSVYGESYK-KCTN-KYSYTLQICRADFSCP--------------------SWFSSG 268 (468)
Q Consensus 211 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~--------------------~~~s~~ 268 (468)
+|..||...+..+....+...... ...... .... ...............| ...++.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQP--IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCC--CCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCC--CCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 999999987766655544321110 000000 0000 0000000000000111 123577
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 269 AKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 269 ~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
+.+||.+||+.||.+|||++|+|+||||+
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 88999999999999999999999999995
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=408.01 Aligned_cols=254 Identities=31% Similarity=0.533 Sum_probs=221.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH-----HHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH-----KMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
..++|++.+.||+|+||+||+|++..+++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45689999999999999999999999999999999986543211 1234567899999999999999999999999
Q ss_pred CEEEEEEEccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 86 TKIYIVLEFIDGG-ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 86 ~~~~lV~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
+.+|+||||+.+| +|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999999766 999999998899999999999999999999999999999999999999999999999999997643
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
. .......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.....
T Consensus 182 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------------- 235 (335)
T 3dls_A 182 R---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------------- 235 (335)
T ss_dssp T---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------------
T ss_pred C---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------------
Confidence 3 23345678999999999999888877899999999999999999999975321
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
........|..+++++.+||.+||+.||.+|||++++++||||++.
T Consensus 236 ---------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 236 ---------TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ---------GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ---------HHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 1122334455689999999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=395.35 Aligned_cols=257 Identities=25% Similarity=0.452 Sum_probs=220.4
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|+..+.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 488999999999999999999999999999999754322 24567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
|++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--ccccc
Confidence 9999999998864 57999999999999999999999999999999999999999999999999998754331 22234
Q ss_pred ccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccc
Q 012228 174 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253 (468)
Q Consensus 174 ~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (468)
..+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+....+...
T Consensus 200 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---------------------- 256 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---------------------- 256 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------------------
T ss_pred cccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------------------
Confidence 5689999999999987766 58999999999999999999999887766655543211
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 254 ~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.......+..+++.+.+||.+||+.||++|||++++++||||.+..
T Consensus 257 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 257 -PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp -SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred -CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 1111222334789999999999999999999999999999998643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=398.00 Aligned_cols=263 Identities=33% Similarity=0.562 Sum_probs=224.7
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH---HHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
...++|++++.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 345679999999999999999999999999999999976443211 12467889999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC----ceEEeccccchh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGLSAI 162 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g----~lkl~DFGla~~ 162 (468)
..|+||||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999999888899999999999999999999999999999999999999888 799999999875
Q ss_pred hhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchh
Q 012228 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 169 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--------- 235 (321)
T 2a2a_A 169 IED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY--------- 235 (321)
T ss_dssp CCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC---------
T ss_pred cCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc---------
Confidence 433 223455679999999999987776 5899999999999999999999998877666655321100
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
......+..++..+.+||.+||..||.+|||++++++||||+.
T Consensus 236 -------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 236 -------------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp -------------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred -------------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 0000112347899999999999999999999999999999974
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=401.09 Aligned_cols=259 Identities=35% Similarity=0.608 Sum_probs=205.3
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 4567999999999999999999999999999999997542 23567899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc---CCceEEeccccchhhhhhh
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~---~g~lkl~DFGla~~~~~~~ 167 (468)
||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~-- 203 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-- 203 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc--
Confidence 9999999999999998888999999999999999999999999999999999999975 88999999999986533
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHH-HHHhhcccccccccccchhhhcc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA-LYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||....... .+..+....
T Consensus 204 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~-------------- 267 (349)
T 2w4o_A 204 -QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE-------------- 267 (349)
T ss_dssp ----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC--------------
T ss_pred -ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC--------------
Confidence 223456789999999999988776 589999999999999999999997654332 333321100
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
..........++.++.+||.+||..||++|||+.|+++||||+...
T Consensus 268 --------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 268 --------YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp --------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred --------CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 0000112234789999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=403.93 Aligned_cols=290 Identities=26% Similarity=0.388 Sum_probs=221.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-----
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----- 84 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----- 84 (468)
..+++|++++.||+|+||+||+|++..+|+.||+|++....... .....+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 36789999999999999999999999999999999986543322 223456799999999999999999999977
Q ss_pred ---CCEEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccc
Q 012228 85 ---KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (468)
Q Consensus 85 ---~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla 160 (468)
.+.+|+||||+++ +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4568999999986 777766554 57999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhh--cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccc
Q 012228 161 AISQQVR--EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 161 ~~~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
....... ........+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+.......+....... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI-TP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-Ch
Confidence 7654221 12234567899999999999876655799999999999999999999999887766655543211100 00
Q ss_pred cchhhhccccccc-ccccccc-CCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 239 ESYKKCTNKYSYT-LQICRAD-FSCPS-----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 239 ~~~~~~~~~~~~~-~~~~~~~-~~~~~-----~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
..+.......... ....... ..... ..++.+.+||.+||+.||++|||++|+|+||||+....|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 0000000000000 0000000 00000 036789999999999999999999999999999875543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=393.93 Aligned_cols=264 Identities=33% Similarity=0.631 Sum_probs=223.1
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhh-HHHHHHHHHHHHHHhcCCCCCeeEEEEEE--EeCCE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-HKMVEQIKREISTMKLIKHPNVIKIIEVM--ASKTK 87 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~hpnIv~l~~~~--~~~~~ 87 (468)
.+++|++++.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.+++.++||||+++++++ .+.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 5689999999999999999999999999999999997654322 22456789999999999999999999998 44568
Q ss_pred EEEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
.|+||||++++ |.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999999986 7777765 35699999999999999999999999999999999999999999999999999986544
Q ss_pred hhcCCcccccCCCCCcCCccccccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
...........||+.|+|||++.+.. +.+.++||||+||++|+|++|..||...+..+....+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i---------------- 225 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI---------------- 225 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----------------
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH----------------
Confidence 33344445677999999999987643 3357999999999999999999999988777666553
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
.......+..+++.+.+||.+||..||.+|||++++++||||++...
T Consensus 226 ----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 226 ----------GKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp ----------HHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred ----------hcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 23344566778999999999999999999999999999999987544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=409.39 Aligned_cols=254 Identities=34% Similarity=0.633 Sum_probs=205.4
Q ss_pred CccccCeEEE-eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHH-hcCCCCCeeEEEEEEEe--
Q 012228 9 RTRVGKYELG-RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIKIIEVMAS-- 84 (468)
Q Consensus 9 ~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~hpnIv~l~~~~~~-- 84 (468)
+..+++|.+. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 3466789887 7899999999999999999999999999642 2356888887 45589999999999876
Q ss_pred --CCEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc---CCceEEecc
Q 012228 85 --KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDF 157 (468)
Q Consensus 85 --~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~---~g~lkl~DF 157 (468)
...+|+|||||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 667999999999999999998754 5999999999999999999999999999999999999997 789999999
Q ss_pred ccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHH----HHHhhccccc
Q 012228 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA----LYRKVSTFHF 233 (468)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~----~~~~~~~~~~ 233 (468)
|+|+.... .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||...+... ....
T Consensus 209 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~------ 278 (400)
T 1nxk_A 209 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR------ 278 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH------
T ss_pred ccccccCC---CCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH------
Confidence 99975432 233457899999999999988777 489999999999999999999997654211 1111
Q ss_pred ccccccchhhhccccccccccccccCCC--C--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 234 LSVYGESYKKCTNKYSYTLQICRADFSC--P--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
+..+.+.+ + ..++.++.+||++||+.||.+|||++++++||||.+..
T Consensus 279 --------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 279 --------------------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp --------------------HHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred --------------------HHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 11111222 2 34899999999999999999999999999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=404.79 Aligned_cols=278 Identities=26% Similarity=0.358 Sum_probs=216.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (468)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 3478999999999999999999999999999999996543 2334567789999999999999999999999765
Q ss_pred -CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 86 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3469999999 7799998876 679999999999999999999999999999999999999999999999999997543
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh-
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK- 243 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (468)
. .....+||++|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+..... ........
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g--~~~~~~~~~ 252 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG--TPPAEFVQR 252 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC--CCCHHHHHT
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC--CCCHHHHHH
Confidence 2 245678999999999998744457999999999999999999999998887666555432110 00000000
Q ss_pred --------hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 244 --------CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 244 --------~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.....+.. ....-....+..++.+.+||.+||..||.+|||++++|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPEL--EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CSCHHHHHHHHHSCCC--CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhHHHHHHHHhCCCC--CCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 00000000 00011123345799999999999999999999999999999998654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=394.63 Aligned_cols=262 Identities=32% Similarity=0.573 Sum_probs=212.0
Q ss_pred CCccccCeEEE-eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeC
Q 012228 8 SRTRVGKYELG-RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (468)
Q Consensus 8 ~~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (468)
+....++|++. +.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 34456789995 789999999999999999999999999976532 1245788999999885 799999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc---eEEeccccchh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFGLSAI 162 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~---lkl~DFGla~~ 162 (468)
+.+|+||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999999999998889999999999999999999999999999999999999998776 99999999875
Q ss_pred hhhhhc-----CCcccccCCCCCcCCcccccc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCchH-----------
Q 012228 163 SQQVRE-----DGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNL----------- 221 (468)
Q Consensus 163 ~~~~~~-----~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~----------- 221 (468)
...... .......+||+.|+|||++.+ ..+ +.++||||+||++|+|++|..||.+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 432111 112345679999999999875 334 5899999999999999999999976531
Q ss_pred ----HHHHHhhcccccccccccchhhhccccccccccccccCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 222 ----MALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 222 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
..+... +....+..| ..+++.+.+||.+||+.||.+|||++|+++|
T Consensus 243 ~~~~~~~~~~--------------------------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 243 PACQNMLFES--------------------------IQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHH--------------------------HHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHH--------------------------HhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111 112222233 3478999999999999999999999999999
Q ss_pred cccccC
Q 012228 294 EWFKKG 299 (468)
Q Consensus 294 pwf~~~ 299 (468)
|||+..
T Consensus 297 p~~~~~ 302 (316)
T 2ac3_A 297 PWVQGC 302 (316)
T ss_dssp TTCC--
T ss_pred hhhcCC
Confidence 999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=404.95 Aligned_cols=260 Identities=24% Similarity=0.430 Sum_probs=214.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC--CCCeeEEEEEEEeCCEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--HPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~l 90 (468)
.+|++++.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+|+.++ ||||+++++++...+.+|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 359999999999999999999865 99999999976543 3345678899999999996 5999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||| +.+++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.........
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 999 56789999999988999999999999999999999999999999999999996 5899999999998654433223
Q ss_pred cccccCCCCCcCCccccccC----------CCCCChhhHHHHHHHHHHHhhCCCCCCCch-HHHHHHhhccccccccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDK----------GYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~----------~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~ 239 (468)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.... .......+.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~---------- 281 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---------- 281 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH----------
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh----------
Confidence 34567899999999998652 234689999999999999999999997642 222222211
Q ss_pred chhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
........|.+.+.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 282 --------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 282 --------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp --------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred --------------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 11233456677889999999999999999999999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=398.00 Aligned_cols=262 Identities=25% Similarity=0.438 Sum_probs=212.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC--CCeeEEEEEEEeCCEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH--PNVIKIIEVMASKTKIY 89 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~ 89 (468)
-++|++++.||+|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.+|+.++| |||+++++++.+.+.+|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 45699999999999999999998 5689999999976543 33456778999999999986 99999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+||| +.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+........
T Consensus 86 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 9999 55779999999999999999999999999999999999999999999999997 688999999999866543333
Q ss_pred CcccccCCCCCcCCcccccc----------CCCCCChhhHHHHHHHHHHHhhCCCCCCCch-HHHHHHhhcccccccccc
Q 012228 170 GLLHTACGTPNYVAPEVLND----------KGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~----------~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~ 238 (468)
......+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.... .......+.
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--------- 234 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--------- 234 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---------
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh---------
Confidence 33456789999999999864 1334689999999999999999999997642 111111110
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
........|...+.++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 235 ---------------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 235 ---------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp ---------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred ---------------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 122334556667889999999999999999999999999999986543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=401.30 Aligned_cols=264 Identities=34% Similarity=0.563 Sum_probs=216.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh--hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL--RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
.++|++++.||+|+||+||+|.+..+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 36799999999999999999999999999999999765432 2234578899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 012228 90 IVLEFIDGGELFDKIAK----------------------------------------HGRLKEDEARRYFQQLINAVDYC 129 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~----------------------------------------~~~l~e~~~~~~~~qll~~l~yL 129 (468)
+|||||+||+|.+++.. ...+++..++.++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998852 11246788999999999999999
Q ss_pred HhCCccccCCCCCCeeeccCC--ceEEeccccchhhhhhhcCC--cccccCCCCCcCCccccccC-CCCCChhhHHHHHH
Q 012228 130 HSRGVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDG--LLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGV 204 (468)
Q Consensus 130 H~~givHrDlKp~NILl~~~g--~lkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APEvl~~~-~~~~~~~DiWSlGv 204 (468)
|++||+||||||+|||++.++ .+||+|||+|.......... .....+||+.|+|||++.+. ..++.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998766 89999999998654322211 23467899999999998752 33468999999999
Q ss_pred HHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCC--CCCCHHHHHHHHHhcCCCCC
Q 012228 205 ILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCP--SWFSSGAKKLIKRILDPNPD 282 (468)
Q Consensus 205 il~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Ll~~~L~~dP~ 282 (468)
++|+|++|..||.+.+..+....+... ...+..+ ..+++.+.+||.+||+.||.
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNK------------------------KLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHC------------------------CCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhc------------------------ccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 999999999999988776665553211 0111111 23789999999999999999
Q ss_pred CCCCHHHHhcCcccccC
Q 012228 283 TRMTISQMLEDEWFKKG 299 (468)
Q Consensus 283 ~R~t~~eil~hpwf~~~ 299 (468)
+|||+.++++||||++.
T Consensus 321 ~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 321 ERFDAMRALQHPWISQF 337 (345)
T ss_dssp TSCCHHHHHHSHHHHTT
T ss_pred HCCCHHHHhcChhhccC
Confidence 99999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=396.19 Aligned_cols=284 Identities=28% Similarity=0.395 Sum_probs=221.0
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..+++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 467899999999999999999999999999999999865432 3334567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 178 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--G 178 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--c
Confidence 99999999999988888888999999999999999999999999999999999999999999999999999765432 2
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...... .............
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN--LIPRHQELFNKNP 256 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS--CCHHHHHHHHHCG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC--CChhhhhHhhhcc
Confidence 23456789999999999987655579999999999999999999999887765544433211000 0000000000000
Q ss_pred c----ccc---cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 250 Y----TLQ---ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 250 ~----~~~---~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
. ... .........+.+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0 000 000000112347899999999999999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=399.21 Aligned_cols=259 Identities=34% Similarity=0.598 Sum_probs=220.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh-----hhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCC
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-----LRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (468)
++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|+.+++.+ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 679999999999999999999999999999999875431 1123356788999999999 7999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
..|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~- 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP- 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT-
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999875543
Q ss_pred hcCCcccccCCCCCcCCccccccC-----CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
.......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 253 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------- 321 (365)
T 2y7j_A 253 --GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ--------- 321 (365)
T ss_dssp --TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------
T ss_pred --CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC---------
Confidence 2334567899999999998632 223689999999999999999999998877666555432110
Q ss_pred hhhccccccccccccccCCC--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 242 KKCTNKYSYTLQICRADFSC--PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
..+.. +..++..+.+||.+||..||++|||++++++||||++
T Consensus 322 ---------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 322 ---------------YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp ---------------CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ---------------CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 00111 1247889999999999999999999999999999973
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=397.82 Aligned_cols=271 Identities=22% Similarity=0.411 Sum_probs=221.1
Q ss_pred CCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
..+....++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 44566778999999999999999999999999999999999876555555677899999999999999999999998665
Q ss_pred C----EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 86 T----KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 86 ~----~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
. ..|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 3 359999999999999999988899999999999999999999999999999999999999999999999999997
Q ss_pred hhhhhhcC-CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc
Q 012228 162 ISQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 162 ~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (468)
........ ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~------- 236 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP------- 236 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-------
Confidence 65432211 22334679999999999988776 5899999999999999999999998876655443211000
Q ss_pred hhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
......+..++.++.+||.+||+.||.+||++.+++.|+|++..
T Consensus 237 ---------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 237 ---------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ---------------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 00001123478999999999999999999999999999999853
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=391.71 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=204.0
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhc-CCCCCeeEEEEEEEeCCEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL-IKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV 91 (468)
++|++.+.||+|+||+||+|++..+|+.||||++........ .......|+..+.. .+||||+++++++.+.+.+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 679999999999999999999999999999999865433222 23344455555544 4899999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||+ +++|.+.+...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---AG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---CC
Confidence 9999 568888876644 599999999999999999999999999999999999999999999999999875433 22
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
.....+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||............
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~---------------------- 267 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG---------------------- 267 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTT----------------------
T ss_pred CCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhcc----------------------
Confidence 3445679999999999876 45 68999999999999999997666554332211110
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
......+..+++++.+||.+||+.||++|||++|+++||||++
T Consensus 268 -----~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 268 -----YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -----CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 0011123457899999999999999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=399.99 Aligned_cols=287 Identities=27% Similarity=0.383 Sum_probs=217.4
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhh--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR--HKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
....++|++++.||+|+||.||+|.+..+|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 456789999999999999999999999999999999997543221 112346789999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..|+||||+++ +|.+.+.... .+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999999987 8888887654 699999999999999999999999999999999999999999999999999986543
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
........+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....... ....+....
T Consensus 165 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~ 241 (346)
T 1ua2_A 165 --PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP-TEEQWPDMC 241 (346)
T ss_dssp --CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC-CTTTSSSTT
T ss_pred --CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC-Chhhhhhhc
Confidence 22334567899999999999776555789999999999999999999999887766655543210000 000000000
Q ss_pred cccccccccccccCC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 246 NKYSYTLQICRADFS-----CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~-----~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
....+. ....... ....++.++.+||.+||..||.+|||++|+++||||++...
T Consensus 242 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 242 SLPDYV--TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp SSTTCC--CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred cCcccc--cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 000000 0000000 11447899999999999999999999999999999987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=388.98 Aligned_cols=261 Identities=36% Similarity=0.657 Sum_probs=222.8
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
....++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHY 81 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence 34567899999999999999999999999999999999764322 235688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee---ccCCceEEeccccchhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl---~~~g~lkl~DFGla~~~~~ 165 (468)
|+||||++|++|.+.+...+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999999999988899999999999999999999999999999999999999 7889999999999875322
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+....
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------------- 223 (304)
T 2jam_A 162 ----GIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY------------- 223 (304)
T ss_dssp ----BTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC-------------
T ss_pred ----CccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 22345679999999999988776 589999999999999999999999887766665542210
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.......+..+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 224 ---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 224 ---------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ---------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ---------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 001112334579999999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=395.80 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=218.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
..|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999997654444445678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||+.| +|.+.+. ....+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 99984 7887775 456799999999999999999999999999999999999999999999999999875432
Q ss_pred ccccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 172 LHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
....+||+.|+|||++.+ ...++.++||||+||++|+|++|..||...+.......+...
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~------------------ 268 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------------ 268 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------------
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------------------
Confidence 235689999999999852 233368999999999999999999999887665544432110
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
......+..+++.+.+||.+||+.||++|||++++++||||....
T Consensus 269 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 269 ------ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp ------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 011112345789999999999999999999999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=403.37 Aligned_cols=276 Identities=26% Similarity=0.376 Sum_probs=213.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe------
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------ 84 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 84 (468)
..++|++++.||+|+||+||+|.+..+|+.||||++..+... ..+|+.+|+.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 457899999999999999999999999999999998754322 2379999999999999999999843
Q ss_pred --------------------------------CCEEEEEEEccCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHH
Q 012228 85 --------------------------------KTKIYIVLEFIDGGELFDKI----AKHGRLKEDEARRYFQQLINAVDY 128 (468)
Q Consensus 85 --------------------------------~~~~~lV~E~~~gg~L~~~i----~~~~~l~e~~~~~~~~qll~~l~y 128 (468)
...+|+||||+++ +|.+.+ .....+++..++.++.||+.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3458999999985 666554 445789999999999999999999
Q ss_pred HHhCCccccCCCCCCeeec-cCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHH
Q 012228 129 CHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 207 (468)
Q Consensus 129 LH~~givHrDlKp~NILl~-~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~ 207 (468)
||++||+||||||+|||++ .++.+||+|||+|..... .......+||+.|+|||++.+...++.++||||+||++|
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9999999999999999998 689999999999985533 223456788999999999987665579999999999999
Q ss_pred HHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc-c-ccc--ccccCCCCCCCCHHHHHHHHHhcCCCCCC
Q 012228 208 VLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY-T-LQI--CRADFSCPSWFSSGAKKLIKRILDPNPDT 283 (468)
Q Consensus 208 ~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~--~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~ 283 (468)
+|++|..||.+.+..+....+........ ............. . ... ..-...++..+++++.+||.+||+.||.+
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPT-KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCC-HHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCC-HHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999998876665554432110000 0000000000000 0 000 00011245568999999999999999999
Q ss_pred CCCHHHHhcCccccc
Q 012228 284 RMTISQMLEDEWFKK 298 (468)
Q Consensus 284 R~t~~eil~hpwf~~ 298 (468)
|||+.|+++||||+.
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=387.25 Aligned_cols=267 Identities=24% Similarity=0.404 Sum_probs=220.8
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
+...-++|++++.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 44566789999999999999999999999999999999976555455567889999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999998654321
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+............
T Consensus 166 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--------------- 228 (294)
T 4eqm_A 166 -LTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS--------------- 228 (294)
T ss_dssp ----------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC---------------
T ss_pred -ccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc---------------
Confidence 122345679999999999988776 589999999999999999999999887655433321100
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
........++.+|+.+.++|.+||..||.+||+..+.+.+.|..
T Consensus 229 ------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 229 ------VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp ------CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred ------CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 00011123455889999999999999999999777777777764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=382.66 Aligned_cols=254 Identities=20% Similarity=0.290 Sum_probs=214.3
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 89 (468)
..++|++.+.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.++..+ +||||+++++++.+.+..|
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 4578999999999999999999999999999999997643322 2356778999999999 8999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC----------------
Q 012228 90 IVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---------------- 149 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~---------------- 149 (468)
+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999999765 679999999999999999999999999999999999999844
Q ss_pred ---CceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHH
Q 012228 150 ---GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYR 226 (468)
Q Consensus 150 ---g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~ 226 (468)
+.+||+|||++..... ....+||+.|+|||++.+....+.++||||+||++|+|++|.+|+..........
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~ 241 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR 241 (289)
T ss_dssp --CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHH
T ss_pred CCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHH
Confidence 4799999999875432 2345699999999999876555689999999999999999998876654322211
Q ss_pred hhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 227 KVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
. ......|..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 242 ~----------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 242 Q----------------------------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp T----------------------------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred c----------------------------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 1 11223556789999999999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=402.44 Aligned_cols=257 Identities=32% Similarity=0.516 Sum_probs=213.1
Q ss_pred cCeEE--EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 13 GKYEL--GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 13 ~~y~i--~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..|++ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 34665 6789999999999999999999999999976532 235678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee--ccCCceEEeccccchhhhhhh
Q 012228 91 VLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL--DSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl--~~~g~lkl~DFGla~~~~~~~ 167 (468)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~-- 241 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-- 241 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT--
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC--
Confidence 99999999999988654 469999999999999999999999999999999999999 5678999999999986543
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....+
T Consensus 242 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-------------- 305 (373)
T 2x4f_A 242 -REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW-------------- 305 (373)
T ss_dssp -TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------------
T ss_pred -ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--------------
Confidence 223445689999999999987665 5899999999999999999999998877766655422100
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.........+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 306 --------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 306 --------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp --------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred --------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 0001112347899999999999999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=381.26 Aligned_cols=255 Identities=25% Similarity=0.456 Sum_probs=215.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----CCEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----KTKI 88 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~~ 88 (468)
..|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3599999999999999999999999999999999765443 3346788999999999999999999999865 4668
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeec-cCCceEEeccccchhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLD-SYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~g--ivHrDlKp~NILl~-~~g~lkl~DFGla~~~~~ 165 (468)
|+||||+++|+|.+++.....+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999999999999998889999999999999999999999999 99999999999998 789999999999875332
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch-HHHHHHhhcccccccccccchhhh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
......+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.... .......+...
T Consensus 185 ----~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------------- 245 (290)
T 1t4h_A 185 ----SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG------------- 245 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-------------
T ss_pred ----cccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc-------------
Confidence 23445789999999999874 34 689999999999999999999998743 33333332110
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
......+...++++.+||.+||+.||.+|||++++++||||++
T Consensus 246 -----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 246 -----------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 0111233446789999999999999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=410.78 Aligned_cols=258 Identities=39% Similarity=0.670 Sum_probs=205.2
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhh-----HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-----HKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
..++|++.+.||+|+||+||+|.+..+++.||+|++.+..... ......+.+|+.+|+.++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 3578999999999999999999999999999999998654321 112335789999999999999999999985 4
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC---ceEEeccccchh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAI 162 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g---~lkl~DFGla~~ 162 (468)
+..|+||||+++|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 56899999999999999998888999999999999999999999999999999999999997544 599999999986
Q ss_pred hhhhhcCCcccccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH-HHHHhhccccccccccc
Q 012228 163 SQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~ 239 (468)
... .....+.+||+.|+|||++.+ ...++.++||||+||++|+|++|..||...... .....
T Consensus 292 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~------------ 356 (419)
T 3i6u_A 292 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ------------ 356 (419)
T ss_dssp CC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH------------
T ss_pred cCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH------------
Confidence 543 233456789999999999864 233358999999999999999999999764321 11111
Q ss_pred chhhhccccccccccccccCCC----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 240 SYKKCTNKYSYTLQICRADFSC----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
+..+.+.. +..+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus 357 --------------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 357 --------------ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp --------------HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred --------------HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 11111111 1347899999999999999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=401.69 Aligned_cols=282 Identities=26% Similarity=0.423 Sum_probs=210.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT---- 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 86 (468)
..++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 56899999999999999999999999999999999976432 3345677889999999999999999999997665
Q ss_pred --EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 87 --KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 87 --~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999986 7888885 469999999999999999999999999999999999999999999999999997543
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc------ccc
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS------VYG 238 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~------~~~ 238 (468)
. .......+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+.+..+....... ...
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 223456789999999999988777 489999999999999999999999888766655543211000 000
Q ss_pred cchhhh---ccccc-cccccccccCCCCC------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 239 ESYKKC---TNKYS-YTLQICRADFSCPS------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 239 ~~~~~~---~~~~~-~~~~~~~~~~~~~~------~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
...... ..... ............|. ..++++.+||++||+.||.+|||++|+|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 000000 00000 00000000001111 1257899999999999999999999999999998654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=383.84 Aligned_cols=264 Identities=31% Similarity=0.529 Sum_probs=223.7
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh------hhHHHHHHHHHHHHHHhcCC-CCCeeEEEEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV------LRHKMVEQIKREISTMKLIK-HPNVIKIIEV 81 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~ 81 (468)
....++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+.+|+.+++.+. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 3467899999999999999999999999999999999975421 11234567889999999996 9999999999
Q ss_pred EEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 82 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 82 ~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
+.+.+..|+||||+++++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999999988899999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhhcCCcccccCCCCCcCCcccccc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccc
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSV 236 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~ 236 (468)
.... .......+||+.|+|||++.+ ....+.++||||+|+++|+|++|..||...+.......+...
T Consensus 173 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----- 244 (298)
T 1phk_A 173 QLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG----- 244 (298)
T ss_dssp ECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----
T ss_pred hcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC-----
Confidence 5432 223456789999999999852 233368999999999999999999999887766665543211
Q ss_pred cccchhhhccccccccccccccCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 237 YGESYKKCTNKYSYTLQICRADFSCP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
...+..+ ..++..+.+||.+||..||.+|||++++++||||++.
T Consensus 245 -------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 245 -------------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp -------------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -------------------CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 0111111 2478999999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=383.84 Aligned_cols=261 Identities=36% Similarity=0.631 Sum_probs=219.8
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH---HHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
.++|++++.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3679999999999999999999999999999999976543211 1246788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC----ceEEeccccchhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGLSAISQ 164 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g----~lkl~DFGla~~~~ 164 (468)
|+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999999888999999999999999999999999999999999999998877 89999999987543
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
. .......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+..+....+.....
T Consensus 164 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 228 (283)
T 3bhy_A 164 A---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY----------- 228 (283)
T ss_dssp -----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----------
T ss_pred C---CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc-----------
Confidence 3 122345679999999999987776 5899999999999999999999998877666555321100
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
......+..++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 229 -----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 229 -----------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp -----------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred -----------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 0000112347889999999999999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=397.80 Aligned_cols=283 Identities=25% Similarity=0.410 Sum_probs=221.2
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-----CE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-----TK 87 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-----~~ 87 (468)
++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 58999999999999999999999999999999997532 233457788999999999999999999999665 46
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
.|+||||+.+ +|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 8999999985 99998875 579999999999999999999999999999999999999999999999999998654332
Q ss_pred c-CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 168 E-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 168 ~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
. .......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+..... ...........
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 260 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQEDLNCII 260 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC--SCCHHHHHTCC
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC--CCCHHHHHHhh
Confidence 2 22345678999999999987666557999999999999999999999988765554444321100 00000000000
Q ss_pred c---cccccccc-ccc---CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 247 K---YSYTLQIC-RAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 247 ~---~~~~~~~~-~~~---~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
. ..+..... ... ....+.+++++.+||.+||+.||.+|||++|+|+||||++...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 0 00000000 000 0112447899999999999999999999999999999987543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=395.37 Aligned_cols=285 Identities=24% Similarity=0.361 Sum_probs=224.3
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
+....++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 4455688999999999999999999999999999999997643 23356788999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
+|+||||++||+|.+++...+.+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999999999999988999999999999999999999996 9999999999999999999999999998755332
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccccc-------
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE------- 239 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~------- 239 (468)
.....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+................
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 2345689999999999988776 5899999999999999999999988776655433221000000000
Q ss_pred --chhhhcc-------cccccccc-ccccCCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 240 --SYKKCTN-------KYSYTLQI-CRADFSC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 240 --~~~~~~~-------~~~~~~~~-~~~~~~~-~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
....... .......+ ....... +..++.++.+||.+||+.||.+|||++|+++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 0000000 00000000 0111112 23378999999999999999999999999999999853
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=396.04 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=208.0
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT---- 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 86 (468)
.+++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 4578999999999999999999999999999999997543 2234577899999999999999999999985543
Q ss_pred -----------------------------------------------------EEEEEEEccCCCCHHHHHHhcCC---C
Q 012228 87 -----------------------------------------------------KIYIVLEFIDGGELFDKIAKHGR---L 110 (468)
Q Consensus 87 -----------------------------------------------------~~~lV~E~~~gg~L~~~i~~~~~---l 110 (468)
.+|+|||||+||+|.+++..... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 38999999999999999987654 5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc----------CCcccccCCCCC
Q 012228 111 KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE----------DGLLHTACGTPN 180 (468)
Q Consensus 111 ~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~----------~~~~~~~~gt~~ 180 (468)
++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .......+||+.
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 5667999999999999999999999999999999999999999999999986543211 122345679999
Q ss_pred cCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCC
Q 012228 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFS 260 (468)
Q Consensus 181 y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (468)
|+|||++.+..+ +.++||||+||++|+|++|..|+.... ....... ....+
T Consensus 242 y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~~--------------------------~~~~~ 292 (332)
T 3qd2_B 242 YMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQMERV--RIITDVR--------------------------NLKFP 292 (332)
T ss_dssp GSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHHH--------------------------TTCCC
T ss_pred ccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHhh--------------------------ccCCC
Confidence 999999988777 599999999999999999977763321 1111110 00000
Q ss_pred -CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 261 -CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 261 -~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.+...++++.+||.+||+.||.+|||++|+++||||++
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 01124678899999999999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=400.32 Aligned_cols=280 Identities=25% Similarity=0.389 Sum_probs=203.7
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC------
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK------ 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 85 (468)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 478999999999999999999999999999999996542 2333466788999999999999999999999654
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..+|+|||++ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 6799888865 6799999999999999999999999999999999999999999999999999975432
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch-hhh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY-KKC 244 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 244 (468)
.....+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+..... ...... ...
T Consensus 185 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g--~p~~~~~~~~ 257 (367)
T 2fst_X 185 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG--TPGAELLKKI 257 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC--SCCHHHHTTC
T ss_pred -----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC--CCCHHHHHHh
Confidence 234578999999999998755557999999999999999999999998887666555432110 000000 000
Q ss_pred cccc--ccccccc-cccC---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 245 TNKY--SYTLQIC-RADF---SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 245 ~~~~--~~~~~~~-~~~~---~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
.... .+..... .... ...+..++.+.+||.+||..||.+|||++|+|+||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 0000 0000000 0000 012346899999999999999999999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=397.63 Aligned_cols=262 Identities=30% Similarity=0.574 Sum_probs=219.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhh-hHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEe
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVL-RHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS 84 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 84 (468)
..+++|++.+.||+|+||+||+|++. .+|+.||||++.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34579999999999999999999984 58999999998754321 111234567899999999 69999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
.+.+|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999997543
Q ss_pred hhhcCCcccccCCCCCcCCccccccC-CCCCChhhHHHHHHHHHHHhhCCCCCCCch----HHHHHHhhccccccccccc
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~----~~~~~~~~~~~~~~~~~~~ 239 (468)
... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... ...+...
T Consensus 211 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~------------ 277 (355)
T 1vzo_A 211 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR------------ 277 (355)
T ss_dssp GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH------------
T ss_pred cCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH------------
Confidence 221 2223456899999999999853 334689999999999999999999997432 2222222
Q ss_pred chhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
+.......|..++..+.+||.+||..||.+|| |++++++||||++
T Consensus 278 --------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 278 --------------ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp --------------HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred --------------HhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 22234456677899999999999999999999 9999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=404.52 Aligned_cols=279 Identities=25% Similarity=0.403 Sum_probs=216.9
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC------CCCCeeEEEEEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI------KHPNVIKIIEVM 82 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l------~hpnIv~l~~~~ 82 (468)
.....+|++++.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.+ +|+||+++++++
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 345678999999999999999999999999999999997543 2345667888888776 578999999999
Q ss_pred EeCCEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc--eEEeccc
Q 012228 83 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--LKISDFG 158 (468)
Q Consensus 83 ~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~--lkl~DFG 158 (468)
...+.+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999996 59999988754 4999999999999999999999999999999999999999887 9999999
Q ss_pred cchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccc
Q 012228 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
+|.... ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+....+.... ....
T Consensus 248 ~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~--~~p~ 319 (429)
T 3kvw_A 248 SSCYEH-----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL--GMPS 319 (429)
T ss_dssp TCEETT-----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH--CCCC
T ss_pred cceecC-----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc--CCCC
Confidence 986432 23456789999999999998877 599999999999999999999999887666554443210 0000
Q ss_pred cchhh-------hccccccc------------cc-----cccccC-----------CCCCCCCHHHHHHHHHhcCCCCCC
Q 012228 239 ESYKK-------CTNKYSYT------------LQ-----ICRADF-----------SCPSWFSSGAKKLIKRILDPNPDT 283 (468)
Q Consensus 239 ~~~~~-------~~~~~~~~------------~~-----~~~~~~-----------~~~~~~s~~~~~Ll~~~L~~dP~~ 283 (468)
..+.. +.....+. .. ...... .++...++.+.+||++||++||++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 00000 00000000 00 000000 011224788999999999999999
Q ss_pred CCCHHHHhcCcccccCC
Q 012228 284 RMTISQMLEDEWFKKGY 300 (468)
Q Consensus 284 R~t~~eil~hpwf~~~~ 300 (468)
|||++|+|+||||++..
T Consensus 400 Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 400 RMTPGQALRHPWLRRRL 416 (429)
T ss_dssp SCCHHHHHTSTTTC---
T ss_pred CCCHHHHhCChhhccCC
Confidence 99999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=390.38 Aligned_cols=262 Identities=31% Similarity=0.493 Sum_probs=218.6
Q ss_pred cccCeEEE-eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEE
Q 012228 11 RVGKYELG-RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKI 88 (468)
Q Consensus 11 ~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 88 (468)
.-++|.+. +.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 34678888 89999999999999999999999999997654322 23457889999999995 69999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc---CCceEEeccccchhh
Q 012228 89 YIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFGLSAIS 163 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~---~g~lkl~DFGla~~~ 163 (468)
|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999999998553 67999999999999999999999999999999999999997 789999999999865
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
.. .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+....+...
T Consensus 185 ~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------------ 248 (327)
T 3lm5_A 185 GH---ACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------------ 248 (327)
T ss_dssp ------------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred CC---ccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc------------
Confidence 43 222345789999999999988777 58999999999999999999999988776665553211
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
........+..+++.+.+||.+||+.||.+|||++++|+||||+..
T Consensus 249 ----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 249 ----------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp ----------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred ----------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 0111122234578999999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=389.28 Aligned_cols=277 Identities=22% Similarity=0.391 Sum_probs=213.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEe--CCE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMAS--KTK 87 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 87 (468)
..++|++++.||+|+||+||+|++..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3578999999999999999999999999999999997432 356789999999997 9999999999988 677
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC-ceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~ 166 (468)
.++||||+++++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~- 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT-
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC-
Confidence 999999999999998875 489999999999999999999999999999999999999777 899999999975433
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc-hHHHHHHhhccccccc----------
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKVSTFHFLS---------- 235 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~-~~~~~~~~~~~~~~~~---------- 235 (468)
.......+||+.|+|||++.+...++.++|||||||++|+|++|..||... +..+....+.......
T Consensus 184 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 223456789999999999987555579999999999999999999999432 2222221111000000
Q ss_pred -ccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 236 -VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.....+...........+........+..+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 0000000000000000000001111223379999999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=383.34 Aligned_cols=264 Identities=30% Similarity=0.476 Sum_probs=217.3
Q ss_pred CCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
......++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDG 89 (302)
T ss_dssp SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence 344556789999999999999999999999999999999875432 23467889999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999999998875 46799999999999999999999999999999999999999999999999999864432
Q ss_pred hhcCCcccccCCCCCcCCccccc-----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (468)
... .....+||+.|+|||++. +..+ +.++||||+||++|+|++|..||...+.......+...
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------- 237 (302)
T 2j7t_A 170 TLQ--KRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--------- 237 (302)
T ss_dssp HHH--C-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---------
T ss_pred ccc--ccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc---------
Confidence 211 123567999999999984 3344 68999999999999999999999987766554443210
Q ss_pred hhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.......+..++..+.+||.+||..||.+|||++++++||||+..
T Consensus 238 --------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 238 --------------DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp --------------CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred --------------CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 111122345578999999999999999999999999999999853
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=385.46 Aligned_cols=261 Identities=28% Similarity=0.441 Sum_probs=214.2
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++.+.||+|+||+||+|.+ +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 3457899999999999999999987 6889999999765432 334677889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 90 IVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~~l~yLH~~g--ivHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
+||||+++|+|.+++...+. +++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999999987654 999999999999999999999999 9999999999999999999999999997543
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.. .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+....+.
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~--------------- 252 (309)
T 3p86_A 191 ST--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG--------------- 252 (309)
T ss_dssp -------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---------------
T ss_pred cc--ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------------
Confidence 21 122345789999999999988777 589999999999999999999999887766655431
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc--CcccccCC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE--DEWFKKGY 300 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~--hpwf~~~~ 300 (468)
........|..+++.+.+||.+||..||.+|||++++++ ++|++...
T Consensus 253 ---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 253 ---------FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp ---------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred ---------hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 122344567779999999999999999999999999998 57776543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=407.60 Aligned_cols=249 Identities=16% Similarity=0.206 Sum_probs=204.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHH---HhcCCCCCeeEEE-------EE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIST---MKLIKHPNVIKII-------EV 81 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~i---l~~l~hpnIv~l~-------~~ 81 (468)
.++|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+ ++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4679999999999999999999999999999999986544444456788999954 5555799999998 77
Q ss_pred EEeCCE-----------------EEEEEEccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCcccc
Q 012228 82 MASKTK-----------------IYIVLEFIDGGELFDKIAKHGRLKE-------DEARRYFQQLINAVDYCHSRGVFHR 137 (468)
Q Consensus 82 ~~~~~~-----------------~~lV~E~~~gg~L~~~i~~~~~l~e-------~~~~~~~~qll~~l~yLH~~givHr 137 (468)
+.+.+. .|+||||+ +|+|.+++...+.+++ ..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 776643 89999999 5799999987666666 7888899999999999999999999
Q ss_pred CCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccC-----------CCCCChhhHHHHHHHH
Q 012228 138 DLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-----------GYDGRASDVWSCGVIL 206 (468)
Q Consensus 138 DlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-----------~~~~~~~DiWSlGvil 206 (468)
||||+|||++.+|.+||+|||+|+... ......+| +.|+|||++.+. .| +.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 999999999999999999999987422 23456778 999999999876 55 5999999999999
Q ss_pred HHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 012228 207 FVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT 286 (468)
Q Consensus 207 ~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t 286 (468)
|+|++|..||...+....... ....+..+++++.+||.+||+.||.+|||
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEW------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHHHHSSCCC------CCSGG------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHHHHCCCCCcccccccchhh------------------------------hhhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 999999999976543221111 11223457999999999999999999999
Q ss_pred HHHHhcCccccc
Q 012228 287 ISQMLEDEWFKK 298 (468)
Q Consensus 287 ~~eil~hpwf~~ 298 (468)
+.++++||||+.
T Consensus 354 ~~e~l~hp~f~~ 365 (377)
T 3byv_A 354 PLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHTSHHHHH
T ss_pred HHHHhhChHHHH
Confidence 999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=380.03 Aligned_cols=261 Identities=30% Similarity=0.527 Sum_probs=221.4
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--eCCE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA--SKTK 87 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~--~~~~ 87 (468)
...++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++. ....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 4678999999999999999999999999999999999765432 334678899999999999999999999874 4678
Q ss_pred EEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCCeeeccCCceEEeccc
Q 012228 88 IYIVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKISDFG 158 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~~l~yLH~~g-----ivHrDlKp~NILl~~~g~lkl~DFG 158 (468)
+|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999999987543 4999999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccc
Q 012228 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
++...... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+..+....+..
T Consensus 162 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-------- 230 (279)
T 2w5a_A 162 LARILNHD--TSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-------- 230 (279)
T ss_dssp HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------
T ss_pred hheeeccc--cccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh--------
Confidence 98764321 112234679999999999988776 4899999999999999999999998877666555321
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
......+..++.++.+||.+||+.||.+|||++++++|+|+...
T Consensus 231 -----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 231 -----------------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -----------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -----------------cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 11123455689999999999999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=397.88 Aligned_cols=279 Identities=29% Similarity=0.393 Sum_probs=210.9
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC--
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-- 86 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-- 86 (468)
.....+|++++.||+|+||+||+|++..+++ ||+|++...... ..+|+.+++.++||||+++++++....
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 3345679999999999999999999987766 888887544322 237999999999999999999985443
Q ss_pred ----EEEEEEEccCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec-cCCceEEecc
Q 012228 87 ----KIYIVLEFIDGGELFDKI----AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDF 157 (468)
Q Consensus 87 ----~~~lV~E~~~gg~L~~~i----~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~-~~g~lkl~DF 157 (468)
.+|+||||++++ +.+.+ .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 108 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 388999999875 43333 2356899999999999999999999999999999999999999 7999999999
Q ss_pred ccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccc
Q 012228 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237 (468)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 237 (468)
|+|+.... .......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+........
T Consensus 187 G~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~- 262 (394)
T 4e7w_A 187 GSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS- 262 (394)
T ss_dssp TTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-
T ss_pred CCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-
Confidence 99976533 22234568899999999998766557999999999999999999999998876655544332100000
Q ss_pred ccchhhhccccc-cc-cccccc--cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 238 GESYKKCTNKYS-YT-LQICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 238 ~~~~~~~~~~~~-~~-~~~~~~--~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
............ .. ..+... ...+++.+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 000000000000 00 000000 0113445789999999999999999999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=379.01 Aligned_cols=259 Identities=22% Similarity=0.364 Sum_probs=200.6
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+.++...++.++||||+++++++.+.+..|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 356889999999999999999999999999999999975432 2223444556666688899999999999999999999
Q ss_pred EEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 90 IVLEFIDGGELFDKIA----KHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
+||||++| +|.+.+. ....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+|....
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999985 7766654 356799999999999999999999998 99999999999999999999999999997654
Q ss_pred hhhcCCcccccCCCCCcCCccccc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCc-hHHHHHHhhcccccccccccc
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~ 240 (468)
.. ......+||+.|+|||++. .....+.++||||+||++|+|++|..||... .........
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------ 226 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV------------ 226 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH------------
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH------------
Confidence 32 2234457999999999972 2333468999999999999999999999853 222222221
Q ss_pred hhhhccccccccccccccCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 241 YKKCTNKYSYTLQICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
....... .+..+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 227 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 227 -------------VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -------------HHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -------------hccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 1111111 22357999999999999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=400.67 Aligned_cols=278 Identities=26% Similarity=0.362 Sum_probs=210.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK----- 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 85 (468)
...+|++.+.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999865432 234799999999999999999988432
Q ss_pred -CEEEEEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC-CceEEecccc
Q 012228 86 -TKIYIVLEFIDGGELFDKIA----KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGL 159 (468)
Q Consensus 86 -~~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~-g~lkl~DFGl 159 (468)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 247799999986 5655543 35679999999999999999999999999999999999999955 6789999999
Q ss_pred chhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccccc
Q 012228 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (468)
|+.... .......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+....... ...
T Consensus 204 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p-~~~ 279 (420)
T 1j1b_A 204 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP-TRE 279 (420)
T ss_dssp CEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC-CHH
T ss_pred hhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-CHH
Confidence 986432 2223457899999999999776545799999999999999999999999877655544432110000 000
Q ss_pred chhhhccccc-ccc-cccccc--CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 240 SYKKCTNKYS-YTL-QICRAD--FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 240 ~~~~~~~~~~-~~~-~~~~~~--~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.+........ ... .+.... ..+++.+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0000000000 000 000000 012345789999999999999999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=397.69 Aligned_cols=280 Identities=22% Similarity=0.459 Sum_probs=222.3
Q ss_pred CCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHH--------------HHHHHHHHHHHHhcCC
Q 012228 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK--------------MVEQIKREISTMKLIK 71 (468)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~--------------~~~~i~~Ei~il~~l~ 71 (468)
.......++|++++.||+|+||.||+|.+ +|+.||+|++......... ..+.+.+|+.+++.++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 101 (348)
T 2pml_X 24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101 (348)
T ss_dssp SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence 44556679999999999999999999999 8999999999765432211 1267889999999999
Q ss_pred CCCeeEEEEEEEeCCEEEEEEEccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCC
Q 012228 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDK------IAK--HGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPE 142 (468)
Q Consensus 72 hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~------i~~--~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~ 142 (468)
||||+++++++.+.+.+|+||||+++|+|.++ +.. ...+++..+..++.|++.||+|||+ +||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999999999999999999999999988 665 5679999999999999999999999 99999999999
Q ss_pred CeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccC-CCCCChhhHHHHHHHHHHHhhCCCCCCCchH
Q 012228 143 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDESNL 221 (468)
Q Consensus 143 NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~ 221 (468)
|||++.++.+||+|||++...... .....+||+.|+|||++.+. .+.+.++||||+||++|+|++|..||...+.
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999998764322 34567899999999999877 4543499999999999999999999987665
Q ss_pred -HHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 222 -MALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.+....+........ ......... .........+..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus 258 ~~~~~~~i~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 258 LVELFNNIRTKNIEYP--LDRNHFLYP-----LTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp SHHHHHHHTSCCCCCC--CSSSSSTTT-----TCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHhccCcCCc--cchhhhhcc-----ccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 555555432211000 000000000 0000011122558999999999999999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=380.24 Aligned_cols=258 Identities=27% Similarity=0.471 Sum_probs=223.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
-+.|++++.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 356999999999999999999999999999999997654322 356788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIK 175 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--BCC
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc--ccc
Confidence 999999999998865 67999999999999999999999999999999999999999999999999998754332 122
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+..
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 233 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK--------------------- 233 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---------------------
T ss_pred cCccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc---------------------
Confidence 345679999999999988776 4899999999999999999999988776555443211
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
......+..++..+.+||.+||..||.+|||+.++++||||.+..
T Consensus 234 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 234 ----NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp ----SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred ----CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 112234556899999999999999999999999999999998643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=382.50 Aligned_cols=258 Identities=30% Similarity=0.496 Sum_probs=215.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3467999999999999999999999999999999997543 13567899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 91 VLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 91 V~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||+++++|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--M 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--B
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--c
Confidence 999999999999987 4567999999999999999999999999999999999999999999999999998754331 1
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+..
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------- 239 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT------------------- 239 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------------
T ss_pred cccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-------------------
Confidence 22345679999999999988776 4899999999999999999999987765444332211
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.....+..+..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 240 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 240 ----NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp ----SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred ----CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 1112233345578999999999999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=386.57 Aligned_cols=289 Identities=27% Similarity=0.377 Sum_probs=219.9
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC---
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK--- 85 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--- 85 (468)
....++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 345689999999999999999999999999999999996432 233456788999999999999999999988654
Q ss_pred --CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 86 --TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 86 --~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
...|+||||+.+ +|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 85 ~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 85 NFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp TCCCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ccceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 679999999974 89998876 67999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhcC--------CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc
Q 012228 164 QQVRED--------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 164 ~~~~~~--------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
...... ......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 422111 113346899999999998765555799999999999999999999999887655544332110000
Q ss_pred ccccchhhhccc--cccccccc----cccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 236 VYGESYKKCTNK--YSYTLQIC----RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 236 ~~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
............ ........ ......++.+++++.+||.+||..||.+|||++++++||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 000000000000 00000000 0000112457999999999999999999999999999999987543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=386.63 Aligned_cols=285 Identities=27% Similarity=0.421 Sum_probs=221.8
Q ss_pred CCCCCCCCCccccCeEEEeeeeecCCeEEEEEEE-cCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC------
Q 012228 1 MSVKVPASRTRVGKYELGRTLGEGSFAKVKFAKN-VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP------ 73 (468)
Q Consensus 1 ~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp------ 73 (468)
|...+..+....++|++.+.||+|+||+||+|.+ ..+++.||+|++.... ...+.+.+|+.+++.++|+
T Consensus 2 ~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~ 77 (339)
T 1z57_A 2 MHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTF 77 (339)
T ss_dssp GGGTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTT
T ss_pred CceeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCce
Confidence 4455667777789999999999999999999999 5688999999997532 2356778999999888655
Q ss_pred CeeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc---
Q 012228 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS--- 148 (468)
Q Consensus 74 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~--- 148 (468)
+|+++++++.+.+.+|+||||+ +++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~ 156 (339)
T 1z57_A 78 RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDY 156 (339)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCE
T ss_pred eeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccc
Confidence 5999999999999999999999 789999998766 6899999999999999999999999999999999999987
Q ss_pred ----------------CCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhC
Q 012228 149 ----------------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG 212 (468)
Q Consensus 149 ----------------~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g 212 (468)
++.+||+|||++..... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g 230 (339)
T 1z57_A 157 TEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLG 230 (339)
T ss_dssp EEEEC----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHS
T ss_pred ccccCCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhC
Confidence 67899999999875322 2345689999999999988777 5899999999999999999
Q ss_pred CCCCCCchHHHHHHhhcccccccccccchhhhccccc-----------------c---ccccccccCCCCCCCCHHHHHH
Q 012228 213 FLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS-----------------Y---TLQICRADFSCPSWFSSGAKKL 272 (468)
Q Consensus 213 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~---~~~~~~~~~~~~~~~s~~~~~L 272 (468)
..||...+..+....+..... ..+........... . ...........+...++++.+|
T Consensus 231 ~~pf~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 308 (339)
T 1z57_A 231 FTVFPTHDSKEHLAMMERILG--PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308 (339)
T ss_dssp SCSCCCSCHHHHHHHHHHHHC--SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred CCCCCCCChHHHHHHHHHHhC--CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHH
Confidence 999988776554443321100 00000000000000 0 0000000111122246789999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 273 IKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 273 l~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
|.+||+.||.+|||++|+++||||+.
T Consensus 309 i~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 309 IQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp HHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred HHHHhCcCcccccCHHHHhcCHHHHH
Confidence 99999999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=388.14 Aligned_cols=260 Identities=39% Similarity=0.672 Sum_probs=210.5
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh-----hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMKLIKHPNVIKIIEVMA 83 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 83 (468)
....++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 34557899999999999999999999999999999999764321 1122345789999999999999999999997
Q ss_pred eCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc---eEEeccccc
Q 012228 84 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFGLS 160 (468)
Q Consensus 84 ~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~---lkl~DFGla 160 (468)
..+ .|+||||+++|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 765 8999999999999999998889999999999999999999999999999999999999987664 999999998
Q ss_pred hhhhhhhcCCcccccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH-HHHHhhccccccccc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKVSTFHFLSVY 237 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~-~~~~~~~~~~~~~~~ 237 (468)
..... .......+||+.|+|||++.+ ...++.++||||+||++|+|++|..||...... .....+
T Consensus 165 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------- 232 (322)
T 2ycf_A 165 KILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--------- 232 (322)
T ss_dssp EECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH---------
T ss_pred eeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH---------
Confidence 75432 122345679999999999742 233368999999999999999999999764321 111111
Q ss_pred ccchhhhccccccccccccccCC----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 238 GESYKKCTNKYSYTLQICRADFS----CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
..+... .+..++..+.+||.+||..||.+|||++++++||||+.
T Consensus 233 -----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 233 -----------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -----------------HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -----------------HhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 011111 12347899999999999999999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=379.25 Aligned_cols=262 Identities=38% Similarity=0.634 Sum_probs=221.8
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++++.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 35678999999999999999999999999999999997654322 23567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC---CceEEeccccchhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKISDFGLSAISQQV 166 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~---g~lkl~DFGla~~~~~~ 166 (468)
+||||+++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~- 176 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC-
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC-
Confidence 999999999999999888899999999999999999999999999999999999999754 4799999999875432
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
........||+.|+|||++.+. + +.++||||+|+++|+|++|..||.+.+..+....+.....
T Consensus 177 --~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 239 (287)
T 2wei_A 177 --NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY------------- 239 (287)
T ss_dssp --CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------
T ss_pred --CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 2223445689999999998764 4 6899999999999999999999998877666555321100
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.........+++++.+||.+||..||.+|||+.++++||||++.
T Consensus 240 ---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 240 ---------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp ---------CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred ---------CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 00111123478999999999999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=385.33 Aligned_cols=273 Identities=26% Similarity=0.464 Sum_probs=197.0
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
....++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 3456789999999999999999999999999999999875432 22356788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccc
Q 012228 89 YIVLEFIDGGELFDKIAK--------HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~--------~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla 160 (468)
|+||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999999874 456999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhc---CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccc
Q 012228 161 AISQQVRE---DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237 (468)
Q Consensus 161 ~~~~~~~~---~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 237 (468)
........ .......+||+.|+|||++.+....+.++||||+||++|+|++|..||...+..............
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 245 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP--- 245 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC---
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC---
Confidence 76543211 122345679999999999876333468999999999999999999999876543332221100000
Q ss_pred ccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
..............++.++.+||.+||+.||.+|||++++++||||++.
T Consensus 246 -------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 246 -------------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -------------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred -------------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 0000011122344578999999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=381.37 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=213.1
Q ss_pred CCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEe-
Q 012228 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS- 84 (468)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~- 84 (468)
......++|++++.||+|+||.||+|.+..+|+.||+|++..... ..+.+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 344567899999999999999999999999999999999975432 235678999999999 79999999999977
Q ss_pred -----CCEEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecc
Q 012228 85 -----KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157 (468)
Q Consensus 85 -----~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DF 157 (468)
.+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 56899999999999999999864 46999999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhhcCCcccccCCCCCcCCcccccc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccc
Q 012228 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHF 233 (468)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~ 233 (468)
|++...... .......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||...+.......+...
T Consensus 174 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-- 249 (326)
T 2x7f_A 174 GVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-- 249 (326)
T ss_dssp TTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--
T ss_pred cCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--
Confidence 998765331 122345679999999999862 223368999999999999999999999887655444332110
Q ss_pred ccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
......+..++..+.+||.+||..||.+|||++++++||||+..
T Consensus 250 ----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 250 ----------------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ----------------------CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ----------------------ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 01111234578999999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=386.00 Aligned_cols=276 Identities=24% Similarity=0.379 Sum_probs=213.4
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC--E
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--K 87 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--~ 87 (468)
..-++|++.+.||+|+||+||+|.+..+|+.||+|++....... ..+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 34578999999999999999999999999999999997654322 2456789999999999999999999998765 7
Q ss_pred EEEEEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee----ccCCceEEeccccc
Q 012228 88 IYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLS 160 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl----~~~g~lkl~DFGla 160 (468)
.|+||||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999986543 9999999999999999999999999999999999999 78888999999999
Q ss_pred hhhhhhhcCCcccccCCCCCcCCcccccc-------CCCCCChhhHHHHHHHHHHHhhCCCCCCCc----hHHHHHHhhc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLND-------KGYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKVS 229 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~-------~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~----~~~~~~~~~~ 229 (468)
..... .......+||+.|+|||++.. ...++.++||||+||++|+|++|..||... ...+....+.
T Consensus 164 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 76543 223456789999999999862 233468999999999999999999999632 2233333322
Q ss_pred ccccccccccchhhhccccccccccccccC----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012228 230 TFHFLSVYGESYKKCTNKYSYTLQICRADF----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295 (468)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpw 295 (468)
.......+........... .....+ ..+..++..+.+||++||+.||++|||++|+|+||=
T Consensus 241 ~~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPI-----DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHCCTTCCEEEECSTTCCE-----EEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCcc-----ccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2111111100000000000 011111 222335678899999999999999999999999983
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=394.38 Aligned_cols=260 Identities=21% Similarity=0.306 Sum_probs=220.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEE-----EcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
..++|++++.||+|+||+||+|. +..++..||||++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 34689999999999999999999 45577899999986432 233455788999999999999999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC---ceEEe
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKIS 155 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g---~lkl~ 155 (468)
...|+|||||+||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+| .+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999999998653 489999999999999999999999999999999999999655 49999
Q ss_pred ccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccc
Q 012228 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFL 234 (468)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~ 234 (468)
|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+.
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~----- 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT----- 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-----
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----
Confidence 9999986654433334455678999999999988777 589999999999999998 999999988777766542
Q ss_pred cccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 235 SVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.......+..++..+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 301 --------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 --------------------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp --------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------------------cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 12233455668999999999999999999999999999988753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=385.46 Aligned_cols=266 Identities=24% Similarity=0.353 Sum_probs=199.8
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCC---EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
.....++|++++.||+|+||+||+|.+..++. .||+|++...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 34455789999999999999999999887765 8999999765332 2346788999999999999999999999988
Q ss_pred CCEE------EEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCce
Q 012228 85 KTKI------YIVLEFIDGGELFDKIAKHG------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVL 152 (468)
Q Consensus 85 ~~~~------~lV~E~~~gg~L~~~i~~~~------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~l 152 (468)
.... |+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7665 99999999999999986543 59999999999999999999999999999999999999999999
Q ss_pred EEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccc
Q 012228 153 KISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTF 231 (468)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~ 231 (468)
||+|||+|................+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+....+
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--- 252 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL--- 252 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH---
Confidence 9999999986544322222334557889999999988776 589999999999999999 99999887655554443
Q ss_pred ccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-------HHHHhcCcccccCC
Q 012228 232 HFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-------ISQMLEDEWFKKGY 300 (468)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-------~~eil~hpwf~~~~ 300 (468)
........++.+++++.+||.+||+.||.+||| ++++++|||+....
T Consensus 253 ----------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 253 ----------------------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp ----------------------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred ----------------------hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 122234456678999999999999999999999 78889999998643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=390.19 Aligned_cols=277 Identities=26% Similarity=0.394 Sum_probs=215.8
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE---
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI--- 88 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~--- 88 (468)
-++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4689999999999999999999999999999999976432 334567888999999999999999999999877654
Q ss_pred ---EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 89 ---YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 89 ---~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
|+||||+. ++|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999998 48887773 4599999999999999999999999999999999999999999999999999975432
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
.....+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+...... .+..+....
T Consensus 197 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~ 269 (371)
T 4exu_A 197 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV--PGTEFVQKL 269 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC--CCHHHHTTC
T ss_pred -----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC--CcHHHHHHh
Confidence 2345689999999999987445569999999999999999999999988766665554321100 000000000
Q ss_pred ccc---ccc---cccc-cccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 246 NKY---SYT---LQIC-RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 246 ~~~---~~~---~~~~-~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
... ... .... ......++.+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 000 000 0000 00011234578999999999999999999999999999999854
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=391.67 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=216.0
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEc-------CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNV-------ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVM 82 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 82 (468)
..++|++++.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+|+.+ +||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4578999999999999999999975 345679999997543 334567889999999999 899999999999
Q ss_pred EeCCEEEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 012228 83 ASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 146 (468)
Q Consensus 83 ~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl 146 (468)
.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 99999999999999999999998753 48999999999999999999999999999999999999
Q ss_pred ccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHH
Q 012228 147 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 225 (468)
Q Consensus 147 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~ 225 (468)
+.+|.+||+|||+|+...............+|+.|+|||++.+..| +.++|||||||++|+|++ |..||.+.+..+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999986543222222344567889999999988776 589999999999999999 99999887655554
Q ss_pred HhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 226 RKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
..+. .......|..++.++.+||.+||..||.+|||+.|++++
T Consensus 316 ~~~~-------------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLK-------------------------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHH-------------------------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHh-------------------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4421 112234566789999999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=400.80 Aligned_cols=283 Identities=24% Similarity=0.381 Sum_probs=198.3
Q ss_pred ccCeEE-EeeeeecCCeEEEEEEEc--CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CC
Q 012228 12 VGKYEL-GRTLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KT 86 (468)
Q Consensus 12 ~~~y~i-~~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~ 86 (468)
.+.|++ +++||+|+||+||+|+++ .+++.||+|++..... ...+.+|+.+|+.++||||+++++++.. ..
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 356887 568999999999999976 5788999999975432 2356799999999999999999999954 77
Q ss_pred EEEEEEEccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee----ccCCceE
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG---------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLK 153 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~---------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl----~~~g~lk 153 (468)
.+|+||||+.+ +|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 89999999975 8888775322 49999999999999999999999999999999999999 6789999
Q ss_pred Eeccccchhhhhhh-cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH---------H
Q 012228 154 ISDFGLSAISQQVR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---------A 223 (468)
Q Consensus 154 l~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~---------~ 223 (468)
|+|||+|+...... ........+||+.|+|||++.+..+++.++||||+||++|+|++|.+||.+.+.. +
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999998654321 1123456789999999999988665679999999999999999999999765431 1
Q ss_pred HHHhhccccccccc-ccchhhhcccccc---ccccccccC----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 012228 224 LYRKVSTFHFLSVY-GESYKKCTNKYSY---TLQICRADF----------SCPSWFSSGAKKLIKRILDPNPDTRMTISQ 289 (468)
Q Consensus 224 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~----------~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~e 289 (468)
....+... .... ...|......... ........+ ......++.+.+||.+||..||.+|||++|
T Consensus 253 ~l~~i~~~--~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 253 QLDRIFNV--MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHH--HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHh--hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 11111100 0000 0000000000000 000000000 111124788999999999999999999999
Q ss_pred HhcCcccccCCCC
Q 012228 290 MLEDEWFKKGYKP 302 (468)
Q Consensus 290 il~hpwf~~~~~~ 302 (468)
+|+||||+....+
T Consensus 331 ~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 331 AMQDPYFLEDPLP 343 (405)
T ss_dssp HHTSGGGTSSSCC
T ss_pred HhcChhhccCCCC
Confidence 9999999876543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=389.99 Aligned_cols=286 Identities=22% Similarity=0.310 Sum_probs=212.7
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh--------hhHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV--------LRHKMVEQIKREISTMKLIKHPNVIKIIEV 81 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~--------~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~ 81 (468)
...++|++++.||+|+||.||+|.+.. |..||||++..... ......+.+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 345889999999999999999999854 99999999854321 223345788999999999999999999999
Q ss_pred EEe-----CCEEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEe
Q 012228 82 MAS-----KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 155 (468)
Q Consensus 82 ~~~-----~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~ 155 (468)
+.. ...+|+||||++| +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 843 3478999999985 8888776544 69999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc
Q 012228 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
|||++..... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.......
T Consensus 177 Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 177 DFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp CTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999974332 2234456899999999999875555799999999999999999999999887666655543211110
Q ss_pred cccc-------chhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 236 VYGE-------SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 236 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
.... ........... ..........++.+++.+.+||.+||+.||.+|||++|+++||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLS-NVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCC-CCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ChHHhhhccchhhhHHHHhhcc-cCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 0000 00000000000 00000111123446899999999999999999999999999999997654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=380.64 Aligned_cols=288 Identities=25% Similarity=0.360 Sum_probs=215.7
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE----
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA---- 83 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~---- 83 (468)
+....++|++++.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 3456689999999999999999999999999999999987542 334677889999999999999999999873
Q ss_pred ----------eCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec-cCCce
Q 012228 84 ----------SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVL 152 (468)
Q Consensus 84 ----------~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~-~~g~l 152 (468)
..+..|+||||++ |+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++ .++.+
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 4478999999998 599998864 6799999999999999999999999999999999999997 56799
Q ss_pred EEeccccchhhhhhh-cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccc
Q 012228 153 KISDFGLSAISQQVR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTF 231 (468)
Q Consensus 153 kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~ 231 (468)
||+|||++....... .........+|+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998654321 1223345678999999999876555578999999999999999999999988766655554321
Q ss_pred ccccccccchhhhccccccccc--cc---cccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 232 HFLSVYGESYKKCTNKYSYTLQ--IC---RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
..... ................ .. ......++.++.++.+||.+||+.||.+|||++++++||||+....
T Consensus 241 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 241 IPVVH-EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp SCCCC-HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred cCCCc-hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 11000 0000000000000000 00 0000123458999999999999999999999999999999986443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=393.21 Aligned_cols=260 Identities=18% Similarity=0.195 Sum_probs=195.2
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC--CCCCeeEEE-------EEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI--KHPNVIKII-------EVMA 83 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l--~hpnIv~l~-------~~~~ 83 (468)
..|++++.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999999999999999999876544445567788885544444 699988866 5554
Q ss_pred eC-----------------CEEEEEEEccCCCCHHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHhCCccccCC
Q 012228 84 SK-----------------TKIYIVLEFIDGGELFDKIAKHG-RLKEDEA------RRYFQQLINAVDYCHSRGVFHRDL 139 (468)
Q Consensus 84 ~~-----------------~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~------~~~~~qll~~l~yLH~~givHrDl 139 (468)
.. ..+|+|||||+ |+|.+++...+ .+++... ..++.||+.||+|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33 34899999999 79999998743 3444444 566799999999999999999999
Q ss_pred CCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCC
Q 012228 140 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFD 217 (468)
Q Consensus 140 Kp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~ 217 (468)
||+|||++.+|.+||+|||+|+.... ......+|+.|+|||++.+ ..| +.++||||+||++|+|++|..||.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999985432 1224567799999999976 455 699999999999999999999998
Q ss_pred CchHHHHHHhhcccccccccccchhhhcccccccccccccc--CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012228 218 ESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRAD--FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295 (468)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpw 295 (468)
..+..... .+.. .. ........ +..++.+++.+.+||.+||+.||++|||+.++++|||
T Consensus 295 ~~~~~~~~--------------~~~~----~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 295 LVTPGIKG--------------SWKR----PS-LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp BCCTTCTT--------------CCCB----CC-TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred CcCccccc--------------chhh----hh-hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 76421000 0000 00 00011122 2233468999999999999999999999999999999
Q ss_pred ccc
Q 012228 296 FKK 298 (468)
Q Consensus 296 f~~ 298 (468)
|++
T Consensus 356 f~~ 358 (371)
T 3q60_A 356 FLQ 358 (371)
T ss_dssp HHH
T ss_pred HHH
Confidence 975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=387.35 Aligned_cols=284 Identities=23% Similarity=0.327 Sum_probs=206.0
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE--
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK-- 87 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 87 (468)
..+++|++.+.||+|+||+||+|.+..+|+.||||++....... ....+|+..++.++||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 45689999999999999999999999999999999986543322 234577888888999999999999865433
Q ss_pred -----EEEEEEccCCCCHHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCCeeecc-CCceEEe
Q 012228 88 -----IYIVLEFIDGGELFDK----IAKHGRLKEDEARRYFQQLINAVDYCH--SRGVFHRDLKPENLLLDS-YGVLKIS 155 (468)
Q Consensus 88 -----~~lV~E~~~gg~L~~~----i~~~~~l~e~~~~~~~~qll~~l~yLH--~~givHrDlKp~NILl~~-~g~lkl~ 155 (468)
+|+||||++++ |... ......+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 89999999874 4433 345667999999999999999999999 999999999999999996 8999999
Q ss_pred ccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccc
Q 012228 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
|||+|..... .......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+.......+.......
T Consensus 175 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 175 DFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9999986543 2233456799999999999776655799999999999999999999999887666655543211000
Q ss_pred ccccchhhhcccccc-c------cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 236 VYGESYKKCTNKYSY-T------LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 236 ~~~~~~~~~~~~~~~-~------~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
. ...+......... . ..........+...++++.+||.+||+.||.+|||+.|+|+||||++...+
T Consensus 252 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 252 S-REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp C-HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred C-HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 0 0000000000000 0 000000111223367899999999999999999999999999999975443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=379.78 Aligned_cols=264 Identities=23% Similarity=0.399 Sum_probs=216.4
Q ss_pred CCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
+|......++|++++.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 2 ~p~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp CCCEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CcceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 344455678999999999999999999999999999999998543 23456788999999999999999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 85 KTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 9999999999999999999987 567999999999999999999999999999999999999999999999999999764
Q ss_pred hhhhcC------------CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccc
Q 012228 164 QQVRED------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTF 231 (468)
Q Consensus 164 ~~~~~~------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~ 231 (468)
...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---- 233 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---- 233 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----
Confidence 332111 11125689999999999988777 5899999999999999999999865321100000
Q ss_pred ccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 232 HFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
... ........|+.+++.+.+|+.+||+.||.+|||++++++ |+.
T Consensus 234 -------~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~ 278 (310)
T 3s95_A 234 -------LNV------------RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE 278 (310)
T ss_dssp -------BCH------------HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred -------hhh------------hccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence 000 000111235668899999999999999999999999987 554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=393.89 Aligned_cols=280 Identities=24% Similarity=0.416 Sum_probs=212.1
Q ss_pred CCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC--------CCCeeE
Q 012228 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--------HPNVIK 77 (468)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--------hpnIv~ 77 (468)
..+....++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.+++.++ ||||++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 334455689999999999999999999999999999999997542 24567889999999885 788999
Q ss_pred EEEEEE----eCCEEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCC
Q 012228 78 IIEVMA----SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYG 150 (468)
Q Consensus 78 l~~~~~----~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g 150 (468)
+++++. +...+|+||||+ +++|.+.+... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 999987 566899999999 55777776654 4699999999999999999999999 999999999999998775
Q ss_pred -------------------------------------------------ceEEeccccchhhhhhhcCCcccccCCCCCc
Q 012228 151 -------------------------------------------------VLKISDFGLSAISQQVREDGLLHTACGTPNY 181 (468)
Q Consensus 151 -------------------------------------------------~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y 181 (468)
.+||+|||+|..... .....+||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcc
Confidence 799999999976432 23456899999
Q ss_pred CCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch------HHHHHHhhcccccccccccc------hh-hhcccc
Q 012228 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN------LMALYRKVSTFHFLSVYGES------YK-KCTNKY 248 (468)
Q Consensus 182 ~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~------~~~~~~~~~~~~~~~~~~~~------~~-~~~~~~ 248 (468)
+|||++.+..| +.++|||||||++|+|++|..||...+ .......+... ....... +. .+....
T Consensus 260 ~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 260 RSLEVLIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL--LGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp CCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHH--HCSCCHHHHHHCTTGGGTBCTT
T ss_pred cCChhhcCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHh--cCCCChHHhhcccccccccCCc
Confidence 99999998877 589999999999999999999997543 11111111100 0000000 00 000000
Q ss_pred ccc-----------cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 249 SYT-----------LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 249 ~~~-----------~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
... .......+..+...++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000 00001112223334677899999999999999999999999999973
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=374.13 Aligned_cols=262 Identities=23% Similarity=0.381 Sum_probs=209.9
Q ss_pred CCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
+..+..+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 27 SREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID 106 (309)
T ss_dssp -------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred cCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence 34566789999999999999999999999999999999999866554555567899999999999999999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
+.+|+||||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999876543
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
.. .......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+...+...+..
T Consensus 187 ~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------------- 249 (309)
T 2h34_A 187 EK-LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ--------------- 249 (309)
T ss_dssp -----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS---------------
T ss_pred cc-cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc---------------
Confidence 21 122345679999999999987766 5899999999999999999999998776544333211
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-CHHHHhc
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-TISQMLE 292 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-t~~eil~ 292 (468)
........++.+|+.+.+||.+||+.||.+|| |++++++
T Consensus 250 --------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 250 --------AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp --------CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred --------CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 00111233556899999999999999999999 7877775
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=379.93 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=215.5
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCC---EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
...++|++.+.||+|+||+||+|.+..+++ .||||++.... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 356789999999999999999999986665 49999997543 2334577889999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..|+||||++||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999999754 5799999999999999999999999999999999999999999999999999986543
Q ss_pred hhcCC-cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 166 VREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 166 ~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
..... ......+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+....+..
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~------------- 269 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE------------- 269 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-------------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-------------
Confidence 22111 1223456788999999987776 589999999999999999 9999998877766665421
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......+..+++.+.+||.+||..||.+|||+.++++.
T Consensus 270 ------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 270 ------------GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp ------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22334566689999999999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=388.15 Aligned_cols=282 Identities=27% Similarity=0.386 Sum_probs=217.1
Q ss_pred CCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CC-----CeeEE
Q 012228 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HP-----NVIKI 78 (468)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hp-----nIv~l 78 (468)
+..+....++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++ |+ +|+++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 3455667789999999999999999999999999999999997532 23456778888888875 54 49999
Q ss_pred EEEEEeCCEEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCCeeec--cCCce
Q 012228 79 IEVMASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCH--SRGVFHRDLKPENLLLD--SYGVL 152 (468)
Q Consensus 79 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH--~~givHrDlKp~NILl~--~~g~l 152 (468)
++++...+.+|+||||+++ +|.+++... ..+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+
T Consensus 122 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCE
T ss_pred eeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcE
Confidence 9999999999999999975 999999875 36999999999999999999999 57999999999999994 57889
Q ss_pred EEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccc
Q 012228 153 KISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH 232 (468)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~ 232 (468)
||+|||+|+.... .....+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 201 kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 274 (382)
T 2vx3_A 201 KIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274 (382)
T ss_dssp EECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEeccCceeccc-----ccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999975432 2446789999999999998877 599999999999999999999999887766655543211
Q ss_pred cccccccch-------hhhccccccccc------cccccCCCCCC---------------------------CCHHHHHH
Q 012228 233 FLSVYGESY-------KKCTNKYSYTLQ------ICRADFSCPSW---------------------------FSSGAKKL 272 (468)
Q Consensus 233 ~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~---------------------------~s~~~~~L 272 (468)
.. ..... .......+...+ .....+..|.. .++++.+|
T Consensus 275 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 352 (382)
T 2vx3_A 275 GI--PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 352 (382)
T ss_dssp CS--CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHH
T ss_pred CC--CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHH
Confidence 00 00000 000000000000 00000000000 01478999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 273 IKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 273 l~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
|.+||++||++|||++|+|+||||++.
T Consensus 353 i~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 353 ILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHhcCCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=386.75 Aligned_cols=256 Identities=30% Similarity=0.536 Sum_probs=219.9
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH---HHHHHHHHHHHHHhcCC--CCCeeEEEEEEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIK--HPNVIKIIEVMA 83 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~--hpnIv~l~~~~~ 83 (468)
....++|++++.||+|+||.||+|.+..+++.||+|++........ ...+.+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456789999999999999999999999999999999976543210 11234668999999996 599999999999
Q ss_pred eCCEEEEEEEccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec-cCCceEEeccccch
Q 012228 84 SKTKIYIVLEFIDG-GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSA 161 (468)
Q Consensus 84 ~~~~~~lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~-~~g~lkl~DFGla~ 161 (468)
..+..++|||++.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999999986 89999999888999999999999999999999999999999999999999 78999999999987
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
.... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+..
T Consensus 199 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------------------- 255 (320)
T 3a99_A 199 LLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------------- 255 (320)
T ss_dssp ECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------------------
T ss_pred cccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-------------------
Confidence 6532 23445679999999999988777678999999999999999999999764321
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.......+..+++++.+||.+||+.||.+|||++++++||||++..
T Consensus 256 -------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 256 -------------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp -------------HHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -------------hcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 1122334566899999999999999999999999999999998643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=372.81 Aligned_cols=259 Identities=28% Similarity=0.496 Sum_probs=206.0
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe------
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------ 84 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 84 (468)
..++|++++.||+|+||.||+|++..+|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 457899999999999999999999999999999999653 2345678899999999999999999998865
Q ss_pred -------CCEEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEec
Q 012228 85 -------KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156 (468)
Q Consensus 85 -------~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~D 156 (468)
.+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 456899999999999999998654 588999999999999999999999999999999999999999999999
Q ss_pred cccchhhhhhh------------cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc-hHHH
Q 012228 157 FGLSAISQQVR------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMA 223 (468)
Q Consensus 157 FGla~~~~~~~------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~-~~~~ 223 (468)
||++....... ........+||+.|+|||++.+....+.++||||+||++|+|++ ||... +...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99987643211 11233456799999999999876555799999999999999998 66533 2333
Q ss_pred HHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 224 LYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
....+... .......++...+..+.+||.+||+.||.+|||++++++||||+.
T Consensus 237 ~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 237 ILKKLRSV----------------------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHST----------------------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHhcccc----------------------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 33332110 000111233446788999999999999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=388.72 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=213.1
Q ss_pred cccCeEEEeeeeecCCeEEEEEE-----EcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEe
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS 84 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 84 (468)
..++|++++.||+|+||.||+|. +..+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 35789999999999999999999 55677899999997543 233456789999999999 79999999999987
Q ss_pred CCE-EEEEEEccCCCCHHHHHHhcCC------------------------------------------------------
Q 012228 85 KTK-IYIVLEFIDGGELFDKIAKHGR------------------------------------------------------ 109 (468)
Q Consensus 85 ~~~-~~lV~E~~~gg~L~~~i~~~~~------------------------------------------------------ 109 (468)
.+. +|+|||||+||+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 654 8999999999999999987543
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCC
Q 012228 110 ------------LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177 (468)
Q Consensus 110 ------------l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 177 (468)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|................|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 89999999999999999999999999999999999999999999999999986543222223345678
Q ss_pred CCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccccc
Q 012228 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICR 256 (468)
Q Consensus 178 t~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (468)
|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+...... ...
T Consensus 258 t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~------------------------~~~ 312 (359)
T 3vhe_A 258 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------------------------KEG 312 (359)
T ss_dssp CGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH------------------------HHT
T ss_pred CceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH------------------------HcC
Confidence 999999999988777 589999999999999998 999998765332222110 112
Q ss_pred ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 257 ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 257 ~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.....|..+++++.+||.+||..||.+|||++++++|
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 2345567789999999999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=381.32 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=217.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
..++|++++.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 4578999999999999999999997 355899999997543 233567889999999999999999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH------------------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 141 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp 141 (468)
+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 9999999999999999999874 5699999999999999999999999999999999
Q ss_pred CCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCch
Q 012228 142 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESN 220 (468)
Q Consensus 142 ~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~ 220 (468)
+|||++.++.+||+|||++................+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999986544332233445678999999999987776 589999999999999999 999999887
Q ss_pred HHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 221 LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
..+....+.. ......|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~-------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 282 HEEVIYYVRD-------------------------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHHT-------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhC-------------------------CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 7666555321 12234566789999999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=382.79 Aligned_cols=275 Identities=26% Similarity=0.395 Sum_probs=215.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE----
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK---- 87 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 87 (468)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999997643 233456778899999999999999999999987654
Q ss_pred --EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 88 --IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 88 --~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
+|+||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 5999999984 8887764 3599999999999999999999999999999999999999999999999999875432
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh--
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK-- 243 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (468)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.... ...+..+..
T Consensus 179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~ 251 (353)
T 3coi_A 179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT--GVPGTEFVQKL 251 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHH--CBCCHHHHTTC
T ss_pred -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--CCCCHHHHHHH
Confidence 23456899999999999874455699999999999999999999999887665554432210 000000000
Q ss_pred -------hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 244 -------CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 244 -------~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
........ ........++.+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 252 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 252 NDKAAKSYIQSLPQT--PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp SCHHHHHHHHTSCBC--SSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhHHHHHHHHhCcCC--CCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00000000 0001112334579999999999999999999999999999999854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=366.98 Aligned_cols=250 Identities=23% Similarity=0.400 Sum_probs=215.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999986 5778999999765432 24678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 162 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 162 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence 9999999999999754 4589999999999999999999999999999999999999999999999999975433211 1
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
......+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+....+..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~------------------- 222 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST------------------- 222 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------------------
T ss_pred cccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-------------------
Confidence 2234567888999999987776 589999999999999999 9999998887776665421
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......|..+++.+.+|+.+||+.||.+|||+.++++|
T Consensus 223 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 223 ------GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 12334456689999999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=384.92 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=219.7
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCC-------CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVET-------GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEV 81 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~ 81 (468)
...++|++++.||+|+||+||+|.+..+ +..||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3457899999999999999999997543 3579999997543 334567889999999999 89999999999
Q ss_pred EEeCCEEEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 012228 82 MASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 145 (468)
Q Consensus 82 ~~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NIL 145 (468)
+.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 999999999999999999999998754 4999999999999999999999999999999999999
Q ss_pred eccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHH
Q 012228 146 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMAL 224 (468)
Q Consensus 146 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~ 224 (468)
++.++.+||+|||+|+...............+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999986544322233445567889999999988776 589999999999999999 9999998887776
Q ss_pred HHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 225 YRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
...+.. ......+..+++++.+||.+||+.||++|||+++++++
T Consensus 303 ~~~~~~-------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 303 FKLLKE-------------------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHT-------------------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHc-------------------------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 665421 22334556689999999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=377.67 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=216.4
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
...++|++++.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 34578999999999999999999983 456889999997543 23456788999999999999999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHGR------------------------LKEDEARRYFQQLINAVDYCHSRGVFHRDLK 140 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~~------------------------l~e~~~~~~~~qll~~l~yLH~~givHrDlK 140 (468)
.+..|+||||+++|+|.+++..... +++..+..++.||+.||+|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 9999999999999999999987543 8999999999999999999999999999999
Q ss_pred CCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCc
Q 012228 141 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDES 219 (468)
Q Consensus 141 p~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~ 219 (468)
|+|||++.++.+||+|||++................+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999876543222222334567889999999987666 589999999999999999 99999887
Q ss_pred hHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 220 NLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
+.......+. .......+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 257 PPERLFNLLK-------------------------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CGGGHHHHHH-------------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHhh-------------------------cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6555444421 112234556689999999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=373.82 Aligned_cols=262 Identities=24% Similarity=0.428 Sum_probs=210.2
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC--CCCeeEEEEEEEeCCEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--HPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~ 89 (468)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++.+.+..|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 457999999999999999999985 589999999976543 2335678899999999997 599999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+||| +.+++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||+++ +.+||+|||++.........
T Consensus 105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 9999 567799999999889999999999999999999999999999999999999965 89999999999865443322
Q ss_pred CcccccCCCCCcCCccccccC----------CCCCChhhHHHHHHHHHHHhhCCCCCCCch-HHHHHHhhcccccccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDK----------GYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~----------~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-~~~~~~~~~~~~~~~~~~ 238 (468)
......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+.
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~--------- 253 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--------- 253 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---------
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH---------
Confidence 233456899999999998752 234689999999999999999999997642 211111110
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
........+...+.++.+||.+||..||.+|||++++++||||+....
T Consensus 254 ---------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 254 ---------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp ---------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred ---------------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 112233456667899999999999999999999999999999986543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=374.10 Aligned_cols=282 Identities=28% Similarity=0.410 Sum_probs=217.1
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEc-CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC---CCCCeeEEEEEEE---
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNV-ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI---KHPNVIKIIEVMA--- 83 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~--- 83 (468)
..++|++.+.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3478999999999999999999995 678999999997543211 1123455777777766 8999999999987
Q ss_pred --eCCEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecccc
Q 012228 84 --SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 84 --~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGl 159 (468)
....+|+||||++ |+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5677999999998 49999998754 499999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccccc
Q 012228 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (468)
+...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+....... ...
T Consensus 167 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~ 241 (326)
T 1blx_A 167 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP-GEE 241 (326)
T ss_dssp CCCCCGG---GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CGG
T ss_pred cccccCC---CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC-Ccc
Confidence 8765432 22445789999999999988776 589999999999999999999999887666555443210000 000
Q ss_pred chhhhcc--ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 240 SYKKCTN--KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 240 ~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.+..... ...............+..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0000000 00000000011112345589999999999999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=380.76 Aligned_cols=254 Identities=32% Similarity=0.587 Sum_probs=210.8
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH---HHHHHHHHHHHHHhcC----CCCCeeEEEEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLI----KHPNVIKIIEVM 82 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l----~hpnIv~l~~~~ 82 (468)
...++|++++.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++.+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 345789999999999999999999999999999999976543221 1233456799999988 899999999999
Q ss_pred EeCCEEEEEEEc-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec-cCCceEEeccccc
Q 012228 83 ASKTKIYIVLEF-IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLS 160 (468)
Q Consensus 83 ~~~~~~~lV~E~-~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~-~~g~lkl~DFGla 160 (468)
.+.+..++|||+ +.+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999999 78999999999888999999999999999999999999999999999999999 8899999999998
Q ss_pred hhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (468)
..... ......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.....
T Consensus 188 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------------- 244 (312)
T 2iwi_A 188 ALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------------- 244 (312)
T ss_dssp EECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------------
T ss_pred hhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------------------
Confidence 76532 2345667999999999998877766789999999999999999999976431
Q ss_pred hhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
+......++..++..+.+||.+||+.||++|||++++++||||+..
T Consensus 245 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 245 -------------ILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp -------------HHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred -------------HhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 1112334566689999999999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=379.83 Aligned_cols=281 Identities=25% Similarity=0.379 Sum_probs=215.8
Q ss_pred CCCCCccccCeEEEeeeeecCCeEEEEEEEcCCC-CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC------eeE
Q 012228 5 VPASRTRVGKYELGRTLGEGSFAKVKFAKNVETG-DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN------VIK 77 (468)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn------Iv~ 77 (468)
+..+....++|++.+.||+|+||+||+|.+..++ ..||+|++.... ...+.+.+|+.+++.++|++ ++.
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 3445556789999999999999999999998777 689999997532 23466788999999887655 999
Q ss_pred EEEEEEeCCEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee---------
Q 012228 78 IIEVMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL--------- 146 (468)
Q Consensus 78 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl--------- 146 (468)
+++++...+.+|+||||+ +++|.+.+.... .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence 999999999999999999 557777776654 69999999999999999999999999999999999999
Q ss_pred ----------ccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCC
Q 012228 147 ----------DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 216 (468)
Q Consensus 147 ----------~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf 216 (468)
+.++.+||+|||++..... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCC
Confidence 6678999999999875322 2345689999999999988777 58999999999999999999999
Q ss_pred CCchHHHHHHhhcccccccccccchhhhccccc-----------------ccc---ccccccCCCCCCCCHHHHHHHHHh
Q 012228 217 DESNLMALYRKVSTFHFLSVYGESYKKCTNKYS-----------------YTL---QICRADFSCPSWFSSGAKKLIKRI 276 (468)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~---~~~~~~~~~~~~~s~~~~~Ll~~~ 276 (468)
...+..+....+..... ..+........... ... .............+.++.+||.+|
T Consensus 240 ~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 317 (355)
T 2eu9_A 240 QTHENREHLVMMEKILG--PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317 (355)
T ss_dssp CCSSHHHHHHHHHHHHC--CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHcC--CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence 98776554433321100 00000000000000 000 000000111122356899999999
Q ss_pred cCCCCCCCCCHHHHhcCccccc
Q 012228 277 LDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 277 L~~dP~~R~t~~eil~hpwf~~ 298 (468)
|+.||.+|||++|+++||||+.
T Consensus 318 L~~dP~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 318 LEFDPAQRITLAEALLHPFFAG 339 (355)
T ss_dssp TCSSTTTSCCHHHHTTSGGGGG
T ss_pred hcCChhhCcCHHHHhcChhhcC
Confidence 9999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=368.71 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=204.3
Q ss_pred CCCCccccCeEEEeeeeecCCeEEEEEEEcCC---CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012228 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVM 82 (468)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~ 82 (468)
+.-....++|++++.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 34455678999999999999999999998654 4569999986532 334567789999999999999999999998
Q ss_pred EeCCEEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 83 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 83 ~~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
. .+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 4 567899999999999999998654 69999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccc
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (468)
...... ........+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+....+.
T Consensus 165 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~----------- 231 (281)
T 1mp8_A 165 YMEDST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE----------- 231 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-----------
T ss_pred ccCccc-ccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-----------
Confidence 654321 112234457889999999987776 589999999999999996 999998766544444321
Q ss_pred hhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......++.+++.+.+||.+||..||.+|||+.+++++
T Consensus 232 --------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 232 --------------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp --------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112234566789999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=365.39 Aligned_cols=252 Identities=26% Similarity=0.385 Sum_probs=215.0
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 35678999999999999999999875 5778999999765432 245789999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+||||+++++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999999999998765 499999999999999999999999999999999999999999999999999875433211
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.......+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+.
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------------------ 219 (268)
T 3sxs_A 160 -VSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS------------------ 219 (268)
T ss_dssp -EECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------------------
T ss_pred -hcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH------------------
Confidence 11233456778999999987776 489999999999999998 999999887766655532
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......|...++.+.+||.+||+.||.+|||+.++++|
T Consensus 220 -------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 220 -------QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -------TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 122334456679999999999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=388.21 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=214.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 468999999999999999999999999999999987532 233456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 99999999999997654 59999999999999999999999999999999999999999999999999987533211111
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
......+++.|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+....+.
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-------------------- 329 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-------------------- 329 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH--------------------
T ss_pred cCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------------------
Confidence 1112235678999999987666 589999999999999998 999999877665554431
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......|..+++++.+||.+||+.||.+|||++++++
T Consensus 330 -----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 330 -----KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 12234556778999999999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=379.84 Aligned_cols=261 Identities=33% Similarity=0.571 Sum_probs=186.2
Q ss_pred CCccccCeEEEe-eeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--
Q 012228 8 SRTRVGKYELGR-TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-- 84 (468)
Q Consensus 8 ~~~~~~~y~i~~-~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-- 84 (468)
.....++|++.+ .||+|+||+||+|.+..+|+.||+|++..... .. ......++.++||||+++++++..
T Consensus 23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~---~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----AR---QEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HH---HHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HH---HHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 345678999965 69999999999999999999999999965321 11 122234567799999999999976
Q ss_pred --CCEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc---CCceEEecc
Q 012228 85 --KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDF 157 (468)
Q Consensus 85 --~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~---~g~lkl~DF 157 (468)
...+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 456899999999999999998764 6999999999999999999999999999999999999986 455999999
Q ss_pred ccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccc
Q 012228 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237 (468)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 237 (468)
|++..... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+...........
T Consensus 176 g~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------ 244 (336)
T 3fhr_A 176 GFAKETTQ----NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR------ 244 (336)
T ss_dssp TTCEEC--------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccceeccc----cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh------
Confidence 99875432 23446789999999999977666 48999999999999999999999766543321111000
Q ss_pred ccchhhhccccccccccccccCC--CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 238 GESYKKCTNKYSYTLQICRADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.......+. ....+++++.+||.+||+.||.+|||++|+++||||++..
T Consensus 245 --------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 245 --------------IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp --------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred --------------hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 000011111 2235899999999999999999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=370.47 Aligned_cols=256 Identities=28% Similarity=0.461 Sum_probs=209.6
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
|.....||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 333449999999999999999999999999997543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-CCceEEeccccchhhhhhhcCC
Q 012228 95 IDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 95 ~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~ 170 (468)
+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||++...... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~ 178 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NP 178 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--CC
Confidence 99999999998653 4679999999999999999999999999999999999997 899999999998754331 12
Q ss_pred cccccCCCCCcCCccccccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCchHHH-HHHhhcccccccccccchhhhcccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMA-LYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~-~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
......||+.|+|||++.+.. ..+.++||||+||++|+|++|..||....... ......
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------------- 239 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG------------------- 239 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH-------------------
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc-------------------
Confidence 234567999999999987543 23589999999999999999999997543211 111100
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
........+..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 240 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 240 -----MFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -----HHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -----cccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 1122234566789999999999999999999999999999999854
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=376.89 Aligned_cols=254 Identities=21% Similarity=0.350 Sum_probs=205.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEE----EEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFV----AIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
..++|++.+.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 4578999999999999999999998888765 677664322 2223567889999999999999999999998765
Q ss_pred EEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
.++|+||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 78999999999999999874 5699999999999999999999999999999999999999999999999999987654
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
...........+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~--------------- 233 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE--------------- 233 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---------------
T ss_pred CcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH---------------
Confidence 333223334567889999999988777 589999999999999999 999998876554443321
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......++.++.++.+|+.+||+.||.+|||+.+++++
T Consensus 234 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 234 ----------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ----------TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ----------cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 122344566789999999999999999999999999976
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=378.33 Aligned_cols=259 Identities=20% Similarity=0.349 Sum_probs=212.7
Q ss_pred CCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCE----EEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Q 012228 6 PASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDF----VAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEV 81 (468)
Q Consensus 6 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~ 81 (468)
.......++|++.+.||+|+||+||+|.+..+++. ||+|.+..... ....+.+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 83 (325)
T 3kex_A 6 LARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGL 83 (325)
T ss_dssp CCCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred HHhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 33445567899999999999999999999888876 67777643321 1123456789999999999999999999
Q ss_pred EEeCCEEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccc
Q 012228 82 MASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 160 (468)
Q Consensus 82 ~~~~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla 160 (468)
+. .+..|+||||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 84 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 84 CP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp EC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred Ec-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence 86 45689999999999999999774 57999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccccccccccc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (468)
+...............||+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------- 231 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE---------- 231 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH----------
T ss_pred cccCcccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH----------
Confidence 87654333334456678899999999987776 589999999999999999 999998876555544431
Q ss_pred chhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......|..++.++.+||.+||..||.+|||+.++++|
T Consensus 232 ---------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 232 ---------------KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---------------TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---------------cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112334556678899999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=364.81 Aligned_cols=252 Identities=22% Similarity=0.378 Sum_probs=213.0
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++++.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 34568999999999999999999885 6778999999765432 245789999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999999999976 56799999999999999999999999999999999999999999999999999976533221
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.......+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+..+....+..
T Consensus 176 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~----------------- 236 (283)
T 3gen_A 176 -TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ----------------- 236 (283)
T ss_dssp -HSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-----------------
T ss_pred -ccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc-----------------
Confidence 11234457888999999987776 589999999999999998 9999998877666655321
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......|...++.+.+||.+||+.||.+|||++++++|
T Consensus 237 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 237 --------GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 12334456679999999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=367.54 Aligned_cols=271 Identities=23% Similarity=0.361 Sum_probs=210.2
Q ss_pred CccccCeEEEeeeeecCCeEEEEEE----EcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
....++|++++.||+|+||+||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3456789999999999999999999 56789999999997542 3345678899999999999999999999854
Q ss_pred --CCEEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 85 --KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 85 --~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
...+|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 456899999999999999998755 49999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcC-CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc
Q 012228 162 ISQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 162 ~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (468)
........ .......+|+.|+|||++.+..+ +.++||||+||++|+|++|..||....... ................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEF-MRMIGNDKQGQMIVFH 240 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHH-HHHHCTTCCTHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHH-HhhhcCccccchhHHH
Confidence 65432211 12234457788999999988777 589999999999999999999997654321 1111100000000000
Q ss_pred hhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.. ...........|..+++++.+||.+||+.||++|||+.++++
T Consensus 241 ~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LI--------ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HH--------HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HH--------HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 000122344567778999999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=378.84 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=212.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (468)
.++|++++.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 468999999999999999999973 456789999997543 223456788999999999 899999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHG-----------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 142 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~ 142 (468)
+..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 99999999999999999998653 2799999999999999999999999999999999
Q ss_pred CeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchH
Q 012228 143 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNL 221 (468)
Q Consensus 143 NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~ 221 (468)
|||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 99999999999999999986544322223344567889999999987776 589999999999999998 9999987653
Q ss_pred HHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012228 222 MALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295 (468)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpw 295 (468)
........ ........|..+++++.+||.+||..||.+|||+.++++|-.
T Consensus 281 ~~~~~~~~------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 281 DANFYKLI------------------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp SHHHHHHH------------------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHH------------------------hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 32222210 111233456678999999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=371.03 Aligned_cols=255 Identities=21% Similarity=0.289 Sum_probs=216.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 4578999999999999999999886 467889999997543 223456788999999999999999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEe
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH----------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 155 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~ 155 (468)
+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 9999999999999999998753 357999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccc
Q 012228 156 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFL 234 (468)
Q Consensus 156 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~ 234 (468)
|||++................+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+....+..
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---- 255 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME---- 255 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT----
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc----
Confidence 9999986544322222334567899999999987776 589999999999999999 8999998877666555321
Q ss_pred cccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 235 SVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......+..++..+.+||.+||+.||.+|||+.++++|
T Consensus 256 ---------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 256 ---------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp ---------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12233456689999999999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=361.01 Aligned_cols=251 Identities=29% Similarity=0.512 Sum_probs=202.3
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhh-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR-HKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..++|++.+.||+|+||.||+|.+ +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 467899999999999999999998 48899999987543322 223567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCCeeecc--------CCceEEeccc
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG---VFHRDLKPENLLLDS--------YGVLKISDFG 158 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~g---ivHrDlKp~NILl~~--------~g~lkl~DFG 158 (468)
+||||++|++|.+++. ...+++..+..++.|++.||+|||++| |+||||||+|||++. ++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999998885 468999999999999999999999999 899999999999986 7889999999
Q ss_pred cchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccc
Q 012228 159 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238 (468)
Q Consensus 159 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (468)
++...... ......||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+.......+.
T Consensus 162 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------- 227 (271)
T 3dtc_A 162 LAREWHRT----TKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA--------- 227 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---------
T ss_pred cccccccc----cccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh---------
Confidence 99754332 2235679999999999987776 589999999999999999999999877655444321
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
........+..+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 228 ---------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 228 ---------------MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ---------------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 1122344566789999999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=373.94 Aligned_cols=261 Identities=20% Similarity=0.295 Sum_probs=214.4
Q ss_pred ccccCeEEEeeeeecCCeEEEEEE-----EcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
...++|++++.||+|+||.||+|. +..++..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 345789999999999999999999 55688899999996432 23345678899999999999999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC---CceEE
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKI 154 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~---g~lkl 154 (468)
....|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999998763 48999999999999999999999999999999999999944 46999
Q ss_pred eccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccccc
Q 012228 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHF 233 (468)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~ 233 (468)
+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---- 259 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT---- 259 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH----
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh----
Confidence 99999986543332233345668999999999987776 589999999999999998 999999887666655432
Q ss_pred ccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.......+..+++.+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 260 ---------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 ---------------------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ---------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------------------cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 11223445668999999999999999999999999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=367.72 Aligned_cols=248 Identities=21% Similarity=0.283 Sum_probs=209.7
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCC-------CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETG-------DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVM 82 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~ 82 (468)
...++|++.+.||+|+||+||+|.+..++ ..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 35678999999999999999999998877 4699999975432 2356788999999999999999999999
Q ss_pred EeCCEEEEEEEccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc--------eE
Q 012228 83 ASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--------LK 153 (468)
Q Consensus 83 ~~~~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~--------lk 153 (468)
.+.+..|+||||++||+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987665 999999999999999999999999999999999999998887 99
Q ss_pred EeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccc
Q 012228 154 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFH 232 (468)
Q Consensus 154 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~ 232 (468)
|+|||++..... .....||+.|+|||++.+....+.++||||+||++|+|++ |.+||...+........
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---- 231 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---- 231 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh----
Confidence 999999865432 1235688999999999874445699999999999999999 56666665544333321
Q ss_pred cccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 233 FLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......|...++++.+||.+||+.||.+|||++++++|
T Consensus 232 -----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 -----------------------EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp -----------------------HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -----------------------hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12233455568889999999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=382.26 Aligned_cols=278 Identities=24% Similarity=0.414 Sum_probs=210.8
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-----------CCCeeEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-----------HPNVIKI 78 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----------hpnIv~l 78 (468)
...++|++.+.||+|+||+||+|.+..+++.||||++..... ..+.+.+|+.+++.++ ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 345789999999999999999999999999999999975432 3456788999998886 8999999
Q ss_pred EEEEEeCC----EEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeecc---
Q 012228 79 IEVMASKT----KIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDS--- 148 (468)
Q Consensus 79 ~~~~~~~~----~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~--- 148 (468)
++++...+ .+++||||+ +++|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99987654 789999999 88999999864 4599999999999999999999998 9999999999999953
Q ss_pred ---CCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH---
Q 012228 149 ---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM--- 222 (468)
Q Consensus 149 ---~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~--- 222 (468)
.+.+||+|||+|..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 34799999999975432 2345689999999999988777 59999999999999999999999865421
Q ss_pred ---HHHHhhcccccccccccchh-------hhcccccc-----------ccccccccCCCCCCCCHHHHHHHHHhcCCCC
Q 012228 223 ---ALYRKVSTFHFLSVYGESYK-------KCTNKYSY-----------TLQICRADFSCPSWFSSGAKKLIKRILDPNP 281 (468)
Q Consensus 223 ---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~-----------~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP 281 (468)
.....+.. .....+.... ........ ........+.++..++.++.+||.+||+.||
T Consensus 245 ~~~~~~~~~~~--~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 245 KDDDHIAQIIE--LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp CHHHHHHHHHH--HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ChHHHHHHHHH--hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 11111110 0000000000 00000000 0001122233444567889999999999999
Q ss_pred CCCCCHHHHhcCcccccCC
Q 012228 282 DTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 282 ~~R~t~~eil~hpwf~~~~ 300 (468)
.+|||++|+++||||++..
T Consensus 323 ~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCT
T ss_pred cccCCHHHHhhChhhhccc
Confidence 9999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=371.60 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=213.2
Q ss_pred ccCeEEEeeeeecCCeEEEEEEE-----cCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKN-----VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (468)
.++|++++.||+|+||.||+|.+ ..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 46899999999999999999985 45778999999975432 23457789999999999 899999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHG------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 147 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~ 147 (468)
+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 99999999999999999998754 489999999999999999999999999999999999999
Q ss_pred cCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHH
Q 012228 148 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 226 (468)
Q Consensus 148 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~ 226 (468)
.++.+||+|||++................||+.|+|||++.+..+ +.++||||+||++|+|++ |..||..........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 999999999999986544322222334567889999999987766 589999999999999998 999998764332222
Q ss_pred hhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 227 KVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
... ........+..++..+.+||.+||..||.+|||+.+++++
T Consensus 259 ~~~------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 259 KMI------------------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHH------------------------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHh------------------------ccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 210 0111223455689999999999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=366.95 Aligned_cols=261 Identities=24% Similarity=0.379 Sum_probs=196.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..+++|++++.||+|+||.||+|.+..+|+.||||++...... ....+.+..+..+++.++||||+++++++.+.+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 3568899999999999999999999999999999999765422 223344555556788889999999999999999999
Q ss_pred EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+||||+ ++.+...... ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-- 177 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC--
Confidence 999999 4455555443 46799999999999999999999995 999999999999999999999999999875433
Q ss_pred cCCcccccCCCCCcCCcccccc----CCCCCChhhHHHHHHHHHHHhhCCCCCCCc-hHHHHHHhhcccccccccccchh
Q 012228 168 EDGLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
.......+||+.|+|||++.+ ....+.++||||+||++|+|++|..||... +..+....+..
T Consensus 178 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------ 244 (318)
T 2dyl_A 178 -DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ------------ 244 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH------------
T ss_pred -CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc------------
Confidence 222345679999999999852 223368999999999999999999999863 33333333211
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
...........+++++.+||.+||..||.+|||++++++||||++
T Consensus 245 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 245 -----------EEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp -----------SCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred -----------cCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 001111222347899999999999999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=359.10 Aligned_cols=251 Identities=19% Similarity=0.315 Sum_probs=214.4
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC--
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-- 85 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-- 85 (468)
.....++|++.+.||+|+||+||+|.+ +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 455678999999999999999999998 4889999999765432 33456789999999999999999999999887
Q ss_pred CEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeeccCCceEEeccccch
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~g--ivHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78999999999999999998766 4899999999999999999999999 9999999999999999999999998865
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCC--ChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccccc
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG--RASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~--~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (468)
... ....+||+.|+|||++.+..+.. .++||||+||++|+|++|..||...+.......+.
T Consensus 162 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---------- 224 (271)
T 3kmu_A 162 SFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA---------- 224 (271)
T ss_dssp TTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH----------
T ss_pred eec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH----------
Confidence 321 23457899999999998765542 37999999999999999999999877665544421
Q ss_pred chhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
........|..+++++.+||.+||+.||.+|||++++++
T Consensus 225 --------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 225 --------------LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp --------------HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112233456678999999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=372.80 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=215.2
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEc-------CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNV-------ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVM 82 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 82 (468)
..++|++++.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 4578999999999999999999985 467789999997543 233467789999999999 899999999999
Q ss_pred EeCCEEEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 012228 83 ASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 146 (468)
Q Consensus 83 ~~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl 146 (468)
.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 99999999999999999999998654 38999999999999999999999999999999999999
Q ss_pred ccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHH
Q 012228 147 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 225 (468)
Q Consensus 147 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~ 225 (468)
+.++.+||+|||++................+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999976543221122234567889999999987666 589999999999999999 99999988777666
Q ss_pred HhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 226 RKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
..+.. ......+..++..+.+||.+||..||.+|||+.+++++
T Consensus 270 ~~~~~-------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKE-------------------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHH-------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhc-------------------------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55321 11233456689999999999999999999999999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=370.62 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=213.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEE--EEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCC
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFV--AIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v--AiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (468)
...++|++.+.||+|+||.||+|++..+|..+ |+|.+.... .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 44589999999999999999999999888865 999886432 223456788999999999 8999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG 150 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g 150 (468)
..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999998754 699999999999999999999999999999999999999999
Q ss_pred ceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhc
Q 012228 151 VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVS 229 (468)
Q Consensus 151 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~ 229 (468)
.+||+|||++..... ........+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+....+.
T Consensus 180 ~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCccccc---cccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 999999999874322 112234567889999999987666 589999999999999998 999999888777666532
Q ss_pred ccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 230 TFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
. ......+..+++.+.+||.+||..||.+|||++++++|
T Consensus 256 ~-------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 Q-------------------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp G-------------------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-------------------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 11234455689999999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=365.43 Aligned_cols=275 Identities=25% Similarity=0.392 Sum_probs=212.9
Q ss_pred CCCCCccccCeEEEeeeeecCCeEEEEEE----EcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEE
Q 012228 5 VPASRTRVGKYELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE 80 (468)
Q Consensus 5 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~ 80 (468)
+........+|++++.||+|+||.||+|+ +..+++.||+|++..... ....+.+.+|+.+++.++||||+++++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKG 90 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeee
Confidence 33444455679999999999999999999 567899999999975432 223567889999999999999999999
Q ss_pred EEEeC--CEEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecc
Q 012228 81 VMASK--TKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 157 (468)
Q Consensus 81 ~~~~~--~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DF 157 (468)
++... +.+|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcc
Confidence 99876 679999999999999999954 457999999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhhcC-CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccc
Q 012228 158 GLSAISQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSV 236 (468)
Q Consensus 158 Gla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~ 236 (468)
|++......... .......||+.|+|||++.+..+. .++||||+||++|+|++|..||........ .........
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-- 246 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFL-KMIGPTHGQ-- 246 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCGG--
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHh-hccCCcccc--
Confidence 999765432111 123456788899999999877764 899999999999999999999765432211 111000000
Q ss_pred cccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 237 YGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
........ ..........++.+++.+.+||.+||+.||.+|||++++++
T Consensus 247 --~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 247 --MTVTRLVN-----TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp --GHHHHHHH-----HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred --cCHHHHHH-----HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00000000 00122344566779999999999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=371.56 Aligned_cols=254 Identities=21% Similarity=0.356 Sum_probs=205.1
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEE----EEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFV----AIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
..++|++.+.||+|+||+||+|.+..+++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4578999999999999999999998888765 555554322 1223567889999999999999999999998765
Q ss_pred EEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
.++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 88999999999999999764 5699999999999999999999999999999999999999999999999999987644
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
...........+|+.|+|||++.+..| +.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~--------------- 233 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE--------------- 233 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---------------
T ss_pred ccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---------------
Confidence 333333344567889999999988777 589999999999999999 999998876555444321
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......+..++.++.+||.+||..||.+|||+.++++.
T Consensus 234 ----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 234 ----------KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ----------TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 122344566789999999999999999999999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=362.00 Aligned_cols=258 Identities=30% Similarity=0.532 Sum_probs=203.7
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
...+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++...+..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 34678999999999999999999999999999999999765444455667889999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 89 YIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998864 4569999999999999999999999999999999999999999999999999987654
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch--HHHHHHhhcccccccccccchh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
.. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. .......+..
T Consensus 188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 252 (310)
T 2wqm_A 188 SK--TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ------------ 252 (310)
T ss_dssp -------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT------------
T ss_pred CC--CccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc------------
Confidence 32 222345679999999999988776 589999999999999999999997542 2222222110
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......+..++.++.+||.+||..||.+|||+++++++
T Consensus 253 ------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 253 ------------CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp ------------TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000111124578999999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=371.17 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=212.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEE-----cCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEe
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKN-----VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMAS 84 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 84 (468)
..++|++++.||+|+||+||+|.+ ..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 347899999999999999999985 3577899999997543 233456788999999999 69999999999877
Q ss_pred CC-EEEEEEEccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 012228 85 KT-KIYIVLEFIDGGELFDKIAKHGR----------------LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 147 (468)
Q Consensus 85 ~~-~~~lV~E~~~gg~L~~~i~~~~~----------------l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~ 147 (468)
.+ .+|+||||+++|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 54 58999999999999999987654 89999999999999999999999999999999999999
Q ss_pred cCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHH-H
Q 012228 148 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMAL-Y 225 (468)
Q Consensus 148 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~-~ 225 (468)
.++.+||+|||++................||+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+.... .
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 999999999999976543222222334568899999999988776 589999999999999998 9999987543222 2
Q ss_pred HhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 226 RKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
..+ ........+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 262 ~~~-------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRL-------------------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHH-------------------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHh-------------------------ccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 221 1112344566789999999999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=357.03 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=214.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 468999999999999999999986 6788999999765432 25688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 160 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 160 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence 9999999999999875 4689999999999999999999999999999999999999999999999999876432211 1
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
......+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+..+....+..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~------------------- 220 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST------------------- 220 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------------------
T ss_pred ccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-------------------
Confidence 2234567889999999987776 589999999999999999 9999998877666555321
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......|..+++.+.+|+.+||+.||.+|||+.+++++
T Consensus 221 ------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 221 ------GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11233455679999999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=364.04 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=217.9
Q ss_pred CCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
.-.....+|++.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 334566789999999999999999999999999999999975432 3467889999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
.+|+||||++|++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999999998744 49999999999999999999999999999999999999999999999999998654
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
... ........+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+.......+.
T Consensus 163 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-------------- 226 (288)
T 3kfa_A 163 GDT-YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------------- 226 (288)
T ss_dssp SSS-SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH--------------
T ss_pred CCc-cccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--------------
Confidence 211 112233457889999999987776 589999999999999999 999998876554444321
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......|..+++.+.+||.+||..||.+|||++++++.
T Consensus 227 -----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 227 -----------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp -----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 112334556689999999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=368.39 Aligned_cols=260 Identities=21% Similarity=0.335 Sum_probs=190.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHH-HHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREIS-TMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+. +++.++||||+++++++.+.+..|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 45789999999999999999999999999999999976432 223345556665 778889999999999999999999
Q ss_pred EEEEccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 90 IVLEFIDGGELFDKIAK-----HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~qll~~l~yLH~~-givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
+||||+++ +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99999986 78777763 56799999999999999999999999 9999999999999999999999999998755
Q ss_pred hhhhcCCcccccCCCCCcCCccccc----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH-HHHHhhcccccccccc
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLN----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKVSTFHFLSVYG 238 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~----~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~ 238 (468)
... ......+||+.|+|||++. +..+ +.++||||+||++|+|++|..||...+.. +....+...
T Consensus 177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------- 245 (327)
T 3aln_A 177 VDS---IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG------- 245 (327)
T ss_dssp --------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS-------
T ss_pred ccc---cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC-------
Confidence 331 2233457999999999983 3444 58999999999999999999999864321 111110000
Q ss_pred cchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
. ........+..+++.+.+||.+||..||.+|||+.++++||||..
T Consensus 246 --------~------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 246 --------D------PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp --------C------CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred --------C------CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 0 000011122347999999999999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=359.33 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=208.7
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHH----HHHHHHHHHHHhcCCCCCeeEEEEEEEe
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKM----VEQIKREISTMKLIKHPNVIKIIEVMAS 84 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~----~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 84 (468)
....++|++.+.||+|+||+||+|++..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 345578999999999999999999999999999999986544322221 1678899999999999999999999977
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeeccCCc-----eEEec
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGV-----LKISD 156 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~g--ivHrDlKp~NILl~~~g~-----lkl~D 156 (468)
.. ++||||+++|+|.+.+.... .+++..+..++.|++.||+|||++| |+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 66 69999999999998886544 6999999999999999999999999 999999999999988776 99999
Q ss_pred cccchhhhhhhcCCcccccCCCCCcCCccccccC-CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHH--HHhhccccc
Q 012228 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDESNLMAL--YRKVSTFHF 233 (468)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~--~~~~~~~~~ 233 (468)
||+|.... ......+||+.|+|||++.+. ...+.++||||+||++|+|++|..||...+.... ...+.
T Consensus 173 fg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---- 243 (287)
T 4f0f_A 173 FGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR---- 243 (287)
T ss_dssp CTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH----
T ss_pred CCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh----
Confidence 99987432 234557899999999998432 2336899999999999999999999976542221 11110
Q ss_pred ccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
........+..+++.+.+||.+||+.||.+|||++++++
T Consensus 244 --------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 244 --------------------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp --------------------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 112233456678999999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=371.52 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=212.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCC-----EEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGD-----FVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (468)
.++|++++.||+|+||+||+|.+..++. .||+|++.... .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 4679999999999999999999977665 79999997543 223457789999999999 899999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH--------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV 151 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~--------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~ 151 (468)
+.+|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence 9999999999999999998753 35899999999999999999999999999999999999999999
Q ss_pred eEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcc
Q 012228 152 LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVST 230 (468)
Q Consensus 152 lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~ 230 (468)
+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+...........
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~- 280 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV- 280 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH-
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH-
Confidence 99999999986543322222334567889999999987776 589999999999999998 999998754332222211
Q ss_pred cccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 231 FHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
........|...++.+.+||.+||+.||.+|||+.+++++
T Consensus 281 -----------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 281 -----------------------KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp -----------------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 0112233456689999999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=361.24 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=211.1
Q ss_pred ccCeEEEe-eeeecCCeEEEEEEE--cCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 12 VGKYELGR-TLGEGSFAKVKFAKN--VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 12 ~~~y~i~~-~LG~G~~g~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
.++|++.+ .||+|+||+||+|.+ ..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 46799998 999999999999954 56788999999976532 233467789999999999999999999999 56778
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999875533211
Q ss_pred C-CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 169 D-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 169 ~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
. .......+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+..+....+..
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---------------- 235 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------------- 235 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----------------
T ss_pred cccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Confidence 1 11223456789999999987766 489999999999999999 9999998877666555321
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 236 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 236 ---------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1223456678999999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=366.30 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=203.6
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcC---CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
....++|++++.||+|+||.||+|.+.. ++..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3445789999999999999999998865 556899999975433 233467788999999999999999999999775
Q ss_pred C-----EEEEEEEccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEE
Q 012228 86 T-----KIYIVLEFIDGGELFDKIAK------HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKI 154 (468)
Q Consensus 86 ~-----~~~lV~E~~~gg~L~~~i~~------~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl 154 (468)
+ ..|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 5 35999999999999999843 356999999999999999999999999999999999999999999999
Q ss_pred eccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhccccc
Q 012228 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHF 233 (468)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~ 233 (468)
+|||++................+++.|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......+.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---- 263 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL---- 263 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH----
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH----
Confidence 99999986543222222334567889999999988776 589999999999999999 999998776554444321
Q ss_pred ccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 264 ---------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 264 ---------------------HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ---------------------TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112334556689999999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=371.47 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=207.4
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 89 (468)
.-++|++++.||+|+||+||+|.+..+|+.||||++..... .+.+.+|+.+++.+ +||||+++++++.+.+..|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 44679999999999999999999999999999999875432 23577999999999 8999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc-----eEEeccccchhh
Q 012228 90 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-----LKISDFGLSAIS 163 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~-----lkl~DFGla~~~ 163 (468)
+||||+ +++|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+|...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 88999999874 67999999999999999999999999999999999999998887 999999999865
Q ss_pred hhhhcCC-----cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc---hHHHHHHhhccccccc
Q 012228 164 QQVREDG-----LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKVSTFHFLS 235 (468)
Q Consensus 164 ~~~~~~~-----~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~---~~~~~~~~~~~~~~~~ 235 (468)
....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +..+.+..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~- 238 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA- 238 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-
Confidence 3322111 1346789999999999998777 58999999999999999999999874 333333332110000
Q ss_pred ccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.........++ ++.+|+..||..||.+|||++++++
T Consensus 239 --------------------~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 239 --------------------TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp --------------------SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------------------CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00000011234 8999999999999999999998876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=359.17 Aligned_cols=257 Identities=24% Similarity=0.321 Sum_probs=209.7
Q ss_pred CCCccccCeEEEeeeeecCCeEEEEEEEcC---CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012228 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA 83 (468)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 83 (468)
......++|++.+.||+|+||+||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 345567899999999999999999999753 34469999987643 2234577899999999999999999999986
Q ss_pred eCCEEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 84 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 84 ~~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
+. ..|+||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 54 5689999999999999997654 599999999999999999999999999999999999999999999999999876
Q ss_pred hhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccch
Q 012228 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
..... ........+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......+.
T Consensus 163 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~------------ 228 (281)
T 3cc6_A 163 IEDED-YYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE------------ 228 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH------------
T ss_pred ccccc-ccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh------------
Confidence 54321 112234567889999999987776 589999999999999998 999997655443333321
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 229 -------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 229 -------------KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 112234456689999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=370.22 Aligned_cols=265 Identities=21% Similarity=0.260 Sum_probs=201.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT---- 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 86 (468)
..++|++++.||+|+||+||+|++. ++.||||++..... ......+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 4578999999999999999999884 79999999975432 2344567999999999999999999997743
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCCCCeeeccCCceEEec
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR----------GVFHRDLKPENLLLDSYGVLKISD 156 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~----------givHrDlKp~NILl~~~g~lkl~D 156 (468)
.+|+|||||++|+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 47999999999999999976 5699999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhhhcCCcccccCCCCCcCCccccccCCC----CCChhhHHHHHHHHHHHhhCCCCCCCchHHHH---HHhhc
Q 012228 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY----DGRASDVWSCGVILFVLMAGFLPFDESNLMAL---YRKVS 229 (468)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~----~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~---~~~~~ 229 (468)
||+|+..............+||+.|+|||++.+... .+.++||||+||++|+|++|..||.+...... .....
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999976554333333455789999999999986422 24678999999999999999999976431100 00000
Q ss_pred ccccccccccchhhhccccccccccccccCCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 230 TFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
. .......... ..........+.. .++++.+||.+||+.||++|||+.++++.
T Consensus 255 ~-------~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 255 Q-------HPSLEDMQEV----VVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp S-------SCCHHHHHHH----HTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-------CCchhhhhhh----hhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 0000000000 0000011111111 24559999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=360.87 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=213.4
Q ss_pred cccCeEEEe-eeeecCCeEEEEEEEc--CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 11 RVGKYELGR-TLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 11 ~~~~y~i~~-~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
..++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 346788887 9999999999999864 467889999997642 234567889999999999999999999999 4566
Q ss_pred EEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999999998654 46999999999999999999999999999999999999999999999999999765332
Q ss_pred hc-CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 167 RE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 167 ~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.. ........+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+....+..
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-------------- 228 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------------- 228 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT--------------
T ss_pred cceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc--------------
Confidence 11 112233457899999999987666 589999999999999998 9999988776655544311
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpw 295 (468)
......|+.+++++.+||.+||..||.+|||+.++++|.+
T Consensus 229 -----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 229 -----------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp -----------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -----------CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1223456678999999999999999999999999998854
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=376.36 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=203.1
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
..++|++.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 3467999999999999999999987 567789999997542 23346778999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 999999999999999998754 6999999999999999999999999999999999999999999999999999865432
Q ss_pred hcCC-cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 167 REDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 167 ~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.... ......+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+....+..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-------------- 265 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-------------- 265 (373)
T ss_dssp -------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT--------------
T ss_pred CccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--------------
Confidence 2111 1122345788999999988777 489999999999999997 9999988777666555321
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+..++..+.+|+.+||+.||.+|||++++++
T Consensus 266 -----------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 266 -----------GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -----------TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 1122344568899999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=359.10 Aligned_cols=257 Identities=19% Similarity=0.260 Sum_probs=211.1
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTK 87 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 87 (468)
....++|++++.||+|+||.||+|.+..+|+.||+|++..... .+.+.+|+.+++.+ +|||++++++++.....
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 4455789999999999999999999999999999999865432 23477899999999 79999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc-----eEEeccccch
Q 012228 88 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-----LKISDFGLSA 161 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~-----lkl~DFGla~ 161 (468)
.|+||||+ +++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+|.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 889999998755 5999999999999999999999999999999999999987776 9999999998
Q ss_pred hhhhhhcC-----CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch---HHHHHHhhccccc
Q 012228 162 ISQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKVSTFHF 233 (468)
Q Consensus 162 ~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~---~~~~~~~~~~~~~ 233 (468)
........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+ ....+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~- 237 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK- 237 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc-
Confidence 65432221 12345689999999999988776 589999999999999999999998742 333332221100
Q ss_pred ccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.........+.+++++.+|+.+||+.||.+|||++++++.
T Consensus 238 --------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 238 --------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp --------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred --------------------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0000011123478999999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=364.47 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=207.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCC----CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETG----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
.-++|++.+.||+|+||+||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 4467999999999999999999987553 359999997543 2334567889999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999999999765 5799999999999999999999999999999999999999999999999999986543
Q ss_pred hhcCC-cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 166 VREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 166 ~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
..... ......+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+....+..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~------------- 265 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND------------- 265 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------------
T ss_pred ccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-------------
Confidence 22111 1223346789999999987776 589999999999999998 9999988777666555321
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 266 ------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 266 ------------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ------------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12234455689999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=359.08 Aligned_cols=258 Identities=24% Similarity=0.410 Sum_probs=196.7
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
....-++|++++.||+|+||+||+|.+. ..||+|++..... .....+.+.+|+.+++.++||||++++++. ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 3445678999999999999999999864 3599999975432 334567889999999999999999999964 5667
Q ss_pred EEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 89999999999999999644 46999999999999999999999999999999999999999999999999999865443
Q ss_pred hcCCcccccCCCCCcCCccccc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHH-HHHhhcccccccccccchh
Q 012228 167 REDGLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA-LYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 242 (468)
.........+||+.|+|||++. +..+ +.++||||+||++|+|++|..||...+..+ ....+....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------- 242 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS---------- 242 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS----------
T ss_pred cccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc----------
Confidence 3333445678999999999986 3334 579999999999999999999998754332 222211100
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
........+..+++.+.+||.+||+.||.+|||++++++
T Consensus 243 -----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 243 -----------LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -----------CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000111223457899999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=357.75 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=208.5
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCC---EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE-E
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI-Y 89 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~-~ 89 (468)
.|++.+.||+|+||+||+|.+..++. .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 58888999999999999999765554 79999986532 334567888999999999999999999999877665 9
Q ss_pred EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh-
Q 012228 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR- 167 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~- 167 (468)
+||||+.+|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999987 4568999999999999999999999999999999999999999999999999997543322
Q ss_pred -cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 168 -EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 168 -~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
.........+|+.|+|||++.+..+ +.++||||+||++|+|++ |.+||...+..+....+
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~----------------- 241 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL----------------- 241 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-----------------
T ss_pred cccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-----------------
Confidence 1223345678899999999988776 589999999999999999 55556655544433332
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
........+..+++.+.+||.+||+.||.+|||++++++.
T Consensus 242 --------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 242 --------AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp --------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------hcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1122344566689999999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=358.05 Aligned_cols=247 Identities=28% Similarity=0.426 Sum_probs=210.1
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe------
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------ 84 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 84 (468)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3468999999999999999999999999999999997543 245689999999999999999998854
Q ss_pred ----------CCEEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCce
Q 012228 85 ----------KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVL 152 (468)
Q Consensus 85 ----------~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~l 152 (468)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence 45589999999999999999754 579999999999999999999999999999999999999999999
Q ss_pred EEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccc
Q 012228 153 KISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH 232 (468)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~ 232 (468)
||+|||++..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.... .....+
T Consensus 162 kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~---- 231 (284)
T 2a19_B 162 KIGDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFETS--KFFTDL---- 231 (284)
T ss_dssp EECCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHH----
T ss_pred EECcchhheeccc---cccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHh----
Confidence 9999999875533 223345679999999999988776 589999999999999999999885322 111111
Q ss_pred cccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 233 FLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.. ...+..++..+.+||.+||..||.+|||+.++++|.|.-+
T Consensus 232 ----------------------~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 232 ----------------------RD--GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ----------------------HT--TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ----------------------hc--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 01 1234557899999999999999999999999999988764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=358.27 Aligned_cols=238 Identities=32% Similarity=0.607 Sum_probs=195.0
Q ss_pred CccccCeEEE-eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHH-hcCCCCCeeEEEEEEEe--
Q 012228 9 RTRVGKYELG-RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHPNVIKIIEVMAS-- 84 (468)
Q Consensus 9 ~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~hpnIv~l~~~~~~-- 84 (468)
+..+++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 4577889998 7899999999999999999999999999642 2355888887 66689999999999977
Q ss_pred --CCEEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc---CCceEEecc
Q 012228 85 --KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDF 157 (468)
Q Consensus 85 --~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~---~g~lkl~DF 157 (468)
...+|+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 678999999999999999998765 6999999999999999999999999999999999999998 789999999
Q ss_pred ccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccc
Q 012228 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237 (468)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 237 (468)
|+|.... +..| +.++||||+||++|+|++|..||...+..........
T Consensus 165 g~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~------- 212 (299)
T 3m2w_A 165 GFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------- 212 (299)
T ss_dssp TTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-------
T ss_pred ccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-------
Confidence 9976321 1223 5799999999999999999999987654332211100
Q ss_pred ccchhhhccccccccccccccCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 238 GESYKKCTNKYSYTLQICRADFSCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
.+.......+ ..+++++.+||.+||+.||.+|||++|+++||||++...
T Consensus 213 ---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 213 ---------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp ---------------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred ---------------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 0112222233 457999999999999999999999999999999987543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=364.72 Aligned_cols=268 Identities=24% Similarity=0.363 Sum_probs=213.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEE----EcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--eC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA--SK 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~--~~ 85 (468)
..+|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 4689999999999999999999 56789999999997543 334567889999999999999999999886 55
Q ss_pred CEEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
+.+|+||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 779999999999999999977 3569999999999999999999999999999999999999999999999999998653
Q ss_pred hhhcC-CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 165 QVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 165 ~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
..... .......||+.|+|||++.+..+ +.++||||+||++|+|++|..||................ .. ....
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~~----~~~~ 252 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD-VP----ALSR 252 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CC----HHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccc-cc----cHHH
Confidence 32111 12234568889999999987766 589999999999999999999997765432221100000 00 0000
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
... ..........+..+++.+.+||.+||+.||.+|||+++++++
T Consensus 253 ~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 253 LLE-----LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHH-----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH-----HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 001223345567789999999999999999999999999765
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=379.15 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=195.5
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
+|++.+.||+|+||+|+. ....+|+.||||++...... .+.+|+.+|+.+ +||||+++++++.+....|+||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 499999999999999764 34468999999999754322 245899999999 7999999999999999999999
Q ss_pred EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-----CCceEEeccccchhhhhh
Q 012228 93 EFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-----YGVLKISDFGLSAISQQV 166 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~-----~g~lkl~DFGla~~~~~~ 166 (468)
|||.| +|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ...+||+|||+|+.....
T Consensus 98 E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 99975 9999997654 4666678899999999999999999999999999999953 235789999999865432
Q ss_pred hc-CCcccccCCCCCcCCccccccC--CCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchh
Q 012228 167 RE-DGLLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 167 ~~-~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
.. .......+||+.|+|||++.+. ...+.++||||+||++|+|++ |..||..............
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~------------ 244 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA------------ 244 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTC------------
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhcc------------
Confidence 11 1234457899999999999742 233579999999999999999 9999976543333222110
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
........+...+..+.+||.+||+.||.+|||++++++||||..
T Consensus 245 -----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 245 -----------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp -----------CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred -----------CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 000011111224567899999999999999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=378.77 Aligned_cols=244 Identities=27% Similarity=0.481 Sum_probs=207.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-EEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-KIY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~ 89 (468)
..++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+|+.++||||+++++++.... .+|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 4578999999999999999999984 7799999997543 2356889999999999999999999987665 799
Q ss_pred EEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|||||++|+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 341 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 341 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc--
Confidence 99999999999999987654 79999999999999999999999999999999999999999999999999874322
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
......+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+....+.
T Consensus 342 ---~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~----------------- 400 (450)
T 1k9a_A 342 ---TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----------------- 400 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-----------------
T ss_pred ---cccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----------------
Confidence 1223467899999999988777 589999999999999998 999998766544444321
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......|..+++.+.+||.+||..||.+|||+.++++
T Consensus 401 --------~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 401 --------KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11234566778999999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=379.00 Aligned_cols=274 Identities=23% Similarity=0.372 Sum_probs=209.2
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC--E
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--K 87 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--~ 87 (468)
..-++|++.+.||+|+||+||+|++..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 34578999999999999999999999999999999997654322 2456779999999999999999999998765 7
Q ss_pred EEEEEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee----ccCCceEEeccccc
Q 012228 88 IYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLS 160 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl----~~~g~lkl~DFGla 160 (468)
.|+|||||+||+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 8999999999999999876443 9999999999999999999999999999999999999 77788999999999
Q ss_pred hhhhhhhcCCcccccCCCCCcCCccccccC-------CCCCChhhHHHHHHHHHHHhhCCCCCCCc----hHHHHHHhhc
Q 012228 161 AISQQVREDGLLHTACGTPNYVAPEVLNDK-------GYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKVS 229 (468)
Q Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-------~~~~~~~DiWSlGvil~~ll~g~~Pf~~~----~~~~~~~~~~ 229 (468)
+..... ......+||+.|+|||++.+. ..++.++||||+||++|+|++|..||... ...+....+.
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 765432 223457899999999998652 22357899999999999999999999642 2223333322
Q ss_pred ccccccccccchhhhccccccccccccccCC----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 230 TFHFLSVYGESYKKCTNKYSYTLQICRADFS----CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......+........... .....++ .+..++..+.+||++||+.||++|||+.+++++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPI-----DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HSCCTTCCEEEECSTTCCE-----EEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cCCCcccchhheeccCCCc-----ccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 2111111000000000000 0111112 222346778999999999999999999998654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=358.12 Aligned_cols=255 Identities=23% Similarity=0.326 Sum_probs=206.1
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCC---CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-EeCC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVM-ASKT 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~-~~~~ 86 (468)
...+|++.+.||+|+||+||+|.+..++ ..+|+|.+.... .....+.+.+|+.+++.++||||+++++++ ...+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 4457999999999999999999976433 358999986532 334567789999999999999999999985 5567
Q ss_pred EEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 889999999999999999764 4589999999999999999999999999999999999999999999999999976533
Q ss_pred hhc--CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchh
Q 012228 166 VRE--DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 166 ~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
... ........||+.|+|||++.+..+ +.++||||+||++|+|++ |.+||...+..+....+
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~-------------- 245 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------------- 245 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH--------------
T ss_pred cchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH--------------
Confidence 221 122334567889999999988776 589999999999999999 67778766544333332
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
........|..++..+.+||.+||+.||.+|||++++++.
T Consensus 246 -----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 246 -----------LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp -----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------hcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1122233456689999999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=369.12 Aligned_cols=262 Identities=16% Similarity=0.217 Sum_probs=200.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcC---CCCEEEEEEeechhhhhHH--------HHHHHHHHHHHHhcCCCCCeeEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRHK--------MVEQIKREISTMKLIKHPNVIKIIEV 81 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~i~~~~~~~~~--------~~~~i~~Ei~il~~l~hpnIv~l~~~ 81 (468)
++|++++.||+|+||+||+|.+.. ++..||+|++......... ....+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999987 7889999998754321100 11346688999999999999999999
Q ss_pred EEe----CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC--ceEEe
Q 012228 82 MAS----KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG--VLKIS 155 (468)
Q Consensus 82 ~~~----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g--~lkl~ 155 (468)
+.. ...+|+||||+ |++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence 987 78899999999 899999998888999999999999999999999999999999999999999877 99999
Q ss_pred ccccchhhhhhhcC-----CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc--hHHHHHHhh
Q 012228 156 DFGLSAISQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES--NLMALYRKV 228 (468)
Q Consensus 156 DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~--~~~~~~~~~ 228 (468)
|||+|+........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||... +........
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 274 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence 99999765432211 12245689999999999988766 58999999999999999999999652 222221111
Q ss_pred cccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
... ........ .....+..+++++.+||.+||..||++|||++++++.
T Consensus 275 ~~~--~~~~~~~~---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 275 TNL--LDELPQSV---------------LKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHH--HHTTTHHH---------------HHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred Hhh--cccccHHH---------------HhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 000 00000000 0001112478999999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=372.77 Aligned_cols=270 Identities=21% Similarity=0.313 Sum_probs=211.4
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++.+.||+|+||+||+|.+ .+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 4568899999999999999999997 4789999999865432 23567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999886543 589999999999999999999999999999999999999999999999999875443
Q ss_pred hhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
..........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||......+...... +.... ...
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~-------~~~~~-~~~ 262 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE-------WAVES-HNN 262 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH-------HTHHH-HTT
T ss_pred ccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH-------Hhhhc-ccc
Confidence 323333445678999999999987776 589999999999999999999997643211100000 00000 000
Q ss_pred cccccccccccc--cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 012228 246 NKYSYTLQICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295 (468)
Q Consensus 246 ~~~~~~~~~~~~--~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpw 295 (468)
.... ..... ....++..+..+.+++.+||+.||++|||+.++++|..
T Consensus 263 ~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 263 GQLE---QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp TCCC---SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccHH---HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 0000 00000 11122335678999999999999999999999998753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=364.28 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=204.6
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE----eCCEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA----SKTKI 88 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~----~~~~~ 88 (468)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. .....
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 57999999999999999999999999999999986532 334567889999999999999999999986 34578
Q ss_pred EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 89 YIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999998876 4679999999999999999999999999999999999999999999999999876532
Q ss_pred hhhcC-------CcccccCCCCCcCCccccccCCC--CCChhhHHHHHHHHHHHhhCCCCCCCchHH--HHHHhhccccc
Q 012228 165 QVRED-------GLLHTACGTPNYVAPEVLNDKGY--DGRASDVWSCGVILFVLMAGFLPFDESNLM--ALYRKVSTFHF 233 (468)
Q Consensus 165 ~~~~~-------~~~~~~~gt~~y~APEvl~~~~~--~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~--~~~~~~~~~~~ 233 (468)
..... .......||+.|+|||++.+..+ .+.++||||+||++|+|++|..||...... .....+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----- 260 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV----- 260 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-----
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh-----
Confidence 21110 01123568999999999876542 358999999999999999999999542110 000000
Q ss_pred ccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 012228 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 294 (468)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hp 294 (468)
........++.+++.+.+||.+||+.||.+|||+++++++-
T Consensus 261 --------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 261 --------------------QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp --------------------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------------------hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 01112233456899999999999999999999999999873
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=379.27 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=210.6
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.+.||+|+||+||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. .+.+|+|
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 467999999999999999999985 567899999975432 2467889999999999999999999986 5678999
Q ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~- 339 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 339 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-
Confidence 99999999999997543 689999999999999999999999999999999999999999999999999986532211
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......+|+.|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~------------------ 400 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER------------------ 400 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH------------------
T ss_pred eccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------------
Confidence 11223456788999999987776 589999999999999999 9999998877766655321
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......|..+++++.+||.+||..||.+|||++++++
T Consensus 401 -------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 401 -------GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1233456678999999999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=367.13 Aligned_cols=263 Identities=14% Similarity=0.203 Sum_probs=201.6
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCC-----CCEEEEEEeechhhhhHHH--------HHHHHHHHHHHhcCCCCCeeEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVET-----GDFVAIKIVDRDQVLRHKM--------VEQIKREISTMKLIKHPNVIKII 79 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~--------~~~i~~Ei~il~~l~hpnIv~l~ 79 (468)
++|++++.||+|+||+||+|.+..+ ++.||+|++.......... .....+|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 3899999999999999999999764 5789999987543211100 12345677788889999999999
Q ss_pred EEEEeC----CEEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec--cCCce
Q 012228 80 EVMASK----TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVL 152 (468)
Q Consensus 80 ~~~~~~----~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~--~~g~l 152 (468)
+++... ...|+||||| |++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 998664 5589999999 89999999876 5799999999999999999999999999999999999999 88999
Q ss_pred EEeccccchhhhhhhcC-----CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHh
Q 012228 153 KISDFGLSAISQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 227 (468)
Q Consensus 153 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~ 227 (468)
||+|||+|+........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 99999999765443221 11234569999999999988776 5999999999999999999999986422111111
Q ss_pred hcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 228 VSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
............ .....+ .+..++.++.+|+..||..||.+|||++++++
T Consensus 273 ~~~~~~~~~~~~--------------~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIAS--------------LMDKCF-PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHH--------------HHHHHS-CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHH--------------HHHHhc-ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 000000000000 000000 12447899999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=386.31 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=213.7
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
..+|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|+.++||||+++++++.....+|+|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 4579999999999999999999999999999999975432 245688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce-
Confidence 9999999999999864 3589999999999999999999999999999999999999999999999999986532111
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......+|+.|+|||++.+..+ +.++|||||||+||+|++ |..||.+.+..+....+.
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~------------------- 433 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------------------- 433 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------------------
T ss_pred eecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------------------
Confidence 11223456788999999987766 589999999999999999 999998876554444321
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 434 ------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 434 ------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 11233456678999999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=353.70 Aligned_cols=245 Identities=27% Similarity=0.475 Sum_probs=202.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-CEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-TKI 88 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-~~~ 88 (468)
...++|++.+.||+|+||+||+|.+ +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++... +..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 4568899999999999999999987 58899999987543 346788999999999999999999997554 578
Q ss_pred EEEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
|+||||+++|+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999999999987554 899999999999999999999999999999999999999999999999998754321
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
.....+++.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+..+....+.
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~---------------- 228 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---------------- 228 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT----------------
T ss_pred -----ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh----------------
Confidence 234468899999999987776 589999999999999998 999998766544444321
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......+..+++.+.+||.+||..||.+|||+.++++
T Consensus 229 ---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 229 ---------KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 11223456678999999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=358.55 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=204.0
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcC-CCC--EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVE-TGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
..++|++.+.||+|+||+||+|.+.. ++. .||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 44689999999999999999998643 343 68999997654444455778999999999999999999999998765
Q ss_pred EEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 89999999999999998764 56999999999999999999999999999999999999999999999999998765332
Q ss_pred hcC-CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 167 RED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 167 ~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
... .......+|+.|+|||++.+..+ +.++||||+|+++|+|++ |..||...+..+....+..
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------------- 239 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------- 239 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT--------------
T ss_pred ccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc--------------
Confidence 111 12234567889999999987766 589999999999999999 9999998877766655321
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......+..++.++.++|.+||..||.+|||+.+++++
T Consensus 240 ----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 240 ----------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp ----------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 112233456689999999999999999999999999973
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=368.56 Aligned_cols=244 Identities=16% Similarity=0.206 Sum_probs=199.8
Q ss_pred cCeEEEeeeeecCCeEEEEE-----EEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC---CCCeeEEEEEEEe
Q 012228 13 GKYELGRTLGEGSFAKVKFA-----KNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK---HPNVIKIIEVMAS 84 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a-----~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~ 84 (468)
++|++.+.||+|+||+||+| .+..+++.||+|++.... ...+.+|+.+++.++ |+||+++++++..
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 56999999999999999999 467789999999997542 234667888888776 9999999999999
Q ss_pred CCEEEEEEEccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-----------
Q 012228 85 KTKIYIVLEFIDGGELFDKIAK-----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS----------- 148 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~----------- 148 (468)
.+..|+|||||+||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999999974 457999999999999999999999999999999999999998
Q ss_pred CCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhh
Q 012228 149 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV 228 (468)
Q Consensus 149 ~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~ 228 (468)
++.+||+|||+|+..............+||+.|+|||++.+..| +.++|||||||++|+|++|..||.......
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 89999999999976544333445567889999999999998876 599999999999999999999996532100
Q ss_pred cccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
+ .....+. ..+.+..+.+++..||+.+|.+|++..+.+.+
T Consensus 293 ------------~------------~~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 ------------C------------KPEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ------------E------------EECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ------------e------------eechhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0 0000011 11357788999999999999999765555544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=352.53 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=209.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.. +..|+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 4578999999999999999999974 5678999999754321 3568899999999999999999999864 55899
Q ss_pred EEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 91 VLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999999987543 699999999999999999999999999999999999999999999999999876533111
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.......+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+....+..
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~----------------- 225 (279)
T 1qpc_A 165 -TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----------------- 225 (279)
T ss_dssp -ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----------------
T ss_pred -ccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc-----------------
Confidence 11234457889999999987666 589999999999999999 9999998877666555321
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
......+..++..+.+||.+||..||++|||++++++
T Consensus 226 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 226 --------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1123345568999999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=373.33 Aligned_cols=264 Identities=27% Similarity=0.341 Sum_probs=194.3
Q ss_pred CCCCcccc-CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEE
Q 012228 6 PASRTRVG-KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMA 83 (468)
Q Consensus 6 ~~~~~~~~-~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~ 83 (468)
|.-...++ .|.+.+.||+|+||+||.+. ..+|+.||||++..+. .+.+.+|+.+++.+ +||||+++++++.
T Consensus 7 p~~~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 79 (434)
T 2rio_A 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSET 79 (434)
T ss_dssp -CCSCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cchhhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 33344444 46667899999999998754 4689999999986542 24567899999876 8999999999999
Q ss_pred eCCEEEEEEEccCCCCHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC-------
Q 012228 84 SKTKIYIVLEFIDGGELFDKIAKHGRLK-------EDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY------- 149 (468)
Q Consensus 84 ~~~~~~lV~E~~~gg~L~~~i~~~~~l~-------e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~------- 149 (468)
+.+.+|+|||||. |+|.+++....... +..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence 9999999999996 59999998765433 33457899999999999999999999999999999754
Q ss_pred ------CceEEeccccchhhhhhhcC--CcccccCCCCCcCCcccccc------CCCCCChhhHHHHHHHHHHHhh-CCC
Q 012228 150 ------GVLKISDFGLSAISQQVRED--GLLHTACGTPNYVAPEVLND------KGYDGRASDVWSCGVILFVLMA-GFL 214 (468)
Q Consensus 150 ------g~lkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~------~~~~~~~~DiWSlGvil~~ll~-g~~ 214 (468)
+.+||+|||+|......... ......+||+.|+|||++.+ ....+.++||||+||++|+|++ |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 48999999999865432111 12345689999999999975 2334699999999999999998 999
Q ss_pred CCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 012228 215 PFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 294 (468)
Q Consensus 215 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hp 294 (468)
||............... . ........+..+++++.+||.+||+.||.+|||+.++++||
T Consensus 239 Pf~~~~~~~~~i~~~~~-----------------~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 239 PFGDKYSRESNIIRGIF-----------------S----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp TTCSTTTHHHHHHHTCC-----------------C----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCCCchhhHHHHhcCCC-----------------C----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 99765432211100000 0 00000011122467899999999999999999999999999
Q ss_pred cccc
Q 012228 295 WFKK 298 (468)
Q Consensus 295 wf~~ 298 (468)
||..
T Consensus 298 ~f~~ 301 (434)
T 2rio_A 298 LFWP 301 (434)
T ss_dssp GGSC
T ss_pred ccCC
Confidence 9963
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=359.82 Aligned_cols=268 Identities=25% Similarity=0.330 Sum_probs=208.0
Q ss_pred cccCe-EEEeeeeecCCeEEEEEEE----cCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-
Q 012228 11 RVGKY-ELGRTLGEGSFAKVKFAKN----VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS- 84 (468)
Q Consensus 11 ~~~~y-~i~~~LG~G~~g~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~- 84 (468)
.-++| ++++.||+|+||+||++.. ..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 34555 9999999999999988754 4588999999997653 23346778999999999999999999999987
Q ss_pred -CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 85 -KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 85 -~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
...+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 4789999999999999999876 45999999999999999999999999999999999999999999999999999865
Q ss_pred hhhhcC-CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchh
Q 012228 164 QQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 164 ~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
...... .......||+.|+|||++.+..+. .++||||+||++|+|++|..||................. ....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~ 258 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ-----MTVL 258 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHH-----HHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccc-----hhHH
Confidence 432111 123345688899999999877764 899999999999999999999976543211110000000 0000
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
... ...........+..+++++.+||.+||+.||.+|||++++++
T Consensus 259 ~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 259 RLT-----ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHH-----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH-----HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000 000112234456678999999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=352.68 Aligned_cols=255 Identities=23% Similarity=0.298 Sum_probs=203.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEE-EEEeCCEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE-VMASKTKIY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~-~~~~~~~~~ 89 (468)
..++|++.+.||+|+||.||+|++..+|+.||+|++...... +.+.+|+.+++.++|++++..+. +....+..|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 457899999999999999999999999999999998754322 34779999999999877655554 447788899
Q ss_pred EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee---ccCCceEEeccccchhhhh
Q 012228 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl---~~~g~lkl~DFGla~~~~~ 165 (468)
+||||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 8899999974 4579999999999999999999999999999999999999 5889999999999986543
Q ss_pred hhcC-----CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchH---HHHHHhhccccccccc
Q 012228 166 VRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---MALYRKVSTFHFLSVY 237 (468)
Q Consensus 166 ~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~---~~~~~~~~~~~~~~~~ 237 (468)
.... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+. ...+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 234 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----- 234 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-----
T ss_pred cccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc-----
Confidence 2221 12345689999999999988776 5899999999999999999999976321 11111110000
Q ss_pred ccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
........+..+|+++.+|+.+||+.||.+|||++++++.
T Consensus 235 ----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 235 ----------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp ----------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred ----------------cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 0000001224578999999999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=359.79 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=187.6
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEE--------
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMA-------- 83 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~-------- 83 (468)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.+. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 47999999999999999999999999999999986542 234567889999999996 999999999984
Q ss_pred eCCEEEEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeeccCCceEEeccc
Q 012228 84 SKTKIYIVLEFIDGGELFDKIAK---HGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFG 158 (468)
Q Consensus 84 ~~~~~~lV~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~~l~yLH~~g--ivHrDlKp~NILl~~~g~lkl~DFG 158 (468)
....+|+||||+. |+|.+++.. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 3455899999997 588888764 567999999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhhcC----------CcccccCCCCCcCCccccc---cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHH
Q 012228 159 LSAISQQVRED----------GLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY 225 (468)
Q Consensus 159 la~~~~~~~~~----------~~~~~~~gt~~y~APEvl~---~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~ 225 (468)
++......... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 99765432110 1112567999999999983 4344 58999999999999999999999765433221
Q ss_pred HhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 226 RKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
.. ......+...+..+.+||.+||+.||.+|||+.++++|-+-
T Consensus 263 ~~----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 263 NG----------------------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp -------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cC----------------------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11 11122334467889999999999999999999999998543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=355.45 Aligned_cols=254 Identities=23% Similarity=0.306 Sum_probs=199.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEE-EEEeCCEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIE-VMASKTKIY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~-~~~~~~~~~ 89 (468)
..++|++++.||+|+||+||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+. ++...+..|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 44789999999999999999999999999999998765432 234778999999999777666555 457788899
Q ss_pred EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee---ccCCceEEeccccchhhhh
Q 012228 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl---~~~g~lkl~DFGla~~~~~ 165 (468)
+||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 8899999885 4579999999999999999999999999999999999999 7899999999999986543
Q ss_pred hhcC-----CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH---HHHHhhccccccccc
Q 012228 166 VRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---ALYRKVSTFHFLSVY 237 (468)
Q Consensus 166 ~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~---~~~~~~~~~~~~~~~ 237 (468)
.... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+.. .....+....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 234 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----- 234 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-----
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-----
Confidence 2221 12345689999999999988776 58999999999999999999999764311 1111100000
Q ss_pred ccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
...........+|+++.+||.+||+.||++|||++++++
T Consensus 235 ----------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 235 ----------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ----------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ----------------ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 000000112447899999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=374.99 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=208.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.+ +.+|+|
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 4679999999999999999999864 467999999764322 3568899999999999999999999876 678999
Q ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~ 335 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y 335 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence 9999999999999743 469999999999999999999999999999999999999999999999999998654311 1
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+....+.
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~------------------- 395 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------------------- 395 (452)
T ss_dssp -------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------------------
T ss_pred ecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------------------
Confidence 11233457789999999987776 589999999999999999 999999887766655532
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC--cccc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED--EWFK 297 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h--pwf~ 297 (468)
.......|+.+++.+.+||.+||+.||++|||++++++. .++.
T Consensus 396 ------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 396 ------RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 112334566789999999999999999999999999863 4544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=386.55 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=207.3
Q ss_pred eEE-EeeeeecCCeEEEEEEE--cCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 15 YEL-GRTLGEGSFAKVKFAKN--VETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 15 y~i-~~~LG~G~~g~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+.+ .+.||+|+||+||+|.+ ..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.. +.+|+|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 444 34899999999999955 45678999999976432 22345778999999999999999999999965 458999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc-CC
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE-DG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~-~~ 170 (468)
||||++|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999986543221 11
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------------------- 586 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------------------- 586 (635)
T ss_dssp -------CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH--------------------
T ss_pred cccCCCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------------------
Confidence 2233457889999999988777 589999999999999998 999999988776666542
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......|..+++++.+||.+||..||++|||++++++
T Consensus 587 -----~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 587 -----KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -----TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 12234556778999999999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=351.76 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=196.1
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhc--CCCCCeeEEEEEEEe--
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL--IKHPNVIKIIEVMAS-- 84 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~hpnIv~l~~~~~~-- 84 (468)
....++|++.+.||+|+||+||+|.+ +|+.||+|++.... .....+|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34568899999999999999999998 68999999986542 2334456666655 789999999998644
Q ss_pred --CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCCeeeccCCceEE
Q 012228 85 --KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH--------SRGVFHRDLKPENLLLDSYGVLKI 154 (468)
Q Consensus 85 --~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH--------~~givHrDlKp~NILl~~~g~lkl 154 (468)
...+|+||||+++|+|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999954 67999999999999999999999 999999999999999999999999
Q ss_pred eccccchhhhhhhcC--CcccccCCCCCcCCccccccCCCC-----CChhhHHHHHHHHHHHhhC----------CCCCC
Q 012228 155 SDFGLSAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYD-----GRASDVWSCGVILFVLMAG----------FLPFD 217 (468)
Q Consensus 155 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~-----~~~~DiWSlGvil~~ll~g----------~~Pf~ 217 (468)
+|||+|......... ......+||+.|+|||++.+.... +.++||||+||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998754332111 112345899999999999876332 2689999999999999999 88885
Q ss_pred Cch-----HHHHHHhhcccccccccccchhhhccccccccccccccCCCC-----CCCCHHHHHHHHHhcCCCCCCCCCH
Q 012228 218 ESN-----LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCP-----SWFSSGAKKLIKRILDPNPDTRMTI 287 (468)
Q Consensus 218 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~Ll~~~L~~dP~~R~t~ 287 (468)
... ......... ........| ...++.+.+||.+||+.||.+|||+
T Consensus 235 ~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 290 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVC------------------------VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290 (301)
T ss_dssp TTSCSSCCHHHHHHHHT------------------------TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred ccCCCCcchhhhhHHHh------------------------ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH
Confidence 421 111111110 001111111 1145779999999999999999999
Q ss_pred HHHhc
Q 012228 288 SQMLE 292 (468)
Q Consensus 288 ~eil~ 292 (468)
.++++
T Consensus 291 ~~i~~ 295 (301)
T 3q4u_A 291 LRIKK 295 (301)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=363.90 Aligned_cols=254 Identities=15% Similarity=0.208 Sum_probs=202.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcC--------CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeE-------
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVE--------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIK------- 77 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~------- 77 (468)
++|++.+.||+|+||.||+|.+.. +++.||+|++... +.+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 689999999999999999999987 4889999998754 24679999999999999887
Q ss_pred --------EEEEEEe-CCEEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee
Q 012228 78 --------IIEVMAS-KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 146 (468)
Q Consensus 78 --------l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl 146 (468)
+++++.. ....|+||||+ +++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6777765 78899999999 89999999886 789999999999999999999999999999999999999
Q ss_pred ccCC--ceEEeccccchhhhhhhcC-----CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc
Q 012228 147 DSYG--VLKISDFGLSAISQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES 219 (468)
Q Consensus 147 ~~~g--~lkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~ 219 (468)
+.++ .+||+|||+|......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9988 9999999999765443221 12244589999999999988776 58999999999999999999999875
Q ss_pred h--HHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 220 N--LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 220 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
. ............ .... ...........+++.+.+||.+||..||.+|||++++++.
T Consensus 272 ~~~~~~~~~~~~~~~-------------~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 272 LPNTEDIMKQKQKFV-------------DKPG----PFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TTCHHHHHHHHHHHH-------------HSCC----CEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CcCHHHHHHHHHhcc-------------CChh----hhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 3 222222211000 0000 0000011122468999999999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=393.86 Aligned_cols=280 Identities=26% Similarity=0.364 Sum_probs=209.8
Q ss_pred CCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--
Q 012228 7 ASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-- 84 (468)
Q Consensus 7 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-- 84 (468)
.++..+++|++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 34556799999999999999999999999999999999987542 23346778899999999999999999999755
Q ss_pred ----CCEEEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCc---eEE
Q 012228 85 ----KTKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKI 154 (468)
Q Consensus 85 ----~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~---lkl 154 (468)
.+..|+|||||+||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++. +||
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence 677899999999999999998754 5999999999999999999999999999999999999997765 999
Q ss_pred eccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccc
Q 012228 155 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFL 234 (468)
Q Consensus 155 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~ 234 (468)
+|||++..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+......+.......
T Consensus 166 ~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~-- 239 (676)
T 3qa8_A 166 IDLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK-- 239 (676)
T ss_dssp CSCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred ccccccccccc---ccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcc--
Confidence 99999986533 233456789999999999988777 589999999999999999999998754322111100000
Q ss_pred cccccchhhhccccccccccccccC----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 235 SVYGESYKKCTNKYSYTLQICRADF----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
............... ...... ..+..+++.+.+||.+||.+||.+|||++++++||||+.
T Consensus 240 ---~~~~~~~~~~l~g~~-~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 240 ---SNEHIVVYDDLTGAV-KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -------CCSCCCCSSSC-CCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ---cchhhhhhhhhcccc-ccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000000000000000 001111 122336788999999999999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=368.15 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=198.5
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCC---CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-eCCEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA-SKTKI 88 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~-~~~~~ 88 (468)
..|++.+.||+|+||+||+|.+..++ ..||+|.+.... .....+.+.+|+.+++.++||||+++++++. ..+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35899999999999999999986433 468999986432 2335678899999999999999999999864 45678
Q ss_pred EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999999999997654 58999999999999999999999999999999999999999999999999997553321
Q ss_pred cC--CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 168 ED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 168 ~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.. .......+|+.|+|||++.+..+ +.++||||+||++|+|++ |.+||...+..+....+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---------------- 309 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---------------- 309 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----------------
T ss_pred cccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----------------
Confidence 11 11234567889999999987776 589999999999999999 78888765533332221
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
........|..++..+.+++.+||..||.+|||+.+++++
T Consensus 310 ---------~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 310 ---------LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1112234466789999999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=351.61 Aligned_cols=243 Identities=27% Similarity=0.450 Sum_probs=197.2
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++.+.||+|+||+||+|.+ +++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+ ..|+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence 457899999999999999999998 47889999986432 34678899999999999999999998764 4799
Q ss_pred EEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCCeeeccCCc-eEEeccccchhh
Q 012228 91 VLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHS---RGVFHRDLKPENLLLDSYGV-LKISDFGLSAIS 163 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~~l~yLH~---~givHrDlKp~NILl~~~g~-lkl~DFGla~~~ 163 (468)
||||++||+|.+++..... +++..+..++.|++.||+|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999999999999987653 7899999999999999999999 89999999999999998887 799999998754
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch--HHHHHHhhcccccccccccch
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~ 241 (468)
.. ......||+.|+|||++.+..+ +.++||||+||++|+|++|..||.... ........
T Consensus 157 ~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 217 (307)
T 2eva_A 157 QT-----HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV------------- 217 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-------------
T ss_pred cc-----ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-------------
Confidence 32 1234579999999999988776 589999999999999999999997532 11111111
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
........+..++..+.+||.+||+.||.+|||+++++++
T Consensus 218 ------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 218 ------------HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp ------------HTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------hcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1112233445689999999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=365.32 Aligned_cols=267 Identities=20% Similarity=0.265 Sum_probs=208.2
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++.+.||+|+||.||+|.+ .+|+.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..|
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 3457899999999999999999985 468999999997643221 1235789999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCeeeccCCceEEeccccchh
Q 012228 90 IVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSR---GVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~~l~yLH~~---givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+|..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 9999999999999998654 399999999999999999999999 999999999999999999999999999976
Q ss_pred hhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH--------HHHHhhcccccc
Q 012228 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM--------ALYRKVSTFHFL 234 (468)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~--------~~~~~~~~~~~~ 234 (468)
.... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||+..... ........
T Consensus 184 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 257 (326)
T 3uim_A 184 MDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK---- 257 (326)
T ss_dssp CCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS----
T ss_pred cCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh----
Confidence 5332 2223445679999999999987766 58999999999999999999999642211 00000000
Q ss_pred cccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 235 SVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
................+...+..+.+|+.+||+.||.+|||+.++++|-+-
T Consensus 258 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 258 -----------EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp -----------SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred -----------chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 000000000001111222245789999999999999999999999998653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=365.79 Aligned_cols=284 Identities=20% Similarity=0.259 Sum_probs=195.6
Q ss_pred CCCCCCccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Q 012228 4 KVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMA 83 (468)
Q Consensus 4 ~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 83 (468)
..+.....+++|++++.||+|+||+||+|++ +++.||+|++...... ......|+..+..++||||+++++.+.
T Consensus 4 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp -----CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cccCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheeccc
Confidence 3345566789999999999999999999987 7899999999754321 112234455556689999999998653
Q ss_pred e-----CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCCeeeccC
Q 012228 84 S-----KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR---------GVFHRDLKPENLLLDSY 149 (468)
Q Consensus 84 ~-----~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~---------givHrDlKp~NILl~~~ 149 (468)
. ...+|+|||||++|+|.+++.. ...++..+..++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 2 3368999999999999999976 4569999999999999999999999 99999999999999999
Q ss_pred CceEEeccccchhhhhhh------cCCcccccCCCCCcCCccccccCC------CCCChhhHHHHHHHHHHHhhCCCCCC
Q 012228 150 GVLKISDFGLSAISQQVR------EDGLLHTACGTPNYVAPEVLNDKG------YDGRASDVWSCGVILFVLMAGFLPFD 217 (468)
Q Consensus 150 g~lkl~DFGla~~~~~~~------~~~~~~~~~gt~~y~APEvl~~~~------~~~~~~DiWSlGvil~~ll~g~~Pf~ 217 (468)
+.+||+|||+|....... ........+||+.|+|||++.+.. ..+.++||||+||++|+|++|..||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999999999997543211 122234567999999999997631 22468999999999999999977663
Q ss_pred CchH-HHHHHhhcccccccccccchhhhccccccccccccccCCCCCC------CCHHHHHHHHHhcCCCCCCCCCHHHH
Q 012228 218 ESNL-MALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW------FSSGAKKLIKRILDPNPDTRMTISQM 290 (468)
Q Consensus 218 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~s~~~~~Ll~~~L~~dP~~R~t~~ei 290 (468)
.... ......... .. . .......... ..........+|.. .++.+.+||.+||+.||++|||++|+
T Consensus 237 ~~~~~~~~~~~~~~-~~-~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~ 309 (336)
T 3g2f_A 237 PGESVPEYQMAFQT-EV-G-NHPTFEDMQV----LVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309 (336)
T ss_dssp TTSCCCCCCCTTHH-HH-C-SSCCHHHHHH----HHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CccchhHHHHhhhc-cc-C-CCchHHHHHh----hhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence 3211 000000000 00 0 0000000000 00001111122222 34579999999999999999999999
Q ss_pred ------hcCcccccCCC
Q 012228 291 ------LEDEWFKKGYK 301 (468)
Q Consensus 291 ------l~hpwf~~~~~ 301 (468)
+.++|-++...
T Consensus 310 l~~L~~ll~~~~~~~~~ 326 (336)
T 3g2f_A 310 EERMAELMMIWERNKSV 326 (336)
T ss_dssp HHHHHHHHHCCCC----
T ss_pred HHHHHHHHHHHHhcccC
Confidence 44677776443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=357.53 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=203.9
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh-hhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-LRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
|..++.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 45568999999999999986 688999999865321 223346778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 94 FIDGGELFDKIAK---HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 94 ~~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999999874 3469999999999999999999999999999999999999999999999999987654322222
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
.....+||+.|+|||++.+. + +.++||||+||++|+|++|..||...........+.... ..........
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~------ 260 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI--EDEEKTIEDY------ 260 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHH--HTTSCCHHHH------
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHh--hhhhhhhhhh------
Confidence 23446799999999998754 4 589999999999999999999998654221111100000 0000000000
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
........+...+..+.+|+.+||..||.+|||+.+++++
T Consensus 261 ---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 261 ---IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ---SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0011111223356789999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=382.43 Aligned_cols=256 Identities=21% Similarity=0.326 Sum_probs=207.5
Q ss_pred cCeEEEe-eeeecCCeEEEEEEEc--CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 13 GKYELGR-TLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 13 ~~y~i~~-~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
+++.+.+ .||+|+||.||+|.+. .++..||||++..... ....+.+.+|+.+|+.++||||+++++++.. +.+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 3466666 8999999999999876 3556799999976432 2235678899999999999999999999976 5699
Q ss_pred EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999999998754 4599999999999999999999999999999999999999999999999999986533211
Q ss_pred C-CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 169 D-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 169 ~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
. .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~----------------- 553 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE----------------- 553 (613)
T ss_dssp ----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-----------------
T ss_pred eeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----------------
Confidence 1 11123346789999999987777 589999999999999998 999999877666655532
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh---cCcccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML---EDEWFK 297 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil---~hpwf~ 297 (468)
.......|..+++++.+||.+||..||.+|||+.+++ ++.|+.
T Consensus 554 --------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 554 --------QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1223456677899999999999999999999999985 455554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=353.84 Aligned_cols=270 Identities=23% Similarity=0.365 Sum_probs=209.8
Q ss_pred ccccCeEEEeeeeecCCeEEEEEE----EcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAK----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK 85 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 85 (468)
...++|++++.||+|+||.||+|. +..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 345679999999999999999999 46789999999997542 33467789999999999999999999998654
Q ss_pred C--EEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 86 T--KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 86 ~--~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
+ .+|+||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 4 7899999999999999998764 599999999999999999999999999999999999999999999999999986
Q ss_pred hhhhhcC-CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch
Q 012228 163 SQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 163 ~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
....... .......+++.|+|||++.+..+ +.++||||+||++|+|++|..||...... ..+...............
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAE-FMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHH-HHHHHCTTCCTHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHH-HHHhhccccchhhhHHHH
Confidence 5432111 11233567888999999987766 58999999999999999999998754321 111111000000000000
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.. ..........+..+++++.+||.+||..||.+|||+.++++
T Consensus 273 ~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 273 IE--------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HH--------HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HH--------HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 00112234456678999999999999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=352.12 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=194.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhc--CCCCCeeEEEEEEEeC---
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL--IKHPNVIKIIEVMASK--- 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~hpnIv~l~~~~~~~--- 85 (468)
..++|++.+.||+|+||.||+|.+. |+.||+|++..... ....+|..++.. ++||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 4578999999999999999999984 89999999865421 223345555554 4899999999999887
Q ss_pred -CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCCeeeccCCceEEec
Q 012228 86 -TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------GVFHRDLKPENLLLDSYGVLKISD 156 (468)
Q Consensus 86 -~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~--------givHrDlKp~NILl~~~g~lkl~D 156 (468)
..+|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 789999999999999999975 5799999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhhhcC--CcccccCCCCCcCCccccccCCCCCC-----hhhHHHHHHHHHHHhhC----------CCCCCCc
Q 012228 157 FGLSAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYDGR-----ASDVWSCGVILFVLMAG----------FLPFDES 219 (468)
Q Consensus 157 FGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~-----~~DiWSlGvil~~ll~g----------~~Pf~~~ 219 (468)
||+|......... ......+||+.|+|||++.+..+... ++||||+||++|+|++| ..||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 9999754332211 11235689999999999987666432 48999999999999999 6666432
Q ss_pred h-----HHHHHHhhcccccccccccchhhhccccccccccccccCCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHH
Q 012228 220 N-----LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS-----WFSSGAKKLIKRILDPNPDTRMTISQ 289 (468)
Q Consensus 220 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~Ll~~~L~~dP~~R~t~~e 289 (468)
. ......... ........|. .+++++.+||.+||+.||.+|||+.+
T Consensus 266 ~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (337)
T 3mdy_A 266 VPSDPSYEDMREIVC------------------------IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321 (337)
T ss_dssp SCSSCCHHHHHHHHT------------------------TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cCCCCchhhhHHHHh------------------------hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence 1 111111100 0111111221 24567999999999999999999999
Q ss_pred HhcC
Q 012228 290 MLED 293 (468)
Q Consensus 290 il~h 293 (468)
+++|
T Consensus 322 ll~~ 325 (337)
T 3mdy_A 322 VKKT 325 (337)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=376.20 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=210.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++.+.||+|+||+||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.+ +.+|+|
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 4679999999999999999999864 467999999764322 3568899999999999999999999866 678999
Q ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 418 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 418 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-
Confidence 9999999999999743 4699999999999999999999999999999999999999999999999999986532111
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......++..|+|||++.+..+ +.++|||||||+||+|++ |..||.+.+..+....+..
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~------------------ 479 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------------ 479 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT------------------
T ss_pred ecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------------
Confidence 11223456788999999987776 589999999999999999 9999998877666655321
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......+..++..+.+||.+||+.||++|||++++++.
T Consensus 480 -------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 480 -------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12334566789999999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=380.98 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=210.2
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCC---CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVET---GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
..++|++++.||+|+||+||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .+.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 346799999999999999999998653 4579999986532 3345677899999999999999999999984 466
Q ss_pred EEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
.|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 899999999999999998654 6999999999999999999999999999999999999999999999999999865332
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
. ........+|+.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+....+.
T Consensus 545 ~-~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~---------------- 606 (656)
T 2j0j_A 545 T-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---------------- 606 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH----------------
T ss_pred c-ceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----------------
Confidence 1 112234567889999999987776 589999999999999997 999999887776665532
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......|+.+++.+.+||.+||..||.+|||+.++++.
T Consensus 607 ---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 607 ---------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp ---------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------cCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 122344567789999999999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=366.75 Aligned_cols=248 Identities=18% Similarity=0.228 Sum_probs=192.2
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC-CCe----------------
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-PNV---------------- 75 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnI---------------- 75 (468)
..|.+++.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.++| +|.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458999999999999999999999999999999874433333345678999999999987 221
Q ss_pred -----eEEEEEEEe-----CCEEEEEEEccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 012228 76 -----IKIIEVMAS-----KTKIYIVLEFIDGGELFDKIAK-------HGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 138 (468)
Q Consensus 76 -----v~l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~~-------~~~l~e~~~~~~~~qll~~l~yLH~~givHrD 138 (468)
..+..++.. ...++++|+++. ++|.+++.. ...+++..+..++.|++.||+|||++||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 111122222 234678888774 699888841 23477888999999999999999999999999
Q ss_pred CCCCCeeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCcccc----------ccCCCCCChhhHHHHHHHHHH
Q 012228 139 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL----------NDKGYDGRASDVWSCGVILFV 208 (468)
Q Consensus 139 lKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl----------~~~~~~~~~~DiWSlGvil~~ 208 (468)
|||+|||++.+|.+||+|||+|+.... .....+| +.|+|||++ .+..| +.++|||||||++|+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHH
Confidence 999999999999999999999875432 1456788 999999999 33334 579999999999999
Q ss_pred HhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 012228 209 LMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 288 (468)
Q Consensus 209 ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~ 288 (468)
|++|..||...+...... ..+.....+|+.+.+||.+||+.||++|||+.
T Consensus 310 lltg~~Pf~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSE------------------------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHHSSCCCCTTGGGSCSG------------------------------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHCCCCCCCcchhhhHH------------------------------HHHhhcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 999999998764321111 11112234789999999999999999999999
Q ss_pred HHhcCccccc
Q 012228 289 QMLEDEWFKK 298 (468)
Q Consensus 289 eil~hpwf~~ 298 (468)
++++||||+.
T Consensus 360 ~~l~~~~~~~ 369 (413)
T 3dzo_A 360 QAMETPEYEQ 369 (413)
T ss_dssp HHTTSHHHHH
T ss_pred HHHhCHHHHH
Confidence 9999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=354.05 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=205.2
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++++.||+|+||.||+|.+.. .+|+|++....... ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 345889999999999999999999854 49999987543211 12345678999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh-
Q 012228 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR- 167 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~- 167 (468)
+||||++|++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 9999999999999998755 699999999999999999999999999999999999998 6899999999987543211
Q ss_pred --cCCcccccCCCCCcCCccccccC--------CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccc
Q 012228 168 --EDGLLHTACGTPNYVAPEVLNDK--------GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237 (468)
Q Consensus 168 --~~~~~~~~~gt~~y~APEvl~~~--------~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 237 (468)
.........||+.|+|||++.+. ...+.++||||+||++|+|++|..||...+.......+...
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------ 258 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG------ 258 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT------
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC------
Confidence 12234456799999999998752 23368999999999999999999999988776665543211
Q ss_pred ccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......+..++.++.+||.+||..||.+|||+.++++.
T Consensus 259 ------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 259 ------------------MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp ------------------CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred ------------------CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00111122478899999999999999999999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=362.77 Aligned_cols=250 Identities=20% Similarity=0.236 Sum_probs=195.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh-----hHHHHHHHHHHHHHHhcCC---------CCCeeE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMKLIK---------HPNVIK 77 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~---------hpnIv~ 77 (468)
.++|++++.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+|+.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 47899999999999999999998 7899999999765321 1122456778888888875 888888
Q ss_pred EEEEEE------------------------------eCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 012228 78 IIEVMA------------------------------SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127 (468)
Q Consensus 78 l~~~~~------------------------------~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~ 127 (468)
+.+++. +.+.+|+|||||++|++.+.+.. +.+++..++.++.||+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 888753 26889999999999987777654 67899999999999999999
Q ss_pred HHH-hCCccccCCCCCCeeeccCC--------------------ceEEeccccchhhhhhhcCCcccccCCCCCcCCccc
Q 012228 128 YCH-SRGVFHRDLKPENLLLDSYG--------------------VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186 (468)
Q Consensus 128 yLH-~~givHrDlKp~NILl~~~g--------------------~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv 186 (468)
||| ++||+||||||+|||++.+| .+||+|||+|+.... ...+||+.|+|||+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhh
Confidence 999 99999999999999999887 899999999986532 24589999999999
Q ss_pred cccCCCCCChhhHHHHHHH-HHHHhhCCCCCCCchH-HHHHHhhcccccccccccchhhhccccccccccccccCCCCCC
Q 012228 187 LNDKGYDGRASDVWSCGVI-LFVLMAGFLPFDESNL-MALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSW 264 (468)
Q Consensus 187 l~~~~~~~~~~DiWSlGvi-l~~ll~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (468)
+.+.. +.++||||+|++ .+++++|..||..... ......+..... . ........++.
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--------------~-----~~~~~~~~~~~ 307 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT--------------F-----KTKCNTPAMKQ 307 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC--------------C-----SSCCCSHHHHH
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc--------------c-----Ccccchhhhhh
Confidence 98765 589999998776 7788999999965321 111111100000 0 00000011223
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHh-cCcccc
Q 012228 265 FSSGAKKLIKRILDPNPDTRMTISQML-EDEWFK 297 (468)
Q Consensus 265 ~s~~~~~Ll~~~L~~dP~~R~t~~eil-~hpwf~ 297 (468)
+|+++.+||++||+.| |++|+| +||||+
T Consensus 308 ~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 308 IKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred cCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 6889999999999987 999999 999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=363.95 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=205.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC-CCeeEEEEEEEeCCEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-PNVIKIIEVMASKTKIY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~ 89 (468)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.|+| ++|..+..++...+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 457899999999999999999999999999999998754322 246789999999986 66677777778889999
Q ss_pred EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeee---ccCCceEEeccccchhhhh
Q 012228 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl---~~~g~lkl~DFGla~~~~~ 165 (468)
+||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 8899999985 4579999999999999999999999999999999999999 6889999999999986543
Q ss_pred hhcC-----CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch---HHHHHHhhccccccccc
Q 012228 166 VRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKVSTFHFLSVY 237 (468)
Q Consensus 166 ~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~---~~~~~~~~~~~~~~~~~ 237 (468)
.... ......+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.. ....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~----- 232 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----- 232 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-----
T ss_pred CccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-----
Confidence 2221 11236789999999999988777 589999999999999999999998643 222222221100
Q ss_pred ccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
........+..++.++.+||.+||..||.+||+++++++
T Consensus 233 ----------------~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 233 ----------------VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ----------------HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ----------------ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000000112346899999999999999999999998765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=346.77 Aligned_cols=249 Identities=21% Similarity=0.344 Sum_probs=200.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhc--CCCCCeeEEEEEEEeCC---
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL--IKHPNVIKIIEVMASKT--- 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~hpnIv~l~~~~~~~~--- 86 (468)
.++|++.+.||+|+||.||+|.+ +|+.||+|++.... ...+.+|+.+++. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 36899999999999999999998 58999999996532 2456688888887 78999999999998876
Q ss_pred -EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCCeeeccCCceEEecc
Q 012228 87 -KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH--------SRGVFHRDLKPENLLLDSYGVLKISDF 157 (468)
Q Consensus 87 -~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH--------~~givHrDlKp~NILl~~~g~lkl~DF 157 (468)
.+|+||||+++|+|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 89999999999999999976 57999999999999999999999 899999999999999999999999999
Q ss_pred ccchhhhhhhcC--CcccccCCCCCcCCccccccCCCC-----CChhhHHHHHHHHHHHhhC----------CCCCCCch
Q 012228 158 GLSAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYD-----GRASDVWSCGVILFVLMAG----------FLPFDESN 220 (468)
Q Consensus 158 Gla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~-----~~~~DiWSlGvil~~ll~g----------~~Pf~~~~ 220 (468)
|++......... ......+||+.|+|||++.+.... +.++||||+||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 998754432111 023456899999999999765332 2589999999999999999 78886532
Q ss_pred -----HHHHHHhhcccccccccccchhhhccccccccccccccCCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 012228 221 -----LMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPS-----WFSSGAKKLIKRILDPNPDTRMTISQM 290 (468)
Q Consensus 221 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~Ll~~~L~~dP~~R~t~~ei 290 (468)
.......+.. .......|. ..+..+.+||.+||+.||++|||++++
T Consensus 272 ~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCE------------------------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp CSSCCHHHHHHHHTT------------------------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCcccHHHHHHHHHH------------------------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 2222222110 000111111 134578999999999999999999999
Q ss_pred hcC
Q 012228 291 LED 293 (468)
Q Consensus 291 l~h 293 (468)
++|
T Consensus 328 ~~~ 330 (342)
T 1b6c_B 328 KKT 330 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.51 Aligned_cols=228 Identities=18% Similarity=0.199 Sum_probs=189.4
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34578999999999999999999999999999999998765544556678899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+||||++|++|.+++.. ...+.++..++.|++.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999854 35667789999999999999999999999999999999999999998554
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
|++| .+.++|||||||++|+|++|..||.+.+........
T Consensus 175 -----------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------------------- 214 (286)
T 3uqc_A 175 -----------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------------------- 214 (286)
T ss_dssp -----------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---------------------
T ss_pred -----------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---------------------
Confidence 3332 358999999999999999999999875421100000
Q ss_pred cccccccccC----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 250 YTLQICRADF----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 250 ~~~~~~~~~~----~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
........ ..++.+++++.+||.+||+.||.+| |+.++++.
T Consensus 215 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 215 --ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp --CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred --HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 00001111 1234589999999999999999999 99999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=376.66 Aligned_cols=245 Identities=23% Similarity=0.371 Sum_probs=201.7
Q ss_pred CCccccCeEEEeeeeecCCeEEEEEEEcC-CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVE-TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 8 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
+....++|++.+.||+|+||+||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 33455899999999999999999999976 78999999986432 2334567889999999999999999999998765
Q ss_pred E-----EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 87 K-----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 87 ~-----~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
. .|+||||++|++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 5 7999999999999987754 79999999999999999999999999999999999999974 99999999987
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
.... ....+||+.|+|||++.+. + +.++||||+||++|+|++|..||.+.....
T Consensus 230 ~~~~------~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------ 283 (681)
T 2pzi_A 230 RINS------FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------ 283 (681)
T ss_dssp ETTC------CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------
T ss_pred hccc------CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCccccccc------------------
Confidence 5432 2457899999999998764 3 689999999999999999999987531000
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
+. ........++.+.+||.+||+.||.+||+..+.+.|+|+.
T Consensus 284 ------------~~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 ------------LP--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------------CC--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------------cc--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 0000001367899999999999999999999999999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=325.52 Aligned_cols=190 Identities=15% Similarity=0.140 Sum_probs=140.3
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhh-------hhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEEEE
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-------LRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l 90 (468)
..++.|++|.+..++....|+.||+|++.+... ..+...+.+.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346778888888888888999999999975421 1233456799999999999 69999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||++|++|.++|...+.+++. .++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... ..
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CS 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--Cc
Confidence 99999999999999998888875 47899999999999999999999999999999999999999999865432 23
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCC
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP 215 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~P 215 (468)
...+.|||+.|+|||++.+.. ..++|+||+|++++.|.++..|
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred cccCceechhhccHHHhCCCC--CCcccccccccchhhhccccch
Confidence 456789999999999998653 3689999999999888766444
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=230.81 Aligned_cols=130 Identities=45% Similarity=0.854 Sum_probs=119.0
Q ss_pred CCCCCChhhhhhcCCCCCCccchhhhcccccccceeeecCChhHHHHHHHHHhcccCceEEecCceeEEeeccCCCCCce
Q 012228 334 KPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQL 413 (468)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 413 (468)
.|..+|||++|++|+++|+|++|+..+..++|+|||+|..|++.|+++||++++++||.|+++++++++++..++++|.|
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l 82 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL 82 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence 46679999999999999999999875545789999999999999999999999999999999888999999999999999
Q ss_pred EEEEEEEEEeCCeEEEEEEEcCCCchhHHHHHHHHHhccccccccccchh
Q 012228 414 SVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENK 463 (468)
Q Consensus 414 ~~~~~i~~~~~~~~~vdf~~~~Gd~le~~~~~~~~~~~l~d~v~~~~~~~ 463 (468)
++.++||+|+|+++||||+|++||++||+++|++|++.|+||||++.++.
T Consensus 83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~diV~~~~~~~ 132 (143)
T 2ehb_D 83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWRATEGI 132 (143)
T ss_dssp EEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHSTTTBCC-----
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhhcceecCCCCC
Confidence 99999999999999999999999999999999999999999999866553
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-30 Score=209.77 Aligned_cols=120 Identities=23% Similarity=0.375 Sum_probs=105.8
Q ss_pred CCCCChhhhhhcCCCCCCccchhhhcccccccceeeecCChhHHHHHHHHHhcccCceEEecCceeEEeeccCCCCCceE
Q 012228 335 PVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLS 414 (468)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 414 (468)
|..+|||++|++|+++|||++|+... ..+|+|||+|..||+.|+++||++++++||+|++++++ +++.++++|.|+
T Consensus 3 ~~~lNAFdiIs~S~g~dLSgLFe~~~-~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l~ 78 (123)
T 2zfd_B 3 ARRMNAFDIISGSPGFNLSGLFGDAR-KYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNFA 78 (123)
T ss_dssp -CCCCHHHHHHTSTTSSSGGGGGGGC-SSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTEE
T ss_pred cccccHHHHHHHCcCCCchHhcCccc-ccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccEE
Confidence 56799999999999999999997632 24789999999999999999999999999999987775 666788899999
Q ss_pred EEEEEEEEeCCeEEEEEEEcCCCchhHHHHH-HHHHhcccccccc
Q 012228 415 VATEVFEVAPTLHIVEVRKTGGDTLEFHKFY-KKFSSGLKDVVWQ 458 (468)
Q Consensus 415 ~~~~i~~~~~~~~~vdf~~~~Gd~le~~~~~-~~~~~~l~d~v~~ 458 (468)
+.++||+++|+++||||+|++||++||++|| ++|++.|+||||.
T Consensus 79 v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 79 MVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 9999999999999999999999999999976 6899999999994
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=271.10 Aligned_cols=189 Identities=21% Similarity=0.203 Sum_probs=144.9
Q ss_pred EEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh-----hHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL-----RHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 16 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
...+.||+|+||+||+|. ..+..+|+|........ .....+.+.+|+.+|+.++||||+++..+....+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 346799999999999994 46789999987543322 12234568999999999999999954444446677799
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||||+|++|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999875 6789999999999999999999999999999998 99999999998654322111
Q ss_pred -----cccccCCCCCcCCcccccc--CCCCCChhhHHHHHHHHHHHhhCCCCCC
Q 012228 171 -----LLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFD 217 (468)
Q Consensus 171 -----~~~~~~gt~~y~APEvl~~--~~~~~~~~DiWSlGvil~~ll~g~~Pf~ 217 (468)
...+.+||+.|+|||++.. .+|. ..+|+||.++-..+...++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 2246789999999999976 5563 77899999988888777666653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=226.52 Aligned_cols=146 Identities=21% Similarity=0.254 Sum_probs=116.2
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH---------------HHHHHHHHHHHHHhcCCCCCeeEEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---------------KMVEQIKREISTMKLIKHPNVIKII 79 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---------------~~~~~i~~Ei~il~~l~hpnIv~l~ 79 (468)
|.+++.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+|+.++|+++..
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~-- 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK-- 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC--
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCe--
Confidence 33449999999999999999 8899999999964322110 13567889999999998544444
Q ss_pred EEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecccc
Q 012228 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 80 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGl 159 (468)
++.. +..|+||||++||+|.+ +. ...+..++.|++.||.|||++||+||||||+|||++ +|.+||+|||+
T Consensus 169 -~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 169 -VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp -EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred -EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 4433 45699999999999987 32 234567999999999999999999999999999999 99999999999
Q ss_pred chhhhhhhcCCcccccCCCCCcCCccccc
Q 012228 160 SAISQQVREDGLLHTACGTPNYVAPEVLN 188 (468)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~APEvl~ 188 (468)
|+. +..|.|||++.
T Consensus 239 a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 239 SVE---------------VGEEGWREILE 252 (282)
T ss_dssp CEE---------------TTSTTHHHHHH
T ss_pred CeE---------------CCCCCHHHHHH
Confidence 862 34578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8.8e-23 Score=193.44 Aligned_cols=139 Identities=22% Similarity=0.284 Sum_probs=109.9
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCE--EEEEEeechhhh---------------------hHHHHHHHHHHHHHHhcCC
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDF--VAIKIVDRDQVL---------------------RHKMVEQIKREISTMKLIK 71 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~--vAiK~i~~~~~~---------------------~~~~~~~i~~Ei~il~~l~ 71 (468)
|++.+.||+|+||.||+|.+..+|+. ||||++...... .......+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999778999 999997543211 0112246789999999998
Q ss_pred CCCe--eEEEEEEEeCCEEEEEEEccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCC
Q 012228 72 HPNV--IKIIEVMASKTKIYIVLEFIDG-G----ELFDKIAKHGRLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKPEN 143 (468)
Q Consensus 72 hpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH-~~givHrDlKp~N 143 (468)
|+++ ..+++. +..|+||||+.+ | .|.+.... .++..+..++.|++.||.||| ++||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 7754 444443 246899999942 3 66665432 346678899999999999999 9999999999999
Q ss_pred eeeccCCceEEeccccchh
Q 012228 144 LLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 144 ILl~~~g~lkl~DFGla~~ 162 (468)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99998 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=178.33 Aligned_cols=136 Identities=18% Similarity=0.241 Sum_probs=102.0
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh---------------hHH----HHHHHHHHHHHHhcCCCCCe
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---------------RHK----MVEQIKREISTMKLIKHPNV 75 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~---------------~~~----~~~~i~~Ei~il~~l~hpnI 75 (468)
|++++.||.|++|.||+|.+ .+|+.||||+++..... ... ..-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999998 47999999997532110 000 11123578888888865544
Q ss_pred e--EEEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC---
Q 012228 76 I--KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG--- 150 (468)
Q Consensus 76 v--~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g--- 150 (468)
. ..++. .. .+|||||++|+.|.+.. ..+.+..++.||+.+|.|||++||+||||||.|||++++|
T Consensus 176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 3 33332 22 27999999998885432 2335677899999999999999999999999999998877
Q ss_pred -------ceEEeccccch
Q 012228 151 -------VLKISDFGLSA 161 (468)
Q Consensus 151 -------~lkl~DFGla~ 161 (468)
.+.|+||+-+.
T Consensus 246 d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CTTSEEEEEEECCCTTCE
T ss_pred cccccccceEEEEeCCcc
Confidence 38899999654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=4e-13 Score=126.82 Aligned_cols=142 Identities=18% Similarity=0.164 Sum_probs=114.6
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKI 88 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 88 (468)
..++.|++...+|.|+.+.||++.. .+..+++|+........ ...+.+|+.+++.+. +..+.+++++..+.+..
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 3567899999999999999999975 46899999986432111 235789999999885 67788999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS------------------------------------- 131 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~------------------------------------- 131 (468)
|+|||+++|.+|.+.+. +......++.++..+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999998876521 223345788999999999998
Q ss_pred ----------------------CCccccCCCCCCeeeccCCceEEeccccch
Q 012228 132 ----------------------RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 132 ----------------------~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
.+++|+|++|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876566799999765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=7.5e-12 Score=117.48 Aligned_cols=136 Identities=15% Similarity=0.183 Sum_probs=102.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC--eeEEEEEEEeCCEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN--VIKIIEVMASKTKI 88 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~ 88 (468)
.+..|.+....+.|+.+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++.+....+..
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 356688766655677799999965 567889999975431 234678999999886444 56688888888889
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG----------------------------------- 133 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~g----------------------------------- 133 (468)
|+||||++|.+|. . ...+ ...++.++...|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999999998873 1 1122 2356777888888888753
Q ss_pred -----------------------ccccCCCCCCeeeccCCceEEeccccch
Q 012228 134 -----------------------VFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 134 -----------------------ivHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
++|+|++|.|||+++++.+.|+|||.|.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999865
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.27 E-value=2.7e-11 Score=99.05 Aligned_cols=86 Identities=17% Similarity=0.297 Sum_probs=76.8
Q ss_pred eeeecCChhHHHHHHHHHhcccCceEEec-CceeEEeeccCCCCCceEEEEEEEEEe-CCeEEEEEEEcCCCchhHHHHH
Q 012228 368 RFTSQRPPNEIMSKIEEAAKPLGFNVRKG-NYKMKLQGDKTGRKGQLSVATEVFEVA-PTLHIVEVRKTGGDTLEFHKFY 445 (468)
Q Consensus 368 rf~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~vdf~~~~Gd~le~~~~~ 445 (468)
..+|..+|++|+.+|++++..+|+.|+.. .|.+++........+.+.|.+||+++. +++++|+|+|.+||.+.|++++
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc 111 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 111 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHH
T ss_pred cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHH
Confidence 44799999999999999999999999875 488888776555667899999999996 7999999999999999999999
Q ss_pred HHHHhccc
Q 012228 446 KKFSSGLK 453 (468)
Q Consensus 446 ~~~~~~l~ 453 (468)
.+|...|+
T Consensus 112 ~~il~~L~ 119 (120)
T 3ose_A 112 SKIANELK 119 (120)
T ss_dssp HHHHHHCC
T ss_pred HHHHHHhc
Confidence 99998775
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.19 E-value=4e-11 Score=118.57 Aligned_cols=140 Identities=17% Similarity=0.314 Sum_probs=106.6
Q ss_pred EEeeeeecCCeEEEEEEEcCCCCEEEEEEee--chhhhhHHHHHHHHHHHHHHhcCC--CCCeeEEEEEEEeC---CEEE
Q 012228 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVD--RDQVLRHKMVEQIKREISTMKLIK--HPNVIKIIEVMASK---TKIY 89 (468)
Q Consensus 17 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~--~~~~~~~~~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~~ 89 (468)
-.+.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.|. +..+.+++.++.+. ...|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4678899999999998863 4678888875 32211 12346789999999997 45688888888766 4489
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-------------------------------------- 131 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~-------------------------------------- 131 (468)
+||||++|..+.+.. -..+++.....++.++...|..||+
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999997774321 2347888889999999999999997
Q ss_pred --------------------CCccccCCCCCCeeeccCCc--eEEeccccchh
Q 012228 132 --------------------RGVFHRDLKPENLLLDSYGV--LKISDFGLSAI 162 (468)
Q Consensus 132 --------------------~givHrDlKp~NILl~~~g~--lkl~DFGla~~ 162 (468)
.+++|+|++|.|||++.++. +.|+||+.|..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=3e-11 Score=116.67 Aligned_cols=186 Identities=18% Similarity=0.203 Sum_probs=123.4
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCC--eeEEEEEEEeCC---EEEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPN--VIKIIEVMASKT---KIYIV 91 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpn--Iv~l~~~~~~~~---~~~lV 91 (468)
.+.++.|....||++. ..+++|+.... .....+.+|..+|+.+. +.. +.+++......+ .-|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3568999999999864 46889986432 23467889999998873 332 344554443333 34899
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS---------------------------------------- 131 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~---------------------------------------- 131 (468)
||+++|..|..... ..++.++...++.|+...+..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865433 357888888899999999999986
Q ss_pred ------------------CCccccCCCCCCeeecc--CCceEEeccccchhhhhhhcCCcccccCCCCCcCCcccccc--
Q 012228 132 ------------------RGVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND-- 189 (468)
Q Consensus 132 ------------------~givHrDlKp~NILl~~--~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~-- 189 (468)
..++|+|++|.||+++. .+.+.|+||+.+........-..+.... .-..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~---~~~~~~~~~~~l 249 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD---EEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT---TSCCHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc---cccCHHHHHHHH
Confidence 13699999999999998 4568899999886532211100000000 0022322110
Q ss_pred CCCCC-----------ChhhHHHHHHHHHHHhhCCCCCCC
Q 012228 190 KGYDG-----------RASDVWSCGVILFVLMAGFLPFDE 218 (468)
Q Consensus 190 ~~~~~-----------~~~DiWSlGvil~~ll~g~~Pf~~ 218 (468)
..|.. .-.+.|++|.+++.+.+|..+|-.
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 01110 125899999999999999888743
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.96 E-value=7.8e-10 Score=90.08 Aligned_cols=85 Identities=14% Similarity=0.221 Sum_probs=75.2
Q ss_pred eeecCChhHHHHHHHHHhcccCceEEe-cCceeEEeeccCCCCCceEEEEEEEEEe-CCeEEEEEEEcCCCchhHHHHHH
Q 012228 369 FTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVA-PTLHIVEVRKTGGDTLEFHKFYK 446 (468)
Q Consensus 369 f~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~vdf~~~~Gd~le~~~~~~ 446 (468)
.+|+.+|++|+.+|.++++++|+.|+. +.|.+++..........+.|.+||+++. .+++.|+|+|.+||.+.|++++.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~ 112 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHH
Confidence 468899999999999999999999986 6788888665444456899999999994 68999999999999999999999
Q ss_pred HHHhccc
Q 012228 447 KFSSGLK 453 (468)
Q Consensus 447 ~~~~~l~ 453 (468)
+|...|+
T Consensus 113 ~IL~eLk 119 (126)
T 1v5s_A 113 KIANELK 119 (126)
T ss_dssp HHHHHTT
T ss_pred HHHHHHh
Confidence 9999887
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=1e-08 Score=80.57 Aligned_cols=90 Identities=19% Similarity=0.332 Sum_probs=77.0
Q ss_pred cccceeeecCChhHHHHHHHHHhcccCceEEe-cCceeEEeeccCCCCCceEEEEEEEEEeCCeEEEEEEEcCCC-----
Q 012228 364 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGD----- 437 (468)
Q Consensus 364 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd----- 437 (468)
+..-...|...|.+||.+|..|++.+|+.|+. +.|.++++...+.....+.|.+++|++.++.+|+||++..||
T Consensus 7 kW~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~ 86 (106)
T 4eai_A 7 KWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGG 86 (106)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSS
T ss_pred cceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCC
Confidence 34456778899999999999999999999986 579999987644444678999999999989999999999995
Q ss_pred ---chhHHHHHHHHHhccc
Q 012228 438 ---TLEFHKFYKKFSSGLK 453 (468)
Q Consensus 438 ---~le~~~~~~~~~~~l~ 453 (468)
.++|-.+|.++-..|.
T Consensus 87 ~~~~~~F~d~ca~li~~la 105 (106)
T 4eai_A 87 GSHTIEFFEMCANLIKILA 105 (106)
T ss_dssp SCHHHHHHHHHHHHHHHCC
T ss_pred CcCcEeHHHHHHHHHHHHh
Confidence 8999999988876663
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.78 E-value=5.1e-08 Score=81.08 Aligned_cols=77 Identities=17% Similarity=0.313 Sum_probs=64.2
Q ss_pred cccceeeecCChhHHHHHHHHHhcccCceEEe-cCceeEEeeccCCCCCceEEEEEEEEEeCCeEEEEEEEcCCCchh
Q 012228 364 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLE 440 (468)
Q Consensus 364 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le 440 (468)
++.-...|..+|.+||.+|.+|++.||+.|++ +.|.|+++...+.....+.|.+++|++.++.+||||++..||+.|
T Consensus 4 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 4 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 44556778889999999999999999999987 679999988754433468999999999999999999999999754
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=1e-07 Score=80.29 Aligned_cols=77 Identities=17% Similarity=0.313 Sum_probs=65.0
Q ss_pred cccceeeecCChhHHHHHHHHHhcccCceEEe-cCceeEEeeccCCCCCceEEEEEEEEEeCCeEEEEEEEcCCCchh
Q 012228 364 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLE 440 (468)
Q Consensus 364 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le 440 (468)
++.-...|..+|.+||..|..|++.||+.|++ +.|.|+++...+.....+.|.+++|++.++.+||||++..||+.|
T Consensus 18 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 18 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 56777889999999999999999999999986 679999988744333468899999999999999999999999876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3.6e-07 Score=86.02 Aligned_cols=139 Identities=15% Similarity=0.183 Sum_probs=101.2
Q ss_pred cCeEEEeeeeecCCe-EEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEEE
Q 012228 13 GKYELGRTLGEGSFA-KVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g-~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 90 (468)
..|+.. .+..|..+ .||+......+..+.+|+-... ....+.+|..+|+.|. +--+.+++.+..+.+..|+
T Consensus 25 ~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~l 97 (272)
T 4gkh_A 25 YGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWL 97 (272)
T ss_dssp TTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred cCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEE
Confidence 345543 34445444 6999888777788999986533 2345778999998885 3346778888889999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS--------------------------------------- 131 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~--------------------------------------- 131 (468)
|||+++|.++.+..... ......+..++...|.-||+
T Consensus 98 vme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp EEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 99999998877765432 22334566677777777775
Q ss_pred -------------------CCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 132 -------------------RGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 132 -------------------~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
..++|+|+.|.|||++..+.+-|+||+.+..
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1278999999999999877778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=6.5e-07 Score=86.18 Aligned_cols=133 Identities=21% Similarity=0.259 Sum_probs=95.3
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC---CeeEEEEEEE-eCCEEEEEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP---NVIKIIEVMA-SKTKIYIVLE 93 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lV~E 93 (468)
.+.++.|....||+. |..+++|+-.. ......+.+|..+|+.|.+. .+.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 356788999999988 56788898532 12356788999999999742 3556666654 4456789999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR----------------------------------------- 132 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~----------------------------------------- 132 (468)
+++|..+..... ..++......++.|+...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999987765322 2345666666666666666666642
Q ss_pred -------------------CccccCCCCCCeeecc---CCce-EEeccccchh
Q 012228 133 -------------------GVFHRDLKPENLLLDS---YGVL-KISDFGLSAI 162 (468)
Q Consensus 133 -------------------givHrDlKp~NILl~~---~g~l-kl~DFGla~~ 162 (468)
.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999987 4554 8999998764
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=1.1e-07 Score=78.61 Aligned_cols=90 Identities=16% Similarity=0.200 Sum_probs=74.8
Q ss_pred cccceeeecCChhHHHHHHHHHhcccCceEEec----------CceeEEeeccCCC-----CCceEEEEEEEEEeCCeEE
Q 012228 364 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKG----------NYKMKLQGDKTGR-----KGQLSVATEVFEVAPTLHI 428 (468)
Q Consensus 364 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~----------~~~~~~~~~~~~~-----~~~l~~~~~i~~~~~~~~~ 428 (468)
++.-...|..+|.+||..|..|++.+|+.|++. .|.|+++...+.. ...+.|.+++|+++++.+|
T Consensus 12 kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YL 91 (137)
T 2qrd_A 12 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM 91 (137)
T ss_dssp CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred ccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEE
Confidence 566777899999999999999999999999854 4888887763321 2357899999999999999
Q ss_pred EEEEEcCCC---------------c----hhHHHHHHHHHhccc
Q 012228 429 VEVRKTGGD---------------T----LEFHKFYKKFSSGLK 453 (468)
Q Consensus 429 vdf~~~~Gd---------------~----le~~~~~~~~~~~l~ 453 (468)
|||++..|+ . ++|-.+|.+|-..|+
T Consensus 92 lDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa 135 (137)
T 2qrd_A 92 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 135 (137)
T ss_dssp EEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EEEEecCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence 999999999 5 899999988776664
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.55 E-value=4.4e-07 Score=73.05 Aligned_cols=76 Identities=17% Similarity=0.328 Sum_probs=61.4
Q ss_pred ccceeeecCChhHHHHHHHHHhcccCceEEe-cCceeEEeeccCCCCCceEEEEEEEEEeCCeEEEEEEEcCCCchh
Q 012228 365 RETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLE 440 (468)
Q Consensus 365 ~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le 440 (468)
+.-...|...|.+||..|.+|++.+|+.|++ +.|.++++.........+.+.+++|+++++.+|+||++..||-.|
T Consensus 8 W~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~ 84 (130)
T 4eag_A 8 WHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVE 84 (130)
T ss_dssp EEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-----
T ss_pred eeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhh
Confidence 3445668888999999999999999999986 579999987755555567899999999999999999999999644
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=98.35 E-value=2.3e-06 Score=72.87 Aligned_cols=89 Identities=19% Similarity=0.247 Sum_probs=72.9
Q ss_pred cccceeeecCChhHHHHHHHHHhcccCceEEec----CceeEEeeccCC---------CCCceEEEEEEEEEeCCeEEEE
Q 012228 364 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKG----NYKMKLQGDKTG---------RKGQLSVATEVFEVAPTLHIVE 430 (468)
Q Consensus 364 ~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~---------~~~~l~~~~~i~~~~~~~~~vd 430 (468)
++.-...|...|.+||..|..|++.+|+.|++. .|.|++++..+. ....+.|.+++|++.++.+|||
T Consensus 50 kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLD 129 (179)
T 3t4n_A 50 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 129 (179)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEE
T ss_pred eeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEE
Confidence 455667889999999999999999999999873 689999865221 1234889999999999999999
Q ss_pred EEEcCC----------------------CchhHHHHHHHHHhccc
Q 012228 431 VRKTGG----------------------DTLEFHKFYKKFSSGLK 453 (468)
Q Consensus 431 f~~~~G----------------------d~le~~~~~~~~~~~l~ 453 (468)
|+ ..| .++.|-.++.+|--.|.
T Consensus 130 fk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa 173 (179)
T 3t4n_A 130 FK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELA 173 (179)
T ss_dssp EE-EEEEECC----------------CCCCHHHHHHHHHHHHHHH
T ss_pred EE-eccccccccccccccccccccccccCCccHHHHHHHHHHHHH
Confidence 99 788 77889999988776664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=1.1e-06 Score=87.75 Aligned_cols=79 Identities=15% Similarity=0.124 Sum_probs=49.8
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhh-hhH---HHHHHHHHHHHHHhcCCC--C-CeeEEEEEEEeCCEEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQV-LRH---KMVEQIKREISTMKLIKH--P-NVIKIIEVMASKTKIYI 90 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~i~~Ei~il~~l~h--p-nIv~l~~~~~~~~~~~l 90 (468)
.+.||.|..+.||++....++..+++|....... ... ...+.+..|..+|+.+.. | .+.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5689999999999998766678999998642210 000 012346678888887742 3 34456544 3445689
Q ss_pred EEEccCCC
Q 012228 91 VLEFIDGG 98 (468)
Q Consensus 91 V~E~~~gg 98 (468)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=3.1e-05 Score=75.10 Aligned_cols=135 Identities=13% Similarity=0.150 Sum_probs=77.5
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-----CCCeeEEE-E--EEEeCCEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-----HPNVIKII-E--VMASKTKIY 89 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 89 (468)
.+.|+.|..+.||++... +..+++|+..... ..+..|..+++.|. .|.++.-. + +....+..|
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 345666788999998763 3358999987521 22334555555442 35544310 0 123467789
Q ss_pred EEEEccCCCCHH--------------HHHHh-cCCC--C-----------HH--------H-------------------
Q 012228 90 IVLEFIDGGELF--------------DKIAK-HGRL--K-----------ED--------E------------------- 114 (468)
Q Consensus 90 lV~E~~~gg~L~--------------~~i~~-~~~l--~-----------e~--------~------------------- 114 (468)
++||+++|..+. ..+.. ...+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986431 11111 1111 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHH-------------hCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 115 ----ARRYFQQLINAVDYCH-------------SRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 115 ----~~~~~~qll~~l~yLH-------------~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
+..+..++..++++|+ ..+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112223344566665 2579999999999999888899999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.8e-06 Score=84.74 Aligned_cols=82 Identities=6% Similarity=0.186 Sum_probs=54.9
Q ss_pred EEEeee-eecCCeEEEEEEEc--C----CCCEEEEEEeechh---hhhHHHHHHHHHHHHHHhcCC-C--CCeeEEEEEE
Q 012228 16 ELGRTL-GEGSFAKVKFAKNV--E----TGDFVAIKIVDRDQ---VLRHKMVEQIKREISTMKLIK-H--PNVIKIIEVM 82 (468)
Q Consensus 16 ~i~~~L-G~G~~g~V~~a~~~--~----~~~~vAiK~i~~~~---~~~~~~~~~i~~Ei~il~~l~-h--pnIv~l~~~~ 82 (468)
...+.| +.|....+|++... . ++..+++|+..... ... ...+.+|+.+++.|. + -.+.+++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 345678 88888999988753 1 25678999865432 101 134668888888874 3 3567777776
Q ss_pred EeC---CEEEEEEEccCCCCH
Q 012228 83 ASK---TKIYIVLEFIDGGEL 100 (468)
Q Consensus 83 ~~~---~~~~lV~E~~~gg~L 100 (468)
.+. ...|+|||+++|..+
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCC
T ss_pred cCCCccCCceEEEEecCCCCh
Confidence 554 346899999988654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.82 E-value=0.0002 Score=64.16 Aligned_cols=97 Identities=15% Similarity=0.124 Sum_probs=64.5
Q ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccccC
Q 012228 99 ELFDKIAKH-GRLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 176 (468)
Q Consensus 99 ~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH-~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 176 (468)
+|.+.+... .+++|+++|.++.|.+.+|.-+- ...-..+=+.|..|++..+|+|.+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 788888654 57999999999999999987762 22222344557899999999998764 2110 1
Q ss_pred CCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhC
Q 012228 177 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG 212 (468)
Q Consensus 177 gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g 212 (468)
....+.|||... ...+.+.-|+|||+++|.-+--
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTT
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhc
Confidence 233567888763 2335788999999999988753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00033 Score=67.20 Aligned_cols=75 Identities=17% Similarity=0.247 Sum_probs=59.1
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC---CCCeeEEEEEEEeCCEEEEEEEc
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK---HPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
.+.|+.|....+|+... ++..+++|+-.... ...+.+|...|+.|. ...+.+++.+....+..|+|||+
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 56789999999999875 46788899875431 345778988888884 35688888888888899999999
Q ss_pred cCCCCH
Q 012228 95 IDGGEL 100 (468)
Q Consensus 95 ~~gg~L 100 (468)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00014 Score=69.37 Aligned_cols=132 Identities=15% Similarity=0.127 Sum_probs=73.8
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCe-eEEEEEEEeCCEEEEEEEcc-
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV-IKIIEVMASKTKIYIVLEFI- 95 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~- 95 (468)
.+.|+.|....+|++ ..+++|+...... ..-...+|+.+++.+...++ .+++.+ +.+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 788999999999998 5688898754211 01122467777777642222 355544 343347899999
Q ss_pred CCCCHHHH------------------HHhcC-CC----C-HHHHHHHHHH--------------HHHHHHHHH----h--
Q 012228 96 DGGELFDK------------------IAKHG-RL----K-EDEARRYFQQ--------------LINAVDYCH----S-- 131 (468)
Q Consensus 96 ~gg~L~~~------------------i~~~~-~l----~-e~~~~~~~~q--------------ll~~l~yLH----~-- 131 (468)
+|..+... +.... .+ . ...+..+..+ +...+..+. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66443211 11111 01 0 1111111111 111111111 1
Q ss_pred --CCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 132 --RGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 132 --~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
..++|+|+.|.||+ ..++.+.|+||..|..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 23899999999999 5667889999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00025 Score=71.14 Aligned_cols=32 Identities=16% Similarity=0.293 Sum_probs=28.0
Q ss_pred HhCCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 130 H~~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999999876 99999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00031 Score=67.48 Aligned_cols=139 Identities=13% Similarity=0.154 Sum_probs=77.8
Q ss_pred EEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-----CCCeeEEE-E--EEEeCCE
Q 012228 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-----HPNVIKII-E--VMASKTK 87 (468)
Q Consensus 16 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~ 87 (468)
.-.+.|+.|....+|++... +| .+++|+..... ..+.+..|+.+++.|. -|.++... + +....+.
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 34567788888999998763 33 68899886521 1234556777777663 23333210 0 1123466
Q ss_pred EEEEEEccCCCCHH--------------HHHHhc-CCC--------CHHHHHHH---------------HHHHHHHHHHH
Q 012228 88 IYIVLEFIDGGELF--------------DKIAKH-GRL--------KEDEARRY---------------FQQLINAVDYC 129 (468)
Q Consensus 88 ~~lV~E~~~gg~L~--------------~~i~~~-~~l--------~e~~~~~~---------------~~qll~~l~yL 129 (468)
.+++|++++|..+. ..+... ..+ ....-... -..+...++.+
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 79999999985421 011110 111 10100000 01133445555
Q ss_pred Hh-------CCccccCCCCCCeeeccCCceEEeccccch
Q 012228 130 HS-------RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 130 H~-------~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
++ .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 52 379999999999999987666899999765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00061 Score=65.84 Aligned_cols=136 Identities=13% Similarity=0.166 Sum_probs=71.0
Q ss_pred EeeeeecCCeE-EEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC--CCeeEEEEEEEeCCEEEEEEEc
Q 012228 18 GRTLGEGSFAK-VKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH--PNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 18 ~~~LG~G~~g~-V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 94 (468)
.+.|+.|+... +|+... .+|..+++|....... ..+..|+.+++.+.. -.+.+++.+..... +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 34565555444 666653 2366777776533210 234467777776642 23455665533333 789999
Q ss_pred cCCCCHHHHHHhc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHH
Q 012228 95 IDGGELFDKIAKH--------------------------GRLKEDEAR-------R-YF------------QQLINAVDY 128 (468)
Q Consensus 95 ~~gg~L~~~i~~~--------------------------~~l~e~~~~-------~-~~------------~qll~~l~y 128 (468)
+.+..+.+.+... ..++..... . +. ..+...++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776665443211 012221110 0 00 011112223
Q ss_pred H------HhCCccccCCCCCCeeeccC----CceEEeccccchh
Q 012228 129 C------HSRGVFHRDLKPENLLLDSY----GVLKISDFGLSAI 162 (468)
Q Consensus 129 L------H~~givHrDlKp~NILl~~~----g~lkl~DFGla~~ 162 (468)
+ +...++|+|+.|.|||++.+ +.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3 23479999999999999874 6899999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0047 Score=58.21 Aligned_cols=78 Identities=10% Similarity=0.046 Sum_probs=53.5
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-C--CCeeEEEEEEEeCCEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-H--PNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 90 (468)
+..-+..+|.|..+.||++.. .+|+.|.+|+-....... ...+..|...|+.|. . --+.+.+.+. . -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceE
Confidence 455678899999999999986 578999999864332111 234678999888874 2 2344555442 2 378
Q ss_pred EEEccCCCC
Q 012228 91 VLEFIDGGE 99 (468)
Q Consensus 91 V~E~~~gg~ 99 (468)
|||+++++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0015 Score=62.70 Aligned_cols=135 Identities=15% Similarity=0.128 Sum_probs=76.4
Q ss_pred eeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCC--CeeEEEEE-----EEeCCEEEEE
Q 012228 19 RTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP--NVIKIIEV-----MASKTKIYIV 91 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~-----~~~~~~~~lV 91 (468)
..|+ |....||++.. .+|+.+++|+...... . ...+..|..+++.|... .+.+++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3466 78889998764 3566799999863221 1 23456788877776411 13333322 2235567899
Q ss_pred EEccCCCCHH-----------H---HHH---hcC------CCCHHHH----------------------HHHHHHHHHHH
Q 012228 92 LEFIDGGELF-----------D---KIA---KHG------RLKEDEA----------------------RRYFQQLINAV 126 (468)
Q Consensus 92 ~E~~~gg~L~-----------~---~i~---~~~------~l~e~~~----------------------~~~~~qll~~l 126 (468)
|++++|..+. . .+. ... ..+.... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999874321 0 011 100 1111110 11112222222
Q ss_pred HHH----HhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 127 DYC----HSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 127 ~yL----H~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
+-+ ....++|+|++|.|||++ + .+.|+||+.+.
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 222 234689999999999999 4 89999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.001 Score=66.89 Aligned_cols=72 Identities=11% Similarity=0.096 Sum_probs=48.3
Q ss_pred EeeeeecCCeEEEEEEEcC-------CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-eeEEEEEEEeCCEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVE-------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKIY 89 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 89 (468)
.+.|+.|....||++.... .+..+++|+..... . .+.+.+|..+++.|...+ ..++++.+. + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence 5678888889999998643 35789999884321 1 123447888888885323 356666553 2 2
Q ss_pred EEEEccCCC
Q 012228 90 IVLEFIDGG 98 (468)
Q Consensus 90 lV~E~~~gg 98 (468)
+|+||++|.
T Consensus 149 ~v~e~l~G~ 157 (429)
T 1nw1_A 149 RLEEYIPSR 157 (429)
T ss_dssp EEECCCCEE
T ss_pred EEEEEeCCc
Confidence 899999863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00085 Score=66.15 Aligned_cols=137 Identities=16% Similarity=0.139 Sum_probs=81.4
Q ss_pred EeeeeecCCeEEEEEEEcC-------CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVE-------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 89 (468)
++.|..|....+|++.... ++..+++|+.... . . ....+.+|..+++.|. +.-..++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~-~--~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L-Q--GVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----C--CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c-c--hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3466668888899988642 3578999986321 1 1 1344568999998885 3223556665543 2
Q ss_pred EEEEccCCCCHH--------------HH---HHhcC-----CCC--HHHHHHHHHHHHH-------------------HH
Q 012228 90 IVLEFIDGGELF--------------DK---IAKHG-----RLK--EDEARRYFQQLIN-------------------AV 126 (468)
Q Consensus 90 lV~E~~~gg~L~--------------~~---i~~~~-----~l~--e~~~~~~~~qll~-------------------~l 126 (468)
+||||++|..|. +. +.... ... ..++..+..++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999875432 11 11110 111 3456666655422 23
Q ss_pred HHHH----h----CCccccCCCCCCeeeccC----CceEEeccccchh
Q 012228 127 DYCH----S----RGVFHRDLKPENLLLDSY----GVLKISDFGLSAI 162 (468)
Q Consensus 127 ~yLH----~----~givHrDlKp~NILl~~~----g~lkl~DFGla~~ 162 (468)
..|. . ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 2 258999999999999876 7899999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0016 Score=63.87 Aligned_cols=73 Identities=11% Similarity=0.065 Sum_probs=43.5
Q ss_pred EeeeeecCCeEEEEEEEcC--------CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-eeEEEEEEEeCCEE
Q 012228 18 GRTLGEGSFAKVKFAKNVE--------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKI 88 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 88 (468)
.+.|+.|....+|++.... .+..+++|+...... .......|..+++.|...+ +.+++... .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 5677888888999998643 136889998754211 0112357888888775323 34666544 22
Q ss_pred EEEEEccCCC
Q 012228 89 YIVLEFIDGG 98 (468)
Q Consensus 89 ~lV~E~~~gg 98 (468)
++|||+++|.
T Consensus 110 ~~v~e~i~G~ 119 (369)
T 3c5i_A 110 GRIEEWLYGD 119 (369)
T ss_dssp EEEEECCCSE
T ss_pred cEEEEEecCC
Confidence 6899999874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0039 Score=60.40 Aligned_cols=31 Identities=19% Similarity=0.305 Sum_probs=27.7
Q ss_pred CCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 132 ~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
.+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888999999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.02 Score=57.77 Aligned_cols=74 Identities=16% Similarity=0.201 Sum_probs=47.3
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCe-eEEEEEEEeCCEEEEEEEccC
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNV-IKIIEVMASKTKIYIVLEFID 96 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~ 96 (468)
.+.|+.|....+|++.....+..+++|+..... . ... ...+|..+++.|...++ .++++++. +. +||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~-~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--D-EII-NREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--C-SCS-CHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--h-hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeC
Confidence 567888888999999875445789999874321 0 001 11488999988864444 56776663 32 5999998
Q ss_pred CCC
Q 012228 97 GGE 99 (468)
Q Consensus 97 gg~ 99 (468)
|..
T Consensus 185 G~~ 187 (458)
T 2qg7_A 185 GYA 187 (458)
T ss_dssp SEE
T ss_pred Ccc
Confidence 743
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.28 E-value=0.043 Score=54.76 Aligned_cols=74 Identities=16% Similarity=0.145 Sum_probs=46.3
Q ss_pred EeeeeecCCeEEEEEEEcCC-------CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVET-------GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 89 (468)
++.|..|....+|++..... +..+++|+..... . ..-...+|..+++.|. +.-..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---G-KFYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---c-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 45666688889999987521 5789999864321 1 0112347888888774 32234555433 23 7
Q ss_pred EEEEccCCCC
Q 012228 90 IVLEFIDGGE 99 (468)
Q Consensus 90 lV~E~~~gg~ 99 (468)
+||||++|..
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 8999999854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.72 E-value=2 Score=38.33 Aligned_cols=114 Identities=16% Similarity=0.176 Sum_probs=83.7
Q ss_pred CCCCeeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCccccCCCCCCeeeccC
Q 012228 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD-YCHSRGVFHRDLKPENLLLDSY 149 (468)
Q Consensus 71 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~-yLH~~givHrDlKp~NILl~~~ 149 (468)
.||++ -..+-.+++.+.+.++.-+++.=+..+. .++.....+++.+|+.... +++ .-+|=-|+|+||++|.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEeCC
Confidence 58888 5566688888888888876665566663 5788999999888888766 443 34666789999999999
Q ss_pred CceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHH-HHHHHHHHHhhCCCCCC
Q 012228 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW-SCGVILFVLMAGFLPFD 217 (468)
Q Consensus 150 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiW-SlGvil~~ll~g~~Pf~ 217 (468)
+.++|.-.|+-. -++|. .-...|.| .+=|++..++.++..|+
T Consensus 121 ~~p~i~hRGi~~-------------------~lpP~-------e~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 121 LEPFFLHVGVKE-------------------SLPPD-------EWDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CCEEESCCEETT-------------------TBSSC-------SCCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred CcEEEEEcCCcc-------------------cCCCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999998777522 12232 22455666 57788999999887774
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.58 E-value=1.2 Score=39.58 Aligned_cols=115 Identities=19% Similarity=0.310 Sum_probs=82.5
Q ss_pred CCCCeeEEEEEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC
Q 012228 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG 150 (468)
Q Consensus 71 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g 150 (468)
.||+.+.. .+-.+.+.+.+.++.-+.+-=+..+. .++.....+++.+|+....+++ .-+|=-|.|+||+++.++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRDG 116 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTTS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCCC
Confidence 58999977 57777788877777765443333343 4788899999999988775544 346677999999999999
Q ss_pred ceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHH-HHHHHHHHHhhCCCCCC
Q 012228 151 VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW-SCGVILFVLMAGFLPFD 217 (468)
Q Consensus 151 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiW-SlGvil~~ll~g~~Pf~ 217 (468)
.++|.--|+-.. ++| |.-...|.| .+=|++..++.++..|+
T Consensus 117 ~p~i~~RGik~~-------------------l~P-------~~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 117 LPIAKTRGLQNV-------------------VDP-------LPVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CEEESCCEETTT-------------------BSC-------CCCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CEEEEEccCccC-------------------CCC-------CCCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999987775221 122 212345666 57789999999988884
|
| >3ost_A Serine/threonine-protein kinase KCC4; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.69A {Saccharomyces cerevisiae} PDB: 3osm_A | Back alignment and structure |
|---|
Probab=85.00 E-value=9.2 Score=30.46 Aligned_cols=85 Identities=13% Similarity=0.160 Sum_probs=60.8
Q ss_pred eeeecCChhHHHHHHHHHhc---ccCc-eEEecCceeEEeeccCC----CCCceEEEEEEEEEeCCe-EEEEEEEcCCCc
Q 012228 368 RFTSQRPPNEIMSKIEEAAK---PLGF-NVRKGNYKMKLQGDKTG----RKGQLSVATEVFEVAPTL-HIVEVRKTGGDT 438 (468)
Q Consensus 368 rf~s~~~~~~~~~~l~~~~~---~~~~-~~~~~~~~~~~~~~~~~----~~~~l~~~~~i~~~~~~~-~~vdf~~~~Gd~ 438 (468)
.+.+..+...+...|...++ ..|+ .++.......+.+.... .-....|.++|++=. +. .+|-|++.+|-.
T Consensus 28 ~l~t~v~k~~~~~~L~~LL~~Wk~yGlkdv~~D~~~~~ItGrvs~~N~L~LRsv~F~i~i~~~g-n~~Slv~f~q~rGSs 106 (128)
T 3ost_A 28 EIHAKIPEKRLYEGLHKLLEGWKQYGLKNLVFNITNMIITGKLVNDSILFLRSTLFEIMVLPNG-DGRSLIKFNKKTGST 106 (128)
T ss_dssp CEEESSCHHHHHHHHHHHHHTCGGGTEEEEEEETTTTEEEEEECCCCSSSCCCEEEEEEEEECS-TTCEEEEEEESSSCH
T ss_pred EEEEecCHHHHHHHHHHHHHHHHHhCccceEecCCCCEEEEEEccccccccceeEEEEEEeecC-CceEEEEEEEeeccH
Confidence 56788999999988888874 6676 34433322233333121 113678999999754 66 999999999999
Q ss_pred hhHHHHHHHHHhccc
Q 012228 439 LEFHKFYKKFSSGLK 453 (468)
Q Consensus 439 le~~~~~~~~~~~l~ 453 (468)
--|++++..|..-|+
T Consensus 107 stf~klv~eiEkVL~ 121 (128)
T 3ost_A 107 KTLTKLATEIQIILQ 121 (128)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999998877664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=81.61 E-value=0.55 Score=46.23 Aligned_cols=29 Identities=31% Similarity=0.422 Sum_probs=25.3
Q ss_pred ccccCCCCCCeee------ccCCceEEeccccchh
Q 012228 134 VFHRDLKPENLLL------DSYGVLKISDFGLSAI 162 (468)
Q Consensus 134 ivHrDlKp~NILl------~~~g~lkl~DFGla~~ 162 (468)
++|+|+.+.|||+ ++++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 468 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-86 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-85 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-81 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-79 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-79 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-77 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-76 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-76 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-75 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-75 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-74 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-73 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-72 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-71 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-71 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-71 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-70 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-70 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-69 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-69 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-67 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-67 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-67 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-67 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-67 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-66 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-66 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-64 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-64 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-63 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-63 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-62 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-60 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-59 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-57 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-57 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-55 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-54 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-46 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-22 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 3e-21 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (673), Expect = 3e-86
Identities = 86/285 (30%), Positives = 148/285 (51%), Gaps = 31/285 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E+GR LG+G F V A+ ++ +A+K++ + Q+ + + Q++RE+ ++HP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++++ T++Y++LE+ G ++ ++ K + E Y +L NA+ YCHS+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRD+KPENLLL S G LKI+DFG S + T CGT +Y+ PE++ + +D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253
D+WS GV+ + + G PF+ + Y++
Sbjct: 183 -EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-------------------------- 215
Query: 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
I R +F+ P + + GA+ LI R+L NP R + ++LE W
Sbjct: 216 ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 260 bits (665), Expect = 5e-85
Identities = 105/290 (36%), Positives = 154/290 (53%), Gaps = 25/290 (8%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
V ++L +TLGEG++ +V+ A N T + VA+KIVD + + E IK+EI K++
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
H NV+K Y+ LE+ GGELFD+I + E +A+R+F QL+ V Y H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
G+ HRD+KPENLLLD LKISDFGL+ + + + LL+ CGT YVAPE+L +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
+ DVWSCG++L ++AG LP+D+ + + Y K +Y
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---------------QEYSDWKEKKTY- 225
Query: 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301
+ S L+ +IL NP R+TI + +D W+ K K
Sbjct: 226 -------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (641), Expect = 3e-81
Identities = 81/290 (27%), Positives = 142/290 (48%), Gaps = 27/290 (9%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ R ++ G+ LGEGSF+ V A+ + T AIKI+++ +++ V + RE M
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
+ HP +K+ K+Y L + GEL I K G E R Y ++++A++Y
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
H +G+ HRDLKPEN+LL+ ++I+DFG + + + ++ GT YV+PE+L
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248
+K ++SD+W+ G I++ L+AG PF N +++K
Sbjct: 184 EKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK--------------------- 221
Query: 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
I + ++ P F A+ L++++L + R+ +M K
Sbjct: 222 -----IIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 2e-79
Identities = 72/304 (23%), Positives = 125/304 (41%), Gaps = 26/304 (8%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+E LG G+ V + +G +A K++ + ++ + QI RE+ + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR- 132
++ S +I I +E +DGG L + K GR+ E + +I + Y +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
+ HRD+KP N+L++S G +K+ DFG+S D + ++ GT +Y++PE L Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHY 180
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALY----------------RKVSTFHFLSV 236
SD+WS G+ L + G P + L R + LS
Sbjct: 181 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 237 YGESYKKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDE 294
YG + + I FS + + + L NP R + Q++
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 295 WFKK 298
+ K+
Sbjct: 300 FIKR 303
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 7e-79
Identities = 82/294 (27%), Positives = 139/294 (47%), Gaps = 33/294 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+E+ LG+G+F KV A+N ET A K++D + +E EI + HPN
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPN 70
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRG 133
++K+++ + ++I++EF GG + + + R L E + + +Q ++A++Y H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ HRDLK N+L G +K++DFG+SA + R + GTP ++APEV+ +
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 194 GR----ASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249
R +DVWS G+ L + P E N M + K++ +
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-------------- 234
Query: 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303
+ PS +SS K +K+ L+ N D R T SQ+L+ + P
Sbjct: 235 ---------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 243 bits (620), Expect = 3e-77
Identities = 88/294 (29%), Positives = 138/294 (46%), Gaps = 32/294 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y++ LG G+F V TG+ A K V E +++EI TM +++HP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHP 83
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSR 132
++ + + ++ ++ EF+ GGELF+K+A +H ++ EDEA Y +Q+ + + H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 133 GVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
H DLKPEN++ + LK+ DFGL+A + + GT + APEV K
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
G +D+WS GV+ ++L++G PF N R V + +
Sbjct: 201 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW----------------- 242
Query: 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
D S S S K I+++L +P+TRMTI Q LE W G P
Sbjct: 243 -----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 291
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 239 bits (612), Expect = 2e-76
Identities = 70/317 (22%), Positives = 126/317 (39%), Gaps = 34/317 (10%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ R +G GSF V FA++V + VAIK + ++ + I +E+ ++ ++HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N I+ + ++V+E+ G L+E E + + Y HS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL---NDK 190
+ HRD+K N+LL G++K+ DFG ++I ++ GTP ++APEV+ ++
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
YDG+ DVWS G+ L P N M+ ++ ++
Sbjct: 190 QYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ------------- 235
Query: 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEE 310
+S + + L P R T +L+ + + P +
Sbjct: 236 -----------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284
Query: 311 VNLDDVDAIFNDSKENL 327
D V + N +
Sbjct: 285 RTKDAVRELDNLQYRKM 301
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 3e-76
Identities = 72/292 (24%), Positives = 130/292 (44%), Gaps = 30/292 (10%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
KY +G+G+ V A +V TG VAI+ ++ Q E I EI M+ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKN 76
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
PN++ ++ ++++V+E++ GG L D + + E + ++ + A+++ HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN 135
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
V HRD+K +N+LL G +K++DFG A Q E T GTP ++APEV+ K Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252
D+WS G++ ++ G P+ N + +
Sbjct: 194 G-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-----------------------A 229
Query: 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 304
+ P S+ + + R LD + + R + ++L+ ++ K
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 238 bits (607), Expect = 3e-75
Identities = 88/380 (23%), Positives = 154/380 (40%), Gaps = 55/380 (14%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ Y++ LG G+F V TG K ++ L +K EIS M
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISIMN 81
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVD 127
+ HP +I + + K ++ ++LEF+ GGELFD+IA ++ E E Y +Q +
Sbjct: 82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 128 YCHSRGVFHRDLKPENLLLDSY--GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
+ H + H D+KPEN++ ++ +KI DFGL + ++ D ++ T + APE
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL---ATKLNPDEIVKVTTATAEFAAPE 198
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245
+++ + +D+W+ GV+ +VL++G PF + + + V +
Sbjct: 199 IVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW------------ 245
Query: 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 305
D S S AK IK +L P R+T+ LE W K +
Sbjct: 246 ----------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS 295
Query: 306 DKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKR 365
+N ++ + + + P A I R +FS R
Sbjct: 296 RIPSSR--------YNKIRQKIKEKYADWPAPQPA---IGRIANFSSL-----------R 333
Query: 366 ETRFTSQRPPNEIMSKIEEA 385
+ R + + + +EA
Sbjct: 334 KHRPQEYQIYDSYFDR-KEA 352
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 7e-75
Identities = 79/297 (26%), Positives = 135/297 (45%), Gaps = 40/297 (13%)
Query: 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
+R YE+ T+G GS+ + + + G + K +D + + + E++ ++
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRE 59
Query: 70 IKHPNVIKIIEVMASKT--KIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLI 123
+KHPN+++ + + +T +YIV+E+ +GG+L I K + L E+ R QL
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 124 NAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
A+ CH R V HRDLKP N+ LD +K+ DFGL+ I + GT
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGT 177
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG 238
P Y++PE +N Y+ SD+WS G +L+ L A PF + L K+ F +
Sbjct: 178 PYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI-- 234
Query: 239 ESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295
P +S ++I R+L+ R ++ ++LE+
Sbjct: 235 -----------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 233 bits (594), Expect = 2e-74
Identities = 84/299 (28%), Positives = 136/299 (45%), Gaps = 41/299 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH------KMVEQIKREISTM 67
YE LG G + V+ + T A+KI+D ++ E +E+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 68 -KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAV 126
K+ HPN+I++ + + T ++V + + GELFD + + L E E R+ + L+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 127 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
H + HRDLKPEN+LLD +K++DFG S Q+ L CGTP+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180
Query: 187 L-----NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241
+ ++ G+ D+WS GVI++ L+AG PF M + R + +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS----------- 229
Query: 242 KKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
F P W +S K L+ R L P R T + L +F++
Sbjct: 230 -------------GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 230 bits (588), Expect = 4e-73
Identities = 103/338 (30%), Positives = 163/338 (48%), Gaps = 46/338 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y+ LG G+F++V A++ T VAIK + + + ++ EI+ + IKHP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHP 67
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++ + ++ S +Y++++ + GGELFD+I + G E +A R Q+++AV Y H G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 134 VFHRDLKPENLLL---DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ HRDLKPENLL D + ISDFGLS + +L TACGTP YVAPEVL K
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
Y +A D WS GVI ++L+ G+ PF + N L+ ++ +
Sbjct: 185 PYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY----------------- 226
Query: 251 TLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 308
+F P W S AK I+ +++ +P+ R T Q L+ W +
Sbjct: 227 -------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQ 279
Query: 309 EEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISR 346
+ K+N K ++ + NA ++
Sbjct: 280 S---------VSEQIKKNFAKSKWKQ--AFNATAVVRH 306
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 5e-72
Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 33/293 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY + LG G F V + K V ++ +K+EIS + + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILNIARHR 61
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSR 132
N++ + E S ++ ++ EFI G ++F++I L E E Y Q+ A+ + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 133 GVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
+ H D++PEN++ + +KI +FG ++Q++ P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQ---ARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 191 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
A+D+WS G +++VL++G PF + + +Y++
Sbjct: 179 VVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENI---------------MNAEYTF 222
Query: 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303
+ S A + R+L +RMT S+ L+ W K+ +
Sbjct: 223 DEEA-------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 2e-71
Identities = 92/338 (27%), Positives = 152/338 (44%), Gaps = 55/338 (16%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL-IKHP 73
+ L + LG+GSF KV A+ +T F AIK + +D VL VE E + L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
+ + +K ++ V+E+++GG+L I + A Y ++I + + HS+G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ +RDLK +N+LLD G +KI+DFG+ + D +T CGTP+Y+APE+L + Y+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253
+ D WS GV+L+ ++ G PF + L+
Sbjct: 182 -HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH--------------------------S 214
Query: 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI-SQMLEDEWFK---------KGYKPP 303
I + P W AK L+ ++ P+ R+ + + + F+ K PP
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPP 274
Query: 304 ------------HFDKE---EEVNLDDVDAIFNDSKEN 326
+FDKE E+ L D +S +
Sbjct: 275 FRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQ 312
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 6e-71
Identities = 69/294 (23%), Positives = 128/294 (43%), Gaps = 40/294 (13%)
Query: 13 GKY-ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
G++ + +G GSF V + ET VA + +D+ L ++ K E +K ++
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 72 HPNVIKIIEVMASKTK----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
HPN+++ + S K I +V E + G L + + +K R + +Q++ +
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 128 YCHSRG--VFHRDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAP 184
+ H+R + HRDLK +N+ + G +KI D GL+ + GTP ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAP 182
Query: 185 EVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKVSTFHFLSVYGESYKK 243
E+ +K YD + DV++ G+ + + P+ E N +YR+V++
Sbjct: 183 EMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---------- 230
Query: 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
S K++I+ + N D R +I +L +F+
Sbjct: 231 --------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 6e-71
Identities = 83/308 (26%), Positives = 139/308 (45%), Gaps = 46/308 (14%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE---QIKREISTMKL 69
+Y++G LG G F V V VAIK V++D++ + ++ E+ +K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 70 IK--HPNVIKIIEVMASKTKIYIVLEFIDGG-ELFDKIAKHGRLKEDEARRYFQQLINAV 126
+ VI++++ ++LE + +LFD I + G L+E+ AR +F Q++ AV
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 127 DYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 185
+CH+ GV HRD+K EN+L+D + G LK+ DFG A+ +D + GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179
Query: 186 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245
+ Y GR++ VWS G++L+ ++ G +PF+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------------------- 214
Query: 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 305
+I R SS + LI+ L P R T ++ W + P
Sbjct: 215 -------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ-- 265
Query: 306 DKEEEVNL 313
+ E++L
Sbjct: 266 -ETAEIHL 272
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 1e-70
Identities = 95/332 (28%), Positives = 158/332 (47%), Gaps = 45/332 (13%)
Query: 9 RTRVGKYE-LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
+ Y+ + LG G KV N T + A+K++ + + +RE+
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELH 58
Query: 68 -KLIKHPNVIKIIEV----MASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQ 120
+ + P++++I++V A + + IV+E +DGGELF +I G E EA +
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 121 QLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKISDFGLSAISQQVREDGLLHTACG 177
+ A+ Y HS + HRD+KPENLL S +LK++DFG +++ L T C
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKETTSHNSLTTPCY 175
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237
TP YVAPEVL + YD ++ D+WS GVI+++L+ G+ PF ++ +A+ + T
Sbjct: 176 TPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR------ 228
Query: 238 GESYKKCTNKYSYTLQICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEW 295
+++ + +F P W S K LI+ +L P RMTI++ + W
Sbjct: 229 --------------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274
Query: 296 FKKGYKPPHFDKEEEVNLDDVDAIFNDSKENL 327
+ K P L + + D KE +
Sbjct: 275 IMQSTKVPQTPLHTSRVLKEDKERWEDVKEEM 306
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 9e-70
Identities = 100/309 (32%), Positives = 150/309 (48%), Gaps = 42/309 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK---MVEQIKREISTMKLI 70
Y+ G LG G FA VK + TG A K + + + + E I+RE+S +K I
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
+HPNVI + EV +KT + ++LE + GGELFD +A+ L E+EA + +Q++N V Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 131 SRGVFHRDLKPENLLLDSYGV----LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV 186
S + H DLKPEN++L V +KI DFGL + ++ GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL---AHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 187 LNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246
+N + +D+WS GVI ++L++G PF VS ++
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY------------- 233
Query: 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK--------- 297
+ S S+ AK I+R+L +P RMTI L+ W K
Sbjct: 234 ---------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS 284
Query: 298 KGYKPPHFD 306
+ P F+
Sbjct: 285 SAWSHPQFE 293
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 7e-69
Identities = 64/283 (22%), Positives = 118/283 (41%), Gaps = 28/283 (9%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
G+ +G+ +G GSF V K VA+K+++ + ++ K E+ ++ +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRH 63
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHS 131
N++ + + ++ IV ++ +G L+ + + + + +Q +DY H+
Sbjct: 64 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN--D 189
+ + HRDLK N+ L +KI DFGL+ + + G+ ++APEV+ D
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249
K SDV++ G++L+ LM G LP+ N + +LS
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS-------------- 228
Query: 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
S K+L+ L D R Q+L
Sbjct: 229 ------PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 219 bits (560), Expect = 8e-69
Identities = 98/342 (28%), Positives = 168/342 (49%), Gaps = 66/342 (19%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+++ RTLG GSF +V ++ G + A+K++ ++ V+R K VE E + ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV 134
+I++ +I++++++I+GGELF + K R A+ Y ++ A++Y HS+ +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 135 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 194
+RDLKPEN+LLD G +KI+DFG + V +T CGTP+Y+APEV++ K Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYN- 179
Query: 195 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254
++ D WS G++++ ++AG+ PF +SN M Y K I
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK--------------------------I 213
Query: 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFK---------KGY 300
A+ P +F+ K L+ R++ + R+ + WFK +
Sbjct: 214 LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 273
Query: 301 KPP-------------HFDK--EEEVNL-----DDVDAIFND 322
+ P FDK EE++N D +F D
Sbjct: 274 ETPYEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLFRD 315
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 218 bits (556), Expect = 2e-67
Identities = 81/364 (22%), Positives = 152/364 (41%), Gaps = 48/364 (13%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--- 71
+ + R +G G F +V + +TG A+K +D+ ++ + E + L+
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
P ++ + + K+ +L+ ++GG+L +++HG E + R Y ++I +++ H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
R V +RDLKP N+LLD +G ++ISD GL+ H + GT Y+APEVL
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGV 181
Query: 192 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
++D +S G +LF L+ G PF + +
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---------------------- 219
Query: 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFK--------- 297
P FS + L++ +L + + R+ ++ E +F+
Sbjct: 220 -MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 278
Query: 298 KGYKPPHFDKEEEVNLDDVDAIFN----DSKENLVTEKKEKPVSMNAFELISRTKSFSLE 353
+ Y PP EVN D I + D+K + + ++ + R + E
Sbjct: 279 QKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAE 338
Query: 354 NLFE 357
+F+
Sbjct: 339 TVFD 342
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (552), Expect = 3e-67
Identities = 79/325 (24%), Positives = 134/325 (41%), Gaps = 14/325 (4%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+Y +GEG++ V A + VAIK + + ++ REI + +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 73 PNVIKIIEVMASKT----KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
N+I I +++ + T K ++ + G +L+ + K L D + Q++ + Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVL 187
HS V HRDLKP NLLL++ LKI DFGL+ G L T Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV-----STFHFLSVYGESYK 242
+ ++ D+WS G IL +++ F + + + S + K
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
S + S A L+ ++L NP R+ + Q L + ++ Y P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
Query: 303 PHFDKEEEVNLDDVDAIFNDSKENL 327
E D++ + + KE L
Sbjct: 305 SDEPIAEAPFKFDME-LDDLPKEKL 328
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-67
Identities = 75/316 (23%), Positives = 125/316 (39%), Gaps = 18/316 (5%)
Query: 3 VKVPASRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKR 62
V+ P V KYE +G+G+F +V A++ +TG VA+K V + + R
Sbjct: 1 VECPFCD-EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALR 58
Query: 63 EISTMKLIKHPNVIKIIEVMASKT--------KIYIVLEFIDGGELFDKIAKHGRLKEDE 114
EI ++L+KH NV+ +IE+ +K IY+V +F + + E
Sbjct: 59 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 118
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED--GLL 172
+R Q L+N + Y H + HRD+K N+L+ GVLK++DFGL+ +
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 173 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH 232
T Y PE+L + G D+W G I+ + + +S
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 233 FLSVYGESYKKCTNKYSYTLQICRA------DFSCPSWFSSGAKKLIKRILDPNPDTRMT 286
+ L++ + D A LI ++L +P R+
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 287 ISQMLEDEWFKKGYKP 302
L ++F P
Sbjct: 299 SDDALNHDFFWSDPMP 314
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 214 bits (545), Expect = 5e-67
Identities = 68/294 (23%), Positives = 125/294 (42%), Gaps = 36/294 (12%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+YELG LG G ++V A+++ VA+K++ D + +RE + H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 73 PNVIKIIEVMASKTK----IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
P ++ + + ++T YIV+E++DG L D + G + A A+++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVL 187
H G+ HRD+KP N+++ + +K+ DFG++ I+ GT Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247
D R SDV+S G +L+ ++ G PF + +++
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--------------------- 224
Query: 248 YSYTLQICRADFSCPS----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
Q R D PS S+ ++ + L NP+ R + + + +
Sbjct: 225 -----QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 5e-67
Identities = 73/291 (25%), Positives = 117/291 (40%), Gaps = 6/291 (2%)
Query: 16 ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK--MVEQIKREISTMKLIKHP 73
E LGEG FA V A++ T VAIK + K + REI ++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N+I +++ K+ I +V +F++ L + Y + ++Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ HRDLKP NLLLD GVLK++DFGL+ + T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV--STFHFLSVYGESYKKCTNKYSYT 251
G D+W+ G IL L+ + + ++ + + ++
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
S LI+ + NP R+T +Q L+ ++F P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 1e-66
Identities = 91/356 (25%), Positives = 161/356 (45%), Gaps = 58/356 (16%)
Query: 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ + ++ + LG+G+F KV + TG + A+KI+ ++ ++ V E ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
+HP + + + ++ V+E+ +GGELF +++ E+ AR Y ++++A++Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 188
HSR V +RD+K ENL+LD G +KI+DFGL + + + + T CGTP Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 189 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248
D Y RA D W GV+++ +M G LPF + L+
Sbjct: 179 DNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL--------------------- 216
Query: 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFK------ 297
I + P S AK L+ +L +P R+ +++E +F
Sbjct: 217 -----ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271
Query: 298 ---KGYKPP------------HFDKE---EEVNLDDVDAIFNDSKENLVTEKKEKP 335
K PP +FD E + + + D + L ++++
Sbjct: 272 VVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEM 327
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 2e-66
Identities = 79/296 (26%), Positives = 138/296 (46%), Gaps = 8/296 (2%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
++ +GEG++ V A+N TG+ VA+K + D + REIS +K + HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 61
Query: 74 NVIKIIEVMASKTKIYIVLEFID-GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
N++K+++V+ ++ K+Y+V EF+ + F + + + Y QL+ + +CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
V HRDLKP+NLL+++ G +K++DFGL+ T Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 193 DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV--STFHFLSVYGESYKKCTNKYSY 250
A D+WS G I ++ F + + ++ + V +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 251 TLQICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP-PH 304
+ R DFS + L+ ++L +P+ R++ L +F+ KP PH
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 2e-64
Identities = 79/342 (23%), Positives = 137/342 (40%), Gaps = 27/342 (7%)
Query: 8 SRTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM 67
R + Y + +G GSF V AK ++G+ VAIK V +D+ RE+ M
Sbjct: 15 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIM 67
Query: 68 KLIKHPNVIKIIEVMAS------KTKIYIVLEFIDGG---ELFDKIAKHGRLKEDEARRY 118
+ + H N++++ S + + +VL+++ L + Y
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVREDGLLHTACG 177
QL ++ Y HS G+ HRD+KP+NLLLD VLK+ DFG ++Q+ +
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS---AKQLVRGEPNVSYIC 184
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237
+ Y APE++ + DVWS G +L L+ G F + + ++
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 238 GESYKKCTNKYSYTLQICRA---DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 294
+ + N + +A A L R+L+ P R+T +
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 295 WFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPV 336
+F + P + N D A+FN + + L + +
Sbjct: 305 FFDELRDPNV----KLPNGRDTPALFNFTTQELSSNPPLATI 342
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (533), Expect = 2e-64
Identities = 94/343 (27%), Positives = 164/343 (47%), Gaps = 61/343 (17%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+++ +TLG GSF +V K+ E+G+ A+KI+D+ +V++ K +E E ++ + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++K+ + +Y+V+E++ GGE+F + + GR E AR Y Q++ +Y HS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
+ +RDLKPENLL+D G ++++DFG + R G T CGTP +APE++ KGY+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQ 253
+A D W+ GV+++ + AG+ PF + +Y +
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--------------------------K 249
Query: 254 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFK---------KG 299
I PS FSS K L++ +L + R ++ + +WF +
Sbjct: 250 IVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRK 309
Query: 300 YKPP------------HFDKEEEVNLDDVDAIFNDSKENLVTE 330
+ P +FD EE +++ N+ TE
Sbjct: 310 VEAPFIPKFKGPGDTSNFDDYEE---EEIRVSINEKCGKEFTE 349
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-63
Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 8/294 (2%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KYE +GEG++ V AKN ET + VA+K V D + REI +K +KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 61
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++++ +V+ S K+ +V EF D + +G L + + + QL+ + +CHSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRDLKP+NLL++ G LK+++FGL+ T Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 194 GRASDVWSCGVILFVLMAGFLPF----DESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249
+ D+WS G I L P D + + ++ + K K
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 303
+ + ++ + L++ +L NP R++ + L+ +F + PP
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD-FCPP 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-63
Identities = 87/331 (26%), Positives = 151/331 (45%), Gaps = 23/331 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
Y + +G G++ V A + TG VAIK + R ++ RE+ +K ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHE 77
Query: 74 NVIKIIEVMASK------TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD 127
NVI +++V T Y+V+ F+ G K+ KH +L ED + Q++ +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 128 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 187
Y H+ G+ HRDLKP NL ++ LKI DFGL+ + D + T Y APEV+
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPEVI 190
Query: 188 NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVS----TFHFLSVYGESYKK 243
+ + D+WS G I+ ++ G F S+ + +++ T V +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 244 CTNKYSYTLQICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302
N ++ + DF S + S A L++++L + + R+T + L +F+ +
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
Query: 303 ---PHFDKEEEVNLDDVDAIFNDSKENLVTE 330
P K ++ + DDVD ++ K E
Sbjct: 311 EDEPQVQKYDD-SFDDVDRTLDEWKRVTYKE 340
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 205 bits (522), Expect = 2e-63
Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 7/288 (2%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
KY +GEG++ V A+N G+ A+K + ++ + REIS +K +KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
N++K+ +V+ +K ++ +V E +D G L+ A+ + QL+N + YCH R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRDLKP+NLL++ G LKI+DFGL+ T Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 194 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHF---LSVYGESYKKCTNKYSY 250
D+WS G I ++ G F + ++ + + ++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298
T+ S L+ ++L +P+ R+T Q LE +FK+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-62
Identities = 66/283 (23%), Positives = 117/283 (41%), Gaps = 42/283 (14%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ +L +T+G+G F V G+ VA+K + D + E S M ++H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60
Query: 74 NVIKIIEVMA-SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCH 130
N+++++ V+ K +YIV E++ G L D + GR L D ++ + A++Y
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK 190
HRDL N+L+ V K+SDFGL+ + + T + APE L +K
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK 175
Query: 191 GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249
+ SDVWS G++L+ + + G +P+ L + +V +
Sbjct: 176 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------- 217
Query: 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
P +++K + R + Q+ E
Sbjct: 218 --------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-60
Identities = 76/297 (25%), Positives = 133/297 (44%), Gaps = 16/297 (5%)
Query: 12 VGKYELGRTLGEGSFAKVKFAKNVETGD-FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+YE +GEG++ KV A++++ G FVA+K V R Q M RE++ ++ +
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHL 64
Query: 71 K---HPNVIKIIEVMAS-----KTKIYIVLEFIDGGEL-FDKIAKHGRLKEDEARRYFQQ 121
+ HPNV+++ +V +TK+ +V E +D + + + + Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 122 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY 181
L+ +D+ HS V HRDLKP+N+L+ S G +K++DFGL+ I + T Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWY 181
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241
APEVL Y D+WS G I + F S+ + K+ L +
Sbjct: 182 RAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 242 KKCT-NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
+ + ++ + + + K L+ + L NP R++ L +F+
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-60
Identities = 75/312 (24%), Positives = 138/312 (44%), Gaps = 21/312 (6%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+Y+ +G G++ V A + +TG VA+K + R ++ RE+ +K +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHE 77
Query: 74 NVIKIIEVMASKTKI----YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC 129
NVI +++V + + L G + I K +L +D + Q++ + Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
HS + HRDLKP NL ++ LKI DFGL+ + T Y APE++ +
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLN 192
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV----STFHFLSVYGESYKKCT 245
+ + D+WS G I+ L+ G F ++ + + + T + S +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 246 NKYSYTLQICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP-- 302
N Q+ + +F+ + A L++++L + D R+T +Q L +F + + P
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312
Query: 303 ----PHFDKEEE 310
+D+ E
Sbjct: 313 EPVADPYDQSFE 324
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-59
Identities = 59/285 (20%), Positives = 101/285 (35%), Gaps = 37/285 (12%)
Query: 21 LGEGSFAKVKFAKNVETGD--FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKI 78
LG G+F V+ VAIK++ + E++ RE M + +P ++++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 79 IEVMASKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHR 137
I V + +V+E GG L + K + Q+ + Y + HR
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 138 DLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 196
DL N+LL + KISDFGLS A+ + APE +N + + R
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192
Query: 197 SDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQIC 255
SDVWS GV ++ ++ G P+ + + + +
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--------------------- 231
Query: 256 RADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS---QMLEDEWFK 297
CP L+ + R Q + ++
Sbjct: 232 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-59
Identities = 65/284 (22%), Positives = 110/284 (38%), Gaps = 32/284 (11%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
L LG+GSF V+ + VA+K + D + + + ++ RE++ M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCH 130
H N+I++ V+ + + +V E G L D++ KH G RY Q+ + Y
Sbjct: 70 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT-ACGTPNYVAPEVLND 189
S+ HRDL NLLL + ++KI DFGL Q + ++ + APE L
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 190 KGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248
+ + ASD W GV L+ + G P+ N + K+
Sbjct: 189 RTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------------------ 229
Query: 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
P ++ + P+ R T + +
Sbjct: 230 ------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-59
Identities = 55/286 (19%), Positives = 110/286 (38%), Gaps = 35/286 (12%)
Query: 19 RTLGEGSFAKVKFA--KNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVI 76
+ LG G+F VK + + VA+KI+ + + +++ E + M+ + +P ++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNPYIV 71
Query: 77 KIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFH 136
++I + ++ +V+E + G L + ++ +K+ Q+ + Y H
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 137 RDLKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR 195
RDL N+LL + KISDFGLS A+ + APE +N + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 196 ASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254
SDVWS GV+++ + G P+ + + +
Sbjct: 191 -SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-------------------- 229
Query: 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ---MLEDEWFK 297
CP+ L+ + + R + L + ++
Sbjct: 230 -----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 192 bits (488), Expect = 4e-58
Identities = 69/300 (23%), Positives = 129/300 (43%), Gaps = 28/300 (9%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKH 72
Y+L R LG G +++V A N+ + V +KI L+ ++IKREI ++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKI------LKPVKKKKIKREIKILENLRGG 89
Query: 73 PNVIKIIEVMASKTK--IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH 130
PN+I + +++ +V E ++ + L + + R Y +++ A+DYCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 131 SRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
S G+ HRD+KP N+++D L++ D+GL+ + + + PE+L D
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVD 203
Query: 190 KGYDGRASDVWSCGVILFVLMAGFLPF----DESNLMALYRKVSTFHFLSVYGE------ 239
+ D+WS G +L ++ PF D + + KV L Y +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 240 --SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297
+ ++S S A + ++L + +R+T + +E +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 6e-58
Identities = 58/281 (20%), Positives = 108/281 (38%), Gaps = 34/281 (12%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ LG G F VK+ K VAIK++ + ++ E M + H
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRG 133
++++ V + I+I+ E++ G L + + R + + + + A++Y S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
HRDL N L++ GV+K+SDFGLS E + + PEVL +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 194 GRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252
+ SD+W+ GV+++ + + G +P++ ++ L
Sbjct: 180 SK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------------- 221
Query: 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293
P S ++ D R T +L +
Sbjct: 222 --------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-57
Identities = 58/309 (18%), Positives = 110/309 (35%), Gaps = 57/309 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDF-----VAIKIVDRDQVLRHKMVEQIKREISTM- 67
E G+ LG G+F KV A VA+K++ E + E+ M
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH-------------------- 107
+L H N++ ++ IY++ E+ G+L + +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 108 ---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164
L ++ + Q+ +++ + HRDL N+L+ V+KI DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA 223
+ A ++APE L + Y SDVWS G++L+ + + G P+ + A
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 224 LYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDT 283
+ K+ N + P + + +++ +
Sbjct: 275 NFYKL---------------IQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRK 310
Query: 284 RMTISQMLE 292
R + +
Sbjct: 311 RPSFPNLTS 319
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (480), Expect = 4e-57
Identities = 62/312 (19%), Positives = 108/312 (34%), Gaps = 38/312 (12%)
Query: 11 RVG-KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKL 69
RVG +Y LGR +G GSF + ++ G+ VAIK+ Q+ E K+
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKM 58
Query: 70 IKHPNVIKIIE-VMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
++ I I A +V+E + + Q+I+ ++Y
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 129 CHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAI-----SQQVREDGLLHTACGTPN 180
HS+ HRD+KP+N L+ ++ I DFGL+ + Q GT
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 181 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240
Y + R D+ S G +L G LP+ +K
Sbjct: 179 YASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY------------ 225
Query: 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFK 297
+ K S ++ + S + D + + Q+ + + +
Sbjct: 226 ERISEKKMSTPIE------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
Query: 298 KGYKPPH-FDKE 308
+G+ + FD
Sbjct: 280 QGFSYDYVFDWN 291
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-57
Identities = 75/300 (25%), Positives = 144/300 (48%), Gaps = 34/300 (11%)
Query: 11 RVG--KYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLRH-KMVEQIKREI 64
+VG +EL + LG G++ KV + + +TG A+K++ + +++ K E + E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 65 STMKLIKH-PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI 123
++ I+ P ++ + ++TK++++L++I+GGELF +++ R E E + Y +++
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 124 NAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 183
A+++ H G+ +RD+K EN+LLDS G + ++DFGLS +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 184 PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243
V +A D WS GV+++ L+ G PF ++S
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR------------- 246
Query: 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298
+I +++ P S+ AK LI+R+L +P R+ ++ E +F+K
Sbjct: 247 ---------RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (474), Expect = 3e-56
Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 36/286 (12%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIK 71
++ + +G G F +V G FVAIK + K E S M
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD 85
Query: 72 HPNVIKIIEVMASKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYCH 130
HPNVI + V+ T + I+ EF++ G L G+ + + + + Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 131 SRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA---CGTPNYVAPEVL 187
HRDL N+L++S V K+SDFGLS + D +A + APE +
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 188 NDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246
+ + SDVWS G++++ +M+ G P+ + + + + L
Sbjct: 206 QYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL------------ 252
Query: 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
P S +L+ + + R Q++
Sbjct: 253 -------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (473), Expect = 3e-56
Identities = 67/303 (22%), Positives = 119/303 (39%), Gaps = 36/303 (11%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+ LG G + +V + VA+K + D VE+ +E + MK IKHP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHP 73
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHS 131
N+++++ V + YI+ EF+ G L D + + R + Q+ +A++Y
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
+ HRDL N L+ ++K++DFGLS + A + APE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
+ SDVW+ GV+L+ + G P+ +L +Y +
Sbjct: 193 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-------------------- 231
Query: 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEE 310
P +L++ NP R + +++ + F+ ++ E E
Sbjct: 232 -----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH--QAFETMFQESSISDEVE 284
Query: 311 VNL 313
L
Sbjct: 285 KEL 287
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-56
Identities = 57/288 (19%), Positives = 115/288 (39%), Gaps = 38/288 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
+L LG G F +V VA+K + + + + E + MK ++H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHS 131
++++ V+ ++ IYI+ E+++ G L D + +L ++ Q+ + +
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
R HRDL+ N+L+ KI+DFGL+ + + E A + APE +N
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGT 186
Query: 192 YDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
+ + SDVWS G++L ++ G +P+ + + + + +
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV--------------- 230
Query: 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE--DEWF 296
P +L++ P+ R T + +++F
Sbjct: 231 ----------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 6e-56
Identities = 58/280 (20%), Positives = 102/280 (36%), Gaps = 34/280 (12%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN 74
+ +G G F V D VAIK + + E E M + HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61
Query: 75 VIKIIEVMASKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYCHSRG 133
++++ V + I +V EF++ G L D + G + + + Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 134 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 193
V HRDL N L+ V+K+SDFG++ + + +PEV + Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 194 GRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTL 252
SDVWS GV+++ + + G +P++ + + +ST
Sbjct: 181 -SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-------------------- 219
Query: 253 QICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
P S+ +++ P+ R S++L
Sbjct: 220 -----RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-55
Identities = 64/324 (19%), Positives = 113/324 (34%), Gaps = 49/324 (15%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM-KLIKHP 73
+ +GEG+F +V A+ + G + I + E+ + KL HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARR 117
N+I ++ + +Y+ +E+ G L D + K L +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 118 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 177
+ + +DY + HRDL N+L+ V KI+DFGLS +
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGRL 188
Query: 178 TPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVSTFHFLSV 236
++A E LN Y SDVWS GV+L+ ++ G P+ LY K+ +
Sbjct: 189 PVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---- 243
Query: 237 YGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE--DE 294
P L+++ P R + +Q+L +
Sbjct: 244 ---------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
Query: 295 WFKKGYKPPHFDKEEEVNLDDVDA 318
++ + E+ +D
Sbjct: 283 MLEERKTYVNTTLYEKFTYAGIDC 306
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-55
Identities = 64/296 (21%), Positives = 112/296 (37%), Gaps = 39/296 (13%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHP 73
L LG+G F +V T VAIK + + E +E MK ++H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 74 NVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHS 131
++++ V+ S+ IYIV E++ G L D + L+ + Q+ + + Y
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 132 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 191
HRDL+ N+L+ V K++DFGL+ + + E A + APE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 192 YDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250
+ SDVWS G++L + G +P+ + +V +
Sbjct: 191 FTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------------ 231
Query: 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE--DEWFKKGYKPPH 304
CP L+ + P+ R T + +++F +P +
Sbjct: 232 -------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF-TSTEPQY 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-55
Identities = 67/285 (23%), Positives = 113/285 (39%), Gaps = 35/285 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGDF---VAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+ ELGR +GEG F V + + VAIK + E+ +E TM+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF 65
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYC 129
HP+++K+I V+ ++ ++I++E GEL + L Y QL A+ Y
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 189
S+ HRD+ N+L+ S +K+ DFGLS + ++APE +N
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINF 183
Query: 190 KGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248
+ + ASDVW GV ++ +LM G PF + ++ L +
Sbjct: 184 RRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------------ 230
Query: 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293
P L+ + +P R +++
Sbjct: 231 -------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (464), Expect = 9e-55
Identities = 62/309 (20%), Positives = 107/309 (34%), Gaps = 58/309 (18%)
Query: 14 KYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
E R +GEG+F +V A+ E VA+K++ + M +RE + M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMA 71
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR------------------- 109
+PN++K++ V A + ++ E++ G+L + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 110 -----LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164
L E +Q+ + Y R HRDL N L+ V+KI+DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFL-PFDESNLMA 223
++ PE + Y SDVW+ GV+L+ + + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 224 LYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDT 283
+ V + L +CP L++ P
Sbjct: 251 VIYYVRDGNIL-------------------------ACPENCPLELYNLMRLCWSKLPAD 285
Query: 284 RMTISQMLE 292
R + +
Sbjct: 286 RPSFCSIHR 294
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-54
Identities = 82/356 (23%), Positives = 144/356 (40%), Gaps = 35/356 (9%)
Query: 2 SVKVPASRTRV-GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQI 60
SV+V S V +Y+ + +G G+ V A + VAIK + R ++
Sbjct: 5 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRA 63
Query: 61 KREISTMKLIKHPNVIKIIEVMASK------TKIYIVLEFIDGGELFDKIAKHGRLKEDE 114
RE+ MK + H N+I ++ V + +Y+V+E +D L +
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHER 120
Query: 115 ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT 174
Q++ + + HS G+ HRDLKP N+++ S LKI DFGL+ + ++
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTP 177
Query: 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV------ 228
T Y APEV+ GY D+WS G I+ ++ + F + + + KV
Sbjct: 178 YVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
Query: 229 ----------STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILD 278
T Y T + + AD +S A+ L+ ++L
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 279 PNPDTRMTISQMLEDEWFKKGYKPPHFD----KEEEVNLDDVDAIFNDSKENLVTE 330
+P R+++ L+ + Y P + + + LD+ + + KE + E
Sbjct: 297 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 352
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-54
Identities = 52/282 (18%), Positives = 105/282 (37%), Gaps = 29/282 (10%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDR--DQVLRHKMVEQIKREISTMKLIKH 72
++ + LG G+F V + G+ V I + + + K ++I E M + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 73 PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR 132
P+V +++ + + T I G L + + Q+ ++Y R
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 133 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY 192
+ HRDL N+L+ + +KI+DFGL+ + ++ ++A E + + Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 193 DGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251
SDVWS GV ++ LM G P+D + + L
Sbjct: 191 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----------------- 232
Query: 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293
P + ++ + + D+R +++ +
Sbjct: 233 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 179 bits (454), Expect = 2e-53
Identities = 53/309 (17%), Positives = 99/309 (32%), Gaps = 39/309 (12%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
Y++GR +GEGSF + N+ VAIK R Q++ E T KL+
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAG 59
Query: 73 -PNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS 131
+ + +V++ + + +Q++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 132 RGVFHRDLKPENLLLDSY-----GVLKISDFGLSAI-----SQQVREDGLLHTACGTPNY 181
+ + +RD+KP+N L+ ++ + DFG+ ++Q GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 182 VAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241
++ + R D+ + G + + G LP+ +K
Sbjct: 180 MSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY------------E 226
Query: 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTR---MTISQMLEDEWFKK 298
+ K S L+ A P F K + + D + + +
Sbjct: 227 RIGEKKQSTPLRELCAG--FPEEF----YKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
Query: 299 GYKPPH-FD 306
FD
Sbjct: 281 NTTEDENFD 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-53
Identities = 68/305 (22%), Positives = 123/305 (40%), Gaps = 53/305 (17%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVETGD-------FVAIKIVDRDQVLRHKMVEQIKREIST 66
+ LG+ LGEG+F +V A+ + VA+K++ D K + + E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 67 MK-LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG----------------R 109
MK + KH N+I ++ +Y+++E+ G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 110 LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169
L + Q+ ++Y S+ HRDL N+L+ V+KI+DFGL+ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKV 228
++APE L D+ Y + SDVWS GV+L+ + G P+ + L++ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 288
H + PS ++ +++ P R T
Sbjct: 251 KEGHRM-------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFK 285
Query: 289 QMLED 293
Q++ED
Sbjct: 286 QLVED 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-52
Identities = 59/303 (19%), Positives = 111/303 (36%), Gaps = 50/303 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTM- 67
+ G+TLG G+F KV A + VA+K++ L + E + E+ +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 81
Query: 68 KLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHG------------------R 109
L H N++ ++ ++ E+ G+L + + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 110 LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169
L ++ + Q+ + + S+ HRDL N+LL + KI DFGL+ +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVS 229
+ A ++APE + + SDVWS G+ L+ L +
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSP------------- 247
Query: 230 TFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 289
+ + V + YK + P + ++K D +P R T Q
Sbjct: 248 -YPGMPVDSKFYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297
Query: 290 MLE 292
+++
Sbjct: 298 IVQ 300
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 5e-51
Identities = 60/299 (20%), Positives = 119/299 (39%), Gaps = 30/299 (10%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
L ++G+G F +V K G+ VA+KI R + + EI +++H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 73 PNVIKIIEVM----ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDY 128
N++ I + T++++V ++ + G LFD + ++ + + + + + +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAH 115
Query: 129 CHS--------RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--DGLLHTACGT 178
H + HRDLK +N+L+ G I+D GL+ + D + GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 179 PNYVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHF 233
Y+APEVL+D + +D+++ G++ + + L
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 234 LSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
SV E +K + I SC + K+++ N R+T ++ +
Sbjct: 236 PSV--EEMRKVVCEQKLRPNIPNRWQSCEA--LRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-50
Identities = 56/285 (19%), Positives = 105/285 (36%), Gaps = 35/285 (12%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+ +G G F +V + VAIK + K E M
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF 66
Query: 71 KHPNVIKIIEVMASKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYC 129
H N+I++ V++ + I+ E+++ G L K G + + + + Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 130 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVLN 188
+ HRDL N+L++S V K+SDFGLS + + E + + APE ++
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 189 DKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247
+ + ASDVWS G++++ +M G P+ E + + + ++
Sbjct: 187 YRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----------------- 228
Query: 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292
P S +L+ + R + ++
Sbjct: 229 --------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 3e-50
Identities = 62/315 (19%), Positives = 115/315 (36%), Gaps = 46/315 (14%)
Query: 14 KYELGRTLGEGSFAKV-----KFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
K + R LG+GSF V K E VAIK V+ +R + + E S MK
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMK 78
Query: 69 LIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGR----------LKEDEARRY 118
+V++++ V++ +++E + G+L + + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 119 FQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 178
++ + + Y ++ HRDL N ++ +KI DFG++ +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 179 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF-LPFDESNLMALYRKVSTFHFLSVY 237
+++PE L D + SDVWS GV+L+ + P+ + + R V L
Sbjct: 199 VRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL--- 254
Query: 238 GESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE--DEW 295
P +L++ NP R + +++ E
Sbjct: 255 ----------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
Query: 296 FKKGYKPPHFDKEEE 310
+ G++ F EE
Sbjct: 293 MEPGFREVSFYYSEE 307
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-48
Identities = 61/311 (19%), Positives = 115/311 (36%), Gaps = 39/311 (12%)
Query: 14 KYELGRTLGEGSFAKVKFAKNVE---TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI 70
+G G F V ++ A+K ++R V Q E MK
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDF 85
Query: 71 KHPNVIKIIEV-MASKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDY 128
HPNV+ ++ + + S+ +VL ++ G+L + + + + Q+ + +
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 129 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEV 186
S+ HRDL N +LD +K++DFGL+ D + + A ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 187 LNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245
L + + SDVWS GV+L+ LM G P+ + N + + L
Sbjct: 206 LQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---------- 254
Query: 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED-EWFKKGYKPPH 304
P + +++ + P + R + S+++ + H
Sbjct: 255 ---------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
Query: 305 FDKEEE--VNL 313
+ VN+
Sbjct: 300 YVHVNATYVNV 310
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-47
Identities = 60/303 (19%), Positives = 107/303 (35%), Gaps = 51/303 (16%)
Query: 14 KYELGRTLGEGSFAKVKFAK-----NVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK 68
+ +LG+ LG G+F +V A T VA+K++ H + E+ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILI 71
Query: 69 LIKHPNVIKIIE--VMASKTKIYIVLEFIDGGELFDKIAKHGR----------------L 110
I H + + + +++EF G L + L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 111 KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170
+ Y Q+ +++ SR HRDL N+LL V+KI DFGL+ + +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF-LPFDESNLMALYRKVS 229
A ++APE + D+ Y SDVWS GV+L+ + + P+ + + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR- 249
Query: 230 TFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 289
P + + + + P R T S+
Sbjct: 250 -----------------------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 286
Query: 290 MLE 292
++E
Sbjct: 287 LVE 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (406), Expect = 8e-46
Identities = 65/355 (18%), Positives = 123/355 (34%), Gaps = 48/355 (13%)
Query: 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH 72
+Y L R LG G F+ V AK++ VA+KIV D+V E + EI ++ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVND 68
Query: 73 PNVIKIIEV---------------MASKTKIYIVLEFIDGGEL-FDKIAKHGRLKEDEAR 116
+ K + + + +V E + L K +H + +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 117 RYFQQLINAVDYC-HSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQVREDGLLHT 174
+ +QL+ +DY G+ H D+KPEN+L++ + ++ + D
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKV------ 228
+ T Y +PEVL + +D+WS ++F L+ G F+ + +
Sbjct: 189 SIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 229 ----------------STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKL 272
T F + G K+ + + +
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 273 IKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF---DKEEEVNLDDVDAIFNDSK 324
+ +L +P R ++ W K D+E + D+ F + +
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVR 362
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 90.6 bits (224), Expect = 7e-22
Identities = 34/213 (15%), Positives = 67/213 (31%), Gaps = 42/213 (19%)
Query: 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIV---------------DRDQVLRHKMVEQ 59
+G+ +GEG + V + E +K D +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 60 IKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF 119
+ E ++ ++ V K+ +++E ID + R++ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAK-------ELYRVRVENPDEVL 109
Query: 120 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 179
++ V + RG+ H DL N+L+ G+ I DF S + +L
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDV--- 165
Query: 180 NYVAPEVLND---KGYDGRASDVWSCGVILFVL 209
+ + Y D+ S I +L
Sbjct: 166 -----RNIITYFSRTY-RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.3 bits (214), Expect = 3e-21
Identities = 14/86 (16%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 370 TSQRPPNEIMSKIEEAAKPLGFNVR-KGNYKMKLQGDKTGRKGQLSVATEVFEVA-PTLH 427
TS P+++M +I + + + + + + + EV ++ +L+
Sbjct: 16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLN 75
Query: 428 IVEVRKTGGDTLEFHKFYKKFSSGLK 453
V ++ G ++ F K ++ LK
Sbjct: 76 GVRFKRISGTSIAFKNIASKIANELK 101
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 468 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.46 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.69 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.61 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 98.29 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.12 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 98.03 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.01 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.11 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.76 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.05 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-66 Score=488.83 Aligned_cols=257 Identities=33% Similarity=0.696 Sum_probs=235.2
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
.+++|++++.||+|+||+||+|+++.+|+.||+|++.+....+....+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 36889999999999999999999999999999999987665554556788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.... ..
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~~ 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SS 159 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----CC
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----CC
Confidence 99999999999999998999999999999999999999999999999999999999999999999999997543 23
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
.....+||+.|+|||++.+..| +.++|||||||+||+|++|..||.+.+..+.+..
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----------------------- 215 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR----------------------- 215 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----------------------
T ss_pred cccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH-----------------------
Confidence 3456789999999999998877 5899999999999999999999999888877776
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
+.+..+.+|..+|+++.+||.+||++||++|||++|+|+||||+.
T Consensus 216 ---i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 216 ---ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ---HHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ---HHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 344556678889999999999999999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-66 Score=494.81 Aligned_cols=264 Identities=39% Similarity=0.656 Sum_probs=225.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.... ...+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 578999999999999999999999999999999999865432 234678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||||+||+|++++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998765544445
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHH-HHHhhcccccccccccchhhhccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA-LYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
...+.+||+.|+|||++.+..|++.++||||+||++|+|++|.+||...+... .+....
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-------------------- 220 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------------------- 220 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--------------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------------
Confidence 56678999999999999988887789999999999999999999997654221 111110
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
........+..+|+++.+||.+||+.||++|||++|+|+||||++..
T Consensus 221 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 221 ----EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp ----TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ----cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 00111122234799999999999999999999999999999998644
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-65 Score=489.35 Aligned_cols=261 Identities=31% Similarity=0.610 Sum_probs=231.3
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
+-++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 44789999999999999999999999999999999987665555556789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.........
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998765544444
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
...+.+||+.|+|||++.+..| +.++||||+||+||+|++|..||.+.+..+++.+
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~----------------------- 221 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----------------------- 221 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------------------
T ss_pred ccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH-----------------------
Confidence 5567899999999999998877 5899999999999999999999999888887776
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH------HhcCccccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ------MLEDEWFKK 298 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~e------il~hpwf~~ 298 (468)
+.+..+.+|..+|+++++||++||+.||++|||++| +++||||+.
T Consensus 222 ---i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 222 ---IIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp ---HHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ---HHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 334556677889999999999999999999999998 577888864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-64 Score=491.06 Aligned_cols=260 Identities=32% Similarity=0.629 Sum_probs=237.9
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 35789999999999999999999999999999999998776555445678899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 90 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
+|||||+||+|++++...+.++|+.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999985432 23
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
....+.|||+.|+|||++.+.+| +.++|||||||++|+|++|.+||.+.+..++++.
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---------------------- 216 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---------------------- 216 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----------------------
T ss_pred cccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH----------------------
Confidence 34567899999999999999888 5899999999999999999999999998888776
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
+....+.+|..+|+++++||++||++||.+|++ ++|+++||||+.
T Consensus 217 ----i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 217 ----ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp ----HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ----HhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 444566778889999999999999999999994 999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-63 Score=478.12 Aligned_cols=257 Identities=28% Similarity=0.496 Sum_probs=225.5
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
-++|++.+.||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+|+.++|||||++++++.+.+.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 357999999999999999999999999999999997654332 46788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~ 172 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK 172 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCC
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--cccc
Confidence 999999999998765 5799999999999999999999999999999999999999999999999999986543 2234
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
....+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--------------------- 230 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--------------------- 230 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---------------------
T ss_pred ccccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh---------------------
Confidence 556789999999999998877 5899999999999999999999988776655444321
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.....+..|+.+|+++++||.+||++||++|||++|+|+||||+.
T Consensus 231 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 231 --NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp --HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred --CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 111233456678999999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-62 Score=477.73 Aligned_cols=256 Identities=34% Similarity=0.719 Sum_probs=234.6
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
.+.+|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 35789999999999999999999999999999999987655444456788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||||+||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----- 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 156 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999986432
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
...+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+.+.+
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----------------------- 212 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----------------------- 212 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----------------------
T ss_pred ccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHH-----------------------
Confidence 34568999999999999988875 899999999999999999999999988877776
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
+..+....|+.+|+++.+||.+||..||.+|+ |++++++||||++
T Consensus 213 ---i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 213 ---ILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp ---HHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred ---HHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 34455677888999999999999999999996 9999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-62 Score=466.28 Aligned_cols=257 Identities=30% Similarity=0.542 Sum_probs=213.8
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe--CCEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS--KTKI 88 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 88 (468)
+.++|++.+.||+|+||+||+|+++.+|+.||+|++...... ....+.+.+|+.+|+.++|||||++++++.+ .+.+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 468899999999999999999999999999999999876543 3346778999999999999999999999864 4668
Q ss_pred EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCCeeeccCCceEEecccc
Q 012228 89 YIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~~l~yLH~~g-----ivHrDlKp~NILl~~~g~lkl~DFGl 159 (468)
|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999998864 457999999999999999999999976 99999999999999999999999999
Q ss_pred chhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccccc
Q 012228 160 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 160 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (468)
|+.... ......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..++...+..
T Consensus 161 a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~--------- 228 (269)
T d2java1 161 ARILNH--DTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--------- 228 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---------
T ss_pred eeeccc--CCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc---------
Confidence 987543 2233456889999999999988877 5899999999999999999999999888877766421
Q ss_pred chhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 012228 240 SYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 296 (468)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf 296 (468)
......|..+|+++.+||.+||+.||++|||++|+++|||+
T Consensus 229 ----------------~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 229 ----------------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ----------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----------------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 11123456689999999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-62 Score=471.77 Aligned_cols=257 Identities=31% Similarity=0.502 Sum_probs=221.2
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
+.|++++.||+|+||+||+|+++.+|+.||+|++++... ...+.+.+|+++|+.++|||||++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 469999999999999999999999999999999976432 23467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...... ..
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence 99999999998765 4569999999999999999999999999999999999999999999999999997543321 12
Q ss_pred ccccCCCCCcCCccccc-----cCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 172 LHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~-----~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
..+.+||+.|+|||++. +..| +.++||||+||++|+|++|.+||.+.+..+.+..+...
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~--------------- 230 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS--------------- 230 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS---------------
T ss_pred ccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---------------
Confidence 45678999999999984 3334 58999999999999999999999887766555543211
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
....+..|..+|+++.+||.+||+.||++|||++|+++||||+.
T Consensus 231 --------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 231 --------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 11123345568999999999999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-62 Score=473.09 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=225.2
Q ss_pred CeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEE
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLE 93 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 93 (468)
.|++.+.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999987665555567789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCccc
Q 012228 94 FIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 173 (468)
Q Consensus 94 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 173 (468)
||.||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 999999988888888999999999999999999999999999999999999999999999999999975432 34
Q ss_pred ccCCCCCcCCccccccC--CCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccccc
Q 012228 174 TACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYT 251 (468)
Q Consensus 174 ~~~gt~~y~APEvl~~~--~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (468)
..+||+.|+|||++.+. +.++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~-------------------- 229 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------------------- 229 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--------------------
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--------------------
Confidence 67899999999998643 23468999999999999999999999887766655543210
Q ss_pred cccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 252 LQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 252 ~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
......+..+|+++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 230 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 230 ----ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp ----CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 011122345799999999999999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-62 Score=474.97 Aligned_cols=261 Identities=36% Similarity=0.670 Sum_probs=211.4
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..+.|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3467999999999999999999999999999999998765432 34568899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec---cCCceEEeccccchhhhhhh
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~---~~g~lkl~DFGla~~~~~~~ 167 (468)
|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+. .+|.+||+|||+|+....
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~-- 162 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-- 162 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC--
Confidence 999999999999999989999999999999999999999999999999999999994 578999999999986433
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.....+.+||+.|+|||++.+..| +.++||||+||+||+|++|.+||.+.+..+....+....
T Consensus 163 -~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--------------- 225 (307)
T d1a06a_ 163 -GSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE--------------- 225 (307)
T ss_dssp -----------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC---------------
T ss_pred -CCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC---------------
Confidence 334567889999999999998877 589999999999999999999999988777766643210
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.......++.+|+++.+||.+||+.||++|||++|+++||||+..
T Consensus 226 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 226 -------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 111122345589999999999999999999999999999999853
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-62 Score=479.51 Aligned_cols=258 Identities=33% Similarity=0.675 Sum_probs=235.4
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
...+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 34578999999999999999999999999999999999876655545567889999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
|+||||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999986432
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--------------------- 249 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK--------------------- 249 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------------------
T ss_pred --ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHH---------------------
Confidence 24567899999999999988874 899999999999999999999999888877776
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
+....+..|..+|+++.+||++||++||.+|+ |++++++||||+.
T Consensus 250 -----i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 250 -----IVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp -----HHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred -----HhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 34455667788999999999999999999995 9999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-61 Score=458.44 Aligned_cols=256 Identities=25% Similarity=0.477 Sum_probs=218.3
Q ss_pred cccCe-EEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe----C
Q 012228 11 RVGKY-ELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----K 85 (468)
Q Consensus 11 ~~~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~ 85 (468)
.-++| ++.+.||+|+||+||+|++..++..||+|++...... ....+.+.+|+++|+.++|||||++++++.+ .
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 34566 7888999999999999999999999999999765543 3346788999999999999999999999865 4
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeec-cCCceEEeccccchh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLD-SYGVLKISDFGLSAI 162 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~g--ivHrDlKp~NILl~-~~g~lkl~DFGla~~ 162 (468)
..+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+.
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 568999999999999999999899999999999999999999999999 99999999999997 579999999999975
Q ss_pred hhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc-hHHHHHHhhcccccccccccch
Q 012228 163 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 163 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
.. .....+.+||+.|+|||++.+ +| +.++||||+||++|+|++|..||.+. +...+++.+...
T Consensus 165 ~~----~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~---------- 228 (270)
T d1t4ha_ 165 KR----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG---------- 228 (270)
T ss_dssp CC----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT----------
T ss_pred cc----CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC----------
Confidence 33 233457799999999999875 45 59999999999999999999999764 444555543211
Q ss_pred hhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 242 KKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
......+...++++.+||.+||++||++|||++|+|+||||+
T Consensus 229 --------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 229 --------------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp --------------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred --------------CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 011123344789999999999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-62 Score=477.12 Aligned_cols=279 Identities=24% Similarity=0.382 Sum_probs=219.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
-++|++++.||+|+||+||+|++..+|+.||+|++++.. .....+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997643 223456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+.....
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---- 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 158 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----
Confidence 9999999999999998999999999999999999999997 59999999999999999999999999999865432
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccc----------cc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYG----------ES 240 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----------~~ 240 (468)
...+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||.+.+..+....... ....... ..
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC-QVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred ccccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-HhcCCcccCCccccccccc
Confidence 2346799999999999998887 5899999999999999999999987653322111100 0000000 00
Q ss_pred hhh-hccccc------cccccc-cccCCCCC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 241 YKK-CTNKYS------YTLQIC-RADFSCPS-WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 241 ~~~-~~~~~~------~~~~~~-~~~~~~~~-~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
... ...... ....+. ......+. .+|.++++||.+||+.||.+|||++|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000 000000 000000 11111222 26899999999999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-61 Score=475.77 Aligned_cols=264 Identities=33% Similarity=0.602 Sum_probs=228.7
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 467899999999999999999999999999999999976532 23567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec--cCCceEEeccccchhhhhh
Q 012228 90 IVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~--~~g~lkl~DFGla~~~~~~ 166 (468)
+|||||+||+|++++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .+|.+||+|||+|+....
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~- 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc-
Confidence 99999999999999854 45799999999999999999999999999999999999996 468899999999986543
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 179 --~~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------------- 242 (350)
T d1koaa2 179 --KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------------- 242 (350)
T ss_dssp --TSCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------------
T ss_pred --ccccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------
Confidence 334567899999999999998887 4899999999999999999999999888877776432110
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
......++.+|+++++||.+||+.||++|||++|+|+||||+....+
T Consensus 243 ---------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 243 ---------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp ---------CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred ---------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 00111223479999999999999999999999999999999876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-61 Score=471.36 Aligned_cols=258 Identities=31% Similarity=0.588 Sum_probs=231.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHh-cCCCCCeeEEEEEEEeCCEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l 90 (468)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++. .++|||||++++++.+++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999998765544444566667777765 6899999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 91 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999975433 223
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
.....+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+++..+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i---------------------- 215 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---------------------- 215 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----------------------
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH----------------------
Confidence 44567899999999999988875 8999999999999999999999999888877763
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH-HHhcCccccc
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS-QMLEDEWFKK 298 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~-eil~hpwf~~ 298 (468)
....+.+|..+|+++.+||++||+.||.+|||+. ++++||||++
T Consensus 216 ----~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 216 ----RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp ----HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred ----HcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 3445667888999999999999999999999996 8999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-61 Score=463.97 Aligned_cols=262 Identities=37% Similarity=0.590 Sum_probs=227.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhH---HHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRH---KMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
.-++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 44679999999999999999999999999999999976543221 135678999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC----ceEEeccccchhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGLSAIS 163 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g----~lkl~DFGla~~~ 163 (468)
+|+|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+| .+||+|||+|...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999999989999999999999999999999999999999999999998776 5999999999765
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
.. .....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+.+..+.....
T Consensus 168 ~~---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---------- 233 (293)
T d1jksa_ 168 DF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY---------- 233 (293)
T ss_dssp TT---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC----------
T ss_pred CC---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------
Confidence 43 234556789999999999988766 5999999999999999999999999888777766432100
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
......++.+|+++++||++||+.||++|||++|+++||||+.
T Consensus 234 ------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 234 ------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp ------------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred ------------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0011122457999999999999999999999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6e-61 Score=473.39 Aligned_cols=262 Identities=30% Similarity=0.542 Sum_probs=228.1
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
...++|++++.||+|+||+||+|++..+|+.||||++.+.... ..+.+.+|+.+|+.|+|||||++++++.+++.+|
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3567899999999999999999999999999999999765422 2457889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec--cCCceEEeccccchhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~--~~g~lkl~DFGla~~~~~~ 166 (468)
+|||||+||+|++.+...+ ++++.+++.++.||+.||+|||++||+||||||+|||++ .+|.+||+|||+|+....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~- 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC-
Confidence 9999999999999876654 699999999999999999999999999999999999998 678999999999986543
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------------- 244 (352)
T d1koba_ 182 --DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD-------------- 244 (352)
T ss_dssp --TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC--------------
T ss_pred --CCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------
Confidence 344567899999999999998877 589999999999999999999999988877776643210
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.......++.+|+++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 245 --------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 245 --------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp --------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred --------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 0111123345899999999999999999999999999999998643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.1e-61 Score=476.26 Aligned_cols=258 Identities=26% Similarity=0.468 Sum_probs=223.3
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHH---HHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVE---QIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~---~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.......... ...+|+.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 467899999999999999999999999999999999866543322222 33445778888899999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|+|||||+||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999986533
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHH---HHHHhhcccccccccccchhhh
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---ALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
......+||+.|+|||++.+...++.++|||||||+||+|++|..||.+.+.. .+...
T Consensus 160 --~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~----------------- 220 (364)
T d1omwa3 160 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----------------- 220 (364)
T ss_dssp --SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-----------------
T ss_pred --CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------------
Confidence 23456789999999999976555569999999999999999999999865422 22222
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCccccc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 298 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t-----~~eil~hpwf~~ 298 (468)
+.......|..+|+++.+||.+||+.||++||| ++|+++||||+.
T Consensus 221 ---------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 221 ---------TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp ---------SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred ---------cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 334455667789999999999999999999999 799999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-60 Score=453.97 Aligned_cols=261 Identities=30% Similarity=0.516 Sum_probs=225.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhh------HHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeC
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR------HKMVEQIKREISTMKLIK-HPNVIKIIEVMASK 85 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~ 85 (468)
++|++.+.||+|+||+||+|++..+|+.||||++.+..... ....+.+.+|+.+|+.++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999999999999999997654321 234567889999999997 99999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
+.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999986543
Q ss_pred hhcCCcccccCCCCCcCCcccccc-----CCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc
Q 012228 166 VREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES 240 (468)
Q Consensus 166 ~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (468)
.......+||+.|+|||++.+ ...++.++||||+||+||+|++|..||.+.+.....+.+....
T Consensus 163 ---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~-------- 231 (277)
T d1phka_ 163 ---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-------- 231 (277)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------
T ss_pred ---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC--------
Confidence 233456789999999999863 2334689999999999999999999999988777766643210
Q ss_pred hhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 241 YKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.......++.+|+++++||.+||++||.+|||++|+|+||||++
T Consensus 232 --------------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 232 --------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp --------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred --------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 00011122348999999999999999999999999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-60 Score=462.69 Aligned_cols=255 Identities=27% Similarity=0.489 Sum_probs=225.2
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 90 (468)
..++|++++.||+|+||+||+|+++.+|+.||||++++... ....+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999999999999999999986542 23457899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC--CceEEeccccchhhhhhh
Q 012228 91 VLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY--GVLKISDFGLSAISQQVR 167 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~--g~lkl~DFGla~~~~~~~ 167 (468)
|||||+||+|++++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence 999999999999998765 69999999999999999999999999999999999999854 5899999999875432
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+.+..+..
T Consensus 157 -~~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~----------------- 217 (321)
T d1tkia_ 157 -GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN----------------- 217 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----------------
T ss_pred -CCcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------------
Confidence 334566789999999999988777 5899999999999999999999999888877776432
Q ss_pred cccccccccccCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 248 YSYTLQICRADFSCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~----~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
..+.++ +.+|+++++||.+||+.||++|||++|+++||||++.
T Consensus 218 ---------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 218 ---------AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ---------TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ---------CCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 222222 3479999999999999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-60 Score=459.51 Aligned_cols=283 Identities=26% Similarity=0.345 Sum_probs=220.0
Q ss_pred EEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhh--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEc
Q 012228 17 LGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLR--HKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEF 94 (468)
Q Consensus 17 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 94 (468)
.++.||+|+||+||+|+++.+|+.||||+++...... ....+.+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999999999999999997654322 12245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCcccc
Q 012228 95 IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT 174 (468)
Q Consensus 95 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 174 (468)
|.|+++..+......+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ......+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Ccccccc
Confidence 99988887777777899999999999999999999999999999999999999999999999999976543 2234456
Q ss_pred cCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccc
Q 012228 175 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254 (468)
Q Consensus 175 ~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (468)
.+||+.|+|||++.+..+++.++||||+||++|+|++|.+||.+.+..+...++........ ...+.............
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-TTTSSSTTSSTTCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCC-hhhccchhccchhhhhc
Confidence 78999999999998766667999999999999999999999998887776665532110000 00000000000000000
Q ss_pred cccc---CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 255 CRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 255 ~~~~---~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
.... ....+.+++++.+||.+||+.||++|||++|+|+||||++...|
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 0000 01123478999999999999999999999999999999875443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-60 Score=456.47 Aligned_cols=254 Identities=31% Similarity=0.542 Sum_probs=221.6
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHH---HHHHHHHHHHHHhcCC--CCCeeEEEEEEEeC
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHK---MVEQIKREISTMKLIK--HPNVIKIIEVMASK 85 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~~ 85 (468)
.-++|++++.||+|+||+||+|++..+|+.||||++.+....... ....+.+|+.+|+.++ |||||++++++.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 457899999999999999999999999999999999765432211 1234668999999997 89999999999999
Q ss_pred CEEEEEEEccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-CCceEEeccccchhh
Q 012228 86 TKIYIVLEFIDG-GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAIS 163 (468)
Q Consensus 86 ~~~~lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~-~g~lkl~DFGla~~~ 163 (468)
+.+|+||||+.+ +++.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999976 688899998899999999999999999999999999999999999999985 579999999999754
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
. .....+.+||+.|+|||++.+..+++.++||||+||++|+|++|..||...+.
T Consensus 162 ~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------------------- 215 (273)
T d1xwsa_ 162 K----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------------------- 215 (273)
T ss_dssp C----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------------
T ss_pred c----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----------------------
Confidence 3 23455788999999999999888877889999999999999999999986431
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
+......+++.+|+++.+||++||+.||++|||++|+++||||++..
T Consensus 216 ----------i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 216 ----------IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ----------HHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ----------HhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 22234456677999999999999999999999999999999998643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-59 Score=451.01 Aligned_cols=286 Identities=26% Similarity=0.405 Sum_probs=222.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|++++.||+|+||+||+|.+..+|+.||||++..... .....+.+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 4789999999999999999999999999999999976542 223456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||.++.+..... ...++++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.... ...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Ccc
Confidence 99998754433333 345699999999999999999999999999999999999999999999999999986533 233
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccc-hhhhccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGES-YKKCTNKYS 249 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 249 (468)
.....+||+.|+|||++....+++.++||||+||++|+|++|..||.+.+..+....+...... .... +........
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPD 235 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC--CCTTTSTTGGGSTT
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC--Cchhhccccccccc
Confidence 4556789999999999988888889999999999999999999999988766554443211100 0000 000000000
Q ss_pred ccc---c-cccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 250 YTL---Q-ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 250 ~~~---~-~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
... . .........+.+|+++.+||++||+.||++|||++|+|+||||++-..|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 000 0 0000001122478999999999999999999999999999999876554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-59 Score=456.77 Aligned_cols=259 Identities=34% Similarity=0.611 Sum_probs=214.3
Q ss_pred CccccCeEEEe-eeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHh-cCCCCCeeEEEEEEEe--
Q 012228 9 RTRVGKYELGR-TLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMK-LIKHPNVIKIIEVMAS-- 84 (468)
Q Consensus 9 ~~~~~~y~i~~-~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~-~l~hpnIv~l~~~~~~-- 84 (468)
...+++|++.+ .||+|+||+||+|++..+|+.||||+++.. ..+.+|+.++. .++|||||+++++|.+
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 34678999875 699999999999999999999999999643 24568999865 4589999999999976
Q ss_pred --CCEEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc---CCceEEecc
Q 012228 85 --KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDF 157 (468)
Q Consensus 85 --~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~---~g~lkl~DF 157 (468)
.+.+|+|||||+||+|++++... ..+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 46799999999999999999874 36999999999999999999999999999999999999985 567999999
Q ss_pred ccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccc
Q 012228 158 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVY 237 (468)
Q Consensus 158 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 237 (468)
|+|+.... .....+.+||+.|+|||++.+..|+ .++|||||||+||+|++|.+||.+.+.......+..
T Consensus 159 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~------- 227 (335)
T d2ozaa1 159 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------- 227 (335)
T ss_dssp TTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred ceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH-------
Confidence 99986543 3345678999999999999988875 899999999999999999999977653322221110
Q ss_pred ccchhhhccccccccccccccCCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 238 GESYKKCTNKYSYTLQICRADFSCPS----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
.+....+.+|. .+|+++.+||++||+.||++|||++|+++||||++...
T Consensus 228 ---------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 228 ---------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp ---------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred ---------------HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 02233333332 37999999999999999999999999999999986543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.4e-58 Score=442.28 Aligned_cols=282 Identities=28% Similarity=0.395 Sum_probs=222.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|++.+.||+|+||+||+|+++ +|+.||||++...... ....+.+.+|+.+|+.++|||||++++++.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 479999999999999999999995 8899999999765432 23356788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccc
Confidence 999998888888777888999999999999999999999999999999999999999999999999999865432 222
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhccccc--
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS-- 249 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 249 (468)
.....|++.|+|||++.+..+++.++||||+||++|+|++|.+||.+.+..+...++....... ....+........
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP-NSKNWPNVTELPKYD 235 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGSTTCC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC-Chhhccchhhhhhcc
Confidence 3456799999999999888777899999999999999999999999887666555543211000 0000000000000
Q ss_pred --cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 250 --YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 250 --~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
............++.+++++.+||++||++||++|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0000011112234557899999999999999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=431.33 Aligned_cols=285 Identities=27% Similarity=0.400 Sum_probs=229.7
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
+++|++++.||+|+||+||+|++..+|+.||||+++.... .....+++.+|+.+|+.++||||+++++++.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4789999999999999999999999999999999976543 334577899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 92 LEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
+|++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|...... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--CSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC--Ccc
Confidence 999999999999998899999999999999999999999999999999999999999999999999999865432 223
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCC-CCchHHHHHHhhcccccccccc--cchhhhcccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKVSTFHFLSVYG--ESYKKCTNKY 248 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 248 (468)
.....+++.|+|||++.+..+.+.++||||+||++|+|++|..|| .+.+..+...++.......... ..........
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 344567889999999988877789999999999999999999885 5555555555543221110000 0000000000
Q ss_pred cc-ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 249 SY-TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 249 ~~-~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.. ...........++.+++.+.+||++||++||.+|||++|+|+||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 00 0011122333445689999999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.2e-57 Score=433.39 Aligned_cols=265 Identities=23% Similarity=0.422 Sum_probs=216.6
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC---
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT--- 86 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--- 86 (468)
..-++|++.+.||+|+||+||+|++..+|+.||||++.+....+....+.+.+|+.+|+.++||||+++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 45578999999999999999999999999999999998766655666778999999999999999999999997654
Q ss_pred -EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhh
Q 012228 87 -KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 165 (468)
Q Consensus 87 -~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~ 165 (468)
.+|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++..+|+|||.+.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 4899999999999999999999999999999999999999999999999999999999999999999999999865433
Q ss_pred hh-cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 166 VR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 166 ~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
.. ......+.+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+..+...++....
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~------------ 230 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED------------ 230 (277)
T ss_dssp ---------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC------------
T ss_pred ccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcC------------
Confidence 22 22344567899999999999887774 89999999999999999999999888776655432110
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 297 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~ 297 (468)
.......++.+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 231 ----------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 ----------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0011123345899999999999999999999555556677765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=441.40 Aligned_cols=290 Identities=26% Similarity=0.341 Sum_probs=220.0
Q ss_pred ccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-----
Q 012228 10 TRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS----- 84 (468)
Q Consensus 10 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----- 84 (468)
..+++|+++++||+|+||+||+|++..+|+.||||++.+.... ......+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 3579999999999999999999999999999999998765432 2235667899999999999999999998854
Q ss_pred ---CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 85 ---KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 85 ---~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
.+.+|+|||||.++.+.........+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 45689999999987777666667789999999999999999999999999999999999999999999999999997
Q ss_pred hhhhhh--cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhccccccccccc
Q 012228 162 ISQQVR--EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGE 239 (468)
Q Consensus 162 ~~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (468)
...... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+.......+....... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~ 244 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI-TPE 244 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC-Chh
Confidence 554322 22334557899999999999877656799999999999999999999999887766655543221110 000
Q ss_pred chhhhcccccc-ccccc-cccCCCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 240 SYKKCTNKYSY-TLQIC-RADFSCP-----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 240 ~~~~~~~~~~~-~~~~~-~~~~~~~-----~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
........... ..... ......+ ...++++++||.+||++||++|||++|+|+||||+..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence 00000000000 00000 0000000 013778999999999999999999999999999996543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-57 Score=438.22 Aligned_cols=281 Identities=27% Similarity=0.395 Sum_probs=216.2
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCC-CCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC---CCCCeeEEEEEEEe---
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVET-GDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI---KHPNVIKIIEVMAS--- 84 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~--- 84 (468)
.++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999999765 6779999997643221 1223456788877766 79999999999853
Q ss_pred --CCEEEEEEEccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccch
Q 012228 85 --KTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 85 --~~~~~lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
...+|++||||+++.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 357899999999977654443 34569999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
.... .......+||+.|+|||++.+..| +.++||||+||++|+|++|.+||.+.+..+....+....... ....+
T Consensus 165 ~~~~---~~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~ 239 (305)
T d1blxa_ 165 IYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP-GEEDW 239 (305)
T ss_dssp CCCG---GGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CGGGS
T ss_pred hhcc---cccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC-chhcc
Confidence 5433 223567889999999999998888 489999999999999999999999988776665543211000 00000
Q ss_pred hhhc--cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 242 KKCT--NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 242 ~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
.... ................+..+++.+.+||++||++||++|||++|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0000 00000000111122344558999999999999999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-56 Score=438.20 Aligned_cols=278 Identities=26% Similarity=0.334 Sum_probs=214.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe------C
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------K 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------~ 85 (468)
--+|+.+++||+|+||+||+|++..+|+.||||++.++... ..+|+.+|+.++||||+++++++.. .
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 34699999999999999999999999999999999765422 2479999999999999999999843 3
Q ss_pred CEEEEEEEccCCCCHH---HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC-ceEEeccccch
Q 012228 86 TKIYIVLEFIDGGELF---DKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSA 161 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~---~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g-~lkl~DFGla~ 161 (468)
.++|||||||++|.+. ........+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 4589999999876332 2334556799999999999999999999999999999999999999775 89999999987
Q ss_pred hhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch
Q 012228 162 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY 241 (468)
Q Consensus 162 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (468)
.... .....+.+||+.|+|||++.+..+++.++||||+||++|+|++|..||...+..+.+..+...... .....+
T Consensus 172 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~-~~~~~~ 247 (350)
T d1q5ka_ 172 QLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT-PTREQI 247 (350)
T ss_dssp ECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC-CCHHHH
T ss_pred hccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC-ChHHhh
Confidence 6533 234556789999999999887666679999999999999999999999988766665554321000 000000
Q ss_pred hhhcccccc-cc-ccc--cccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 242 KKCTNKYSY-TL-QIC--RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 242 ~~~~~~~~~-~~-~~~--~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
......... .. ... ...-...+..++++.+||.+||+.||++|||++|+|+||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000000000 00 000 000112345799999999999999999999999999999998643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=437.93 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=213.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCC-----EEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCC
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGD-----FVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKT 86 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~ 86 (468)
++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+++ +|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 579999999999999999999876554 69999986543 223456788999999988 8999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 012228 87 KIYIVLEFIDGGELFDKIAKHG-----------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 143 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~N 143 (468)
.+|+|||||+||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 9999999999999999997643 48999999999999999999999999999999999
Q ss_pred eeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHH
Q 012228 144 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLM 222 (468)
Q Consensus 144 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~ 222 (468)
||++.++++||+|||+|+............+.+||+.|+|||++.+..| +.++||||+||+||+|++ |.+||.+.+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987655433334456778999999999988777 589999999999999997 89999876543
Q ss_pred HHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 223 ALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
+...++. .....+..|..+|+++.+||.+||+.||++|||++||++|
T Consensus 274 ~~~~~~~------------------------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLI------------------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHH------------------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHH------------------------hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3333221 1122345677899999999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=428.10 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=204.2
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
-++|++++.||+|+||+||+|+.. ..||||+++...... ...+.+.+|+.+|++++|||||+++++.. .+.+|+|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence 467999999999999999999853 369999997654332 34678899999999999999999999864 4568999
Q ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 92 LEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
||||+||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999999999754 569999999999999999999999999999999999999999999999999998765544444
Q ss_pred cccccCCCCCcCCccccccCC--CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHH-HHhhcccccccccccchhhhccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESNLMAL-YRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~--~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
...+.+||+.|+|||++.+.. .++.++||||+||+||+|++|..||.+.+.... ...+....
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~--------------- 226 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY--------------- 226 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS---------------
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC---------------
Confidence 556778999999999986432 236899999999999999999999987654333 22211100
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
........+..+|+++.+||.+||+.||++|||++|+++|
T Consensus 227 ------~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 227 ------LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ------CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0001112355689999999999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=435.88 Aligned_cols=286 Identities=26% Similarity=0.381 Sum_probs=217.7
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC-----E
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT-----K 87 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-----~ 87 (468)
.+|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.+|+.++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997643 3345678889999999999999999999996653 3
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+|++ +|+.||+|++++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 86 ~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 5555 55668899999975 579999999999999999999999999999999999999999999999999998654432
Q ss_pred c-CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccch----h
Q 012228 168 E-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESY----K 242 (468)
Q Consensus 168 ~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----~ 242 (468)
. .......+||+.|+|||++....+++.++||||+||++|+|++|..||.+.+..+.................. .
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2 2345667899999999999776666799999999999999999999999877655544432111100000000 0
Q ss_pred hhccccccccccccc-cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCCC
Q 012228 243 KCTNKYSYTLQICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 302 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 302 (468)
............... .....+.+|+++++||.+||+.||.+|||++|+|+||||+....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 000000000000000 001233478999999999999999999999999999999876543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-56 Score=437.93 Aligned_cols=279 Identities=25% Similarity=0.360 Sum_probs=216.4
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC----
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT---- 86 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~---- 86 (468)
.-++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 34789999999999999999999999999999999976533 4445678899999999999999999999997654
Q ss_pred --EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 87 --KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 87 --~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
.+|+||||| |++|...+. .+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 579999999 556666654 5789999999999999999999999999999999999999999999999999997543
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
...+..+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+.......+...... ........
T Consensus 173 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~ 245 (346)
T d1cm8a_ 173 -----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT--PPAEFVQR 245 (346)
T ss_dssp -----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC--CCHHHHHT
T ss_pred -----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC--CcHHHHhh
Confidence 23456789999999999988777789999999999999999999999988766555443321110 00000000
Q ss_pred cc------cccccccccc-ccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccC
Q 012228 245 TN------KYSYTLQICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 299 (468)
Q Consensus 245 ~~------~~~~~~~~~~-~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~ 299 (468)
.. .......... ......+.+++++.+||++||..||++|||++|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00 0000000001 1112334579999999999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-56 Score=427.36 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=205.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCC---EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGD---FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
.+.|++.+.||+|+||+||+|+++.+++ .||||.+.... .....+.+.+|+.+|++++|||||++++++.+++.+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 5789999999999999999999987665 58899886543 233456789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|+|||||++|+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999988774 469999999999999999999999999999999999999999999999999998764422
Q ss_pred cCCc---ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhh
Q 012228 168 EDGL---LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKK 243 (468)
Q Consensus 168 ~~~~---~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (468)
.... .....||+.|+|||++.+..| +.++|||||||+||||++ |..||.+.+..+....+..
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~------------- 248 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ------------- 248 (299)
T ss_dssp -------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------------
T ss_pred CcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------------
Confidence 2111 122457999999999988777 489999999999999998 8999998887777666421
Q ss_pred hccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 244 CTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
....+.|..+|+++.+|+.+||+.||++|||+.|++++
T Consensus 249 ------------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 249 ------------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ------------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 22344566789999999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=425.87 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=209.2
Q ss_pred eeeeecCCeEEEEEEEc--CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEEEccC
Q 012228 19 RTLGEGSFAKVKFAKNV--ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVLEFID 96 (468)
Q Consensus 19 ~~LG~G~~g~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 96 (468)
+.||+|+||+||+|.+. .+++.||||++..... .....+.+.+|+.+|++++|||||++++++.++ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 47999999999999864 4567899999975432 334567899999999999999999999998654 5789999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc-CCccccc
Q 012228 97 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE-DGLLHTA 175 (468)
Q Consensus 97 gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~-~~~~~~~ 175 (468)
+|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....... .......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 999999999989999999999999999999999999999999999999999999999999999986543221 1122345
Q ss_pred CCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccccccc
Q 012228 176 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSYTLQI 254 (468)
Q Consensus 176 ~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (468)
.||+.|+|||++.+..| +.++||||+||++|+|++ |..||.+.+..+....+.
T Consensus 171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~------------------------- 224 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE------------------------- 224 (277)
T ss_dssp CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------------------------
T ss_pred CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-------------------------
Confidence 79999999999988776 589999999999999997 899999888777666542
Q ss_pred ccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH---hcCcccc
Q 012228 255 CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQM---LEDEWFK 297 (468)
Q Consensus 255 ~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~ei---l~hpwf~ 297 (468)
.......|..+|+++.+||.+||+.||++|||++++ |+|+|+.
T Consensus 225 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 225 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 122345677789999999999999999999999998 4566653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-56 Score=428.24 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=214.1
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++++.||+|+||+||+|+++.+|+.||||+++.+... .+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 35799999999999999999999999999999999765322 45688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++++||+|||+|+..... ..
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~ 170 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TY 170 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC-Cc
Confidence 9999999999998764 46899999999999999999999999999999999999999999999999999865431 11
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCC-CCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFL-PFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~-Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
.......||+.|+|||++.+..| +.++||||+||++|+|++|.. ||.+.+...+.+.+.
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~------------------- 230 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------------------- 230 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------------------
T ss_pred eeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh-------------------
Confidence 12233458899999999988877 589999999999999999655 556666666555432
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.......|..+|+++.+||.+||+.||++|||++|+++
T Consensus 231 ------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 231 ------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 12234566778999999999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-56 Score=419.67 Aligned_cols=249 Identities=23% Similarity=0.405 Sum_probs=205.5
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|++++.||+|+||+||+|++. +++.||||+++..... .+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 47999999999999999999985 5778999999765432 256889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
|||++|+|.+++... ..++++.+..++.|++.||+|||++||+||||||+|||++.++++||+|||+|+....... ..
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 999999999988755 4689999999999999999999999999999999999999999999999999986543221 22
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
.....||+.|+|||++.+..| +.++||||+||++|+|++ |.+||...+..++...+..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-------------------- 217 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-------------------- 217 (263)
T ss_dssp ------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH--------------------
T ss_pred ecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh--------------------
Confidence 334679999999999998887 489999999999999998 6777887777776665421
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......|..+++++.+|+.+||+.||++|||++|+++|
T Consensus 218 -----~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 218 -----GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----cCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 12334566689999999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=436.66 Aligned_cols=267 Identities=30% Similarity=0.557 Sum_probs=223.4
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEc---CCCCEEEEEEeechhhhh-HHHHHHHHHHHHHHhcCCC-CCeeEEEEEEE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNV---ETGDFVAIKIVDRDQVLR-HKMVEQIKREISTMKLIKH-PNVIKIIEVMA 83 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~ 83 (468)
...+++|++++.||+|+||+||+|.+. .+|+.||||++++..... ....+.+.+|+.+|++++| |||+++++++.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 345788999999999999999999974 478999999997654321 2234567899999999976 89999999999
Q ss_pred eCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhh
Q 012228 84 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 163 (468)
Q Consensus 84 ~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~ 163 (468)
+...+|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhcCCcccccCCCCCcCCccccccCC-CCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchh
Q 012228 164 QQVREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 164 ~~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
... ......+.+|++.|+|||.+.+.. +++.++|||||||+||+|++|..||.+.+..+....+...
T Consensus 180 ~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~----------- 247 (322)
T d1vzoa_ 180 VAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR----------- 247 (322)
T ss_dssp CGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH-----------
T ss_pred ccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-----------
Confidence 432 223345678999999999997654 4568999999999999999999999775432222211100
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCccccc
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 298 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~-----t~~eil~hpwf~~ 298 (468)
........|..+|+++.+||.+||++||.+|| |++|+++||||+.
T Consensus 248 -----------~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 248 -----------ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp -----------HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred -----------cccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 12334456677999999999999999999999 5899999999974
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=423.32 Aligned_cols=256 Identities=21% Similarity=0.334 Sum_probs=216.2
Q ss_pred cCeEEEee-eeecCCeEEEEEEEcC--CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 13 GKYELGRT-LGEGSFAKVKFAKNVE--TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 13 ~~y~i~~~-LG~G~~g~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
++|.+.+. ||+|+||+||+|.++. ++..||||+++... .....+.+.+|+.+|+.++|||||++++++.+ +.+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 56888885 9999999999998764 44579999997543 23346788999999999999999999999865 4589
Q ss_pred EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+|||||+||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 999999999999987654 5799999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 169 -DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 169 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.......+||+.|+|||++.+..| +.++||||+||++|||+| |..||.+.+..+....+.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~----------------- 226 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE----------------- 226 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-----------------
T ss_pred ccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-----------------
Confidence 122345679999999999987777 589999999999999998 999999877666665542
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH---hcCcccc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQM---LEDEWFK 297 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~ei---l~hpwf~ 297 (468)
.......|+.+|+++.+||.+||+.||++|||+.+| |+|+|+.
T Consensus 227 --------~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 227 --------QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 122345677899999999999999999999999888 6788875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-56 Score=422.74 Aligned_cols=253 Identities=22% Similarity=0.376 Sum_probs=214.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
++|++++.||+|+||+||+|.++ ++..||||+++..... .+.+.+|+.+|++++|||||++++++.+ +.+|+||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 68999999999999999999985 6788999999764432 3568899999999999999999998754 5679999
Q ss_pred EccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCC
Q 012228 93 EFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDG 170 (468)
Q Consensus 93 E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 170 (468)
|||++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~ 165 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT 165 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence 9999999999765433 59999999999999999999999999999999999999999999999999998654321 12
Q ss_pred cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccccc
Q 012228 171 LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYS 249 (468)
Q Consensus 171 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (468)
......||+.|+|||++.+..| +.++||||+||++|+|+| |.+||...+..+..+.+.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-------------------- 224 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------------------- 224 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH--------------------
T ss_pred cccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------------------
Confidence 2345679999999999987777 589999999999999999 566677777766666542
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc--Cccccc
Q 012228 250 YTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE--DEWFKK 298 (468)
Q Consensus 250 ~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~--hpwf~~ 298 (468)
.......|..+|+++.+|+.+||+.||++|||++++++ |+||+.
T Consensus 225 -----~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 225 -----RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----hcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 12234456779999999999999999999999999998 899864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.9e-55 Score=428.44 Aligned_cols=276 Identities=23% Similarity=0.397 Sum_probs=211.9
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeC--CE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASK--TK 87 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~--~~ 87 (468)
..++|++++.||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|+.++ ||||+++++++... ..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3468999999999999999999999999999999997542 346789999999996 99999999999754 56
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCC-ceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g-~lkl~DFGla~~~~~~ 166 (468)
+|+|||||.+++|.... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence 99999999999997653 5799999999999999999999999999999999999998655 699999999986543
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch-HHHHHHhhccccc---c--------
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKVSTFHF---L-------- 234 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~-~~~~~~~~~~~~~---~-------- 234 (468)
.......+||+.|+|||++.+...++.++||||+||++|+|++|..||.... .......+..... .
T Consensus 183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2335567899999999998877766799999999999999999999996543 2221111110000 0
Q ss_pred cccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccccc
Q 012228 235 SVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 298 (468)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~ 298 (468)
......+.......................+|+++.+||++||++||++|||++|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0000000000000000000000011122337899999999999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=413.70 Aligned_cols=249 Identities=23% Similarity=0.394 Sum_probs=217.8
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIVL 92 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 92 (468)
.+|+++++||+|+||+||+|++ .++..||||++++.... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 5789999999999999999998 47889999999875443 246889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcCCc
Q 012228 93 EFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 171 (468)
Q Consensus 93 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 171 (468)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Ccee
Confidence 99999999998655 456999999999999999999999999999999999999999999999999999865442 2223
Q ss_pred ccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcccccc
Q 012228 172 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKYSY 250 (468)
Q Consensus 172 ~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (468)
....+||+.|+|||++.+..|+ .++||||+||++|+|+| |..||.+.+..+...++..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-------------------- 216 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-------------------- 216 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT--------------------
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh--------------------
Confidence 3456799999999999988875 89999999999999998 8999999888877776422
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 251 TLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 251 ~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
......|...++++.+||.+||+.||++|||+++|++|
T Consensus 217 -----~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 217 -----GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 12344566789999999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-55 Score=431.08 Aligned_cols=281 Identities=25% Similarity=0.346 Sum_probs=218.0
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeC-----C
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASK-----T 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 86 (468)
-++|++++.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3689999999999999999999999999999999986543 333456788999999999999999999998643 3
Q ss_pred EEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 87 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
..+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 34566777789999998854 6799999999999999999999999999999999999999999999999999875432
Q ss_pred hcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 167 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 167 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
...+.+||+.|+|||++.+..+++.++||||+||++|+|++|.+||.+.+.......+...... ..........
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~--~~~~~~~~~~ 247 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT--PGAELLKKIS 247 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC--CCHHHHTTCC
T ss_pred ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC--CChHHhhhcc
Confidence 2456789999999999888887789999999999999999999999988876666555322111 0000000000
Q ss_pred ccc------cccccccccC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCCC
Q 012228 247 KYS------YTLQICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 301 (468)
Q Consensus 247 ~~~------~~~~~~~~~~-~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~~ 301 (468)
... .........+ .....+++++++||++||+.||.+|||++|+|+||||++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 000 0000000000 012347899999999999999999999999999999987543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=413.66 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=203.0
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCC---CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIY 89 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 89 (468)
++|++++.||+|+||+||+|++..++ ..||||.++... .....+.+.+|+.+|+.++|||||++++++. .+.+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 57999999999999999999987543 468888885432 3445678899999999999999999999985 56789
Q ss_pred EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhc
Q 012228 90 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE 168 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~ 168 (468)
+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~-~ 162 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-T 162 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-c
Confidence 999999999999987654 46999999999999999999999999999999999999999999999999999865432 2
Q ss_pred CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhccc
Q 012228 169 DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 169 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.......+||+.|+|||++.+..| +.++||||+||++|+|++ |.+||...+..+....+.
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~------------------ 223 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------------------ 223 (273)
T ss_dssp --------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------------------
T ss_pred ceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH------------------
Confidence 223345678999999999988777 489999999999999997 899999887766666542
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.....+.|+.+|+++.+||.+||+.||++|||++|+++|
T Consensus 224 -------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 224 -------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 122345677799999999999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=429.56 Aligned_cols=282 Identities=25% Similarity=0.393 Sum_probs=208.7
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe------
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS------ 84 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 84 (468)
.+.+|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 55789999999999999999999999999999999986543 33456678999999999999999999999953
Q ss_pred CCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhh
Q 012228 85 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 164 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~ 164 (468)
.+++|+|||||.++ +++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 47899999999774 55554 3579999999999999999999999999999999999999999999999999987554
Q ss_pred hhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccc---ccc---c
Q 012228 165 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFL---SVY---G 238 (468)
Q Consensus 165 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~---~~~---~ 238 (468)
. .......+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+......++...... ..+ .
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 171 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred c---ccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 3 233456789999999999998777 58999999999999999999999988766555544321110 000 0
Q ss_pred cchhhhcccc-cc-----ccccccc----cCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccccCC
Q 012228 239 ESYKKCTNKY-SY-----TLQICRA----DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 300 (468)
Q Consensus 239 ~~~~~~~~~~-~~-----~~~~~~~----~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hpwf~~~~ 300 (468)
.......... .. ....... ....+...|+++.+||++||..||++||||+|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0000000000 00 0000000 0001112477899999999999999999999999999998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-54 Score=410.38 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=209.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKIYIV 91 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 91 (468)
.++|++++.||+|+||+||+|+++.+ +.||||++...... .+.+.+|+.+|++++|||||++++++.+ +.+|+|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 47899999999999999999999654 57999999765432 3568899999999999999999999854 568999
Q ss_pred EEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC
Q 012228 92 LEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 169 (468)
||||++|+|..++.. ...+++.++..++.||+.||+|||++||+||||||+|||+|.++++||+|||+|+...... .
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~ 168 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y 168 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC-c
Confidence 999999999988754 3579999999999999999999999999999999999999999999999999998654321 2
Q ss_pred CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCchHHHHHHhhcccccccccccchhhhcccc
Q 012228 170 GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKVSTFHFLSVYGESYKKCTNKY 248 (468)
Q Consensus 170 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (468)
......+||+.|+|||++.+..+ +.++||||+||++|+|++| .+||......+....+.
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~------------------- 228 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------------------- 228 (285)
T ss_dssp -------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------------------
T ss_pred eeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------------------
Confidence 23345679999999999988777 5899999999999999995 56666676666666542
Q ss_pred ccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc--CcccccC
Q 012228 249 SYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE--DEWFKKG 299 (468)
Q Consensus 249 ~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~--hpwf~~~ 299 (468)
.......++.+|+++.+||.+||+.||++|||++++++ |+||+..
T Consensus 229 ------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 229 ------RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ------hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 12234567778999999999999999999999999988 8898754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-54 Score=418.04 Aligned_cols=253 Identities=21% Similarity=0.342 Sum_probs=207.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCC----EEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGD----FVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
.+|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+|++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 579999999999999999999988876 47888775432 222356789999999999999999999999865 56
Q ss_pred EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+++|||+.+|+|.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 7888999999999887764 579999999999999999999999999999999999999999999999999998765433
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
.........||+.|+|||++.+..| +.++||||+||++|+|+| |.+||.+.+..++...+.
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~----------------- 227 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------------- 227 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-----------------
T ss_pred ccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----------------
Confidence 3333444568999999999988777 589999999999999998 899998876655554431
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 294 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~hp 294 (468)
.......|+.+++++.+|+.+||..||.+|||+.|+++|.
T Consensus 228 --------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 228 --------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp --------HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 1223456677899999999999999999999999999984
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=406.93 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=205.4
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCC----CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETG----DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
...|++.+.||+|+||+||+|.++.++ ..||||++.... .......+.+|+.+|++++|||||++++++.+.+.
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 357999999999999999999987654 369999996543 23345678899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhh
Q 012228 88 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 166 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~ 166 (468)
+++|||||.+|++.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999999987655 57999999999999999999999999999999999999999999999999999875442
Q ss_pred hcC-CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCchHHHHHHhhcccccccccccchhhh
Q 012228 167 RED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKVSTFHFLSVYGESYKKC 244 (468)
Q Consensus 167 ~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (468)
... ......+||+.|+|||++.+..|. .++||||+||++|||++| .+||...+..+.++.+.
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~--------------- 227 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN--------------- 227 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---------------
T ss_pred CccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh---------------
Confidence 221 223345789999999999887774 899999999999999985 55666666666665532
Q ss_pred ccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 245 TNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.....+.|..++..+.+||.+||+.||++|||+.|+++
T Consensus 228 ----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 228 ----------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ----------TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 12234556668999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-53 Score=410.83 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=216.9
Q ss_pred cCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTK 87 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 87 (468)
++|++++.||+|+||+||+|+.+ .+++.||||+++... .....+.+.+|+.+|+.++||||+++++++...+.
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 57999999999999999999975 356789999997543 23346778999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 012228 88 IYIVLEFIDGGELFDKIAKHG------------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 143 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~N 143 (468)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 999999999999999986532 38899999999999999999999999999999999
Q ss_pred eeeccCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCC-CCCCCchHH
Q 012228 144 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF-LPFDESNLM 222 (468)
Q Consensus 144 ILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~-~Pf~~~~~~ 222 (468)
||+|.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||++|+|++|. +||.+.+..
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 99999999999999999876555444455677899999999999988775 8999999999999999985 789988888
Q ss_pred HHHHhhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 223 ALYRKVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
+....+.. ......|..+|+++.+||.+||+.||++|||+.|+++
T Consensus 250 e~~~~v~~-------------------------~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 250 EVIYYVRD-------------------------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHT-------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHc-------------------------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77766422 1223456678999999999999999999999999964
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=411.49 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=201.4
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcC-----CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeC-
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK- 85 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~- 85 (468)
++|++++.||+|+||+||+|.+.. +++.||||++..... ....+.+.+|+.++.++ +||||+.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 679999999999999999999754 446899999875432 23355677888877766 689999999987654
Q ss_pred CEEEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccC
Q 012228 86 TKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 149 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~ 149 (468)
..+|+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 5689999999999999999754 248999999999999999999999999999999999999999
Q ss_pred CceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCchHHHHHHhh
Q 012228 150 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKV 228 (468)
Q Consensus 150 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g-~~Pf~~~~~~~~~~~~ 228 (468)
+++||+|||+|+..............+||+.|+|||++.+..| +.++||||+||++|+|++| .+||.+.+..+.+...
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999986554433344556789999999999988777 5999999999999999986 5688765433322221
Q ss_pred cccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 229 STFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
. .....+..|..+++++.+||.+||+.||++|||++|+++|
T Consensus 250 ~------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 L------------------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp H------------------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H------------------------hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 1122345667789999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=409.91 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=212.8
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCE--EEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeCCEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDF--VAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 88 (468)
.++|++.+.||+|+||+||+|.++.+|.. ||||.+.... .....+.+.+|+.+|+++ +|||||++++++.+.+.+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 46999999999999999999999888875 6777765432 223456789999999999 799999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCce
Q 012228 89 YIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVL 152 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~l 152 (468)
|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 9999999999999999754 569999999999999999999999999999999999999999999
Q ss_pred EEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCchHHHHHHhhccc
Q 012228 153 KISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKVSTF 231 (468)
Q Consensus 153 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g-~~Pf~~~~~~~~~~~~~~~ 231 (468)
||+|||+|+..... ......+||+.|+|||.+.+..| +.++|||||||++|+|++| .+||.+.+..+++..+..
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~- 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ- 241 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-
Confidence 99999999754332 22345679999999999988777 5899999999999999996 568988888888776421
Q ss_pred ccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 232 HFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
...+..|..+++++.+||.+||+.||++|||++++++|
T Consensus 242 ------------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 ------------------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp ------------------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22345667789999999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=408.38 Aligned_cols=253 Identities=26% Similarity=0.460 Sum_probs=215.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCC-------CEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETG-------DFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMA 83 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~ 83 (468)
.++|++++.||+|+||.||+|++..++ ..||||+++++.. ......+.+|...+.++ +|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 478999999999999999999986554 3699999976542 33456788898888888 7999999999999
Q ss_pred eCCEEEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 012228 84 SKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 147 (468)
Q Consensus 84 ~~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~ 147 (468)
+++.+|+|||||++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 9999999999999999999997553 489999999999999999999999999999999999999
Q ss_pred cCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHH
Q 012228 148 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 226 (468)
Q Consensus 148 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~ 226 (468)
.++.+||+|||+++..............+||+.|+|||++.+..| +.++||||+||++|+|++ |.+||.+.+..+.+.
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 999999999999987765544445566789999999999988777 599999999999999997 799999888877766
Q ss_pred hhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 227 KVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.+. ....+..|.++|+++.+||.+||+.||++|||+.|+++
T Consensus 249 ~i~-------------------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 249 LLK-------------------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHH-------------------------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH-------------------------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 542 22345667789999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=405.05 Aligned_cols=255 Identities=26% Similarity=0.406 Sum_probs=203.8
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcC-CC--CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCCEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVE-TG--DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKTKI 88 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~-~~--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 88 (468)
-++|++.+.||+|+||+||+|+... ++ ..||||++.+.........+.+.+|+.+|+.++|||||++++++.+ ..+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3679999999999999999998653 33 3689999987655555567789999999999999999999999976 467
Q ss_pred EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 89 YIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
|+|||||++|++.+.+... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 8999999999999877654 469999999999999999999999999999999999999999999999999998654432
Q ss_pred cCC-cccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhc
Q 012228 168 EDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCT 245 (468)
Q Consensus 168 ~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (468)
... .....+||+.|+|||++.+..+ +.++||||+||++|||++ |..||.+.+..+....+..
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~--------------- 229 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--------------- 229 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---------------
T ss_pred CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh---------------
Confidence 222 2334568889999999988766 589999999999999998 8999999888877766421
Q ss_pred cccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 246 NKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
....++.++.+|+++.+||.+||+.||++|||+++|++
T Consensus 230 ---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 230 ---------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ---------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11233456678999999999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-53 Score=399.18 Aligned_cols=245 Identities=27% Similarity=0.470 Sum_probs=204.5
Q ss_pred cccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-CCEEE
Q 012228 11 RVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-KTKIY 89 (468)
Q Consensus 11 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~ 89 (468)
..++|++++.||+|+||.||+|++ +|..||||+++.+. ..+.+.+|+.++++++||||+++++++.+ .+.+|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 457899999999999999999998 47889999997543 24568899999999999999999998854 56789
Q ss_pred EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhh
Q 012228 90 IVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 90 lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~ 167 (468)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC--
Confidence 9999999999999987654 489999999999999999999999999999999999999999999999999875432
Q ss_pred cCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHHhhcccccccccccchhhhcc
Q 012228 168 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKVSTFHFLSVYGESYKKCTN 246 (468)
Q Consensus 168 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (468)
...+.++|+.|+|||++.+..+ +.++||||+||++|||++ |.+||...+..+....+.
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~----------------- 214 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----------------- 214 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-----------------
T ss_pred ---CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----------------
Confidence 2345678999999999988777 599999999999999998 799998877666655542
Q ss_pred ccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 247 KYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.......|+.+++++.+||++||+.||.+|||+.+++++
T Consensus 215 --------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 215 --------KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 123445677789999999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=404.77 Aligned_cols=259 Identities=21% Similarity=0.282 Sum_probs=221.9
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcC-----CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVE-----TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT 86 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 86 (468)
-++|++++.||+|+||+||+|.+.. ++..||||+++... .......+.+|+.++++++||||+++++++..++
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 3789999999999999999999853 45789999997543 2334567899999999999999999999999999
Q ss_pred EEEEEEEccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEec
Q 012228 87 KIYIVLEFIDGGELFDKIAKH----------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 156 (468)
Q Consensus 87 ~~~lV~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~D 156 (468)
..++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 999999999999999988653 2468899999999999999999999999999999999999999999999
Q ss_pred cccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhC-CCCCCCchHHHHHHhhccccccc
Q 012228 157 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKVSTFHFLS 235 (468)
Q Consensus 157 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g-~~Pf~~~~~~~~~~~~~~~~~~~ 235 (468)
||+|+..............+||+.|+|||.+.+..+. .++||||+||++|+|++| .+||.+.+..+.+..+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~------ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------ 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH------
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------
Confidence 9999876554433334456789999999999887774 899999999999999998 68899888887776642
Q ss_pred ccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc------Cccccc
Q 012228 236 VYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE------DEWFKK 298 (468)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~------hpwf~~ 298 (468)
.......|..+|+.+.+||.+||+.||++|||++++++ +|+|++
T Consensus 250 -------------------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 250 -------------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp -------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred -------------------hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 12334556778999999999999999999999999998 566653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-52 Score=402.20 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=213.6
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEc-----CCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEEeC
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNV-----ETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLI-KHPNVIKIIEVMASK 85 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 85 (468)
.++|++++.||+|+||+||+|+.. .+++.||||++..... ......+.+|+.+++.+ +|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 378999999999999999999863 4667899999976542 33456788999999999 699999999999999
Q ss_pred CEEEEEEEccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec
Q 012228 86 TKIYIVLEFIDGGELFDKIAKHG------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 147 (468)
Q Consensus 86 ~~~~lV~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~ 147 (468)
+.+|+|||||++|+|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999987643 589999999999999999999999999999999999999
Q ss_pred cCCceEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhh-CCCCCCCchHHHHHH
Q 012228 148 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 226 (468)
Q Consensus 148 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~-g~~Pf~~~~~~~~~~ 226 (468)
.++.+||+|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||...+..+.+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999987654333334455789999999999987666 589999999999999998 677776655433333
Q ss_pred hhcccccccccccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 227 KVSTFHFLSVYGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
.+. ........|..+|+.+.+||.+||+.||++|||+++|++
T Consensus 259 ~~i------------------------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMI------------------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHH------------------------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH------------------------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 221 112233455668999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=387.32 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=203.2
Q ss_pred EEEeeeeecCCeEEEEEEEcCCC---CEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEe-CCEEEEE
Q 012228 16 ELGRTLGEGSFAKVKFAKNVETG---DFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMAS-KTKIYIV 91 (468)
Q Consensus 16 ~i~~~LG~G~~g~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV 91 (468)
.+.++||+|+||+||+|++..++ ..||||.+++.. .....+.+.+|+++|++++|||||++++++.. +...|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 44689999999999999986543 369999987532 34456789999999999999999999999765 5689999
Q ss_pred EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEeccccchhhhhhhcC-
Q 012228 92 LEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED- 169 (468)
Q Consensus 92 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGla~~~~~~~~~- 169 (468)
||||++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999999887544 5778899999999999999999999999999999999999999999999999865432221
Q ss_pred -CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCc-hHHHHHHhhcccccccccccchhhhccc
Q 012228 170 -GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKVSTFHFLSVYGESYKKCTNK 247 (468)
Q Consensus 170 -~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (468)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||... +..+....+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i------------------- 247 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------------------- 247 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH-------------------
T ss_pred ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH-------------------
Confidence 12334578999999999988777 59999999999999999977777543 332222221
Q ss_pred cccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 248 YSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
........|..+++++.+||.+||+.||++|||+.|+++|
T Consensus 248 ------~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 248 ------LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------HcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1122345667789999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-50 Score=388.21 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=204.3
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCC-eeEEEEEEEeCCEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPN-VIKIIEVMASKTKIYIV 91 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV 91 (468)
++|++++.||+|+||+||+|++..+|+.||||++...... +.+.+|+++++.++|+| |+.+..++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 4799999999999999999999999999999998764322 34678999999998665 56666777888999999
Q ss_pred EEccCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeec---cCCceEEeccccchhhhhhh
Q 012228 92 LEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGLSAISQQVR 167 (468)
Q Consensus 92 ~E~~~gg~L~~~i-~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~---~~g~lkl~DFGla~~~~~~~ 167 (468)
|||+.+ +|.+.+ ...+.+++..+..++.|++.||+|||++||+||||||+|||++ .+..+||+|||+|+......
T Consensus 82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 999965 555554 4456799999999999999999999999999999999999975 45579999999998764422
Q ss_pred cC-----CcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccccccccccchh
Q 012228 168 ED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFHFLSVYGESYK 242 (468)
Q Consensus 168 ~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (468)
.. ....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||...........+......
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-------- 231 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-------- 231 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH--------
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc--------
Confidence 21 12345689999999999998887 58999999999999999999999876543332221100000
Q ss_pred hhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHH---HHhcCcccccCCC
Q 012228 243 KCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS---QMLEDEWFKKGYK 301 (468)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~---eil~hpwf~~~~~ 301 (468)
. ........+..+|+++.+|+.+||+.||++|||++ ++|+|+|.+....
T Consensus 232 ~----------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 232 K----------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp H----------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred c----------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 0 00000112345789999999999999999999987 5578888776543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-48 Score=375.28 Aligned_cols=253 Identities=19% Similarity=0.273 Sum_probs=205.3
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC-CCeeEEEEEEEeCCEEEE
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-PNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~l 90 (468)
-++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.|.| +||+.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4689999999999999999999999999999999865432 2346789999999975 899999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeecc-----CCceEEeccccchhhh
Q 012228 91 VLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-----YGVLKISDFGLSAISQ 164 (468)
Q Consensus 91 V~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~-----~g~lkl~DFGla~~~~ 164 (468)
||||| |++|.+.+...+ .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 579999887654 6999999999999999999999999999999999999974 5789999999998754
Q ss_pred hhhc-----CCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCch---HHHHHHhhcccccccc
Q 012228 165 QVRE-----DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKVSTFHFLSV 236 (468)
Q Consensus 165 ~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~---~~~~~~~~~~~~~~~~ 236 (468)
.... .....+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+ ....+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~---- 232 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---- 232 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH----
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc----
Confidence 3221 123445689999999999998777 589999999999999999999997543 222222221100
Q ss_pred cccchhhhccccccccccccccCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 012228 237 YGESYKKCTNKYSYTLQICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 292 (468)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R~t~~eil~ 292 (468)
........++.+|+++.+++..|+..+|++||+.+.+.+
T Consensus 233 -----------------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 233 -----------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -----------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 000000122347889999999999999999999877754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=375.53 Aligned_cols=266 Identities=20% Similarity=0.272 Sum_probs=193.6
Q ss_pred ccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEeCC----E
Q 012228 12 VGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKHPNVIKIIEVMASKT----K 87 (468)
Q Consensus 12 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 87 (468)
..+|.+.+.||+|+||.||+|+. +|+.||||+++..... ......|+..++.++|||||++++++.+.+ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 45799999999999999999987 6899999999754321 122345666677889999999999987654 6
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCCeeeccCCceEEecccc
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS--------RGVFHRDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~--------~givHrDlKp~NILl~~~g~lkl~DFGl 159 (468)
+|+|||||++|+|.+++.. ..++++....++.|++.||+|||+ +||+||||||+|||++.+|.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 8999999999999999976 479999999999999999999996 5999999999999999999999999999
Q ss_pred chhhhhhhc--CCcccccCCCCCcCCccccccCCC-----CCChhhHHHHHHHHHHHhhCCCCCCCchHHHHHHhhcccc
Q 012228 160 SAISQQVRE--DGLLHTACGTPNYVAPEVLNDKGY-----DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKVSTFH 232 (468)
Q Consensus 160 a~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~~~~~~~~~~ 232 (468)
++....... .......+||+.|+|||++.+... .+.++|||||||+||+|++|..||...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~----- 229 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY----- 229 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-----
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-----
Confidence 986543221 123345789999999999876432 24689999999999999999988854221100000
Q ss_pred cccccccchhhhccccccccccccccCCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 012228 233 FLSVYGESYKKCTNKYSYTLQICRADFSCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLED 293 (468)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~s~~~~~Ll~~~L~~dP~~R~t~~eil~h 293 (468)
.............. ..........+|.. .+..+.+|+.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~----~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 230 DLVPSDPSVEEMRK----VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTSCSSCCHHHHHH----HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hcccccchHHHHHH----HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00000000000000 00000011111111 23458899999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-48 Score=382.90 Aligned_cols=274 Identities=23% Similarity=0.396 Sum_probs=200.3
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-----------CCCeeEEEEE
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-----------HPNVIKIIEV 81 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----------hpnIv~l~~~ 81 (468)
++|++++.||+|+||+||+|+++.+|+.||||+++++.. ..+.+.+|+.+++.++ ||||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 579999999999999999999999999999999986542 2356678898888775 5889999988
Q ss_pred EE--eCCEEEEEEEccCCCCHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeeccCCc----
Q 012228 82 MA--SKTKIYIVLEFIDGGELFD---KIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGV---- 151 (468)
Q Consensus 82 ~~--~~~~~~lV~E~~~gg~L~~---~i~~~~~l~e~~~~~~~~qll~~l~yLH~-~givHrDlKp~NILl~~~g~---- 151 (468)
+. .....+++|+++..+.... .......+++..++.++.|++.||+|||+ +||+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 74 4567788888776544322 22334579999999999999999999998 89999999999999987664
Q ss_pred --eEEeccccchhhhhhhcCCcccccCCCCCcCCccccccCCCCCChhhHHHHHHHHHHHhhCCCCCCCchHHH------
Q 012228 152 --LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA------ 223 (468)
Q Consensus 152 --lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiWSlGvil~~ll~g~~Pf~~~~~~~------ 223 (468)
+|++|||.|..... .....+||+.|+|||++.+..|+ .++||||+||++++|++|..||...+...
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 99999999875432 23567899999999999988885 89999999999999999999997543211
Q ss_pred -HHHhhcccccccccccchh-------hhccccccc-----------cccccccCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 012228 224 -LYRKVSTFHFLSVYGESYK-------KCTNKYSYT-----------LQICRADFSCPSWFSSGAKKLIKRILDPNPDTR 284 (468)
Q Consensus 224 -~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-----------~~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R 284 (468)
+...+. ..+....... ......... ..........+...++++.+||.+||++||.+|
T Consensus 243 ~~~~~~~---~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 243 HIAQIIE---LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHH---HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHH---HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 111100 0000000000 000000000 000111222333457889999999999999999
Q ss_pred CCHHHHhcCcccccC
Q 012228 285 MTISQMLEDEWFKKG 299 (468)
Q Consensus 285 ~t~~eil~hpwf~~~ 299 (468)
||++|+|+||||++.
T Consensus 320 pta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 320 ADAGGLVNHPWLKDT 334 (362)
T ss_dssp BCHHHHHTCGGGTTC
T ss_pred cCHHHHhcCcccCCC
Confidence 999999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1e-26 Score=208.29 Aligned_cols=136 Identities=20% Similarity=0.270 Sum_probs=109.7
Q ss_pred eEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhh---------------hHHHHHHHHHHHHHHhcCCCCCeeEEE
Q 012228 15 YELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVL---------------RHKMVEQIKREISTMKLIKHPNVIKII 79 (468)
Q Consensus 15 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~---------------~~~~~~~i~~Ei~il~~l~hpnIv~l~ 79 (468)
|.++++||+|+||+||+|++. +|+.||||+++..... .........+|..++..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999984 7899999987532110 011234566899999999999999988
Q ss_pred EEEEeCCEEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeeccCCceEEecccc
Q 012228 80 EVMASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 159 (468)
Q Consensus 80 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~~givHrDlKp~NILl~~~g~lkl~DFGl 159 (468)
++.. .+++|||++++.+. .+++..+..++.|++.||+|||++||+||||||+|||++++ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 7642 27999999986542 35667788999999999999999999999999999999965 589999999
Q ss_pred chhh
Q 012228 160 SAIS 163 (468)
Q Consensus 160 a~~~ 163 (468)
|...
T Consensus 149 a~~~ 152 (191)
T d1zara2 149 SVEV 152 (191)
T ss_dssp CEET
T ss_pred cccC
Confidence 8654
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.46 E-value=1.3e-13 Score=107.16 Aligned_cols=88 Identities=16% Similarity=0.260 Sum_probs=80.5
Q ss_pred cceeeecCChhHHHHHHHHHhcccCceEEe-cCceeEEeeccCCCCCceEEEEEEEEEe-CCeEEEEEEEcCCCchhHHH
Q 012228 366 ETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVA-PTLHIVEVRKTGGDTLEFHK 443 (468)
Q Consensus 366 ~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~vdf~~~~Gd~le~~~ 443 (468)
....+|..||++|+.+|++|++.+|+.|++ ++|.++.+...++.++.+.|.+||+++. +++++|+|+|.+||.++|++
T Consensus 12 sv~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~ 91 (102)
T d1ul7a_ 12 SMKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKN 91 (102)
T ss_dssp CCCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHH
T ss_pred eeecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHH
Confidence 445679999999999999999999999976 4699999998888899999999999995 79999999999999999999
Q ss_pred HHHHHHhccc
Q 012228 444 FYKKFSSGLK 453 (468)
Q Consensus 444 ~~~~~~~~l~ 453 (468)
++.+|...|+
T Consensus 92 l~~~il~~l~ 101 (102)
T d1ul7a_ 92 IASKIANELK 101 (102)
T ss_dssp HHHHHHHHCC
T ss_pred HHHHHHHhcc
Confidence 9999988775
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.69 E-value=3.7e-08 Score=79.21 Aligned_cols=73 Identities=18% Similarity=0.343 Sum_probs=63.6
Q ss_pred eeeecCChhHHHHHHHHHhcccCceEEe-cCceeEEeeccCCCCCceEEEEEEEEEeCCeEEEEEEEcCCCchh
Q 012228 368 RFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLE 440 (468)
Q Consensus 368 rf~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le 440 (468)
.+.|...|.+||..|..|++.||+.|++ +.|.|++++........+.|.+++|+++++.|||||++..|+-.|
T Consensus 4 GIrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 4 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp SEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ccccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 4568889999999999999999999986 679999998866666788999999999999999999999998655
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.61 E-value=6.6e-08 Score=88.39 Aligned_cols=144 Identities=18% Similarity=0.158 Sum_probs=99.9
Q ss_pred CccccCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeCCE
Q 012228 9 RTRVGKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASKTK 87 (468)
Q Consensus 9 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 87 (468)
...++.|+..+..+-++.+.||+.. .++..+.+|+....... ....+.+|...++.|. +--+.+++.+..+++.
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 3456789988887667778999876 35667888987643221 1234668888887764 3335677788888899
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 012228 88 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS------------------------------------ 131 (468)
Q Consensus 88 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH~------------------------------------ 131 (468)
.|+||++++|..+.+.... ......+..++...+..||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 9999999999777554321 11223334455555555553
Q ss_pred -----------------------CCccccCCCCCCeeeccCCceEEeccccchh
Q 012228 132 -----------------------RGVFHRDLKPENLLLDSYGVLKISDFGLSAI 162 (468)
Q Consensus 132 -----------------------~givHrDlKp~NILl~~~g~lkl~DFGla~~ 162 (468)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1378999999999999866667999998753
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=98.29 E-value=1.4e-06 Score=68.52 Aligned_cols=89 Identities=15% Similarity=0.230 Sum_probs=67.6
Q ss_pred ccceeeecCChhHHHHHHHHHhcccCceEEecC----------ceeEEeeccC-----CCCCceEEEEEEEEEeCCeEEE
Q 012228 365 RETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGN----------YKMKLQGDKT-----GRKGQLSVATEVFEVAPTLHIV 429 (468)
Q Consensus 365 ~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~----------~~~~~~~~~~-----~~~~~l~~~~~i~~~~~~~~~v 429 (468)
..-..-|...|.+||..|..|+++||+.|++.+ +.|+++...+ .....+.|.+++|+++++.+||
T Consensus 3 WhfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLl 82 (127)
T d2qrda1 3 WHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFML 82 (127)
T ss_dssp CEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEE
T ss_pred ceeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEE
Confidence 344567899999999999999999999998643 6788876422 2234578899999999999999
Q ss_pred EEE-----EcCC--------------CchhHHHHHHHHHhccc
Q 012228 430 EVR-----KTGG--------------DTLEFHKFYKKFSSGLK 453 (468)
Q Consensus 430 df~-----~~~G--------------d~le~~~~~~~~~~~l~ 453 (468)
||+ .+.| .+.+|-.++.+|--.|.
T Consensus 83 DFK~dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~ 125 (127)
T d2qrda1 83 DVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 125 (127)
T ss_dssp EEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EEccCCcccccCCccccccCccccccCCccHHHHHHHHHHHHh
Confidence 997 2222 24678888877665553
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.12 E-value=3.3e-06 Score=76.27 Aligned_cols=134 Identities=16% Similarity=0.205 Sum_probs=85.3
Q ss_pred ccCeEEEeeeeecC-CeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC--CCCeeEEEEEEEeCCEE
Q 012228 12 VGKYELGRTLGEGS-FAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK--HPNVIKIIEVMASKTKI 88 (468)
Q Consensus 12 ~~~y~i~~~LG~G~-~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--hpnIv~l~~~~~~~~~~ 88 (468)
+..++.... ..|. -+.||+... ..+..+.+|...... ...+..|...|+.|. .-.+.+++.+..+++..
T Consensus 10 l~g~~~~~~-~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~ 81 (255)
T d1nd4a_ 10 LFGYDWAQQ-TIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 81 (255)
T ss_dssp TTTCEEEEC-SCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred ccCCceEEc-CCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccce
Confidence 344555433 4444 468998876 457778889865432 224667888887774 33366778888888899
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 012228 89 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH-------------------------------------- 130 (468)
Q Consensus 89 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~~l~yLH-------------------------------------- 130 (468)
++||++++|.++.+. ..+... ...++...|.-||
T Consensus 82 ~~v~~~i~G~~~~~~-----~~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (255)
T d1nd4a_ 82 WLLLGEVPGQDLLSS-----HLAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 153 (255)
T ss_dssp EEEEECCSSEETTTS-----CCCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEeeeccccccc-----cccHHH---HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence 999999988554220 111111 1122222222233
Q ss_pred -------------hC-------CccccCCCCCCeeeccCCceEEeccccch
Q 012228 131 -------------SR-------GVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 131 -------------~~-------givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
+. .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 21 37999999999999987667899999764
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=98.03 E-value=7.6e-06 Score=67.69 Aligned_cols=71 Identities=18% Similarity=0.236 Sum_probs=54.3
Q ss_pred ccccceeeecCChhHHHHHHHHHhcccCceEEec----CceeEEeeccC---------CCCCceEEEEEEEEEeCCeEEE
Q 012228 363 VKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKG----NYKMKLQGDKT---------GRKGQLSVATEVFEVAPTLHIV 429 (468)
Q Consensus 363 ~~~~~rf~s~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~---------~~~~~l~~~~~i~~~~~~~~~v 429 (468)
.++.-..-|..+|.+||..|..|++.||+.|++. .|.|++++..+ .....+.|.+++|+++++.+||
T Consensus 44 ~kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLl 123 (171)
T d2qlva1 44 TRWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLV 123 (171)
T ss_dssp CCCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEE
T ss_pred ceeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEE
Confidence 3567788899999999999999999999999864 38888876422 1123478999999999999999
Q ss_pred EEEE
Q 012228 430 EVRK 433 (468)
Q Consensus 430 df~~ 433 (468)
||+-
T Consensus 124 DFK~ 127 (171)
T d2qlva1 124 DFKF 127 (171)
T ss_dssp EEEE
T ss_pred EEec
Confidence 9973
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.01 E-value=4.6e-06 Score=80.75 Aligned_cols=81 Identities=16% Similarity=0.152 Sum_probs=49.7
Q ss_pred EeeeeecCCeEEEEEEEcCCCCEEEEEEeech-hhhhH---HHHHHHHHHHHHHhcCC-C--CCeeEEEEEEEeCCEEEE
Q 012228 18 GRTLGEGSFAKVKFAKNVETGDFVAIKIVDRD-QVLRH---KMVEQIKREISTMKLIK-H--PNVIKIIEVMASKTKIYI 90 (468)
Q Consensus 18 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~-~~~~~---~~~~~i~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 90 (468)
.+.||.|....||++.+..+++.+++|.-... ....+ -...+...|...|+.+. + ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 55789999999999998878889999964311 10000 01234567888887663 2 345566654 4455578
Q ss_pred EEEccCCCCH
Q 012228 91 VLEFIDGGEL 100 (468)
Q Consensus 91 V~E~~~gg~L 100 (468)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.11 E-value=0.00051 Score=63.99 Aligned_cols=67 Identities=12% Similarity=0.140 Sum_probs=43.4
Q ss_pred eEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCCC-----CCeeEE--EEEEEeCCEEEEEEEccCCC
Q 012228 27 AKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIKH-----PNVIKI--IEVMASKTKIYIVLEFIDGG 98 (468)
Q Consensus 27 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-----pnIv~l--~~~~~~~~~~~lV~E~~~gg 98 (468)
-.||++.. .+|+.|++|+.+..... .+++..|...+..|.. +..+.. -..+......+.++++++|.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 47999987 57889999998654221 3557788888877642 111111 01234567789999999873
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.76 E-value=0.0019 Score=61.64 Aligned_cols=76 Identities=11% Similarity=0.082 Sum_probs=50.1
Q ss_pred CeEEEeeeeecCCeEEEEEEEcC-------CCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEeC
Q 012228 14 KYELGRTLGEGSFAKVKFAKNVE-------TGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-HPNVIKIIEVMASK 85 (468)
Q Consensus 14 ~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~ 85 (468)
..+ ++.|+.|-.=.+|++.... .++.|.+++..... . .-...+|..+++.+. +.-..++++++.+
T Consensus 44 ~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred ceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 344 4677778888999998753 34568888865221 1 123558999998885 4334577777643
Q ss_pred CEEEEEEEccCCCC
Q 012228 86 TKIYIVLEFIDGGE 99 (468)
Q Consensus 86 ~~~~lV~E~~~gg~ 99 (468)
.+|+||++|..
T Consensus 117 ---g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 ---GRLEEYIPSRP 127 (395)
T ss_dssp ---EEEECCCCEEE
T ss_pred ---ceEEEEecccc
Confidence 67999998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.05 E-value=0.018 Score=52.52 Aligned_cols=142 Identities=14% Similarity=0.139 Sum_probs=75.1
Q ss_pred cCeEEEeeeeecCCeEEEEEEEcCCCCEEEEEEeechhhhhHHHHHHHHHHHHHHhcCC-----CCCeeEEE---EEEEe
Q 012228 13 GKYELGRTLGEGSFAKVKFAKNVETGDFVAIKIVDRDQVLRHKMVEQIKREISTMKLIK-----HPNVIKII---EVMAS 84 (468)
Q Consensus 13 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----hpnIv~l~---~~~~~ 84 (468)
|+..-.+.|..|.--+.|+.... +| .+++|+..... ..+.+..|+.+|..|. .|..+... .+..-
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~ 90 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 90 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCCCcceee
Confidence 44444455667777788988763 34 58999986432 1234566777777764 22222211 01223
Q ss_pred CCEEEEEEEccCCCCHH--------------HHHHhc---C------CCC------------------HHHHHHHHHHHH
Q 012228 85 KTKIYIVLEFIDGGELF--------------DKIAKH---G------RLK------------------EDEARRYFQQLI 123 (468)
Q Consensus 85 ~~~~~lV~E~~~gg~L~--------------~~i~~~---~------~l~------------------e~~~~~~~~qll 123 (468)
......++.+..|.... ..+... . ... .......+..+.
T Consensus 91 ~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 170 (316)
T d2ppqa1 91 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 170 (316)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred ecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHH
Confidence 45566677776653220 000000 0 000 011122222333
Q ss_pred HHHHHHHh----CCccccCCCCCCeeeccCCceEEeccccch
Q 012228 124 NAVDYCHS----RGVFHRDLKPENLLLDSYGVLKISDFGLSA 161 (468)
Q Consensus 124 ~~l~yLH~----~givHrDlKp~NILl~~~g~lkl~DFGla~ 161 (468)
..+.-.+. .|++|+|+.++||+++++...-|.||+.|.
T Consensus 171 ~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 171 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 33333332 479999999999999988878899999875
|